PT J
AU Madreiter-Sokolowski, CT
   Sokolowski, AA
   Waldeck-Weiermair, M
   Malli, R
   Graier, WF
AF Madreiter-Sokolowski, Corina T.
   Sokolowski, Armin A.
   Waldeck-Weiermair, Markus
   Malli, Roland
   Graier, Wolfgang F.
TI Targeting Mitochondria to Counteract Age-Related Cellular Dysfunction
SO GENES
LA English
DT Review
DE mitochondria; aging; caloric restriction; exercise; caloric restriction mimetics; polyphenols; aspirin
ID nonsteroidal antiinflammatory drugs; operated ca2+ entry; increase life-span; oxidative stress; skeletal-muscle; endoplasmic-reticulum; calorie restriction; dna deletions; drosophila-melanogaster; cardiovascular-disease
AB Senescence is related to the loss of cellular homeostasis and functions, which leads to a progressive decline in physiological ability and to aging-associated diseases. Since mitochondria are essential to energy supply, cell differentiation, cell cycle control, intracellular signaling and Ca2+ sequestration, fine-tuning mitochondrial activity appropriately, is a tightrope walk during aging. For instance, the mitochondrial oxidative phosphorylation (OXPHOS) ensures a supply of adenosine triphosphate (ATP), but is also the main source of potentially harmful levels of reactive oxygen species (ROS). Moreover, mitochondrial function is strongly linked to mitochondrial Ca2+ homeostasis and mitochondrial shape, which undergo various alterations during aging. Since mitochondria play such a critical role in an organism's process of aging, they also offer promising targets for manipulation of senescent cellular functions. Accordingly, interventions delaying the onset of age-associated disorders involve the manipulation of mitochondrial function, including caloric restriction (CR) or exercise, as well as drugs, such as metformin, aspirin, and polyphenols. In this review, we discuss mitochondria's role in and impact on cellular aging and their potential to serve as a target for therapeutic interventions against age-related cellular dysfunction.
C1 [Madreiter-Sokolowski, Corina T.; Waldeck-Weiermair, Markus; Malli, Roland; Graier, Wolfgang F.] Med Univ Graz, Gottfried Schatz Res Ctr, Mol Biol & Biochem, Neue Stiftingtalstr 6-6, A-8010 Graz, Austria.
   [Sokolowski, Armin A.] Med Univ Graz, Dept Dent & Maxillofacial Surg, Billrothgasse 4, A-8010 Graz, Austria.
   [Malli, Roland; Graier, Wolfgang F.] BioTechMed, Mozartgasse 12-2, A-8010 Graz, Austria.
C3 Medical University of Graz; Medical University of Graz
RP Madreiter-Sokolowski, CT; Graier, WF (corresponding author), Med Univ Graz, Gottfried Schatz Res Ctr, Mol Biol & Biochem, Neue Stiftingtalstr 6-6, A-8010 Graz, Austria.; Graier, WF (corresponding author), BioTechMed, Mozartgasse 12-2, A-8010 Graz, Austria.
EM corina.madreiter@medunigraz.at; armin.sokolowski@medunigraz.at; markus.weiermair@medunigraz.at; roland.malli@medunigraz.at; wolfgang.graier@medunigraz.at
FU Austrian Science Fund (FWF) [P28529] Funding Source: Austrian Science Fund (FWF)
CR Afshordel S, 2015, PROSTAG LEUKOTR ESS, V92, P23, DOI 10.1016/j.plefa.2014.05.008
   Alvarez-Illera P, 2017, ONCOTARGET, V8, P55889, DOI 10.18632/oncotarget.18600
   Amigo I, 2017, AGING CELL, V16, P73, DOI 10.1111/acel.12527
   Andrzejewski S, 2014, CANCER METAB, V2, P0, DOI 10.1186/2049-3002-2-12
   Babayev E, 2016, MATURITAS, V93, P121, DOI 10.1016/j.maturitas.2016.06.015
   Baker DJ, 2017, TRENDS BIOCHEM SCI, V42, P702, DOI 10.1016/j.tibs.2017.06.005
   Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Berman AY, 2017, NPJ PRECIS ONCOL, V1, P0, DOI 10.1038/s41698-017-0038-6
   Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200
   Brandt T, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.24662
   Brenmoehl J, 2013, MITOCHONDRION, V13, P755, DOI 10.1016/j.mito.2013.04.002
   Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620
   Brini M, 2011, COLD SPRING HARB PER, V3, P0, DOI 10.1101/CSHPERSPECT.A004168
   Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, PE108, DOI 10.1152/ajpendo.00524.2009
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Calvo-Rodríguez M, 2016, BBA-MOL CELL RES, V1863, P2637, DOI 10.1016/j.bbamcr.2016.08.001
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Cárdenas C, 2016, CELL REP, V14, P2313, DOI 10.1016/j.celrep.2016.02.030
   Cerella C, 2016, CURR DRUG TARGETS, V17, P405, DOI 10.2174/1389450116666150202155915
   Chacko BK, 2011, HEPATOLOGY, V54, P153, DOI 10.1002/hep.24377
   Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914
   Chen LJ, 2008, AGING CELL, V7, P866, DOI 10.1111/j.1474-9726.2008.00432.x
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Chinnery PF, 1993, GENEREVIEWS, V0, P0
   Chung JH, 2012, TRENDS CELL BIOL, V22, P546, DOI 10.1016/j.tcb.2012.07.004
   Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Conti V, 2016, FRONT PHARMACOL, V7, P0, DOI 10.3389/fphar.2016.00024
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Cuyàs E, 2016, CELL CYCLE, V15, P3355, DOI 10.1080/15384101.2016.1249547
   Danilov A, 2015, ONCOTARGET, V6, P19428, DOI 10.18632/oncotarget.5118
   Daubert MA, 2017, CIRC-HEART FAIL, V10, P0, DOI 10.1161/CIRCHEARTFAILURE.117.004389
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/3565127
   de Oliveira MR, 2016, BIOTECHNOL ADV, V34, P532, DOI 10.1016/j.biotechadv.2015.12.014
   De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Degli Esposti M, 2014, GENOME BIOL EVOL, V6, P3238, DOI 10.1093/gbe/evu257
   Dehghan M, 2017, LANCET, V390, P2050, DOI 10.1016/S0140-6736(17)32252-3
   DENTON RM, 1978, INT J BIOCHEM, V9, P545, DOI 10.1016/0020-711X(78)90113-1
   Desjardins D, 2017, AGING CELL, V16, P104, DOI 10.1111/acel.12528
   Dong D, 2017, ONCOTARGET, V8, P16109, DOI 10.18632/oncotarget.14884
   Dong ZW, 2017, MOL CELL, V65, P1014, DOI 10.1016/j.molcel.2017.01.032
   Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   Eldarov CM, 2015, BIOCHEMISTRY-MOSCOW+, V80, P604, DOI 10.1134/S0006297915050132
   Farfariello V, 2015, BBA-MOL CELL RES, V1853, P1974, DOI 10.1016/j.bbamcr.2015.03.005
   Fernandez-Sanz C, 2014, CELL DEATH DIS, V5, P0, DOI 10.1038/cddis.2014.526
   Ferrières J, 2004, HEART, V90, P107, DOI 10.1136/heart.90.1.107
   Fesik SW, 2001, SCIENCE, V294, P1477, DOI 10.1126/science.1062236
   Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002
   Forkink M, 2015, REDOX BIOL, V6, P607, DOI 10.1016/j.redox.2015.09.003
   Frazier AE, 2003, MOL CELL BIOL, V23, P7818, DOI 10.1128/MCB.23.21.7818-7828.2003
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Gane EJ, 2010, LIVER INT, V30, P1019, DOI 10.1111/j.1478-3231.2010.02250.x
   Gauba E, 2017, J ALZHEIMERS DIS, V55, P1351, DOI 10.3233/JAD-160822
   Gellerich FN, 2000, BIOCHEM SOC T, V28, P164, DOI 10.1042/bst0280164
   Gioscia-Ryan RA, 2016, AGING-US, V8, P2897, DOI 10.18632/aging.101099
   Görlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010
   Gonzalez-Freire M, 2015, J GERONTOL A-BIOL, V70, P1334, DOI 10.1093/gerona/glv070
   Guignabert C, 2016, J CLIN INVEST, V126, P3207, DOI 10.1172/JCI86249
   Halling JF, 2017, EXP GERONTOL, V96, P1, DOI 10.1016/j.exger.2017.05.020
   Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327
   Hekimi S, 2013, ONCOIMMUNOLOGY, V2, P0, DOI 10.4161/onci.23793
   Hoffman NE, 2014, MOL BIOL CELL, V25, P936, DOI 10.1091/mbc.E13-08-0502
   Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293
   Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960
   Huang XB, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0184027
   Huffman DM, 2016, EXP GERONTOL, V86, P73, DOI 10.1016/j.exger.2016.05.012
   Jensen MB, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.26952
   Jiang YF, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep45474
   Joseph AM, 2016, J PHYSIOL-LONDON, V594, P5105, DOI 10.1113/JP270659
   Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200
   Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014
   Kamer KJ, 2014, EMBO REP, V15, P299, DOI 10.1002/embr.201337946
   Kang CH, 2013, EXP GERONTOL, V48, P1343, DOI 10.1016/j.exger.2013.08.004
   Kirkland JL, 2017, J AM GERIATR SOC, V65, P2297, DOI 10.1111/jgs.14969
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lalia AZ, 2017, AGING-US, V9, P1096, DOI 10.18632/aging.101210
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   LAWLIS VB, 1981, BIOCHEMISTRY-US, V20, P2512, DOI 10.1021/bi00512a023
   Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x
   Lewis SC, 2016, SCIENCE, V353, P0, DOI 10.1126/science.aaf5549
   Li HZ, 2017, BBA-MOL BASIS DIS, V1863, P2266, DOI 10.1016/j.bbadis.2017.05.022
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Lodgdon MD, 1999, INT J RADIAT ONCOL, V44, P19
   Lopez T, 2014, J MED FOOD, V17, P1314, DOI 10.1089/jmf.2013.0190
   López-Lluch G, 2016, J PHYSIOL-LONDON, V594, P2043, DOI 10.1113/JP270543
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lu YW, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00003
   Lunnon K, 2017, NEUROBIOL AGING, V53, P36, DOI 10.1016/j.neurobiolaging.2016.12.029
   Madreiter-Sokolowski CT, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9101117
   Maiti AK, 2017, NEUROTOX RES, V31, P358, DOI 10.1007/s12640-016-9692-7
   Malli R, 2003, J BIOL CHEM, V278, P10807, DOI 10.1074/jbc.M212971200
   Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200
   Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622
   Manczak M, 2010, J ALZHEIMERS DIS, V20, PS609, DOI 10.3233/JAD-2010-100564
   Manzo-Avalos S, 2010, INT J ENV RES PUB HE, V7, P4281, DOI 10.3390/ijerph7124281
   Mao K, 2013, DEV CELL, V26, P9, DOI 10.1016/j.devcel.2013.05.024
   Marin TL, 2017, SCI SIGNAL, V10, P0, DOI 10.1126/scisignal.aaf7478
   Martín-Hernández E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   Mattison JA, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms14063
   Menezes SL, 2017, FREE RADICAL BIO MED, V110, P219, DOI 10.1016/j.freeradbiomed.2017.06.013
   Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012
   Merry TL, 2016, FREE RADICAL BIO MED, V98, P123, DOI 10.1016/j.freeradbiomed.2015.11.032
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   Morita M, 2015, CELL CYCLE, V14, P473, DOI 10.4161/15384101.2014.991572
   Morozov YM, 2017, NEUROBIOL AGING, V51, P9, DOI 10.1016/j.neurobiolaging.2016.12.001
   Mungai PT, 2011, MOL CELL BIOL, V31, P3531, DOI 10.1128/MCB.05124-11
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Naghdi S, 2010, J CELL SCI, V123, P2553, DOI 10.1242/jcs.070151
   Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, PR1244, DOI 10.1152/ajpregu.00226.2004
   Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006
   Ocampo A, 2016, TRENDS MOL MED, V22, P725, DOI 10.1016/j.molmed.2016.06.005
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Park YY, 2010, J CELL SCI, V123, P619, DOI 10.1242/jcs.061481
   Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013
   Pérez VI, 2011, J GERONTOL A-BIOL, V66, P1286, DOI 10.1093/gerona/glr125
   Pérez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x
   Pestronk A, 2017, MUSCLE NERVE, V56, P122, DOI 10.1002/mus.25442
   Picca A, 2017, CLIN INTERV AGING, V12, P1887, DOI 10.2147/CIA.S126458
   Pinto M, 2017, CELL DEATH DIFFER, V24, P288, DOI 10.1038/cdd.2016.123
   Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126
   Pugh TD, 2013, AGING CELL, V12, P672, DOI 10.1111/acel.12091
   Qi WB, 2017, AGING CELL, V16, P1125, DOI 10.1111/acel.12651
   Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485
   Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157
   Rana A, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00525-4
   Rich P, 2003, NATURE, V421, P583, DOI 10.1038/421583a
   Richter-Dennerlein R, 2016, CELL, V167, P471, DOI 10.1016/j.cell.2016.09.003
   Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613
   Ristow M, 2014, NAT MED, V20, P709, DOI 10.1038/nm.3624
   Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow
   Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5
   Rottenberg H, 2017, AGING CELL, V16, P943, DOI 10.1111/acel.12650
   Safdar A, 2016, SKELET MUSCLE, V6, P0, DOI 10.1186/s13395-016-0075-9
   Sakellariou GK, 2016, FASEB J, V30, P3771, DOI 10.1096/fj.201600450R
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Shabalina IG, 2017, AGING-US, V9, P315, DOI 10.18632/aging.101174
   Shen QF, 2014, MOL BIOL CELL, V25, P145, DOI 10.1091/mbc.E13-09-0525
   Shirihai OS, 2015, CIRC RES, V116, P1835, DOI 10.1161/CIRCRESAHA.116.306374
   Sies H, 2017, REDOX BIOL, V11, P613, DOI 10.1016/j.redox.2016.12.035
   Smieszek A, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18040872
   Son JM, 2017, AGING CELL, V16, P1136, DOI 10.1111/acel.12649
   Sorensen HT, 2000, AM J GASTROENTEROL, V95, P2218
   Sparks LM, 2017, J CLIN ENDOCR METAB, V102, P111, DOI 10.1210/jc.2016-3211
   Stöckl P, 2007, FREE RADICAL BIO MED, V43, P947, DOI 10.1016/j.freeradbiomed.2007.06.005
   Strong R, 2008, AGING CELL, V7, P641, DOI 10.1111/j.1474-9726.2008.00414.x
   Sylow L, 2016, ENDOCRINOLOGY, V157, P4184, DOI 10.1210/en.2016-1398
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Tepp K, 2017, MOL CELL BIOCHEM, V432, P141, DOI 10.1007/s11010-017-3005-1
   Tezze C, 2017, CELL METAB, V25, P1374, DOI 10.1016/j.cmet.2017.04.021
   Tian Y, 2016, TRENDS CELL BIOL, V26, P563, DOI 10.1016/j.tcb.2016.06.006
   Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X
   Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556
   Trepanowski JF, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-107
   Trnka J, 2009, FREE RADICAL RES, V43, P4, DOI 10.1080/10715760802582183
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Uzhachenko R, 2017, AGING-US, V9, P627, DOI 10.18632/aging.101213
   Vais H, 2016, CELL REP, V14, P403, DOI 10.1016/j.celrep.2015.12.054
   Valencia WM, 2017, DIABETOLOGIA, V60, P1630, DOI 10.1007/s00125-017-4349-5
   Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038
   Waldeck-Weiermair M, 2013, J BIOL CHEM, V288, P15367, DOI 10.1074/jbc.M113.462259
   Ward MS, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-10209-0
   Wiel C, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4792
   Wierman MB, 2017, MOL CELL BIOL, V37, P0, DOI 10.1128/MCB.00562-16
   Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x
   Wu J, 2017, FRONT CELL NEUROSCI, V11, P0, DOI 10.3389/fncel.2017.00119
   Wu LF, 2016, CELL, V167, P1705, DOI 10.1016/j.cell.2016.11.055
   Yamano K, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.01612
   Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055
   Yi JK, 2016, ONCOTARGET, V7, P21124, DOI 10.18632/oncotarget.8195
   Zampieri S, 2016, PHYSIOL REP, V4, P0, DOI 10.14814/phy2.13005
   Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445
   Zong WX, 2016, MOL CELL, V61, P667, DOI 10.1016/j.molcel.2016.02.011
   ZORATTI M, 1994, J BIOENERG BIOMEMBR, V26, P543, DOI 10.1007/BF00762739
   Zwerschke W, 2003, BIOCHEM J, V376, P403, DOI 10.1042/BJ20030816
NR 181
TC 36
Z9 43
U1 1
U2 17
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD MAR 15
PY 2018
VL 9
IS 3
BP 
EP 
DI 10.3390/genes9030165
PG 20
WC Genetics & Heredity
SC Genetics & Heredity
GA GA7IE
UT WOS:000428508800048
PM 29547561
DA 2024-11-01
ER

PT J
AU Bacman, SR
   Kauppila, JHK
   Pereira, CV
   Nissanka, N
   Miranda, M
   Pinto, M
   Williams, SL
   Larsson, NG
   Stewart, JB
   Moraes, CT
AF Bacman, Sandra R.
   Kauppila, Johanna H. K.
   Pereira, Claudia, V
   Nissanka, Nadee
   Miranda, Maria
   Pinto, Milena
   Williams, Sion L.
   Larsson, Nils-Goeran
   Stewart, James B.
   Moraes, Carlos T.
TI MitoTALEN reduces mutant mtDNA load and restores tRNA<SUP>Ala</SUP> levels in a mouse model of heteroplasmic mtDNA mutation
SO NATURE MEDICINE
LA English
DT Article
ID mitochondrial-dna; elimination; phenotype; deletions; domain
AB Mutations in the mitochondrial DNA ( mtDNA) are responsible for several metabolic disorders, commonly involving muscle and the central nervous system(1). Because of the critical role of mtDNA in oxidative phosphorylation, the majority of pathogenic mtDNA mutations are heteroplasmic, co-existing with wild-type molecules(1). Using a mouse model with a heteroplasmic mtDNA mutation(2), we tested whether mitochondrialtargeted TALENs (mitoTALENs)(3,4) could reduce the mutant mtDNA load in muscle and heart. AAV9-mitoTALEN was administered via intramuscular, intravenous, and intraperitoneal injections. Muscle and heart were efficiently transduced and showed a robust reduction in mutant mtDNA, which was stable over time. The molecular defect, namely a decrease in transfer RNA(Ala) levels, was restored by the treatment. These results showed that mitoTALENs, when expressed in affected tissues, could revert disease-related phenotypes in mice.
C1 [Bacman, Sandra R.; Pereira, Claudia, V; Nissanka, Nadee; Pinto, Milena; Williams, Sion L.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Kauppila, Johanna H. K.; Miranda, Maria; Larsson, Nils-Goeran; Stewart, James B.] Max Planck Inst Biol & Ageing, Dept Mitochondrial Biol, Cologne, Germany.
C3 University of Miami; Max Planck Society
RP Bacman, SR; Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
EM sbacman@med.miami.edu; cmoraes@med.miami.edu
FU National Institutes of Health [5R01EY010804]; NIH [1R01AG036871, 1R01NS079965]; Muscular Dystrophy Association; JDM Fund for Mitochondrial Research; American Heart Association [16PRE30480009]; Biscardi family; American Heart Association (AHA) [16PRE30480009] Funding Source: American Heart Association (AHA)
CR Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   Cermak T, 2011, NUCLEIC ACIDS RES, V39, P0, DOI 10.1093/nar/gkr218
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Davies SMK, 2012, FEBS LETT, V586, P3555, DOI 10.1016/j.febslet.2012.07.043
   Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539
   El-Hattab AW, 2016, FRONT CARDIOVASC MED, V3, P0, DOI 10.3389/fcvm.2016.00025
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770
   Lamb BM, 2013, NUCLEIC ACIDS RES, V41, P9779, DOI 10.1093/nar/gkt754
   Lehmann D, 2015, EUR J HUM GENET, V23, P1735, DOI 10.1038/ejhg.2015.73
   Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704
   Lochmüller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407
   Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Nissanka N, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04895-1
   Peeva V, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04131-w
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Pinto M, 2018, J NEUROSCI, V38, P1042, DOI 10.1523/JNEUROSCI.1384-17.2017
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957
   Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155
NR 27
TC 175
Z9 205
U1 0
U2 40
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD NOV 15
PY 2018
VL 24
IS 11
BP 1696
EP +
DI 10.1038/s41591-018-0166-8
PG 7
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine
GA GZ4VS
UT WOS:000449404200021
PM 30250143
DA 2024-11-01
ER

PT J
AU Plutino, M
   Chaussenot, A
   Rouzier, C
   Ait-El-Mkadem, S
   Fragaki, K
   Paquis-Flucklinger, V
   Bannwarth, S
AF Plutino, Morgane
   Chaussenot, Annabelle
   Rouzier, Cecile
   Ait-El-Mkadem, Samira
   Fragaki, Konstantina
   Paquis-Flucklinger, Veronique
   Bannwarth, Sylvie
TI Targeted next generation sequencing with an extended gene panel does not impact variant detection in mitochondrial diseases
SO BMC MEDICAL GENETICS
LA English
DT Article
DE Mitochondrial disorders; Next generation sequencing; Targeted panel; Exome
ID mutations; neuropathy; phenotype; myopathy; spectrum; cohort; ataxia; common
AB Background: Since the advent of next generation sequencing (NGS), several studies have tried to evaluate the relevance of targeted gene panel sequencing and whole exome sequencing for molecular diagnosis of mitochondrial diseases. The comparison between these different strategies is extremely difficult. A recent study analysed a cohort of patients affected by a mitochondrial disease using a NGS approach based on a targeted gene panel including 132 genes. This strategy led to identify the causative mutations in 15.2% of cases. The number of novel genes responsible for respiratory chain deficiency increases very rapidly. Methods: In order to determine the impact of larger panels used as a first screening strategy on molecular diagnosis success, we analysed a cohort of 80 patients affected by a mitochondrial disease with a first mitochondrial DNA (mtDNA) NGS screening and secondarily a targeted mitochondrial panel of 281 nuclear genes. Results: Pathogenic mtDNA abnormalities were identified in 4.1% (1/24) of children and 25% (14/56) of adult patients. The remaining 65 patients were analysed with our targeted mitochondrial panel and this approach enabled us to achieve an identification rate of 21.7% (5/23) in children versus 7.1% (3/42) in adults. Conclusions: Our results confirm that larger gene panels do not improve diagnostic yield of mitochondrial diseases due to (i) their very high genetic heterogeneity, (ii) the ongoing discovery of novel genes and (iii) mutations in genes apparently not related to mitochondrial function that lead to secondary respiratory chain deficiency.
C1 [Plutino, Morgane; Chaussenot, Annabelle; Rouzier, Cecile; Ait-El-Mkadem, Samira; Fragaki, Konstantina; Paquis-Flucklinger, Veronique; Bannwarth, Sylvie] Univ Cote Azur, CHU Nice, INSERM, CNRS,IRCAN, Nice, France.
   [Bannwarth, Sylvie] INSERM U1081, IRCAN, UMR CNRS 7284, Sch Med, 28 Valombrose, F-06107 Nice 2, France.
C3 CHU Nice; Centre National de la Recherche Scientifique (CNRS); Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Cote d'Azur
RP Paquis-Flucklinger, V; Bannwarth, S (corresponding author), Univ Cote Azur, CHU Nice, INSERM, CNRS,IRCAN, Nice, France.; Bannwarth, S (corresponding author), INSERM U1081, IRCAN, UMR CNRS 7284, Sch Med, 28 Valombrose, F-06107 Nice 2, France.
EM paquis@unice.fr; bannwarth@unice.fr
FU French ministry health
CR Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200
   Ardissone A, 2015, NEUROLOGY, V84, P2193, DOI 10.1212/WNL.0000000000001613
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Chung KW, 2006, BRAIN, V129, P2103, DOI 10.1093/brain/awl174
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   DaRe JT, 2013, BMC MED GENET, V14, P0, DOI 10.1186/1471-2350-14-118
   Di Meglio C, 2016, BRAIN DEV-JPN, V38, P498, DOI 10.1016/j.braindev.2015.11.006
   Duis J, 2016, ANN NEUROL, V80, P633, DOI 10.1002/ana.24744
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Ferré M, 2009, HUM MUTAT, V30, PE692, DOI 10.1002/humu.21025
   Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378
   Gros-Louis F, 2007, NAT GENET, V39, P80, DOI 10.1038/ng1927
   Kocaefe YÇ, 2003, EUR J HUM GENET, V11, P102, DOI 10.1038/sj.ejhg.5200908
   Legati A, 2016, BBA-BIOENERGETICS, V1857, P1326, DOI 10.1016/j.bbabio.2016.02.022
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Liu YT, 2014, NEUROLOGY, V83, P612, DOI 10.1212/WNL.0000000000000691
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Monnot S, 2009, HUM MUTAT, V30, P734, DOI 10.1002/humu.20908
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Morel G, 2016, NEUROMUSCULAR DISORD, V26, P885, DOI 10.1016/j.nmd.2016.09.012
   Neubauer J, 2017, EUR J HUM GENET, V25, P404, DOI 10.1038/ejhg.2016.199
   Ohtake A, 2014, BBA-GEN SUBJECTS, V1840, P1355, DOI 10.1016/j.bbagen.2014.01.025
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Saneto RP, 2017, ADV GENET, V98, P63, DOI 10.1016/bs.adgen.2017.06.002
   Sergouniotis PI, 2015, NEUROGENETICS, V16, P69, DOI 10.1007/s10048-014-0416-y
   Synofzik M, 2016, BRAIN, V139, P1378, DOI 10.1093/brain/aww079
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tiranti V, 2006, J MED GENET, V43, P340, DOI 10.1136/jmg.2005.036210
   Van Maldergem L, 2017, ANN CLIN TRANSL NEUR, V4, P4, DOI 10.1002/acn3.361
   Vasta V, 2012, PEDIATR INT, V54, P585, DOI 10.1111/j.1442-200X.2012.03644.x
   Vasta V, 2009, GENOME MED, V1, P0, DOI 10.1186/gm100
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wightman PJ, 2003, HUM MUTAT, V22, P288, DOI 10.1002/humu.10264
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 42
TC 16
Z9 17
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1471-2350
J9 BMC MED GENET
JI BMC Med. Genet.
PD APR 7
PY 2018
VL 19
IS 
BP 
EP 
DI 10.1186/s12881-018-0568-y
PG 13
WC Genetics & Heredity
SC Genetics & Heredity
GA GC1UR
UT WOS:000429568400001
PM 29625556
DA 2024-11-01
ER

PT J
AU Witters, P
   Saada, A
   Honzik, T
   Tesarova, M
   Kleinle, S
   Horvath, R
   Goldstein, A
   Morava, E
AF Witters, Peter
   Saada, Ann
   Honzik, Tomas
   Tesarova, Marketa
   Kleinle, Stephanie
   Horvath, Rita
   Goldstein, Amy
   Morava, Eva
TI Revisiting mitochondrial diagnostic criteria in the new era of genomics
SO GENETICS IN MEDICINE
LA English
DT Article
DE diagnosis; mitochondrial disease; mitochondrial disease criteria; muscle biopsy; whole-exome sequencing
ID complex i deficiency; disease; disorders; mutations; leukoencephalopathy; adults
AB Purpose: Diagnosing primary mitochondrial diseases (MDs) is challenging in clinical practice. The mitochondrial disease criteria (MDC) have been developed to quantify the clinical picture and evaluate the probability of an underlying MD and the need for a muscle biopsy. In this new genetic era with next-generation sequencing in routine practice, we aim to validate the diagnostic value of MDC.& para;& para;Methods: We retrospectively studied MDC in a multicenter cohort of genetically confirmed primary MD patients.& para;& para;Results: We studied 136 patients (61 male, 91 nuclear DNA (nDNA) mutations). Forty-five patients (33%) had probable MD and 69 (51%) had definite MD according to the MDC. A muscle biopsy was performed in 63 patients (47%). Patients with nDNA mutations versus mitochondrial DNA mutations were younger (6.4 +/- 9.7 versus 19.5 +/- 17.3 y) and had higher MDC (7.07 +/- 1.12/8 versus 5.69 +/- 1.94/8). At a cutoff of 6.5/8, the sensitivity to diagnose patients with nDNA mutations is 72.5% with a positive predictive value of 69.5%. In the nDNA mutation group, whole-exome sequencing could diagnose patients with lower scores (MDC (6.84 +/- 1.51/8) compared to Sanger sequencing MDC (7.44 +/- 1.13/8, P = 0.025)). Moreover 7/8 patients diagnosed with possible MD by MDC were diagnosed by whole-exome sequencing.& para;& para;Conclusion: MDC remain very useful in the clinical diagnosis of MD, in interpreting whole-exome results and deciding on the need for performing muscle biopsy.
C1 [Witters, Peter; Morava, Eva] Katholieke Univ Leuven, Dept Paediat, Leuven, Belgium.
   [Witters, Peter; Morava, Eva] Katholieke Univ Leuven, Metab Ctr, Univ Hosp Leuven, Dept Dev & Regenerat, Leuven, Belgium.
   [Saada, Ann] Hadassah Hebrew Univ, Med Ctr, Monique & Jacques Roboh Dept Genet Res, Jerusalem, Israel.
   [Saada, Ann] Hadassah Hebrew Univ, Med Ctr, Dept Genet & Metab Dis, Jerusalem, Israel.
   [Honzik, Tomas; Tesarova, Marketa] Charles Univ Prague, Fac Med 1, Dept Pediat, Prague, Czech Republic.
   [Honzik, Tomas; Tesarova, Marketa] Gen Univ Hosp, Prague, Czech Republic.
   [Kleinle, Stephanie] Med Genet Ctr, Munich, Germany.
   [Horvath, Rita] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England.
   [Goldstein, Amy; Morava, Eva] Tulane Univ, Sch Med, Hayward Genet Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA.
C3 KU Leuven; KU Leuven; University Hospital Leuven; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Charles University Prague; General University Hospital Prague; Newcastle University - UK; Tulane University
RP Witters, P (corresponding author), Katholieke Univ Leuven, Dept Paediat, Leuven, Belgium.; Witters, P (corresponding author), Katholieke Univ Leuven, Metab Ctr, Univ Hosp Leuven, Dept Dev & Regenerat, Leuven, Belgium.
EM peter.witters@uzleuven.be; emoravakozicz@tulane.edu
FU Ministry of Health of the Czech Republic [MZ CR AZV 16-32341A]; Grant Agency of the Czech Republic [14-36804G]; Charles University in Prague PRVOUK [P24/LF1/3]; Hayward Genetics Trustees; Clinical Research Foundation of University Hospitals Leuven, Leuven, Belgium; Pakula family via American Friends of the Hebrew University; MRC [G1000848, MR/N010035/1, MR/N025431/2, MR/N025431/1] Funding Source: UKRI; Newton Fund [MR/N027302/1, MR/N027302/2] Funding Source: UKRI
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079
   Dallabona C, 2016, BRAIN, V139, P782, DOI 10.1093/brain/awv392
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Griffin HR, 2014, GENET MED, V16, P962, DOI 10.1038/gim.2014.66
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   Kevelam SH, 2013, NEUROLOGY, V80, P1577, DOI 10.1212/WNL.0b013e31828f1914
   Koene S, 2012, J INHERIT METAB DIS, V35, P737, DOI 10.1007/s10545-012-9492-z
   Kohda M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005679
   Koopman WJH, 2016, EMBO MOL MED, V8, P311, DOI 10.15252/emmm.201506131
   Legati A, 2016, BBA-BIOENERGETICS, V1857, P1326, DOI 10.1016/j.bbabio.2016.02.022
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Morava E, 2015, J INHERIT METAB DIS, V38, P387, DOI 10.1007/s10545-015-9852-6
   Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450
   Oliveira R, 2016, LETHAL NEONATAL LTBL, V0, P0
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pronicka E, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0930-9
   Rahman S, 2015, J INHERIT METAB DIS, V38, P641, DOI 10.1007/s10545-015-9855-3
   Rivera-Cruz Berenice, 2013, AANA J, V81, P237
   Saada A, 2014, INT J BIOCHEM CELL B, V48, P60, DOI 10.1016/j.biocel.2013.12.010
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Shamseldin HE, 2012, J MED GENET, V49, P234, DOI 10.1136/jmedgenet-2012-100836
   Steenweg ME, 2011, BRAIN, V134, P3333, DOI 10.1093/brain/awr254
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
NR 29
TC 52
Z9 55
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1098-3600
EI 1530-0366
J9 GENET MED
JI Genet. Med.
PD APR 15
PY 2018
VL 20
IS 4
BP 444
EP 451
DI 10.1038/gim.2017.125
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA GC6OZ
UT WOS:000429912900010
PM 29261183
DA 2024-11-01
ER

PT J
AU Piekutowska-Abramczuk, D
   Assouline, Z
   Matakovic, L
   Feichtinger, RG
   Konariková, E
   Jurkiewicz, E
   Stawinski, P
   Gusic, M
   Koller, A
   Pollak, A
   Gasperowicz, P
   Trubicka, J
   Ciara, E
   Iwanicka-Pronicka, K
   Rokicki, D
   Hanein, S
   Wortmann, SB
   Sperl, W
   Rötig, A
   Prokisch, H
   Pronicka, E
   Ploski, R
   Barcia, G
   Mayr, JA
AF Piekutowska-Abramczuk, Dorota
   Assouline, Zahra
   Matakovic, Lavinija
   Feichtinger, Rene G.
   Konarikova, Eliska
   Jurkiewicz, Elzbieta
   Stawinski, Piotr
   Gusic, Mirjana
   Koller, Andreas
   Pollak, Agnieszka
   Gasperowicz, Piotr
   Trubicka, Joanna
   Ciara, Elzbieta
   Iwanicka-Pronicka, Katarzyna
   Rokicki, Dariusz
   Hanein, Sylvain
   Wortmann, Saskia B.
   Sperl, Wolfgang
   Rotig, Agnes
   Prokisch, Holger
   Pronicka, Ewa
   Ploski, Rafa
   Barcia, Giulia
   Mayr, Johannes A.
TI <i>NDUFB8</i> Mutations Cause Mitochondrial Complex I Deficiency in Individuals with Leigh-like Encephalomyopathy
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID respiratory-chain deficiency; acad9 mutations; disease; architecture; diagnosis; features
AB Respiratory chain complex I deficiency is the most frequently identified biochemical defect in childhood mitochondrial diseases. Clinical symptoms range from fatal infantile lactic acidosis to Leigh syndrome and other encephalomyopathies or cardiomyopathies. To date, disease-causing variants in genes coding for 27 complex I subunits, including 7 mitochondrial DNA genes, and in 11 genes encoding complex I assembly factors have been reported. Here, we describe rare biallelic variants in NDUFB8 encoding a complex I accessory subunit revealed by whole-exome sequencing in two individuals from two families. Both presented with a progressive course of disease with encephalo(cardio) myopathic features including muscular hypotonia, cardiac hypertrophy, respiratory failure, failure to thrive, and developmental delay. Blood lactate was elevated. Neuroimaging disclosed progressive changes in the basal ganglia and either brain stem or internal capsule. Biochemical analyses showed an isolated decrease in complex I enzymatic activity in muscle and fibroblasts. Complementation studies by expression of wild-type NDUFB8 in cells from affected individuals restored mitochondrial function, confirming NDUFB8 variants as the cause of complex I deficiency. Hereby we establish NDUFB8 as a relevant gene in childhood-onset mitochondrial disease.
C1 [Piekutowska-Abramczuk, Dorota; Trubicka, Joanna; Ciara, Elzbieta; Pronicka, Ewa] Childrens Mem Hlth Inst, Dept Med Genet, PL-04730 Warsaw, Poland.
   [Assouline, Zahra; Barcia, Giulia] Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France.
   [Matakovic, Lavinija; Feichtinger, Rene G.; Koller, Andreas; Wortmann, Saskia B.; Sperl, Wolfgang; Mayr, Johannes A.] Salzburger Landeskliniken, Dept Pediat, A-5020 Salzburg, Austria.
   [Matakovic, Lavinija; Feichtinger, Rene G.; Koller, Andreas; Wortmann, Saskia B.; Sperl, Wolfgang; Mayr, Johannes A.] Paracelsus Med Univ Salzburg, A-5020 Salzburg, Austria.
   [Konarikova, Eliska; Gusic, Mirjana; Wortmann, Saskia B.; Prokisch, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany.
   [Konarikova, Eliska; Gusic, Mirjana; Wortmann, Saskia B.; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.
   [Jurkiewicz, Elzbieta] Childrens Mem Hlth Inst, Dept Diagnost Imaging, PL-04730 Warsaw, Poland.
   [Stawinski, Piotr; Gasperowicz, Piotr; Ploski, Rafa] Med Univ Warsaw, Dept Med Genet, PL-02106 Warsaw, Poland.
   [Stawinski, Piotr; Pollak, Agnieszka] Inst Physiol & Pathol Hearing, Dept Genet, PL-05830 Warsaw, Poland.
   [Iwanicka-Pronicka, Katarzyna] Childrens Mem Hlth Inst, Dept Audiol & Phoniatr, PL-04730 Warsaw, Poland.
   [Rokicki, Dariusz; Pronicka, Ewa] Childrens Mem Hlth Inst, Dept Paediat Nutr & Metab Dis, PL-04730 Warsaw, Poland.
   [Hanein, Sylvain; Rotig, Agnes] Univ Paris 05, Sorbonne Paris Cite,Inst Imagine, INSERM, U1163, F-75015 Paris, France.
C3 Children's Memorial Health Institute; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Paracelsus Private Medical University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Children's Memorial Health Institute; Medical University of Warsaw; Institute of Physiology & Hearing Pathology; Children's Memorial Health Institute; Children's Memorial Health Institute; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)
RP Mayr, JA (corresponding author), Salzburger Landeskliniken, Dept Pediat, A-5020 Salzburg, Austria.; Mayr, JA (corresponding author), Paracelsus Med Univ Salzburg, A-5020 Salzburg, Austria.; Ploski, R (corresponding author), Med Univ Warsaw, Dept Med Genet, PL-02106 Warsaw, Poland.
EM rploski@wp.pl; h.mayr@salk.at
FU NSC [2012/05/B/NZ2/01627]; CMHI [S136/13, S145/16]; E-Rare project GENOMIT [01GM1603, 01GM1207, O1GML 1207]; E-Rare project GENOMIT (Austrian Science Fonds [FWF]) [I 2741-B26]; PMU-FFF [R-16/03/082-FEK]; EC PEOPLE-ITN (MEET) [317433]; Austrian Science Fund (FWF) [I2741] Funding Source: Austrian Science Fund (FWF)
CR Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539
   Bricout M, 2014, J MED GENET, V51, P429, DOI 10.1136/jmedgenet-2013-102256
   Collet M, 2016, EUR J HUM GENET, V24, P1112, DOI 10.1038/ejhg.2015.264
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Gu JK, 2016, NATURE, V537, P639, DOI 10.1038/nature19359
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Herzer M, 2010, NEUROPEDIATRICS, V41, P30, DOI 10.1055/s-0030-1255062
   Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kremer LS, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15824
   Kremer LS, 2017, METHODS MOL BIOL, V1567, P391, DOI 10.1007/978-1-4939-6824-4_24
   Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015
   Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   Metodiev MD, 2014, J MED GENET, V51, P834, DOI 10.1136/jmedgenet-2014-102532
   Olsen RKJ, 2016, AM J HUM GENET, V98, P1130, DOI 10.1016/j.ajhg.2016.04.006
   Pronicka E, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0930-9
   Rodenburg RJ, 2016, BBA-BIOENERGETICS, V1857, P938, DOI 10.1016/j.bbabio.2016.02.012
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686
   Wu M, 2016, CELL, V167, P1598, DOI 10.1016/j.cell.2016.11.012
   Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095
   Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859
NR 24
TC 41
Z9 45
U1 0
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD MAR 1
PY 2018
VL 102
IS 3
BP 460
EP 467
DI 10.1016/j.ajhg.2018.01.008
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA FX9ZL
UT WOS:000426469600016
PM 29429571
DA 2024-11-01
ER

PT J
AU De Michele, G
   Sorrentino, P
   Nesti, C
   Rubegni, A
   Ruggiero, L
   Peluso, S
   Antenora, A
   Quarantelli, M
   Filla, A
   De Michele, G
   Santorelli, FM
AF De Michele, Giovanna
   Sorrentino, Pierpaolo
   Nesti, Claudia
   Rubegni, Anna
   Ruggiero, Lucia
   Peluso, Silvio
   Antenora, Antonella
   Quarantelli, Mario
   Filla, Alessandro
   De Michele, Giuseppe
   Santorelli, Filippo M.
TI Reversible Valproate-Induced Subacute Encephalopathy Associated With a <i>MT-ATP8 </i>Variant in the Mitochondrial Genome
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE valproate; mitochondria; MT-ATP8; metabolic encephalopathy; ammonia
ID induced hyperammonemic encephalopathy; acid; pseudoatrophy; synthase; therapy; brain
AB Introduction: There are several reported cases of patients developing motor and cognitive neurological impairment under treatment with valproic acid (VPA). We describe a woman who developed a subacute encephalopathy after VPA intake, harboring a mitochondrial DNA variant, previously described as causing VPA sensitivity in one pediatric patient. Material and Methods: A 65-year old woman developed a progressive, severe neurological deterioration after a 3 month treatment with valproate sodium, 800 mg daily. Magnetic resonance spectroscopy (MRS), muscle histochemical analysis and assay of mitochondrial enzymatic activities, and mitochondrial DNA sequencing were performed. Results: Neurological examination showed drowsiness, vertical gaze palsy, inability to either stand or walk, diffuse weakness, increased tendon reflexes. Blood lactate was increased, EEG showed diffuse theta and delta activity, MRI subcortical atrophy and leukoencephalopathy, MRS marked reduction of the NAA spectrum, with a small signal compatible with presence of lactate. Muscle biopsy evidenced presence of ragged red fibers (20%) and reduced COX reactivity. Assay of the muscle enzymatic activities showed multiple deficiencies of the electron transport chain and reduced ATP production. The mt.8393C>T variant in the MT-ATP8 gene was found in homoplasmy. The patient considerably improved after valproate withdrawal. Conclusion: The variant we found has been reported both as a polymorphism and, in a single patient, as related to the valproate-induced encephalopathy. The present case is the first bearing this mutation in homoplasmy. In case of neurological symptoms after starting VPA therapy, once hyperammonemia and liver failure have been ruled out, mtDNA abnormalities should be considered.
C1 [De Michele, Giovanna; Sorrentino, Pierpaolo; Ruggiero, Lucia; Peluso, Silvio; Antenora, Antonella; Filla, Alessandro; De Michele, Giuseppe] Univ Napoli Federico II, Dept Neurosci & Reprod & Odontostomatol Sci, Naples, Italy.
   [Nesti, Claudia; Rubegni, Anna; Santorelli, Filippo M.] IRCCS Fdn Stella Maris, Mol Med, Pisa, Italy.
   [Quarantelli, Mario] CNR, Inst Biostruct & Bioimaging, Naples, Italy.
C3 University of Naples Federico II; IRCCS Fondazione Stella Maris; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)
RP De Michele, G (corresponding author), Univ Napoli Federico II, Dept Neurosci & Reprod & Odontostomatol Sci, Naples, Italy.
EM giodemic@gmail.com
CR BAGANZ MD, 1994, AM J NEURORADIOL, V15, P1779
   Bianco A, 2016, BRAIN, V139, P0, DOI 10.1093/brain/awv216
   Chaudhry Neera, 2013, J PEDIATR NEUROSCI, V8, P135, DOI 10.4103/1817-1745.117847
   Dautant A, 2018, FRONT PHYSIOL, V9, P0, DOI 10.3389/fphys.2018.00329
   Galimberti CA, 2006, NEUROLOGY, V67, P1715, DOI 10.1212/01.wnl.0000242882.58086.9a
   Gerstner T, 2006, SEIZURE-EUR J EPILEP, V15, P443, DOI 10.1016/j.seizure.2006.05.007
   Guerrini R, 1998, EPILEPSIA, V39, P27, DOI 10.1111/j.1528-1157.1998.tb01270.x
   Hroudova J, 2010, NEUROENDOCRINOL LETT, V31, P336
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   Lewis C, 2012, CURR MED RES OPIN, V28, P1039, DOI 10.1185/03007995.2012.694362
   Luís PBM, 2007, BBA-BIOENERGETICS, V1767, P1126, DOI 10.1016/j.bbabio.2007.06.007
   Mock CM, 2012, AM J HEALTH-SYST PH, V69, P35, DOI 10.2146/ajhp110049
   Nesti C, 2015, HUM MOL GENET, V24, P3248, DOI 10.1093/hmg/ddv078
   Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8
   Tomson T, 2016, LANCET NEUROL, V15, P210, DOI 10.1016/S1474-4422(15)00314-2
   Verrotti A, 2002, METAB BRAIN DIS, V17, P367, DOI 10.1023/A:1021918104127
   Ziyeh S, 2002, EPILEPSIA, V43, P1101, DOI 10.1046/j.1528-1157.2002.42201.x
NR 17
TC 10
Z9 10
U1 0
U2 12
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
EI 
J9 FRONT NEUROL
JI Front. Neurol.
PD AUG 30
PY 2018
VL 9
IS 
BP 
EP 
DI 10.3389/fneur.2018.00728
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GS0HD
UT WOS:000443170300001
PM 30214424
DA 2024-11-01
ER

PT J
AU Vincent, AE
   Rosa, HS
   Pabis, K
   Lawless, C
   Chen, C
   Grünewald, A
   Rygiel, KA
   Rocha, MC
   Reeve, AK
   Falkous, G
   Perissi, V
   White, K
   Davey, T
   Petrof, BJ
   Sayer, AA
   Cooper, C
   Deehan, D
   Taylor, RW
   Turnbull, DM
   Picard, M
AF Vincent, Amy E.
   Rosa, Hannah S.
   Pabis, Kamil
   Lawless, Conor
   Chen, Chun
   Gruenewald, Anne
   Rygiel, Karolina A.
   Rocha, Mariana C.
   Reeve, Amy K.
   Falkous, Gavin
   Perissi, Valentina
   White, Kathryn
   Davey, Tracey
   Petrof, Basil J.
   Sayer, Avan A.
   Cooper, Cyrus
   Deehan, David
   Taylor, Robert W.
   Turnbull, Doug M.
   Picard, Martin
TI Subcellular origin of mitochondrial DNA deletions in human skeletal muscle
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID disease; cells; mutations; fibers; accumulation; mechanisms; myopathy; intermediate; maintenance; dysfunction
AB ObjectiveIn patients with mitochondrial DNA (mtDNA) maintenance disorders and with aging, mtDNA deletions sporadically form and clonally expand within individual muscle fibers, causing respiratory chain deficiency. This study aimed to identify the sub-cellular origin and potential mechanisms underlying this process. MethodsSerial skeletal muscle cryosections from patients with multiple mtDNA deletions were subjected to subcellular immunofluorescent, histochemical, and genetic analysis. ResultsWe report respiratory chain-deficient perinuclear foci containing mtDNA deletions, which show local elevations of both mitochondrial mass and mtDNA copy number. These subcellular foci of respiratory chain deficiency are associated with a local increase in mitochondrial biogenesis and unfolded protein response signaling pathways. We also find that the commonly reported segmental pattern of mitochondrial deficiency is consistent with the three-dimensional organization of the human skeletal muscle mitochondrial network. InterpretationWe propose that mtDNA deletions first exceed the biochemical threshold causing biochemical deficiency in focal regions adjacent to the myonuclei, and induce mitochondrial biogenesis before spreading across the muscle fiber. These subcellular resolution data provide new insights into the possible origin of mitochondrial respiratory chain deficiency in mitochondrial myopathy. Ann Neurol 2018;84:289-301
C1 [Vincent, Amy E.; Rosa, Hannah S.; Pabis, Kamil; Lawless, Conor; Chen, Chun; Gruenewald, Anne; Rygiel, Karolina A.; Rocha, Mariana C.; Reeve, Amy K.; Falkous, Gavin; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Univ, Inst Neurosci, Newcastle Ctr Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Picard, Martin] Columbia Univ, Dept Psychiat, Med Ctr, Div Behav Med, New York, NY 10032 USA.
   [Vincent, Amy E.; Rosa, Hannah S.; Pabis, Kamil; Lawless, Conor; Chen, Chun; Gruenewald, Anne; Rygiel, Karolina A.; Rocha, Mariana C.; Reeve, Amy K.; Falkous, Gavin; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Gruenewald, Anne] Univ Lubeck, Inst Neurogenet, Lubeck, Germany.
   [Gruenewald, Anne] Univ Luxembourg, Mol & Funct Neurobiol Grp, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg.
   [Perissi, Valentina] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.
   [White, Kathryn; Davey, Tracey] Newcastle Univ, Electron Microscopy Res Serv, Newcastle Upon Tyne, Tyne & Wear, England.
   [Petrof, Basil J.] McGill Univ, Hlth Ctr, Dept Med, Meakins Christie Labs, Montreal, PQ, Canada.
   [Sayer, Avan A.] Newcastle Upon Tyne Hosp Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, Newcastle Biomed Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England.
   [Sayer, Avan A.] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England.
   [Cooper, Cyrus] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England.
   [Deehan, David] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.
   [Picard, Martin] Columbia Univ, Dept Neurol, Med Ctr, H Houston Merritt Ctr, New York, NY 10032 USA.
   [Picard, Martin] Columbia Univ, Med Ctr, H Houston Merritt Ctr, Columbia Translat Neurosci Initiat, New York, NY 10032 USA.
   [Picard, Martin] Columbia Univ, Aging Ctr, New York, NY 10032 USA.
C3 Newcastle University - UK; Columbia University; Newcastle University - UK; University of Lubeck; University of Luxembourg; Boston University; Newcastle University - UK; McGill University; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; University of Southampton; Newcastle University - UK; Columbia University; Columbia University; Columbia University
RP Turnbull, DM (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Ctr Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.; Picard, M (corresponding author), Columbia Univ, Dept Psychiat, Med Ctr, Div Behav Med, New York, NY 10032 USA.
EM doug.turnbull@ncl.ac.uk; martin.picard@columbia.edu
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC) Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort [G0800674]; UK National Institute for Health Research Biomedical Research Centre in Age and Age Related Diseases; MRC/Engineering and Physical Sciences Research Council Molecular Pathology Node; Lily Foundation; UK NHS Specialist Commissioners "Rare Mitochondrial Disorders of Adults and Children" Service; MRC as part of the MRC Centre for Neuromuscular Disease [MR/K501074/1, MR/K000608/1]; MRC as part of the Centre for Ageing and Vitality [MR/L016354/1]; National Research Fund of Luxembourg; Barbour Foundation; Wharton Fund; NIH [R35GM119793]; senior Parkinson's UK fellowship [F-1401]; BBSRC [BB/M012093/1] Funding Source: UKRI; MRC [G0400491, G0800674, MR/K000608/1, MC_U147585827, MR/L016354/1, MC_U147585819] Funding Source: UKRI
CR Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Cardamone MD, 2017, FASEB J, V31, P0
   Cederquist CT, 2017, MOL METAB, V6, P125, DOI 10.1016/j.molmet.2016.10.007
   Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Elson JL, 2002, NEUROMUSCULAR DISORD, V12, P858, DOI 10.1016/S0960-8966(02)00047-0
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Glancy B, 2015, NATURE, V523, P617, DOI 10.1038/nature14614
   Glancy B, 2014, MICROCIRCULATION, V21, P131, DOI 10.1111/micc.12098
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   KASAMATSU H, 1971, P NATL ACAD SCI USA, V68, P2252, DOI 10.1073/pnas.68.9.2252
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Margariti A, 2013, J BIOL CHEM, V288, P859, DOI 10.1074/jbc.M112.412783
   MATSUOKA T, 1992, MUSCLE NERVE, V15, P209, DOI 10.1002/mus.880150213
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012
   Picard M, 2012, AM J RESP CRIT CARE, V186, P1140, DOI 10.1164/rccm.201206-0982OC
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Rygiel KA, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep09906
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   Syddall HE, 2005, INT J EPIDEMIOL, V34, P1234, DOI 10.1093/ije/dyi127
   Vincent AE, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep30610
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X
NR 32
TC 34
Z9 35
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD AUG 15
PY 2018
VL 84
IS 2
BP 289
EP 301
DI 10.1002/ana.25288
PG 13
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GT5UV
UT WOS:000444576400013
PM 30014514
DA 2024-11-01
ER

PT J
AU Picca, A
   Mankowski, RT
   Burman, JL
   Donisi, L
   Kim, JS
   Marzetti, E
   Leeuwenburgh, C
AF Picca, Anna
   Mankowski, Robert T.
   Burman, Jonathon L.
   Donisi, Luca
   Kim, Jae-Sung
   Marzetti, Emanuele
   Leeuwenburgh, Christiaan
TI Mitochondrial quality control mechanisms as molecular targets in cardiac ageing
SO NATURE REVIEWS CARDIOLOGY
LA English
DT Review
ID term caloric restriction; dna mutations; life-span; endoplasmic-reticulum; oxidative stress; muscle-cells; transcriptional control; contractile function; cellular senescence; hydrogen-peroxide
AB Cardiovascular disease is the leading cause of morbidity and mortality worldwide. Advancing age is a major risk factor for developing cardiovascular disease because of the lifelong exposure to cardiovascular risk factors and specific alterations affecting the heart and the vasculature during ageing. Indeed, the ageing heart is characterized by structural and functional changes that are caused by alterations in fundamental cardiomyocyte functions. In particular, the myocardium is heavily dependent on mitochondrial oxidative metabolism and is especially susceptible to mitochondrial dysfunction. Indeed, primary alterations in mitochondrial function, which are subsequently amplified by defective quality control mechanisms, are considered to be major contributing factors to cardiac senescence. In this Review, we discuss the mechanisms linking defective mitochondrial quality control mechanisms (that is, proteostasis, biogenesis, dynamics, and autophagy) to organelle dysfunction in the context of cardiac ageing. We also illustrate relevant molecular pathways that might be exploited for the prevention and treatment of age-related heart dysfunction.
C1 [Picca, Anna; Donisi, Luca; Marzetti, Emanuele] Univ Cattolica Sacro Cuore, Sch Med, Teaching Hosp Agostino Gemelli, Dept Geriatr Neurosci & Orthoped, Rome, Italy.
   [Mankowski, Robert T.; Burman, Jonathon L.; Donisi, Luca; Leeuwenburgh, Christiaan] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL 32611 USA.
   [Burman, Jonathon L.] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
   [Kim, Jae-Sung] Univ Florida, Dept Surg, Gainesville, FL USA.
C3 Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); State University System of Florida; University of Florida
RP Marzetti, E (corresponding author), Univ Cattolica Sacro Cuore, Sch Med, Teaching Hosp Agostino Gemelli, Dept Geriatr Neurosci & Orthoped, Rome, Italy.; Leeuwenburgh, C (corresponding author), Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL 32611 USA.
EM emanuele.marzetti@policlinicogemelli.it; cleeuwen@ufl.edu
FU Fondazione Roma; Innovative Medicine Initiative-Joint Undertaking [IMI-JU 115621]; Catholic University of the Sacred Heart [D3.2 2013, D3.2 2015]; Centro Studi Achille e Linda Lorenzon; Claude D. Pepper Older Americans Independence Center at the University of Florida's Institute on Aging [NIA 1P30AG028740]
CR Adam-Vizi V, 2010, J ALZHEIMERS DIS, V20, PS413, DOI 10.3233/JAD-2010-100465
   AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481
   Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014
   Anmann T, 2014, BBA-BIOENERGETICS, V1837, P1350, DOI 10.1016/j.bbabio.2014.03.015
   [Anonymous], 2017, CARDIOL, V0, P0
   Bánsághi S, 2014, J BIOL CHEM, V289, P8170, DOI 10.1074/jbc.M113.504159
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Basatemur GL, 2019, NAT REV CARDIOL, V16, P727, DOI 10.1161/CIRCRESAHA.115.306361
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Blice-Baum AC, 2017, AGING CELL, V16, P93, DOI 10.1111/acel.12543
   Boateng SY, 2008, CARDIOVASC RES, V77, P667, DOI 10.1093/cvr/cvm048
   Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106
   Calì T, 2013, BBA-MOL BASIS DIS, V1832, P495, DOI 10.1016/j.bbadis.2013.01.004
   Calvani R, 2013, BIOL CHEM, V394, P393, DOI 10.1515/hsz-2012-0247
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chen HC, 2015, J CELL BIOL, V211, P795, DOI 10.1083/jcb.201507035
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Chen Y, 2010, P NATL ACAD SCI USA, V107, P9035, DOI 10.1073/pnas.0914013107
   Chiao YA, 2015, CSH PERSPECT MED, V5, P0, DOI 10.1101/cshperspect.a025148
   Chun SK, 2016, TOX RESEARCH, V32, P35, DOI 10.5487/TR.2016.32.1.035
   Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002
   Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Cuervo AM, 2008, J GERONTOL A-BIOL, V63, P547, DOI 10.1093/gerona/63.6.547
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Das KC, 2013, EXP GERONTOL, V48, P947, DOI 10.1016/j.exger.2013.06.002
   Delbridge LMD, 2017, NAT REV CARDIOL, V14, P412, DOI 10.1038/nrcardio.2017.35
   Divald A, 2010, CIRC RES, V106, P1829, DOI 10.1161/CIRCRESAHA.110.219485
   Dorn GW, 2015, GENE DEV, V29, P1981, DOI 10.1101/gad.269894.115
   Duicu OM, 2013, CAN J PHYSIOL PHARM, V91, P593, DOI 10.1139/cjpp-2012-0422
   Dutta D, 2012, CIRC RES, V110, P1125, DOI 10.1161/CIRCRESAHA.111.246108
   Edwards MG, 2007, BMC GENOMICS, V8, P0, DOI 10.1186/1471-2164-8-80
   Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123
   Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222
   Eldarov CM, 2015, BIOCHEMISTRY-MOSCOW+, V80, P604, DOI 10.1134/S0006297915050132
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Esterhammer R, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0097368
   Faerber G, 2011, J THORAC CARDIOV SUR, V141, P492, DOI 10.1016/j.jtcvs.2010.03.029
   Feng WJ, 2016, J GERONTOL A-BIOL, V71, P178, DOI 10.1093/gerona/glu210
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, P884S, DOI 10.3945/ajcn.110.001917
   Ferrara N, 2008, REJUV RES, V11, P139, DOI 10.1089/rej.2007.0576
   Fischer F, 2012, TRENDS BIOCHEM SCI, V37, P284, DOI 10.1016/j.tibs.2012.02.004
   Fougère B, 2017, J GERONTOL A-BIOL, V72, P1218, DOI 10.1093/gerona/glw240
   Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241
   Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301
   Gispert S, 2013, HUM MOL GENET, V22, P4871, DOI 10.1093/hmg/ddt338
   Glancy B, 2017, CELL REP, V19, P487, DOI 10.1016/j.celrep.2017.03.063
   Glancy B, 2015, NATURE, V523, P617, DOI 10.1038/nature14614
   Greaves LC, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1003082
   Gurkar AU, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3189
   Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485
   Han XF, 2012, J NUTR BIOCHEM, V23, P1592, DOI 10.1016/j.jnutbio.2011.11.002
   Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Hoshino A, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3308
   Hsu YJ, 2017, INT J CARDIOL, V228, P543, DOI 10.1016/j.ijcard.2016.11.247
   Huang R, 2015, MOL CELL, V57, P456, DOI 10.1016/j.molcel.2014.12.013
   Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3
   Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004
   Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3
   Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Itsara LS, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1003974
   Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084
   Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Khrapko K, 2007, NAT GENET, V39, P445, DOI 10.1038/ng0407-445
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   KLEIN I, 1991, CIRC RES, V68, P1100, DOI 10.1161/01.RES.68.4.1100
   Klepinin A, 2016, J BIOENERG BIOMEMBR, V48, P531, DOI 10.1007/s10863-016-9687-3
   Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kuka S, 2013, GEN PHYSIOL BIOPHYS, V32, P415, DOI 10.4149/gpb_2013049
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004
   Leone TC, 2011, COLD SH Q B, V76, P175, DOI 10.1101/sqb.2011.76.011965
   Lewis KN, 2013, ANTIOXID REDOX SIGN, V19, P1388, DOI 10.1089/ars.2012.4911
   Lin CC, 2016, FRONT PHARMACOL, V6, P0, DOI 10.3389/fphar.2015.00310
   Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422
   Logan A, 2014, AGING CELL, V13, P765, DOI 10.1111/acel.12212
   Lok NS, 1996, INT J CARDIOL, V54, P231, DOI 10.1016/0167-5273(96)02601-0
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Maejima Y, 2016, J MOL CELL CARDIOL, V95, P19, DOI 10.1016/j.yjmcc.2015.10.032
   Maltecca F, 2008, J NEUROSCI, V28, P2827, DOI 10.1523/JNEUROSCI.4677-07.2008
   Manella G, 2016, FRONT ENDOCRINOL, V7, P0, DOI 10.3389/fendo.2016.00162
   Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653
   Marzetti E, 2014, FRONT AGING NEUROSCI, V6, P0, DOI 10.3389/fnagi.2014.00233
   Marzetti E, 2013, AM J PHYSIOL-HEART C, V305, PH459, DOI 10.1152/ajpheart.00936.2012
   Marzetti E, 2009, CLIN GERIATR MED, V25, P715, DOI 10.1016/j.cger.2009.07.002
   McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   Mozaffarian D, 2016, CIRCULATION, V133, PE38, DOI 10.1161/CIR.0000000000000350
   MULLERHOCKER J, 1989, HUM PATHOL, V20, P666, DOI 10.1016/0046-8177(89)90154-8
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Murakawa T, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8527
   NAG AC, 1980, CYTOBIOS, V28, P41
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Nathania M, 2018, HEART, V104, P111, DOI 10.1136/heartjnl-2017-311275
   Ngo JK, 2007, ANN NY ACAD SCI, V1119, P78, DOI 10.1196/annals.1404.015
   North BJ, 2012, CIRC RES, V110, P1097, DOI 10.1161/CIRCRESAHA.111.246876
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Okatsu K, 2015, J CELL BIOL, V209, P111, DOI 10.1083/jcb.201410050
   PALMER JW, 1977, J BIOL CHEM, V252, P8731
   PALMER JW, 1985, ARCH BIOCHEM BIOPHYS, V236, P691, DOI 10.1016/0003-9861(85)90675-7
   Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200
   Parone PA, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0003257
   Patterson C, 2011, CIRC RES, V109, P453, DOI 10.1161/CIRCRESAHA.110.239749
   Peng LY, 2013, BIOCHEM BIOPH RES CO, V430, P822, DOI 10.1016/j.bbrc.2012.11.062
   Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001
   Portbury AL, 2011, J BIOL CHEM, V286, P9929, DOI 10.1074/jbc.R110.170571
   Powell SR, 2006, AM J PHYSIOL-HEART C, V291, PH1, DOI 10.1152/ajpheart.00062.2006
   Quirós PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984
   Rattanasopa C, 2015, J STEROID BIOCHEM, V147, P1, DOI 10.1016/j.jsbmb.2014.11.009
   Razeghi P, 2003, CIRCULATION, V108, P2536, DOI 10.1161/01.CIR.0000096481.45105.13
   Ren J, 2017, AGING CELL, V16, P976, DOI 10.1111/acel.12616
   Rhee SG, 2016, FREE RADICAL BIO MED, V100, P73, DOI 10.1016/j.freeradbiomed.2016.10.011
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Sallam N, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/7239639
   Sano R, 2012, GENE DEV, V26, P1041, DOI 10.1101/gad.184325.111
   Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003
   Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043
   Sciarretta S, 2012, CIRCULATION, V125, P1134, DOI 10.1161/CIRCULATIONAHA.111.078212
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002
   Shimizu Y, 2018, J MOL CELL CARDIOL, V116, P29, DOI 10.1016/j.yjmcc.2018.01.011
   Shinmura K, 2011, J MOL CELL CARDIOL, V50, P117, DOI 10.1016/j.yjmcc.2010.10.018
   Shirakabe A, 2016, CIRC RES, V118, P1563, DOI 10.1161/CIRCRESAHA.116.307474
   Someya S, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0171159
   Song MS, 2017, CELL METAB, V26, P872, DOI 10.1016/j.cmet.2017.09.023
   Song MS, 2015, CELL METAB, V21, P273, DOI 10.1016/j.cmet.2014.12.011
   Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057
   Srivastava S, 2017, GENES-BASEL, V8, P0, DOI 10.3390/genes8120398
   Sumandea MP, 2011, J BIOL CHEM, V286, P9921, DOI 10.1074/jbc.R110.175489
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Szklarczyk R, 2014, PHILOS T R SOC B, V369, P0, DOI 10.1098/rstb.2013.0439
   Tan VP, 2016, J MOL CELL CARDIOL, V95, P31, DOI 10.1016/j.yjmcc.2016.01.005
   Tatarková Z, 2011, PHYSIOL RES, V60, P281, DOI 10.33549/physiolres.932019
   TATE EL, 1976, J GERONTOL, V31, P129, DOI 10.1093/geronj/31.2.129
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Tepp K, 2017, MOL CELL BIOCHEM, V432, P141, DOI 10.1007/s11010-017-3005-1
   Theurey P, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9010022
   Tocchi A, 2015, BBA-BIOENERGETICS, V1847, P1424, DOI 10.1016/j.bbabio.2015.07.009
   Tóth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Troncoso R, 2012, CARDIOVASC RES, V93, P320, DOI 10.1093/cvr/cvr321
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   VLIEGEN HW, 1991, EUR HEART J, V12, P488, DOI 10.1093/oxfordjournals.eurheartj.a059928
   Voos W, 2013, BBA-MOL CELL RES, V1833, P388, DOI 10.1016/j.bbamcr.2012.06.005
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
   Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001
   Wohlgemuth SE, 2007, REJUV RES, V10, P281, DOI 10.1089/rej.2006.0535
   Wohlgemuth SE, 2014, J MOL CELL CARDIOL, V71, P62, DOI 10.1016/j.yjmcc.2014.03.007
   Wojtovich AP, 2012, EXP GERONTOL, V47, P1, DOI 10.1016/j.exger.2011.11.001
   Wong HS, 2017, J BIOL CHEM, V292, P16804, DOI 10.1074/jbc.R117.789271
   Wu H, 2016, FREE RADICAL BIO MED, V100, P199, DOI 10.1016/j.freeradbiomed.2016.03.030
   Yaniv Y, 2013, TRENDS ENDOCRIN MET, V24, P495, DOI 10.1016/j.tem.2013.06.001
   Yen WL, 2008, PHYSIOLOGY, V23, P248, DOI 10.1152/physiol.00013.2008
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Yuan H, 2009, AM J PHYSIOL-HEART C, V296, PH470, DOI 10.1152/ajpheart.01051.2008
   Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246
   Zhang YM, 2017, BBA-MOL BASIS DIS, V1863, P1919, DOI 10.1016/j.bbadis.2017.03.016
   Zhang YM, 2014, FREE RADICAL BIO MED, V71, P208, DOI 10.1016/j.freeradbiomed.2014.03.018
   Zhou J, 2017, AGING-US, V9, P583, DOI 10.18632/aging.101181
   Zierer J, 2016, AGING-US, V8, P77, DOI 10.18632/aging.100874
NR 177
TC 223
Z9 239
U1 6
U2 73
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 1759-5002
EI 1759-5010
J9 NAT REV CARDIOL
JI Nat. Rev. Cardiol.
PD SEP 15
PY 2018
VL 15
IS 9
BP 543
EP 554
DI 10.1038/s41569-018-0059-z
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GQ3WU
UT WOS:000441599300008
PM 30042431
DA 2024-11-01
ER

PT J
AU Punzi, G
   Porcelli, V
   Ruggiu, M
   Hossain, MF
   Menga, A
   Scarcia, P
   Castegna, A
   Gorgoglione, R
   Pierri, CL
   Laera, L
   Lasorsa, FM
   Paradies, E
   Pisano, I
   Marobbio, CMT
   Lamantea, E
   Ghezzi, D
   Tiranti, V
   Giannattasio, S
   Donati, MA
   Guerrini, R
   Palmieri, L
   Palmieri, F
   De Grassi, A
AF Punzi, Giuseppe
   Porcelli, Vito
   Ruggiu, Matteo
   Hossain, Md F.
   Menga, Alessio
   Scarcia, Pasquale
   Castegna, Alessandra
   Gorgoglione, Ruggiero
   Pierri, Ciro L.
   Laera, Luna
   Lasorsa, Francesco M.
   Paradies, Eleonora
   Pisano, Isabella
   Marobbio, Carlo M. T.
   Lamantea, Eleonora
   Ghezzi, Daniele
   Tiranti, Valeria
   Giannattasio, Sergio
   Donati, Maria A.
   Guerrini, Renzo
   Palmieri, Luigi
   Palmieri, Ferdinando
   De Grassi, Anna
TI <i>SLC25A10</i> biallelic mutations in intractable epileptic encephalopathy with complex I deficiency
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID mitochondrial dicarboxylate carrier; bacterial expression; functional-characterization; saccharomyces-cerevisiae; respiratory-chain; reconstitution; transport; identification; glutathione; sequence
AB Mitochondrial diseases are a plethora of inherited neuromuscular disorders sharing defects in mitochondrial respiration, but largely different from one another for genetic basis and pathogenic mechanism. Whole exome sequencing was performed in a familiar trio (trio-WES) with a child affected by severe epileptic encephalopathy associated with respiratory complex I deficiency and mitochondrial DNA depletion in skeletal muscle. By trio-WES we identified biallelic mutations in SLC25A10, a nuclear gene encoding a member of the mitochondrial carrier family. Genetic and functional analyses conducted on patient fibroblasts showed that SLC25A10 mutations are associated with reduction in RNA quantity and aberrant RNA splicing, and to absence of SLC25A10 protein and its transporting function. The yeast SLC25A10 ortholog knockout strain showed defects in mitochondrial respiration and mitochondrial DNA content, similarly to what observed in the patient skeletal muscle, and growth susceptibility to oxidative stress. Albeit patient fibroblasts were depleted in the main antioxidant molecules NADPH and glutathione, transport assays demonstrated that SLC25A10 is unable to transport glutathione. Here, we report the first recessive mutations of SLC25A10 associated to an inherited severe mitochondrial neurodegenerative disorder. We propose that SLC25A10 loss-of-function causes pathological disarrangements in respiratory-demanding conditions and oxidative stress vulnerability.
C1 [Punzi, Giuseppe; Porcelli, Vito; Menga, Alessio; Scarcia, Pasquale; Castegna, Alessandra; Gorgoglione, Ruggiero; Pierri, Ciro L.; Laera, Luna; Pisano, Isabella; Marobbio, Carlo M. T.; Palmieri, Luigi; Palmieri, Ferdinando; De Grassi, Anna] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4, I-70125 Bari, Italy.
   [Ruggiu, Matteo; Hossain, Md F.] St Johns Univ, Dept Biol Sci, Queens, NY 11439 USA.
   [Laera, Luna; Lasorsa, Francesco M.; Paradies, Eleonora; Giannattasio, Sergio; Palmieri, Ferdinando] CNR, Inst Biomembranes Bioenerget & Mol Biotech, I-70125 Bari, Italy.
   [Lamantea, Eleonora; Ghezzi, Daniele; Tiranti, Valeria] Fdn IRCCS, Inst Neurol C Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.
   [Ghezzi, Daniele] Univ Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy.
   [Donati, Maria A.; Guerrini, Renzo] Childrens Hosp A Meyer, Dept Neurosci, I-50139 Florence, Italy.
   [Guerrini, Renzo] IRCCS, Stella Maris Fdn, I-56128 Pisa, Italy.
C3 Universita degli Studi di Bari Aldo Moro; Saint John's University; Consiglio Nazionale delle Ricerche (CNR); Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Milan; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; IRCCS Fondazione Stella Maris
RP De Grassi, A (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4, I-70125 Bari, Italy.
EM anna.degrassi@uniba.it
FU MITOCON; Italian Association; General Medical Sciences of the National Institutes of Health [R15GM119099]; European Union Seventh Framework Programme under the project 'DESIRE' [602531]
CR Booty LM, 2015, FEBS LETT, V589, P621, DOI 10.1016/j.febslet.2015.01.027
   Castegna A, 2010, J BIOL CHEM, V285, P17359, DOI 10.1074/jbc.M109.097188
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Fiermonte G, 1999, BIOCHEM J, V344, P953, DOI 10.1042/0264-6021:3440953
   Fiermonte G, 1998, J BIOL CHEM, V273, P24754, DOI 10.1074/jbc.273.38.24754
   Hess DC, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000407
   Kamga CK, 2010, AM J PHYSIOL-CELL PH, V299, PC497, DOI 10.1152/ajpcell.00058.2010
   Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737
   Lash LH, 2015, J CLIN MED, V4, P1428, DOI 10.3390/jcm4071428
   Lauderback CM, 2003, FREE RADICAL RES, V37, P355, DOI 10.1080/1071576021000040664
   Menga A, 2015, INT J BIOCHEM CELL B, V60, P157, DOI 10.1016/j.biocel.2015.01.004
   Musatov A, 2012, FREE RADICAL RES, V46, P1313, DOI 10.3109/10715762.2012.717273
   Palmieri EM, 2015, BBA-BIOENERGETICS, V1847, P729, DOI 10.1016/j.bbabio.2015.04.009
   Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3
   PALMIERI F, 1971, EUR J BIOCHEM, V22, P66, DOI 10.1111/j.1432-1033.1971.tb01515.x
   Palmieri F, 1979, METHODS ENZYMOL, V56, P279
   Palmieri L, 1999, MOL MICROBIOL, V31, P569, DOI 10.1046/j.1365-2958.1999.01197.x
   Palmieri L, 1996, FEBS LETT, V399, P299, DOI 10.1016/S0014-5793(96)01350-6
   Palmieri L, 2008, BIOCHEM J, V410, P621, DOI 10.1042/BJ20070867
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   Schapira AHV, 2002, J INHERIT METAB DIS, V25, P207, DOI 10.1023/A:1015629912477
   Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Wilkins HM, 2013, J BIOL CHEM, V288, P5091, DOI 10.1074/jbc.M112.405738
   Zhou XS, 2015, ONCOTARGET, V6, P9271, DOI 10.18632/oncotarget.3375
NR 26
TC 36
Z9 38
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD FEB 1
PY 2018
VL 27
IS 3
BP 499
EP 504
DI 10.1093/hmg/ddx419
PG 6
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA FU8WF
UT WOS:000424136000009
PM 29211846
DA 2024-11-01
ER

PT J
AU Byrnes, J
   Ganetzky, R
   Lightfoot, R
   Tzeng, M
   Nakamaru-Ogiso, E
   Seiler, C
   Falk, MJ
AF Byrnes, James
   Ganetzky, Rebecca
   Lightfoot, Richard
   Tzeng, Michael
   Nakamaru-Ogiso, Eiko
   Seiler, Christoph
   Falk, Marni J.
TI Pharmacologic modeling of primary mitochondrial respiratory chain dysfunction in zebrafish
SO NEUROCHEMISTRY INTERNATIONAL
LA English
DT Article
DE D. rerio; Complex I; Complex IV; Complex V; Mitochondrial translation
ID leigh-syndrome; dna mutations; human-disease; deficiency; system; improves; chloramphenicol; translation; prevalence; disorders
AB Mitochondrial respiratory chain (RC) disease is a heterogeneous and highly morbid group of energy deficiency disorders for which no proven effective therapies exist. Robust vertebrate animal models of primary RC dysfunction are needed to explore the effects of variation in RC disease subtypes, tissue-specific manifestations, and major pathogenic factors contributing to each disorder, as well as their pre-clinical response to therapeutic candidates. We have developed a series of zebrafish (Danio rerio) models that inhibit, to variable degrees, distinct aspects of RC function, and enable quantification of animal development, survival, behaviors, and organ-level treatment effects as well as effects on mitochondrial biochemistry and physiology. Here, we characterize four pharmacologic inhibitor models of mitochondrial RC dysfunction in early larval zebrafish, including rotenone (complex I inhibitor), azide (complex IV inhibitor), oligomycin (complex V inhibitor), and chloramphenicol (mitochondrial translation inhibitor that leads to multiple RC complex dysfunction). A range of concentrations and exposure times of each RC inhibitor were systematically evaluated on early larval development, animal survival, integrated behaviors (touch and startle responses), organ physiology (brain death, neurologic tone, heart rate), and fluorescence-based analyses of mitochondrial physiology in zebrafish skeletal muscle. Pharmacologic RC inhibitor effects were validated by spectrophotometric analysis of Complex I, II and IV enzyme activities, or relative quantitation of ATP levels in larvae. Outcomes were prioritized that utilize in vivo animal imaging and quantitative behavioral assessments, as may optimally inform the translational potential of pre-clinical drug screens for future clinical study in human mitochondrial disease subjects. The RC complex inhibitors each delayed early embryo development, with short-term exposures of these three agents or chloramphenicol from 5 to 7 days post fertilization also causing reduced larval survival and organ-specific defects ranging from brain death, behavioral and neurologic alterations, reduced mitochondrial membrane potential in skeletal muscle (rotenone), and/or cardiac edema with visible blood pooling (oligomycin). Remarkably, we demonstrate that treating animals with probucol, a nutrient-sensing signaling network modulating drug that has been shown to yield therapeutic effects in a range of other RC disease cellular and animal models, both prevented acute rotenone-induced brain death in zebrafish larvae, and significantly rescued early embryo developmental delay from either rotenone or oligomycin exposure. Overall, these zebrafish pharmacologic RC function inhibition models offer a unique opportunity to gain novel insights into diverse developmental, survival, organ-level, and behavioral defects of varying severity, as well as their individual response to candidate therapies, in a highly tractable and cost-effective vertebrate animal model system. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Byrnes, James; Ganetzky, Rebecca; Lightfoot, Richard; Tzeng, Michael; Nakamaru-Ogiso, Eiko; Falk, Marni J.] Childrens Hosp, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA.
   [Seiler, Christoph] Childrens Hosp, Res Inst, Aquat Core Facil, Philadelphia, PA 19104 USA.
   [Falk, Marni J.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania
RP Falk, MJ (corresponding author), ARC 1002c,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.
EM falkm@email.chop.edu
FU National Institutes of Health [R01-HD065858, R01-GM120762, T32-GM008638]; Will Woleben Family Research Fund; Jaxson Flynt Family Research Fund; Children's Hospital of Philadelphia Research Institute Genes, Genomes, and Pediatric Disease (GGPD) research affinity group
CR ABOUKHALIL S, 1980, AM J HEMATOL, V8, P71, DOI 10.1002/ajh.2830080109
   Albrecht SC, 2014, J BIOMOL SCREEN, V19, P379, DOI 10.1177/1087057113499634
   Ali S, 2011, PLOS ONE, V6, P0
   Ali S, 2014, ZEBRAFISH, V11, P129, DOI 10.1089/zeb.2013.0901
   Avula S, 2014, CURR TREAT OPTION NE, V16, P0, DOI 10.1007/s11940-014-0292-7
   Baden KN, 2007, J BIOL CHEM, V282, P34839, DOI 10.1074/jbc.M703528200
   Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bretaud S, 2004, NEUROTOXICOL TERATOL, V26, P857, DOI 10.1016/j.ntt.2004.06.014
   Camp KM, 2016, MOL GENET METAB, V119, P187, DOI 10.1016/j.ymgme.2016.09.002
   Chinnery P, 2006, COCHRANE DB SYST REV, V1, P0
   Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909
   DiMauro S, 2009, BBA-MOL BASIS DIS, V1792, P1159, DOI 10.1016/j.bbadis.2008.10.015
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Falk MJ, 2011, EMBO MOL MED, V3, P410, DOI 10.1002/emmm.201100149
   Fashing M, 2016, MITOCHONDRIA PHYSL N, V1413, P1
   GALANTE YM, 1979, J BIOL CHEM, V254, P2372
   Garcia-Cazorla A, 2008, NEUROLOGY, V70, P1360, DOI 10.1212/01.wnl.0000309223.98616.e4
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Irving Brian A, 2007, CURR DIAB REP, V7, P249, DOI 10.1007/s11892-007-0039-x
   Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Li CH, 2010, TOXICOL SCI, V116, P140, DOI 10.1093/toxsci/kfq085
   López-Gallardo E, 2014, HUM MOL GENET, V23, P6191, DOI 10.1093/hmg/ddu339
   Mandemakers W, 2007, J CELL SCI, V120, P1707, DOI 10.1242/jcs.03443
   Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007
   McCormack S, 2015, MITOCHONDRION, V22, P45, DOI 10.1016/j.mito.2015.02.005
   McCormick E, 2013, NEUROTHERAPEUTICS, V10, P251, DOI 10.1007/s13311-012-0174-1
   McKee EE, 2006, ANTIMICROB AGENTS CH, V50, P2042, DOI 10.1128/AAC.01411-05
   Padilla PA, 2001, P NATL ACAD SCI USA, V98, P7331, DOI 10.1073/pnas.131213198
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Peng M, 2013, PLOS ONE, V8, P0
   Peng M, 2015, HUM MOL GENET, V24, P4829, DOI 10.1093/hmg/ddv207
   Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129
   Pinho BR, 2013, BRIT J PHARMACOL, V169, P1072, DOI 10.1111/bph.12186
   Rea SL, 2010, DEV DISABIL RES REV, V16, P200, DOI 10.1002/ddrr.114
   Ruzzenente B, 2016, HUM MOL GENET, V25, PR115, DOI 10.1093/hmg/ddw176
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Segref A, 2014, CELL METAB, V19, P642, DOI 10.1016/j.cmet.2014.01.016
   Seiler C, 2012, PLOS BIOL, V10, P0, DOI 10.1371/journal.pbio.1001386
   Sperl W, 2006, NEUROMUSCULAR DISORD, V16, P821, DOI 10.1016/j.nmd.2006.08.008
   STANNARD JN, 1948, J BIOL CHEM, V172, P599
   Steele SL, 2014, TRANSL RES, V163, P79, DOI 10.1016/j.trsl.2013.08.008
   Stocker R, 2009, CURR OPIN LIPIDOL, V20, P227, DOI 10.1097/MOL.0b013e32832aee68
   Wang YK, 2016, AEROSP SCI TECHNOL, V58, P103, DOI 10.1016/j.ast.2016.08.009
   Zhang Z, 2014, METHODS, V69, P315, DOI 10.1016/j.ymeth.2014.06.003
NR 50
TC 40
Z9 45
U1 1
U2 21
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0197-0186
EI 1872-9754
J9 NEUROCHEM INT
JI Neurochem. Int.
PD JUL 15
PY 2018
VL 117
IS 
BP 23
EP 34
DI 10.1016/j.neuint.2017.07.008
PG 12
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA GN0LN
UT WOS:000438660000004
PM 28732770
DA 2024-11-01
ER

PT J
AU Waldrop, MA
   Gumienny, F
   Boue, D
   de los Reyes, E
   Shell, R
   Weiss, RB
   Flanigan, KM
AF Waldrop, Megan A.
   Gumienny, Felecia
   Boue, Daniel
   de los Reyes, Emily
   Shell, Richard
   Weiss, Robert B.
   Flanigan, Kevin M.
TI Low-level expression of <i>EPG5</i> leads to an attenuated Vici syndrome phenotype
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE agenesis of the corpus callosum; EPG5; myopathy; Vici syndrome
ID sensorineural hearing-loss; corpus-callosum; muscle biopsy; mutation; agenesis; immunodeficiency; albinism
AB Vici syndrome is a multisystem disorder characterized by agenesis of the corpus callosum, oculocutaneous hypopigmentation, cataracts, cardiomyopathy, combined immunodeficiency, failure to thrive, profound developmental delay, and acquired microcephaly. Most individuals are severely affected and have a markedly reduced life span. Here we describe an 8-year-old boy with a history of developmental delay, agenesis of the corpus callosum, failure to thrive, myopathy, and well-controlled epilepsy. He was initially diagnosed with a mitochondrial disorder, based in part upon nonspecific muscle biopsy findings, but mitochondrial DNA mutation analysis revealed no mutations. Whole exome sequencing revealed compound heterozygosity for two EPG5 variants, inherited in trans. One was a known pathogenic mutation in exon 13 (c.2461C>T, p.Arg821X). The second was reported as a variant of unknown significance found within intron 16, six nucleotides before the exon 17 splice acceptor site (c.3099-6C>G). Reverse transcription-polymerase chain reaction of the EPG5 mRNA showed skipping of exon 17-which maintains an open reading frame-in 77% of the transcript, along with 23% expression of wild-type mRNA suggesting that intronic mutations may affect splicing of the EPG5 gene and result in symptoms. However, the expression of 23% wild-type mRNA may result in a significantly attenuated Vici syndrome phenotype.
C1 [Waldrop, Megan A.; Gumienny, Felecia; Flanigan, Kevin M.] Nationwide Childrens Hosp, Ctr Gene Therapy, Columbus, OH USA.
   [Waldrop, Megan A.; Flanigan, Kevin M.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA.
   [Waldrop, Megan A.; Flanigan, Kevin M.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA.
   [Boue, Daniel] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.
   [de los Reyes, Emily] Nationwide Childrens Hosp, Dept Pediat Neurol, Columbus, OH USA.
   [Shell, Richard] Nationwide Childrens Hosp, Dept Pulmonol, Columbus, OH USA.
   [Weiss, Robert B.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA.
C3 University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Utah System of Higher Education; University of Utah
RP Flanigan, KM (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, 700 Childrens Dr,Rm WA3011, Columbus, OH 43205 USA.
EM kevin.flanigan@nationwidechildrens.org
FU National Institute for Health [4T32NS077984-05]
CR Al-Owain M, 2010, AM J MED GENET A, V152A, P1849, DOI 10.1002/ajmg.a.33421
   Byrne S, 2016, ORPHANET J RARE DIS, V11, P0, DOI 10.1186/s13023-016-0399-x
   Byrne S, 2016, BRAIN, V139, P765, DOI 10.1093/brain/awv393
   Chiyonobu T, 2002, AM J MED GENET, V109, P61, DOI 10.1002/ajmg.10298
   Cullup T, 2013, NAT GENET, V45, P83, DOI 10.1038/ng.2497
   del Campo M, 1999, AM J MED GENET, V85, P479, DOI 10.1002/(SICI)1096-8628(19990827)85:5<479::AID-AJMG9>3.0.CO;2-D
   Ehmke N, 2014, AM J MED GENET A, V164, P3170, DOI 10.1002/ajmg.a.36772
   Finocchi A, 2012, AM J MED GENET A, V158A, P434, DOI 10.1002/ajmg.a.34244
   Hedberg-Oldfors C, 2017, NEUROMUSCULAR DISORD, V27, P771, DOI 10.1016/j.nmd.2017.05.005
   Maillard C, 2017, AM J MED GENET A, V173, P706, DOI 10.1002/ajmg.a.38061
   McClelland V, 2010, AM J MED GENET A, V152A, P741, DOI 10.1002/ajmg.a.33296
   Miyata R, 2007, AM J MED GENET A, V143A, P189, DOI 10.1002/ajmg.a.31584
   Miyata R, 2014, AM J MED GENET A, V164, P3203, DOI 10.1002/ajmg.a.36753
   Nickless A, 2017, CELL BIOSCI, V7, P0, DOI 10.1186/s13578-017-0153-7
   Özkale M, 2012, PEDIATR NEUROL, V47, P375, DOI 10.1016/j.pediatrneurol.2012.07.007
   Rogers RC, 2011, CASE REP GENET, V2011, P0
   Said E, 2012, AM J MED GENET A, V158A, P440, DOI 10.1002/ajmg.a.34273
   Tasdemir S, 2016, AM J MED GENET A, V170, P220, DOI 10.1002/ajmg.a.37398
   Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418
NR 19
TC 8
Z9 8
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD MAY 15
PY 2018
VL 176
IS 5
BP 1207
EP 1211
DI 10.1002/ajmg.a.38676
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA GH5FA
UT WOS:000433440600021
PM 29681093
DA 2024-11-01
ER

PT J
AU Vantroys, E
   Smet, J
   Vanlander, AV
   Vergult, S
   De Bruyne, R
   Roels, F
   Stepman, H
   Roeyers, H
   Menten, B
   Van Coster, R
AF Vantroys, Elise
   Smet, Joel
   Vanlander, Arnaud V.
   Vergult, Sarah
   De Bruyne, Ruth
   Roels, Frank
   Stepman, Hedwig
   Roeyers, Herbert
   Menten, Bjorn
   Van Coster, Rudy
TI Severe hepatopathy and neurological deterioration after start of valproate treatment in a 6-year-old child with mitochondrial tryptophanyl-tRNA synthetase deficiency
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Article
DE Mitochondrial tryptophanyl-tRNA synthetase; WARS2; Mitochondria; Mitochondrial aminoacyl-tRNA synthetase; Valproate; Hepatotoxicity; Cytochrome c oxidase; Mosaic
ID alpers-syndrome; status epilepticus; dna depletion; mutations; gene; encephalopathy; disease; liver; leukoencephalopathy; myopathy
AB Background: The first subjects with deficiency of mitochondrial tryptophanyl-tRNA synthetase (WARS2) were reported in 2017. Their clinical characteristics can be subdivided into three phenotypes (neonatal phenotype, severe infantile onset phenotype, Parkinson-like phenotype). Results: Here, we report on a subject who presented with early developmental delay, motor weakness and intellectual disability and who was considered during several years as having a non-progressive encephalopathy. At the age of six years, she had an epileptic seizure which was treated with sodium valproate. In the months after treatment was started, she developed acute liver failure and severe progressive encephalopathy. Although valproate was discontinued, she died six months later. Spectrophotometric analysis of the oxidative phosphorylation complexes in liver revealed a deficient activity of complex III and low normal activities of the complexes I and IV. Activity staining in the BN-PAGE gel confirmed the low activities of complex I, III and IV and, in addition, showed the presence of a subcomplex of complex V. Histochemically, a mosaic pattern was seen in hepatocytes after cytochrome c oxidase staining. Using Whole Exome Sequencing two known pathogenic variants were detected in WARS2 (c. 797delC, p. Pro266ArgfsTer10/c. 938 A > T, p. Lys313Met). Conclusion: This is the first report of severe hepatopathy in a subject with WARS2 deficiency. The hepatopathy occurred soon after start of sodium valproate treatment. In the literature, valproate-induced hepatotoxicity was reported in the subjects with pathogenic mutations in POLG and TWNK. This case report illustrates that the course of the disease in the subjects with a mitochondrial defect can be non-progressive during several years. The subject reported here was first diagnosed as having cerebral palsy. Only after a mitochondriotoxic medication was started, the disease became progressive, and the diagnosis of a mitochondrial defect was made.
C1 [Vantroys, Elise; Smet, Joel; Vanlander, Arnaud V.; Van Coster, Rudy] Ghent Univ Hosp, Dept Pediat Neurol & Metab, Ghent, Belgium.
   [Vergult, Sarah; Menten, Bjorn] Univ Ghent, Ctr Med Genet Ghent, Ghent, Belgium.
   [De Bruyne, Ruth] Ghent Univ Hosp, Dept Pediat Gastroenterol Hepatol & Nutr, Ghent, Belgium.
   [Roels, Frank] Ghent Univ Hosp, Dept Pathol, Ghent, Belgium.
   [Stepman, Hedwig] Ghent Univ Hosp, Dept Lab Med, Ghent, Belgium.
   [Roeyers, Herbert] Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium.
C3 Ghent University; Ghent University Hospital; Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University
RP Van Coster, R (corresponding author), Ghent Univ Hosp, Dept Pediat Neurol & Metab, Ghent, Belgium.
EM rudy.vancoster@ugent.be
FU Marguerite-Marie Delacroix; Special Research Fund (BOF) from the Ghent University [BOF.24 J.2014.0005.02]; Fund for Scientific Research Flanders (FWO)
CR Bao XH, 2008, BRAIN DEV-JPN, V30, P295, DOI 10.1016/j.braindev.2007.08.009
   Bolar NA, 2013, HUM MOL GENET, V22, P2590, DOI 10.1093/hmg/ddt107
   Burke EA, 2017, CLIN GENET, V0, P0
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497
   DiMauro S, 1993, GENEREVIEWS, V0, P0
   Diodato Daria, 2014, INT J CELL BIOL, V2014, P787956, DOI 10.1155/2014/787956
   Finsterer J, 2012, EXPERT OPIN DRUG MET, V8, P71, DOI 10.1517/17425255.2012.644535
   Gauthier-Villars M, 2001, NEUROPEDIATRICS, V32, P150, DOI 10.1055/s-2001-16614
   Krähenbühl S, 2000, LIVER, V20, P346, DOI 10.1034/j.1600-0676.2000.020004346.x
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9
   Martinez-Dominguez MT, 1998, CYTOGENET CELL GENET, V83, P249, DOI 10.1159/000015196
   Müller-Höcker J, 2011, J CELL MOL MED, V15, P445, DOI 10.1111/j.1582-4934.2009.00819.x
   Müller-Höcker J, 2002, HUM PATHOL, V33, P247, DOI 10.1053/hupa.2002.31477
   Musante L, 2017, HUM MUTAT, V0, P0
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nikali K, 1993, GENEREVIEWS, V0, P0
   PONCHAUT S, 1992, BIOCHEM PHARMACOL, V43, P644, DOI 10.1016/0006-2952(92)90590-F
   Rasmussen M, 2000, J CHILD NEUROL, V15, P473, DOI 10.1177/088307380001500709
   Roels F, 2009, BMC CLIN PATHOL, V9, P0, DOI 10.1186/1472-6890-9-4
   Schaller A, 2011, BMC NEUROL, V11, P0, DOI 10.1186/1471-2377-11-4
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Theisen BE, 2017, AM J MED GENET A, V173, P2505, DOI 10.1002/ajmg.a.38339
   Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   van der Westhuizen FH, 2010, J INHERIT METAB DIS, V33, PS55, DOI 10.1007/s10545-009-9020-y
   Vanlander AV, 2015, HUM MUTAT, V36, P222, DOI 10.1002/humu.22728
   Vantroys E, 2017, MOL GENET METAB, V122, P172, DOI 10.1016/j.ymgme.2017.10.004
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   Wortmann SB, 2017, HUM MUTAT, V38, P1786, DOI 10.1002/humu.23340
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P99, DOI 10.1007/s10545-014-9759-7
NR 36
TC 14
Z9 16
U1 0
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1750-1172
EI 
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD MAY 21
PY 2018
VL 13
IS 
BP 
EP 
DI 10.1186/s13023-018-0822-6
PG 9
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA GH0ME
UT WOS:000433095900001
PM 29783990
DA 2024-11-01
ER

PT J
AU Yu, XL
   Yan, CZ
   Ji, KQ
   Lin, PF
   Xu, XB
   Dai, TJ
   Li, W
   Zhao, YY
AF Yu, Xiao-Lin
   Yan, Chuan-Zhu
   Ji, Kun-Qian
   Lin, Peng-Fei
   Xu, Xue-Bi
   Dai, Ting-Jun
   Li, Wei
   Zhao, Yu-Ying
TI Clinical, Neuroimaging, and Pathological Analyses of 13 Chinese Leigh Syndrome Patients with Mitochondrial DNA Mutations
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
DE Clinical Features; Leigh Syndrome; Mitochondrial DNA; Neuroimaging; Pathology
ID complex-i; children; disease; manifestations; identification; phenotype; genetics; brain
AB Background: Leigh syndrome (LS) is a rare disease caused by mitochondrial defects and has high phenotypic and genotypic heterogeneity. We analyzed the clinical symptoms, neuroimaging, muscular histopathology, and genotypes of 13 Chinese LS patients with mitochondrial DNA (mtDNA) mutations. Methods: Mutations in mtDNA were identified by targeted sequencing. The brain imaging features on magnetic resonance imaging (MRI) were analyzed. The levels of lactate in fasting blood and cerebrospinal fluid (CSF) were routinely tested. The levels of urinary organic acids, plasma amino acids, and acylcarnitines were examined with gas chromatographyumass spectrometry and tandem mass spectrometry. The histopathological traits of skeletal muscles were analyzed under microscope. Results: Among 13 patients, mutations of MT-NDs (n = 8) and MT-ATP6 (n = 4) genes were most common. Strabismus (8/13), muscle weakness (8/13), and ataxia (5/13) were also common, especially for the patients with late-onset age after 2 years old. However, respiratory distress was common in patients with early-onset age before 2 years old. The most frequently affected brain area in these patients was the brain stem (12/13), particularly the dorsal part of midbrain, followed by basal ganglia (6/13), thalamus (6/13), cerebellum (5/13), and supratentorial white matter (2/13). Besides, the elevated lactate levels in CSF (6/6) were more common than those in serum (7/13). However, the analysis of abnormal plasma amino acid and urinary organic acid showed limited results (0/3 and 1/4, respectively). Muscular histopathology showed mitochondrial myopathy in the three late-onset patients but not in the early-onset ones. Conclusions: Noninvasive genetic screening is recommended for mtDNA mutations in MT-NDs and MT-ATP6 genes in patients with ophthalmoplegia, muscle weakness, ataxia, and respiratory disorder. Furthermore, the lactate detection in CSF and the brain MRI scanning are suggested as the diagnosis methods for LS patients with mtDNA mutations.
C1 [Yu, Xiao-Lin] Shandong Univ, Qilu Hosp, Dept Geriatr Med, Jinan 250012, Shandong, Peoples R China.
   [Yu, Xiao-Lin; Yan, Chuan-Zhu; Ji, Kun-Qian; Lin, Peng-Fei; Xu, Xue-Bi; Dai, Ting-Jun; Li, Wei; Zhao, Yu-Ying] Shandong Univ, Res Inst Neuromuscular & Neurodegenerat Dis, Qilu Hosp, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
   [Yu, Xiao-Lin] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Prote Shandong Prov, Jinan 250012, Shandong, Peoples R China.
   [Yan, Chuan-Zhu] Shandong Univ, Qilu Hosp Qingdao, Mitochondrial Med Lab, Qingdao 266035, Shandong, Peoples R China.
   [Yan, Chuan-Zhu] Shandong Univ, Brain Sci Res Inst, Jinan 250012, Shandong, Peoples R China.
C3 Shandong University; Shandong University; Shandong University; Shandong University; Shandong University
RP Zhao, YY (corresponding author), Shandong Univ, Res Inst Neuromuscular & Neurodegenerat Dis, Qilu Hosp, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
EM zyy72@126.com
FU National Natural Science Foundation of China [81671235, 81701237]; Taishan Scholars Program of Shandong Province
CR Arii J, 2000, AM J NEURORADIOL, V21, P1502
   Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Bonfante E, 2016, PEDIATR RADIOL, V46, P443, DOI 10.1007/s00247-015-3523-5
   Chomyn A, 2001, J BIOENERG BIOMEMBR, V33, P251, DOI 10.1023/A:1010791204961
   Chourasia N, 2017, PEDIATR NEUROL, V74, P97, DOI 10.1016/j.pediatrneurol.2017.05.008
   Fang F, 2017, SCI CHINA LIFE SCI, V60, P746, DOI 10.1007/s11427-017-9080-y
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2017, BIOMED REP, V6, P487, DOI 10.3892/br.2017.892
   Gerards M, 2016, MOL GENET METAB, V117, P300, DOI 10.1016/j.ymgme.2015.12.004
   Han J, 2015, BRIT J OPHTHALMOL, V99, P528, DOI 10.1136/bjophthalmol-2014-305704
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   Ji KQ, 2014, NEUROMOL MED, V16, P119, DOI 10.1007/s12017-013-8264-8
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lake NJ, 2015, J NEUROPATH EXP NEUR, V74, P482, DOI 10.1097/NEN.0000000000000195
   Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624
   Lee HF, 2009, PEDIATR NEUROL, V40, P88, DOI 10.1016/j.pediatrneurol.2008.09.020
   Lee JS, 2016, J CLIN NEUROL, V12, P181, DOI 10.3988/jcn.2016.12.2.181
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Ma YY, 2013, J CLIN NEUROSCI, V20, P1591, DOI 10.1016/j.jocn.2013.03.034
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   McKelvie P, 2012, J CLIN NEUROSCI, V19, P195, DOI 10.1016/j.jocn.2011.09.009
   Naess K, 2009, BBA-BIOENERGETICS, V1787, P484, DOI 10.1016/j.bbabio.2008.11.014
   Ogawa E, 2017, J INHERIT METAB DIS, V40, P685, DOI 10.1007/s10545-017-0042-6
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Sijens PE, 2008, BRAIN DEV-JPN, V30, P579, DOI 10.1016/j.braindev.2008.01.011
   Sinko G, 2014, PEDIATR NEUROL, V51, P585, DOI 10.1016/j.pediatrneurol.2014.07.015
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Sofou K, 2018, J MED GENET, V55, P21, DOI 10.1136/jmedgenet-2017-104891
   Sofou K, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-52
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Zhu CC, 2017, OPHTHALMIC GENET, V38, P67, DOI 10.3109/13816810.2015.1130153
NR 35
TC 13
Z9 15
U1 0
U2 12
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0366-6999
EI 
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD NOV 20
PY 2018
VL 131
IS 22
BP 2705
EP +
DI 10.4103/0366-6999.245265
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA HA3AJ
UT WOS:000450120700009
PM 30425197
DA 2024-11-01
ER

PT J
AU Pelnena, D
   Burnyte, B
   Jankevics, E
   Lace, B
   Dagyte, E
   Grigalioniene, K
   Utkus, A
   Krumina, Z
   Rozentale, J
   Adomaitiene, I
   Stavusis, J
   Pliss, L
   Inashkina, I
AF Pelnena, Dita
   Burnyte, Birute
   Jankevics, Eriks
   Lace, Baiba
   Dagyte, Evelina
   Grigalioniene, Kristina
   Utkus, Algirdas
   Krumina, Zita
   Rozentale, Jolanta
   Adomaitiene, Irina
   Stavusis, Janis
   Pliss, Liana
   Inashkina, Inna
TI Complete mtDNA sequencing reveals mutations m.9185T&gt;C and m.13513G&gt;A in three patients with Leigh syndrome
SO MITOCHONDRIAL DNA PART A
LA English
DT Article
DE Leigh syndrome; mitochondria DNA; brain MRI
ID mitochondrial-dna mutations; disease phenotypes; i-deficiency; common-cause; mtatp6 gene; children; melas; muscle
AB The most common mitochondrial disorder in children is Leigh syndrome, which is a progressive and genetically heterogeneous neurodegenerative disorder caused by mutations in nuclear genes or mito-chondrial DNA (mtDNA). In the present study, a novel and robust method of complete mtDNA sequenc-ing, which allows amplification of the whole mitochondrial genome, was tested. Complete mtDNA sequencing was performed in a cohort of patients with suspected mitochondrial mutations. Patients from Latvia and Lithuania (n = 92 and n = 57, respectively) referred by clinical geneticists were included. The de novo point mutations m.9185T>C and m.13513G>A, respectively, were detected in two patients with lactic acidosis and neurodegenerative lesions. In one patient with neurodegenerative lesions, the mutation m.9185T>C was identified. These mutations are associated with Leigh syndrome. The present data suggest that full-length mtDNA sequencing is recommended as a supplement to nuclear gene testing and enzymatic assays to enhance mitochondrial disease diagnostics.
C1 [Pelnena, Dita; Jankevics, Eriks; Lace, Baiba; Stavusis, Janis; Pliss, Liana; Inashkina, Inna] Latvian Biomed Res & Study Ctr, Ratsupites 1, LV-1067 Riga, Latvia.
   [Burnyte, Birute; Dagyte, Evelina; Grigalioniene, Kristina; Utkus, Algirdas] Vilnius Univ, Fac Med, Dept Human & Med Genet, Vilnius, Lithuania.
   [Lace, Baiba] Ctr Hosp Univ Quebec, Ville De Quebec, PQ, Canada.
   [Krumina, Zita] Childrens Clin Univ Hosp, Riga, Latvia.
   [Rozentale, Jolanta] Pauls Stradins Clin Univ Hosp, Riga, Latvia.
   [Adomaitiene, Irina] Vilnius Univ Hosp Santaros Klin, Childrens Hosp, Dept Radiol, Vilnius, Lithuania.
C3 Latvian Biomedical Research & Study Centre; Vilnius University; Laval University; Pauls Stradins Clinical University Hospital
RP Pelnena, D (corresponding author), Latvian Biomed Res & Study Ctr, Ratsupites 1, LV-1067 Riga, Latvia.
EM dita@biomed.lu.lv
FU European Regional Development Fund (ERDF) [2010/0223/2DP/2.1.1.1.0/10/APIA/VIAA/025]; ERDF [2014/0021/2DP/2.1.1.1.0/14/APIA/VIAA/058]; Taiwan-Latvian-Lithuanian Collaboration Project 'Functional model for the mitochondrial disease evaluation'
CR Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Brautbar A, 2008, MOL GENET METAB, V94, P485, DOI 10.1016/j.ymgme.2008.04.004
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   Childs AM, 2007, NEUROPEDIATRICS, V38, P313, DOI 10.1055/s-2008-1065355
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   Hsieh YT, 2011, OPHTHALMIC GENET, V32, P31, DOI 10.3109/13816810.2010.531880
   Jankevics E, 2016, EUROPEAN PATENT, V0, Patent No. [EP3091083 (A1)-2016-11-09, 3091083]
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Kolarova H, 2016, OPHTHALMIC GENET, V37, P419, DOI 10.3109/13816810.2015.1092045
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Makino M, 2000, J HUM GENET, V45, P69, DOI 10.1007/s100380050014
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107
   Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845
   Naess K, 2009, BBA-BIOENERGETICS, V1787, P484, DOI 10.1016/j.bbabio.2008.11.014
   Pliss L, 2011, EXP GERONTOL, V46, P560, DOI 10.1016/j.exger.2011.02.016
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Ramos A, 2009, ELECTROPHORESIS, V30, P1587, DOI 10.1002/elps.200800601
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Thorburn DR, 1993, GENEREVIEWS, V0, P0
   Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511
   Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398
   Wang ZX, 2010, NEUROPATHOLOGY, V30, P606, DOI 10.1111/j.1440-1789.2010.01115.x
   Wishart DS, 2013, NUCLEIC ACIDS RES, V41, PD801, DOI 10.1093/nar/gks1065
   Wortmann SB, 2017, NEUROPEDIATRICS, V48, P309, DOI 10.1055/s-0037-1603776
NR 30
TC 3
Z9 4
U1 0
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2470-1394
EI 2470-1408
J9 MITOCHONDRIAL DNA A
JI Mitochondrial DNA Part A
PD JUN 15
PY 2018
VL 29
IS 7
BP 1115
EP 1120
DI 10.1080/24701394.2017.1413365
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA HA4YU
UT WOS:000450274300013
PM 29228836
DA 2024-11-01
ER

PT J
AU Babin, PL
   Rao, SNR
   Chacko, A
   Alvina, FB
   Panwala, A
   Panwala, L
   Fumagalli, DC
AF Babin, Patricia L.
   Rao, Sudheendra N. R.
   Chacko, Anita
   Alvina, Fidelia B.
   Panwala, Anil
   Panwala, Leena
   Fumagalli, Danielle C.
TI Infantile Neuroaxonal Dystrophy: Diagnosis and Possible Treatments
SO FRONTIERS IN GENETICS
LA English
DT Article
DE infantile neuroaxonal dystrophy; rare disease; exome sequencing; enzyme replacement therapy; vector gene therapy; CRISPR/Cas9
ID independent phospholipase a(2); genetic-variation; brain; mitochondrial; therapy; cells; neurodegeneration; inhibition; ipla(2); disease
AB Infantile Neuroaxonal Dystrophy (INAD) is a rare neurodegenerative disease that often cuts short the life span of a child to 10 years. With a typical onset at 6 months of age, INAD is characterized by regression of acquired motor skills, delayed motor coordination and eventual loss of voluntary muscle control. Biallelic mutations in the PLA2G6 gene have been identified as the most frequent cause of INAD. We highlight the salient features of INAD molecular pathology and the progress made in molecular diagnostics. We reiterate that enhanced molecular diagnostic methodologies such as targeted gene panel testing, exome sequencing, and whole genome sequencing can help ascertain a molecular diagnosis. We describe how the defective catalytic activity of the PLA2G6 gene could be potentially overcome by enzyme replacement or gene correction, giving examples and challenges specific to INAD. This is expected to encourage steps toward developing and testing emerging therapies that might alleviate INAD progression and help realize objectives of patient formed organizations such as the INADcure Foundation.
C1 [Babin, Patricia L.; Rao, Sudheendra N. R.; Chacko, Anita; Alvina, Fidelia B.; Fumagalli, Danielle C.] Rare Genom Inst, Downey, CA 90241 USA.
   [Panwala, Anil; Panwala, Leena] INADcure Fdn, Fairfield, NJ USA.
RP Rao, SNR (corresponding author), Rare Genom Inst, Downey, CA 90241 USA.
EM sudhee26@gmail.com
CR BALSINDE J, 1995, P NATL ACAD SCI USA, V92, P8527, DOI 10.1073/pnas.92.18.8527
   Beck G, 2011, J NEUROSCI, V31, P11411, DOI 10.1523/JNEUROSCI.0345-11.2011
   Bey K, 2017, GENE THER, V24, P325, DOI 10.1038/gt.2017.18
   Dai Wei-Jing, 2016, MOL THER NUCLEIC ACIDS, V5, Pe349, DOI 10.1038/mtna.2016.58
   Engel LA, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0012897
   FDA, 2017, FDA APPR 1 TREATM FO, V0, P0
   Gregory A, 1993, GENEREVIEWS, V0, P0
   Iodice A, 2017, BRAIN DEV-JPN, V39, P93, DOI 10.1016/j.braindev.2016.08.012
   Jardim L, 2004, J INHERIT METAB DIS, V27, P229, DOI 10.1023/B:BOLI.0000028794.04349.91
   Kapoor S, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0155605
   Kurian MA, 2017, PLA2G6 ASS NEURODEGE, V0, P0
   LaFountaine JS, 2015, INT J PHARMACEUT, V494, P180, DOI 10.1016/j.ijpharm.2015.08.029
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Lessard S, 2017, P NATL ACAD SCI USA, V114, PE11257, DOI 10.1073/pnas.1714640114
   Levi S, 2014, FRONT PHARMACOL, V5, P0, DOI 10.3389/fphar.2014.00099
   Liou JY, 2005, EXP CELL RES, V306, P75, DOI 10.1016/j.yexcr.2005.01.011
   Macauley SL, 2009, EXP NEUROL, V218, P5, DOI 10.1016/j.expneurol.2009.03.040
   Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nassif Daniel, 2016, DEMENT. NEUROPSYCHOL., V10, P160, DOI 10.1590/S1980-5764-2016DN1002014
   Nishiyama J, 2017, NEURON, V96, P755, DOI 10.1016/j.neuron.2017.10.004
   Ong WY, 2005, J NEUROCYTOL, V34, P447, DOI 10.1007/s11068-006-8730-4
   Pardridge William M, 2005, NEURORX, V2, P3
   Pardridge WM, 2005, MOL BIOTECHNOL, V30, P57, DOI 10.1385/MB:30:1:057
   Pardridge WM, 2002, NAT REV DRUG DISCOV, V1, P131, DOI 10.1038/nrd725
   Ramanadham S, 2015, J LIPID RES, V56, P1643, DOI 10.1194/jlr.R058701
   Roca C, 2017, HUM MOL GENET, V26, P1535, DOI 10.1093/hmg/ddx058
   Scott DA, 2017, NAT MED, V23, P1095, DOI 10.1038/nm.4377
   Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200
   Smith AJ, 2012, GENE THER, V19, P154, DOI 10.1038/gt.2011.161
   Sorrentino NC, 2016, PEDIATR ENDOCR REV P, V13, P630
   Sorrentino NC, 2013, EMBO MOL MED, V5, P675, DOI 10.1002/emmm.201202083
   Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567
   Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023
   Yu-Wai-Man P, 2016, BRIT J OPHTHALMOL, V100, P1322, DOI 10.1136/bjophthalmol-2015-308329
   Zhao ZS, 2010, ENDOCRINOLOGY, V151, P3038, DOI 10.1210/en.2010-0016
NR 37
TC 10
Z9 14
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-8021
EI 
J9 FRONT GENET
JI Front. Genet.
PD DEC 10
PY 2018
VL 9
IS 
BP 
EP 
DI 10.3389/fgene.2018.00597
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA HD6MU
UT WOS:000452655000001
PM 30619446
DA 2024-11-01
ER

PT J
AU Vellers, HL
   Kleeberger, SR
   Lightfoot, JT
AF Vellers, Heather L.
   Kleeberger, Steven R.
   Lightfoot, J. Timothy
TI Inter-individual variation in adaptations to endurance and resistance exercise training: genetic approaches towards understanding a complex phenotype
SO MAMMALIAN GENOME
LA English
DT Article
ID quantitative trait loci; spontaneous physical-activity; all-cause mortality; skeletal-muscle; collaborative cross; artificial selection; voluntary exercise; familial aggregation; protein-synthesis; hindlimb muscles
AB Exercise training which meets the recommendations set by the National Physical Activity Guidelines ensues a multitude of health benefits towards the prevention and treatment of various chronic diseases. However, not all individuals respond well to exercise training. That is, some individuals have no response, while others respond poorly. Genetic background is known to contribute to the inter-individual (human) and -strain (e.g., mice, rats) variation with acute exercise and exercise training, though to date, no specific genetic factors have been identified that explain the differential responses to exercise. In this review, we provide an overview of studies in human and animal models that have shown a significant contribution of genetics in acute exercise and exercise training-induced adaptations with standardized endurance and resistance training regimens, and further describe the genetic approaches which have been used to demonstrate such responses. Finally, our current understanding of the role of genetics and exercise is limited primarily to the nuclear genome, while only a limited focus has been given to a potential role of the mitochondrial genome and its interactions with the nuclear genome to predict the exercise training-induced phenotype(s) responses. We therefore discuss the mitochondrial genome and literature that suggests it may play a significant role, particularly through interactions with the nuclear genome, in the inherent ability to respond to exercise.
C1 [Vellers, Heather L.; Kleeberger, Steven R.] NIEHS, Immun Inflammat & Dis Lab, 111 TW Alexander Dr,Bldg 101,E-224, Res Triangle Pk, NC 27709 USA.
   [Lightfoot, J. Timothy] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX 77843 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Texas A&M University System; Texas A&M University College Station
RP Vellers, HL (corresponding author), NIEHS, Immun Inflammat & Dis Lab, 111 TW Alexander Dr,Bldg 101,E-224, Res Triangle Pk, NC 27709 USA.
EM Heather.vellers@nih.gov
CR Acosta W, 2017, BEHAV PROCESS, V135, P56, DOI 10.1016/j.beproc.2016.11.018
   Alevizos A, 2005, INT J CLIN PRACT, V59, P922, DOI 10.1111/j.1742-1241.2005.00536.x
   Andersson SGE, 2003, PHILOS T R SOC B, V358, P165, DOI 10.1098/rstb.2002.1193
   [Anonymous], 2014, ACSMS GUID EX TEST P, V0, P0
   [Anonymous], 2008, PHYSICAL ACTIVITY GUIDELINES FOR AMERICANS, V0, P15
   Atanur SS, 2013, CELL, V154, P691, DOI 10.1016/j.cell.2013.06.040
   Aylor DL, 2011, GENOME RES, V21, P1213, DOI 10.1101/gr.111310.110
   BAILEY DW, 1971, TRANSPLANTATION, V11, P325, DOI 10.1097/00007890-197103000-00013
   Barbato JC, 1998, J APPL PHYSIOL, V85, P530, DOI 10.1152/jappl.1998.85.2.530
   Belardinelli R, 1999, CIRCULATION, V99, P1173, DOI 10.1161/01.CIR.99.9.1173
   Bell R, 2011, CIRC-CARDIOVASC GENE, V4, P223, DOI 10.1161/CIRCGENETICS.110.958934
   Bodine SC, 2012, METHODS MOL BIOL, V798, P213, DOI 10.1007/978-1-61779-343-1_12
   Bonafiglia JT, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0167790
   Bottomly D, 2012, G3-GENES GENOM GENET, V2, P213, DOI 10.1534/g3.111.001800
   Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003
   Bouchard C, 2001, MED SCI SPORT EXER, V33, PS446, DOI 10.1097/00005768-200106001-00013
   Bouchard C, 2015, PROG CARDIOVASC DIS, V57, P337, DOI 10.1016/j.pcad.2014.08.005
   Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010
   Bray MS, 2009, MED SCI SPORT EXER, V41, P34, DOI 10.1249/MSS.0b013e3181844179
   Brearley MB, 2001, SPORTSCIENCE, V5, P0
   Britton S L, 2001, EXERC SPORT SCI REV, V29, P7
   BURGESS ML, 1993, AM J PHYSIOL, V264, PR149, DOI 10.1152/ajpregu.1993.264.1.R149
   Campbell KL, 2007, J NUTR, V137, P161S, DOI 10.1093/jn/137.1.161S
   Chen Q, 2000, ZHONGGUO YING YONG SHENG LI XUE ZA ZHI, V16, P327
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Chow LS, 2007, J APPL PHYSIOL, V102, P1078, DOI 10.1152/japplphysiol.00791.2006
   Church RJ, 2015, FOOD CHEM TOXICOL, V76, P19, DOI 10.1016/j.fct.2014.11.008
   Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133
   Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2
   Courtney SM, 2012, PHYSIOL GENOMICS, V44, P948, DOI 10.1152/physiolgenomics.00051.2012
   Courtney SM, 2014, F1000RESEARCH, V3, P0
   Crowley JJ, 2015, NAT GENET, V47, P353, DOI 10.1038/ng.3222
   Davis MS, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0103087
   Desai KH, 1997, AM J PHYSIOL-HEART C, V272, PH1053, DOI 10.1152/ajpheart.1997.272.2.H1053
   DIONNE FT, 1991, MED SCI SPORT EXER, V23, P177
   Epp T S, 2006, EQUINE VET J SUPPL, V0, P502
   Farrell PA, 1999, J APPL PHYSIOL, V87, P1075, DOI 10.1152/jappl.1999.87.3.1075
   Favier FB, 2016, J APPL PHYSIOL, V120, P455, DOI 10.1152/japplphysiol.00171.2015
   Ferguson DP, 2014, J APPL PHYSIOL, V116, P1057, DOI 10.1152/japplphysiol.00911.2013
   Ferris LT, 2007, MED SCI SPORT EXER, V39, P728, DOI 10.1249/mss.0b013e31802f04c7
   Ferris MT, 2013, PLOS PATHOG, V9, P0, DOI 10.1371/journal.ppat.1003196
   Firshman AM, 2015, AM J VET RES, V76, P1058, DOI 10.2460/ajvr.76.12.1058
   Fluckey JD, 1996, J GERONTOL A-BIOL, V51, PB323, DOI 10.1093/gerona/51A.5.B323
   Fluckey JD, 1996, AM J PHYSIOL-ENDOC M, V270, PE313, DOI 10.1152/ajpendo.1996.270.2.E313
   FLUCKEY JD, 1995, J APPL PHYSIOL, V79, P1100, DOI 10.1152/jappl.1995.79.4.1100
   Garland T, 2006, J EXP BIOL, V209, P2344, DOI 10.1242/jeb.02244
   Garland T, 2011, J EXP BIOL, V214, P206, DOI 10.1242/jeb.048397
   Harrill AH, 2016, DRUG DISCOVERY TOXICOLOGY: FROM TARGET ASSESSMENT TO TRANSLATIONAL BIOMARKERS, V0, P314
   Hirano M, 2001, SEMINARS CELL DEV BI, V0, P0
   Hubal MJ, 2005, MED SCI SPORT EXER, V37, P964, DOI 10.1249/01.mss.0000170469.90461.5f
   Huffman KM, 2014, DIABETOLOGIA, V57, P2282, DOI 10.1007/s00125-014-3343-4
   Iestra JA, 2005, CIRCULATION, V112, P924, DOI 10.1161/CIRCULATIONAHA.104.503995
   Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639
   KAO FF, 1956, AM J PHYSIOL, V185, P145, DOI 10.1152/ajplegacy.1956.185.1.145
   Kemi OJ, 2002, J APPL PHYSIOL, V93, P1301, DOI 10.1152/japplphysiol.00231.2002
   Kesterson RA, 2016, BIOPROTOCOL, V6, P0
   Kilikevicius A, 2013, SCAND J MED SCI SPOR, V23, P657, DOI 10.1111/j.1600-0838.2012.01451.x
   KLITGAARD H, 1988, J APPL PHYSIOL, V64, P1740, DOI 10.1152/jappl.1988.64.4.1740
   Koch LG, 2013, PHYSIOL GENOMICS, V45, P606, DOI 10.1152/physiolgenomics.00021.2013
   Koch LG, 1998, AM J PHYSIOL-REG I, V275, PR1455, DOI 10.1152/ajpregu.1998.275.5.R1455
   Koch LG, 1999, PHYSIOL GENOMICS, V1, P63, DOI 10.1152/physiolgenomics.1999.1.2.63
   Koch LG, 2005, AM J PHYSIOL-REG I, V288, PR466, DOI 10.1152/ajpregu.00621.2004
   Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45
   KOHRT WM, 1991, J APPL PHYSIOL, V71, P2004, DOI 10.1152/jappl.1991.71.5.2004
   Kregel KC, 2006, AM PHYSL SOC, V0, P152
   Kuster DWD, 2014, J MOL CELL CARDIOL, V77, P168, DOI 10.1016/j.yjmcc.2014.10.006
   LaMonte MJ, 2005, J APPL PHYSIOL, V99, P1205, DOI 10.1152/japplphysiol.00193.2005
   Lightfoot JT, 2008, PHYSIOL GENOMICS, V32, P401, DOI 10.1152/physiolgenomics.00241.2007
   Lightfoot JT, 2007, J APPL PHYSIOL, V103, P105, DOI 10.1152/japplphysiol.01328.2006
   Lightfoot JT, 2010, J APPL PHYSIOL, V109, P623, DOI 10.1152/japplphysiol.00525.2010
   Lightfoot JT, 2001, MED SCI SPORT EXER, V33, P2053, DOI 10.1097/00005768-200112000-00012
   Lowe DA, 2002, J ORTHOP SPORT PHYS, V32, P36, DOI 10.2519/jospt.2002.32.2.36
   Lundby C, 2017, ACTA PHYSIOL, V220, P218, DOI 10.1111/apha.12827
   Ma LH, 2000, CHIN J SPORTS MED, V19, P349
   Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904
   Massett MP, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0145741
   Massett MP, 2009, PHYSIOL GENOMICS, V40, P15, DOI 10.1152/physiolgenomics.00116.2009
   Massett MP, 2005, AM J PHYSIOL-REG I, V288, PR1006, DOI 10.1152/ajpregu.00476.2004
   Mathes WF, 2011, AM J PHYSIOL-ENDOC M, V300, PE1124, DOI 10.1152/ajpendo.00707.2010
   Matin A, 1999, NAT GENET, V23, P237, DOI 10.1038/13874
   Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863
   Montero D, 2017, J PHYSIOL-LONDON, V595, P3377, DOI 10.1113/JP273480
   Moore SC, 2012, PLOS MED, V9, P0, DOI 10.1371/journal.pmed.1001335
   Nicastro H, 2012, BIOMED RES INT, V2012, P7
   PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003
   Park JH, 2016, FEBS LETT, V590, P924, DOI 10.1002/1873-3468.12061
   Pérusse L, 2001, MED SCI SPORT EXER, V33, P597
   Petrosino JM, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0148010
   Poole DC, 2007, EQUINE VET J, V39, P292, DOI 10.2746/042516407X204078
   Poole DC, 2011, COMPR PHYSIOL, V1, P1, DOI 10.1002/cphy.c091001
   Prudhomme D, 1983, MED SCI SPORTS EXERC, V0, P0
   PUNTSCHART A, 1995, AM J PHYSIOL-CELL PH, V269, PC619, DOI 10.1152/ajpcell.1995.269.3.C619
   Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595
   Rivera MA, 1998, MED SCI SPORT EXER, V30, P687, DOI 10.1097/00005768-199805000-00007
   Roberts A, 2007, MAMM GENOME, V18, P473, DOI 10.1007/s00335-007-9045-1
   Roberts MD, 2014, J PHYSIOL-LONDON, V592, P2119, DOI 10.1113/jphysiol.2013.268805
   Roberts MD, 2013, AM J PHYSIOL-REG I, V304, PR1024, DOI 10.1152/ajpregu.00581.2012
   Robinson MM, 2017, CELL METAB, V25, P581, DOI 10.1016/j.cmet.2017.02.009
   Rogala AR, 2014, MAMM GENOME, V25, P95, DOI 10.1007/s00335-013-9499-2
   Rubio DM, 2010, ACAD MED, V85, P470, DOI 10.1097/ACM.0b013e3181ccd618
   Safdar A, 2016, SKELET MUSCLE, V6, P0, DOI 10.1186/s13395-016-0075-9
   Saleem A, 2009, PHYSIOL GENOMICS, V37, P58, DOI 10.1152/physiolgenomics.90346.2008
   Schaeffer PJ, 1996, J EXP BIOL, V199, P351
   Schmidt CW, 2015, ENVIRON HEALTH PERSP, V123, PA64, DOI 10.1289/ehp.123-A64
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Scott RA, 2005, COMP BIOCHEM PHYS B, V140, P497, DOI 10.1016/j.cbpc.2004.11.014
   Seo DY, 2014, PFLUG ARCH EUR J PHY, V466, P1673, DOI 10.1007/s00424-014-1496-0
   Swallow JG, 1998, J APPL PHYSIOL, V84, P69, DOI 10.1152/jappl.1998.84.1.69
   Swallow JG, 1998, BEHAV GENET, V28, P227, DOI 10.1023/A:1021479331779
   TAMAKI T, 1992, MED SCI SPORT EXER, V24, P881
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thomis MAI, 1998, MED SCI SPORT EXER, V30, P724, DOI 10.1097/00005768-199805000-00013
   Thompson PD, 2004, MED SCI SPORT EXER, V36, P1132, DOI 10.1249/01.MSS.0000132274.26612.23
   Threadgill DW, 2012, G3-GENES GENOM GENET, V2, P153, DOI 10.1534/g3.111.001891
   Threadgill DW, 2011, ILAR J, V52, P24, DOI 10.1093/ilar.52.1.24
   Threadgill DW, 2002, MAMM GENOME, V13, P175, DOI 10.1007/s00335-001-4001-Y
   Trounce I, 2000, HUM REPROD, V15 Suppl 2, P18
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252
   Voet D, 2013, FUNDAMENTALS OF BIOCHEMISTRY, V0, P0
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wang PY, 2013, NEW ENGL J MED, V368, P1027, DOI 10.1056/NEJMoa1214091
   WATT PW, 1982, J APPL PHYSIOL, V53, P1144, DOI 10.1152/jappl.1982.53.5.1144
   Wilmore JH, 1998, AM J CLIN NUTR, V68, P66, DOI 10.1093/ajcn/68.1.66
   Wirth O, 2003, J APPL PHYSIOL, V95, P402, DOI 10.1152/japplphysiol.00919.2002
   Xu SZ, 2017, GENETICS, V207, P785, DOI 10.1534/genetics.117.300102
   Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zou F, 2005, GENETICS, V170, P1299, DOI 10.1534/genetics.104.035709
   Zou F, 2014, GENETICS, V197, P389, DOI 10.1534/genetics.113.160119
NR 130
TC 29
Z9 32
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0938-8990
EI 1432-1777
J9 MAMM GENOME
JI Mamm. Genome
PD FEB 15
PY 2018
VL 29
IS 1-2
BP 48
EP 62
DI 10.1007/s00335-017-9732-5
PG 15
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity
GA FZ1WZ
UT WOS:000427369600005
PM 29356897
DA 2024-11-01
ER

PT J
AU Tranah, GJ
   Katzman, SM
   Lauterjung, K
   Yaffe, K
   Manini, TM
   Kritchevsky, S
   Newman, AB
   Harris, TB
   Cummings, SR
AF Tranah, Gregory J.
   Katzman, Shana M.
   Lauterjung, Kevin
   Yaffe, Kristine
   Manini, Todd M.
   Kritchevsky, Stephen
   Newman, Anne B.
   Harris, Tamara B.
   Cummings, Steven R.
TI Mitochondrial DNA m.3243A &gt; G heteroplasmy affects multiple aging phenotypes and risk of mortality
SO SCIENTIFIC REPORTS
LA English
DT Article
ID lactic-acidosis; a3243g mutation; melas mutation; transfer rna(leu(uur)); clinical-features; clonal expansions; read alignment; nd3 gene; mtdna; muscle
AB Mitochondria contain many copies of a circular DNA molecule (mtDNA), which has been observed as a mixture of normal and mutated states known as heteroplasmy. Elevated heteroplasmy at a single mtDNA site, m.3243A > G, leads to neurologic, sensory, movement, metabolic, and cardiopulmonary impairments. We measured leukocyte mtDNA m.3243A > G heteroplasmy in 789 elderly men and women from the bi-racial, population-based Health, Aging, and Body Composition Study to identify associations with age-related functioning and mortality. Mutation burden for the m.3243A > G ranged from 0-19% and elevated heteroplasmy was associated with reduced strength, cognitive, metabolic, and cardiovascular functioning. Risk of all-cause, dementia and stroke mortality was significantly elevated for participants in the highest tertiles of m.3243A > G heteroplasmy. These results indicate that the accumulation of a rare genetic disease mutation, m.3243A > G, manifests as several aging outcomes and that some diseases of aging may be attributed to the accumulation of mtDNA damage.
C1 [Tranah, Gregory J.; Lauterjung, Kevin; Cummings, Steven R.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA.
   [Katzman, Shana M.] LA Eye Ctr & Clin, Los Angeles, CA 90037 USA.
   [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94121 USA.
   [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94121 USA.
   [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94121 USA.
   [Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA 94121 USA.
   [Manini, Todd M.] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL 32601 USA.
   [Kritchevsky, Stephen] Wake Forest Sch Med, Sticht Ctr Aging, Winston Salem, NC 27157 USA.
   [Newman, Anne B.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15213 USA.
   [Harris, Tamara B.] NIA, Intramural Res Program, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA.
C3 California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; State University System of Florida; University of Florida; Wake Forest University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh
RP Tranah, GJ (corresponding author), Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA.
EM gtranah@sfcc-cpmc.net
FU Intramural Research Program of the NIH, National Institute on Aging [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106]; National Institutes of Health [R01-AG028050, R03-AG032498, R01-NR012459, Z01A6000932, R01-HL121023]; Research and Education Leadership Committee of the CPMC Foundation; L.K. Whittier Foundation
CR ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   BERES CA, 1981, J GERONTOL, V36, P591, DOI 10.1093/geronj/36.5.591
   Blakely EL, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011296
   Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, ANN NEUROL, V47, P381, DOI 10.1002/1531-8249(200003)47:3<381::AID-ANA17>3.0.CO;2-2
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Comte C, 2013, NUCLEIC ACIDS RES, V41, P418, DOI 10.1093/nar/gks965
   Coon KD, 2006, MITOCHONDRION, V6, P194, DOI 10.1016/j.mito.2006.07.002
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   DAMIAN MS, 1995, ACTA NEUROL SCAND, V92, P409
   Dubeau F, 2000, ANN NEUROL, V47, P179, DOI 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Figueiredo PA, 2009, J GERONTOL A-BIOL, V64, P21, DOI 10.1093/gerona/gln048
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   Gilchrist JM, 1996, STROKE, V27, P1420, DOI 10.1161/01.STR.27.8.1420
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   Hao HL, 1999, HUM MOL GENET, V8, P1117, DOI 10.1093/hmg/8.6.1117
   Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263
   Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382
   JEANFRANCOIS MJB, 1994, AUST NZ J MED, V24, P188, DOI 10.1111/j.1445-5994.1994.tb00556.x
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Kärppä M, 2004, J NEUROL, V251, P556, DOI 10.1007/s00415-004-0363-x
   Khrapko K, 2003, MUTAT RES-FUND MOL M, V522, P13, DOI 10.1016/S0027-5107(02)00306-8
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirches E, 2001, J MED GENET, V38, P312, DOI 10.1136/jmg.38.5.312
   KOGA Y, 1988, ANN NEUROL, V24, P749, DOI 10.1002/ana.410240609
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li H, 2009, BIOINFORMATICS, V25, P1094, DOI 10.1093/bioinformatics/btp100
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Marotta R, 2009, J CLIN NEUROSCI, V16, P1223, DOI 10.1016/j.jocn.2008.11.012
   MARTINUZZI A, 1992, J NEUROL SCI, V113, P222, DOI 10.1016/0022-510X(92)90250-O
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Naue J, 2015, MITOCHONDRION, V20, P82, DOI 10.1016/j.mito.2014.12.002
   Naviaux RK, 2000, EUR J PEDIATR, V159, PS219, DOI 10.1007/PL00014407
   OZAWA T, 1995, BBA-MOL BASIS DIS, V1271, P177, DOI 10.1016/0925-4439(95)00026-Z
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   PENISSONBESNIER I, 1992, J NEUROL SCI, V110, P144, DOI 10.1016/0022-510X(92)90021-C
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Pons R, 2004, J PEDIATR-US, V144, P81, DOI 10.1016/j.jpeds.2003.10.023
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147
   Ross JM, 2013, NATURE, V0, P0
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Russell O, 2014, EXP CELL RES, V325, P38, DOI 10.1016/j.yexcr.2014.03.012
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Spyropoulos A, 2013, JAMA NEUROL, V70, P1552, DOI 10.1001/jamaneurol.2013.4111
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   TENG EL, 1987, J CLIN PSYCHIAT, V48, P314
   Tranah GJ, 2015, J GERONTOL A-BIOL, V70, P1418, DOI 10.1093/gerona/glv097
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Tyrrell DJ, 2015, J GERONTOL A-BIOL, V70, P1394, DOI 10.1093/gerona/glu096
   van den Ouweland JMW, 1999, DIABETOLOGIA, V42, P485, DOI 10.1007/s001250051183
   Van Remmen H, 2009, J GERONTOL A-BIOL, V64, P171, DOI 10.1093/gerona/gln058
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   WALLACE DC, 1992, J INHERIT METAB DIS, V15, P472, DOI 10.1007/BF01799605
   Wechsler D, 1997, WECHSLER ADULT INTELLIGENCE SCALE - FOURTH EDITION (WAIS-IV), V0, P0
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
NR 76
TC 36
Z9 39
U1 3
U2 10
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD AUG 8
PY 2018
VL 8
IS 
BP 
EP 
DI 10.1038/s41598-018-30255-6
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GP6JH
UT WOS:000440985500010
PM 30089816
DA 2024-11-01
ER

PT J
AU Lemoine, S
   Panaye, M
   Rabeyrin, M
   Errazuriz-Cerda, E
   de Camaret, BM
   Petiot, P
   Juillard, L
   Guebre-Egziabher, F
AF Lemoine, Sandrine
   Panaye, Marine
   Rabeyrin, Maud
   Errazuriz-Cerda, Elisabeth
   de Camaret, Benedicte Mousson
   Petiot, Philippe
   Juillard, Laurent
   Guebre-Egziabher, Fitsum
TI Renal Involvement in Neuropathy, Ataxia, Retinitis Pigmentosa (NARP) Syndrome: A Case Report
SO AMERICAN JOURNAL OF KIDNEY DISEASES
LA English
DT Article
ID mitochondrial dysfunction; disease; mutation; injury; gene
AB We report a case of a patient who had the mitochondrial cytopathy complex of neuropathy, ataxia, and retinitis pigmentosa (NARP) syndrome diagnosed at age 11 years with a biopsy-proven kidney involvement that progressed to end-stage renal disease at age 21 years. Mutations of mitochondrial DNA (mtDNA) are maternally inherited and lead to mitochondrial cytopathies with predominant neurologic manifestations: psychomotor retardation, epilepsy, ataxia, neuropathy, and myopathy. Given the ubiquitous nature of mitochondria, cellular dysfunction can also appear in tissues with high metabolic turnover; thus, there can be cardiac, digestive, ophthalmologic, and kidney complications. Mutations in the MT-ATP6 gene of mtDNA have been shown to cause NARP syndrome without renal involvement. We report a patient who had NARP syndrome diagnosed at age 11 years in whom glomerular proteinuria was present very early after diagnosis. Although neurologic manifestations were stable over time, he developed worsening proteinuria and kidney function. He started dialysis therapy at age 21 years. Kidney biopsy confirmed the mitochondrial cytopathy histologically, with abnormal mitochondria seen on electron microscopy. The MT-ATP6 gene mutation was detected in the kidney biopsy specimen.
C1 [Lemoine, Sandrine; Panaye, Marine; Juillard, Laurent] Hosp Edouard Herriot, Hosp Civils Lyon, Serv Nephrol, Lyon, France.
   [Lemoine, Sandrine; Juillard, Laurent; Guebre-Egziabher, Fitsum] Univ Lyon 1, Univ Lyon, INSERM U1060, CarMeN, Lyon, France.
   [Rabeyrin, Maud] Hosp Civils Lyon, Hop Edouard Herriot, Lab Anat & Cytol Pathol, Lyon, France.
   [Errazuriz-Cerda, Elisabeth] Ctr Imagerie Quantitat Lyon Est, Fac Med Laennec Lyon, Lyon, France.
   [de Camaret, Benedicte Mousson] Hosp Civils Lyon, Ctr Biol & Pathol Est, Serv Maladiea Hereditaires Metab, Lyon, France.
   [Petiot, Philippe] Hop Croix Rousse, Hop Civils Lyon, Ctr Reference Maladies Neuro Musculaires, Explorat Fonctionnelles Neurol, Lyon, France.
   [Guebre-Egziabher, Fitsum] Ctr hosp Univ Grenoble Alpes, Dept Nephrol Dialysis Apheresis Transplantat, Blvd Chantourne, F-38700 La Tronche, France.
C3 bioMerieux; CHU Lyon; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; CHU Lyon; CHU Lyon; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes
RP Guebre-Egziabher, F (corresponding author), Ctr hosp Univ Grenoble Alpes, Dept Nephrol Dialysis Apheresis Transplantat, Blvd Chantourne, F-38700 La Tronche, France.
EM fguebreegziabher@chu-grenoble.fr
CR Che RC, 2014, AM J PHYSIOL-RENAL, V306, PF367, DOI 10.1152/ajprenal.00571.2013
   DICKMAN KG, 1990, AM J PHYSIOL, V258, PF1608, DOI 10.1152/ajprenal.1990.258.6.F1608
   Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214
   Emma F, 2012, PEDIATR NEPHROL, V27, P539, DOI 10.1007/s00467-011-1926-6
   Gelfand JM, 2011, J NEUROL, V258, P440, DOI 10.1007/s00415-010-5775-1
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Jung J, 2007, NEUROLOGY, V68, P1429, DOI 10.1212/01.wnl.0000264019.53959.10
   Menegon LF, 2004, RENAL FAILURE, V26, P195, DOI 10.1081/JDI-120038522
   Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194
   Niaudet P, 2013, NEPHROL THER, V9, P116, DOI 10.1016/j.nephro.2012.10.004
   Parfait B, 1999, EUR J PEDIATR, V158, P55, DOI 10.1007/s004310051009
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
NR 14
TC 15
Z9 16
U1 0
U2 8
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0272-6386
EI 1523-6838
J9 AM J KIDNEY DIS
JI Am. J. Kidney Dis.
PD MAY 15
PY 2018
VL 71
IS 5
BP 754
EP 757
DI 10.1053/j.ajkd.2017.09.020
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA GD7EH
UT WOS:000430672400022
PM 29224958
DA 2024-11-01
ER

PT J
AU Molnar, MJ
   Kovacs, GG
AF Molnar, Maria J.
   Kovacs, Gabor G.
TI Mitochondrial diseases
SO NEUROPATHOLOGY
LA English
DT Article; Book Chapter
ID mutations; disorders; encephalomyopathy; nuclear; genes
AB Mitochondrial disorders represent a major challenge in medicine. Most of the mitochondrial proteins are encoded by the nuclearDNA(nDNA), whereas a very small fraction is encoded by the mitochondrial DNA (mtDNA). Mutations in mtDNA or mitochondria-related nDNA genes can result in mitochondrial dysfunction. The disease usually affects multiple organs in varying locations and severity; however, there are some forms which affect a single organ. The diagnosis of mitochondrial disorders is based on clinical examination, biochemical and histopathologic examinations, functional studies, and molecular genetic testing. Neuropathologic alterations of the muscle are variable and can range from striking abnormalities, such as cytochrome oxidase-negative and ragged red fibers, to nonspecific or minimal changes. Neuropathologic alterations in the brain show common features in disorders with different genetic background. These are characterized by various degrees of vacuolation in the white and gray matter, regional neurodegeneration with reactive astrogliosis, loss of oligodendrocytes, presence of macrophages and microgliosis, capillary proliferation, and mineralization of vessel walls. The advent of molecular genetics, the discovery of biomarkers and new sequencing platforms to perform targeted exome and whole-genome sequencing have changed traditional approaches to diagnose mitochondrial diseases.
C1 [Molnar, Maria J.] Semmelweis Univ, Rare Disorders, Inst Genom Med, Budapest, Hungary.
   [Kovacs, Gabor G.] Med Univ Vienna, Inst Neurol, Vienna, Austria.
C3 Semmelweis University; Medical University of Vienna
RP Molnar, MJ (corresponding author), Semmelweis Univ, Inst Genom Med & Rare Disorders, Tomostr 25-29, H-1083 Budapest, Hungary.
EM molnarmj@gmail.com
CR Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Cohen BH, 2013, NEUROTHERAPEUTICS, V10, P227, DOI 10.1007/s13311-013-0188-3
   CRIMMINS D, 1993, J NEUROL NEUROSUR PS, V56, P900, DOI 10.1136/jnnp.56.8.900
   Delarue A, 2000, PEDIATR TRANSPLANT, V4, P67, DOI 10.1034/j.1399-3046.2000.00090.x
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Kovács GG, 2005, BRAIN, V128, P35, DOI 10.1093/brain/awh310
   Legati A, 2016, BBA-BIOENERGETICS, V1857, P1326, DOI 10.1016/j.bbabio.2016.02.022
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Molnar MJ, 2009, ENCY MOL MECH DIS, V0, P0
   Remenyi V, 2015, MITOCHONDR DNA, V26, P572, DOI 10.3109/19401736.2013.878901
   Saneto RP, 2013, NEUROTHERAPEUTICS, V10, P199, DOI 10.1007/s13311-012-0167-0
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Shoubridge EA, 2003, STRUCTURAL MOL BASIS, V0, P202
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Szalardy L, 2016, FOLIA NEUROPATHOL, V54, P9, DOI 10.5114/fn.2016.58911
   Taft RJ, 2013, AM J HUM GENET, V92, P774, DOI 10.1016/j.ajhg.2013.04.006
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2010, DEV DISABIL RES REV, V16, P154, DOI 10.1002/ddrr.104
NR 25
TC 30
Z9 30
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0072-9752
EI 
J9 HAND CLINIC
PD JUN 15
PY 2018
VL 145
IS 
BP 147
EP 155
DI 10.1016/B978-0-12-802395-2.00010-9
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA BM3UR
UT WOS:000462710900012
DA 2024-11-01
ER

PT J
AU Isohanni, P
   Carroll, CJ
   Jackson, CB
   Pohjanpelto, M
   Lönnqvist, T
   Suomalainen, A
AF Isohanni, Pirjo
   Carroll, Christopher J.
   Jackson, Christopher B.
   Pohjanpelto, Max
   Lonnqvist, Tuula
   Suomalainen, Anu
TI Defective mitochondrial ATPase due to rare mtDNA m.8969G&gt;A mutation-causing lactic acidosis, intellectual disability, and poor growth
SO NEUROGENETICS
LA English
DT Article
DE Mitochondrial diseases; Mitochondrial DNA; Intellectual disability; Lactic acidosis
ID oxidative-phosphorylation; atp6 gene; deficiency; disease; ataxia
AB Mutations in mitochondrial ATP synthase 6 (MT-ATP6) are a frequent cause of NARP (neurogenic muscle weakness, ataxia, and retinitis pigmentosa) or Leigh syndromes, especially a point mutation at nucleotide position 8993. M.8969G > A is a rare MT-ATP6 mutation, previously reported only in three individuals, causing multisystem disorders with mitochondrial myopathy, lactic acidosis, and sideroblastic anemia or IgA nephropathy. We present two siblings with the m.8969G > A mutation and a novel, substantially milder phenotype with lactic acidosis, poor growth, and intellectual disability. Our findings expand the phenotypic spectrum and show that mtDNA mutations should be taken account also with milder, stable phenotypes.
C1 [Isohanni, Pirjo; Lonnqvist, Tuula] Univ Helsinki, Childrens Hosp, Dept Child Neurol, Helsinki, Finland.
   [Isohanni, Pirjo; Lonnqvist, Tuula] Helsinki Univ Hosp, Helsinki, Finland.
   [Isohanni, Pirjo; Carroll, Christopher J.; Jackson, Christopher B.; Pohjanpelto, Max; Suomalainen, Anu] Univ Helsinki, Res Programs Unit, Mol Neurol, Biomedicum Helsinki, Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Neurosci Ctr, Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki
RP Isohanni, P (corresponding author), Univ Helsinki, Childrens Hosp, Dept Child Neurol, Helsinki, Finland.; Isohanni, P (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.; Isohanni, P (corresponding author), Univ Helsinki, Res Programs Unit, Mol Neurol, Biomedicum Helsinki, Helsinki, Finland.
EM pirjo.isohanni@helsinki.fi
FU Foundation for Pediatric Research; Helsinki University Hospital; University of Helsinki; Swiss National Foundation; Novartis Foundation; Sigrid Juselius Foundation; Academy of Finland; Jane and Aatos Erkko Foundation
CR Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   Courage C, 2017, AM J MED GENET A, V173, P225, DOI 10.1002/ajmg.a.37986
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Götz A, 2012, PEDIATR RES, V72, P90, DOI 10.1038/pr.2012.43
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Jackson CB, 2017, EUR J MED GENET, V60, P345, DOI 10.1016/j.ejmg.2017.04.006
   LAMMINEN T, 1995, AM J HUM GENET, V56, P1238
   Leary SC, 2009, METHODS MOL BIOL, V554, P143, DOI 10.1007/978-1-59745-521-3_10
   Rantamäki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Sulonen AM, 2011, GENOME BIOL, V12, P0, DOI 10.1186/gb-2011-12-9-r94
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Wen SZ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep36313
NR 15
TC 9
Z9 9
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1364-6745
EI 1364-6753
J9 NEUROGENETICS
JI Neurogenetics
PD JAN 15
PY 2018
VL 19
IS 1
BP 49
EP 53
DI 10.1007/s10048-018-0537-9
PG 5
WC Genetics & Heredity; Clinical Neurology
SC Genetics & Heredity; Neurosciences & Neurology
GA FU2SG
UT WOS:000423699700006
PM 29350304
DA 2024-11-01
ER

PT J
AU Kang, I
   Chu, CT
   Kaufman, BA
AF Kang, Inhae
   Chu, Charleen T.
   Kaufman, Brett A.
TI The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms
SO FEBS LETTERS
LA English
DT Review
DE mitochondrial DNA; neurodegeneration; TFAM
ID factor-a tfam; appswe/ps1de9 mouse model; mtdna copy number; alzheimers-disease; huntingtons-disease; parkinsons-disease; dna mutations; energy-metabolism; skeletal-muscle; dysfunction
AB The mitochondrial transcription factor A, or TFAM, is a mitochondrial DNA (mtDNA)-binding protein essential for genome maintenance. TFAM functions in determining the abundance of the mitochondrial genome by regulating packaging, stability, and replication. More recently, TFAM has been shown to play a central role in the mtDNA stress-mediated inflammatory response. Emerging evidence indicates that decreased mtDNA copy number is associated with several aging-related pathologies; however, little is known about the association of TFAM abundance and disease. In this Review, we evaluate the potential associations of altered TFAM levels or mtDNA copy number with neurodegeneration. We also describe potential mechanisms by which mtDNA replication, transcription initiation, and TFAM-mediated endogenous danger signals may impact mitochondrial homeostasis in Alzheimer, Huntington, Parkinson, and other neurodegenerative diseases.
C1 [Kang, Inhae] Jeju Natl Univ, Dept Food Sci & Nutr, Jeju City, South Korea.
   [Kang, Inhae; Kaufman, Brett A.] Univ Pittsburgh, Sch Med, Ctr Metab & Mitochondrial Med C3M, Dept Med,Div Cardiol,Vasc Med Inst, Pittsburgh, PA USA.
   [Chu, Charleen T.] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, McGowan Inst Regenerat Med, Conformat Prot Dis Ctr,Dept Pathol,Ctr Neurosci, Pittsburgh, PA USA.
C3 Jeju National University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh
RP Kaufman, BA (corresponding author), Univ Pittsburgh, Sch Med, Vasc Med Inst, Dept Med,Ctr Metab & Mitochondrial Med C3M, 200 Lothrop St,BST E1241, Pittsburgh, PA 15261 USA.
EM bkauf@pitt.edu
FU National Institutes of Health [TR000503, GM110424, NS065789, NS101628, AG026389]
CR Acevedo-Torres K, 2009, DNA REPAIR, V8, P126, DOI 10.1016/j.dnarep.2008.09.004
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Andreeva L, 2017, NATURE, V549, P394, DOI 10.1038/nature23890
   Andreu AL, 1998, BIOCHEM BIOPH RES CO, V252, P577, DOI 10.1006/bbrc.1998.9703
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Belin AC, 2007, NEUROSCI LETT, V420, P257, DOI 10.1016/j.neulet.2007.05.010
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bogaerts V, 2008, HUM MUTAT, V29, P832, DOI 10.1002/humu.20713
   Bose A, 2016, J NEUROCHEM, V139, P216, DOI 10.1111/jnc.13731
   Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293
   Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002
   Cannon JR, 2011, TOXICOL SCI, V124, P225, DOI 10.1093/toxsci/kfr239
   Chaturvedi RK, 2010, HUM MOL GENET, V19, P3190, DOI 10.1093/hmg/ddq229
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008
   Coskun Pinar E, 2012, CURR GERONTOL GERIATR RES, V2012, P383170, DOI 10.1155/2012/383170
   Coskun PE, 2010, J ALZHEIMERS DIS, V20, PS293, DOI 10.3233/JAD-2010-100351
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458
   Dagda RK, 2014, J NEUROCHEM, V128, P864, DOI 10.1111/jnc.12494
   Dinardo MM, 2003, BIOCHEM BIOPH RES CO, V301, P187, DOI 10.1016/S0006-291X(02)03008-5
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Farge G, 2014, CELL REP, V8, P66, DOI 10.1016/j.celrep.2014.05.046
   Farshbaf MJ, 2017, NEUROTOX RES, V32, P518, DOI 10.1007/s12640-017-9766-1
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, P884S, DOI 10.3945/ajcn.110.001917
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   FISHER RP, 1985, J BIOL CHEM, V260, P1330
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Fuke S, 2011, BBA-BIOENERGETICS, V1807, P270, DOI 10.1016/j.bbabio.2010.11.016
   Galter D, 2010, GENES BRAIN BEHAV, V9, P173, DOI 10.1111/j.1601-183X.2009.00542.x
   Garstka HL, 2003, NUCLEIC ACIDS RES, V31, P5039, DOI 10.1093/nar/gkg717
   Gatt AP, 2013, NEUROSCI LETT, V557, P177, DOI 10.1016/j.neulet.2013.10.045
   Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002
   Gaweda-Walerych K, 2010, NEUROSCI LETT, V469, P24, DOI 10.1016/j.neulet.2009.11.037
   Giannoccaro MP, 2017, MOVEMENT DISORD, V32, P346, DOI 10.1002/mds.26966
   Good CH, 2011, FASEB J, V25, P1333, DOI 10.1096/fj.10-173625
   Grimm A, 2016, BIOGERONTOLOGY, V17, P281, DOI 10.1007/s10522-015-9618-4
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Günther C, 2004, NEUROSCI LETT, V369, P219, DOI 10.1016/j.neulet.2004.07.070
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011
   Hayashi Y, 2008, J NEUROSCI, V28, P8624, DOI 10.1523/JNEUROSCI.1957-08.2008
   Hillen HS, 2017, CELL, V171, P1072, DOI 10.1016/j.cell.2017.10.036
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   Ikeda M, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0119687
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Jiang M, 2017, CELL METAB, V26, P429, DOI 10.1016/j.cmet.2017.07.003
   Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI 10.1042/BSE0470069
   Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831
   Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004
   Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Keeney PM, 2010, MOL NEURODEGENER, V5, P0, DOI 10.1186/1750-1326-5-21
   Keeney PM, 2009, HUM GENE THER, V20, P897, DOI 10.1089/hum.2009.023
   Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306
   Kirches E, 2009, CURR GENOMICS, V10, P585, DOI 10.2174/138920209789503879
   Kühl I, 2016, SCI ADV, V2, P0, DOI 10.1126/sciadv.1600963
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lee JY, 2014, INT J ENDOCRINOL, V2014, P0, DOI 10.1155/2014/586017
   Lillenes MS, 2017, NEUROSCI LETT, V645, P46, DOI 10.1016/j.neulet.2017.02.062
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Malarkey CS, 2012, NUCLEIC ACIDS RES, V40, P614, DOI 10.1093/nar/gkr787
   Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107
   McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3
   Memon Ashfaque A, 2017, BIOMOL DETECT QUANTIF, V13, P32, DOI 10.1016/j.bdq.2017.08.001
   Morimoto N, 2012, J NEUROSCI RES, V90, P1200, DOI 10.1002/jnr.23000
   Morozov YI, 2015, NUCLEIC ACIDS RES, V43, P3726, DOI 10.1093/nar/gkv235
   Morozov YI, 2014, NUCLEIC ACIDS RES, V42, P3884, DOI 10.1093/nar/gkt1356
   Ngo Huu B, 2014, NAT COMMUN, V5, P3077, DOI 10.1038/ncomms4077
   Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159
   Niccoli T, 2012, CURR BIOL, V22, PR741, DOI 10.1016/j.cub.2012.07.024
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Nishiyama S, 2010, BIOCHEM BIOPH RES CO, V401, P26, DOI 10.1016/j.bbrc.2010.08.143
   Oka S, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep37889
   Pedrós I, 2014, BBA-MOL BASIS DIS, V1842, P1556, DOI 10.1016/j.bbadis.2014.05.025
   Petrov D, 2016, MOL NEUROBIOL, V53, P6183, DOI 10.1007/s12035-015-9522-6
   Phillips NR, 2014, ALZHEIMERS DEMENT, V10, P393, DOI 10.1016/j.jalz.2013.04.508
   Piao Y, 2012, BBA-GEN SUBJECTS, V1820, P577, DOI 10.1016/j.bbagen.2011.08.007
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001
   Pohjoismäki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703
   Posse V, 2017, J BIOL CHEM, V292, P2637, DOI 10.1074/jbc.M116.751008
   Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784
   Ramachandran A, 2017, NUCLEIC ACIDS RES, V45, P861, DOI 10.1093/nar/gkw1157
   Reeve A, 2013, J NEUROSCI, V33, P10790, DOI 10.1523/JNEUROSCI.3525-12.2013
   Rice AC, 2014, J ALZHEIMERS DIS, V40, P319, DOI 10.3233/JAD-131715
   Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5
   Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291
   Rubio-Cosials A, 2011, NAT STRUCT MOL BIOL, V18, P1281, DOI 10.1038/nsmb.2160
   Santos JM, 2014, EXP EYE RES, V121, P168, DOI 10.1016/j.exer.2014.02.010
   Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397
   Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schilling G, 2004, HUM MOL GENET, V13, P1599, DOI 10.1093/hmg/ddh175
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x
   Shlevkov E, 2016, P NATL ACAD SCI USA, V113, PE6097, DOI 10.1073/pnas.1612283113
   Smith EF, 2017, NEUROSCI LETT, V0, P0
   Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Steer EK, 2015, ANTIOXID REDOX SIGN, V22, P1047, DOI 10.1089/ars.2014.6206
   Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108
   Stevens DA, 2015, P NATL ACAD SCI USA, V112, P11696, DOI 10.1073/pnas.1500624112
   Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013
   Suarez J, 2008, AM J PHYSIOL-CELL PH, V295, PC1561, DOI 10.1152/ajpcell.00076.2008
   Taherzadeh-Fard E, 2011, MOL NEURODEGENER, V6, P0, DOI 10.1186/1750-1326-6-32
   Takamatsu C, 2002, EMBO REP, V3, P451, DOI 10.1093/embo-reports/kvf099
   Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430
   Thomas RR, 2012, AGING-US, V4, P620, DOI 10.18632/aging.100488
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Turnbull HE, 2010, BBA-MOL BASIS DIS, V1802, P111, DOI 10.1016/j.bbadis.2009.07.010
   Van Laar VS, 2011, HUM MOL GENET, V20, P927, DOI 10.1093/hmg/ddq531
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
   Wang J, 2005, J NEUROCHEM, V93, P953, DOI 10.1111/j.1471-4159.2005.03053.x
   Wang KZQ, 2014, MITOCHONDRION, V17, P132, DOI 10.1016/j.mito.2014.04.008
   Wang Y, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0059449
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, P0, DOI 10.1186/s40478-016-0404-6
   West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   Woo DK, 2012, AM J PATHOL, V180, P24, DOI 10.1016/j.ajpath.2011.10.003
   Wright AF, 2004, NAT GENET, V36, P1153, DOI 10.1038/ng1448
   Xu SC, 2009, FEBS J, V276, P4224, DOI 10.1111/j.1742-4658.2009.07094.x
   Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955
   Zhang Q, 2011, BRAIN RES, V1368, P355, DOI 10.1016/j.brainres.2010.10.074
   Zhong Y, 2011, FEBS J, V278, P2500, DOI 10.1111/j.1742-4658.2011.08176.x
   Zhu JH, 2012, CELL DEATH DIS, V3, P0, DOI 10.1038/cddis.2012.46
   Zhu JH, 2003, BRAIN PATHOL, V13, P473
   Zhu JH, 2002, AM J PATHOL, V161, P2087, DOI 10.1016/S0002-9440(10)64487-2
   Zsurka G, 2013, IUBMB LIFE, V65, P263, DOI 10.1002/iub.1126
NR 138
TC 188
Z9 204
U1 1
U2 29
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD MAR 15
PY 2018
VL 592
IS 5
BP 793
EP 811
DI 10.1002/1873-3468.12989
PG 19
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA FZ3FW
UT WOS:000427473100011
PM 29364506
DA 2024-11-01
ER

PT J
AU Burke, EA
   Frucht, SJ
   Thompson, K
   Wolfe, LA
   Yokoyama, T
   Bertoni, M
   Huang, Y
   Sincan, M
   Adams, DR
   Taylor, RW
   Gahl, WA
   Toro, C
   Malicdan, MCV
AF Burke, E. A.
   Frucht, S. J.
   Thompson, K.
   Wolfe, L. A.
   Yokoyama, T.
   Bertoni, M.
   Huang, Y.
   Sincan, M.
   Adams, D. R.
   Taylor, R. W.
   Gahl, W. A.
   Toro, C.
   Malicdan, M. C. V.
TI Biallelic mutations in mitochondrial tryptophanyl-tRNA synthetase cause Levodopa-responsive infantile-onset Parkinsonism
SO CLINICAL GENETICS
LA English
DT Article
DE medical genetics; Parkinsonism; precision medicine; tRNA synthetase
ID dna-sequencing data; disease; framework; discovery; program; genome; wars2
AB Mitochondrial aminoacyl-tRNA synthetases (mtARSs) are essential, ubiquitously expressed enzymes that covalently attach amino acids to their corresponding tRNA molecules during translation of mitochondrial genes. Deleterious variants in the mtARS genes cause a diverse array of phenotypes, many of which involve the nervous system. Moreover, distinct mutations in mtARSs often cause different clinical manifestations. Recently, the gene encoding mitochondrial tryptophanyl tRNA synthetase (WARS2) was reported to cause 2 different neurological phenotypes, a form of autosomal recessive intellectual disability and a syndrome of severe infantile-onset leukoencephalopathy. Here, we report the case of a 17-year-old boy with compound heterozygous mutations in WARS2 (p.Trp13Gly, p.Ser228Trp) who presented with infantile-onset, Levodopa-responsive Parkinsonism at the age of 2years. Analysis of patient-derived dermal fibroblasts revealed decreased steady-state WARS2 protein and normal OXPHOS content. Muscle mitochondrial studies suggested mitochondrial proliferation without obvious respiratory chain deficiencies at the age of 9years. This case expands the phenotypic spectrum of WARS2 deficiency and emphasizes the importance of mitochondrial protein synthesis in the pathogenesis of Parkinsonism.
C1 [Burke, E. A.; Wolfe, L. A.; Bertoni, M.; Sincan, M.; Adams, D. R.; Gahl, W. A.; Toro, C.; Malicdan, M. C. V.] NHGRI, NIH Undiagnosed Dis Program, Common Fund, Off Director,NIH, Bethesda, MD 20892 USA.
   [Frucht, S. J.] New York Univ Langone, Sch Med, Movement Disorders Div, New York, NY USA.
   [Thompson, K.; Taylor, R. W.] Newcastle Univ, Inst Neurosci, Sch Med, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Wolfe, L. A.; Huang, Y.; Adams, D. R.; Gahl, W. A.; Toro, C.; Malicdan, M. C. V.] NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA.
   [Yokoyama, T.; Gahl, W. A.] NHGRI, Sect Human Biochem Genet, Med Genet Branch, NIH, Bethesda, MD 20892 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); New York University; Newcastle University - UK; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)
RP Malicdan, MCV (corresponding author), NIH, NIH Undiagnosed Dis Program, Common Fund, Off Director, Bldg 10, Bethesda, MD 20892 USA.; Malicdan, MCV (corresponding author), NHGRI, Bethesda, MD 20892 USA.
EM malicdanm@mail.nih.gov
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; NIH Office of the Director; National Human Genome Research Institute; Mitochondrial Disease Patient Cohort [G0800674]; UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children; Medical Research Council (MRC) Centre for Translational Research in Neuromuscular Disease; Lily Foundation; MRC [G0800674] Funding Source: UKRI
CR Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011
   Brás J, 2015, CELL, V160, P570, DOI 10.1016/j.cell.2015.01.019
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Diodato D, 2014, HUM MUTAT, V35, P983, DOI 10.1002/humu.22590
   Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Kun-Rodrigues C, 2015, HUM MOL GENET, V24, P6711, DOI 10.1093/hmg/ddv376
   Lynch DS, 2016, JAMA NEUROL, V73, P1433, DOI 10.1001/jamaneurol.2016.2229
   Malicdan MCV, 2015, J MED GENET, V52, P830, DOI 10.1136/jmedgenet-2015-103316
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Musante L, 2017, HUM MUTAT, V38, P621, DOI 10.1002/humu.23205
   Schrag A, 2006, LANCET NEUROL, V5, P355, DOI 10.1016/S1474-4422(06)70411-2
   Siitonen A, 2017, NEUROBIOL AGING, V53, P0, DOI 10.1016/j.neurobiolaging.2017.01.019
   Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002
   Smedley D, 2015, NAT PROTOC, V10, P2004, DOI 10.1038/nprot.2015.124
   Theisen BE, 2017, AM J MED GENET A, V173, P2505, DOI 10.1002/ajmg.a.38339
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Tuschl K, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms11601
   Stormo Gary D, 2013, CURR PROTOC BIOINFORMATICS, V43, P0, DOI 10.1002/0471250953.bi1110s43
NR 22
TC 30
Z9 32
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9163
EI 1399-0004
J9 CLIN GENET
JI Clin. Genet.
PD MAR 15
PY 2018
VL 93
IS 3
BP 712
EP 718
DI 10.1111/cge.13172
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA FX7GJ
UT WOS:000426255400034
PM 29120065
DA 2024-11-01
ER

PT J
AU Genin, EC
   Bannwarth, S
   Lespinasse, F
   Ortega-Vila, B
   Fragaki, K
   Itoh, K
   Villa, E
   Lacas-Gervais, S
   Jokela, M
   Auranen, M
   Ylikallio, E
   Mauri-Crouzet, A
   Tyynismaa, H
   Vihola, A
   Augé, G
   Cochaud, C
   Sesaki, H
   Ricci, JE
   Udd, B
   Vives-Bauza, C
   Paquis-Flucklinger, V
AF Genin, Emmanuelle C.
   Bannwarth, Sylvie
   Lespinasse, Francoise
   Ortega-Vila, Bernardo
   Fragaki, Konstantina
   Itoh, Kie
   Villa, Elodie
   Lacas-Gervais, Sandra
   Jokela, Manu
   Auranen, Mari
   Ylikallio, Emil
   Mauri-Crouzet, Alessandra
   Tyynismaa, Henna
   Vihola, Anna
   Auge, Gaelle
   Cochaud, Charlotte
   Sesaki, Hiromi
   Ricci, Jean-Ehrland
   Udd, Bjarne
   Vives-Bauza, Cristofol
   Paquis-Flucklinger, Veronique
TI Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of <i>CHCHD10</i>-related diseases
SO NEUROBIOLOGY OF DISEASE
LA English
DT Article
DE CHCHD10; SMAJ; FTD-ALS; Mitochondria; TDP-43
ID frontotemporal lobar degeneration; amyotrophic-lateral-sclerosis; motor-neuron disease; chchd10 mutations; hexanucleotide repeat; patient; cells; individuals; inhibition; inclusions
AB Following the involvement of CHCHD10 in FrontoTemporal-Dementia-Amyotrophic Lateral Sclerosis (FTD-ALS) clinical spectrum, a founder mutation (p.Gly66Val) in the same gene was identified in Finnish families with late onset spinal motor neuronopathy (SMAJ). SMAJ is a slowly progressive form of spinal muscular atrophy with a life expectancy within normal range. In order to understand why the p.Ser59Leu mutation, responsible for severe FTD-ALS, and the p.Gly66Val mutation could lead to different levels of severity, we compared their effects in patient cells. Unlike affected individuals bearing the p.Ser59Leu mutation, patients presenting with SMAJ phenotype have neither mitochondrial myopathy nor mtDNA instability. The expression of CHCHD10(S59L) mutant allele leads to disassembly of mitochondrial contact site and cristae organizing system (MICOS) with mitochondria] dysfunction and loss of cristae in patient fibroblasts. We also show that G66V fibroblasts do not display the loss of MICOS complex integrity and mitochondrial damage found in S59L cells. However, S59L and G66V fibroblasts show comparable accumulation of phosphorylated mitochondrial TDP-43 suggesting that the severity of phenotype and mitochondrial damage do not depend on mitochondrial TDP-43 localization. The expression of the CHCHD10(G66V) allele is responsible for mitochondrial network fragmentation and decreased sensitivity towards apoptotic stimuli, but with a less severe effect than that found in cells expressing the CHCHD10(S59L) allele. Taken together, our data show that cellular phenotypes associated with p.Ser59Leu and p.Gly66Val mutations in CHCHD10 are different; loss of MICOS complex integrity and mitochondrial dysfunction, but not TDP-43 mitochondrial localization, being likely essential to develop a severe motor neuron disease.
C1 [Genin, Emmanuelle C.; Bannwarth, Sylvie; Lespinasse, Francoise; Fragaki, Konstantina; Mauri-Crouzet, Alessandra; Auge, Gaelle; Cochaud, Charlotte; Paquis-Flucklinger, Veronique] Univ Cote dAzur, INSERM, CNRS, IRCAN,CHU Nice, Nice, France.
   [Ortega-Vila, Bernardo; Vives-Bauza, Cristofol] Son Espases Univ Hosp, Res Hlth Inst Balear Isl IdISB, Res Unit, Palma De Mallorca, Spain.
   [Itoh, Kie; Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD USA.
   [Villa, Elodie; Ricci, Jean-Ehrland] Univ Cote dAzur, C3M, Inserm, Nice, France.
   [Lacas-Gervais, Sandra] Univ Cote dAzur, Ctr Commun Microscopie Appl, Nice, France.
   [Jokela, Manu; Udd, Bjarne] Tampere Univ, Neuromuscular Res Ctr, Tampere, Finland.
   [Jokela, Manu; Udd, Bjarne] Univ Hosp, Tampere, Finland.
   [Jokela, Manu] Univ Turku, Turku Univ Hosp, Dept Clin Neurosci, Turku, Finland.
   [Auranen, Mari; Ylikallio, Emil] Univ Helsinki, Helsinki Univ Hosp, Neurol, Clin Neurosci, Helsinki, Finland.
   [Auranen, Mari; Ylikallio, Emil; Tyynismaa, Henna] Univ Helsinki, Res Programs Unit, Mol Neurol, Helsinki, Finland.
   [Vihola, Anna; Udd, Bjarne] Univ Helsinki, Folkhalsan Inst Genet, Haartman Inst, Dept Med Genet, Helsinki, Finland.
C3 Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CHU Nice; Institut Investigacio Sanitaria Illes Balears (IdISBa); Hospital Universitari Son Espases; Johns Hopkins University; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Cote d'Azur; Tampere University; Tampere University; Tampere University Hospital; University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki
RP Paquis-Flucklinger, V (corresponding author), UNS, Sch Med, IRCAN UMR CNRS 7284, INSERM U1081, 28 Av Valombrose, F-06107 Nice 2, France.
EM paquis@hermes.unice.fr
FU ANR (French Research Agency) [ANR-16-CE16-0024-01]; Fondation ARC (Association pour la Recherche sur le Cancer); La Ligue contre le Cancer; Agence Nationale de la Recherche (ANR) [ANR-16-CE16-0024] Funding Source: Agence Nationale de la Recherche (ANR)
CR Adachi Y, 2016, MOL CELL, V63, P1034, DOI 10.1016/j.molcel.2016.08.013
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093
   Auranen M, 2015, NEUROL-GENET, V1, P0, DOI 10.1212/NXG.0000000000000003
   Ballinger SW, 1999, EXP EYE RES, V68, P765, DOI 10.1006/exer.1998.0661
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774
   Chanson JB, 2010, NEURODEGENER DIS, V7, P260, DOI 10.1159/000273591
   Chaussenot A, 2014, NEUROBIOL AGING, V35, P0, DOI 10.1016/j.neurobiolaging.2014.07.022
   Cozzolino M, 2015, FRONT CELL NEUROSCI, V9, P0, DOI 10.3389/fncel.2015.00031
   De Conti L, 2015, NUCLEIC ACIDS RES, V43, P8990, DOI 10.1093/nar/gkv814
   DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011
   Friedman JR, 2015, ELIFE, V4, P0, DOI 10.7554/eLife.07739
   Genin EC, 2016, EMBO MOL MED, V8, P58, DOI 10.15252/emmm.201505496
   Guarani V, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.17163
   Janssens J, 2013, HUM MOL GENET, V22, PR77, DOI 10.1093/hmg/ddt349
   Jokela ME, 2016, J NEUROL, V263, P1461, DOI 10.1007/s00415-016-8134-z
   Josephs KA, 2015, ANN NEUROL, V78, P697, DOI 10.1002/ana.24493
   Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132
   Kageyama Y, 2011, CURR OPIN CELL BIOL, V23, P427, DOI 10.1016/j.ceb.2011.04.009
   Kim JS, 2007, MOL CELL BIOL, V27, P662, DOI 10.1128/MCB.00537-06
   Knott AB, 2008, ANN NY ACAD SCI, V1147, P283, DOI 10.1196/annals.1427.030
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Pasanen P, 2016, ACTA NEUROL SCAND, V133, P361, DOI 10.1111/ane.12470
   Penttilä S, 2017, J NEUROL NEUROSUR PS, V88, P272, DOI 10.1136/jnnp-2016-314154
   Penttilä S, 2015, ANN NEUROL, V77, P163, DOI 10.1002/ana.24319
   Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010
   ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351
   Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584
   Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5
   Wang WZ, 2017, MOL THER, V25, P127, DOI 10.1016/j.ymthe.2016.10.013
   Wang WZ, 2016, NAT MED, V22, P869, DOI 10.1038/nm.4130
   Wang WZ, 2013, HUM MOL GENET, V22, P4706, DOI 10.1093/hmg/ddt319
   Weishaupt JH, 2016, TRENDS MOL MED, V22, P769, DOI 10.1016/j.molmed.2016.07.005
   Woo JAA, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15558
   Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 42
TC 46
Z9 48
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0969-9961
EI 1095-953X
J9 NEUROBIOL DIS
JI Neurobiol. Dis.
PD NOV 15
PY 2018
VL 119
IS 
BP 159
EP 171
DI 10.1016/j.nbd.2018.07.027
PG 13
WC Neurosciences
SC Neurosciences & Neurology
GA GU5JV
UT WOS:000445322700014
PM 30092269
DA 2024-11-01
ER

PT J
AU Guyatt, AL
   Burrows, K
   Guthrie, PAI
   Ring, S
   McArdle, W
   Day, INM
   Ascione, R
   Lawlor, DA
   Gaunt, TR
   Rodriguez, S
AF Guyatt, Anna L.
   Burrows, Kimberley
   Guthrie, Philip A. I.
   Ring, Sue
   McArdle, Wendy
   Day, Ian N. M.
   Ascione, Raimondo
   Lawlor, Debbie A.
   Gaunt, Tom R.
   Rodriguez, Santiago
TI Cardiometabolic phenotypes and mitochondrial DNA copy number in two cohorts of UK women
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial DNA; Copy number; ALSPAC; Complex traits; Cardiovascular disease; Diabetes
ID coronary-heart-disease; peripheral-blood; skeletal-muscle; telomere length; association; risk; deletion; cells; mtdna; age
AB The mitochondrial genome is present at variable copy number between individuals. Mitochondria are vulnerable to oxidative stress, and their dysfunction may be associated with cardiovascular disease. The association of mitochondrial DNA copy number with cardiometabolic risk factors (lipids, glycaemic traits, inflammatory markers, anthropometry and blood pressure) was assessed in two independent cohorts of European origin women, one in whom outcomes were measured at mean (SD) age 30 (4.3) years (N = 2278) and the second at 69.4 (5.5) years (N = 2872). Mitochondrial DNA copy number was assayed by quantitative polymerase chain reaction. Associations were adjusted for smoking, sociodemographic status, laboratory factors and white cell traits. Out of a total of 12 outcomes assessed in both cohorts, mitochondrial DNA copy number showed little or no association with the majority (point estimates were close to zero and nearly all p-values were > 0.01). The strongest evidence was for an inverse association in the older cohort with insulin (standardised beta [95%CI]: 0.06, [0.098, 0.022], p = 0.002), but this association did not replicate in the younger cohort. Our findings do not provide support for variation in mitochondrial DNA copy number having an important impact on cardio-metabolic risk factors in European origin women.
C1 [Guyatt, Anna L.; Burrows, Kimberley; Ring, Sue; McArdle, Wendy; Lawlor, Debbie A.; Gaunt, Tom R.; Rodriguez, Santiago] Univ Bristol, MRC Integrat Epidemiol Unit, Oakfield House, Bristol BS8 2BN, Avon, England.
   [Guyatt, Anna L.; Burrows, Kimberley; Guthrie, Philip A. I.; Ring, Sue; McArdle, Wendy; Day, Ian N. M.; Lawlor, Debbie A.; Gaunt, Tom R.; Rodriguez, Santiago] Univ Bristol, Sch Social & Community Med, Oakfield House, Bristol BS8 2BN, Avon, England.
   [Ascione, Raimondo] Univ Bristol, Sch Clin Sci, Bristol Heart Inst, Bristol, Avon, England.
C3 University of Bristol; University of Bristol; University of Bristol
RP Rodriguez, S (corresponding author), Univ Bristol, Sch Social & Community Med, Oakfield House, Bristol BS8 2BN, Avon, England.
EM santi.rodriguez@bristol.ac.uk
FU UK Medical Research Council; Wellcome Trust [102215/2/13/2]; British Heart Foundation [PG/13/66/30442]; Medical Research Council (MRC) [MR/K002767/1]; Wellcome Trust PhD studentship [102433/Z/13/Z]; Wellcome Trust [102433/Z/13/Z] Funding Source: Wellcome Trust; MRC [MR/K002767/1, MC_UU_00011/4, MC_UU_12013/8, MC_UU_12013/5] Funding Source: UKRI
CR ANTONETTI DA, 1995, J CLIN INVEST, V95, P1383, DOI 10.1172/JCI117790
   Arai T, 2003, AGING CLIN EXP RES, V15, P1
   Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3
   Asmann YW, 2006, DIABETES, V55, P3309, DOI 10.2337/db05-1230
   Bersani FS, 2016, PROG NEURO-PSYCHOPH, V64, P10, DOI 10.1016/j.pnpbp.2015.06.012
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Chang CC, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0125855
   Chang CC, 2014, PSYCHIAT CLIN NEUROS, V68, P551, DOI 10.1111/pcn.12163
   Chen SY, 2014, ATHEROSCLEROSIS, V237, P220, DOI 10.1016/j.atherosclerosis.2014.08.051
   Chien MC, 2012, GENET MOL RES, V11, P3339, DOI 10.4238/2012.September.17.4
   Chinnery PF, 2007, J MED GENET, V44, P0, DOI 10.1136/jmg.2007.048876
   Chinnery P F, 2014, MITOCHONDRIAL DISORDERS OVERVIEW, V0, P0
   Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008
   de Sousa RT, 2014, PROG NEURO-PSYCHOPH, V48, P32, DOI 10.1016/j.pnpbp.2013.09.002
   Diba LZ, 2016, MITOCHONDRIAL DNA A, V27, P3008, DOI 10.3109/19401736.2015.1063046
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Ding J, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005306
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066
   Gatt AP, 2013, NEUROSCI LETT, V557, P177, DOI 10.1016/j.neulet.2013.10.045
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hosnijeh FS, 2014, BLOOD, V124, P530, DOI 10.1182/blood-2013-10-532085
   Houseman EA, 2012, BMC BIOINFORMATICS, V13, P0, DOI 10.1186/1471-2105-13-86
   Hsieh CJ, 2011, DIABETES RES CLIN PR, V92, P106, DOI 10.1016/j.diabres.2011.01.010
   Huang CH, 2011, J ATHEROSCLER THROMB, V18, P867, DOI 10.5551/jat.8698
   Huang J, 2016, MEDICINE, V95, P0, DOI 10.1097/MD.0000000000003323
   Hudson G, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004369
   Hulgan T, 2011, AIDS, V25, P37, DOI 10.1097/QAD.0b013e32833f9d02
   Jaffe AE, 2014, GENOME BIOL, V15, P0, DOI 10.1186/gb-2014-15-2-r31
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6
   Kim JH, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067227
   Kim JH, 2012, MENOPAUSE, V19, P1109, DOI 10.1097/gme.0b013e3182503e97
   Kim JH, 2012, MENOPAUSE, V19, P582, DOI 10.1097/gme.0b013e31823a3e46
   Kim MY, 2011, ARCH GERONTOL GERIAT, V53, PE218, DOI 10.1016/j.archger.2010.11.019
   Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175
   Kofler B, 2009, BMC MED GENET, V10, P0, DOI 10.1186/1471-2350-10-35
   Laubenthal L, 2016, J DAIRY SCI, V99, P1571, DOI 10.3168/jds.2015-9847
   Lawlor DA, 2005, J EPIDEMIOL COMMUN H, V59, P785, DOI 10.1136/jech.2004.029991
   Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P134, DOI 10.1136/jech.57.2.134
   Lee JY, 2014, INT J ENDOCRINOL, V2014, P0, DOI 10.1155/2014/586017
   Lee JW, 2010, CLIN CHIM ACTA, V411, P592, DOI 10.1016/j.cca.2010.01.024
   Lindinger A, 2010, OBES SURG, V20, P84, DOI 10.1007/s11695-009-9987-3
   Liu CS, 2005, ANN NY ACAD SCI, V1042, P70, DOI 10.1196/annals.1338.008
   Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320
   Malik AN, 2011, BIOCHEM BIOPH RES CO, V412, P1, DOI 10.1016/j.bbrc.2011.06.067
   Malik Afshan N, 2009, DIABETES RES CLIN PRACT, V86, Pe22, DOI 10.1016/j.diabres.2009.07.002
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Mohamed SA, 2006, EXP GERONTOL, V41, P508, DOI 10.1016/j.exger.2006.03.014
   Moslehi J, 2012, CIRC RES, V110, P1226, DOI 10.1161/CIRCRESAHA.111.246868
   Mozhei O I, 2014, MOL BIOL (MOSK), V48, P677
   Nardelli C, 2013, BIOMED RES INT, V2013, P0, DOI 10.1155/2013/631082
   Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251
   Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2
   Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955
   Purdue MP, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0043149
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Pyle A, 2010, INTENS CARE MED, V36, P956, DOI 10.1007/s00134-010-1823-7
   Qiu CF, 2015, CLIN LAB, V61, P363, DOI 10.7754/Clin.Lab.2014.140313
   Rea IM, 2013, AGE, V35, P1445, DOI 10.1007/s11357-012-9444-4
   Rice AC, 2014, J ALZHEIMERS DIS, V40, P319, DOI 10.3233/JAD-131715
   Richmond RC, 2015, HUM MOL GENET, V24, P2201, DOI 10.1093/hmg/ddu739
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003
   Sahin E, 2012, NAT REV MOL CELL BIO, V13, P397, DOI 10.1038/nrm3352
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Tin A, 2016, J AM SOC NEPHROL, V27, P2467, DOI 10.1681/ASN.2015060661
   Urata M, 2008, ANN CLIN BIOCHEM, V45, P513, DOI 10.1258/acb.2008.008008
   Weng SW, 2009, DIABETES RES CLIN PR, V83, P94, DOI 10.1016/j.diabres.2008.10.002
   WIESNER RJ, 1992, BIOCHEM BIOPH RES CO, V183, P553, DOI 10.1016/0006-291X(92)90517-O
   Yu XH, 2013, CLIN CHIM ACTA, V424, P245, DOI 10.1016/j.cca.2013.06.006
   Zabaneh D, 2011, ANN HUM GENET, V75, P456, DOI 10.1111/j.1469-1809.2011.00654.x
   Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287
NR 81
TC 11
Z9 14
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR 15
PY 2018
VL 39
IS 
BP 9
EP 19
DI 10.1016/j.mito.2017.08.007
PG 11
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA FY0YL
UT WOS:000426538500002
PM 28818596
DA 2024-11-01
ER

PT J
AU Luigetti, M
   Primiano, G
   Cuccagna, C
   Bernardo, D
   Sauchelli, D
   Vollono, C
   Servidei, S
AF Luigetti, Marco
   Primiano, Guido
   Cuccagna, Cristina
   Bernardo, Daniela
   Sauchelli, Donato
   Vollono, Catello
   Servidei, Serenella
TI Small fibre neuropathy in mitochondrial diseases explored with sudoscan
SO CLINICAL NEUROPHYSIOLOGY
LA English
DT Article
DE Mitochondrial diseases; Small fibres; Peripheral neuropathy; Sudoscan; MELAS; MERRF; PEO
ID familial amyloid polyneuropathy; single-center experience; peripheral neuropathy; nerve-conduction; mutation; disorders; melas; gene; dna
AB Objective: Polyneuropathy in mitochondrial diseases (MDs) is relatively common and widely investigated, but few data are instead reported about small fibres involvement. Methods: In order to investigate the involvement of small fibres in MDs we performed extensive neurophysiological test (nerve conduction studies; sympathetic skin response; sudoscan) in 27 patients with genetic diagnosis of MD (7 m. 3243A > G; 4 m. 8344A > G; 9 single mtDNA deletion; 7 multiple mtDNA deletions). Results: NCS showed a polyneuropathy in 11/27 cases (41%). The incidence was very high in POLG1 (100%), m. 8344A > G (75%) and m. 3243A > G (43%), while only 11% of patients with single deletion had evidence of large fibres involvement. Sympathetic skin response was abnormal only in three patients (one progressive external ophthalmoplegia with single mtDNA deletion; one patient with m. 3243A > G mutation; one patient with POLG1 mutation). Sudoscan revealed the presence of an autonomic small fibres dysfunction in 9/27 cases (33%), most of them (7/9) carrying a single mtDNA deletion. Sudoscan data were also confirmed in a sub-group of patients by laser evoked potentials study. Considering only patients with single mtDNA deletion 7/9 (78%) showed abnormal results at sudoscan. Conclusions: Small fibre neuropathy is another feature to investigate in mitochondrial diseases and seems specifically associated with the presence of single mtDNA deletion. Significance: The correct identification through specific neurophysiological tests of small fibres involvement in MDs represents another tile in this challenging diagnosis. (C) 2018 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.
C1 [Luigetti, Marco; Primiano, Guido; Cuccagna, Cristina; Bernardo, Daniela; Sauchelli, Donato; Vollono, Catello; Servidei, Serenella] Univ Cattolica Sacro Cuore, UOC Neurol, Fdn Policlin Univ A Gemelli, Inst Neurol, Rome, Italy.
C3 Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli
RP Luigetti, M (corresponding author), UOC Neurol, Largo A Gemelli 8, I-00168 Rome, Italy.
EM mluigetti@gmail.com
CR [Anonymous], 1989, ELECTRODIAGNOSIS DIS, V0, P0
   Ayoub H, 2012, DEV ELECTROCHEMISTRY, V0, P0
   Bouillot S, 2002, J PERIPHER NERV SYST, V7, P213, DOI 10.1046/j.1529-8027.2002.02027.x
   Castro J, 2016, CLIN NEUROPHYSIOL, V127, P2222, DOI 10.1016/j.clinph.2016.02.013
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Conceicao IM, 2008, CLIN NEUROPHYSIOL, V119, P1082, DOI 10.1016/j.clinph.2008.01.006
   Finsterer J, 2011, J NEUROL SCI, V304, P9, DOI 10.1016/j.jns.2011.02.012
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Haanpää M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031
   Henning F, 2007, J NEUROL, V254, P1281, DOI 10.1007/s00415-006-0487-2
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horga A, 2014, BRAIN, V137, P3200, DOI 10.1093/brain/awu279
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   KUNDE V, 1993, ELECTROEN CLIN NEURO, V88, P280, DOI 10.1016/0168-5597(93)90052-Q
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lehmann HC, 2011, ANN NEUROL, V69, P100, DOI 10.1002/ana.22150
   Luigetti M, 2016, EUR J NEUROL, V23, PE55, DOI 10.1111/ene.13049
   Luigetti M, 2016, EUR J NEUROL, V23, P1020, DOI 10.1111/ene.12954
   Luigetti M, 2013, CLIN NEUROPHYSIOL, V124, P1899, DOI 10.1016/j.clinph.2013.02.116
   Luigetti M, 2012, CLIN NEUROPHYSIOL, V123, P1891, DOI 10.1016/j.clinph.2012.02.075
   Mayaudon H, 2010, DIABETES METAB, V36, P450, DOI 10.1016/j.diabet.2010.05.004
   Menezes MP, 2012, DEV MED CHILD NEUROL, V54, P407, DOI 10.1111/j.1469-8749.2012.04271.x
   Merolli A, 2013, J RECONSTR MICROSURG, V29, P0, DOI 10.1055/s-0033-1348038
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Persson AK, 2016, TRENDS MOL MED, V22, P377, DOI 10.1016/j.molmed.2016.03.008
   Primiano G, 2014, NEUROLOGY, V82, P1932, DOI 10.1212/WNL.0000000000000458
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Rawson RL, 2014, CURR BIOL, V24, P760, DOI 10.1016/j.cub.2014.02.025
   Yajnik Chittaranjan S, 2012, ISRN ENDOCRINOL, V2012, P103714, DOI 10.5402/2012/103714
   Zochodne DW, 2007, MUSCLE NERVE, V36, P144, DOI 10.1002/mus.20785
NR 32
TC 14
Z9 14
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 1388-2457
EI 1872-8952
J9 CLIN NEUROPHYSIOL
JI Clin. Neurophysiol.
PD AUG 15
PY 2018
VL 129
IS 8
BP 1618
EP 1623
DI 10.1016/j.clinph.2018.04.755
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GM5BB
UT WOS:000438140900016
PM 29890373
DA 2024-11-01
ER

PT J
AU Suman, M
   Sharpe, JA
   Bentham, RB
   Kotiadis, VN
   Menegollo, M
   Pignataro, V
   Molgó, J
   Muntoni, F
   Duchen, MR
   Pegoraro, E
   Szabadkai, G
AF Suman, Matteo
   Sharpe, Jenny A.
   Bentham, Robert B.
   Kotiadis, Vassilios N.
   Menegollo, Michela
   Pignataro, Viviana
   Molgo, Jordi
   Muntoni, Francesco
   Duchen, Michael R.
   Pegoraro, Elena
   Szabadkai, Gyorgy
TI Inositol trisphosphate receptor-mediated Ca<SUP>2+</SUP> signalling stimulates mitochondrial function and gene expression in core myopathy patients
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID congenital myopathy; skeletal-muscle; sarcoplasmic-reticulum; er-mitochondrial; calcium; mutation; stress; cells; fiber; mice
AB Core myopathies are a group of childhood muscle disorders caused by mutations of the ryanodine receptor (RyR1), the Ca2+ release channel of the sarcoplasmic reticulum. These mutations have previously been associated with elevated inositol trisphosphate receptor (IP3R) levels in skeletal muscle myotubes derived from patients. However, the functional relevance and the relationship of IP3R mediated Ca2+ signalling with the pathophysiology of the disease is unclear. It has also been suggested that mitochondrial dysfunction underlies the development of central and diffuse multi-mini-cores, devoid of mitochondrial activity, which is a key pathological consequence of RyR1 mutations. Here we qusedmuscle biopsies of central core and multi-minicore disease patients with RyR1 mutations, as well as cellular and in vivo mouse models of the disease to characterize global cellular and mitochondrial Ca2+ signalling, mitochondrial function and gene expression associated with the disease. We show that RyR1 mutations that lead to the depletion of the channel are associated with increased IP3-mediated nuclear and mitochondrial Ca2+ signals and increased mitochondrial activity. Moreover, western blot and microarray analysis indicated enhanced mitochondrial biogenesis at the transcriptional and protein levels and was reflected in increased mitochondrial DNA content. The phenotype was recapitulated by RYR1 silencing in mouse cellular myotube models. Altogether, these data indicate that remodelling of skeletal muscle Ca2+ signalling following loss of functional RyR1 mediates bioenergetic adaptation.
C1 [Suman, Matteo; Menegollo, Michela; Pignataro, Viviana; Szabadkai, Gyorgy] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy.
   [Suman, Matteo; Pegoraro, Elena] Univ Padua, Dept Neurosci, Neuromuscular Unit, I-35131 Padua, Italy.
   [Sharpe, Jenny A.; Bentham, Robert B.; Kotiadis, Vassilios N.; Duchen, Michael R.; Szabadkai, Gyorgy] UCL, Dept Cell & Dev Biol, Consortium Mitochondrial Res, London WC1E 6BT, England.
   [Bentham, Robert B.; Szabadkai, Gyorgy] Francis Crick Inst, London NW1 1AT, England.
   [Molgo, Jordi] Univ Paris Saclay, Commissariat Energie Atom & Energies Alternat CEA, Inst Sci Vivant Frederic Joliot, Serv Ingn Mol Prot, F-91191 Gif Sur Yvette, France.
   [Molgo, Jordi] Univ Paris Sud, CNRS, UMR 9197, Inst Neurosci Paris Saclay, F-91198 Gif Sur Yvette, France.
   [Muntoni, Francesco] UCL, Great Ormond St Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England.
   [Muntoni, Francesco] MRC, Ctr Neuromuscular Dis, London WC1N 1EH, England.
C3 University of Padua; University of Padua; University of London; University College London; Francis Crick Institute; CEA; Universite Paris Cite; Universite Paris Saclay; Universite Paris Cite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of London; University College London; University of London; University College London
RP Szabadkai, G (corresponding author), Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy.; Szabadkai, G (corresponding author), UCL, Dept Cell & Dev Biol, Consortium Mitochondrial Res, London WC1E 6BT, England.; Szabadkai, G (corresponding author), Francis Crick Inst, London NW1 1AT, England.
EM g.szabadkai@ucl.ac.uk
FU Telethon [GEP12066, GGP16026]; University College London COMPLeX/British Heart Foundation Fund [SP/08/004]; Biotechnology and Biological Sciences Research Council [BB/L020874/1, BB/P018726/1]; Ricerca Finalizzata, Italian Ministry of Health [RF-2013-02359065]; Medical Research Council; Telethon BioBank [GTB12001D]; EuroBioBank network; National Institute of Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; MDUK; NHSE; Action Medical Research [GN2158]; Biotechnology and Biological Sciences Research Council; BBSRC [BB/L020874/1, BB/P018726/1] Funding Source: UKRI; MRC [MR/M02492X/1] Funding Source: UKRI
CR Amburgey K, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-117
   Arias-Calderón M, 2016, SKELET MUSCLE, V6, P0, DOI 10.1186/s13395-016-0087-5
   Boncompagni S, 2010, AGING CELL, V9, P958, DOI 10.1111/j.1474-9726.2010.00623.x
   Boncompagni S, 2009, P NATL ACAD SCI USA, V106, P21996, DOI 10.1073/pnas.0911496106
   Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783
   Bravo R, 2011, J CELL SCI, V124, P2143, DOI 10.1242/jcs.080762
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Cárdenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007
   Chiesa A, 2001, BIOCHEM J, V355, P1, DOI 10.1042/0264-6021:3550001
   Dowling JJ, 2012, BRAIN, V135, P1115, DOI 10.1093/brain/aws036
   Freyssenet D, 2004, AM J PHYSIOL-CELL PH, V286, PC1053, DOI 10.1152/ajpcell.00418.2003
   Giorgio V, 2018, CELL CALCIUM, V70, P56, DOI 10.1016/j.ceca.2017.05.004
   Glancy B, 2015, NATURE, V523, P617, DOI 10.1038/nature14614
   Hill JM, 2014, METHOD ENZYMOL, V543, P47, DOI 10.1016/B978-0-12-801329-8.00003-9
   Hwang JH, 2012, TRENDS MOL MED, V18, P644, DOI 10.1016/j.molmed.2012.09.006
   Ibarra C, 2013, CIRC RES, V112, P236, DOI 10.1161/CIRCRESAHA.112.273839
   Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270
   Jaimovich E, 2005, FEBS LETT, V579, P2051, DOI 10.1016/j.febslet.2005.02.053
   Jones AWE, 2012, MITOCHONDRION, V12, P86, DOI 10.1016/j.mito.2011.09.009
   Jungbluth H, 2014, FRONT AGING NEUROSCI, V6, P0, DOI 10.3389/fnagi.2014.00339
   Jungbluth H, 2011, SEMIN PEDIATR NEUROL, V18, P239, DOI 10.1016/j.spen.2011.10.005
   Jungbluth H, 2007, ORPHANET J RARE DIS, V2, P0, DOI 10.1186/1750-1172-2-31
   Klein A, 2012, HUM MUTAT, V33, P981, DOI 10.1002/humu.22056
   Loy RE, 2011, J GEN PHYSIOL, V137, P43, DOI 10.1085/jgp.201010523
   North KN, 2014, NEUROMUSCULAR DISORD, V24, P97, DOI 10.1016/j.nmd.2013.11.003
   Ravenscroft G, 2015, BRAIN, V138, P246, DOI 10.1093/brain/awu368
   Reimand J, 2016, NUCLEIC ACIDS RES, V44, PW83, DOI 10.1093/nar/gkw199
   Rokach O, 2015, HUM MOL GENET, V24, P4636, DOI 10.1093/hmg/ddv195
   Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3
   Rossi AE, 2011, AM J PHYSIOL-CELL PH, V301, PC1128, DOI 10.1152/ajpcell.00194.2011
   Sato I, 2008, NEUROLOGY, V70, P114, DOI 10.1212/01.wnl.0000269792.63927.86
   Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010
   Sewry CA, 2017, NEUROPATH APPL NEURO, V43, P5, DOI 10.1111/nan.12369
   Snoeck M, 2016, CELL BIOCHEM BIOPHYS, V74, P85, DOI 10.1007/s12013-015-0704-7
   Suzuki J, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms5153
   Szabadkai G, 2001, PFLUG ARCH EUR J PHY, V441, P678, DOI 10.1007/s004240000466
   Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007
   Vassilopoulos S, 2005, J BIOL CHEM, V280, P28601, DOI 10.1074/jbc.M501484200
   Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016
   Wright FA, 2016, PROG MOL BIOL TRANSL, V141, P141, DOI 10.1016/bs.pmbts.2016.02.004
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yi MQ, 2012, CELL CALCIUM, V52, P355, DOI 10.1016/j.ceca.2012.05.012
   ZHOU H, 2012, NEUROMUSCULAR DIS S1, V22, P0
   Zhou H, 2007, BRAIN, V130, P2024, DOI 10.1093/brain/awm096
   Zhou HY, 2013, HUM MUTAT, V34, P986, DOI 10.1002/humu.22326
   Zvaritch E, 2007, P NATL ACAD SCI USA, V104, P18537, DOI 10.1073/pnas.0709312104
   Zvaritch E, 2009, P NATL ACAD SCI USA, V106, P21813, DOI 10.1073/pnas.0912126106
NR 47
TC 12
Z9 12
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JUL 1
PY 2018
VL 27
IS 13
BP 2367
EP 2382
DI 10.1093/hmg/ddy149
PG 16
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA GM9OJ
UT WOS:000438578900011
PM 29701772
DA 2024-11-01
ER

PT J
AU Kärppä, M
   Kytövuori, L
   Saari, M
   Majamaa, K
AF Karppa, Mikko
   Kytovuori, Laura
   Saari, Markku
   Majamaa, Kari
TI Mutation m.15923A&gt;G in the <i>MT</i>-<i>TT</i> gene causes mild myopathy - case report of an adult-onset phenotype
SO BMC NEUROLOGY
LA English
DT Article
DE Case report; Mitochondrial diseases; Mitochondrial tRNA(Thr); Single-fibre analysis; Neuromuscular disorders
ID mitochondrial-dna mutations; encephalomyopathy; prevalence; infantile; disease
AB Background: Only five patients have previously been reported to harbor mutations in the MT-TT gene encoding mitochondrial tRNA threonine. The m.15923A > G mutation has been found in three severely affected children. One of these patients died within days after birth and two had a phenotype of myoclonic epilepsy with ragged red fibers (MERRF) in early childhood. We have now found the mutation in an adult patient with mild myopathy. Case presentation: The patient is a 64-year-old Finnish man, who developed bilateral ptosis, diplopia and exercise intolerance in his fifties. Family history was unremarkable. Muscle histology showed cytochrome c-oxidase (COX) negative and ragged red fibres. The m.15923A > G mutation heteroplasmy was 33% in the skeletal muscle and 2% in buccal epithelial cells. The mutation was undetectable in the blood. Single-fibre analysis was performed and COX-negative fibres had a substantially higher heteroplasmy of 92%, than the normal fibres in which it was 43%. Conclusions: We report the fourth patient with m. 15923A > G and with a remarkably milder phenotype than the previous three patients. Our findings and recent biochemical studies suggest that the mutation m.15923A > G is a definite disease-causing mutation. Our results also suggest that heteroplasmy of the m.15923A > G mutation correlates with the severity of the phenotype. This study expands the catalog of the phenotypes caused by mutations in mtDNA.
C1 [Karppa, Mikko; Kytovuori, Laura; Majamaa, Kari] Univ Oulu, Res Unit Clin Neurosci, POB 5000, FI-90014 Oulu, Finland.
   [Karppa, Mikko; Kytovuori, Laura; Majamaa, Kari] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland.
   [Karppa, Mikko; Kytovuori, Laura; Majamaa, Kari] Univ Oulu, OYS Oulu, Oulu, Finland.
   [Karppa, Mikko; Kytovuori, Laura; Majamaa, Kari] Oulu Univ Hosp, Dept Neurol, POB 20, FI-90029 Oulu, Finland.
   [Saari, Markku] Univ Turku, Turku Ctr Biotechnol Cell Imaging Core, FI-20520 Turku, Finland.
C3 University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Turku
RP Kytövuori, L (corresponding author), Univ Oulu, Res Unit Clin Neurosci, POB 5000, FI-90014 Oulu, Finland.; Kytövuori, L (corresponding author), Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland.; Kytövuori, L (corresponding author), Univ Oulu, OYS Oulu, Oulu, Finland.; Kytövuori, L (corresponding author), Oulu Univ Hosp, Dept Neurol, POB 20, FI-90029 Oulu, Finland.
EM laura.kytovuori@oulu.fi
FU Sigrid Juselius Foundation; Medical Research Center, University of Oulu; Oulu University Hospital
CR OCallaghan MD, 2012, NEUROGENETICS, V13, P245, DOI 10.1007/s10048-012-0322-0
   Dubowitz V, 2006, MUSCLE BIOPSY PRACTI, V0, P0
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Lin H, 2018, NAT COMMUN, V9, P0
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   MITOMAP, 2018, HUM MIT GEN DAT, V0, P0
   Nishino I, 1996, BIOCHEM BIOPH RES CO, V225, P180, DOI 10.1006/bbrc.1996.1150
   Sievers F, 2011, MOL SYST BIOL, V7, P0, DOI 10.1038/msb.2011.75
   Soini HK, 2017, BMC MED GENET, V18, P0, DOI 10.1186/s12881-017-0377-8
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang Y, 2018, NUCLEIC ACIDS RES, V46, P4662, DOI 10.1093/nar/gky243
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   YOON KL, 1991, BIOCHEM BIOPH RES CO, V176, P1112, DOI 10.1016/0006-291X(91)90399-R
   YOON KL, 1993, PEDIATR RES, V33, P433, DOI 10.1203/00006450-199305000-00002
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 15
TC 6
Z9 6
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2377
EI 
J9 BMC NEUROL
JI BMC Neurol.
PD SEP 20
PY 2018
VL 18
IS 
BP 
EP 
DI 10.1186/s12883-018-1159-4
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA GU4MT
UT WOS:000445258700002
PM 30236074
DA 2024-11-01
ER

PT J
AU Bakhoum, MF
   Wu, WP
   White, EC
   Sengillo, JD
   Sanfilippo, C
   Morcos, MM
   Freund, KB
   Perry, HD
   Sarraf, D
   Tsang, SH
AF Bakhoum, Mathieu F.
   Wu, Wei-Pu
   White, Eugenia C.
   Sengillo, Jesse D.
   Sanfilippo, Christian
   Morcos, Marcelle M.
   Freund, K. Bailey
   Perry, Henry D.
   Sarraf, David
   Tsang, Stephen H.
TI Mitochondrial A3243G mutation results in corneal endothelial polymegathism
SO GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
LA English
DT Article
DE Mitochondrial diseases; Endothelial corneal dystrophy; Retinal dystrophy; Specular microscopy; Genetics
ID kearns-sayre-syndrome; ii diabetes-mellitus; specular microscopy; population; dystrophy; gene; morphology; myopathy; deafness
AB The mitochondrial DNA point mutation A3243G leads to a spectrum of syndromes ranging from MIDD to MELAS. Ocular manifestations include pattern macular dystrophy and concentric perifoveal atrophy. Given the high metabolic demand of corneal endothelial cells, we performed specular biomicroscopy analysis in patients harboring the mitochondrial DNA point mutation A3243G to assess for the associated presence of corneal endothelial abnormalities. We present a case series with participants from two institutions. Patients diagnosed with macular dystrophy associated with MIDD or MELAS, and the mitochondrial DNA point mutation A3243G were recruited. Exclusion criteria included a prior diagnosis, or a positive family history, of endothelial corneal dystrophy. Slit-lamp corneal examination and specular biomicroscopy were performed. Corneal endothelial cell count, cell size and polymegathism, and central corneal thickness were assessed. Patients diagnosed with MIDD or MELAS based on clinical history and examination were genetically tested for the mitochondrial DNA point mutation A3243G using pyrosequencing. Five patients (two male and three female participants) from five different families, and with different ethnic backgrounds, met the inclusion criteria. Their ages ranged from 41 to 60 years. Corneal endothelial changes observed using slit-lamp examination were primarily mild to rare guttata. Specular biomicroscopy displayed mainly polymegathism associated with guttata. The average endothelial cell count was 2358 +/- 456 cells per mm(2), the average endothelial cell size was 442 +/- 103 mu m(2) and the average central corneal thickness (CCT) was 551 +/- 33 mu m. These values were similar to that of the average population. The average coefficient of variation (COV), an index of heterogeneity in cell size, was 42.0 +/- 4.1%. When compared to the average population, the average COV was significantly higher than predicted for the patients' age. None of the patients had signs of corneal edema. One patient had a pre-Descemet's opacity. In patients with the mitochondrial DNA point mutation A3243G, corneal endothelial polymegathism is present. This is mainly associated with mild guttata. The findings of corneal endothelial cell polymegathism may be a biomarker of mitochondrial disease, specifically in patients with the mitochondrial DNA A3243G mutation.
C1 [Bakhoum, Mathieu F.; Wu, Wei-Pu; White, Eugenia C.; Sengillo, Jesse D.; Tsang, Stephen H.] Columbia Univ, Jonas Childrens Vis Care, New York, NY 10027 USA.
   [Bakhoum, Mathieu F.; Wu, Wei-Pu; White, Eugenia C.; Sengillo, Jesse D.; Tsang, Stephen H.] Columbia Univ, Bernard & Shirlee Brown Glaucoma Lab, New York, NY 10027 USA.
   [Bakhoum, Mathieu F.; Wu, Wei-Pu; Sengillo, Jesse D.; Freund, K. Bailey; Tsang, Stephen H.] Columbia Univ, Dept Ophthalmol, Coll Phys & Surg, New York, NY 10027 USA.
   [Bakhoum, Mathieu F.; Morcos, Marcelle M.; Perry, Henry D.] Nassau Univ, Dept Ophthalmol, Med Ctr, E Meadow, NY USA.
   [Sanfilippo, Christian; Sarraf, David] Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 90095 USA.
   [Freund, K. Bailey] Vitreous Retina Macula Consultants New York, New York, NY USA.
   [Perry, Henry D.] Ophthalm Consultants Long Isl, Long Isl City, NY USA.
   [Sarraf, David] Greater Los Angeles Vet Affairs Healthcare Syst, Los Angeles, CA USA.
   [Tsang, Stephen H.] Columbia Univ, Dept Pathol, Inst Human Nutr, Coll Phys & Surg, New York, NY 10027 USA.
   [Tsang, Stephen H.] Columbia Univ, Dept Cell Biol, Inst Human Nutr, Coll Phys & Surg, New York, NY 10027 USA.
C3 Columbia University; Columbia University; Columbia University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Vitreous Retina Macula Consultants of New York; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Columbia University; Columbia University
RP Tsang, SH (corresponding author), Columbia Univ, Jonas Childrens Vis Care, New York, NY 10027 USA.; Tsang, SH (corresponding author), Columbia Univ, Bernard & Shirlee Brown Glaucoma Lab, New York, NY 10027 USA.; Tsang, SH (corresponding author), Columbia Univ, Dept Ophthalmol, Coll Phys & Surg, New York, NY 10027 USA.; Tsang, SH (corresponding author), Columbia Univ, Dept Pathol, Inst Human Nutr, Coll Phys & Surg, New York, NY 10027 USA.; Tsang, SH (corresponding author), Columbia Univ, Dept Cell Biol, Inst Human Nutr, Coll Phys & Surg, New York, NY 10027 USA.
EM sht2@cumc.columbia.edu
FU National Institute of Health [5P30EY019007, R01EY018213, R01EY024698, R01EY026682, R21AG050437]; National Cancer Institute Core [5P30CA013696]; Research to Prevent Blindness (RPB) Physician-Scientist Award; RPB, New York, NY, USA; RPB medical student fellowship; Tistou and Charlotte Kerstan Foundation; Schneeweiss Stem Cell Fund, New York State [C029572]; Foundation Fighting Blindness New York Regional Research Center Grant [C-NY05-0705-0312]; Gebroe Family Foundation
CR Albin RL, 1998, J MED GENET, V35, P258, DOI 10.1136/jmg.35.3.258
   Alfawaz AM, 2016, OPHTHALMOLOGY, V123, P1637, DOI 10.1016/j.ophtha.2016.04.036
   BACHYNSKI BN, 1986, OPHTHALMOLOGY, V93, P391
   CARLSON KH, 1988, EXP EYE RES, V47, P27, DOI 10.1016/0014-4835(88)90021-8
   CHANG TS, 1993, ARCH OPHTHALMOL-CHIC, V111, P1254, DOI 10.1001/archopht.1993.01090090106028
   CHANG TS, 1994, CORNEA, V13, P269, DOI 10.1097/00003226-199405000-00014
   Colyer MH, 2007, BRIT J OPHTHALMOL, V91, P696, DOI 10.1136/bjo.2006.101055
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Gottsch JD, 2003, INVEST OPHTH VIS SCI, V44, P594, DOI 10.1167/iovs.02-0300
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Maassen JA, 1996, DIABETOLOGIA, V39, P375
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   MATSUDA M, 1985, ARCH OPHTHALMOL-CHIC, V103, P68
   McCarey BE, 2008, CORNEA, V27, P1, DOI 10.1097/ICO.0b013e31815892da
   Michaelides M, 2008, ARCH OPHTHALMOL-CHIC, V126, P320, DOI 10.1001/archopht.126.3.320
   OHKOSHI K, 1989, CORNEA, V8, P210
   RUMMELT V, 1993, OPHTHALMOLOGY, V100, P1757
   SCHULTZ RO, 1984, AM J OPHTHALMOL, V98, P401, DOI 10.1016/0002-9394(84)90120-X
   STEFANSSON A, 1982, GRAEF ARCH CLIN EXP, V218, P200, DOI 10.1007/BF02150095
   Sudhir RR, 2012, CORNEA, V31, P1119, DOI 10.1097/ICO.0b013e31823f8e00
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Yan JB, 2014, J MOL DIAGN, V16, P431, DOI 10.1016/j.jmoldx.2014.03.005
   Zarnowski T, 2003, ACTA OPHTHALMOL SCAN, V81, P543, DOI 10.1034/j.1600-0420.2003.00120.x
NR 23
TC 8
Z9 8
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0721-832X
EI 1435-702X
J9 GRAEF ARCH CLIN EXP
JI Graefes Arch. Clin. Exp. Ophthalmol.
PD MAR 15
PY 2018
VL 256
IS 3
BP 583
EP 588
DI 10.1007/s00417-018-3914-z
PG 6
WC Ophthalmology
SC Ophthalmology
GA FX4QC
UT WOS:000426062100018
PM 29376197
DA 2024-11-01
ER

PT J
AU Masotti, C
   Brito, LA
   Nica, AC
   Ludwig, KU
   Nunes, K
   Savastano, CP
   Malcher, C
   Ferreira, SG
   Kobayashi, GS
   Bueno, DF
   Alonso, N
   Franco, D
   Rojas-Martinez, A
   dos Santos, SE
   Galante, PA
   Meyer, D
   Hünemeier, T
   Mangold, E
   Dermitzakis, ET
   Passos-Bueno, MR
AF Masotti, C.
   Brito, L. A.
   Nica, A. C.
   Ludwig, K. U.
   Nunes, K.
   Savastano, C. P.
   Malcher, C.
   Ferreira, S. G.
   Kobayashi, G. S.
   Bueno, D. F.
   Alonso, N.
   Franco, D.
   Rojas-Martinez, A.
   dos Santos, S. E.
   Galante, P. A.
   Meyer, D.
   Huenemeier, T.
   Mangold, E.
   Dermitzakis, E. T.
   Passos-Bueno, M. R.
TI <i>MRPL53</i>, a New Candidate Gene for Orofacial Clefting, Identified Using an eQTL Approach
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE cleft lip; cleft palate; genetic variation; risk factors; single nucleotide polymorphism; mitochondrial ribosomes
ID genome-wide association; mesoamerican population; palate development; lip; expression; loci; variants; proteins; disease; tissue
AB A valuable approach to understand how individual and population genetic differences can predispose to disease is to assess the impact of genetic variants on cellular functions (e.g., gene expression) of cell and tissue types related to pathological states. To understand the genetic basis of nonsyndromic cleft lip with or without cleft palate (NSCL/P) susceptibility, a complex and highly prevalent congenital malformation, we searched for genetic variants with a regulatory role in a disease-related tissue, the lip muscle (orbicularis oris muscle [OOM]), of affected individuals. From 46 OOM samples, which are frequently discarded during routine corrective surgeries on patients with orofacial clefts, we derived mesenchymal stem cells and correlated the individual genetic variants with gene expression from these cultured cells. Through this strategy, we detected significant cis-eQTLs (i.e., DNA variants affecting gene expression) and selected a few candidates to conduct an association study in a large Brazilian cohort (624 patients and 668 controls). This resulted in the discovery of a novel susceptibility locus for NSCL/P, rs1063588, the best eQTL for the MRPL53 gene, where evidence for association was mostly driven by the Native American ancestry component of our Brazilian sample. MRPL53 (2p13.1) encodes a 39S protein subunit of mitochondrial ribosomes and interacts with MYC, a transcription factor required for normal facial morphogenesis. Our study illustrates not only the importance of sampling admixed populations but also the relevance of measuring the functional effects of genetic variants over gene expression to dissect the complexity of disease phenotypes.
C1 [Masotti, C.; Brito, L. A.; Nunes, K.; Savastano, C. P.; Malcher, C.; Ferreira, S. G.; Kobayashi, G. S.; Bueno, D. F.; Meyer, D.; Huenemeier, T.; Passos-Bueno, M. R.] Univ Sao Paulo, Dept Genet & Evolutionary Biol, Rua Matao 277,Sala 200, BR-05508090 Sao Paulo, SP, Brazil.
   [Masotti, C.; Galante, P. A.] Hosp Sirio Libanes, Mol Oncol Ctr, Sao Paulo, SP, Brazil.
   [Nica, A. C.; Dermitzakis, E. T.] Univ Geneva, Dept Genet Med & Dev, Med Sch, Geneva, Switzerland.
   [Nica, A. C.; Dermitzakis, E. T.] Univ Geneva, Inst Genet & Genom Geneva iGE3, Geneva, Switzerland.
   [Nica, A. C.; Dermitzakis, E. T.] Swiss Inst Bioinformat, Geneva, Switzerland.
   [Ludwig, K. U.; Mangold, E.] Univ Bonn, Inst Human Genet, Bonn, Germany.
   [Ludwig, K. U.] Univ Bonn, Dept Genom, Life & Brain Ctr, Bonn, Germany.
   [Alonso, N.] Univ Sao Paulo, Dept Plast Surg, Med Sch, Sao Paulo, SP, Brazil.
   [Franco, D.] Univ Fed Rio de Janeiro, Hosp Clementino Braga Filho, Dept Plast Surg, Med Sch, Rio De Janeiro, RJ, Brazil.
   [Rojas-Martinez, A.] Univ Autonoma Nuevo Leon, Sch Med, Dept Biochem & Mol Med, Monterrey, Mexico.
   [Rojas-Martinez, A.] Univ Autonoma Nuevo Leon, Ctr Invest & Desarrollo Ciencias Salud, Monterrey, Mexico.
   [dos Santos, S. E.] Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil.
C3 Universidade de Sao Paulo; Hospital Sirio Libanes; University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; University of Bonn; University of Bonn; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; Universidade Federal do Para
RP Passos-Bueno, MR (corresponding author), Univ Sao Paulo, Dept Genet & Evolutionary Biol, Rua Matao 277,Sala 200, BR-05508090 Sao Paulo, SP, Brazil.
EM passos@ib.usp.br
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP [2009/54841-0, 2015/17208-9, 13/08028-1]; CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [201582/2012-0]
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Agrawal P, 2010, CELL CYCLE, V9, P4908, DOI 10.4161/cc.9.24.14199
   Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580
   Bryois J, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004461
   Bueno DF, 2009, TISSUE ENG PT A, V15, P427, DOI 10.1089/ten.tea.2007.0417
   Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630
   Clarke GM, 2011, NAT PROTOC, V6, P121, DOI 10.1038/nprot.2010.182
   Delaneau O, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15452
   Dermitzakis ET, 2012, NAT REV GENET, V13, P215, DOI 10.1038/nrg3115
   Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148
   Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933
   Falush D, 2003, GENETICS, V164, P1567
   Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394
   He FL, 2012, FRONT ORAL BIOL, V16, P81, DOI 10.1159/000337619
   Hindorff LA, 2011, CARCINOGENESIS, V32, P945, DOI 10.1093/carcin/bgr056
   Homburger JR, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005602
   Jugessur A, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0005385
   Leslie EJ, 2016, HUM MOL GENET, V25, P2862, DOI 10.1093/hmg/ddw104
   Leslie EJ, 2012, BIRTH DEFECTS RES A, V94, P934, DOI 10.1002/bdra.23076
   Ludwig KU, 2017, HUM MOL GENET, V26, P829, DOI 10.1093/hmg/ddx012
   Ludwig KU, 2014, BIRTH DEFECTS RES A, V100, P43, DOI 10.1002/bdra.23209
   Ludwig KU, 2012, NAT GENET, V44, P968, DOI 10.1038/ng.2360
   Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506
   Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794
   Melé M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355
   Naslavsky MS, 2017, HUM MUTAT, V38, P751, DOI 10.1002/humu.23220
   Parada C, 2012, FRONT ORAL BIOL, V16, P60, DOI 10.1159/000337617
   Petryszak R, 2016, NUCLEIC ACIDS RES, V44, PD746, DOI 10.1093/nar/gkv1045
   Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959
   Rojas-Martinez A, 2010, BIRTH DEFECTS RES A, V88, P535, DOI 10.1002/bdra.20689
   Savastano CP, 2017, CLIN GENET, V91, P683, DOI 10.1111/cge.12823
   Stanier P, 2012, FRONT ORAL BIOL, V16, P71, DOI 10.1159/000337618
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   Sun YM, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7414
   Sylvester JE, 2004, GENET MED, V6, P73, DOI 10.1097/01.GIM.0000117333.21213.17
   Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248
   Uslu VV, 2014, NAT GENET, V46, P753, DOI 10.1038/ng.2971
   Weinberg SM, 2008, AM J MED GENET A, V146A, P1670, DOI 10.1002/ajmg.a.32291
   Wilkie AOM, 2001, NAT REV GENET, V2, P458, DOI 10.1038/35076601
   Zhang XQ, 2015, NAT STRUCT MOL BIOL, V22, P404, DOI 10.1038/nsmb.3010
NR 40
TC 9
Z9 12
U1 1
U2 9
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD JAN 15
PY 2018
VL 97
IS 1
BP 33
EP 40
DI 10.1177/0022034517735805
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA FQ7NF
UT WOS:000418548700005
PM 29053389
DA 2024-11-01
ER

PT J
AU Shen, CZ
   Xian, WB
   Zhou, HY
   Li, XH
   Liang, XL
   Chen, L
AF Shen, Cunzhou
   Xian, Wenbiao
   Zhou, Hongyan
   Li, Xunhua
   Liang, Xiuling
   Chen, Ling
TI Overlapping Leigh Syndrome/Myoclonic Epilepsy With Ragged Red Fibres in an Adolescent Patient With a Mitochondrial DNA A8344G Mutation
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE Leigh syndrome; MERRF; mitochondrial DNA; A8344G mutation; mitochondrial disease
ID mtdna merrf mutation; myoclonic epilepsy; clinical-features; disease; abnormality; diagnosis; family
AB We present the case of a 16-year-old boy with a family history of epilepsy who presented with acute respiratory failure, limb weakness, diabetes mellitus, sinus tachycardia, lactic acidosis, and pneumonia. He went on to develop cranial nerve palsy, myoclonus, generalized seizures, ataxia, recurrent pneumonia, and hypotension. Biochemical investigation revealed elevated lactate, pyruvate, and glucose levels. Cerebral magnetic resonance imaging (MRI) revealed bilateral, symmetric, high-intensity T2-weighted signals in the thalamus, brainstem, and gray matter of the spinal cord. Histochemical analyses revealed ragged red fibers (RRF) and decreased cytochrome oxidase activity. Blood and muscle-derived DNA demonstrated a high level (95% and 96%, respectively) of the m.8344A>G mutation, while almost all of his maternal relatives (n = 17, including his mother) carried the same point mutation. The point mutation level of his mother (who had short stature, high blood lactate levels, and epilepsy) was 77% (blood-derived DNA). Although this mutation has been identified in approximately 30 individuals with these disorders, to our knowledge, this is the first reported case of overlapping Leigh syndrome/myoclonic epilepsy with RRF in an adolescent patient, and the largest reported pedigree of mitochondrial DNA A8344G mutation.
C1 [Chen, Ling] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Natl Key Clin Dept, Guangzhou, Guangdong, Peoples R China.
   Sun Yat Sen Univ, Affiliated Hosp 1, Key Discipline Neurol, Guangzhou, Guangdong, Peoples R China.
C3 Sun Yat Sen University; Sun Yat Sen University
RP Chen, L (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Natl Key Clin Dept, Guangzhou, Guangdong, Peoples R China.
EM chenl2@mail.sysu.edu.cn
FU Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases [2014B030301035]; Southern China International Cooperation Base for Early Intervention and Functional Rehabilitation of Neurological Diseases [2015B050501003]; Guangzhou Clinical Research and Translational Center for Major Neurological Diseases [201604020010]; Guangdong Provincial Engineering Center for Major Neurological Disease Treatment
CR Alston CL, 2011, EUR J HUM GENET, V19, P1226, DOI 10.1038/ejhg.2011.124
   Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   BERKOVIC SF, 1991, LANCET, V338, P457, DOI 10.1016/0140-6736(91)91090-H
   Emmanuele V, 2011, MUSCLE NERVE, V44, P448, DOI 10.1002/mus.22149
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Liu KM, 2014, METAB BRAIN DIS, V29, P139, DOI 10.1007/s11011-013-9464-5
   Lorenzoni PJ, 2014, ARQ NEURO-PSIQUIAT, V72, P803, DOI 10.1590/0004-282X20140124
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Marie TL, 2014, CURR PROTOC BIOINFOR, V1, P0, DOI 10.1002/0471250953.bi0123s44
   Monden Y, 2013, BRAIN DEV-JPN, V35, P582, DOI 10.1016/j.braindev.2012.08.006
   Nakamura M, 2010, J MED GENET, V47, P659, DOI 10.1136/jmg.2009.072058
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   SWEENEY MG, 1994, J NEUROL SCI, V121, P57, DOI 10.1016/0022-510X(94)90157-0
   Tavares WC, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0177403
   Tuppen HAL, 2010, BRAIN, V133, P2952, DOI 10.1093/brain/awq232
NR 20
TC 4
Z9 5
U1 0
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
EI 
J9 FRONT NEUROL
JI Front. Neurol.
PD SEP 13
PY 2018
VL 9
IS 
BP 
EP 
DI 10.3389/fneur.2018.00724
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GT4GV
UT WOS:000444463100001
PM 30271374
DA 2024-11-01
ER

PT J
AU Ermolaeva, M
   Neri, F
   Ori, A
   Rudolph, KL
AF Ermolaeva, Maria
   Neri, Francesco
   Ori, Alessandro
   Rudolph, K. Lenhard
TI Cellular and epigenetic drivers of stem cell ageing
SO NATURE REVIEWS MOLECULAR CELL BIOLOGY
LA English
DT Review
ID mitochondrial-dna mutations; intestinal-stem; skeletal-muscle; life-span; clonal hematopoiesis; progenitor cells; self-renewal; dietary restriction; gene-expression; p38 mapk
AB Adult tissue stem cells have a pivotal role in tissue maintenance and regeneration throughout the lifespan of multicellular organisms. Loss of tissue homeostasis during post-reproductive reproductive lifespan is caused, at least in part, by a decline in stem cell function and is associated with an increased incidence of diseases. Hallmarks of ageing include the accumulation of molecular damage, failure of quality control systems, metabolic changes and alterations in epigenome stability. In this Review, we discuss recent evidence in support of a novel concept whereby cell-intrinsic damage that accumulates during ageing and cell-extrinsic changes in ageing stem cell niches and the blood result in modifications of the stem cell epigenome. These cumulative epigenetic alterations in stem cells might be the cause of the deregulation of developmental pathways seen during ageing. In turn, they could confer a selective advantage to mutant and epigenetically drifted stem cells with altered self-renewal and functions, which contribute to the development of ageing-associated organ dysfunction and disease.
C1 [Ermolaeva, Maria; Neri, Francesco; Ori, Alessandro; Rudolph, K. Lenhard] FLI, Leibniz Inst Aging, Jena, Germany.
   [Rudolph, K. Lenhard] Univ Hosp Jena UKJ, Med Fac Jena, Jena, Germany.
C3 Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Loeffler Institute
RP Ermolaeva, M; Neri, F; Ori, A; Rudolph, KL (corresponding author), FLI, Leibniz Inst Aging, Jena, Germany.; Rudolph, KL (corresponding author), Univ Hosp Jena UKJ, Med Fac Jena, Jena, Germany.
EM Maria.Ermolaeva@leibniz-fli.de; Francesco.Neri@leibniz-fli.de; Alessandro.Ori@leibniz-fli.de; Lenhard.Rudolph@leibniz-fli.de
FU Alexander von Humboldt Foundation; German Federal Ministry for Education and Research; European Research Council Advanced Grant; federal government of Germany; State of Thuringia
CR Agathocleous M, 2017, NATURE, V549, P476, DOI 10.1038/nature23876
   Al Alam D, 2015, AM J PHYSIOL-GASTR L, V308, PG678, DOI 10.1152/ajpgi.00158.2014
   Alabert C, 2014, NAT CELL BIOL, V16, P281, DOI 10.1038/ncb2918
   Alcolea MP, 2014, NAT CELL BIOL, V16, P612, DOI 10.1038/ncb2963
   Arai K, 2014, ORG LETT, V16, P5560, DOI 10.1021/ol502556c
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Avgustinova A, 2016, NAT REV MOL CELL BIO, V17, P643, DOI 10.1038/nrm.2016.76
   Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721
   Basak O, 2017, CELL STEM CELL, V20, P177, DOI 10.1016/j.stem.2016.11.001
   Baylin Stephen B, 2012, PROC AM THORAC SOC, V9, P64, DOI 10.1513/pats.201201-001MS
   Beerman I, 2015, CELL STEM CELL, V16, P613, DOI 10.1016/j.stem.2015.05.009
   Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016
   Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017
   Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928
   Berent-Maoz B, 2012, BLOOD, V119, P5715, DOI 10.1182/blood-2011-12-400002
   Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465
   Berry DC, 2017, CELL METAB, V25, P166, DOI 10.1016/j.cmet.2016.10.023
   Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024
   Biteau B, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001159
   Blagosklonny MV, 2013, CELL CYCLE, V12, P3736, DOI 10.4161/cc.27188
   Blau HM, 2015, NAT MED, V21, P854, DOI 10.1038/nm.3918
   Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Booth LN, 2016, MOL CELL, V62, P728, DOI 10.1016/j.molcel.2016.05.013
   Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Bradley E, 2012, STEM CELLS, V30, P1624, DOI 10.1002/stem.1143
   Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012
   Buchwalter A, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00322-z
   Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965
   Bufalino MR, 2013, J CELL BIOL, V201, P523, DOI 10.1083/jcb.201207052
   Burkhalter MD, 2015, AGEING RES REV, V23, P29, DOI 10.1016/j.arr.2015.01.004
   Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413
   Cabezas-Wallscheid N, 2017, CELL, V169, P807, DOI 10.1016/j.cell.2017.04.018
   Cairney CJ, 2009, BBA-MOL BASIS DIS, V1792, P353, DOI 10.1016/j.bbadis.2009.01.015
   Camp JG, 2014, GENOME RES, V24, P1504, DOI 10.1101/gr.165845.113
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034
   Castellano JM, 2017, NATURE, V544, P488, DOI 10.1038/nature22067
   Cecco M, 2013, AGING CELL, V12, P247, DOI 10.1111/acel.12047
   Cellerino A, 2017, SEMIN CELL DEV BIOL, V70, P177, DOI 10.1016/j.semcdb.2017.06.012
   Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002
   Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438
   Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chen KY, 2017, MOL SYST BIOL, V13, P0, DOI 10.15252/msb.20167324
   Cheng CW, 2017, CELL, V168, P775, DOI 10.1016/j.cell.2017.01.040
   Cheung P, 2018, CELL, V173, P1385, DOI 10.1016/j.cell.2018.03.079
   Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937
   Ciccocioppo R, 2002, GERONTOLOGY, V48, P204, DOI 10.1159/000058351
   Cimmino L, 2017, CELL, V170, P1079, DOI 10.1016/j.cell.2017.07.032
   Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018
   Cole JJ, 2017, GENOME BIOL, V18, P0, DOI 10.1186/s13059-017-1185-3
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573
   Corazza GR, 1998, MECH AGEING DEV, V104, P1, DOI 10.1016/S0047-6374(98)00044-X
   Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464
   Crowder SW, 2016, CELL STEM CELL, V18, P39, DOI 10.1016/j.stem.2015.12.012
   Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002
   DAniello C, 2017, STEM CELLS INT, V2017, P0, DOI 10.1155/2017/8936156
   Das C, 2012, BBA-GENE REGUL MECH, V1819, P332, DOI 10.1016/j.bbagrm.2011.08.001
   de Haan G, 2003, DEV CELL, V4, P241, DOI 10.1016/S1534-5807(03)00018-2
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144
   Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164
   Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010
   Elabd C, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms5082
   Enge M, 2017, CELL, V171, P321, DOI 10.1016/j.cell.2017.09.004
   Ergen AV, 2012, BLOOD, V119, P2500, DOI 10.1182/blood-2011-11-391730
   Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307
   Espada J, 2008, J CELL BIOL, V181, P27, DOI 10.1083/jcb.200801096
   Famili F, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.326
   Fernández AF, 2015, GENOME RES, V25, P27, DOI 10.1101/gr.169011.113
   Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015
   Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015
   Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619
   Florian MC, 2013, NATURE, V503, P392, DOI 10.1038/nature12631
   Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007
   Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, PS4, DOI 10.1093/gerona/glu057
   Fry CS, 2017, CELL STEM CELL, V20, P56, DOI 10.1016/j.stem.2016.09.010
   Fusco S, 2016, CELL REP, V14, P1195, DOI 10.1016/j.celrep.2015.12.092
   Fuster JJ, 2017, SCIENCE, V355, P842, DOI 10.1126/science.aag1381
   Gambetta MC, 2014, DEV CELL, V31, P629, DOI 10.1016/j.devcel.2014.10.020
   Gancz D, 2013, ANNU REV CELL DEV BI, V29, P137, DOI 10.1146/annurev-cellbio-101512-122331
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433
   Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405
   Glorevski N, 2016, NATURE, V539, P560, DOI 10.1038/nature20168
   Goldberg EL, 2015, AGING CELL, V14, P130, DOI 10.1111/acel.12280
   Goloubinoff P, 2018, NAT CHEM BIOL, V14, P388, DOI 10.1038/s41589-018-0013-8
   Gorbunova V, 2016, MUTAT RES-FUND MOL M, V788, P2, DOI 10.1016/j.mrfmmm.2016.02.004
   Goriely A, 2012, AM J HUM GENET, V90, P175, DOI 10.1016/j.ajhg.2011.12.017
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Guidi N, 2017, EMBO J, V36, P840, DOI 10.15252/embj.201694969
   Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018
   Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957
   Hahn O, 2017, GENOME BIOL, V18, P0, DOI 10.1186/s13059-017-1187-1
   Hammond CM, 2017, NAT REV MOL CELL BIO, V18, P141, DOI 10.1038/nrm.2016.159
   He J, 2010, J MOL CELL BIOL, V2, P231, DOI 10.1093/jmcb/mjp054
   Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388
   Horvath S, 2013, GENOME BIOL, V14, P0, DOI 10.1186/gb-2013-14-10-r115
   Horvath S, 2012, GENOME BIOL, V13, P0, DOI 10.1186/gb-2012-13-10-r97
   Hsieh JCF, 2013, AGING CELL, V12, P269, DOI 10.1111/acel.12053
   Igarashi M, 2016, CELL, V166, P436, DOI 10.1016/j.cell.2016.05.044
   Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002
   Irimia M, 2012, CURR OPIN CELL BIOL, V24, P323, DOI 10.1016/j.ceb.2012.03.005
   Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388
   Jadhav U, 2017, CELL STEM CELL, V21, P65, DOI 10.1016/j.stem.2017.05.001
   Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719
   Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617
   Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159
   Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127
   Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578
   Kaaij LTJ, 2013, GENOME BIOL, V14, P0, DOI 10.1186/gb-2013-14-5-r50
   Kaiko GE, 2016, CELL, V165, P1708, DOI 10.1016/j.cell.2016.05.018
   Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384
   Kauppinen TM, 2013, BBA-MOL CELL RES, V1833, P1985, DOI 10.1016/j.bbamcr.2013.04.005
   Kazakevych J, 2017, NUCLEIC ACIDS RES, V45, P5770, DOI 10.1093/nar/gkx167
   Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017
   Kim JH, 2016, NAT CELL BIOL, V18, P930, DOI 10.1038/ncb3401
   Kim JM, 2017, SCIENCE, V356, P717, DOI 10.1126/science.aal3096
   Kim JY, 2005, BMC MED, V3, P0, DOI 10.1186/1741-7015-3-10
   Kim KM, 2002, ONCOGENE, V21, P5441, DOI 10.1038/sj.onc.1205604
   KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133
   Kirschner K, 2017, CELL REP, V19, P1503, DOI 10.1016/j.celrep.2017.04.074
   Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108
   Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253
   Lahtz C, 2011, J MOL CELL BIOL, V3, P51, DOI 10.1093/jmcb/mjq053
   Lapierre LR, 2015, AUTOPHAGY, V11, P867, DOI 10.1080/15548627.2015.1034410
   Lazare S, 2017, EXP HEMATOL, V53, P26, DOI 10.1016/j.exphem.2017.06.002
   Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460
   Liu DW, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0058310
   Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043
   Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126
   Lu R, 2016, CANCER CELL, V30, P92, DOI 10.1016/j.ccell.2016.05.008
   Lukjanenko L, 2016, NAT MED, V22, P897, DOI 10.1038/nm.4126
   Maegawa S, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00607-3
   Mair W, 2010, AGING CELL, V9, P916, DOI 10.1111/j.1474-9726.2010.00602.x
   Mantel CR, 2015, CELL, V161, P1553, DOI 10.1016/j.cell.2015.04.054
   Martin N, 2014, TRENDS MOL MED, V20, P667, DOI 10.1016/j.molmed.2014.09.008
   Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806
   Maryanovich M, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8901
   Maunakea AK, 2013, CELL RES, V23, P1256, DOI 10.1038/cr.2013.110
   McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005
   Meena JK, 2015, EMBO J, V34, P1371, DOI 10.15252/embj.201490070
   Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647
   Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012
   Mian SA, 2013, HAEMATOLOGICA, V98, P1058, DOI 10.3324/haematol.2012.075325
   Missios P, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms5924
   Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361
   Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014
   Moore DL, 2015, SCIENCE, V349, P1334, DOI 10.1126/science.aac9868
   Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984
   Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026
   Mosteiro L, 2016, SCIENCE, V354, P0, DOI 10.1126/science.aaf4445
   Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Murgatroyd C, 2010, AGING-US, V2, P107
   Nakada D, 2014, NATURE, V505, P555, DOI 10.1038/nature12932
   Nalapareddy K, 2017, CELL REP, V18, P2608, DOI 10.1016/j.celrep.2017.02.056
   Nazemalhosseini Mojarad Ehsan, 2013, GASTROENTEROL HEPATOL BED BENCH, V6, P120
   Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104
   Neri F, 2017, NATURE, V543, P72, DOI 10.1038/nature21373
   Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875
   Noormohammadi A, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13649
   Nuschke A, 2016, STEM CELL RES THER, V7, P0, DOI 10.1186/s13287-016-0436-7
   OSullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897
   Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052
   Ogino S, 2006, GUT, V55, P1000, DOI 10.1136/gut.2005.082933
   Okuchi Y, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0162300
   Öst A, 2014, CELL, V159, P1352, DOI 10.1016/j.cell.2014.11.005
   Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313
   Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Park JS, 2009, AGING-US, V1, P637, DOI 10.18632/aging.100054
   Parker SJ, 2015, PHARMACOL THERAPEUT, V152, P54, DOI 10.1016/j.pharmthera.2015.05.003
   Passos JF, 2010, MOL SYST BIOL, V6, P0, DOI 10.1038/msb.2010.5
   Peth A, 2013, J BIOL CHEM, V288, P29215, DOI 10.1074/jbc.M113.482570
   Petkovich DA, 2017, CELL METAB, V25, P954, DOI 10.1016/j.cmet.2017.03.016
   Povinelli BJ, 2014, STEM CELLS, V32, P105, DOI 10.1002/stem.1513
   Reddington JP, 2013, BIOCHEM J, V451, P13, DOI 10.1042/BJ20121585
   Regan JC, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10956
   Ro S, 2001, P NATL ACAD SCI USA, V98, P10519, DOI 10.1073/pnas.201405498
   Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049
   Rodríguez-Colman MJ, 2017, NATURE, V543, P424, DOI 10.1038/nature21673
   Rosenberger G, 2017, NAT METHODS, V14, P921, DOI 10.1038/NMETH.4398
   Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862
   Rozo M, 2016, NAT MED, V22, P889, DOI 10.1038/nm.4116
   Ryall JG, 2015, CELL STEM CELL, V16, P171, DOI 10.1016/j.stem.2014.12.004
   Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708
   Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012
   Schwörer S, 2016, NATURE, V540, P428, DOI 10.1038/nature20603
   Scourzic L, 2016, LEUKEMIA, V30, P1388, DOI 10.1038/leu.2016.29
   Sheaffer KL, 2014, GENE DEV, V28, P652, DOI 10.1101/gad.230318.113
   Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038
   Shpilka T, 2018, NAT REV MOL CELL BIO, V19, P109, DOI 10.1038/nrm.2017.110
   Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442
   Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035
   Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011
   Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152
   Siudeja K, 2015, CELL STEM CELL, V17, P663, DOI 10.1016/j.stem.2015.09.016
   Smith P, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.27014
   Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016
   Solanas G, 2017, CELL, V170, P678, DOI 10.1016/j.cell.2017.07.035
   Song ZF, 2012, AGING CELL, V11, P449, DOI 10.1111/j.1474-9726.2012.00802.x
   Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059
   Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013
   Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691
   Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420
   Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363
   Stearns-Reider KM, 2017, AGING CELL, V16, P518, DOI 10.1111/acel.12578
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Stubbs TM, 2017, GENOME BIOL, V18, P0, DOI 10.1186/s13059-017-1203-5
   Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041
   Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002
   Takahashi K, 2011, J BIOL CHEM, V286, P35755, DOI 10.1074/jbc.M111.271007
   Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011
   Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020
   Tang DZ, 2016, J EXP MED, V213, P535, DOI 10.1084/jem.20151100
   Tao S, 2015, EMBO J, V34, P624, DOI 10.15252/embj.201490700
   Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47
   Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002
   Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011
   Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436
   van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659
   van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228
   Van Meter M, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms6011
   van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125
   Vidrich A, 2009, AM J PHYSIOL-GASTR L, V297, PG168, DOI 10.1152/ajpgi.90589.2008
   Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
   Vrba L, 2008, BMC GENOMICS, V9, P0, DOI 10.1186/1471-2164-9-486
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131
   Wang LF, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005220
   Weidner CI, 2014, GENOME BIOL, V15, P0, DOI 10.1186/gb-2014-15-2-r24
   Weir HJ, 2017, CELL METAB, V26, P884, DOI 10.1016/j.cmet.2017.09.024
   Yan KS, 2017, NATURE, V545, P238, DOI 10.1038/nature22313
   Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104
   Yang LB, 2016, CANCER CELL, V29, P922, DOI 10.1016/j.ccell.2016.05.003
   Yang LB, 2015, NAT REV CANCER, V15, P152, DOI 10.1038/nrc3895
   Yearim A, 2015, CELL REP, V10, P1122, DOI 10.1016/j.celrep.2015.01.038
   Yilmaz ÖH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163
   Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011
   You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008
   Yuan T, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1004996
   Zhang CH, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3163
   Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693
   Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401
   Zhang WQ, 2015, SCIENCE, V348, P1160, DOI 10.1126/science.aaa1356
   Zhang XT, 2016, NAT GENET, V48, P1014, DOI 10.1038/ng.3610
   Zou CB, 2014, BBA-MOL CELL RES, V1843, P694, DOI 10.1016/j.bbamcr.2013.12.016
NR 257
TC 166
Z9 188
U1 0
U2 49
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 1471-0072
EI 1471-0080
J9 NAT REV MOL CELL BIO
JI Nat. Rev. Mol. Cell Biol.
PD SEP 15
PY 2018
VL 19
IS 9
BP 594
EP 610
DI 10.1038/s41580-018-0020-3
PG 17
WC Cell Biology
SC Cell Biology
GA GR2CL
UT WOS:000442367400008
PM 29858605
DA 2024-11-01
ER

PT J
AU Mori, D
   Matsui, I
   Shimomura, A
   Hashimoto, N
   Matsumoto, A
   Shimada, K
   Yamaguchi, S
   Oka, T
   Kubota, K
   Yonemoto, S
   Sakaguchi, Y
   Takahashi, A
   Shintani, Y
   Takashima, S
   Takabatake, Y
   Hamano, T
   Isaka, Y
AF Mori, Daisuke
   Matsui, Isao
   Shimomura, Akihiro
   Hashimoto, Nobuhiro
   Matsumoto, Ayumi
   Shimada, Karin
   Yamaguchi, Satoshi
   Oka, Tatsufumi
   Kubota, Keiichi
   Yonemoto, Sayoko
   Sakaguchi, Yusuke
   Takahashi, Atsushi
   Shintani, Yasunori
   Takashima, Seiji
   Takabatake, Yoshitsugu
   Hamano, Takayuki
   Isaka, Yoshitaka
TI Protein carbamylation exacerbates vascular calcification
SO KIDNEY INTERNATIONAL
LA English
DT Article
DE oxidative stress; urea; vascular calcification
ID oxidative stress; inorganic pyrophosphate; kidney-disease; heart-failure; narp mutation; atp synthase; mineralization; risk; urea; nephrocalcinosis
AB Protein carbamylation is a posttranslational modification that can occur non-enzymatically in the presence of high concentrations of urea. Although carbamylation is recognized as a prognostic biomarker, the contribution of protein carbamylation to organ dysfunction remains uncertain. Because vascular calcification is common under carbamylation-prone situations, we investigated the effects of carbamylation on this pathologic condition. Protein carbamylation exacerbated the calcification of human vascular smooth muscle cells (hVSMCs) by suppressing the expression of ectonucleotide pyrophosphate/phosphodiesterase 1 (ENPP1), a key enzyme in the generation of pyrophosphate, which is a potent inhibitor of ectopic calcification. Several mitochondrial proteins were carbamylated, although ENPP1 itself was not identified as a carbamylated protein. Rather, protein carbamylation reduced mitochondrial membrane potential and exaggerated mitochondria-derived oxidative stress, which down-regulated ENPP1. The effects of carbamylation on ectopic calcification were abolished in hVSMCs by ENPP1 knockdown, in mitochondrial-DNA-depleted hVSMCs, and in hVSMCs treated with a mitochondria-targeted superoxide scavenger. We also evaluated the carbamylation effects using ex vivo and in vivo models. The tunica media of a patient with end-stage renal disease was carbamylated. Thus, our findings have uncovered a previously unrecognized aspect of uremia-related vascular pathology.
C1 [Mori, Daisuke; Matsui, Isao; Hashimoto, Nobuhiro; Matsumoto, Ayumi; Shimada, Karin; Yamaguchi, Satoshi; Oka, Tatsufumi; Kubota, Keiichi; Yonemoto, Sayoko; Takahashi, Atsushi; Takabatake, Yoshitsugu; Isaka, Yoshitaka] Osaka Univ, Grad Sch Med, Dept Nephrol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
   [Shimomura, Akihiro] Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA.
   [Sakaguchi, Yusuke; Hamano, Takayuki] Osaka Univ, Grad Sch Med, Dept Comprehens Kidney Dis Res, Suita, Osaka 5650871, Japan.
   [Shintani, Yasunori; Takashima, Seiji] Osaka Univ, Grad Sch Med, Dept Med Biochem, Suita, Osaka, Japan.
C3 Osaka University; University of California System; University of California Irvine; Osaka University; Osaka University
RP Matsui, I (corresponding author), Osaka Univ, Grad Sch Med, Dept Nephrol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM matsui@kid.med.osaka-u.ac.jp
FU Japan Society for the Promotion of Science KAKENHI grant [JP15K19454]; Osaka Kidney Foundation; Kidney Foundation Japan; Takeda Research Support; Novartis Research Support
CR Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200
   Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177
   Berg AH, 2013, SCI TRANSL MED, V5, P0, DOI 10.1126/scitranslmed.3005218
   Cachofeiro V, 2008, KIDNEY INT, V74, PS4, DOI 10.1038/ki.2008.516
   Cannata-Andia JB, 2011, NEPHROL DIAL TRANSPL, V26, P3429, DOI 10.1093/ndt/gfr591
   Chernoivanenko IS, 2015, FASEB J, V29, P820, DOI 10.1096/fj.14-259903
   Dounousi E, 2006, AM J KIDNEY DIS, V48, P752, DOI 10.1053/j.ajkd.2006.08.015
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   FLEISCH H, 1966, NATURE, V212, P901, DOI 10.1038/212901a0
   García JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075
   Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221
   Gorissea L, 2016, P NATL ACAD SCI USA, V113, P1191, DOI 10.1073/pnas.1517096113
   Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7
   Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485
   Hernández D, 2005, KIDNEY INT, V67, P2015, DOI 10.1111/j.1523-1755.2005.00303.x
   Hirose J, 2002, ARTHRITIS RHEUM-US, V46, P3218, DOI 10.1002/art.10632
   Houstek J, 2006, BBA-BIOENERGETICS, V1757, P1400, DOI 10.1016/j.bbabio.2006.04.006
   Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W
   Inoue K, 2012, LAB INVEST, V92, P1686, DOI 10.1038/labinvest.2012.107
   Jaisson S, 2011, CLIN CHEM, V57, P1499, DOI 10.1373/clinchem.2011.163188
   Kalim S, 2014, AM J KIDNEY DIS, V64, P793, DOI 10.1053/j.ajkd.2014.04.034
   Kempf H, 2011, J BONE MINER RES, V26, P1543
   Koeth RA, 2013, J AM SOC NEPHROL, V24, P853, DOI 10.1681/ASN.2012030254
   Leening MJG, 2012, JACC-CARDIOVASC IMAG, V5, P874, DOI 10.1016/j.jcmg.2012.03.016
   Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313
   Li QL, 2014, LAB INVEST, V94, P623, DOI 10.1038/labinvest.2014.52
   Lomashvili KA, 2005, J AM SOC NEPHROL, V16, P2495, DOI 10.1681/ASN.2004080694
   LOTZ M, 1995, P NATL ACAD SCI USA, V92, P10364, DOI 10.1073/pnas.92.22.10364
   Matsui I, 2013, AM J PHYSIOL-RENAL, V304, PF751, DOI 10.1152/ajprenal.00329.2012
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   MEYER JL, 1984, ARCH BIOCHEM BIOPHYS, V231, P1, DOI 10.1016/0003-9861(84)90356-4
   MOSS DW, 1967, BIOCHEM J, V102, P53, DOI 10.1042/bj1020053
   Mrácek T, 2006, EXP GERONTOL, V41, P683, DOI 10.1016/j.exger.2006.02.009
   Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205
   Namba T, 2014, J AM SOC NEPHROL, V25, P2254, DOI 10.1681/ASN.2013090986
   Nilsson L, 1996, CLIN CHEM, V42, P482
   ONeill WC, 2011, KIDNEY INT, V79, P512, DOI 10.1038/ki.2010.461
   Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956
   Olmez U, 1994, OSTEOARTHRITIS CARTILAGE, V2, P149, DOI 10.1016/S1063-4584(05)80065-2
   Persy V, 2009, TRENDS MOL MED, V15, P405, DOI 10.1016/j.molmed.2009.07.001
   Price PA, 2006, KIDNEY INT, V70, P1577, DOI 10.1038/sj.ki.5001841
   Rutsch F, 2001, AM J PATHOL, V158, P543, DOI 10.1016/S0002-9440(10)63996-X
   Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221
   Schultz BE, 2001, ANNU REV BIOPH BIOM, V30, P23, DOI 10.1146/annurev.biophys.30.1.23
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   Shimokado A, 2014, EXP MOL PATHOL, V97, P458, DOI 10.1016/j.yexmp.2014.10.005
   Shimomura A, 2014, J AM SOC NEPHROL, V25, P1954, DOI 10.1681/ASN.2013090967
   Speer T, 2014, EUR HEART J, V35, P3021, DOI 10.1093/eurheartj/ehu111
   STARK GR, 1960, J BIOL CHEM, V235, P3177
   Verbrugge FH, 2015, KIDNEY INT, V88, P474, DOI 10.1038/ki.2015.166
   VERONESE FM, 1972, J BIOL CHEM, V247, P754
   Walsh CR, 2002, AM HEART J, V144, P733, DOI 10.1067/mhj.2002.124404
   Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637
   Wilson PWF, 2001, CIRCULATION, V103, P1529, DOI 10.1161/01.cir.103.11.1529
   Zhang Z, 2004, P NATL ACAD SCI USA, V101, P9491, DOI 10.1073/pnas.0402961101
   Zhang Z, 1999, AM J PHYSIOL-RENAL, V276, PF786, DOI 10.1152/ajprenal.1999.276.5.F786
NR 56
TC 49
Z9 52
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0085-2538
EI 1523-1755
J9 KIDNEY INT
JI Kidney Int.
PD JUL 15
PY 2018
VL 94
IS 1
BP 72
EP 90
DI 10.1016/j.kint.2018.01.033
PG 19
WC Urology & Nephrology
SC Urology & Nephrology
GA GL9MY
UT WOS:000437660400012
PM 29716796
DA 2024-11-01
ER

PT J
AU Su, TH
   Turnbull, DM
   Greaves, LC
AF Su, Tianhong
   Turnbull, Doug M.
   Greaves, Laura C.
TI Roles of Mitochondrial DNA Mutations in Stem Cell Ageing
SO GENES
LA English
DT Review
DE stem cell; mitochondrial DNA mutation; ageing; purifying selection; mitochondrial mutagenesis; progenitor; mitochondrial disease; ageing mouse model; mitochondrial DNA-mutator mouse; mitochondria
ID pathogenic mtdna mutations; human skeletal-muscle; 4977 bp deletion; sequence heterogeneity; purifying selection; autophagy maintains; point mutations; transmission; accumulate; phenotypes
AB Mitochondrial DNA (mtDNA) mutations accumulate in somatic stem cells during ageing and cause mitochondrial dysfunction. In this review, we summarize the studies that link mtDNA mutations to stem cell ageing. We discuss the age-related behaviours of the somatic mtDNA mutations in stem cell populations and how they potentially contribute to stem cell ageing by altering mitochondrial properties in humans and in mtDNA-mutator mice. We also draw attention to the diverse fates of the mtDNA mutations with different origins during ageing, with potential selective pressures on the germline inherited but not the somatic mtDNA mutations.
C1 [Su, Tianhong; Turnbull, Doug M.; Greaves, Laura C.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Turnbull, Doug M.; Greaves, Laura C.] Newcastle Univ, Med Sch, LLHW Ctr Aging & Vital, Inst Aging, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK
RP Greaves, LC (corresponding author), Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Greaves, LC (corresponding author), Newcastle Univ, Med Sch, LLHW Ctr Aging & Vital, Inst Aging, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM t.su2@newcastle.ac.uk; doug.tumbull@newcastle.ac.uk; laura.greaves@newcastle.ac.uk
FU Newcastle University Centre for Aging and Vitality - Biotechnology and Biological Sciences Research Council (BBSRC); Newcastle University Centre for Aging and Vitality - Engineering and Physical Sciences Research Council (EPSRC); Newcastle University Centre for Aging and Vitality - Economic and Social Research Council (ESRC); Newcastle University Centre for Aging and Vitality - Medical Research Council (MRC) as part of the cross-council Lifelong Health and Wellbeing Initiative; Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; UK National Institute for Health Research (NIHR) Biomedical Research Centre in Age and Age Related Diseases; UK NHS Highly Specialized Service for Rare Mitochondrial Disorders of Adults and Children; MRC [MR/L016354/1] Funding Source: UKRI
CR Ahlqvist KJ, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7494
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Alexeyev M, 2013, COLD SPRING HARB PERSPECT BIOL, V5, P0, DOI 10.1101/CSHPERSPECT.A012641
   Baines HL, 2014, MECH AGEING DEV, V139, P22, DOI 10.1016/j.mad.2014.06.003
   Baines HL, 2014, AGING CELL, V13, P201, DOI 10.1111/acel.12199
   Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fellous TG, 2009, HEPATOLOGY, V49, P1655, DOI 10.1002/hep.22791
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, PG914, DOI 10.1152/ajpgi.00402.2011
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Greaves LC, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1003082
   Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Gutierrez-Gonzalez L, 2009, J PATHOL, V217, P489, DOI 10.1002/path.2502
   Hämäläinen RH, 2016, CURR OPIN GENET DEV, V38, P83, DOI 10.1016/j.gde.2016.04.008
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388
   Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506
   Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   Khacho M, 2016, CELL STEM CELL, V19, P232, DOI 10.1016/j.stem.2016.04.015
   Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Li-Harms X, 2015, BLOOD, V125, P162, DOI 10.1182/blood-2014-07-586396
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nooteboom M, 2010, AGING CELL, V9, P96, DOI 10.1111/j.1474-9726.2009.00531.x
   NORBY S, 1994, J MED GENET, V31, P45, DOI 10.1136/jmg.31.1.45
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   Olsson C, 2001, EUR J HUM GENET, V9, P917, DOI 10.1038/sj.ejhg.5200742
   Orogo AM, 2015, J BIOL CHEM, V290, P22061, DOI 10.1074/jbc.M115.649657
   Pallotti F, 1996, AM J HUM GENET, V59, P591
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pinto M, 2017, CELL DEATH DIFFER, V24, P288, DOI 10.1038/cdd.2016.123
   Popadin K, 2014, AM J PATHOL, V184, P2852, DOI 10.1016/j.ajpath.2014.09.001
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958
   Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   Shin MG, 2004, BLOOD, V103, P4466, DOI 10.1182/blood-2003-11-3949
   Shin MG, 2004, BLOOD, V103, P553, DOI 10.1182/blood-2003-05-1724
   Someya S, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0171159
   Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952
   Tan DQ, 2018, ANTIOXID REDOX SIGN, V29, P149, DOI 10.1089/ars.2017.7273
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   tHart LM, 1996, HUM MUTAT, V7, P193
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Wang T, 2014, CELL, V157, P1591, DOI 10.1016/j.cell.2014.04.042
   Wang X, 2013, HUM MOL GENET, V22, P3976, DOI 10.1093/hmg/ddt251
   Zheng YJ, 2012, BOSNIAN J BASIC MED, V12, P187, DOI 10.17305/bjbms.2012.2480
NR 76
TC 11
Z9 11
U1 1
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD APR 15
PY 2018
VL 9
IS 4
BP 
EP 
DI 10.3390/genes9040182
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA GJ3HH
UT WOS:000435182200010
PM 29584704
DA 2024-11-01
ER

PT J
AU Kasahara, T
   Kato, T
AF Kasahara, Takaoki
   Kato, Tadafumi
TI What Can Mitochondrial DNA Analysis Tell Us About Mood Disorders?
SO BIOLOGICAL PSYCHIATRY
LA English
DT Review
DE Chronic progressive external ophthalmoplegia; Mitochondrial disease; Mitochondrial DNA; Mitochondrial dysfunction; Paraventricular thalamus; POLG
ID genome-wide association; bipolar disorder; 3243a-greater-than-g mutation; external ophthalmoplegia; quantitative-analysis; psychiatric-symptoms; multiple deletions; oxidative stress; common deletion; mtdna
AB Variants in mitochondrial DNA (mtDNA) and nuclear genes encoding mitochondrial proteins in bipolar disorder, depression, or other psychiatric disorders have been studied for decades, since mitochondrial dysfunction was first suggested in the brains of patients with these diseases. Candidate gene association studies initially resulted in findings compatible with the mitochondrial dysfunction hypothesis. Many of those studies, however, were conducted with modest sample sizes (N, 1000), which could cause false positive findings. Furthermore, the DNA samples examined in these studies, including genome-wide association studies, were generally derived from peripheral tissues. One key unanswered question is whether there is an association between mood disorders and somatic mtDNA mutations (deletions and point mutations) in brain regions that accumulate a high amount of mtDNA mutations and/or are involved in the regulation of mood. Two lines of robust evidence supporting the importance of mtDNA mutations in brain tissues for mood disorders have come from clinical observation of mitochondrial disease patients who carry primary mtDNA mutations or accumulate secondary mtDNA mutations due to nuclear mutations and an animal model study. More than half of mitochondrial disease patients have comorbid mood disorders, and mice with neuronspecific accumulation of mtDNA mutations show spontaneous depression-like episodes. In this review, we first summarize the current knowledge of mtDNA and its genetics and discuss what mtDNA analysis tells us about neuropsychiatric disorders based on an example of Parkinson's disease. We also discuss challenges and future directions beyond mtDNA analysis toward an understanding of the pathophysiology of "idiopathic" mood disorders.
C1 [Kasahara, Takaoki; Kato, Tadafumi] RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
C3 RIKEN
RP Kato, T (corresponding author), RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
EM kato@brain.riken.jp
FU Advanced Genome Research and Bioinformatics Study to Facilitate Medical Innovation from the Japan Agency for Medical Research and Development [16815678]; MEXT [17H01573]; Grants-in-Aid for Scientific Research [17H01573] Funding Source: KAKEN
CR Alexeyev M, 2013, COLD SPRING HARB PERSPECT BIOL, V5, P0, DOI 10.1101/CSHPERSPECT.A012641
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Anglin RE, 2012, TRANSL PSYCHIAT, V2, P0, DOI 10.1038/tp.2012.107
   BARON M, 1994, BIOL PSYCHIAT, V35, P757, DOI 10.1016/0006-3223(94)91135-5
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Birur B, 2017, NPJ SCHIZOPHR, V3, P0, DOI 10.1038/s41537-017-0013-9
   Bohnert M, 2007, FEBS LETT, V581, P2802, DOI 10.1016/j.febslet.2007.03.004
   Bose A, 2016, J NEUROCHEM, V139, P216, DOI 10.1111/jnc.13731
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   CACCAMO DV, 1989, AM J PATHOL, V135, P801
   Cai N, 2015, CURR BIOL, V25, P3170, DOI 10.1016/j.cub.2015.10.065
   Calabrese C, 2014, BIOINFORMATICS, V30, P3115, DOI 10.1093/bioinformatics/btu483
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022
   Carter MJ, 2014, THER RECREAT J, V48, P275
   Chen C, 2015, PROTEIN CELL, V6, P862, DOI 10.1007/s13238-015-0175-z
   Chow J, 2017, NAT REV ENDOCRINOL, V13, P92, DOI 10.1038/nrendo.2016.151
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Croteau DL, 1997, J BIOL CHEM, V272, P25409, DOI 10.1074/jbc.272.41.25409
   DErchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303
   Fu ZX, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00043-3
   Fuke S, 2008, NEUROSCI LETT, V439, P173, DOI 10.1016/j.neulet.2008.05.009
   Fuke S, 2014, ANN CLIN TRANSL NEUR, V1, P909, DOI 10.1002/acn3.133
   Goldsmith DR, 2016, MOL PSYCHIATR, V21, P1696, DOI 10.1038/mp.2016.3
   Goulopoulou S, 2012, CLIN SCI, V123, P429, DOI 10.1042/CS20120130
   Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Hazkani-Covo E, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1000834
   Hu QS, 2016, TRANSL NEURODEGENER, V5, P0, DOI 10.1186/s40035-016-0060-6
   Hudson G, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004369
   Ikeda M, 2018, MOL PSYCHIATR, V23, P639, DOI 10.1038/mp.2016.259
   Inczedy-Farkas G, 2012, BEHAV BRAIN FUNCT, V8, P0, DOI 10.1186/1744-9081-8-9
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Ju YS, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.02935
   Kakiuchi C, 2005, INT J NEUROPSYCHOPH, V8, P515, DOI 10.1017/S1461145705005213
   Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824
   Kasahara T, 2016, MOL PSYCHIATR, V21, P39, DOI 10.1038/mp.2015.156
   Kasahara T, 2017, PSYCHIAT CLIN NEUROS, V71, P518, DOI 10.1111/pcn.12496
   Kataoka M, 2016, MOL PSYCHIATR, V21, P885, DOI 10.1038/mp.2016.69
   Kato T, 1997, BIOL PSYCHIAT, V42, P871, DOI 10.1016/S0006-3223(97)00012-7
   Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x
   Kato T, 2001, MOL PSYCHIATR, V6, P625, DOI 10.1038/sj.mp.4000926
   Kato T, 2008, TRENDS NEUROSCI, V31, P495, DOI 10.1016/j.tins.2008.07.007
   Kato T, 2017, SCHIZOPHR RES, V187, P62, DOI 10.1016/j.schres.2016.10.037
   Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128
   Kirches E, 2009, CURR GENOMICS, V10, P585, DOI 10.2174/138920209789503879
   Kirk R, 1999, AM J HUM GENET, V65, P508, DOI 10.1086/302507
   Kivisild T, 2015, INVESTIG GENET, V6, P0, DOI 10.1186/s13323-015-0022-2
   Koene S, 2009, J AFFECT DISORDERS, V114, P327, DOI 10.1016/j.jad.2008.06.023
   Köhler CA, 2017, ACTA PSYCHIAT SCAND, V135, P373, DOI 10.1111/acps.12698
   Ku C, 2015, NATURE, V524, P427, DOI 10.1038/nature14963
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lax NZ, 2017, NEUROPATH APPL NEURO, V43, P102, DOI 10.1111/nan.12333
   Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Lin MK, 2014, GENOME MED, V6, P0, DOI 10.1186/gm566
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mamdani F, 2014, SCHIZOPHR RES, V159, P370, DOI 10.1016/j.schres.2014.08.026
   Mancuso M, 2008, J AFFECT DISORDERS, V106, P173, DOI 10.1016/j.jad.2007.05.016
   Mancuso M, 2013, NEUROL SCI, V34, P71, DOI 10.1007/s10072-011-0901-0
   Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229
   Modica-Napolitano JS, 2003, ARCH PHARM RES, V26, P951, DOI 10.1007/BF02980205
   Molinari F, 2005, AM J HUM GENET, V76, P334, DOI 10.1086/427564
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Morén C, 2016, CURR DRUG METAB, V17, P648, DOI 10.2174/1389200217666160322143631
   Mühleisen TW, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4339
   Munakata K, 2005, BIOL PSYCHIAT, V57, P525, DOI 10.1016/j.biopsych.2004.11.041
   Munakata K, 2004, GENOMICS, V84, P1041, DOI 10.1016/j.ygeno.2004.08.015
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277
   Pandey A, 2002, ONCOGENE, V21, P3939, DOI 10.1038/sj.onc.1205478
   Perier C, 2012, CSH PERSPECT MED, V2, P0, DOI 10.1101/cshperspect.a009332
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   PONCHAUT S, 1993, BIOCHEM PHARMACOL, V46, P199, DOI 10.1016/0006-2952(93)90404-K
   Rodríguez-Ezpeleta N, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0030520
   Rollins B, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0004913
   Ross JM, 2011, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/3266
   Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682
   Sato A, 2005, P NATL ACAD SCI USA, V102, P6057, DOI 10.1073/pnas.0408666102
   Schneider S, 1999, GENETICS, V152, P1079
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sequeira A, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0127280
   Sequeira Adolfo, 2012, FRONTIERS IN GENETICS, V3, P103, DOI 10.3389/fgene.2012.00103
   Shao L, 2008, ANN MED, V40, P281, DOI 10.1080/07853890801923753
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Smits BW, 2011, NEUROMUSCULAR DISORD, V21, P272, DOI 10.1016/j.nmd.2010.12.008
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   STINE OC, 1993, BIOL PSYCHIAT, V33, P141, DOI 10.1016/0006-3223(93)90317-7
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260
   Thrash JC, 2011, SCI REP-UK, V1, P0, DOI 10.1038/srep00013
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trifunovic A, 2006, BBA-BIOENERGETICS, V1757, P611, DOI 10.1016/j.bbabio.2006.03.003
   Tyrka AR, 2016, BIOL PSYCHIAT, V79, P78, DOI 10.1016/j.biopsych.2014.12.025
   Uhlen M, 2015, SCIENCE, V347, P0, DOI 10.1126/science.1260419
   Vawter MP, 2006, MOL PSYCHIATR, V11, P663, DOI 10.1038/sj.mp.4001830
   Wenceslau CF, 2014, EUR HEART J, V35, P1172, DOI 10.1093/eurheartj/ehu047
NR 107
TC 43
Z9 47
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0006-3223
EI 1873-2402
J9 BIOL PSYCHIAT
JI Biol. Psychiatry
PD MAY 1
PY 2018
VL 83
IS 9
BP 731
EP 738
DI 10.1016/j.biopsych.2017.09.010
PG 8
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA GB9YQ
UT WOS:000429431400005
PM 29102411
DA 2024-11-01
ER

PT J
AU Nissanka, N
   Moraes, CT
AF Nissanka, Nadee
   Moraes, Carlos T.
TI Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease
SO FEBS LETTERS
LA English
DT Review
DE mitochondrial DNA; neurodegeneration; reactive oxygen species
ID complex-i-deficiency; multiple mtdna deletions; transgenic mouse model; human skeletal-muscle; leigh-syndrome; substantia-nigra; alzheimers-disease; parkinsons-disease; point mutations; oxidative stress
AB Mitochondria are essential organelles within the cell where most ATP is produced through oxidative phosphorylation (OXPHOS). A subset of the genes needed for this process are encoded by the mitochondrial DNA (mtDNA). One consequence of OXPHOS is the production of mitochondrial reactive oxygen species (ROS), whose role in mediating cellular damage, particularly in damaging mtDNA during ageing, has been controversial. There are subsets of neurons that appear to be more sensitive to ROS-induced damage, and mitochondrial dysfunction has been associated with several neurodegenerative disorders. In this review, we will discuss the current knowledge in the field of mtDNA and neurodegeneration, the debate about ROS as a pathological or beneficial contributor to neuronal function, bona fide mtDNA diseases, and insights from mouse models of mtDNA defects affecting the central nervous system.
C1 [Nissanka, Nadee; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Neurosci Grad Program, Miami, FL 33136 USA.
   [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, 1420 NW 9th Ave,Rm 229, Miami, FL 33136 USA.
C3 University of Miami; University of Miami
RP Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, 1420 NW 9th Ave,Rm 229, Miami, FL 33136 USA.
EM cmoraes@med.miami.edu
FU National Institutes of Health [1R01AG036871, 5R01EY010804, 1R01NS079965]; American Heart Association [16PRE30480009]; Lois Pope LIFE Fellows Program; NEI center grant from the National Institutes of Health (NIH) [P30-EY014801]; American Heart Association (AHA) [16PRE30480009] Funding Source: American Heart Association (AHA)
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Andalib S, 2013, J NEUROL SCI, V330, P10, DOI 10.1016/j.jns.2013.04.018
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7
   Andrus PK, 1998, J NEUROCHEM, V71, P2041
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8
   Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Campbell GR, 2013, NEUROPATH APPL NEURO, V39, P377, DOI 10.1111/j.1365-2990.2012.01290.x
   Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109
   Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509
   Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Coppedè F, 2015, MUTAT RES-FUND MOL M, V776, P84, DOI 10.1016/j.mrfmmm.2014.11.010
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Dhaliwal GK, 2000, NEUROREPORT, V11, P2507, DOI 10.1097/00001756-200008030-00032
   Diaz F, 2012, HUM MOL GENET, V21, P5066, DOI 10.1093/hmg/dds350
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107
   Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Ferrante RJ, 1997, J NEUROCHEM, V69, P2064
   Finkel T, 2001, IUBMB LIFE, V52, P3, DOI 10.1080/15216540252774694
   Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095
   Franco-Iborra S, 2016, NEUROSCIENTIST, V22, P266, DOI 10.1177/1073858415574600
   Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Garrido-Maraver J, 2012, BRIT J PHARMACOL, V167, P1311, DOI 10.1111/j.1476-5381.2012.02086.x
   GIBB WRG, 1991, J NEUROL NEUROSUR PS, V54, P388, DOI 10.1136/jnnp.54.5.388
   Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536
   Gyulkhandanyan AV, 2004, J NEUROCHEM, V90, P405, DOI 10.1111/j.1471-4159.2004.02489.x
   HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008
   Hoekstra JG, 2016, ANN NEUROL, V80, P301, DOI 10.1002/ana.24709
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   HUOPONEN K, 1991, AM J HUM GENET, V48, P1147
   HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172
   Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026
   Ingram CJE, 2012, AMYOTROPH LATERAL SC, V13, P341, DOI 10.3109/17482968.2012.654394
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lapointe J, 2012, J CELL BIOL, V199, P215, DOI 10.1083/jcb.201203090
   Lax NZ, 2017, NEUROPATH APPL NEURO, V43, P102, DOI 10.1111/nan.12333
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Liu RG, 1998, ANN NEUROL, V44, P763, DOI 10.1002/ana.410440510
   Lotharius J, 2002, HUM MOL GENET, V11, P2395, DOI 10.1093/hmg/11.20.2395
   Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661
   Lubos E, 2011, J BIOL CHEM, V286, P35407, DOI 10.1074/jbc.M110.205708
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Makino M, 2000, J HUM GENET, V45, P69, DOI 10.1007/s100380050014
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Mancuso Michelangelo, 2008, HUMAN GENOMICS, V3, P71
   Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Marin SE, 2013, GENE, V516, P162, DOI 10.1016/j.gene.2012.12.024
   Martín MA, 2005, ARCH NEUROL-CHICAGO, V62, P659, DOI 10.1001/archneur.62.4.659
   Massaad CA, 2011, ANTIOXID REDOX SIGN, V14, P2013, DOI 10.1089/ars.2010.3208
   MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886
   Mawrin C, 2004, NEUROREPORT, V15, P939, DOI 10.1097/00001756-200404290-00002
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Meredith GE, 2011, J PARKINSON DIS, V1, P19, DOI 10.3233/JPD-2011-11023
   Mossmann D, 2014, CELL METAB, V20, P662, DOI 10.1016/j.cmet.2014.07.024
   Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nakada K, 2001, BIOCHEM BIOPH RES CO, V288, P901, DOI 10.1006/bbrc.2001.5873
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   Nesbitt V, 2012, DEV MED CHILD NEUROL, V54, P500, DOI 10.1111/j.1469-8749.2012.04224.x
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313
   Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018
   Parkinson Gemma M, 2014, CURR AGING SCI, V7, P155
   Pickrell AM, 2011, J NEUROSCI, V31, P9895, DOI 10.1523/JNEUROSCI.6223-10.2011
   Pinto M, 2013, NEUROBIOL AGING, V34, P2399, DOI 10.1016/j.neurobiolaging.2013.04.014
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rao VK, 2014, BBA-MOL BASIS DIS, V1842, P1267, DOI 10.1016/j.bbadis.2013.09.003
   Reeve A, 2014, AGEING RES REV, V14, P19, DOI 10.1016/j.arr.2014.01.004
   Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Samuels DC, 2003, NUCLEIC ACIDS RES, V31, P6043, DOI 10.1093/nar/gkg784
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Sau D, 2007, HUM MOL GENET, V16, P1604, DOI 10.1093/hmg/ddm110
   Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, PC1640, DOI 10.1152/ajpcell.1998.275.6.C1640
   Sims-Robinson C, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0068011
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Swerdlow RH, 2014, BBA-MOL BASIS DIS, V1842, P1219, DOI 10.1016/j.bbadis.2013.09.010
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trounce I A, 1996, METHODS ENZYMOL, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Tzoulis C, 2016, MITOCHONDRION, V28, P33, DOI 10.1016/j.mito.2016.03.003
   Vergani L, 1999, HUM MOL GENET, V8, P1751, DOI 10.1093/hmg/8.9.1751
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang XK, 2010, FRONT AGING NEUROSCI, V2, P0, DOI 10.3389/fnagi.2010.00012
   WIESNER RJ, 1992, BIOCHEM BIOPH RES CO, V183, P553, DOI 10.1016/0006-291X(92)90517-O
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Wojtala A, 2017, MITOCHONDRION, V37, P62, DOI 10.1016/j.mito.2017.07.002
   Yang W, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000556
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
NR 139
TC 290
Z9 321
U1 6
U2 76
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD MAR 15
PY 2018
VL 592
IS 5
BP 728
EP 742
DI 10.1002/1873-3468.12956
PG 15
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA FZ3FW
UT WOS:000427473100007
PM 29281123
DA 2024-11-01
ER

PT J
AU Ryzhkova, AI
   Sazonova, MA
   Sinyov, VV
   Galitsyna, EV
   Chicheva, MM
   Melnichenko, AA
   Grechko, AV
   Postnov, AY
   Orekhov, AN
   Shkurat, TP
AF Ryzhkova, Anastasia I.
   Sazonova, Margarita A.
   Sinyov, Vasily V.
   Galitsyna, Elena V.
   Chicheva, Mariya M.
   Melnichenko, Alexandra A.
   Grechko, Andrey V.
   Postnov, Anton Yu
   Orekhov, Alexander N.
   Shkurat, Tatiana P.
TI Mitochondrial diseases caused by mtDNA mutations: a mini-review
SO THERAPEUTICS AND CLINICAL RISK MANAGEMENT
LA English
DT Review
DE mitochondrial cytopathy; mitochondrial dysfunction; mtDNA mutation; mitochondrial gene mutation
ID hereditary optic neuropathy; stroke-like-episodes; progressive external ophthalmoplegia; trna(val) t1658c mutation; type-2 diabetes-mellitus; kearns-sayre-syndrome; ragged-red fibers; lactic-acidosis; leigh-syndrome; gene mutation
AB There are several types of mitochondrial cytopathies, which cause a set of disorders, arise as a result of mitochondria's failure. Mitochondria's functional disruption leads to development of physical, growing and cognitive disabilities and includes multiple organ pathologies, essentially disturbing the nervous and muscular systems. The origins of mitochondrial cytopathies are mutations in genes of nuclear DNA encoding mitochondrial proteins or in mitochondrial DNA. Nowadays, numerous mtDNA mutations significant to the appearance and progress of pathologies in humans are detected. In this mini-review, we accent on the mitochondrial cytopathies related to mutations of mtDNA. As well known, there are definite set of symptoms of mitochondrial cytopathies distinguishing or similar for different syndromes. The present article contains data about mutations linked with cytopathies that facilitate diagnosis of different syndromes by using genetic analysis methods. In addition, for every individual, more effective therapeutic approach could be developed after wide-range mutant background analysis of mitochondrial genome.
C1 [Ryzhkova, Anastasia I.; Sazonova, Margarita A.; Sinyov, Vasily V.; Postnov, Anton Yu] Natl Med Res Ctr Cardiol, Lab Med Genet, Moscow, Russia.
   [Ryzhkova, Anastasia I.] KI Skryabin Moscow State Acad Vet Med & Biotechno, Dept Virol, 23 Skryabina St, Moscow 109472, Russia.
   [Sazonova, Margarita A.; Orekhov, Alexander N.] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, Moscow, Russia.
   [Galitsyna, Elena V.; Chicheva, Mariya M.; Melnichenko, Alexandra A.; Shkurat, Tatiana P.] Southern Fed Univ, Dept Genet, Rostov Na Donu, Russia.
   [Grechko, Andrey V.] Fed Res & Clin Ctr Reanimatol & Rehabilitol, Moscow, Russia.
   [Orekhov, Alexander N.] Skolkovo Innovat Ctr, Inst Atherosclerosis Res, Moscow, Moscow Region, Russia.
C3 National Medical Research Center of Cardiology; Moscow State Academy of Veterinary Medicine & Biotechnology named after K.I. Skryabin; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; Southern Federal University; Federal Research & Clinical Center of Intensive Care Medicine & Rehabilitology
RP Ryzhkova, AI (corresponding author), KI Skryabin Moscow State Acad Vet Med & Biotechno, Dept Virol, 23 Skryabina St, Moscow 109472, Russia.
EM ryzhkovaai@gmail.com
FU Russian Science Foundation [14-14-01038]; Russian Science Foundation [17-14-00092] Funding Source: Russian Science Foundation
CR Al-Enezi M, 2008, MIDDLE EAST AFR J OP, V15, P81, DOI 10.4103/0974-9233.51998
   ALCOLADO JC, 1995, DIABETIC MED, V12, P102, DOI 10.1111/j.1464-5491.1995.tb00438.x
   Arbustini E, 1998, CARDIOMYOPATHIES ADV, V0, P117
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Berardo A, 2011, ACTA MYOL, V30, P9
   Bonekamp NA, 2017, CELL, V172, P0
   Buhmann C, 2002, ACTA NEUROL SCAND, V106, P236, DOI 10.1034/j.1600-0404.2002.01323.x
   Cao YY, 2010, MITOCHONDRION, V10, P330, DOI 10.1016/j.mito.2010.01.008
   Cardaioli E, 2008, J NEUROL SCI, V272, P106, DOI 10.1016/j.jns.2008.05.005
   Chan SSL, 2017, TOXICOLOGY, V391, P75, DOI 10.1016/j.tox.2017.07.014
   Chen FL, 2006, MUTAT RES-FUND MOL M, V602, P26, DOI 10.1016/j.mrfmmm.2006.07.006
   Dahiya Neha, 2018, INDIAN J MED ETHICS, V3, P169, DOI 10.20529/IJME.2017.097
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   Dominic EA, 2014, HEART, V100, P611, DOI 10.1136/heartjnl-2013-304657
   Donthamsetty S, 2014, CELL CYCLE, V13, P2056, DOI 10.4161/cc.29061
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   El-Hattab AW, 2016, CELL CALCIUM, V60, P199, DOI 10.1016/j.ceca.2016.03.003
   Elson JL, 2009, HUM MUTAT, V30, PE984, DOI 10.1002/humu.21113
   Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214
   Fetterman JL, 2016, CARDIOVASC DIABETOL, V15, P0, DOI 10.1186/s12933-016-0372-y
   Finsterer J, 2011, EUR J NEUROL, V18, P28, DOI 10.1111/j.1468-1331.2010.03086.x
   Finsterer Josef, 2012, OPEN NEUROL J, V6, P26, DOI 10.2174/1874205X01206010026
   Finsterer J, 2013, SEIZURE-EUR J EPILEP, V22, P119, DOI 10.1016/j.seizure.2012.11.005
   Florian A, 2015, J CARDIOVASC MAGN R, V17, P0, DOI 10.1186/s12968-015-0145-x
   Fosslien E, 2003, ANN CLIN LAB SCI, V33, P371
   Gelfand JM, 2011, J NEUROL, V258, P440, DOI 10.1007/s00415-010-5775-1
   Borlado MCG, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0012801
   Gray MW, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a011403
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Griffin HR, 2014, GENET MED, V16, P962, DOI 10.1038/gim.2014.66
   Herst PM, 2017, FRONT ENDOCRINOL, V8, P0, DOI 10.3389/fendo.2017.00296
   Hirai M, 1996, BIOCHEM BIOPH RES CO, V219, P951, DOI 10.1006/bbrc.1996.0324
   Huang SS, 2015, INT J PEDIATR OTORHI, V79, P1067, DOI 10.1016/j.ijporl.2015.04.028
   Iida Y, 2016, J NEUROL SCI, V363, P77, DOI 10.1016/j.jns.2016.02.036
   Ivanova M M, 2012, PATOL FIZIOL EKSP TER, V0, P115
   Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795
   Jaksch M, 2001, NEUROLOGY, V57, P1440, DOI 10.1212/WNL.57.8.1440
   Jun AS, 1996, MOL CELL BIOL, V16, P771
   Kabunga P, 2015, INT J CARDIOL, V181, P303, DOI 10.1016/j.ijcard.2014.12.038
   Karadimas CL, 2002, NEUROMUSCULAR DISORD, V12, P865, DOI 10.1016/S0960-8966(02)00072-X
   Kauppila JHK, 2015, BBA-BIOENERGETICS, V1847, P1354, DOI 10.1016/j.bbabio.2015.06.001
   Kaushal PS, 2015, BIOCHIMIE, V114, P119, DOI 10.1016/j.biochi.2015.03.013
   Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737
   Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000
   Lee SR, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/8060949
   Lee SR, 2017, FRONT BIOSCI-LANDMRK, V22, P1177, DOI 10.2741/4541
   Lee WTY, 2015, ANN NY ACAD SCI, V1350, P95, DOI 10.1111/nyas.12873
   Leis JA, 2015, CAN MED ASSOC J, V187, PE52, DOI 10.1503/cmaj.140339
   Leng YL, 2015, MITOCHONDR DNA, V26, P208, DOI 10.3109/19401736.2014.905860
   Liu YQ, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-03303-w
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   Lorenzoni PJ, 2014, ARQ NEURO-PSIQUIAT, V72, P803, DOI 10.1590/0004-282X20140124
   Ma LJ, 2000, CHINESE MED J-PEKING, V113, P111
   Maassen JA, 1997, HORM METAB RES, V29, P50, DOI 10.1055/s-2007-978984
   Mancuso M, 2007, BIOCHEM BIOPH RES CO, V354, P1058, DOI 10.1016/j.bbrc.2007.01.099
   Marie Suely Kazue Nagahashi, 2014, MEDICALEXPRESS (SÃO PAULO, V0, P0
   Martín MA, 2005, ARCH NEUROL-CHICAGO, V62, P659, DOI 10.1001/archneur.62.4.659
   Meng FL, 2017, J BIOL CHEM, V292, P2881, DOI 10.1074/jbc.M116.749374
   Mimaki M, 2003, J HUM GENET, V48, P47, DOI 10.1007/s100380300005
   Mkaouar-Rebai E, 2014, MITOCHONDR DNA, V25, P394, DOI 10.3109/19401736.2013.803086
   Mohammed Shamayel, 2012, FRONT BIOSCI (ELITE ED), V4, P1706
   Naing A, 2014, J DIABETES COMPLICAT, V28, P542, DOI 10.1016/j.jdiacomp.2014.03.006
   Nikitin AG, 2012, DIAB MET SYND CLIN R, V6, P150, DOI 10.1016/j.dsx.2012.09.005
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   OBrien T, 2003, IUBMB LIFE, V55, P505, DOI 10.1080/15216540310001626610
   OBrien TW, 2002, GENE, V286, P73, DOI 10.1016/S0378-1119(01)00808-3
   Ohkubo E, 2000, BIOCHEM BIOPH RES CO, V278, P808, DOI 10.1006/bbrc.2000.3867
   Orogo AM, 2015, J BIOL CHEM, V290, P22061, DOI 10.1074/jbc.M115.649657
   Parikh S, 2010, DEV DISABIL RES REV, V16, P120, DOI 10.1002/ddrr.110
   Pätsi J, 2008, BIOCHEM J, V409, P129, DOI 10.1042/BJ20070866
   Pereira L, 2011, AM J HUM GENET, V88, P433, DOI 10.1016/j.ajhg.2011.03.006
   Persad PJ, 2017, INVEST OPHTH VIS SCI, V58, P4027, DOI 10.1167/iovs.17-21734
   Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x
   Rawle MJ, 2013, CASE REP NEUROL, V5, P204, DOI 10.1159/000357518
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rusecka J, 2018, J APPL GENET, V59, P43, DOI 10.1007/s13353-017-0424-3
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   Schinwelski M, 2015, METAB BRAIN DIS, V30, P1083, DOI 10.1007/s11011-014-9645-x
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Sobenin IA, 2013, WORLD J CARDIOL, V5, P132, DOI 10.4330/wjc.v5.i5.132
   St John J, 2014, BBA-GEN SUBJECTS, V1840, P1345, DOI 10.1016/j.bbagen.2013.10.036
   St John JC, 2016, SEMIN CELL DEV BIOL, V52, P93, DOI 10.1016/j.semcdb.2016.01.028
   Steriade C, 2014, PEDIATR NEUROL, V50, P498, DOI 10.1016/j.pediatrneurol.2014.01.009
   Szczepanowska K, 2015, BBA-BIOENERGETICS, V1847, P1362, DOI 10.1016/j.bbabio.2015.05.016
   Tang Jing, 2005, ZHONGHUA YIXUE YICHUANXUE ZAZHI, V22, P198
   Tansel T, 2014, CARDIOL YOUNG, V24, P531, DOI 10.1017/S1047951113000668
   Tawata M, 2000, DIABETES, V49, P1269, DOI 10.2337/diabetes.49.7.1269
   Thomas T, 2015, MOLEC GENET METAB RE, V4, P9, DOI 10.1016/j.ymgmr.2015.05.002
   TROUNCE I, 1994, P NATL ACAD SCI USA, V91, P8334, DOI 10.1073/pnas.91.18.8334
   Turnbull DM, 2016, NEUROBIOL DIS, V92, P55, DOI 10.1016/j.nbd.2015.02.003
   Ueki I, 2006, MITOCHONDRION, V6, P29, DOI 10.1016/j.mito.2005.10.003
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Wallace DC, 2001, MENT RETARD DEV D R, V7, P158, DOI 10.1002/mrdd.1023
   Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wang K, 2009, NEUROGENETICS, V10, P337, DOI 10.1007/s10048-009-0194-0
   Wang YX, 2015, CHINESE MED J-PEKING, V128, P1820, DOI 10.4103/0366-6999.159360
   Wang ZX, 2010, NEUROPATHOLOGY, V30, P606, DOI 10.1111/j.1440-1789.2010.01115.x
   Williams AJ, 1999, HUM MOL GENET, V8, P1691, DOI 10.1093/hmg/8.9.1691
   Wortmann SB, 2012, EUR J MED GENET, V55, P552, DOI 10.1016/j.ejmg.2012.06.002
   Wu J, 2015, J MED GENET, V52, P95, DOI 10.1136/jmedgenet-2014-102753
   Yan NH, 2010, MOL VIS, V16, P1736
   Yoshii Y, 2012, NUCL MED BIOL, V39, P177, DOI 10.1016/j.nucmedbio.2011.08.008
   Young TJ, 2005, PACE, V28, P454, DOI 10.1111/j.1540-8159.2005.40049.x
   Yu JL, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0114650
   Zapico SC, 2013, AGING DIS, V4, P364, DOI 10.14336/AD.2013.0400364
   Zhelankin A V, 2012, PATOL FIZIOL EKSP TER, V0, P123
   Zhou LJ, 2014, MITOCHONDR DNA, V25, P385, DOI 10.3109/19401736.2013.803097
   Zhu CC, 2017, OPHTHALMIC GENET, V38, P67, DOI 10.3109/13816810.2015.1130153
NR 113
TC 49
Z9 55
U1 1
U2 24
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-203X
EI 
J9 THER CLIN RISK MANAG
JI Therap. Clin. Risk Manag.
PD JUN 15
PY 2018
VL 14
IS 
BP 1933
EP 1942
DI 10.2147/TCRM.S154863
PG 10
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA GW3EP
UT WOS:000446775200001
PM 30349272
DA 2024-11-01
ER

PT J
AU Ng, YS
   Lax, NZ
   Maddison, P
   Alston, CL
   Blakely, EL
   Hepplewhite, PD
   Riordan, G
   Meldau, S
   Chinnery, PF
   Pierre, G
   Chronopoulou, E
   Du, AL
   Hughes, I
   Morris, AA
   Kamakari, S
   Chrousos, G
   Rodenburg, RJ
   Saris, CGJ
   Feeney, C
   Hardy, SA
   Sakakibara, T
   Sudo, A
   Okazaki, Y
   Murayama, K
   Mundy, H
   Hanna, MG
   Ohtake, A
   Schaefer, AM
   Champion, MP
   Turnbull, DM
   Taylor, RW
   Pitceathly, RDS
   McFarland, R
   Gorman, GS
AF Ng, Yi Shiau
   Lax, Nichola Z.
   Maddison, Paul
   Alston, Charlotte L.
   Blakely, Emma L.
   Hepplewhite, Philippa D.
   Riordan, Gillian
   Meldau, Surita
   Chinnery, Patrick F.
   Pierre, Germaine
   Chronopoulou, Efstathia
   Du, Ailian
   Hughes, Imelda
   Morris, Andrew A.
   Kamakari, Smaragda
   Chrousos, Georgia
   Rodenburg, Richard J.
   Saris, Christiaan G. J.
   Feeney, Catherine
   Hardy, Steven A.
   Sakakibara, Takafumi
   Sudo, Akira
   Okazaki, Yasushi
   Murayama, Kei
   Mundy, Helen
   Hanna, Michael G.
   Ohtake, Akira
   Schaefer, Andrew M.
   Champion, Mike P.
   Turnbull, Doug M.
   Taylor, Robert W.
   Pitceathly, Robert D. S.
   McFarland, Robert
   Gorman, Grainne S.
TI <i>MT</i>-<i>ND5</i> Mutation Exhibits Highly Variable Neurological Manifestations at Low Mutant Load
SO EBIOMEDICINE
LA English
DT Article
DE Mitochondrial encephalomyopathy Lactic acidosis and stroke-like episodes (MELAS); Leigh syndrome (LS); Mitochondrial DNA; Heteroplasmy; Neuropathology
ID mitochondrial-dna; leigh-syndrome; complex i; clinical-features; g13513a mutation; overlap-syndrome; nd5 gene; melas; diseases; abnormality
AB Mutations in the m.13094TNC MT-ND5 gene have been previously described in three cases of Leigh Syndrome (LS). In this retrospective, international cohort study we identified 20 clinically affected individuals (13 families) and four asymptomatic carriers. Ten patients were deceased at the time of analysis (median age of death was 10 years (range: 5.4months-37 years, IQR = 17.9 years). Nine patients manifested with LS, one with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), and one with Leber hereditary optic neuropathy. The remaining nine patients presented with either overlapping syndromes or isolated neurological symptoms. Mitochondrial respiratory chain activity analysis was normal in five out of ten muscle biopsies. We confirmed maternal inheritance in six families, and demonstrated marked variability in tissue segregation, and phenotypic expression at relatively low blood mutant loads. Neuropathological studies of two patients manifesting with LS/MELAS showed prominent capillary proliferation, microvacuolation and severe neuronal cell loss in the brainstem and cerebellum, with conspicuous absence of basal ganglia involvement. These findings suggest that whole mtDNA genome sequencing should be considered in patients with suspected mitochondrial disease presenting with complex neurological manifestations, which would identify over 300 known pathogenic variants including the m.13094TNC. (C) 2018 The Authors. Published by Elsevier B.V.
C1 [Ng, Yi Shiau; Lax, Nichola Z.; Alston, Charlotte L.; Blakely, Emma L.; Hepplewhite, Philippa D.; Chinnery, Patrick F.; Feeney, Catherine; Hardy, Steven A.; Schaefer, Andrew M.; Turnbull, Doug M.; Taylor, Robert W.; McFarland, Robert; Gorman, Grainne S.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Maddison, Paul] Queens Med Ctr, Dept Neurol, Nottingham, England.
   [Riordan, Gillian] Red Cross War Mem Childrens Hosp, Paediat Neurol Dept, Cape Town, South Africa.
   [Meldau, Surita] Univ Cape Town, Fac Hlth Sci, Div Chem Pathol, Cape Town, South Africa.
   [Chinnery, Patrick F.] Med Res Council Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge, England.
   [Pierre, Germaine; Chronopoulou, Efstathia] Univ Hosp Bristol NHS Fdn Trust, Dept Inherited Metab Dis, Div Womens & Childrens Serv, Bristol, Avon, England.
   [Du, Ailian] Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Shanghai, Peoples R China.
   [Hughes, Imelda] Cent Manchester Univ Hosp NHS Fdn Trust, Royal Manchester Childrens Hosp, Manchester, Lancs, England.
   [Morris, Andrew A.] Univ Manchester, Inst Human Dev, Manchester M13 9WL, Lancs, England.
   [Kamakari, Smaragda] OMMA, Inst Ophthalmol, Ophthalm Genet Unit, Athens, Greece.
   [Chrousos, Georgia] MITERA Childrens Hosp, Pediat Ophthalmol Dept, Athens, Greece.
   [Rodenburg, Richard J.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Radboud Ctr Mitochondrial Med, Nijmegen, Netherlands.
   [Saris, Christiaan G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Nijmegen, Netherlands.
   [Sakakibara, Takafumi] Nara Med Univ Hosp, Dept Pediat, Nara 6348522, Japan.
   [Sudo, Akira] Sapporo City Gen Hosp, Dept Pediat, Sapporo, Hokkaido 0608604, Japan.
   [Okazaki, Yasushi] Juntendo Univ, Grad Sch Med, Intractable Dis Res Ctr, Diagnost & Therapeut Intractable Dis, Tokyo 1138421, Japan.
   [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Chiba 2660007, Japan.
   [Mundy, Helen; Champion, Mike P.] Guys & St Thomas NHS Fdn Trust, Evelina London Childrens Hosp, London, England.
   [Hanna, Michael G.; Pitceathly, Robert D. S.] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London, England.
   [Hanna, Michael G.; Pitceathly, Robert D. S.] Natl Hosp Neurol & Neurosurg, London, England.
   [Ohtake, Akira] Saitama Med Univ, Fac Med, Dept Pediat, Saitama 3500495, Japan.
   [Meldau, Surita] Natl Hlth Lab Serv, Cape Town, South Africa.
   [Morris, Andrew A.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England.
C3 Newcastle University - UK; University of Nottingham; University of Cape Town; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Bristol; Shanghai Jiao Tong University; Royal Manchester Children's Hospital; University of Manchester; University of Manchester; Radboud University Nijmegen; Radboud University Nijmegen; Nara Medical University; Sapporo City General Hospital; Juntendo University; Chiba Children's Hospital; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Saitama Medical University; University of Manchester
RP Gorman, GS (corresponding author), Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
EM grainne.gorman@ncl.ac.uk
FU Wellcome Trust [203105]; Newcastle University Centre for Ageing and Vitality (Biotechnology and Biological Sciences Research Council and Medical Research Council) [L016354]; UK NIHR Biomedical Research Centre for Ageing and Age-related disease award; National Institute for Health Research (NIHR); UK NHS; UK Medical Research Council (MRC) Centre Mitochondrial Disease Patient Cohort: A Natural History Study and Patient Registry [13/NE/0326]; NIHR Biomedical Research Centre, Newcastle and North Tyneside Comprehensive Local Research Network; MRC Centre of Neuromuscular diseases [MR/K000608/1]; National Institute for Health Research (NIHR) doctoral fellowship [NIHR-HCS-D12-03-04]; Medical Research Council Centre grant [G0601943]; Department of Health's National Institute for Health Research Biomedical Research Centres; Japanese Ministry of Education, Culture, Sports, Science and Technology; Agency for Medical Research and Development (AMED); AMED; MRC [G0601943, G1100540, G0400074, G0502157, MR/L016354/1, MR/K000608/1, G0900652, G0800674] Funding Source: UKRI
CR Ahmed ST, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-14623-2
   Alston CL, 2010, NEUROMUSCULAR DISORD, V20, P131, DOI 10.1016/j.nmd.2009.10.010
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Blok MJ, 2007, J MED GENET, V44, P0, DOI 10.1136/jmg.2006.045716
   Ching CK, 2013, HONG KONG MED J, V19, P357, DOI 10.12809/hkmj133673
   Crimi M, 2003, NEUROLOGY, V60, P1857, DOI 10.1212/01.WNL.0000066048.72780.69
   Diodato Daria, 2014, INT J CELL BIOL, V2014, P787956, DOI 10.1155/2014/787956
   Downham E, 2008, NEUROMUSCULAR DISORD, V18, P310, DOI 10.1016/j.nmd.2008.01.003
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   HOWELL N, 1993, AM J HUM GENET, V53, P959
   Katramados AM, 2009, EPILEPSIA, V50, P265, DOI 10.1111/j.1528-1167.2008.01736.x
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Matthews L, 2015, J NEUROL NEUROSUR PS, V86, P537, DOI 10.1136/jnnp-2014-308186
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450
   Palesi F, 2015, BRAIN STRUCT FUNCT, V220, P3369, DOI 10.1007/s00429-014-0861-2
   Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rodenburg RJ, 2016, BBA-BIOENERGETICS, V1857, P938, DOI 10.1016/j.bbabio.2016.02.012
   Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   TIEN RD, 1992, AM J ROENTGENOL, V158, P1155, DOI 10.2214/ajr.158.5.1566683
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Yu-Wai-Man P, 2016, ANN CLIN TRANSL NEUR, V3, P723, DOI 10.1002/acn3.323
   Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095
NR 30
TC 44
Z9 45
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
EI 
J9 EBIOMEDICINE
JI EBioMedicine
PD APR 15
PY 2018
VL 30
IS 
BP 86
EP 93
DI 10.1016/j.ebiom.2018.02.010
PG 8
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA GD2AR
UT WOS:000430303000014
PM 29506874
DA 2024-11-01
ER

PT J
AU Haast, RAM
   Ivanov, D
   IJsselstein, RJT
   Sallevelt, SCEH
   Jansen, JFA
   Smeets, HJM
   de Coo, IFM
   Formisano, E
   Uludag, K
AF Haast, Roy A. M.
   Ivanov, Dimo
   IJsselstein, Rutger J. T.
   Sallevelt, Suzanne C. E. H.
   Jansen, Jacobus F. A.
   Smeets, Hubert J. M.
   de Coo, Irenaeus F. M.
   Formisano, Elia
   Uludag, Kamil
TI Anatomic & metabolic brain markers of the m.3243A &GT; G mutation: A multi-parametric 7T MRI study
SO NEUROIMAGE-CLINICAL
LA English
DT Article
DE 7T MRI; Brain; Quantitative; m.3243A > G; Mitochondrial
ID stroke-like episodes; concurrent functional perfusion; mitochondrial-dna mutations; participants aged 24-81; normative data; hearing-loss; megalencephalic leukoencephalopathy; m.3243a-greater-than-g mutation; lactic-acidosis; a3243g mutation
AB One of the most common mitochondrial DNA (mtDNA) mutations, the A to G transition at base pair 3243, has been linked to changes in the brain, in addition to commonly observed hearing problems, diabetes and myopathy. However, a detailed quantitative description of m.3243A> G patients' brains has not been provided so far. In this study, ultra-high field MRI at 7T and volume-and surface-based data analyses approaches were used to highlight morphology (i.e. atrophy)-, microstructure (i.e. myelin and iron concentration)-and metabolism (i.e. cerebral blood flow)-related differences between patients (N = 22) and healthy controls (N = 15). The use of quantitative MRI at 7T allowed us to detect subtle changes of biophysical processes in the brain with high accuracy and sensitivity, in addition to typically assessed lesions and atrophy. Furthermore, the effect of m. 3243A> G mutation load in blood and urine epithelial cells on these MRI measures was assessed within the patient population and revealed that blood levels were most indicative of the brain's state and disease severity, based on MRI as well as on neuropsychological data. Morphometry MRI data showed a wide-spread reduction of cortical, subcortical and cerebellar gray matter volume, in addition to significantly enlarged ventricles. Moreover, surface-based analyses revealed brain area-specific changes in cortical thickness (e.g. of the auditory cortex), and in T-1, T-2* and cerebral blood flow as a function of mutation load, which can be linked to typically m. 3243A> G-related clinical symptoms (e.g. hearing impairment). In addition, several regions linked to attentional control (e.g. middle frontal gyrus), the sensorimotor network (e.g. banks of central sulcus) and the default mode network (e.g. precuneus) were characterized by alterations in cortical thickness, T-1, T-2* and/or cerebral blood flow, which has not been described in previous MRI studies. Finally, several hypotheses, based either on vascular, metabolic or astroglial implications of the m. 3243A> G mutation, are discussed that potentially explain the underlying pathobiology. To conclude, this is the first 7T and also the largest MRI study on this patient population that provides macroscopic brain correlates of the m. 3243A> G mutation indicating potential MRI biomarkers of mitochondrial diseases and might guide future (longitudinal) studies to extensively track neuropathological and clinical changes.
C1 [Haast, Roy A. M.; Ivanov, Dimo; Formisano, Elia; Uludag, Kamil] Maastricht Univ, Dept Cognit Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands.
   [Haast, Roy A. M.; Formisano, Elia] Maastricht Univ, Maastricht Ctr Syst Biol, POB 616, NL-6200 MD Maastricht, Netherlands.
   [IJsselstein, Rutger J. T.; de Coo, Irenaeus F. M.] Erasmus MC, Dept Neurol, Postbus 2040, NL-3000 CA Rotterdam, Netherlands.
   [Sallevelt, Suzanne C. E. H.] Maastricht Univ, Med Ctr, Dept Clin Genet, POB 5800, NL-6202 AZ Maastricht, Netherlands.
   [Jansen, Jacobus F. A.] Maastricht Univ, Med Ctr, Dept Radiol, POB 5800, NL-6202 AZ Maastricht, Netherlands.
   [Jansen, Jacobus F. A.] Maastricht Univ, Sch Mental Hlth & Neurosci, POB 5800, NL-6202 AZ Maastricht, Netherlands.
   [Smeets, Hubert J. M.] Maastricht Univ, Dept Genet & Cell Biol, POB 616, NL-6200 MD Maastricht, Netherlands.
   [Smeets, Hubert J. M.; de Coo, Irenaeus F. M.] NeMo Expertise Ctr, Postbus 2060, NL-3000 CB Rotterdam, Netherlands.
   [Smeets, Hubert J. M.] Maastricht Univ, Res Sch GROW, POB 616, NL-6200 MD Maastricht, Netherlands.
C3 Maastricht University; Maastricht University; Erasmus University Rotterdam; Erasmus MC; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University
RP Haast, RAM; Uludag, K (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands.
EM roy.haast@maastrichtuniversity.nl; kamil.uludag@maastrichtuniversity.nl
FU Maastricht University; Netherlands Organization for Scientific Research (NWO) [452-11-002]; Technology Foundation STW [12724]; Ride4Kids; Join4Energy; NeMo
CR Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Barragán-Campos HM, 2005, ARCH NEUROL-CHICAGO, V62, P737, DOI 10.1001/archneur.62.5.737
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Bindu PS, 2015, MITOCHONDRION, V25, P6, DOI 10.1016/j.mito.2015.08.002
   Bock NA, 2013, NEUROIMAGE, V65, P1, DOI 10.1016/j.neuroimage.2012.09.051
   Bugiani M, 2017, ANN CLIN TRANSL NEUR, V4, P450, DOI 10.1002/acn3.405
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Dinopoulos A, 2005, NEUROPEDIATRICS, V36, P290, DOI 10.1055/s-2005-872807
   Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104
   Eckert MA, 2012, JARO-J ASSOC RES OTO, V13, P703, DOI 10.1007/s10162-012-0332-5
   Eggenschwiler F, 2012, MAGN RESON MED, V67, P1609, DOI 10.1002/mrm.23145
   Fayssoil A, 2017, EUR J NEUROL, V24, P255, DOI 10.1111/ene.13176
   Finsterer J, 2012, ACTA NEUROL SCAND, V126, P1, DOI 10.1111/j.1600-0404.2012.01649.x
   Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4
   Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X
   Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   Gardener AG, 2009, MAGN RESON MED, V61, P874, DOI 10.1002/mrm.21796
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Haast RAM, 2016, FRONT NEUROANAT, V10, P0, DOI 10.3389/fnana.2016.00112
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Ikawa M, 2013, MITOCHONDRION, V13, P676, DOI 10.1016/j.mito.2013.09.007
   Ivanov D, 2017, MAGN RESON MED, V78, P121, DOI 10.1002/mrm.26351
   Ivanov D, 2017, NEUROIMAGE, V156, P363, DOI 10.1016/j.neuroimage.2017.05.038
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Keuken MC, 2017, BRAIN STRUCT FUNCT, V222, P2487, DOI 10.1007/s00429-016-1352-4
   Kollia K, 2009, AM J NEURORADIOL, V30, P699, DOI 10.3174/ajnr.A1434
   Kullar PJ, 2016, BRAIN, V139, PE33, DOI 10.1093/brain/aww051
   Lax NZ, 2016, NEUROPATH APPL NEURO, V42, P180, DOI 10.1111/nan.12238
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Li R, 2017, J MAGN RESON IMAGING, V45, P199, DOI 10.1002/jmri.25354
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Lorio S, 2016, HUM BRAIN MAPP, V37, P1801, DOI 10.1002/hbm.23137
   Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035
   Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002
   Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5
   Milham MP, 2002, BRAIN COGNITION, V49, P277, DOI 10.1006/brcg.2001.1501
   Nakada T, 2008, J NEUROIMAGING, V18, P125, DOI 10.1111/j.1552-6569.2007.00179.x
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Norris DG, 2003, J MAGN RESON IMAGING, V18, P519, DOI 10.1002/jmri.10390
   Pfeuffer J, 2002, NEUROIMAGE, V17, P272, DOI 10.1006/nimg.2002.1103
   Pohmann R, 2016, MAGN RESON MED, V75, P801, DOI 10.1002/mrm.25677
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   Rodan LH, 2015, MITOCHONDRION, V22, P66, DOI 10.1016/j.mito.2015.03.002
   Romero JE, 2017, NEUROIMAGE, V147, P916, DOI 10.1016/j.neuroimage.2016.11.003
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sallevelt SCEH, 2013, J MED GENET, V50, P125, DOI 10.1136/jmedgenet-2012-101172
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Scaglia F, 2005, AM J NEURORADIOL, V26, P1675
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Seidler R, 2015, NEUROIMAGE, V108, P47, DOI 10.1016/j.neuroimage.2014.12.023
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Sofou K, 2013, MITOCHONDRION, V13, P364, DOI 10.1016/j.mito.2013.04.008
   SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   Stüber C, 2014, NEUROIMAGE, V93, P95, DOI 10.1016/j.neuroimage.2014.02.026
   Syka J, 2002, PHYSIOL REV, V82, P601, DOI 10.1152/physrev.00002.2002
   Teeuwisse WM, 2012, MAGN RESON MED, V67, P1285, DOI 10.1002/mrm.23108
   Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110
   Trattnig S, 2016, NEUROIMAGE, V0, P30651
   Tschampa HJ, 2013, J NEUROL, V260, P1071, DOI 10.1007/s00415-012-6763-4
   Tsujikawa K, 2016, MITOCHONDRION, V30, P229, DOI 10.1016/j.mito.2016.08.011
   Tsujikawa T, 2010, BRAIN DEV-JPN, V32, P143, DOI 10.1016/j.braindev.2008.12.003
   Ugurbil K, 2017, NEUROIMAGE, V0, P30575
   Uludag K, 2017, NEUROIMAGE, V0, P0
   Van der Elst W, 2006, ASSESSMENT, V13, P62, DOI 10.1177/1073191105283427
   Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344
   van der Elst W, 2006, J CLIN EXP NEUROPSYC, V28, P998, DOI 10.1080/13803390591004428
   van der Knaap MS, 2012, LANCET NEUROL, V11, P973, DOI 10.1016/S1474-4422(12)70192-8
   van der Zwaag W, 2016, NMR BIOMED, V29, P1274, DOI 10.1002/nbm.3275
   Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156
   Virtanen SM, 2011, AM J NEURORADIOL, V32, P522, DOI 10.3174/ajnr.A2309
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Yacoub E, 2008, P NATL ACAD SCI USA, V105, P10607, DOI 10.1073/pnas.0804110105
   Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015
   Zhu XH, 2012, NEUROIMAGE, V60, P2107, DOI 10.1016/j.neuroimage.2012.02.013
NR 83
TC 14
Z9 14
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2213-1582
EI 
J9 NEUROIMAGE-CLIN
JI NeuroImage-Clin.
PD JUN 15
PY 2018
VL 18
IS 
BP 231
EP 244
DI 10.1016/j.nicl.2018.01.017
PG 14
WC Neuroimaging
SC Neurosciences & Neurology
GA GH1NG
UT WOS:000433169000023
PM 29868447
DA 2024-11-01
ER

PT J
AU Peter, B
   Waddington, CL
   Oláhová, M
   Sommerville, EW
   Hopton, S
   Pyle, A
   Champion, M
   Ohlson, M
   Siibak, T
   Chrzanowska-Lightowlers, ZMA
   Taylor, RW
   Falkenberg, M
   Lightowlers, RN
AF Peter, Bradley
   Waddington, Christie L.
   Olahova, Monika
   Sommerville, Ewen W.
   Hopton, Sila
   Pyle, Angela
   Champion, Michael
   Ohlson, Monica
   Siibak, Triinu
   Chrzanowska-Lightowlers, Zofia M. A.
   Taylor, Robert W.
   Falkenberg, Maria
   Lightowlers, Robert N.
TI Defective mitochondrial protease LonP1 can cause classical mitochondrial disease
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID codas syndrome; aaa protease; transcription factor; copy number; dna; mutations; binding; translocation; degradation; substrate
AB LonP1 is a mitochondrial matrix protease whose selective substrate specificity is essential for maintaining mitochondrial homeostasis. Recessively inherited, pathogenic defects in LonP1 have been previously reported to underlie cerebral, ocular, dental, auricular and skeletal anomalies (CODAS) syndrome, a complex multisystemic and developmental disorder. Intriguingly, although classical mitochondrial disease presentations are well-known to exhibit marked clinical heterogeneity, the skeletal and dental features associated with CODAS syndrome are pathognomonic. We have applied whole exome sequencing to a patient with congenital lactic acidosis, muscle weakness, profound deficiencies in mitochondrial oxidative phosphorylation associated with loss of mtDNA copy number and MRI abnormalities consistent with Leigh syndrome, identifying biallelic variants in the LONP1 (NM_004793.3) gene; c.1693T > C predicting p.(Tyr565His) and c.2197G > A predicting p.(Glu733Lys); no evidence of the classical skeletal or dental defects observed in CODAS syndrome patients were noted in our patient. In vitro experiments confirmed the p.(Tyr565His) LonP1 mutant alone could not bind or degrade a substrate, consistent with the predicted function of Tyr565, whilst a second missense [p.(Glu733Lys)] variant had minimal effect. Mixtures of p.(Tyr565His) mutant and wild-type LonP1 retained partial protease activity but this was severely depleted when the p.(Tyr565His) mutant was mixed with the p.(Glu733Lys) mutant, data consistent with the compound heterozygosity detected in our patient. In summary, we conclude that pathogenic LONP1 variants can lead to a classical mitochondrial disease presentations associated with severe biochemical defects in oxidative phosphorylation in clinically relevant tissues.
C1 [Peter, Bradley; Ohlson, Monica; Siibak, Triinu; Falkenberg, Maria] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Gothenburg, Sweden.
   [Waddington, Christie L.; Olahova, Monika; Sommerville, Ewen W.; Hopton, Sila; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Sch Med, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Sommerville, Ewen W.; Chrzanowska-Lightowlers, Zofia M. A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Pyle, Angela] Newcastle Univ, Inst Genet, Sch Med, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Champion, Michael] Guys NHS Fdn Trust, Evelina London Childrens Hosp, Dept Inherited Metab Dis, London, England.
   [Champion, Michael] St Thomas NHS Fdn Trust, Evelina London Childrens Hosp, Dept Inherited Metab Dis, London, England.
   [Lightowlers, Robert N.] Newcastle Univ, Sch Med, Wellcome Ctr Mitochondrial Res, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England.
C3 University of Gothenburg; Newcastle University - UK; Baylor College of Medicine; Newcastle University - UK; Guy's & St Thomas' NHS Foundation Trust; Newcastle University - UK
RP Lightowlers, RN (corresponding author), Newcastle Univ, Sch Med, Wellcome Ctr Mitochondrial Res, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England.
EM robert.lightowlers@ncl.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Swedish Research Council [2013-3621]; Swedish Cancer Foundation [CAN 2016/816]; European Research Council; MRC Centre for Neuromuscular Diseases [G0601943]; UK NHS Highly Specialized 'Rare Mitochondrial Disorders of Adults and Children' Service; Lily Foundation; Medical Research Council (MRC); Wellcome; MRC [G0601943] Funding Source: UKRI
CR Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7
   Bar-Nun S, 2012, BBA-MOL CELL RES, V1823, P67, DOI 10.1016/j.bbamcr.2011.07.009
   Bota DA, 2016, FREE RADICAL BIO MED, V100, P188, DOI 10.1016/j.freeradbiomed.2016.06.031
   Chen SH, 2008, NUCLEIC ACIDS RES, V36, P1273, DOI 10.1093/nar/gkm1140
   Dikoglu E, 2015, AM J MED GENET A, V167, P1501, DOI 10.1002/ajmg.a.37029
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Farge G, 2014, CELL REP, V8, P66, DOI 10.1016/j.celrep.2014.05.046
   Fu GK, 1998, BIOCHEMISTRY-US, V37, P1905, DOI 10.1021/bi970928c
   Gerdes F, 2012, BBA-MOL CELL RES, V1823, P49, DOI 10.1016/j.bbamcr.2011.09.015
   Graef M, 2006, J STRUCT BIOL, V156, P101, DOI 10.1016/j.jsb.2006.01.009
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012
   Inui T, 2017, J HUM GENET, V62, P653, DOI 10.1038/jhg.2017.11
   Kereïche S, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep33631
   Khan Arif O, 2015, TRANS AM OPHTHALMOL SOC, V113, P0
   Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200
   Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503
   Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107
   Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v
   Okuno T, 2006, J STRUCT BIOL, V156, P109, DOI 10.1016/j.jsb.2006.02.003
   Oláhová M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   Oppenheim MLS, 2009, J INHERIT METAB DIS, V32, P269, DOI 10.1007/s10545-009-1061-8
   Quirós PM, 2014, CELL REP, V8, P541, DOI 10.1016/j.celrep.2014.06.018
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623
   Strauss KA, 2015, AM J HUM GENET, V96, P121, DOI 10.1016/j.ajhg.2014.12.003
   Voss NR, 2010, NUCLEIC ACIDS RES, V38, PW555, DOI 10.1093/nar/gkq395
   Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200
NR 28
TC 41
Z9 46
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAY 15
PY 2018
VL 27
IS 10
BP 1743
EP 1753
DI 10.1093/hmg/ddy080
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA GF3VX
UT WOS:000431886200006
PM 29518248
DA 2024-11-01
ER

PT J
AU Gramegna, LL
   Pisano, A
   Testa, C
   Manners, DN
   D'Angelo, R
   Boschetti, E
   Giancola, F
   Pironi, L
   Caporali, L
   Capristo, M
   Valentino, ML
   Plazzi, G
   Casali, C
   Dotti, MT
   Cenacchi, G
   Hirano, M
   Giordano, C
   Parchi, P
   Rinaldi, R
   De Giorgio, R
   Lodi, R
   Carelli, V
   Tonon, C
AF Gramegna, L. L.
   Pisano, A.
   Testa, C.
   Manners, D. N.
   D'Angelo, R.
   Boschetti, E.
   Giancola, F.
   Pironi, L.
   Caporali, L.
   Capristo, M.
   Valentino, M. L.
   Plazzi, G.
   Casali, C.
   Dotti, M. T.
   Cenacchi, G.
   Hirano, M.
   Giordano, C.
   Parchi, P.
   Rinaldi, R.
   De Giorgio, R.
   Lodi, R.
   Carelli, V.
   Tonon, C.
TI Cerebral Mitochondrial Microangiopathy Leads to Leukoencephalopathy in Mitochondrial Neurogastrointestinal Encephalopathy
SO AMERICAN JOURNAL OF NEURORADIOLOGY
LA English
DT Article
ID thymidine phosphorylase-deficiency; small vessel disease; blood-brain-barrier; stem-cell transplantation; in-vivo; encephalomyopathy mngie; corpus-callosum; dna depletion; quantification; demyelination
AB BACKGROUND AND PURPOSE: Mitochondrial neurogastrointestinal encephalopathy is a rare disorder due to recessive mutations in the thymidine phosphorylase gene, encoding thymidine phosphorylase protein required for mitochondrial DNA replication. Clinical manifestations include gastrointestinal dysmotility and diffuse asymptomatic leukoencephalopathy. This study aimed to elucidate the mechanisms underlying brain leukoencephalopathy in patients with mitochondrial neurogastrointestinal encephalopathy by correlating multimodal neuroradiologic features to postmortem pathology. MATERIALS AND METHODS: Seven patients underwent brain MR imaging, including single-voxel proton MR spectroscopy and diffusion imaging. Absolute concentrations of metabolites calculated by acquiring unsuppressed water spectra at multiple TEs, along with diffusion metrics based on the tensor model, were compared with those of healthy controls using unpaired t tests in multiple white matters regions. Brain postmortem histologic, immunohistochemical, and molecular analyses were performed in 1 patient. RESULTS: All patients showed bilateral and nearly symmetric cerebral white matter hyperintensities on T2-weighted images, extending to the cerebellar white matter and brain stem in 4. White matter, N-acetylaspartate, creatine, and choline concentrations were significantly reduced compared with those in controls, with a prominent increase in the radial water diffusivity component. At postmortem examination, severe fibrosis of brain vessel smooth muscle was evident, along with mitochondrial DNA replication depletion in brain and vascular smooth-muscle and endothelial cells, without neuronal loss, myelin damage, or gliosis. Prominent periependymal cytochrome C oxidase deficiency was also observed. CONCLUSIONS: Vascular functional and histologic alterations account for leukoencephalopathy in mitochondrial neurogastrointestinal encephalopathy. Thymidine toxicity and mitochondrial DNA replication depletion may induce microangiopathy and blood-brain-barrier dysfunction, leading to increased water content in the white matter. Periependymal cytochrome C oxidase deficiency could explain prominent periventricular impairment.
C1 [Gramegna, L. L.; Testa, C.; Manners, D. N.; Lodi, R.; Tonon, C.] St Orsola Marcello Malpighi Hosp, Funct MR Unit, Via Massarenti 9, I-40138 Bologna, Italy.
   [D'Angelo, R.; Rinaldi, R.] St Orsola Marcello Malpighi Hosp, Neurol Unit, Bologna, Italy.
   [Gramegna, L. L.; Testa, C.; Manners, D. N.; Caporali, L.; Capristo, M.; Valentino, M. L.; Plazzi, G.; Cenacchi, G.; Parchi, P.; Lodi, R.; Carelli, V.] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy.
   [Boschetti, E.; Giancola, F.; Pironi, L.; De Giorgio, R.] Univ Bologna, Dept Surg & Med Sci, Bologna, Italy.
   [Pisano, A.; Giordano, C.] Sapienza Univ Rome, Dept Radiol Oncol & Pathol, Rome, Italy.
   [Casali, C.] Sapienza Univ Rome, Dept Med Surg Sci & Biotechnol, Rome, Italy.
   [Caporali, L.; Capristo, M.; Valentino, M. L.; Plazzi, G.; Parchi, P.; Carelli, V.] Inst Neurol Sci, Ist Ricovero & Cura Carattere Sci, Bologna, Italy.
   [Dotti, M. T.] Univ Siena, Dept Med Surg & Neurosci, Siena, Italy.
   [Hirano, M.] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA.
C3 IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; Sapienza University Rome; Sapienza University Rome; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Siena; Columbia University
RP Lodi, R (corresponding author), St Orsola Marcello Malpighi Hosp, Funct MR Unit, Via Massarenti 9, I-40138 Bologna, Italy.
EM raffaele.lodi@unibo.it
FU Italian Ministry of Health [RF-2009-1492481 ITA-MNGIE]
CR Aung Wint Yan, 2013, IMAGING MED, V5, P427
   De Giorgio R, 2016, ANN NEUROL, V80, P448, DOI 10.1002/ana.24724
   Fazekas F, 1999, AM J NEURORADIOL, V20, P637
   Filosto M, 2012, J NEUROL, V259, P2699, DOI 10.1007/s00415-012-6572-9
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Giordano C, 2006, GASTROENTEROLOGY, V130, P893, DOI 10.1053/j.gastro.2006.01.004
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   Giordano C, 2011, METHODS MOL BIOL, V755, P223, DOI 10.1007/978-1-61779-163-5_18
   Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   Inzitari D, 2009, BMJ-BRIT MED J, V339, P0, DOI 10.1136/bmj.b2477
   Klistorner A, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0122114
   Kreis R, 2005, MAGN RESON MED, V54, P761, DOI 10.1002/mrm.20673
   KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405
   MacKay A, 2006, MAGN RESON IMAGING, V24, P515, DOI 10.1016/j.mri.2005.12.037
   Malucelli E, 2009, NMR BIOMED, V22, P1003, DOI 10.1002/nbm.1402
   Martí R, 2003, BIOCHEM BIOPH RES CO, V303, P14, DOI 10.1016/S0006-291X(03)00294-8
   Millar WS, 2004, AM J ROENTGENOL, V182, P1537, DOI 10.2214/ajr.182.6.1821537
   Mohamed S, 2014, J CHROMATOGR B, V949, P58, DOI 10.1016/j.jchromb.2014.01.003
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nishino I, 2001, NEUROMUSCULAR DISORD, V11, P7, DOI 10.1016/S0960-8966(00)00159-0
   Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6
   Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698
   Rousset P, 2008, J NEURORADIOLOGY, V35, P121, DOI 10.1016/j.neurad.2007.07.003
   Scarpelli M, 2013, NEURORADIOL J, V26, P520, DOI 10.1177/197140091302600505
   Schuepbach WMM, 2007, J NEUROL, V254, P146, DOI 10.1007/s00415-006-0255-3
   Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Sun SW, 2006, NEUROIMAGE, V32, P1195, DOI 10.1016/j.neuroimage.2006.04.212
   Szigeti K, 2004, ANN NEUROL, V56, P881, DOI 10.1002/ana.20302
   Wardlaw JM, 2010, J NEUROL SCI, V299, P66, DOI 10.1016/j.jns.2010.08.042
   Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7
   Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8
   Xie MQ, 2010, J NEUROPATH EXP NEUR, V69, P704, DOI 10.1097/NEN.0b013e3181e3de90
NR 36
TC 17
Z9 17
U1 0
U2 0
PU AMER SOC NEURORADIOLOGY
PI DENVILLE
PA PO BOX 3000, DENVILLE, NJ 07834-9349 USA
SN 0195-6108
EI 1936-959X
J9 AM J NEURORADIOL
JI Am. J. Neuroradiol.
PD MAR 15
PY 2018
VL 39
IS 3
BP 427
EP 434
DI 10.3174/ajnr.A5507
PG 8
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA GB7RK
UT WOS:000429272400010
PM 29348134
DA 2024-11-01
ER

PT J
AU Newell, C
   Hume, S
   Greenway, SC
   Podemski, L
   Shearer, J
   Khan, A
AF Newell, Christopher
   Hume, Stacey
   Greenway, Steven C.
   Podemski, Lynn
   Shearer, Jane
   Khan, Aneal
TI Plasma-derived cell-free mitochondrial DNA: A novel non-invasive methodology to identify mitochondrial DNA haplogroups in humans
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Mitochondrial disease; Cell-free mitochondrial DNA; mtDNA Mutations; mtDNA Haplotype
ID nucleic-acids; transcription; mutations; damage; tool
AB Background: Mitochondrial diseases are a clinically heterogeneous group of diseases caused by mutations in either nuclear or mitochondrial DNA (mtDNA). The diagnosis is challenging and has frequently required a tissue biopsy to obtain a sufficient quantity of mtDNA. Less-invasive sources mtDNA, such as peripheral blood leukocytes, urine sediment, or buccal swab, contain a lower quantity of mtDNA compared to tissue sources which may reduce sensitivity. Cellular apoptosis of tissues and hematopoetic cells releases fragments of DNA and mtDNA into the circulation and these molecules can be extracted from plasma as cell-free DNA (cfDNA). However, entire mtDNA has not been successfully identified from the cell free fraction previously. We hypothesized that the circular nature of mtDNA would prevent its degradation and a higher sensitivity method, such as next generation sequencing, could identify intact cf-mtDNA from human plasma. Methods: Plasma was obtained from patients with mitochondrial disease diagnosed from skeletal muscle biopsy (n = 7) and healthy controls (n = 7) using a specially cfDNA collection tube (Streck Inc.; La Vista, NE). To demonstrate the presence of mtDNA within these samples, we amplified the isolated DNA using custom PCR primers specific to overlapping fragments of mtDNA. cfDNA samples were then sequenced using the Illumina MiSeq sequencing platform. Results: We confirmed the presence of mtDNA, demonstrating that the full mitochondrial genome is in fact present within the cell-free plasma fraction of human blood. Sequencing identified the mitochondrial haplogroup matching with the tissue specimen for all patients. Conclusion: We report the existence of full length mtDNA in cell-free human plasma that was successfully used to perform haplogroup matching. Clinical applications for this work include patient monitoring for heteroplasmy status after mitochondrially-targeted therapies or haplogroup monitoring as a measure of stem cell transplantation.
C1 [Newell, Christopher; Khan, Aneal] Univ Calgary, Cumming Sch Med, Dept Med Genet, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.
   [Hume, Stacey; Podemski, Lynn] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.
   [Greenway, Steven C.] Univ Calgary, Dept Cardiac Sci, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada.
   [Shearer, Jane] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.
   [Greenway, Steven C.; Khan, Aneal] Univ Calgary, Cumming Sch Med, Alberta Childrens Hosp, Dept Pediat,Res Inst, Calgary, AB, Canada.
C3 University of Calgary; University of Alberta; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; University of Calgary; Alberta Childrens Hospital
RP Newell, C (corresponding author), Univ Calgary, Cumming Sch Med, Dept Med Genet, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.
EM cnewell@ucalgary.ca
FU Alberta Children's Hospital Research Foundation; Department of Pediatrics; MitoCanada; Alberta Innovates - Health Solutions MD/PhD Studentship
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Bettegowda C, 2014, SCI TRANSL MED, V6, P0, DOI 10.1126/scitranslmed.3007094
   Bohers E, 2015, HAEMATOLOGICA, V100, PE280, DOI 10.3324/haematol.2015.123612
   Brandon MC, 2009, HUM MUTAT, V30, P1, DOI 10.1002/humu.20801
   Chan AKC, 2003, ANN CLIN BIOCHEM, V40, P122, DOI 10.1258/000456303763046030
   Chiu RWK, 2003, CLIN CHEM, V49, P719, DOI 10.1373/49.5.719
   Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002
   DErchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Gordon PMK, 2016, FRONT CARDIOVASC MED, V3, P0, DOI 10.3389/fcvm.2016.00033
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Kohler C, 2009, MOL CANCER, V8, P0, DOI 10.1186/1476-4598-8-105
   Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009
   Lee CH, 2013, TRENDS ENDOCRIN MET, V24, P222, DOI 10.1016/j.tem.2013.01.005
   Lehmann-Werman R, 2016, P NATL ACAD SCI USA, V113, PE1826, DOI 10.1073/pnas.1519286113
   Li L, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep23992
   Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005
   Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205
   Norton SE, 2013, CLIN BIOCHEM, V46, P1561, DOI 10.1016/j.clinbiochem.2013.06.002
   Phillips NR, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep03887
   Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050
   Sparks AB, 2012, AM J OBSTET GYNECOL, V206, P0, DOI 10.1016/j.ajog.2012.01.030
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tsang JCH, 2007, PATHOLOGY, V39, P197, DOI 10.1080/00313020701230831
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, PW58, DOI 10.1093/nar/gkw233
   Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, PW64, DOI 10.1093/nar/gkw247
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Zhong Xiao Yan, 2007, ARCHIVES OF GYNECOLOGY AND OBSTETRICS, V276, P327, DOI 10.1007/s00404-007-0345-1
NR 33
TC 18
Z9 20
U1 0
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD DEC 15
PY 2018
VL 125
IS 4
BP 332
EP 337
DI 10.1016/j.ymgme.2018.10.002
PG 6
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA HE7RO
UT WOS:000453637800003
PM 30361042
DA 2024-11-01
ER

PT J
AU Kaphan, E
   Ali, HB
   Gastaldi, M
   Acquaviva, C
   Vianey-Saban, C
   Rouzier, C
   Fragaki, K
   Bannwarth, S
   Paquis-Flucklinger, V
   Romero, N
   Behin, A
   Lombès, A
   Jardel, C
   Rigal, O
   Laforêt, P
AF Kaphan, E.
   Ali, H. Bou
   Gastaldi, M.
   Acquaviva, C.
   Vianey-Saban, C.
   Rouzier, C.
   Fragaki, K.
   Bannwarth, S.
   Paquis-Flucklinger, V
   Romero, N.
   Behin, A.
   Lombes, A.
   Jardel, C.
   Rigal, O.
   Laforet, P.
TI Myopathy with MTCYB mutation mimicking Multiple Acyl-CoA Dehydrogenase Deficiency
SO REVUE NEUROLOGIQUE
LA English
DT Article
DE Mitochondrial disease; MADD; Multiple acyl-CoA dehydrogenase deficiency; Myopathy; Exercise intolerance; Cytochrome b
ID complex-iii deficiency; stop-codon mutation; cytochrome-b gene; missense mutation; mitochondrial
AB We describe two patients with mitochondrial DNA mutations in the gene encoding cytochrome b (m. 15579A>G, p. Tyr278Cys and m. 15045G>A p. Arg100Gln), which presented as a pure myopathic form (exercise intolerance), with an onset in childhood. Diagnosis was delayed, because acylcarnitine profile showed an increase in medium and long-chain acylcarnitines, suggestive of multiple acyl-CoA dehydrogenase deficiency, riboflavin transporter deficiency or FAD metabolism disorder. Implication of cytochrome b in fatty acid oxidation, and physiopathology of the mutations are discussed. (C) 2018 Elsevier Masson SAS. All rights reserved.
C1 [Kaphan, E.; Ali, H. Bou] CHU Timone, AP HM, Serv Neurol, Pole Neurosci Clin, 264 Rue St Pierre, F-13005 Marseille, France.
   [Gastaldi, M.] CHU Timone, AP HM, Lab Biochim Metab, F-13005 Marseille, France.
   [Acquaviva, C.; Vianey-Saban, C.] CHU Lyon, Grp Hosp Est, Ctr Biol & Pathol Est, Serv Malad Hereditaires Metab, F-69500 Bron, France.
   [Rouzier, C.; Fragaki, K.; Bannwarth, S.; Paquis-Flucklinger, V] Univ Cote dAzur, CHU, Inserm, CNRS,IRCAN, Nice, France.
   [Lombes, A.; Jardel, C.] GHU Pitie Salpetriere, AP HP, Inserm, Serv Biochim Metab,U1016, F-75651 Paris, France.
   [Lombes, A.; Jardel, C.] GHU Pitie Salpetriere, AP HP, Ctr Genet Mol & Chromosom, Inst Cochin, F-75651 Paris, France.
   [Rigal, O.] Hop Robert Debre, AP HP, Ctr Reference Malad Metab, Serv Biochim Hormonol, F-75019 Paris, France.
   [Romero, N.; Behin, A.; Laforet, P.] GH Pitie Salpetriere, Inst Myol, Ctr Reference Pathol Neuromusculaire Paris Est, F-75013 Paris, France.
C3 Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Lyon; Universite Cote d'Azur; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Sorbonne Universite; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite
RP Kaphan, E (corresponding author), CHU Timone, AP HM, Serv Neurol, Pole Neurosci Clin, 264 Rue St Pierre, F-13005 Marseille, France.
EM elsa.kaphan@mail.ap-hm.fr
CR Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008
   Bosch AM, 2011, J INHERIT METAB DIS, V34, P159, DOI 10.1007/s10545-010-9242-z
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   Dumoulin R, 1996, MOL CELL PROBE, V10, P389, DOI 10.1006/mcpr.1996.0053
   Ghelli A, 2013, HUM MOL GENET, V22, P2141, DOI 10.1093/hmg/ddt067
   Hogrel JY, 2014, NEUROMUSCULAR DISORD, V24, P604, DOI 10.1016/j.nmd.2014.04.009
   Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900
   Legros F, 2001, EUR J HUM GENET, V9, P510, DOI 10.1038/sj.ejhg.5200678
   Mancuso M, 2003, J NEUROL SCI, V209, P61, DOI 10.1016/S0022-510X(02)00462-8
   Olsen RKJ, 2016, AM J HUM GENET, V98, P1130, DOI 10.1016/j.ajhg.2016.04.006
   Olsen RKJ, 2003, HUM MUTAT, V22, P12, DOI 10.1002/humu.10226
   Sauer SW, 2008, BBA-BIOENERGETICS, V1777, P1276, DOI 10.1016/j.bbabio.2008.05.447
   Schiff M, 2016, NEW ENGL J MED, V374, P795, DOI 10.1056/NEJMc1513610
   Spaan AN, 2005, MOL GENET METAB, V86, P441, DOI 10.1016/j.ymgme.2005.07.014
   Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224
NR 15
TC 5
Z9 6
U1 0
U2 3
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0035-3787
EI 2213-0004
J9 REV NEUROL-FRANCE
JI Rev. Neurol.
PD DEC 15
PY 2018
VL 174
IS 10
BP 731
EP 735
DI 10.1016/j.neurol.2018.03.014
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA HC0BH
UT WOS:000451459300014
PM 30318261
DA 2024-11-01
ER

PT J
AU Rodríguez-Nuevo, A
   Díaz-Ramos, A
   Noguera, E
   Díaz-Sáez, F
   Duran, X
   Muñoz, JP
   Romero, M
   Plana, N
   Sebastián, D
   Tezze, C
   Romanello, V
   Ribas, F
   Seco, J
   Planet, E
   Doctrow, SR
   González, J
   Borràs, M
   Liesa, M
   Palacín, M
   Vendrell, J
   Villarroya, F
   Sandri, M
   Shirihai, O
   Zorzano, A
AF Rodriguez-Nuevo, Aida
   Diaz-Ramos, Angels
   Noguera, Eduard
   Diaz-Saez, Francisco
   Duran, Xavier
   Pablo Munoz, Juan
   Romero, Montserrat
   Plana, Natalia
   Sebastian, David
   Tezze, Caterina
   Romanello, Vanina
   Ribas, Francesc
   Seco, Jordi
   Planet, Evarist
   Doctrow, Susan R.
   Gonzalez, Javier
   Borras, Miquel
   Liesa, Marc
   Palacin, Manuel
   Vendrell, Joan
   Villarroya, Francesc
   Sandri, Marco
   Shirihai, Orian
   Zorzano, Antonio
TI Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency
SO EMBO JOURNAL
LA English
DT Article
DE endosome; mitochondrial dynamics; muscle disease; systemic inflammation
ID dominant optic atrophy; skeletal-muscle; tnf-alpha; kappa-b; growth; mutations; autophagy; damage; fgf21; resistance
AB Opa1 participates in inner mitochondrial membrane fusion and cristae morphogenesis. Here, we show that muscle-specific Opa1 ablation causes reduced muscle fiber size, dysfunctional mitochondria, enhanced Fgf21, and muscle inflammation characterized by NF-B activation, and enhanced expression of pro-inflammatory genes. Chronic sodium salicylate treatment ameliorated muscle alterations and reduced the muscle expression of Fgf21. Muscle inflammation was an early event during the progression of the disease and occurred before macrophage infiltration, indicating that it is a primary response to Opa1 deficiency. Moreover, Opa1 repression in muscle cells also resulted in NF-B activation and inflammation in the absence of necrosis and/or apoptosis, thereby revealing that the activation is a cell-autonomous process and independent of cell death. The effects of Opa1 deficiency on the expression NF-B target genes and inflammation were absent upon mitochondrial DNA depletion. Under Opa1 deficiency, blockage or repression of TLR9 prevented NF-B activation and inflammation. Taken together, our results reveal that Opa1 deficiency in muscle causes initial mitochondrial alterations that lead to TLR9 activation, and inflammation, which contributes to enhanced Fgf21 expression and to growth impairment.
C1 [Rodriguez-Nuevo, Aida; Diaz-Ramos, Angels; Noguera, Eduard; Pablo Munoz, Juan; Romero, Montserrat; Plana, Natalia; Sebastian, David; Seco, Jordi; Planet, Evarist; Palacin, Manuel; Zorzano, Antonio] Inst Res Biomed IRB Barcelona, Barcelona, Spain.
   [Rodriguez-Nuevo, Aida; Diaz-Ramos, Angels; Noguera, Eduard; Diaz-Saez, Francisco; Pablo Munoz, Juan; Romero, Montserrat; Plana, Natalia; Sebastian, David; Ribas, Francesc; Seco, Jordi; Palacin, Manuel; Villarroya, Francesc; Zorzano, Antonio] Univ Barcelona, Fac Biol, Dept Bioquim & Biomed Mol, Barcelona, Spain.
   [Rodriguez-Nuevo, Aida; Diaz-Ramos, Angels; Noguera, Eduard; Duran, Xavier; Pablo Munoz, Juan; Romero, Montserrat; Plana, Natalia; Sebastian, David; Seco, Jordi; Vendrell, Joan; Zorzano, Antonio] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain.
   [Duran, Xavier; Vendrell, Joan] Univ Rovira & Virgili, Hosp Univ Tarragona Joan IISPV 23, Fac Med, Tarragona, Spain.
   [Tezze, Caterina; Romanello, Vanina; Sandri, Marco] Venetian Inst Mol Med, Padua, Italy.
   [Ribas, Francesc; Villarroya, Francesc] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Barcelona, Spain.
   [Doctrow, Susan R.; Shirihai, Orian] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.
   [Gonzalez, Javier; Borras, Miquel] Expt Toxicol & Ecotoxicol Unit CERETOX, Barcelona Sci Pk, Barcelona, Spain.
   [Liesa, Marc; Shirihai, Orian] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA.
   [Palacin, Manuel] Inst Salud Carlos III, CIBERER, Barcelona, Spain.
C3 Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Veneto Institute Molecular Medicine; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Boston University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III
RP Zorzano, A (corresponding author), Inst Res Biomed IRB Barcelona, Barcelona, Spain.; Zorzano, A (corresponding author), Univ Barcelona, Fac Biol, Dept Bioquim & Biomed Mol, Barcelona, Spain.; Zorzano, A (corresponding author), Inst Salud Carlos III, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain.
EM antonio.zorzano@irbbarcelona.org
FU FPI fellowship from the "Ministerio de Educacion y Cultura," Spain; MINECO [SAF2013-40987R, SAF2016-75246R]; Generalitat de Catalunya [2014SGR48]; CIBERDEM grant from the "Instituto de Salud Carlos III" [PIE14/00045]; INFLAMES grant from the "Instituto de Salud Carlos III" [PIE14/00045]; grant "Todos somos raros, todos somos unicos" from Fundacion Isabel Gemio; INTERREG IV-B-SUDOE-FEDER (DIOMED) [SOE1/P1/E178]; ICREA "Academia" (Generalitat de Catalunya); Severo Ochoa Award of Excellence from MINECO (Government of Spain)
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157
   Baixauli F, 2015, CELL METAB, V22, P485, DOI 10.1016/j.cmet.2015.07.020
   Caielli S, 2016, J EXP MED, V213, P697, DOI 10.1084/jem.20151876
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   De Leo MG, 2016, NAT CELL BIOL, V18, P839, DOI 10.1038/ncb3386
   DeBenedetti F, 1997, J CLIN INVEST, V99, P643, DOI 10.1172/JCI119207
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Demers-Lamarche J, 2016, J BIOL CHEM, V291, P10263, DOI 10.1074/jbc.M115.695825
   Fernández-Mosquera L, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep45076
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006
   Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184
   Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439
   Julian MW, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0072354
   Kherif S, 1999, DEV BIOL, V205, P158, DOI 10.1006/dbio.1998.9107
   Kim JY, 2005, NEUROLOGY, V64, P966, DOI 10.1212/01.WNL.0000157282.76715.B1
   Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014
   KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854
   Kutukculer N, 1998, CLIN RHEUMATOL, V17, P288, DOI 10.1007/BF01451007
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102
   Liao CY, 2017, NEUROLOGY, V88, P131, DOI 10.1212/WNL.0000000000003491
   Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   Liu Y, 2015, J HEPATOL, V63, P114, DOI 10.1016/j.jhep.2015.02.009
   Lovy A, 2012, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/3991
   McLelland GL, 2016, J CELL BIOL, V214, P275, DOI 10.1083/jcb.201603105
   McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902
   Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001
   Munoz Juan Pablo, 2015, METHODS MOL BIOL, V1265, P307, DOI 10.1007/978-1-4939-2288-8_21
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038
   OConnor JC, 2008, CELL IMMUNOL, V252, P91, DOI 10.1016/j.cellimm.2007.09.010
   Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Muñoz JP, 2013, EMBO J, V32, P2348, DOI 10.1038/emboj.2013.168
   Pereira RO, 2017, EMBO J, V36, P2126, DOI 10.15252/embj.201696179
   Pesch UEA, 2001, HUM MOL GENET, V10, P1359, DOI 10.1093/hmg/10.13.1359
   Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106
   Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037
   Sebastián D, 2016, EMBO J, V35, P1677, DOI 10.15252/embj.201593084
   Sebastián D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109
   Tezze C, 2017, CELL METAB, V25, P1374, DOI 10.1016/j.cmet.2017.04.021
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Wei XW, 2015, CELL RES, V25, P237, DOI 10.1038/cr.2015.9
   Wenceslau CF, 2014, EUR HEART J, V35, P1172, DOI 10.1093/eurheartj/ehu047
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036
   Wong SC, 2016, ENDOCR REV, V37, P62, DOI 10.1210/er.2015-1026
   Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948
   Yu EPK, 2014, TRENDS ENDOCRIN MET, V25, P481, DOI 10.1016/j.tem.2014.06.008
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
   Zhang JZ, 2014, INT J MOL MED, V33, P817, DOI 10.3892/ijmm.2014.1650
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhao YS, 2014, AM J PHYSIOL-ENDOC M, V307, PE186, DOI 10.1152/ajpendo.00652.2013
NR 64
TC 139
Z9 148
U1 1
U2 39
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD MAY 15
PY 2018
VL 37
IS 10
BP 
EP 
DI 10.15252/embj.201796553
PG 18
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA GH7AZ
UT WOS:000433597000002
PM 29632021
DA 2024-11-01
ER

PT J
AU Puusepp, S
   Reinson, K
   Pajusalu, S
   Murumets, Ü
   Oiglane-Shlik, E
   Rein, R
   Talvik, I
   Rodenburg, RJ
   Ounap, K
AF Puusepp, Sanna
   Reinson, Karit
   Pajusalu, Sander
   Murumets, Ulle
   Oiglane-Shlik, Eve
   Rein, Reet
   Talvik, Inga
   Rodenburg, Richard J.
   Ounap, Katrin
TI Effectiveness of whole exome sequencing in unsolved patients with a clinical suspicion of a mitochondrial disorder in Estonia
SO MOLECULAR GENETICS AND METABOLISM REPORTS
LA English
DT Article
DE Mitochondrial disorders; Whole exome sequencing; mtDNA sequencing; Muscle biopsy
ID respiratory-chain disorders; diagnostic-criteria; read alignment; mutations; dna; disease; genetics; nuclear; muscle; association
AB Objective: Reaching a genetic diagnosis of mitochondrial disorders (MDs) is challenging due to their broad phenotypic and genotypic heterogeneity. However, there is growing evidence that the use of whole exome sequencing (WES) for diagnosing patients with a clinical suspicion of an MD is effective (39-60%). We aimed to study the effectiveness of WES in clinical practice in Estonia, in patients with an unsolved, but suspected MD. We also show our first results of mtDNA analysis obtained from standard WES reads. Methods: Retrospective cases were selected from a database of 181 patients whose fibroblast cell cultures had been stored from 2003 to 2013. Prospective cases were selected during the period of 2014-2016 from patients referred to a clinical geneticist in whom an MD was suspected. We scored each patient according to the mitochondrial disease criteria (MDC) (Morava et al., 2006) after re-evaluation of their clinical data, and then performed WES analysis. Results: A total of 28 patients were selected to the study group. A disease-causing variant was found in 16 patients (57%) using WES. An MD was diagnosed in four patients (14%), with variants in the SLC25A4, POLG, SPATA5, and NDUFB11 genes. Other variants found were associated with a neuromuscular disease (SMN1, MYH2, and LMNA genes), neurodegenerative disorder (TSPOAP1, CACNA1A, ALS2, and SCN2A genes), multisystemic disease (EPG5, NKX1-2, ATRX, and ABCC6 genes), and one in an isolated cardiomyopathy causing gene (MYBPC3). The mtDNA point mutation was found in the MT-ATP6 gene of one patient upon mtDNA analysis. Conclusions: The diagnostic yield of WES in our cohort was 57%, proving to be a very good effectiveness. However, MDs were found in only 14% of the patients. We suggest WES analysis as a first-tier method in clinical genetic practice for children with any multisystem, neurological, and/or neuromuscular problem, as nuclear DNA variants are more common in children with MDs; a large number of patients harbor disease-causing variants in genes other than the mitochondria-related ones, and the clinical presentation might not always point towards an MD. We have also successfully conducted analysis of mtDNA from standard WES reads, providing further evidence that this method could be routinely used in the future.
C1 [Puusepp, Sanna; Reinson, Karit; Pajusalu, Sander; Ounap, Katrin] Univ Tartu, Inst Clin Med, Dept Clin Genet, 2 L Puusepa St, EE-51014 Tartu, Estonia.
   [Puusepp, Sanna; Reinson, Karit; Pajusalu, Sander; Murumets, Ulle; Ounap, Katrin] Tartu Univ Hosp, United Labs, Dept Clin Genet, 2 L Puusepa St, EE-51014 Tartu, Estonia.
   [Oiglane-Shlik, Eve; Rein, Reet] Tartu Univ Hosp, Childrens Clin, 6 Lunini St, EE-51014 Tartu, Estonia.
   [Oiglane-Shlik, Eve] Univ Tartu, Inst Clin Med, Dept Pediat, 6 Lunini St, EE-51014 Tartu, Estonia.
   [Talvik, Inga] Tallinn Childrens Hosp, 28 Tervise St, EE-13419 Tallinn, Estonia.
   [Rodenburg, Richard J.] Radboud Univ Nijmegen, Med Ctr, Translat Metab Lab 830, Radboud Ctr Mitochondrial Med, Geert Grootepl Zuid 10, NL-6525 GA Nijmegen, Netherlands.
C3 University of Tartu; University of Tartu; Radboud University Nijmegen
RP Ounap, K (corresponding author), Tartu Univ Hosp, United Labs, Dept Clin Genet, 2 Puusepa St, EE-51014 Tartu, Estonia.
EM katrin.ounap@kliinikum.ee
FU Estonian Research Council grants [GARLA8175, PUT0355]
CR Acuna C, 2016, NEURON, V91, P792, DOI 10.1016/j.neuron.2016.07.042
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Brookes E, 2015, HUM MOL GENET, V24, P2861, DOI 10.1093/hmg/ddv046
   BROWN GK, 1994, J MED GENET, V31, P875, DOI 10.1136/jmg.31.11.875
   Carroll J, 2002, J BIOL CHEM, V277, P50311, DOI 10.1074/jbc.M209166200
   Cingolani Pablo, 2012, FRONTIERS IN GENETICS, V3, P35, DOI 10.3389/fgene.2012.00035
   Clynes D, 2013, CURR OPIN GENET DEV, V23, P289, DOI 10.1016/j.gde.2013.01.005
   Cruciat CM, 1999, EMBO J, V18, P5226, DOI 10.1093/emboj/18.19.5226
   Cullup T, 2013, NAT GENET, V45, P83, DOI 10.1038/ng.2497
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Dinwiddie DL, 2013, GENOMICS, V102, P148, DOI 10.1016/j.ygeno.2013.04.013
   FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450
   Germain DP, 2017, ORPHANET J RARE DIS, V12, P0, DOI 10.1186/s13023-017-0639-8
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Hadano S, 2006, HUM MOL GENET, V15, P233, DOI 10.1093/hmg/ddi440
   Hedberg-Oldfors C, 2017, NEUROMUSCULAR DISORD, V27, P771, DOI 10.1016/j.nmd.2017.05.005
   Hikmat O, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18091845
   Joost K, 2012, MOL SYNDROMOL, V3, P113, DOI 10.1159/000341375
   Katsetos CD, 2013, SEMIN PEDIATR NEUROL, V20, P202, DOI 10.1016/j.spen.2013.10.010
   Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Kucharczyk R, 2010, BBA-BIOENERGETICS, V1797, P1105, DOI 10.1016/j.bbabio.2009.12.022
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Liao Y, 2010, NEUROLOGY, V75, P1454, DOI 10.1212/WNL.0b013e3181f8812e
   Lorson CL, 1998, HUM MOL GENET, V7, P1269, DOI 10.1093/hmg/7.8.1269
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Morava E, 2015, J INHERIT METAB DIS, V38, P387, DOI 10.1007/s10545-015-9852-6
   Narayanaswami P, 2014, NEUROLOGY, V83, P1453, DOI 10.1212/WNL.0000000000000892
   Nissenkorn A, 1999, ARCH DIS CHILD, V81, P209, DOI 10.1136/adc.81.3.209
   Pajusalu S, 2018, CLIN GENET, V93, P78, DOI 10.1111/cge.13031
   Phadke R, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6070064
   Picardi E, 2012, NAT METHODS, V9, P523, DOI 10.1038/nmeth.2029
   Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602
   Pronicka E, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0930-9
   Puusepp S, 2018, EUR J HUM GENET, V26, P407, DOI 10.1038/s41431-017-0001-6
   Pyle A, 2015, NEUROL-GENET, V1, P0, DOI 10.1212/NXG.0000000000000006
   Reinson K, 2016, AM J MED GENET A, V170, P2173, DOI 10.1002/ajmg.a.37678
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Ripolone M, 2015, JAMA NEUROL, V72, P666, DOI 10.1001/jamaneurol.2015.0178
   Schuelke M, 2017, NEUROPATH APPL NEURO, V43, P44, DOI 10.1111/nan.12374
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Soden SE, 2014, SCI TRANSL MED, V6, P0, DOI 10.1126/scitranslmed.3010076
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Thorwarth A, 2014, J MED GENET, V51, P375, DOI 10.1136/jmedgenet-2013-102248
   Stormo Gary D, 2013, CURR PROTOC BIOINFORMATICS, V43, P0, DOI 10.1002/0471250953.bi1110s43
   Verity CM, 2010, DEV MED CHILD NEUROL, V52, P434, DOI 10.1111/j.1469-8749.2009.03463.x
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Wang K, 2010, NUCLEIC ACIDS RES, V38, P0, DOI 10.1093/nar/gkq603
   Wang YL, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067087
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wortmann SB, 2017, NEUROPEDIATRICS, V48, P309, DOI 10.1055/s-0037-1603776
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
NR 56
TC 35
Z9 36
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 
EI 2214-4269
J9 MOL GENET METAB REP
JI Molec. Genet. Metab. Rep.
PD JUN 15
PY 2018
VL 15
IS 
BP 80
EP 89
DI 10.1016/j.ymgmr.2018.03.004
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA GH1SO
UT WOS:000433183100021
PM 30009132
DA 2024-11-01
ER

PT J
AU Dombi, E
   Mortiboys, H
   Poulton, J
AF Dombi, Eszter
   Mortiboys, Heather
   Poulton, Joanna
TI Modulating Mitophagy in Mitochondrial Disease
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Review
DE Mitophagy; AICAR; metformin; Coenzyme Q10; idebenone; phenanthroline
ID activated protein-kinase; skeletal-muscle; coenzyme q(10); direct phosphorylation; muscular-dystrophy; sirt3 deacetylates; oxidative stress; heme-synthesis; autophagy; parkin
AB Mitochondrial diseases may result from mutations in the maternally-inherited mitochondrial DNA (mtDNA) or from mutations in nuclear genes encoding mitochondrial proteins. Their bi-genomic nature makes mitochondrial diseases a very heterogeneous group of disorders that can present at any age and can affect any type of tissue. The autophagic-lysosomal degradation pathway plays an important role in clearing dysfunctional and redundant mitochondria through a specific quality control mechanism termed mitophagy. Mitochondria could be targeted for autophagic degradation for a variety of reasons including basal turnover for recycling, starvation induced degradation, and degradation due to damage. While the core autophagic machinery is highly conserved and common to most pathways, the signaling pathways leading to the selective degradation of damaged mitochondria are still not completely understood. Type 1 mitophagy due to nutrient starvation is dependent on PI3K (phosphoinositide 3-kinase) for autophagosome formation but independent of mitophagy proteins, PINK1 (PTEN-induced putative kinase 1) and Parkin. Whereas type 2 mitophagy that occurs due to damage is dependent on PINK1 and Parkin but does not require PI3K. Autophagy and mitophagy play an important role in human disease and hence could serve as therapeutic targets for the treatment of mitochondrial as well as neurodegenerative disorders. Therefore, we reviewed drugs that are known modulators of autophagy (AICAR and metformin) and may affect this by activating the AMP-activated protein kinase signaling pathways. Furthermore, we reviewed the data available on supplements, such as Coenzyme Q and the quinone idebenone, that we assert rescue increased mitophagy in mitochondrial disease by benefiting mitochondrial function.
C1 [Dombi, Eszter; Poulton, Joanna] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.
   [Mortiboys, Heather] Univ Sheffield, Neurosci Dept, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England.
C3 University of Oxford; University of Sheffield
RP Poulton, J (corresponding author), Univ Oxford, Womens Ctr, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.
EM Joanna.poulton@obs-gyn.ox.ac.uk
FU Lily Foundation; Parkinson's UK; MRC [MR/J010448/1] Funding Source: UKRI
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Beal MF, 2014, JAMA NEUROL, V71, P543, DOI 10.1001/jamaneurol.2014.131
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, NUTR RES, V28, P172, DOI 10.1016/j.nutres.2008.01.001
   Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200
   BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189
   Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019
   Chan EY, 2009, SCI SIGNAL, V2, P0, DOI 10.1126/scisignal.284pe51
   Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232
   Chiang MC, 2016, EXP CELL RES, V347, P322, DOI 10.1016/j.yexcr.2016.08.013
   Chu CT, 2007, AUTOPHAGY, V3, P663, DOI 10.4161/auto.4625
   Cornelius N, 2013, HUM MOL GENET, V22, P3819, DOI 10.1093/hmg/ddt232
   CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x
   Cotán D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340
   CRANE FL, 1989, BIOCHIM BIOPHYS ACTA, V1000, P358, DOI 10.1016/S0006-3002(89)80030-7
   Cullup T, 2013, NAT GENET, V45, P83, DOI 10.1038/ng.2497
   Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537
   Diot A, 2015, PHARMACOL RES, V100, P24, DOI 10.1016/j.phrs.2015.07.014
   Dombi E, 2016, NEUROLOGY, V86, P1921, DOI 10.1212/WNL.0000000000002688
   Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x
   Dulovic M, 2014, NEUROBIOL DIS, V63, P1, DOI 10.1016/j.nbd.2013.11.002
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Erb M, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0036153
   Fang EF, 2016, NAT REV MOL CELL BIO, V17, P308, DOI 10.1038/nrm.2016.14
   Fleming A, 2011, NAT CHEM BIOL, V7, P9, DOI 10.1038/nchembio.500
   Galpern WR, 2007, MITOCHONDRION, V7, PS146, DOI 10.1016/j.mito.2007.01.004
   Garrido-Maraver J, 2015, BBA-MOL BASIS DIS, V1852, P2535, DOI 10.1016/j.bbadis.2015.08.027
   Garrido-Maraver J, 2012, BRIT J PHARMACOL, V167, P1311, DOI 10.1111/j.1476-5381.2012.02086.x
   Gharanei M, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0077713
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   GILLIS JC, 1994, DRUG AGING, V5, P133, DOI 10.2165/00002512-199405020-00007
   Golubitzky A, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0026883
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Haginoya K, 2009, J NEUROL SCI, V278, P112, DOI 10.1016/j.jns.2008.11.008
   Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982
   Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821
   Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248
   ICHAS F, 1994, FEBS LETT, V348, P211, DOI 10.1016/0014-5793(94)00615-6
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Johnson JA, 2005, DIABETIC MED, V22, P497, DOI 10.1111/j.1464-5491.2005.01448.x
   JONES MS, 1969, BIOCHEM J, V113, P507, DOI 10.1042/bj1130507
   Jose C, 2011, BBA-BIOENERGETICS, V1807, P707, DOI 10.1016/j.bbabio.2010.12.002
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Klionsky DJ, 2016, GUIDELINES FOR THE USE AND INTERPRETATION OF ASSAYS FOR MONITORING AUTOPHAGY, V3rd, P0
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Kooncumchoo P, 2006, J MOL NEUROSCI, V28, P125, DOI 10.1385/JMN:28:2:125
   Kuznetsov AV, 1998, MOL CELL BIOCHEM, V183, P87, DOI 10.1023/A:1006868130002
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039
   Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011
   Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3
   Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004
   Liao C, 1900, V22, V0, PS3
   Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200
   Lu M, 2016, INT J NEUROPSYCHOPH, V19, P0, DOI 10.1093/ijnp/pyw047
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Mardones P, 2016, SCI SIGNAL, V9, P0, DOI 10.1126/scisignal.aaf1937
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011
   Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   Mordente A, 1998, CHEM RES TOXICOL, V11, P54, DOI 10.1021/tx970136j
   Mortensen M, 2010, AUTOPHAGY, V6, P423, DOI 10.4161/auto.6.3.11528
   Mortiboys H, 2013, BRAIN, V136, P3038, DOI 10.1093/brain/awt224
   Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426
   Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4
   Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256
   Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Park SJ, 2012, FEBS LETT, V586, P4303, DOI 10.1016/j.febslet.2012.10.035
   Pauly M, 2012, AM J PATHOL, V181, P583, DOI 10.1016/j.ajpath.2012.04.004
   Peng M, 2015, HUM MOL GENET, V24, P4829, DOI 10.1093/hmg/ddv207
   Porceddu PF, 2016, NEUROTOX RES, V30, P101, DOI 10.1007/s12640-016-9633-5
   Rodríguez VA, 2016, ARCH BIOCHEM BIOPHYS, V591, P28, DOI 10.1016/j.abb.2015.12.006
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Samant SA, 2014, MOL CELL BIOL, V34, P807, DOI 10.1128/MCB.01483-13
   Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006
   Santos RX, 2010, J ALZHEIMERS DIS, V20, PS401, DOI 10.3233/JAD-2010-100666
   Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002
   Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104
   Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408
   Shah DI, 2012, NATURE, V491, P608, DOI 10.1038/nature11536
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200
   Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482
   Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89
   Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08
   Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138
   Tseng AHH, 2013, FREE RADICAL BIO MED, V63, P222, DOI 10.1016/j.freeradbiomed.2013.05.002
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Weitzel JM, 2003, EXP PHYSIOL, V88, P121, DOI 10.1113/eph8802506
   Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102
   Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129
   Yoritaka A, 2015, PARKINSONISM RELAT D, V21, P911, DOI 10.1016/j.parkreldis.2015.05.022
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104
   Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797
NR 102
TC 64
Z9 71
U1 1
U2 29
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 0929-8673
EI 1875-533X
J9 CURR MED CHEM
JI Curr. Med. Chem.
PD JUN 15
PY 2018
VL 25
IS 40
BP 5597
EP 5612
DI 10.2174/0929867324666170616101741
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA HI2HZ
UT WOS:000456267300011
PM 28618992
DA 2024-11-01
ER

PT J
AU Antipova, VN
   Lomaeva, MG
   Zyrina, NV
AF Antipova, Valeriya N.
   Lomaeva, Milena G.
   Zyrina, Nadezhda V.
TI Mitochondrial DNA deletions in tissues of mice after ionizing radiation exposure
SO INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
LA English
DT Article
DE Large mitochondrial DNA deletions; ionizing radiation; mice
ID substantia-nigra neurons; multiple deletions; skeletal-muscle; copy number; blood-cells; x-rays; genome; disease; accumulation; irradiation
AB Purpose: The objective of the study was to estimate the presence of large mtDNA deletions in brain and spleen tissues of mice four months after exposure to 2 and 5Gy.Materials and methods: The male BALB/c mice underwent X-ray total-body acute radiation. Four months after irradiation, the mice were decapitated, and the samples of spleen and brain tissues were examined. A long-distance PCR was used to detect mtDNA deletions and their levels in samples of brain and spleen tissues.Results: Four months after irradiation the levels of mtDNA deletions in the brain and spleen tissues were higher in animals exposed to 5Gy than in animals at an irradiation dose of 2Gy and in control mice. The levels of deletions in the mice brain tissues were higher 4 months than 1 month after X-ray exposure to both doses (2 and 5Gy). In spleen tissues, a higher level of deletions was observed only at an irradiation dose of 5Gy.Conclusions: Our data have shown that ionizing radiation induces an increase of mtDNA copies with deletions in tissues of mice four months after the post-irradiation period. The level of deletions depends on the animal age, type of tissue, irradiation dose and length of the post-irradiation period.
C1 [Antipova, Valeriya N.] Russian Acad Sci, Inst Theoret & Expt Biophys, Lab Biophys Act Media, Pushchino 142290, Moscow Region, Russia.
   [Lomaeva, Milena G.] Russian Acad Sci, Inst Theoret & Expt Biophys, Lab Radiat Mol Biol, Pushchino, Moscow Region, Russia.
   [Zyrina, Nadezhda V.] Russian Acad Sci, Inst Theoret & Expt Biophys, Lab Crystallophys & Xray Res, Pushchino, Moscow Region, Russia.
C3 Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics
RP Antipova, VN (corresponding author), Russian Acad Sci, Inst Theoret & Expt Biophys, Lab Biophys Act Media, Pushchino 142290, Moscow Region, Russia.
EM valery_a@rambler.ru
CR [Anonymous], 1989, MOL CLONING LAB MANU, V0, P0
   Antipova V N, 2011, BIOFIZIKA, V56, P439
   Antipova V N, 2011, GENETIKA, V47, P425
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Blakely WF, 2001, RADIAT PROT DOSIM, V97, P17, DOI 10.1093/oxfordjournals.rpd.a006633
   BROSSAS JY, 1994, BIOCHEM BIOPH RES CO, V202, P654, DOI 10.1006/bbrc.1994.1980
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Eimon PM, 1996, DEV GENET, V18, P107, DOI 10.1002/(SICI)1520-6408(1996)18:2<107::AID-DVG3>3.0.CO;2-D
   Forster L, 2002, P NATL ACAD SCI USA, V99, P13950, DOI 10.1073/pnas.202400499
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Hamada A, 2003, INT CONGR SER, V1258, P169, DOI 10.1016/S0531-5131(03)01221-4
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Ikushima T, 2002, INT CONGR SER, V1236, P331, DOI 10.1016/S0531-5131(01)00852-4
   IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616
   Kazachkova N, 2013, AGING DIS, V4, P337, DOI 10.14336/AD.2013.0400337
   Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kubota N, 1997, RADIAT RES, V148, P395, DOI 10.2307/3579525
   Malakhova LV, 2006, VOPROSY ONKOLOGII (ST. PETERSBURG), V52, P398
   Marcelino LA, 1999, MUTAT RES-DNA REPAIR, V434, P177, DOI 10.1016/S0921-8777(99)00028-2
   Nicholas A, 2009, EXP NEUROL, V218, P316, DOI 10.1016/j.expneurol.2009.04.029
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Prasanna Pataje G S, 2002, MIL MED, V167, P10
   Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Sawyer DE, 1999, MUTAT RES-DNA REPAIR, V434, P161, DOI 10.1016/S0921-8777(99)00027-0
   Schilling-Tóth B, 2011, MUTAT RES-FUND MOL M, V716, P33, DOI 10.1016/j.mrfmmm.2011.07.018
   Seol MA, 2012, J VET SCI, V13, P331, DOI 10.4142/jvs.2012.13.4.331
   Siqueira RG, 2014, AN ACAD BRAS CIENC, V86, P685, DOI 10.1590/0001-37652014110912
   Takeda K, 2000, GENETICS, V155, P777
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trifunovic A, 2006, BBA-BIOENERGETICS, V1757, P611, DOI 10.1016/j.bbabio.2006.03.003
   Wang L, 2007, INT J RADIAT BIOL, V83, P433, DOI 10.1080/09553000701370878
   Wardell TM, 2003, MUTAT RES-FUND MOL M, V525, P19, DOI 10.1016/S0027-5107(02)00313-5
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Zhang SB, 2013, RADIAT RES, V180, P407, DOI 10.1667/RR3373.1
   Zhao XT, 2012, BIOMED ENVIRON SCI, V25, P533, DOI 10.3967/0895-3988.2012.05.006
NR 44
TC 4
Z9 4
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0955-3002
EI 1362-3095
J9 INT J RADIAT BIOL
JI Int. J. Radiat. Biol.
PD JUN 15
PY 2018
VL 94
IS 3
BP 282
EP 288
DI 10.1080/09553002.2018.1419299
PG 7
WC Biology; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging
SC Life Sciences & Biomedicine - Other Topics; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging
GA FY7ZD
UT WOS:000427081300008
PM 29256737
DA 2024-11-01
ER

PT J
AU Chen, QY
   Kirk, K
   Shurubor, YI
   Zhao, DZ
   Arreguin, AJ
   Shahi, I
   Valsecchi, F
   Primiano, G
   Calder, EL
   Carelli, V
   Denton, TT
   Beal, MF
   Gross, SS
   Manfredi, G
   D'Aurelio, M
AF Chen, Qiuying
   Kirk, Kathryne
   Shurubor, Yevgeniya I.
   Zhao, Dazhi
   Arreguin, Andrea J.
   Shahi, Ifrah
   Valsecchi, Federica
   Primiano, Guido
   Calder, Elizabeth L.
   Carelli, Valerio
   Denton, Travis T.
   Beal, M. Flint
   Gross, Steven S.
   Manfredi, Giovanni
   D'Aurelio, Marilena
TI Rewiring of Glutamine Metabolism Is a Bioenergetic Adaptation of Human Cells with Mitochondrial DNA Mutations
SO CELL METABOLISM
LA English
DT Article
ID amino-acid-metabolism; stop-codon mutation; alpha-ketoglutarate; oxidative-phosphorylation; reductive carboxylation; muscle; cancer; mtdna; disease; dehydrogenase
AB Using molecular, biochemical, and untargeted stable isotope tracing approaches, we identify a previously unappreciated glutamine-derived alpha-ketoglutarate (alpha KG ) energy-generating anaplerotic flux to be critical in mitochondrial DNA (mtDNA) mutant cells that harbor human disease-associated oxidative phosphorylation defects. Stimulating this flux with alpha KG supplementation enables the survival of diverse mtDNA mutant cells under otherwise lethal obligatory oxidative conditions. Strikingly, we demonstrate that when residual mitochondrial respiration in mtDNA mutant cells exceeds 45% of control levels, alpha KG oxidative flux prevails over reductive carboxylation. Furthermore, in a mouse model of mitochondrial myopathy, we show that increased oxidative alpha KG flux in muscle arises from enhanced alanine synthesis and release into blood, concomitant with accelerated amino acid catabolism from protein breakdown. Importantly, in this mouse model of mitochondriopathy, muscle amino acid imbalance is normalized by alpha KG supplementation. Taken together, our findings provide a rationale for alpha KG supplementation as a therapeutic strategy for mitochondrial myopathies.
C1 [Kirk, Kathryne; Shurubor, Yevgeniya I.; Zhao, Dazhi; Arreguin, Andrea J.; Shahi, Ifrah; Valsecchi, Federica; Beal, M. Flint; Manfredi, Giovanni; D'Aurelio, Marilena] Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA.
   [Chen, Qiuying; Gross, Steven S.] Weill Cornell Med, Dept Pharmacol, New York, NY 10065 USA.
   [Primiano, Guido] Univ Cattolica Sacro Cuore, Inst Neurol, Rome, Italy.
   [Calder, Elizabeth L.] Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY 10065 USA.
   [Calder, Elizabeth L.] Sloan Kettering Inst Canc Res, Dev Biol Program, New York, NY 10065 USA.
   [Carelli, Valerio] Bellaria Hosp, Inst Neurol Sci Bologna, IRCCS, Bologna, Italy.
   [Carelli, Valerio] Univ Bologna, Dept Biomed & NeuroMotor Sci DIBINEM, Bologna, Italy.
   [Denton, Travis T.] Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, Spokane, WA 99210 USA.
C3 Cornell University; Weill Cornell Medicine; Cornell University; Weill Cornell Medicine; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; Washington State University
RP Manfredi, G; D'Aurelio, M (corresponding author), Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA.
EM gim2004@med.cornell.edu; mad2003@med.cornell.edu
FU Muscular Dystrophy Association [MDA276237]; NIH [GM088999, NS084524]
CR Albrecht J, 2007, FRONT BIOSCI-LANDMRK, V12, P332, DOI 10.2741/2067
   Avissar NE, 2001, AM J PHYSIOL-CELL PH, V281, PC963, DOI 10.1152/ajpcell.2001.281.3.C963
   Baracca A, 2005, ARCH NEUROL-CHICAGO, V62, P730, DOI 10.1001/archneur.62.5.730
   BERGSTROM J, 1974, J APPL PHYSIOL, V36, P693, DOI 10.1152/jappl.1974.36.6.693
   Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016
   Brosnan ME, 2004, J NUTR, V134, P2791S, DOI 10.1093/jn/134.10.2791S
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Bunik VI, 2005, BIOCHEMISTRY-US, V44, P10552, DOI 10.1021/bi0503100
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   CHANG TW, 1978, J BIOL CHEM, V253, P3685
   Chen L, 2015, INT J MOL SCI, V16, P22830, DOI 10.3390/ijms160922830
   Chen QY, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0037149
   Curis E, 2005, AMINO ACIDS, V29, P177, DOI 10.1007/s00726-005-0235-4
   CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025
   DAurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200
   DAurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Dai ZL, 2014, J CHROMATOGR B, V964, P116, DOI 10.1016/j.jchromb.2014.03.025
   Danhauser K, 2015, J INHERIT METAB DIS, V38, P467, DOI 10.1007/s10545-014-9796-2
   Daye D, 2012, SEMIN CELL DEV BIOL, V23, P362, DOI 10.1016/j.semcdb.2012.02.002
   de la Rosa V, 2009, NEUROCHEM INT, V55, P76, DOI 10.1016/j.neuint.2009.02.021
   Debray FG, 2010, J CHILD NEUROL, V25, P1000, DOI 10.1177/0883073809351983
   Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307
   Eales KL, 2016, ONCOGENESIS, V5, P0, DOI 10.1038/oncsis.2015.50
   Edmonds JL, 2002, ARCH OTOLARYNGOL, V128, P355, DOI 10.1001/archotol.128.4.355
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Elgadi KM, 1999, PHYSIOL GENOMICS, V1, P51, DOI 10.1152/physiolgenomics.1999.1.2.51
   Fendt SM, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3236
   Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   HAUSSINGER D, 1986, ADV ENZYME REGUL, V25, P159, DOI 10.1016/0065-2571(86)90013-0
   He YJ, 2010, J BIOL CHEM, V285, P9516, DOI 10.1074/jbc.M109.092429
   Hofhaus G, 1996, METHODS ENZYMOL, V264, P476, DOI 10.1016/S0076-6879(96)64043-9
   Ismailoglu I, 2014, DEV BIOL, V391, P230, DOI 10.1016/j.ydbio.2014.04.005
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kita K, 2007, TOXICOL APPL PHARM, V220, P262, DOI 10.1016/j.taap.2007.01.009
   Kjobsted R, 2018, FASEB J, V32, P1741, DOI 10.1096/fj.201700442R
   KOTLYAR AB, 1984, BIOCHIM BIOPHYS ACTA, V784, P24, DOI 10.1016/0167-4838(84)90168-7
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Longo N, 2003, NEUROL CLIN, V21, P817, DOI 10.1016/S0733-8619(03)00015-X
   Marin M, 2003, J VIROL, V77, P2936, DOI 10.1128/JVI.77.5.2936-2945.2003
   MARLISS EB, 1971, J CLIN INVEST, V50, P814, DOI 10.1172/JCI106552
   McGivan JD, 2007, FRONT BIOSCI, V12, P874, DOI 10.2741/2109
   Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602
   Metallo CM, 2010, GENE DEV, V24, P2717, DOI 10.1101/gad.2010510
   Meyer O A, 1979, NEUROBEHAV TOXICOL, V1, P233
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Mullen AR, 2014, CELL REP, V7, P1679, DOI 10.1016/j.celrep.2014.04.037
   Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Neel BA, 2013, TRENDS ENDOCRIN MET, V24, P635, DOI 10.1016/j.tem.2013.09.004
   NEWSHOLME EA, 1988, NUTRITION, V4, P261
   Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Palmada M, 2005, BIOCHEM BIOPH RES CO, V331, P272, DOI 10.1016/j.bbrc.2005.03.159
   Parfait B, 1999, EUR J PEDIATR, V158, P55, DOI 10.1007/s004310051009
   Rabier D, 1998, J INHERIT METAB DIS, V21, P216, DOI 10.1023/A:1005391300203
   Robinson B H, 1996, METHODS ENZYMOL, V264, P454, DOI 10.1016/S0076-6879(96)64041-5
   Sakuma K, 2016, J CACHEXIA SARCOPENI, V7, P204, DOI 10.1002/jcsm.12045
   Santos SS, 2006, J NEUROSCI RES, V83, P450, DOI 10.1002/jnr.20749
   Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107
   Shatla HM, 2014, PEDIATR NEUROL, V51, P820, DOI 10.1016/j.pediatrneurol.2014.08.009
   Shin CS, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15074
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040
   Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017
   Tan HWS, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00369-y
   Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P446, DOI 10.1016/S0753-3322(02)00285-8
   Taylor L, 2004, BIOCHEM MOL BIOL EDU, V32, P291, DOI 10.1002/bmb.2004.494032050388
   Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7
   Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883
   Wagenmakers AJM, 1998, EXERCISE SPORT SCI R, V26, P287
   Wagenmakers AJM, 1998, ADV EXP MED BIOL, V441, P307
   Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003
   Wu GY, 2008, METHOD ENZYMOL, V440, P177, DOI 10.1016/S0076-6879(07)00810-5
   Wu GY, 2009, AMINO ACIDS, V37, P153, DOI 10.1007/s00726-008-0210-y
   Wu GY, 1998, J NUTR, V128, P1249, DOI 10.1093/jn/128.8.1249
NR 80
TC 123
Z9 136
U1 2
U2 35
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD MAY 1
PY 2018
VL 27
IS 5
BP 1007
EP +
DI 10.1016/j.cmet.2018.03.002
PG 24
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA GG1HN
UT WOS:000432438100009
PM 29657030
DA 2024-11-01
ER

PT J
AU Su, TH
   Grady, JP
   Afshar, S
   McDonald, SAC
   Taylor, RW
   Turnbull, DM
   Greaves, LC
AF Su, Tianhong
   Grady, John P.
   Afshar, Sorena
   McDonald, Stuart A. C.
   Taylor, Robert W.
   Turnbull, Doug M.
   Greaves, Laura C.
TI Inherited pathogenic mitochondrial DNA mutations and gastrointestinal stem cell populations
SO JOURNAL OF PATHOLOGY
LA English
DT Article
DE mitochondrial DNA mutation; selection; segregation; mitochondrial disease; intestinal stem cell; gastrointestinal epithelium; MELAS; MERRF; m.3243A>G; alimentary canal
ID mtdna mutation; disease; deficiency; mechanisms; adult; blood
AB Inherited mitochondrial DNA (mtDNA) mutations cause mitochondrial disease, but mtDNA mutations also occur somatically and accumulate during ageing. Studies have shown that the mutation load of some inherited mtDNA mutations decreases over time in blood, suggesting selection against the mutation. However, it is unknown whether such selection occurs in other mitotic tissues, and where it occurs within the tissue. Gastrointestinal epithelium is a canonical mitotic tissue rapidly renewed by stem cells. Intestinal crypts (epithelium) undergo monoclonal conversion with a single stem cell taking over the niche and producing progeny. We show: (1) that there is a significantly lower mtDNA mutation load in the mitotic epithelium of the gastrointestinal tract when compared to the smooth muscle in the same tissue in patients with the pathogenic m.3243A>G and m.8344A>G mutations; (2) that there is considerable variation seen in individual crypts, suggesting changes in the stem cell population; (3) that this lower mutation load is reflected in the absence of a defect in oxidative phosphorylation in the epithelium. This suggests that there is selection against inherited mtDNA mutations in the gastrointestinal stem cells that is in marked contrast to the somatic mtDNA mutations that accumulate with age in epithelial stem cells leading to a biochemical defect. (c) 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
C1 [Su, Tianhong; Grady, John P.; Taylor, Robert W.; Turnbull, Doug M.; Greaves, Laura C.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Afshar, Sorena] Newcastle Univ, Inst Cellular Med, Human Nutr Res Ctr, Campus Ageing & Vital, Newcastle Upon Tyne, Tyne & Wear, England.
   [McDonald, Stuart A. C.] Queen Mary Univ London, Barts Canc Inst, Ctr Tumour Biol, London, England.
   [Turnbull, Doug M.; Greaves, Laura C.] Newcastle Univ, Med Sch, LLHW Ctr Ageing & Vital, Inst Ageing, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; University of London; Queen Mary University London; Newcastle University - UK
RP Greaves, LC (corresponding author), Newcastle Univ, Med Sch, Inst Neurosci, LLHW Ctr Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM laura.greaves@ncl.ac.uk
FU Newcastle University Centre for Ageing and Vitality - BBSRC; EPSRC; ESRC; MRC as part of the cross-council Lifelong Health and Wellbeing Initiative [203105/Z/16/Z]; UK NIHR Biomedical Research Centre in Age and Age Related Diseases; UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children; Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; MRC [MR/L016354/1] Funding Source: UKRI
CR Betts J, 2008, NEUROLOGY, V70, P1290, DOI 10.1212/01.wnl.0000308940.38092.74
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cardaioli E, 2000, J NEUROL, V247, P885, DOI 10.1007/s004150070080
   Chrysostomou A, 2016, NEUROPATH APPL NEURO, V42, P477, DOI 10.1111/nan.12282
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Greaves LC, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1003082
   Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Olsson C, 2001, EUR J HUM GENET, V9, P917, DOI 10.1038/sj.ejhg.5200742
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Rygiel KA, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep09906
   Shin MG, 2004, BLOOD, V103, P4466, DOI 10.1182/blood-2003-11-3949
   Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
NR 21
TC 11
Z9 11
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
EI 1096-9896
J9 J PATHOL
JI J. Pathol.
PD DEC 15
PY 2018
VL 246
IS 4
BP 427
EP 432
DI 10.1002/path.5156
PG 6
WC Oncology; Pathology
SC Oncology; Pathology
GA HA6AD
UT WOS:000450360400006
PM 30146801
DA 2024-11-01
ER

PT J
AU Bahreini, F
   Houshmand, M
   Modarressi, MH
   Akrami, SM
AF Bahreini, Fatemeh
   Houshmand, Massoud
   Modarressi, Mohammad Hossein
   Akrami, Seyed Mohammad
TI Mitochondrial Variants in Pompe Disease: A Comparison between Classic and Non-Classic Forms
SO CELL JOURNAL
LA English
DT Article
DE Alpha-Glucosidase; Cytochrome-C Oxidase; Mitochondria; Pompe
ID genotype-phenotype correlation; skeletal-muscle; late-onset; mutations; dna; glycogenosis; oxidase; gene; deficiency; pathology
AB Objective: Pompe disease (PD) is a progressive neuromuscular disorder that is caused by glucosidase acid alpha (GAA) deleterious mutations. Mitochondrial involvement is an important contributor to neuromuscular diseases. In this study the sequence of MT-ATP 6/8 and Cytochrome C oxidase I/II genes along with the expression levels of the former genes were compared in classic and non-classic patients. Materials and Methods: In this case-control study, the sequence of MT-ATP 6/8 and Cytochrome C oxidase was analyzed by polymerase chain reaction (PCR)-Sanger sequencing and expression of MT-ATP genes were quantified by real time-PCR (RT-PCR) in 28 Pompe patients. The results were then compared with 100 controls. All sequences were compared with the revised Cambridge reference sequence as reference. Results: Screening of MT-ATP6/8 resulted in the identification of three novel variants, namely T9117A, A8456C and A8524C. There was a significant decrease in MT-ATP6 expression between classic (i.e. adult) and control groups (P=0.030). Additionally, the MT-ATP8 expression was significantly decreased in classic (P=0.004) and non-classic (i.e. infant) patients (P=0.013). In total, 22 variants were observed in Cytochrome C oxidase, five of which were nonsynonymous, one leading to a stop codon and another (C9227G) being a novel heteroplasmic variant. The A8302G in the lysine tRNA gene was found in two brothers in a pedigree, while a T7572C variant in the aspartate tRNA gene was observed in two brothers in another pedigree. Conclusion: The extent of mitochondrial involvement in the classic group was more significant than in the non-classic form. Beside GAA deleterious mutations, it seems that mtDNA variants have a secondary effect on PD. Understanding, the role of mitochondria in the pathogenesis of Pompe may potentially be helpful in developing new therapeutic strategies.
C1 [Bahreini, Fatemeh; Modarressi, Mohammad Hossein; Akrami, Seyed Mohammad] Univ Tehran Med Sci, Sch Med, Dept Med Genet, POB 14176-13151,Keshavarz BLV,Poursina St, Tehran, Iran.
   [Bahreini, Fatemeh] Hamadan Univ Med Sci, Sch Med, Dept Mol Med & Genet, Hamadan, Iran.
   [Houshmand, Massoud] Natl Inst Genet Engn & Biotechnol, Dept Med Genet, Tehran, Iran.
C3 Tehran University of Medical Sciences; Hamadan University of Medical Sciences
RP Akrami, SM (corresponding author), Univ Tehran Med Sci, Sch Med, Dept Med Genet, POB 14176-13151,Keshavarz BLV,Poursina St, Tehran, Iran.
EM akramism@tums.ac.ir
FU Tehran University of Medical Sciences, Tehran, Iran [23162]
CR Ahari SE, 2007, IRAN J CHILD NEUROL, V2, P41
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   DiMauro S, 1998, BBA-BIOENERGETICS, V1366, P199, DOI 10.1016/S0005-2728(98)00113-3
   ENGEL AG, 1968, MAYO CLIN PROC, V43, P233
   Fernández R, 1999, NEUROMUSCULAR DISORD, V9, P136, DOI 10.1016/S0960-8966(98)00117-5
   Ghaffarpour M, 2014, CANCER CELL INT, V14, P0, DOI 10.1186/1475-2867-14-21
   Govindaraj P, 2013, MITOCHONDRION, V13, P721, DOI 10.1016/j.mito.2013.02.003
   Gurses C, 2014, GENE, V538, P323, DOI 10.1016/j.gene.2014.01.030
   Herzog A, 2012, ORPHANET J RARE DIS, V7, P0, DOI 10.1186/1750-1172-7-35
   Hobson-Webb LD, 2012, MOL GENET METAB, V106, P462, DOI 10.1016/j.ymgme.2012.05.007
   HOUSHMAND M, 1994, BBA-MOL BASIS DIS, V1226, P49, DOI 10.1016/0925-4439(94)90058-2
   Houshmand M, 2011, ARCH MED SCI, V7, P523, DOI 10.5114/aoms.2011.23424
   Houshmand M, 2011, ARCH MED SCI, V7, P242, DOI 10.5114/aoms.2011.22074
   HUDGSON P, 1975, J PATHOL, V116, P139, DOI 10.1002/path.1711160303
   Kasraie S, 2008, CELL MOL NEUROBIOL, V28, P933, DOI 10.1007/s10571-008-9261-6
   Kishnani PS, 2006, J PEDIATR-US, V148, P671, DOI 10.1016/j.jpeds.2005.11.033
   Kishnani PS, 2006, GENET MED, V8, P267, DOI 10.1097/01.gim.0000218152.87434.f3
   Kishnani PS, 2012, AM J MED GENET C, V160C, P1, DOI 10.1002/ajmg.c.31324
   Kroos M, 2012, AM J MED GENET C, V160C, P59, DOI 10.1002/ajmc.31318
   Kulawiec M, 2009, CANCER BIOL THER, V8, P1378, DOI 10.4161/cbt.8.14.8751
   Laforêt P, 2000, NEUROLOGY, V55, P1122, DOI 10.1212/WNL.55.8.1122
   Lewandowska E, 2008, FOLIA NEUROPATHOL, V46, P123
   Li LJ, 2017, BIOMED RES-INDIA, V28, P4908
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mkaouar-Rebai E, 2014, MITOCHONDR DNA, V25, P394, DOI 10.3109/19401736.2013.803086
   Nardin RA, 2001, MUSCLE NERVE, V24, P170, DOI 10.1002/1097-4598(200102)24:2<170::AID-MUS30>3.0.CO;2-0
   Pecina P, 2004, PHYSIOL RES, V53, PS213, DOI 10.33549/physiolres.930000.53.S213
   Pittis M G, 2008, HUM MUTAT, V29, PE27, DOI 10.1002/humu.20753
   Reddy PL, 2002, BRIT J HAEMATOL, V116, P564, DOI 10.1046/j.0007-1048.2001.03323.x
   Schüller A, 2012, AM J MED GENET C, V160C, P80, DOI 10.1002/ajmc.31322
   Selak MA, 2000, PEDIATR NEUROL, V23, P54, DOI 10.1016/S0887-8994(00)00145-4
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Sisková A, 2001, PHYSIOL RES, V50, P267, DOI 10.33549/physiolres.930083
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Thurberg BL, 2006, LAB INVEST, V86, P1208, DOI 10.1038/labinvest.3700484
   Tzen CY, 2005, ANN NY ACAD SCI, V1042, P19, DOI 10.1196/annals.1338.002
   Tzen CY, 2001, FORENSIC SCI INT, V120, P204, DOI 10.1016/S0379-0738(01)00389-9
   VANDENOUWELAND JMW, 1992, NUCLEIC ACIDS RES, V20, P679, DOI 10.1093/nar/20.4.679
   VERITY MA, 1991, MUSCLE NERVE, V14, P435, DOI 10.1002/mus.880140509
NR 40
TC 2
Z9 2
U1 0
U2 6
PU ROYAN INST
PI TEHRAN
PA PO BOX 19395-4644, TEHRAN, 00000, IRAN
SN 2228-5806
EI 2228-5814
J9 CELL J
JI Cell J.
PD FAL 15
PY 2018
VL 20
IS 3
BP 333
EP 339
DI 10.22074/cellj.2018.5238
PG 7
WC Cell Biology
SC Cell Biology
GA GI7NY
UT WOS:000434690400006
PM 29845786
DA 2024-11-01
ER

PT J
AU Zampiga, M
   Flees, J
   Meluzzi, A
   Dridi, S
   Sirri, F
AF Zampiga, Marco
   Flees, Joshua
   Meluzzi, Adele
   Dridi, Sami
   Sirri, Federico
TI Application of omics technologies for a deeper insight into quali-quantitative production traits in broiler chickens: A review
SO JOURNAL OF ANIMAL SCIENCE AND BIOTECHNOLOGY
LA English
DT Review
DE Broiler chicken; Feed efficiency; Meat quality; Nutrition; Omics technologies
ID pectoralis-major muscle; single genetic line; dietary lysine deficiency; feed efficient broilers; disease virus-infection; genome-wide association; higher oxidative stress; breast muscle; mitochondrial-function; meat quality
AB The poultry industry is continuously facing substantial and different challenges such as the increasing cost of feed ingredients, the European Union's ban of antibiotic as growth promoters, the antimicrobial resistance and the high incidence of muscle myopathies and breast meat abnormalities. In the last decade, there has been an extraordinary development of many genomic techniques able to describe global variation of genes, proteins and metabolites expression level. Proper application of these cutting-edge omics technologies (mainly transcriptomics, proteomics and metabolomics) paves the possibility to understand much useful information about the biological processes and pathways behind different complex traits of chickens. The current review aimed to highlight some important knowledge achieved through the application of omics technologies and proteo-genomics data in the field of feed efficiency, nutrition, meat quality and disease resistance in broiler chickens.
C1 [Zampiga, Marco; Meluzzi, Adele; Sirri, Federico] Univ Bologna, Alma Mater Studiorum, Dept Agr & Food Sci, Via Florio 2, I-40064 Ozzano Dellemilia, Italy.
   [Flees, Joshua; Dridi, Sami] Univ Arkansas, Ctr Excellence Poultry Sci, Fayetteville, AR 72701 USA.
C3 University of Bologna; University of Arkansas System; University of Arkansas Fayetteville
RP Sirri, F (corresponding author), Univ Bologna, Alma Mater Studiorum, Dept Agr & Food Sci, Via Florio 2, I-40064 Ozzano Dellemilia, Italy.
EM federico.sirri@unibo.it
CR Abasht B, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0153750
   Adamski J, 2013, CURR OPIN BIOTECH, V24, P39, DOI 10.1016/j.copbio.2012.10.003
   Aggrey SE, 2010, GENET SEL EVOL, V42, P0, DOI 10.1186/1297-9686-42-25
   Alnahhas N, 2016, BMC GENET, V17, P0, DOI 10.1186/s12863-016-0369-2
   Bai J, 2015, MOL NUTR FOOD RES, V59, P1171, DOI 10.1002/mnfr.201400918
   Bailey RA, 2015, POULTRY SCI, V94, P2870, DOI 10.3382/ps/pev304
   Beauclercq S, 2016, J PROTEOME RES, V15, P1168, DOI 10.1021/acs.jproteome.5b01050
   Berri C, 2008, POULTRY SCI, V87, P480, DOI 10.3382/ps.2007-00226
   Bhanja SK, 2014, CZECH J ANIM SCI, V59, P399, DOI 10.17221/7651-CJAS
   Blankenship K, 2016, NEUROPEPTIDES, V58, P31, DOI 10.1016/j.npep.2015.12.007
   Bortoluzzi C, 2018, POULTRY SCI, V97, P937, DOI 10.3382/ps/pex394
   Bottje W, 2006, POULTRY SCI, V85, P8, DOI 10.1093/ps/85.1.8
   Bottje W, 2013, J ANIM SCI, V91, P1582, DOI 10.2527/jas.2012-5787
   Bottje W, 2002, POULTRY SCI, V81, P546, DOI 10.1093/ps/81.4.546
   Bottje W, 2009, POULTRY SCI, V88, P1683, DOI 10.3382/ps.2009-00100
   Bottje WG, 2012, POULTRY SCI, V91, P2576, DOI 10.3382/ps.2012-02204
   Bottje WG, 2009, J ANIM SCI, V87, PE48, DOI 10.2527/jas.2008-1379
   Bottje W, 2017, BMC SYST BIOL, V11, P0, DOI 10.1186/s12918-017-0396-2
   Bottje WG, 2017, FRONT PHYSIOL, V8, P0, DOI 10.3389/fphys.2017.00306
   Bottje WG, 2014, BIOCH PHYSL, V0, P0, DOI DOI 10.4172/2168-9652.10001252
   Brautigan L, 2017, POULTRY SCI, V96, P2889, DOI 10.3382/ps/pex078
   Brennan KM, 2013, BRIT POULTRY SCI, V54, P238, DOI 10.1080/00071668.2013.775404
   Bungo T, 2011, J POULT SCI, V48, P1, DOI 10.2141/jpsa.010117
   Cai K, 2018, POULTRY SCI, V97, P337, DOI 10.3382/ps/pex284
   Calenge F, 2009, ANIM GENET, V40, P590, DOI 10.1111/j.1365-2052.2009.01884.x
   Calenge Fanny, 2012, FRONTIERS IN GENETICS, V3, P261, DOI 10.3389/fgene.2012.00261
   Calenge F, 2010, GENET SEL EVOL, V42, P0, DOI 10.1186/1297-9686-42-11
   Chapman HD, 2014, POULTRY SCI, V93, P501, DOI 10.3382/ps.2013-03634
   Chen X, 2014, BIOL TRACE ELEM RES, V161, P334, DOI 10.1007/s12011-014-0150-1
   Cheng HH, 2015, BMC GENOMICS, V16, P0, DOI 10.1186/s12864-015-2016-0
   Cheng HH, 2013, ANNU REV ANIM BIOSCI, V1, P239, DOI 10.1146/annurev-animal-031412-103701
   Corzo A, 2006, BRIT J NUTR, V95, P703, DOI 10.1079/BJN20051716
   Cox CM, 2015, BENEF MICROBES, V6, P45, DOI 10.3920/BM2014.0062
   DAlessandro A, 2013, J PROTEOMICS, V78, P558, DOI 10.1016/j.jprot.2012.10.023
   Davis RVN, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0122525
   De Cesare A, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0176309
   Deusch S, 2015, COMPUT STRUCT BIOTEC, V13, P55, DOI 10.1016/j.csbj.2014.12.005
   Dridi S, 2005, BRAIN RES, V1047, P214, DOI 10.1016/j.brainres.2005.04.034
   Erf GF, 1998, POULTRY SCI, V77, P529, DOI 10.1093/ps/77.4.529
   Fontanesi L, 2016, ANIM FRONT, V6, P73, DOI 10.2527/af.2016-0011
   Fouad AM, 2013, ANIMAL, V7, P1239, DOI 10.1017/S1751731113000347
   Gao SY, 2017, GEN COMP ENDOCR, V240, P46, DOI 10.1016/j.ygcen.2016.09.005
   García-Cañas V, 2012, ANAL CHEM, V84, P10150, DOI 10.1021/ac301680q
   Gómez-Verduzco G, 2013, J POULT SCI, V50, P60, DOI 10.2141/jpsa.0120071
   Gong J, 2008, J APPL MICROBIOL, V104, P1372, DOI 10.1111/j.1365-2672.2007.03699.x
   Gou ZY, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0033627
   Hajati H, 2010, INTER. J. POULT. SCI, V9, P298, DOI 10.3923/IJPS.2010.298.304
   Hamzic E, 2015, J ANIM SCI, V93, P1830, DOI 10.2527/jas.2014-8592
   Hamzic E, 2015, GENET SEL EVOL, V47, P0, DOI 10.1186/s12711-015-0170-0
   Honda K, 2017, J POULT SCI, V54, P103, DOI 10.2141/jpsa.0160100
   Hong YH, 2009, POULTRY SCI, V88, P511, DOI 10.3382/ps.2008-00344
   Hu Y, 2015, BRIT POULTRY SCI, V56, P408, DOI 10.1080/00071668.2015.1052371
   Huber K, 2015, POULTRY SCI, V94, P1009, DOI 10.3382/ps/pev065
   Iqbal M, 2005, POULTRY SCI, V84, P933, DOI 10.1093/ps/84.6.933
   Iqbal M, 2004, POULTRY SCI, V83, P474, DOI 10.1093/ps/83.3.474
   Jlali M, 2012, J ANIM SCI, V90, P4280, DOI 10.2527/jas.2012-5240
   Jlali M, 2012, J ANIM SCI, V90, P447, DOI 10.2527/jas.2011-4405
   Jlali M, 2014, BRIT J NUTR, V111, P2079, DOI 10.1017/S0007114514000312
   Junot C, 2014, MASS SPECTROM REV, V33, P471, DOI 10.1002/mas.21401
   Kabir SML, 2009, INT J MOL SCI, V10, P3531, DOI 10.3390/ijms10083531
   Khonyoung D, 2015, LIVEST SCI, V176, P111, DOI 10.1016/j.livsci.2015.03.011
   Khoso PA, 2015, BIOL TRACE ELEM RES, V167, P48, DOI 10.1007/s12011-015-0282-y
   Kidd MT, 1998, J APPL POULTRY RES, V7, P351, DOI 10.1093/japr/7.4.351
   Kim DK, 2010, POULTRY SCI, V89, P68, DOI 10.3382/ps.2009-00275
   Kim DK, 2013, POULTRY SCI, V92, P2625, DOI 10.3382/ps.2013-03092
   Kim DK, 2013, POULTRY SCI, V92, P2635, DOI 10.3382/ps.2013-03095
   Kim DK, 2013, BRIT J NUTR, V109, P76, DOI 10.1017/S0007114512000530
   Kim ES, 2006, POULTRY SCI, V85, P2028, DOI 10.1093/ps/85.11.2028
   Klasing KC, 2007, BRIT POULTRY SCI, V48, P525, DOI 10.1080/00071660701671336
   Kong BW, 2011, POULTRY SCI, V90, P2535, DOI 10.3382/ps.2011-01435
   Kong BW, 2017, BMC GENOMICS, V18, P0, DOI 10.1186/s12864-016-3471-y
   Kong BW, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0155679
   Konjufca VK, 2004, POULTRY SCI, V83, P1530, DOI 10.1093/ps/83.9.1530
   Koutsos EAKCKlasing, 2014, AVIAN IMMUNOLOGY, VSecond, P299, DOI 10.1016/B978-0-12-396965-1.00017-0
   Kuenzel WJ, 1999, J EXP ZOOL, V283, P348, DOI 10.1002/(SICI)1097-010X(19990301/01)283:4/5<348::AID-JEZ5>3.0.CO;2-5
   Kuttappan VA, 2016, POULTRY SCI, V95, P2724, DOI 10.3382/ps/pew216
   Kuttappan VA, 2013, POULTRY SCI, V92, P339, DOI 10.3382/ps.2012-02647
   Kuttappan VA, 2017, POULTRY SCI, V96, P2992, DOI 10.3382/ps/pex069
   Lassiter K, 2006, POULTRY SCI, V85, P2251, DOI 10.1093/ps/85.12.2251
   Le Bihan-Duval E, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0014825
   Lee J, 2016, GENET MOL RES, V15, P0, DOI 10.4238/gmr.15027120
   Lee J, 2015, MOL GENET GENOMICS, V290, P1673, DOI 10.1007/s00438-015-1025-7
   Lee SA, 2016, WORLD POULTRY SCI J, V72, P743, DOI 10.1017/S0043933916000660
   Lee SH, 2014, POULTRY SCI, V93, P1113, DOI 10.3382/ps.2013-03770
   Lee SH, 2014, VET PARASITOL, V206, P115, DOI 10.1016/j.vetpar.2014.10.025
   Lee SH, 2011, VET PARASITOL, V181, P97, DOI 10.1016/j.vetpar.2011.05.003
   Lee SH, 2010, J POULT SCI, V47, P89, DOI 10.2141/jpsa.009025
   Lee Y, 2017, RES VET SCI, V112, P149, DOI 10.1016/j.rvsc.2017.03.019
   Li JL, 2011, BIOMETALS, V24, P291, DOI 10.1007/s10534-010-9395-0
   Li P, 2017, POULTRY SCI, V96, P2040, DOI 10.3382/ps/pex010
   Liebler DC, 2001, INTRO PROTEOMICS TOO, V0, P0
   Lillehoj HS, 2008, DEV BIOLOGICALS, V132, P67, DOI 10.1159/000317145
   Liu RR, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0061172
   Luo JJ, 2013, J PROTEOMICS, V91, P226, DOI 10.1016/j.jprot.2013.07.017
   Maceachern Sean, 2011, BMC PROC, V5 Suppl 4, PS14, DOI 10.1186/1753-6561-5-S4-S14
   Mignon-Grasteau S, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0135488
   Miller MM, 2016, POULTRY SCI, V95, P375, DOI 10.3382/ps/pev379
   MOLETTE C, 2006, P 12 EUR POULTR C VE, V0, P0
   Mudalal S, 2014, POULTRY SCI, V93, P2108, DOI 10.3382/ps.2014-03911
   Mutryn MF, 2015, BMC GENOMICS, V16, P0, DOI 10.1186/s12864-015-1623-0
   Nadaf J, 2007, BMC GENOMICS, V8, P0, DOI 10.1186/1471-2164-8-155
   Oakley BB, 2014, BMC VET RES, V10, P0, DOI 10.1186/s12917-014-0282-8
   Oh ST, 2016, AVIAN PATHOL, V45, P313, DOI 10.1080/03079457.2016.1154503
   Ojano-Dirain C, 2007, POULTRY SCI, V86, P372, DOI 10.1093/ps/86.2.372
   Ojano-Dirain CP, 2004, POULTRY SCI, V83, P1394, DOI 10.1093/ps/83.8.1394
   Patterson JA, 2003, POULTRY SCI, V82, P627, DOI 10.1093/ps/82.4.627
   Perumbakkam S, 2013, BMC GENOMICS, V14, P0, DOI 10.1186/1471-2164-14-64
   Petracci M, 2015, WORLD POULTRY SCI J, V71, P363, DOI 10.1017/S0043933915000367
   Picard B, 2010, BRIEF FUNCT GENOMICS, V9, P259, DOI 10.1093/bfgp/elq005
   Psifidi A, 2016, BMC GENOMICS, V17, P0, DOI 10.1186/s12864-016-2612-7
   Richards MP, 2007, POULTRY SCI, V86, P1478, DOI 10.1093/ps/86.7.1478
   Richards MP, 2003, POULTRY SCI, V82, P907, DOI 10.1093/ps/82.6.907
   Sarson AJ, 2008, ANIM GENET, V39, P232, DOI 10.1111/j.1365-2052.2008.01710.x
   Scanes CG, 2014, AVIAN BIOL RES, V7, P193, DOI 10.3184/175815514X14162292284822
   Schmeisser J, 2017, J ANIM PHYSIOL AN N, V101, P563, DOI 10.1111/jpn.12482
   Schokker D, 2011, COMP BIOCHEM PHYS D, V6, P339, DOI 10.1016/j.cbd.2011.07.004
   Selle PH, 2007, ANIM FEED SCI TECH, V135, P1, DOI 10.1016/j.anifeedsci.2006.06.010
   Sintubin P, 2014, NEUROPEPTIDES, V48, P213, DOI 10.1016/j.npep.2014.04.007
   Soares R, 2012, J PROTEOMICS, V75, P4190, DOI 10.1016/j.jprot.2012.04.009
   Sporer KRB, 2011, BMC GENOMICS, V12, P0, DOI 10.1186/1471-2164-12-143
   Spring P, 2015, JOURNAL OF APPLIED ANIMAL NUTRITION, V2015, P0
   Stanley D, 2016, FRONT MICROBIOL, V7, P0, DOI 10.3389/fmicb.2016.00187
   Stanley D, 2012, APPL MICROBIOL BIOT, V96, P1361, DOI 10.1007/s00253-011-3847-5
   Sterling KG, 2006, POULTRY SCI, V85, P1045, DOI 10.1093/ps/85.6.1045
   Sun B, 2011, BIOL TRACE ELEM RES, V143, P1516, DOI 10.1007/s12011-011-8995-z
   Sun XL, 2015, INT J BIOMETEOROL, V59, P127, DOI 10.1007/s00484-014-0829-1
   Sun YF, 2013, BMC GENOMICS, V14, P0, DOI 10.1186/1471-2164-14-458
   Sundekilde UK, 2017, FOOD CHEM, V217, P151, DOI 10.1016/j.foodchem.2016.08.104
   Swaggerty CL, 2017, POULTRY SCI, V96, P1623, DOI 10.3382/ps/pew465
   Swaggerty CL, 2016, POULTRY SCI, V95, P370, DOI 10.3382/ps/pev348
   Swaggerty CL, 2015, POULTRY SCI, V94, P37, DOI 10.3382/ps/peu053
   Swaggerty CL, 2014, POULTRY SCI, V93, P535, DOI 10.3382/ps.2013-03559
   Tan JZ, 2015, J SCI FOOD AGR, V95, P126, DOI 10.1002/jsfa.6692
   Tan JZ, 2014, BRIT J NUTR, V112, P1098, DOI 10.1017/S0007114514001846
   Tan JZ, 2014, BRIT J NUTR, V111, P1394, DOI 10.1017/S0007114513003863
   Tesseraud S, 2011, WORLD POULTRY SCI J, V67, P243, DOI 10.1017/S0043933911000274
   Tesseraud S, 2001, J ANIM SCI, V79, P927
   Tesseraud S, 1996, BRIT J NUTR, V75, P853, DOI 10.1079/BJN19960191
   Tesseraud S, 2009, J NUTR, V139, P38, DOI 10.3945/jn.108.095752
   Tian F, 2012, GENOMICS, V99, P152, DOI 10.1016/j.ygeno.2011.11.004
   Tinsley N, 2010, POULTRY SCI, V89, P349, DOI 10.3382/ps.2009-00138
   Tohidi R, 2018, J APPL ANIM RES, V46, P331, DOI 10.1080/09712119.2017.1301256
   Twyman RM, 2014, PRINCIPLES OF PROTEOMICS, V0, P1
   Velleman SG, 2015, AVIAN DIS, V59, P410, DOI 10.1637/11097-042015-Reg.1
   Vignale K, 2017, POULTRY SCI, V96, P886, DOI 10.3382/ps/pew315
   Vignale K, 2015, J NUTR, V145, P855, DOI 10.3945/jn.114.207936
   Walugembe M, 2015, POULTRY SCI, V94, P2351, DOI 10.3382/ps/pev242
   Wen C, 2017, POULTRY SCI, V96, P1707, DOI 10.3382/ps/pew432
   Wen C, 2014, J ANIM SCI, V92, P1068, DOI 10.2527/jas.2013-6485
   Wen C, 2014, BRIT J NUTR, V111, P201, DOI 10.1017/S0007114513002419
   Xiao R, 2012, POULTRY SCI, V91, P1660, DOI 10.3382/ps.2011-02035
   Xu SZ, 2015, RES VET SCI, V98, P66, DOI 10.1016/j.rvsc.2014.12.004
   Yang ZJ, 2016, BIOL TRACE ELEM RES, V172, P209, DOI 10.1007/s12011-015-0578-y
   Yu D, 2011, BIOL TRACE ELEM RES, V144, P678, DOI 10.1007/s12011-011-9062-5
   Yunis R, 2002, ANIM GENET, V33, P407, DOI 10.1046/j.1365-2052.2002.00890.x
   Zambonelli P, 2016, POULTRY SCI, V95, P2771, DOI 10.3382/ps/pew268
   Zampiga M, 2016, ITAL J ANIM SCI, V15, P521, DOI 10.1080/1828051X.2016.1192965
   Zekarias B, 2002, VET RES, V33, P109, DOI 10.1051/vetres:2002001
   Zhai W, 2012, POULTRY SCI, V91, P2548, DOI 10.3382/ps.2012-02213
   Zhang T, 2015, GENET MOL RES, V14, P10452, DOI 10.4238/2015.September.8.6
   Zheng AJ, 2016, BMC GENOMICS, V17, P0, DOI 10.1186/s12864-016-2371-5
   Zheng AJ, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-1167
   Zhou N, 2015, BMC GENOMICS, V16, P0, DOI 10.1186/s12864-015-1364-0
   Zhu JJ, 2003, POULTRY SCI, V82, P9, DOI 10.1093/ps/82.1.9
   Zhuo Z, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0135810
   Zuidhof MJ, 2014, POULTRY SCI, V93, P2970, DOI 10.3382/ps.2014-04291
NR 167
TC 31
Z9 36
U1 3
U2 66
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2049-1891
EI 
J9 J ANIM SCI BIOTECHNO
JI J. Anim. Sci. Biotechnol.
PD SEP 10
PY 2018
VL 9
IS 
BP 
EP 
DI 10.1186/s40104-018-0278-5
PG 18
WC Agriculture, Dairy & Animal Science
SC Agriculture
GA GT5JU
UT WOS:000444544500001
PM 30214720
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Zarrouk-Mahjoub, S
AF Finsterer, Josef
   Zarrouk-Mahjoub, Sinda
TI Biomarkers for Detecting Mitochondrial Disorders
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Review
DE biomarker; diagnosis; mitochondrial disorder; mtDNA; oxidative phosphorylation; ATP
ID stroke-like episodes; lactic-acidosis; glucose-metabolism; cerebral oxygen; melas syndrome; dna mutation; diseases; lactate; stress; encephalomyopathy
AB (1) Objectives: Mitochondrial disorders (MIDs) are a genetically and phenotypically heterogeneous group of slowly or rapidly progressive disorders with onset from birth to senescence. Because of their variegated clinical presentation, MIDs are difficult to diagnose and are frequently missed in their early and late stages. This is why there is a need to provide biomarkers, which can be easily obtained in the case of suspecting a MID to initiate the further diagnostic work-up. (2) Methods: Literature review. (3) Results: Biomarkers for diagnostic purposes are used to confirm a suspected diagnosis and to facilitate and speed up the diagnostic work-up. For diagnosing MIDs, a number of dry and wet biomarkers have been proposed. Dry biomarkers for MIDs include the history and clinical neurological exam and structural and functional imaging studies of the brain, muscle, or myocardium by ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), MR-spectroscopy (MRS), positron emission tomography (PET), or functional MRI. Wet biomarkers from blood, urine, saliva, or cerebrospinal fluid (CSF) for diagnosing MIDs include lactate, creatine-kinase, pyruvate, organic acids, amino acids, carnitines, oxidative stress markers, and circulating cytokines. The role of microRNAs, cutaneous respirometry, biopsy, exercise tests, and small molecule reporters as possible biomarkers is unsolved. (4) Conclusions: The disadvantages of most putative biomarkers for MIDs are that they hardly meet the criteria for being acceptable as a biomarker (missing longitudinal studies, not validated, not easily feasible, not cheap, not ubiquitously available) and that not all MIDs manifest in the brain, muscle, or myocardium. There is currently a lack of validated biomarkers for diagnosing MIDs.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Postfach 20, A-1180 Vienna, Austria.
   [Zarrouk-Mahjoub, Sinda] Univ Tunis, Pasteur Inst Tunis, El Manar & Genom Platform, Tunis 1068, Tunisia.
C3 Rudolfstiftung Hospital; Universite de Tunis; Pasteur Network; Universite de Tunis-El-Manar; Institut Pasteur Tunis
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de; sinda.z.m@gmail.com
CR Balasubramaniam S, 2017, J INHERIT METAB DIS, V40, P745, DOI 10.1007/s10545-017-0036-4
   Carmi E, 2001, ANN DERMATOL VENER, V128, P1031
   Chi CS, 2011, J CHIN MED ASSOC, V74, P305, DOI 10.1016/j.jcma.2011.05.006
   de la Barca JMC, 2016, BRAIN, V139, P2864, DOI 10.1093/brain/aww222
   DeBrosse C, 2016, JCI INSIGHT, V1, P0, DOI 10.1172/jci.insight.88207
   Finsterer J, 2004, EUR J NEUROL, V11, P811, DOI 10.1111/j.1468-1331.2004.00859.x
   Finsterer J, 2002, CAN J NEUROL SCI, V29, P49, DOI 10.1017/S0317167100001712
   Finsterer J, 2017, J NEUROL SCI UNPUB, V0, P0
   Finsterer J, 2017, NEUROPSYCH DIS TREAT, V13, P2569, DOI 10.2147/NDT.S149067
   Finsterer J, 2016, BMC MUSCULOSKEL DIS, V17, P0, DOI 10.1186/s12891-016-0869-2
   Finsterer J, 2012, BMC MUSCULOSKEL DIS, V13, P0, DOI 10.1186/1471-2474-13-218
   Finsterer J, 2009, CAN J NEUROL SCI, V36, P143, DOI 10.1017/S0317167100006508
   Florian A, 2015, J CARDIOVASC MAGN R, V17, P0, DOI 10.1186/s12968-015-0145-x
   FRACKOWIAK RSJ, 1988, BRAIN, V111, P1009, DOI 10.1093/brain/111.5.1009
   Golla S, 2017, NEUROL-GENET, V3, P0, DOI 10.1212/NXG.0000000000000160
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Haginoya K, 2016, J NEUROL SCI, V362, P309, DOI 10.1016/j.jns.2016.02.008
   Hall AM, 2015, KIDNEY INT, V87, P610, DOI 10.1038/ki.2014.297
   Harms F, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0159544
   Harms FA, 2015, J CLIN MONIT COMPUT, V29, P509, DOI 10.1007/s10877-014-9628-9
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Koene S, 2014, NEUROLOGY, V83, P125, DOI 10.1212/WNL.0000000000000578
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Lindroos MM, 2009, BRAIN, V132, P3274, DOI 10.1093/brain/awp259
   Liu AH, 2014, CNS NEUROSCI THER, V20, P509, DOI 10.1111/cns.12257
   Mesegueri S, 2015, HUM MOL GENET, V24, P167, DOI 10.1093/hmg/ddu427
   Morovat A, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6080080
   Nariai R, 2001, J NEUROIMAGING, V11, P325, DOI 10.1111/j.1552-6569.2001.tb00057.x
   Pennuto M, 2015, NEUROMUSCULAR DISORD, V25, P802, DOI 10.1016/j.nmd.2015.06.462
   Pitceathly RDS, 2016, EUR RADIOL, V26, P130, DOI 10.1007/s00330-015-3801-5
   Rasool N, 2016, SEMIN OPHTHALMOL, V31, P107, DOI 10.3109/08820538.2015.1115251
   Srikun D, 2010, J AM CHEM SOC, V132, P4455, DOI 10.1021/ja100117u
   Steele HE, 2017, BRAIN, V140, P2530, DOI 10.1093/brain/awx168
   Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Tranchant C, 2016, REV NEUROL-FRANCE, V172, P524, DOI 10.1016/j.neurol.2016.07.003
   Weiduschat N, 2014, NEUROLOGY, V82, P798, DOI 10.1212/WNL.0000000000000169
   Yu-Wai-Man C, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0075048
NR 41
TC 29
Z9 30
U1 0
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2077-0383
EI 
J9 J CLIN MED
JI J. Clin. Med.
PD FEB 15
PY 2018
VL 7
IS 2
BP 
EP 
DI 10.3390/jcm7020016
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA FZ3WQ
UT WOS:000427522200006
PM 29385732
DA 2024-11-01
ER

PT J
AU Inbar-Feigenberg, M
   Blaser, S
   Hawkins, C
   Shannon, P
   Hewson, S
   Chitayat, D
AF Inbar-Feigenberg, Michal
   Blaser, Susan
   Hawkins, Cynthia
   Shannon, Patrick
   Hewson, Stacy
   Chitayat, David
TI Mitochondrial POLG related disorder presenting prenatally with fetal cerebellar growth arrest
SO METABOLIC BRAIN DISEASE
LA English
DT Article
DE Mitochondrial disorder; Polymerase gamma (POLG1) gene; POLG related disorders; Cerebellar growth arrest; Prenatal diagnosis; MRI; Fetal
ID recessive ataxia; mutations; disease
AB We report the prenatal findings of severe cerebellar growth arrest in two siblings with POLG1 mutations. The first presented with seizures and lactic acidosis immediately after premature birth and was diagnosed with mitochondrial disease on muscle biopsy. Molecular DNA analysis confirmed homozygous missense mutation in the POLG1 gene. The pregnancy of the second sibling was monitored closely by repeat fetal ultrasounds since the parents declined invasive testing. A detailed fetal ultrasound at 19 weeks gestation showed a small cerebellum with transcerebellar diameter (TCD) on axial cranial imaging, measuring below the 5th centile for gestational age. Molecular analysis confirmed the same homozygous familial mutation in the POLG1gene. This report further delineates the phenotypic features of the POLG related disorders and expands it to the prenatal era. Subsequent pregnancies were monitored by molecular analysis, using chorionic villus sampling (CVS).
C1 [Inbar-Feigenberg, Michal; Hewson, Stacy; Chitayat, David] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Dept Paediat, Toronto, ON, Canada.
   [Blaser, Susan] Univ Toronto, Hosp Sick Children, Div Neuroradiol, Dept Diagnost Imaging, Toronto, ON, Canada.
   [Hawkins, Cynthia] Univ Toronto, Hosp Sick Children, Div Neuropathol, Dept Paediat Lab Med, Toronto, ON, Canada.
   [Shannon, Patrick] Univ Toronto, Mt Sinai Hosp, Div Neuropathol, Dept Pathol & Lab Med, Toronto, ON, Canada.
   [Chitayat, David] Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynecol, Prenatal Diag & Med Genet Program, Toronto, ON, Canada.
C3 University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute
RP Inbar-Feigenberg, M (corresponding author), Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Dept Paediat, Toronto, ON, Canada.
EM michal.inbar-feigenberg@sickkids.ca
CR Cagnoli C, 2008, J NEUROL, V255, P1079, DOI 10.1007/s00415-008-0772-3
   Cohen BH, 2014, POLG RELATED DISORDE, V0, P0
   Fellman V, 2011, SEMIN FETAL NEONAT M, V16, P222, DOI 10.1016/j.siny.2011.05.002
   Giordano C, 2009, NEUROLOGY, V72, P1103, DOI 10.1212/01.wnl.0000345002.47396.e1
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Isohanni P, 2011, NEUROLOGY, V76, P811, DOI 10.1212/WNL.0b013e31820e7b25
   Klinghorn KJ, 2013, J NEUROL, V260, P3
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Mehta AR, 2011, MOVEMENT DISORD, V26, P753, DOI 10.1002/mds.23510
   Palin EJH, 2012, J NEUROL SCI, V315, P160, DOI 10.1016/j.jns.2011.11.028
   Poretti Andrea, 2015, CEREBELLUM ATAXIAS, V2, P8, DOI 10.1186/s40673-015-0027-x
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Synofzik M, 2012, CEREBELLUM, V11, P1002, DOI 10.1007/s12311-012-0378-2
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067
NR 15
TC 6
Z9 6
U1 0
U2 2
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0885-7490
EI 1573-7365
J9 METAB BRAIN DIS
JI Metab. Brain Dis.
PD AUG 15
PY 2018
VL 33
IS 4
BP 1369
EP 1373
DI 10.1007/s11011-018-0218-2
PG 5
WC Endocrinology & Metabolism; Neurosciences
SC Endocrinology & Metabolism; Neurosciences & Neurology
GA GL7QG
UT WOS:000437396300036
PM 29574624
DA 2024-11-01
ER

PT J
AU Narumi, K
   Mishima, E
   Akiyama, Y
   Matsuhashi, T
   Nakamichi, T
   Kisu, K
   Nishiyama, S
   Ikenouchi, H
   Kikuchi, A
   Izumi, R
   Miyazaki, M
   Abe, T
   Sato, H
   Ito, S
AF Narumi, Kaori
   Mishima, Eikan
   Akiyama, Yukako
   Matsuhashi, Tetsuro
   Nakamichi, Takashi
   Kisu, Kiyomi
   Nishiyama, Shuhei
   Ikenouchi, Hajime
   Kikuchi, Akio
   Izumi, Rumiko
   Miyazaki, Mariko
   Abe, Takaaki
   Sato, Hiroshi
   Ito, Sadayoshi
TI Focal Segmental Glomerulosclerosis Associated with Chronic Progressive External Ophthalmoplegia and Mitochondrial DNA A3243G Mutation
SO NEPHRON
LA English
DT Article
DE Mitochondrial disease; Chronic progressive external ophthalmoplegia; Focal segmental glomerulosclerosis
ID resistant nephrotic syndrome; kearns-sayre-syndrome; disease; cytopathy; melas
AB Focal segmental glomerulosclerosis (FSGS) is caused by various etiologies, with mitochondrial dysfunction being one of the causes. FSGS is known to be associated with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), which is a subclass of mitochondrial disease. However, it has rarely been reported in other mitochondrial disease subclasses. Here, we reported a 20-year-old man diagnosed with FSGS associated with chronic progressive external ophthalmoplegia (CPEO) due to mitochondrial DNA (mtDNA) 3243A>G mutation. He presented with left ptosis, short stature, mild sensorineural deafness, and cardiac conduction block. A renal biopsy sample showed segmental sclerosis and adhesions between capillaries and Bowman's capsule, indicating FSGS. Electron microscopy demonstrated abnormal aggregated mitochondria in podocytes, and the basement membrane and epithelial cells of Bowman's capsule. Skeletal muscle biopsy also showed accumulation of abnormal mitochondria. mtDNA analysis identified heteroplasmic mtDNA 3243A>G mutation with no large-scale deletions. From these findings, we diagnosed the case as CPEO with multi-organ involvement including FSGS. Our report demonstrates that CPEO, as well as MELAS, can be associated with FSGS. Because mitochondrial disease presents with a variety of clinical symptoms, atypical cases with non-classical manifestations are observed. Thus, mitochondrial disease should be considered as an underlying cause of FSGS with systemic manifestations even with atypical phenotypes. (c) 2017 S. Karger AG, Basel
C1 [Narumi, Kaori; Mishima, Eikan; Akiyama, Yukako; Nakamichi, Takashi; Kisu, Kiyomi; Miyazaki, Mariko; Abe, Takaaki; Sato, Hiroshi; Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi, Japan.
   [Matsuhashi, Tetsuro] Tohoku Univ, Grad Sch Med, Dept Pediat, Sendai, Miyagi, Japan.
   [Ikenouchi, Hajime; Kikuchi, Akio; Izumi, Rumiko] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi, Japan.
   [Abe, Takaaki] Tohoku Univ, Grad Sch Biomed Engn, Div Med Sci, Sendai, Miyagi, Japan.
   [Abe, Takaaki] Tohoku Univ, Grad Sch Med, Dept Clin Biol & Hormonal Regulat, Sendai, Miyagi, Japan.
   [Sato, Hiroshi] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol & Therapeut, Sendai, Miyagi, Japan.
C3 Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University
RP Narumi, K (corresponding author), Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Aoba Ku, 1-1 Seiryo Cho, Sendai, Miyagi 9808574, Japan.
EM k-n-0922@med.tohoku.ac.jp
FU Grants-in-Aid for Scientific Research [16K19474, 17K09789, 26461303] Funding Source: KAKEN
CR Ashraf S, 2013, J CLIN INVEST, V123, P5179, DOI 10.1172/JCI69000
   BAN S, 1992, ACTA PATHOL JAPON, V42, P818
   Binder V, 2012, J PEDIAT HEMATOL ONC, V34, P283, DOI 10.1097/MPH.0b013e3182288249
   Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   Doleris LM, 2000, KIDNEY INT, V58, P1851, DOI 10.1046/j.1523-1755.2000.00356.x
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   Grunfeld JP, 1996, NEPHROL DIAL TRANSPL, V11, P760, DOI 10.1093/oxfordjournals.ndt.a027391
   Güçer S, 2005, PEDIATR DEVEL PATHOL, V8, P710, DOI 10.1007/s10024-005-0058-z
   Harita Y, 2017, CLIN EXP NEPHROL, V0, P0
   Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Caballero PEJ, 2007, NEUROLOGIST, V13, P33, DOI 10.1097/01.nrl.0000252953.49721.f5
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Matsuhashi T, 2017, EBIOMEDICINE, V20, P27, DOI 10.1016/j.ebiom.2017.05.016
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   Mihai Cristina Maria, 2009, J MED CASE REP, V3, P101, DOI 10.1186/1752-1947-3-101
   Mkaouar-Rebai E, 2010, MITOCHONDRION, V10, P449, DOI 10.1016/j.mito.2010.04.003
   Motoda Atsuko, 2013, RINSHO SHINKEIGAKU, V53, P446
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Nishigaki Y, 2010, MITOCHONDRION, V10, P300, DOI 10.1016/j.mito.2010.01.003
   Sadowski CE, 2015, J AM SOC NEPHROL, V26, P1279, DOI 10.1681/ASN.2014050489
NR 23
TC 11
Z9 13
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1660-8151
EI 2235-3186
J9 NEPHRON
JI Nephron
PD JUN 15
PY 2018
VL 138
IS 3
BP 243
EP 248
DI 10.1159/000485109
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA FY6YC
UT WOS:000427007800011
PM 29190634
DA 2024-11-01
ER

PT J
AU Ilie, IR
AF Ilie, Ioana R.
TI Advances in PCOS Pathogenesis and Progression-Mitochondrial Mutations and Dysfunction
SO ADVANCES IN CLINICAL CHEMISTRY, VOL 86
LA English
DT Review; Book Chapter
ID polycystic-ovary-syndrome; dna copy number; activated receptor-gamma; transfer-rna mutations; factor-a tfam; transcription-factor; insulin-resistance; oxidative stress; skeletal-muscle; essential-hypertension
AB Polycystic ovary syndrome (PCOS) is a common female endocrine disorder, which still remains largely unsolved in terms of etiology and pathogenesis despite important advances in our understanding of its genetic, epigenetic, or environmental factor implications. It is a heterogeneous disease, frequently associated with insulin resistance, chronic inflammation, and oxidative stress and probably accompanied with subclinical cardiovascular disease (CVD) and some malignant lesions as well, such as endometrial cancer. Discrepancies in the clinical phenotype and progression of PCOS exist between different population groups, which nuclear genetic studies have so far failed to explain. Over the last years, mitochondrial dysfunction has been increasingly recognized as an important contributor to an array of diseases. Because mitochondria are under the dual genetic control of both the mitochondrial and nuclear genomes, mutations within either DNA molecule may result in deficiency in respiratory chain function that leads to a reduced ability to produce cellular adenosine-5'-triphosphate and to an excessive production of reactive oxygen species. However, the association between variants in mitochondrial genome, mitochondrial dysfunction, and PCOS has been investigated to a lesser extent. May mutations in mitochondrial DNA (mtDNA) become an additional target of investigations on the missing PCOS heritability? Are mutations in mtDNA implicated in the initiation and progression of PCOS complications, e. g., CVDs, diabetes mellitus, cancers?
C1 [Ilie, Ioana R.] Univ Med & Pharm Iuliu Hatieganu, Dept Endocrinol, Cluj Napoca, Romania.
C3 Iuliu Hatieganu University of Medicine & Pharmacy
RP Ilie, IR (corresponding author), Univ Med & Pharm Iuliu Hatieganu, Dept Endocrinol, Cluj Napoca, Romania.
EM ioana.ilie@umfcluj.ro
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   Alvarez V, 2008, NEUROSCI LETT, V432, P79, DOI 10.1016/j.neulet.2007.12.010
   Andrulionytè L, 2004, DIABETOLOGIA, V47, P2176, DOI 10.1007/s00125-004-1577-2
   Bandelt HJ, 2009, HUM MUTAT, V30, P191, DOI 10.1002/humu.20846
   Barroso I, 2006, DIABETOLOGIA, V49, P501, DOI 10.1007/s00125-005-0130-2
   Belin AC, 2007, NEUROSCI LETT, V420, P257, DOI 10.1016/j.neulet.2007.05.010
   Bersani FS, 2016, PROG NEURO-PSYCHOPH, V64, P10, DOI 10.1016/j.pnpbp.2015.06.012
   Böttger EC, 2013, HEARING RES, V303, P12, DOI 10.1016/j.heares.2013.01.006
   Cai W, 2008, J GENET GENOMICS, V35, P649, DOI 10.1016/S1673-8527(08)60086-7
   Chae SJ, 2010, GYNECOL OBSTET INVES, V70, P1, DOI 10.1159/000279309
   Chen JB, 2009, J NEGAT RESULTS BIOM, V8, P0, DOI 10.1186/1477-5751-8-10
   Chen L, 2014, FERTIL STERIL, V102, P1167, DOI 10.1016/j.fertnstert.2014.06.027
   Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732
   Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005
   Choksi KB, 2004, BBA-MOL BASIS DIS, V1688, P95, DOI 10.1016/j.bbadis.2003.11.007
   Czajka A, 2015, EBIOMEDICINE, V2, P499, DOI 10.1016/j.ebiom.2015.04.002
   Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5
   De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025
   Ding Y, 2018, GENE, V642, P299, DOI 10.1016/j.gene.2017.11.049
   Ding Y, 2017, AM J TRANSL RES, V9, P2984
   Ding Y, 2016, MOL MED REP, V13, P3169, DOI 10.3892/mmr.2016.4916
   Ding Y, 2016, REPROD SCI, V23, P228, DOI 10.1177/1933719115602777
   Ding Y, 2013, INT J MOL MED, V32, P768, DOI 10.3892/ijmm.2013.1459
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Eriksen MB, 2011, J CLIN ENDOCR METAB, V96, PE1298, DOI 10.1210/jc.2011-0278
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Finsterer J, 2018, AM J TRANSL RES, V10, P13
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   GHIVIZZANI SC, 1994, MOL CELL BIOL, V14, P7717, DOI 10.1128/MCB.14.12.7717
   Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013
   Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466
   González F, 2006, J CLIN ENDOCR METAB, V91, P336, DOI 10.1210/jc.2005-1696
   González F, 2012, AM J PHYSIOL-ENDOC M, V302, PE297, DOI 10.1152/ajpendo.00416.2011
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Govatati S, 2013, FERTIL STERIL, V99, P1980, DOI 10.1016/j.fertnstert.2013.02.021
   Gruber AR, 2008, NUCLEIC ACIDS RES, V36, PW70, DOI 10.1093/nar/gkn188
   Higuchi M, 2007, MITOCHONDRION, V7, P53, DOI 10.1016/j.mito.2006.12.001
   HUOPONEN K, 1993, HUM GENET, V92, P379, DOI 10.1007/BF01247339
   Hyderali BN, 2015, EUR J OBSTET GYN R B, V191, P15, DOI 10.1016/j.ejogrb.2015.05.005
   Ilie IR, 2015, ADV CLIN CHEM, V71, P25, DOI 10.1016/bs.acc.2015.06.001
   Jaksch M, 2001, J MED GENET, V38, P665, DOI 10.1136/jmg.38.10.665
   Jeng JY, 2008, J CELL BIOCHEM, V103, P347, DOI 10.1002/jcb.21625
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001
   Kosova G, 2013, MOL CELL ENDOCRINOL, V373, P29, DOI 10.1016/j.mce.2012.10.009
   Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6
   Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011
   Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7
   Lee SH, 2011, METABOLISM, V60, P1677, DOI 10.1016/j.metabol.2011.04.010
   Li Peng, 2004, CELL, VS116, PS57, DOI 10.1016/S0092-8674(04)00031-5
   Li RH, 2009, HYPERTENSION, V54, P329, DOI 10.1161/HYPERTENSIONAHA.109.129270
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Liu XL, 2011, OPHTHALMOLOGY, V118, P978, DOI 10.1016/j.ophtha.2010.09.003
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Madamanchi NR, 2013, FREE RADICAL BIO MED, V61, P473, DOI 10.1016/j.freeradbiomed.2013.04.001
   Malik AN, 2015, DIABETES RES CLIN PR, V110, P257, DOI 10.1016/j.diabres.2015.10.006
   Mambo E, 2003, P NATL ACAD SCI USA, V100, P1838, DOI 10.1073/pnas.0437910100
   McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3
   Montoya J, 1997, MOL CELL BIOCHEM, V174, P227, DOI 10.1023/A:1006812625445
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Murphy MP, 2006, AM J PHYSIOL-HEART C, V290, PH1754, DOI 10.1152/ajpheart.00040.2006
   Murri M, 2013, HUM REPROD UPDATE, V19, P268, DOI 10.1093/humupd/dms059
   Naviaux RK, 2000, EUR J PEDIATR, V159, PS219, DOI 10.1007/PL00014407
   OMalley BW, 2009, CANCER RES, V69, P8217, DOI 10.1158/0008-5472.CAN-09-2223
   Palmieri VO, 2011, NUTRITION, V27, P773, DOI 10.1016/j.nut.2010.08.016
   Paradisi G, 2001, CIRCULATION, V103, P1410, DOI 10.1161/01.CIR.103.10.1410
   Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Pisoschi AM, 2015, EUR J MED CHEM, V97, P55, DOI 10.1016/j.ejmech.2015.04.040
   Pravenec M, 2007, GENOME RES, V17, P1319, DOI 10.1101/gr.6548207
   Rabol R, 2011, EUR J ENDOCRINOL, V165, P631, DOI 10.1530/EJE-11-0419
   Reddy TV, 2017, IMPACT MITOCHONDRIAL, V0, P0
   Reddy TV, 2018, GENE, V641, P129, DOI 10.1016/j.gene.2017.10.010
   Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8
   Rusecka J, 2018, J APPL GENET, V59, P43, DOI 10.1007/s13353-017-0424-3
   Sagvekar Pooja, 2018, FRONT BIOSCI (ELITE ED), V10, P384
   Sahin E, 2012, NAT REV MOL CELL BIO, V13, P397, DOI 10.1038/nrm3352
   Savic-Radojevic A, 2015, HORM-INT J ENDOCRINO, V14, P101, DOI 10.14310/horm.2002.1525
   Sazonova M, 2009, ATHEROSCLEROSIS, V204, P184, DOI 10.1016/j.atherosclerosis.2008.09.001
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Serra D, 2013, ANTIOXID REDOX SIGN, V19, P269, DOI 10.1089/ars.2012.4875
   Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591
   Skov V, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0002466
   Skov V, 2007, DIABETES, V56, P2349, DOI 10.2337/db07-0275
   Sobenin IA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0068070
   Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092
   Suzuki T, 2011, WIRES RNA, V2, P376, DOI 10.1002/wrna.65
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Teng LL, 2012, MITOCHONDR DNA, V23, P461, DOI 10.3109/19401736.2012.710205
   Tipirisetti NR, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0085363
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Turner N, 2008, TRENDS ENDOCRIN MET, V19, P324, DOI 10.1016/j.tem.2008.08.001
   Urbanek M, 2007, NAT CLIN PRACT ENDOC, V3, P103, DOI 10.1038/ncpendmet0400
   Venter M, 2017, J AFR, V28, P1
   Verma Mukesh, 2007, CANCER RES, V67, P437, DOI 10.1158/0008-5472.CAN-06-4119
   Victor VM, 2009, J CLIN ENDOCR METAB, V94, P3505, DOI 10.1210/jc.2009-0466
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
   Wallace DC, 2007, EMERY AND RIMOINS PRINCIPLES AND PRACTICE OF MEDICAL GENETICS, V5th, P194
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang Y, 2006, FERTIL STERIL, V85, P1536, DOI 10.1016/j.fertnstert.2005.10.047
   Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, PW58, DOI 10.1093/nar/gkw233
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   Yang XY, 2017, FRONT PHYSIOL, V8, P0, DOI 10.3389/fphys.2017.00600
   Ye W, 2013, MOL MED REP, V8, P1060, DOI 10.3892/mmr.2013.1616
   Yin SL, 2015, GENET MOL RES, V14, P17692, DOI 10.4238/2015.December.21.42
   Zhu HY, 2009, CLIN CHIM ACTA, V410, P64, DOI 10.1016/j.cca.2009.09.023
   Zhuo GC, 2012, ARCH GYNECOL OBSTET, V286, P653, DOI 10.1007/s00404-012-2358-7
   Zhuo GC, 2010, BIOCHEM GENET, V48, P157, DOI 10.1007/s10528-009-9308-5
   Zuo T, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/8589318
NR 115
TC 24
Z9 25
U1 0
U2 14
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0065-2423
EI 
J9 ADV CLIN CHEM
JI Advan. Clin. Chem.
PD JUN 15
PY 2018
VL 86
IS 
BP 127
EP 155
DI 10.1016/bs.acc.2018.05.003
PG 29
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA BL6ED
UT WOS:000453661400005
PM 30144838
DA 2024-11-01
ER

PT J
AU Willis-Owen, SAG
   Thompson, A
   Kemp, PR
   Polkey, MI
   Cookson, WOCM
   Moffatt, MF
   Natanek, SA
AF Willis-Owen, Saffron A. G.
   Thompson, Anna
   Kemp, Paul R.
   Polkey, Michael I.
   Cookson, William O. C. M.
   Moffatt, Miriam F.
   Natanek, Samantha A.
TI COPD is accompanied by coordinated transcriptional perturbation in the quadriceps affecting the mitochondria and extracellular matrix
SO SCIENTIFIC REPORTS
LA English
DT Article
ID genome-wide association; obstructive pulmonary-disease; vastus lateralis; muscle endurance; lung-function; loci; variants; susceptibility; dysfunction; follistatin
AB Skeletal muscle dysfunction is a frequent extra-pulmonary manifestation of Chronic Obstructive Pulmonary Disease (COPD) with implications for both quality of life and survival. The underlying biology nevertheless remains poorly understood. We measured global gene transcription in the quadriceps using Affymetrix HuGene1.1ST arrays in an unselected cohort of 79 stable COPD patients in secondary care and 16 healthy age-and gender-matched controls. We detected 1,826 transcripts showing COPD-related variation. Eighteen exhibited >= 2fold changes (SLC22A3, FAM184B, CDKN1A, FST, LINC01405, MUSK, PANX1, ANKRD1, C12orf75, MYH1, POSTN, FRZB, TNC, ACTC1, LINC00310, MYH3, MYBPH and AREG). Thirty-one transcripts possessed previous reported evidence of involvement in COPD through genome-wide association, including FAM13A. Network analysis revealed a substructure comprising 6 modules of co-expressed genes. We identified modules with mitochondrial and extracellular matrix features, of which IDH2, a central component of the mitochondrial antioxidant pathway, and ABI3BP, a proposed switch between proliferation and differentiation, represent hubs respectively. COPD is accompanied by coordinated patterns of transcription in the quadriceps involving the mitochondria and extracellular matrix and including genes previously implicated in primary disease processes.
C1 [Willis-Owen, Saffron A. G.; Thompson, Anna; Cookson, William O. C. M.; Moffatt, Miriam F.] Imperial Coll London, Natl Heart & Lung Inst, Ctr Genom Med, London SW3 6LY, England.
   [Kemp, Paul R.; Polkey, Michael I.; Natanek, Samantha A.] Imperial Coll London, Natl Heart & Lung Inst, Resp Sci, London SW3 6NP, England.
C3 Imperial College London; Imperial College London
RP Willis-Owen, SAG (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Ctr Genom Med, London SW3 6LY, England.; Natanek, SA (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Resp Sci, London SW3 6NP, England.
EM s.willis-owen@imperial.ac.uk; a.natanek@imperial.ac.uk
FU Wellcome Trust Clinical Research Training Fellowship [WT 079686/Z/06/Z]; Wellcome Trust [WT09694, WT097117]; NIHR Respiratory Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust; Imperial College London; Wellcome Trust [079686/Z/06/Z] Funding Source: Wellcome Trust
CR Allaire J, 2004, THORAX, V59, P673, DOI 10.1136/thx.2003.020636
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bentley AR, 2012, FREE RADICAL BIO MED, V52, P1577, DOI 10.1016/j.freeradbiomed.2012.02.025
   Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904
   Burkart KM, 2018, AM J RESP CRIT CARE, V198, P208, DOI 10.1164/rccm.201707-1493OC
   Castaldi PJ, 2014, AM J RESP CRIT CARE, V190, P399, DOI 10.1164/rccm.201403-0569OC
   Chai B, 2013, J NEUROENDOCRINOL, V25, P292, DOI 10.1111/j.1365-2826.2012.02378.x
   Chen LG, 2010, PHARMACOGENET GENOM, V20, P687, DOI 10.1097/FPC.0b013e32833fe789
   Cho MH, 2015, AM J RESP CRIT CARE, V192, P559, DOI 10.1164/rccm.201501-0148OC
   Cho MH, 2014, LANCET RESP MED, V2, P214, DOI 10.1016/S2213-2600(14)70002-5
   Cho MH, 2012, HUM MOL GENET, V21, P947, DOI 10.1093/hmg/ddr524
   Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535
   Coronell C, 2004, EUR RESPIR J, V24, P129, DOI 10.1183/09031936.04.00079603
   Gosker HR, 2007, EUR RESPIR J, V30, P73, DOI 10.1183/09031936.00146906
   Gosker HR, 2007, THORAX, V62, P944, DOI 10.1136/thx.2007.078980
   Graat-Verboom L, 2009, EUR RESPIR J, V34, P209, DOI 10.1183/09031936.50130408
   Hansel NN, 2015, AM J RESP CELL MOL, V53, P226, DOI 10.1165/rcmb.2014-0198OC
   Hansen JS, 2016, J CLIN ENDOCR METAB, V101, P550, DOI 10.1210/jc.2015-3668
   Hardin M, 2016, PHARMACOGENOMICS J, V16, P326, DOI 10.1038/tpj.2015.65
   Himes BE, 2013, BMC MED GENET, V14, P0, DOI 10.1186/1471-2350-14-86
   Hobbs BD, 2017, NAT GENET, V49, P426, DOI 10.1038/ng.3752
   Hodgkinson CP, 2013, STEM CELLS, V31, P1669, DOI 10.1002/stem.1416
   Jones AE, 2015, SKELET MUSCLE, V5, P0, DOI 10.1186/s13395-015-0038-6
   Lacasse Y, 2006, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD003793.pub2
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, P0, DOI 10.1186/1471-2105-9-559
   Latini FRM, 2008, ENDOCR-RELAT CANCER, V15, P787, DOI 10.1677/ERC-08-0079
   Lee JH, 2015, AM J RESP CELL MOL, V52, P365, DOI 10.1165/rcmb.2014-0210OC
   Lee JH, 2014, RESP RES, V15, P0, DOI 10.1186/s12931-014-0113-2
   Lutz SM, 2015, BMC GENET, V16, P0, DOI 10.1186/s12863-015-0299-4
   MacArthur J, 2017, NUCLEIC ACIDS RES, V45, PD896, DOI 10.1093/nar/gkw1133
   Makarenkova HP, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00063
   Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031
   Najafi H, 2017, RNA, V23, P70, DOI 10.1261/rna.056317.116
   Natanek SA, 2013, MUSCLE NERVE, V48, P488, DOI 10.1002/mus.23784
   Niijima-Yaoita F, 2012, BIOL PHARM BULL, V35, P91, DOI 10.1248/bpb.35.91
   Patel MS, 2014, AM J RESP CRIT CARE, V190, P350, DOI 10.1164/rccm.201404-0713LE
   Rabinovich RA, 2015, RESP RES, V16, P0, DOI 10.1186/s12931-014-0139-5
   Romero SA, 2016, J PHYSIOL-LONDON, V594, P5009, DOI 10.1113/JP272177
   Schiaffino S, 2015, SKELET MUSCLE, V5, P0, DOI 10.1186/s13395-015-0046-6
   Seymour JM, 2010, EUR RESPIR J, V36, P81, DOI 10.1183/09031936.00104909
   Siedlinski M, 2011, THORAX, V66, P894, DOI 10.1136/thoraxjnl-2011-200154
   Swallow EB, 2007, J APPL PHYSIOL, V103, P739, DOI 10.1152/japplphysiol.00025.2007
   Tényi A, 2018, J TRANSL MED, V16, P0, DOI 10.1186/s12967-018-1405-y
   Thomas K, 2015, CONNECT TISSUE RES, V56, P1, DOI 10.3109/03008207.2014.947369
   Vohwinkel CU, 2011, J BIOL CHEM, V286, P37067, DOI 10.1074/jbc.M111.290056
   Wain LV, 2017, NAT GENET, V49, P416, DOI 10.1038/ng.3787
   Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108
   Yu GC, 2015, BIOINFORMATICS, V31, P608, DOI 10.1093/bioinformatics/btu684
   Zuber V, 2011, STAT APPL GENET MOL, V10, P0, DOI 10.2202/1544-6115.1730
NR 49
TC 31
Z9 32
U1 0
U2 4
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD AUG 15
PY 2018
VL 8
IS 
BP 
EP 
DI 10.1038/s41598-018-29789-6
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GQ4EY
UT WOS:000441623200005
PM 30111857
DA 2024-11-01
ER

PT J
AU Suomalainen, A
   Battersby, BJ
AF Suomalainen, Anu
   Battersby, Brendan J.
TI Mitochondrial diseases: the contribution of organelle stress responses to pathology
SO NATURE REVIEWS MOLECULAR CELL BIOLOGY
LA English
DT Review
ID progressive external ophthalmoplegia; unfolded-protein response; c-oxidase deficiency; transcription factor; mtdna maintenance; dna polymerase; aaa protease; myoclonic epilepsy; multiple deletions; oxidative stress
AB Mitochondrial diseases affect one in 2,000 individuals; they can present at any age and they can manifest in any organ. How defects in mitochondria can cause such a diverse range of human diseases remains poorly understood. Insight into this diversity is emerging from recent research that investigated defects in mitochondrial protein synthesis and mitochondrial DNA maintenance, which showed that many cell-specific stress responses are induced in response to mitochondrial dysfunction. Studying the molecular regulation of these stress responses might increase our understanding of the pathogenesis and variability of human mitochondrial diseases.
C1 [Suomalainen, Anu] Univ Helsinki, Res Programs Unit, Mol Neurol, Biomedicum Helsinki, FIN-00290 Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Neurosci Ctr, Helsinki 00790, Finland.
   [Suomalainen, Anu] Helsinki Univ Hosp, Dept Neurol, Helsinki 00290, Finland.
   [Battersby, Brendan J.] Univ Helsinki, Inst Biotechnol, Helsinki 00790, Finland.
C3 University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki
RP Suomalainen, A (corresponding author), Univ Helsinki, Res Programs Unit, Mol Neurol, Biomedicum Helsinki, FIN-00290 Helsinki, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, Neurosci Ctr, Helsinki 00790, Finland.; Suomalainen, A (corresponding author), Helsinki Univ Hosp, Dept Neurol, Helsinki 00290, Finland.
EM anu.wartiovaara@helsinki.fi; brendan.battersby@helsinki.fi
FU Academy of Finland; University of Helsinki; United Mitochondrial Disease Foundation USA; Sigrid Juselius Foundation; European Research Council; Jane and Aatos Erkko Foundation
CR Ahlqvist KJ, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7494
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Ahola S, 2016, EMBO MOL MED, V8, P1234, DOI 10.15252/emmm.201606592
   Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Akabane S, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004616
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193
   [Anonymous], 2014, GENE REV, V0, P0
   Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004
   Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Bao XR, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10575
   Bemben MG, 2005, SPORTS MED, V35, P107, DOI 10.2165/00007256-200535020-00002
   Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Couvillion MT, 2016, NATURE, V533, P499, DOI 10.1038/nature18015
   De Silva D, 2015, CELL CYCLE, V14, P2226, DOI 10.1080/15384101.2015.1053672
   Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544
   DIMAURO S, 1981, T AM NEUROL ASSOC, V106, P205
   Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004
   Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   FISCHELGHODSIAN N, 1993, AM J OTOLARYNG, V14, P399, DOI 10.1016/0196-0709(93)90113-L
   French JB, 2016, SCIENCE, V351, P733, DOI 10.1126/science.aac6054
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   GALPER JB, 1974, J CELL BIOL, V60, P755, DOI 10.1083/jcb.60.3.755
   Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Hämäläinen RH, 2015, CELL REP, V11, P1614, DOI 10.1016/j.celrep.2015.05.009
   Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002
   Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016
   Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002
   Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Hsuchou H, 2007, PEPTIDES, V28, P2382, DOI 10.1016/j.peptides.2007.10.007
   Itakura E, 2016, MOL CELL, V63, P21, DOI 10.1016/j.molcel.2016.05.020
   Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989
   Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Janssen GMC, 2007, HUM MOL GENET, V16, P2472, DOI 10.1093/hmg/ddm203
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Jones CN, 2009, MITOCHONDRION, V9, P429, DOI 10.1016/j.mito.2009.08.001
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606
   Kim JM, 2013, MEDIAT INFLAMM, V2013, P0, DOI 10.1155/2013/641851
   Kondadi AK, 2014, EMBO J, V33, P1011, DOI 10.1002/embj.201387009
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lake NJ, 2015, J NEUROPATH EXP NEUR, V74, P482, DOI 10.1097/NEN.0000000000000195
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Lewis SC, 2016, SCIENCE, V353, P0, DOI 10.1126/science.aaf5549
   Lind C, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3940
   Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Maruyama R, 2016, BIOSCI BIOTECH BIOCH, V80, P929, DOI 10.1080/09168451.2015.1135045
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Mehrmohamadi M, 2014, CELL REP, V9, P1507, DOI 10.1016/j.celrep.2014.10.026
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Nguyen TN, 2016, TRENDS CELL BIOL, V26, P733, DOI 10.1016/j.tcb.2016.05.008
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Nilsson R, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4128
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Ost M, 2016, MOL METAB, V5, P79, DOI 10.1016/j.molmet.2015.11.002
   Ost M, 2015, FASEB J, V29, P1314, DOI 10.1096/fj.14-261503
   Ott M, 2016, ANNU REV BIOCHEM, V85, P77, DOI 10.1146/annurev-biochem-060815-014334
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129
   Quirós PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984
   Reczek CR, 2015, CURR OPIN CELL BIOL, V33, P8, DOI 10.1016/j.ceb.2014.09.010
   Richter U, 2015, J CELL BIOL, V211, P373, DOI 10.1083/jcb.201504062
   Richter U, 2013, CURR BIOL, V23, P535, DOI 10.1016/j.cub.2013.02.019
   Rorbach J, 2016, P NATL ACAD SCI USA, V113, P12198, DOI 10.1073/pnas.1609338113
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015
   Soleimanpour-Lichaei HR, 2007, MOL CELL, V27, P745, DOI 10.1016/j.molcel.2007.06.031
   Sood A, 2014, P NATL ACAD SCI USA, V111, P16017, DOI 10.1073/pnas.1408061111
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Suomalainen A, 2011, SEMIN FETAL NEONAT M, V16, P236, DOI 10.1016/j.siny.2011.05.003
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tsai VWW, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0055174
   Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   VANDENBOGERT C, 1981, BIOCHEM PHARMACOL, V30, P1706, DOI 10.1016/0006-2952(81)90403-2
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Wai T, 2015, SCIENCE, V350, P0, DOI 10.1126/science.aad0116
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445
NR 127
TC 325
Z9 352
U1 4
U2 121
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-0072
EI 1471-0080
J9 NAT REV MOL CELL BIO
JI Nat. Rev. Mol. Cell Biol.
PD FEB 15
PY 2018
VL 19
IS 2
BP 77
EP 92
DI 10.1038/nrm.2017.66
PG 16
WC Cell Biology
SC Cell Biology
GA FT3YH
UT WOS:000423085400008
PM 28792006
DA 2024-11-01
ER

PT J
AU Maselli, RA
   Vázquez, J
   Schrumpf, L
   Arredondo, J
   Lara, M
   Strober, JB
   Pytel, P
   Wollmann, RL
   Ferns, M
AF Maselli, Ricardo A.
   Vazquez, Jessica
   Schrumpf, Leah
   Arredondo, Juan
   Lara, Marian
   Strober, Jonathan B.
   Pytel, Peter
   Wollmann, Robert L.
   Ferns, Michael
TI Presynaptic congenital myasthenic syndrome with altered synaptic vesicle homeostasis linked to compound heterozygous sequence variants in <i>RPH3A</i>
SO MOLECULAR GENETICS & GENOMIC MEDICINE
LA English
DT Article
DE congenital myasthenic syndrome (CMS); presynaptic; rabphilin 3a; RPH3A
ID cortical hyperexcitability; rabphilin; synaptotagmin; protein; ca2+; exocytosis; mutations; binding; domain
AB BackgroundMonogenic defects of synaptic vesicle (SV) homeostasis have been implicated in many neurologic diseases, including autism, epilepsy, and movement disorders. In addition, abnormal vesicle exocytosis has been associated with several endocrine dysfunctions. MethodsWe report an 11year old girl with learning disabilities, tremors, ataxia, transient hyperglycemia, and muscle fatigability responsive to albuterol sulfate. Failure of neuromuscular transmission was confirmed by single fiber electromyography. Electron microscopy of motor nerve terminals revealed marked reduction in SV density, double-membrane-bound sacs containing SVs, abundant endosomes, and degenerative lamellar bodies. The patient underwent whole exome sequencing (WES) and relevant sequence variants were expressed and studied in a mammalian cell line. ResultsChromosomal microarray studies and next generation sequencing (NGS) of mitochondrial DNA were unrevealing; however, NGS of genomic DNA showed two rare sequence variants in the gene encoding rabphilin 3a (RPH3A). The paternally inherited variant c.806G>A (p.Arg269Gln) involves a substitution of a conserved residue in the linker region, while the maternally inherited variant c.1390G>T (p.Val464Leu) involves a conserved amino acid substitution in the highly conserved C2A region. Expression studies revealed that p.Arg269Gln strongly impairs the binding of rabphilin 3a to 14-3-3, which is a proposed regulator of synaptic transmission and plasticity. In contrast, the binding of rabphilin 3a to 14-3-3 is only marginally impaired by p.Val464Leu; thus, the pathogenic role of p.Val464Leu remains unclear. ConclusionIn summary, we report a patient with a multisystem neurologic disorder and altered SV regulation attributed to defects in RPH3A, which grants further studies of this gene in human disorders of synaptic transmission.
C1 [Maselli, Ricardo A.; Vazquez, Jessica; Schrumpf, Leah; Arredondo, Juan; Lara, Marian] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA.
   [Strober, Jonathan B.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA.
   [Pytel, Peter; Wollmann, Robert L.] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.
   [Ferns, Michael] Univ Calif Davis, Dept Anesthesiol & Pain Med, Sacramento, CA 95817 USA.
C3 University of California System; University of California Davis; University of California System; University of California San Francisco; University of Chicago; University of California System; University of California Davis
RP Maselli, RA (corresponding author), Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA.
EM ramaselli@ucdavis.edu
FU National Institute of Neurological Disorders and Stroke [R01NS049117-01]
CR Burns ME, 1998, J GEN PHYSIOL, V111, P243, DOI 10.1085/jgp.111.2.243
   CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667
   CHUNG SH, 1995, J BIOL CHEM, V270, P16714, DOI 10.1074/jbc.270.28.16714
   Corbalan-Garcia S, 2014, BBA-BIOMEMBRANES, V1838, P1536, DOI 10.1016/j.bbamem.2014.01.008
   Cossins J, 2013, BRAIN, V136, P944, DOI 10.1093/brain/awt010
   Coudevylle N, 2008, J BIOL CHEM, V283, P35918, DOI 10.1074/jbc.M804094200
   Deák F, 2006, EMBO J, V25, P2856, DOI 10.1038/sj.emboj.7601165
   Engel AG, 2016, NEUROL-GENET, V2, P0, DOI 10.1212/NXG.0000000000000105
   Engel AG, 2015, LANCET NEUROL, V14, P420, DOI 10.1016/S1474-4422(14)70201-7
   Foletti DL, 2001, J NEUROSCI, V21, P5461, DOI 10.1523/JNEUROSCI.21-15-05461.2001
   Herrmann DN, 2014, AM J HUM GENET, V95, P332, DOI 10.1016/j.ajhg.2014.08.007
   Kato M, 1996, J BIOL CHEM, V271, P31775, DOI 10.1074/jbc.271.50.31775
   Kochubey O, 2011, TRENDS NEUROSCI, V34, P237, DOI 10.1016/j.tins.2011.02.006
   Palace J, 2007, BRAIN, V130, P1507, DOI 10.1093/brain/awm072
   Schlüter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999
   Shen XM, 2017, ANN CLIN TRANSL NEUR, V4, P130, DOI 10.1002/acn3.387
   Shen XM, 2014, NEUROLOGY, V83, P2247, DOI 10.1212/WNL.0000000000001079
   SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061
   Staunton J, 2001, J NEUROSCI, V21, P9255, DOI 10.1523/JNEUROSCI.21-23-09255.2001
   Sun L, 2003, J BIOL CHEM, V278, P38301, DOI 10.1074/jbc.M212801200
   Tsuboi T, 2005, J BIOL CHEM, V280, P39253, DOI 10.1074/jbc.M507173200
NR 21
TC 8
Z9 8
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2324-9269
EI 
J9 MOL GENET GENOM MED
JI Mol. Genet. Genom. Med.
PD MAY 15
PY 2018
VL 6
IS 3
BP 434
EP 440
DI 10.1002/mgg3.370
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA GK2HD
UT WOS:000435947300015
PM 29441694
DA 2024-11-01
ER

PT J
AU Ahuja, AS
AF Ahuja, Abhimanyu S.
TI Understanding mitochondrial myopathies: a review
SO PEERJ
LA English
DT Review
DE Genetic mutations; Pathology; Treatment
ID manifestations; cells
AB Mitochondria are small, energy-producing structures vital to the energy needs of the body. Genetic mutations cause mitochondria to fail to produce the energy needed by cells and organs which can cause severe disease and death. These genetic mutations are likely to be in the mitochondrial DNA (mtDNA), or possibly in the nuclear DNA (nDNA). The goal of this review is to assess the current understanding of mitochondrial diseases. This review focuses on the pathology, causes, risk factors, symptoms, prevalence data, symptomatic treatments, and new research aimed at possible preventions and/or treatments of mitochondrial diseases. Mitochondrial myopathies are mitochondrial diseases that cause prominent muscular symptoms such as muscle weakness and usually present with a multitude of symptoms and can affect virtually all organ systems. There is no cure for these diseases as of today. Treatment is generally supportive and emphasizes symptom management. Mitochondrial diseases occur infrequently and hence research funding levels tend to be low in comparison with more common diseases. On the positive side, quite a few genetic defects responsible for mitochondrial diseases have been identified, which are in turn being used to investigate potential treatments. Speech therapy, physical therapy, and respiratory therapy have been used in mitochondrial diseases with variable results. These therapies are not curative and at best help with maintaining a patients current abilities to move and function.
C1 [Ahuja, Abhimanyu S.] Florida Atlantic Univ, Wilkes Honors Coll, Jupiter, FL 33458 USA.
C3 State University System of Florida; Florida Atlantic University
RP Ahuja, AS (corresponding author), Florida Atlantic Univ, Wilkes Honors Coll, Jupiter, FL 33458 USA.
EM aahuja2016@fau.edu
CR Agamanolis D, 2017, NEUROPATHOLOGY, V0, P0
   Alberts B, 2007, MOL BIOL CELL, V0, P0
   Australian Mitochondrial Disease Foundation (AMDF), 2017, MIT DIS INF, V0, P0
   Bartsakoulia M, 2018, HUM MOL GENET, V27, P1186, DOI 10.1093/hmg/ddy033
   Berridge MV, 2016, CURR OPIN GENET DEV, V38, P75, DOI 10.1016/j.gde.2016.04.003
   Clarke C, 2016, NEUROLOGY QUEEN SQUA, V0, P0, DOI DOI 10.1002/9781118186160
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Komen JC, 2014, BRIT J PHARMACOL, V171, P1818, DOI 10.1111/bph.12413
   Lemonick Michael D, 2006, TIME, V168, P58
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   Martikainen M, 2012, MITOCHONDRIAL DIS SW, V0, P0
   Millhouse-Flourie T, 2016, 101 MITO UN MIT DIS, V0, P0
   Millhouse-Flourie T, 2016, BENEFITS SUPPLEMENTA, V0, P0
   Muscular Dystrophy Association (MDA), 2009, PROGR MIT MYOP, V0, P0
   Muscular Dystrophy Association (MDA), 2009, MDAS SEARCH TREATM C, V0, P0
   Muscular Dystrophy Association (MDA), 2018, MIT MYOP CAUS INH, V0, P0
   Muscular Dystrophy Association (MDA), 2018, MIT MYOP SIGNS SYMPT, V0, P0
   Muscular Dystrophy Association (MDA), 2009, FACTS GEN NEUR DIS, V0, P0
   Muscular Dystrophy Association (MDA), 2009, AR MIT DIS TREAT, V0, P0
   National Institute of Neurological Disorders and Stroke (NINDS), 2018, NINDS MIT MYOP INF P, V0, P0
   Nightingale H, 2016, BRAIN, V139, P1633, DOI 10.1093/brain/aww081
   Noe N, 2013, MITOCHONDRION, V13, P417, DOI 10.1016/j.mito.2012.12.003
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Powledge T, 2014, 3 PARENT BABY DEBATE, V0, P0
   Scarpelli M, 2018, NEUROMUSCULAR DISORD, V28, P137, DOI 10.1016/j.nmd.2017.10.006
   Science 20, 2015, MIT DIS 2500 UK WOM, V0, P0
   Shrikhande DY, 2010, ITAL J PEDIATR, V36, P0, DOI 10.1186/1824-7288-36-62
   Torralba D, 2016, FRONT CELL DEV BIOL, V4, P0, DOI 10.3389/fcell.2016.00107
   United Mitochondrial Disease Foundation, 2017, UND MIT DIS, V0, P0
   United Mitochondrial Disease Foundation, 2017, SUPP THER, V0, P0
   United Mitochondrial Disease Foundation, 2013, EPI73 UN MIT DIS FDN, V0, P0
   Vandana VP, 2015, J PEDIATR NEUROSCI, V10, P31, DOI 10.4103/1817-1745.154326
NR 35
TC 14
Z9 15
U1 0
U2 4
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
EI 
J9 PEERJ
JI PeerJ
PD MAY 21
PY 2018
VL 6
IS 
BP 
EP 
DI 10.7717/peerj.4790
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GI2VG
UT WOS:000434229400005
PM 29844960
DA 2024-11-01
ER

PT J
AU Ban, R
   Guo, JH
   Pu, CQ
   Shi, Q
   Liu, HX
   Zhang, YT
AF Ban, Rui
   Guo, Jun-Hong
   Pu, Chuan-Qiang
   Shi, Qiang
   Liu, Hua-Xu
   Zhang, Yu-Tong
TI A Novel Mutation of Mitochondrial T14709C Causes Myoclonic Epilepsy with Ragged Red Fibers Syndrome in a Chinese Patient
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
DE m.T14709C; Myoclonic Epilepsy with Ragged Red Fibers Syndrome; Novel Mutation
ID diabetes-mellitus; transfer rnalys; onset myopathy; dna; merrf; prevalence; disorders; diagnosis
AB Background: Myoclonic epilepsy with ragged red fibers (MERRF) syndrome is characterized by myoclonus, generalized epilepsy, cerebellar ataxia, and ragged red fibers (RRFs) in the muscle. T-to-C transition at nucleotide position 14709 in the mitochondrial tRNA glutamic acid (tRNA(G/U)) gene has previously been associated with maternally inherited diabetes and deafness. However, the association between MERRF and mitochondrial T14709C mutation (m.T14709C) has never been reported before. Methods: Clinical information of a 17-year-old patient was collected; muscle biopsy and next-generation sequencing (NGS) of whole mitochondrial and neuromuscular disease panel were then conducted. Finally, sanger sequencing was carried out to confirm the mutations. Results: The patient presented a typical MERRF phenotype with muscle weakness, epileptic seizure, clonic episodes, cerebellar ataxia, and spinal scoliosis. Muscle biopsy showed RRFs which indicated abnormal mitochondrial functions. NGS of whole mitochondrial gene revealed m.T14709C mutation, confirmed by Sanger sequencing. Conclusion: We present a sporadic patient with typical MERRF presentation carrying the mutation of m.T14709C, which expanded the spectrum of m.T14709C.
C1 [Ban, Rui; Pu, Chuan-Qiang; Shi, Qiang; Liu, Hua-Xu; Zhang, Yu-Tong] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing 100853, Peoples R China.
   [Ban, Rui] Nankai Univ, Sch Med, Dept Neurol, Tianjin 300071, Peoples R China.
   [Guo, Jun-Hong] Shanxi Med Univ, Hosp 1, Dept Neurol, Taiyuan 030001, Shanxi, Peoples R China.
C3 Chinese People's Liberation Army General Hospital; Nankai University; Shanxi Medical University
RP Pu, CQ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing 100853, Peoples R China.
EM pucq30128@sina.cn
FU National Natural Science Foundation of China [81771358]
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   Berio A, 1995, PEDIATR MED CHIR, V17, P455
   Bindu PS, 2018, CLIN NEUROL NEUROSUR, V164, P182, DOI 10.1016/j.clineuro.2017.12.010
   Brackmann F, 2012, EUR J PEDIATR, V171, P859, DOI 10.1007/s00431-011-1662-8
   Chen Gang, 2008, YICHUAN, V30, P1279, DOI 10.3724/SP.J.1005.2008.01279
   Cohen BH, 2013, NEUROTHERAPEUTICS, V10, P227, DOI 10.1007/s13311-013-0188-3
   Damore ME, 1999, J PEDIATR ENDOCR MET, V12, P207
   DiMauro S, 2002, J CHILD NEUROL, V17, P0
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Finsterer J, 2017, SEIZURE-EUR J EPILEP, V50, P166, DOI 10.1016/j.seizure.2017.06.010
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   FUKUHARA N, 1995, MUSCLE NERVE, V0, PS90
   [高枫 Gao Feng], 2003, 中风与神经疾病杂志 JOURNAL OF APOPLEXY AND NERVOUS DISEASES, V20, P117
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   Hiniker A, 2014, ACTA NEUROPATHOL COM, V2, P0, DOI 10.1186/s40478-014-0137-3
   Li Z, 2015, MEDICINE, V94, P0, DOI 10.1097/MD.0000000000000513
   Longworth B, 2014, ARCH PHYS MED REHAB, V95, P1725, DOI 10.1016/j.apmr.2014.02.027
   Lu H, 2014, J BRAIN NERV DIS, V22, P245
   Mancuso M, 2005, J NEUROL SCI, V228, P93, DOI 10.1016/j.jns.2004.10.018
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   Meulemans A, 2007, EUR J PAEDIATR NEURO, V11, P17, DOI 10.1016/j.ejpn.2006.10.004
   Mezghani N, 2010, J DIABETES COMPLICAT, V24, P270, DOI 10.1016/j.jdiacomp.2009.11.002
   SHOFFNER JM, 1992, AM J HUM GENET, V51, P1179
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Sofou K, 2013, MITOCHONDRION, V13, P364, DOI 10.1016/j.mito.2013.04.008
   Song DL, 2001, CHINESE MED J-PEKING, V114, P1273
   Stratilova L, 1999, CAS LEK CESK, V138, P401
   Vialettes BH, 1997, DIABETES CARE, V20, P1731, DOI 10.2337/diacare.20.11.1731
   YONEDA M, 1990, BIOCHEM INT, V21, P789
   Zhao Juan, 2012, ZHONGHUA YI XUE ZA ZHI, V92, P2835
   Zhao Man-man, 2015, BEIJING DA XUE XUE BAO YI XUE BAN, V47, P1034
NR 34
TC 8
Z9 8
U1 0
U2 3
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0366-6999
EI 
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD JUL 5
PY 2018
VL 131
IS 13
BP 1569
EP 1574
DI 10.4103/0366-6999.235120
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA GL1NK
UT WOS:000436869700009
PM 29941710
DA 2024-11-01
ER

PT J
AU Varela-Lopez, A
   Pérez-López, MP
   Ramirez-Tortosa, CL
   Battino, M
   Granados-Principal, S
   Ramirez-Tortosa, MD
   Ochoa, JJ
   Vera-Ramirez, L
   Giampieri, F
   Quiles, JL
AF Varela-Lopez, Alfonso
   Patricia Perez-Lopez, Maria
   Luis Ramirez-Tortosa, Cesar
   Battino, Maurizio
   Granados-Principal, Sergio
   del Carmen Ramirez-Tortosa, Maria
   Jose Ochoa, Julio
   Vera-Ramirez, Laura
   Giampieri, Francesca
   Luis Quiles, Jose
TI Gene pathways associated with mitochondrial function, oxidative stress and telomere length are differentially expressed in the liver of rats fed lifelong on virgin olive, sunflower or fish oils
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE Gene expression; Mitochondria; MUFA; Oxidative stress; PUFA; Telomere
ID age-related-changes; quantitative pcr; skeletal-muscle; dna deletion; disease; acid; diet; steatohepatitis; proteins; supplementation
AB This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated (virgin olive oil), n6 polyunsaturated (sunflower oil) or n3 polyunsaturated (fish oil) fatty acids in the aged liver. Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age. Liver histopathology, mitochondrial ultrastructure, biogenesis, oxidative stress, mitochondrial electron transport chain, relative telomere length and gene expression profiles were studied. Aging led to lipid accumulation in the liver. Virgin olive oil led to the lowest oxidation and ultrastructural alterations. Sunflower oil induced fibrosis, ultrastructural alterations and high oxidation. Fish oil intensified oxidation associated with age, lowered electron transport chain activity and enhanced the relative telomere length. Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondria] function and oxidative stress pathways, followed by cell cycle and telomere length control. Sunflower oil avoided gene expression changes related to age. According to the results, virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process. (C) 2017 Published by Elsevier Inc.
C1 [Varela-Lopez, Alfonso; Patricia Perez-Lopez, Maria; Jose Ochoa, Julio; Luis Quiles, Jose] Univ Granada, Inst Nutr & Food Technol Jose Mataix Verdu, Dept Physiol, Biomed Res Ctr, Av Conocimiento S-N, Armilla 18100, Granada, Spain.
   [Luis Ramirez-Tortosa, Cesar] Complejo Hosp Jaen, Dept Pathol, Av Ejercito Espanol 10, Jaen 23007, Spain.
   [Battino, Maurizio; Giampieri, Francesca] Univ Politecn Marche, Dip Sci Clin Specialist & Odontostomatol, Via Ranieri 65, I-60131 Ancona, Italy.
   [Granados-Principal, Sergio] Hosp Complex Jaen, Dept Oncol, Av Ilustrac 114, Granada 18007, Spain.
   [Granados-Principal, Sergio] Univ Granada Junta Andalucia Genom & Invest Oncol, Ctr Pfizer, Av Ilustrac 114, Granada 18007, Spain.
   [del Carmen Ramirez-Tortosa, Maria] Univ Granada, Inst Nutr & Food Technol Jose Mataix Verdu, Dept Biochem & Mol Biol 2, Biomed Res Ctr, Av Conocimiento S-N, Armilla 18100, Granada, Spain.
   [Vera-Ramirez, Laura] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA.
C3 University of Granada; Complejo Hospitalario de Jaen; Marche Polytechnic University; Pfizer; University of Granada; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)
RP Quiles, JL (corresponding author), Inst Nutr & Tecnol Alimentos Jose Mataix Verdu, Dept Fisiol, Lab 250,Parque Tecnol Ciencias Salud, Armilla 18100, Granada, Spain.
EM alvarela@ugr.es; patriciapl@ugr.es; cesarl.ramirez.sspa@juntadeandalucia.es; m.a.battino@univpm.it; sgranados@fibao.es; mramirez@ugr.es; jjoh@ugr.es; laura.veraramirez@nih.gov; f.giampieri@univpm.it; jlquiles@ugr.es
FU Spanish Ministry of Education and Science [AGL2008-01057]; Government of Andalusia [AGR832]; CEI BioTic Granada [CEI2013-P-20]; FPU program from the Spanish Ministry of Education; FPI program from the Spanish Ministry of Education
CR AI-Dwairi A, 2012, PLOS ONE, V7, P0
   Amano A, 2013, J NUTR SCI VITAMINOL, V59, P489, DOI 10.3177/jnsv.59.489
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Aoun M, 2012, BRIT J NUTR, V107, P647, DOI 10.1017/S000711451100331X
   Bakala H, 2013, BBA-MOL BASIS DIS, V1832, P2057, DOI 10.1016/j.bbadis.2013.07.015
   Barden A, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8030175
   Bardia A, 2012, INFLAMM RES, V61, P359, DOI 10.1007/s00011-011-0418-2
   Barja G, 2013, ANTIOXID REDOX SIGN, V19, P1420, DOI 10.1089/ars.2012.5148
   Bose C, 2005, MECH AGEING DEV, V126, P740, DOI 10.1016/j.mad.2005.02.003
   Cakatay Ufuk, 2013, CURR AGING SCI, V6, P135
   Ramirez-Tortosa MC, 2009, FREE RADICAL BIO MED, V47, P924, DOI 10.1016/j.freeradbiomed.2009.06.015
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/30.10.e47
   Chou HC, 2007, CANCER LETT, V253, P138, DOI 10.1016/j.canlet.2007.01.016
   Clichici S, 2011, ACTA PHYSIOL HUNG, V98, P195, DOI 10.1556/APhysiol.98.2011.2.11
   Cogger VC, 2014, J GERONTOL A-BIOL, V69, P1076, DOI 10.1093/gerona/glt169
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Diamanti J, 2014, J AGR FOOD CHEM, V0, P0
   Espinosa-Diez C, 2015, REDOX BIOL, V6, P183, DOI 10.1016/j.redox.2015.07.008
   Fiamoncini J, 2013, OBESITY, V21, P1200, DOI 10.1002/oby.20132
   Fleischer S, 1979, METHODS ENZYMOL, V55, P32
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Gan L, 2011, CURR GERONTOL GERIAT, V0, P0
   Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119
   Hsieh CC, 2003, MECH AGEING DEV, V124, P733, DOI 10.1016/S0047-6374(03)00083-6
   Jiang WQ, 2012, CANCER RES, V72, P3795, DOI 10.1158/0008-5472.CAN-12-1047
   Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200
   LEPAGE G, 1986, J LIPID RES, V27, P114
   Li SP, 2016, J NUTR BIOCHEM, V27, P96, DOI 10.1016/j.jnutbio.2015.08.021
   Lin CF, 2007, J CELL SCI, V120, P2935, DOI 10.1242/jcs.03473
   Liu J, 2012, CURR MOL MED, V12, P982, DOI 10.2174/156652412802480916
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lopez-Cruzan M, 2013, BIOGERONTOLOGY, V14, P121, DOI 10.1007/s10522-013-9415-x
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LUDWIG J, 1980, MAYO CLIN PROC, V55, P434
   Meng QY, 2007, MECH AGEING DEV, V128, P286, DOI 10.1016/j.mad.2006.12.008
   OLeary MF, 2013, AM J PHYSIOL-CELL PH, V304, PC422, DOI 10.1152/ajpcell.00240.2012
   Ochoa JJ, 2003, J BIOENERG BIOMEMBR, V35, P267, DOI 10.1023/A:1024615816839
   Ochoa JJ, 2007, J GERONTOL A-BIOL, V62, P1211, DOI 10.1093/gerona/62.11.1211
   Ochoa JJ, 2011, FREE RADICAL BIO MED, V50, P1053, DOI 10.1016/j.freeradbiomed.2011.02.004
   Ochoa-Herrera JJ, 2001, J NUTR BIOCHEM, V12, P357, DOI 10.1016/S0955-2863(01)00150-4
   Penumathsa SV, 2006, TOXICOL MECH METHOD, V16, P267, DOI 10.1080/15376520500194734
   Pereira AF, 2012, J BIOENERG BIOMEMBR, V44, P587, DOI 10.1007/s10863-012-9463-y
   Picca A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0074644
   Pierce AA, 2016, J NUTR BIOCHEM, V29, P12, DOI 10.1016/j.jnutbio.2015.10.020
   Port M, 2012, HEALTH PHYS, V103, P159, DOI 10.1097/HP.0b013e31824ac318
   Quiles JL, 2006, J GERONTOL A-BIOL, V61, P107, DOI 10.1093/gerona/61.2.107
   Quiles JL, 2004, EXP GERONTOL, V39, P1189, DOI 10.1016/j.exger.2004.05.002
   Quiles JL, 2002, BRIT J NUTR, V88, P57, DOI 10.1079/BJNBJN2002588
   Quiles JL, 2004, ENDOCRINOL NUTR, V51, P107
   Quiles JL, 2010, MECH AGEING DEV, V131, P38, DOI 10.1016/j.mad.2009.11.004
   Rasband WS, 1900, P1997, V0, P0
   Reeves PG, 1997, J NUTR, V127, P0
   Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003
   Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445
   Solanas M, 2010, CARCINOGENESIS, V31, P871, DOI 10.1093/carcin/bgp243
   Sunny NE, 2017, TRENDS ENDOCRIN MET, V28, P250, DOI 10.1016/j.tem.2016.11.006
   Tao LL, 2012, CHIN J INTEGR MED, V18, P582, DOI 10.1007/s11655-012-1180-1
   Yeh MM, 2007, AM J CLIN PATHOL, V128, P837, DOI 10.1309/RTPM1PY6YGBL2G2R
NR 61
TC 35
Z9 35
U1 1
U2 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD FEB 15
PY 2018
VL 52
IS 
BP 36
EP 44
DI 10.1016/j.jnutbio.2017.09.007
PG 9
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA FX1VQ
UT WOS:000425840400005
PM 29144994
DA 2024-11-01
ER

PT J
AU Scholle, LM
   Lehmann, D
   Deschauer, M
   Kraya, T
   Zierz, S
AF Scholle, Leila Motlagh
   Lehmann, Diana
   Deschauer, Marcus
   Kraya, Torsten
   Zierz, Stephan
TI FGF-21 as a Potential Biomarker for Mitochondrial Diseases
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Review
DE FGF-21; Mitochondrial diseases; biomarker; GDF-15; COX; diagnosis
ID growth-factor 21; dna mutations; ppar-alpha; fgf21; expression; liver; diagnosis; obesity; fibroblast-growth-factor-21; pathogenesis
AB The diagnosis of mitochondrial diseases is still challenging due to clinical and genetical heterogeneity. The development of advanced technologies including Whole-Exome-Sequencing (WES) and Whole-Genome-Sequencing (WGS) has led to improvements in genetic diagnosis. However, a reliable biomarker in serum could enhance and ease the diagnosis and indeed reduce the need for muscle biopsy. Several studies suggest Fibroblast growth factor 21 (FGF-21) as a biomarker for diagnosis in mitochondrial disorders. It is known, that in patients with mitochondrial disorders, the expression of FGF-21 gets elevated in an effort to counteract the underlying metabolic deficiency. The growth and differentiation factor 15 (GDF-15) has been described as a potential biomarker for mitochondrial diseases, too. In the present review, a literature research, using PubMed database about the reliability of FGF-21 as a biomarker for mitochondrial disorders and its comparison with GDF-15 has been performed.
C1 [Scholle, Leila Motlagh; Kraya, Torsten; Zierz, Stephan] Martin Luther Univ Halle Wittenberg, Dept Neurol, Ernst Grube Str 40, D-06120 Halle, Germany.
   [Lehmann, Diana] Univ Ulm, Dept Neurol, Ulm, Germany.
   [Deschauer, Marcus] Tech Univ Munich, Dept Neurol, Munich, Germany.
C3 Martin Luther University Halle Wittenberg; Ulm University; Technical University of Munich
RP Scholle, LM (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Neurol, Ernst Grube Str 40, D-06120 Halle, Germany.
EM Leila.scholle@medizin.uni-halle.de
CR Al Payne B, 2013, AIDS RES THER, V10, P0, DOI 10.1186/1742-6405-10-27
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   Baird MF, 2012, J NUTR METAB, V2012, P0, DOI 10.1155/2012/960363
   Bisgaard A, 2014, INT J PEDIATR ENDOCR, V0, P0, DOI DOI 10.1186/1687-9856-2014-7
   Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107
   Clarke C, 2013, MOL GENET METAB, V110, P145, DOI 10.1016/j.ymgme.2013.07.011
   Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816
   Davis RL, 2016, NEUROLOGY, V86, P2010, DOI 10.1212/WNL.0000000000002705
   Davis RL, 2013, NEUROLOGY, V81, P1819, DOI 10.1212/01.wnl.0000436068.43384.ef
   Davis RL, 2011, SEMIN NEUROL, V31, P519, DOI 10.1055/s-0031-1299790
   Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166
   Dimitriadi FF, 2015, PEDIAT ENDOCRINOLOGY, V0, P0
   Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054
   Finsterer J, 2001, ACTA MED AUST, V28, P152, DOI 10.1046/j.1563-2571.2001.01036.x
   Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339
   Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006
   Ge X, 2012, ACTA PHARM SIN B, V2, P350, DOI 10.1016/j.apsb.2012.06.011
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119
   Huang XQ, 2006, MOL CARCINOGEN, V45, P934, DOI 10.1002/mc.20241
   Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003
   Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021
   Ji KQ, 2015, FREE RADICAL BIO MED, V84, P161, DOI 10.1016/j.freeradbiomed.2015.03.020
   Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606
   Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168
   Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014
   Klaus S, 2005, PHYSIOL GENOMICS, V21, P193, DOI 10.1152/physiolgenomics.00299.2004
   Kliewer SA, 2010, AM J CLIN NUTR, V91, P254S, DOI 10.3945/ajcn.2009.28449B
   Koene S, 2015, JIMD REP, V24, P69, DOI 10.1007/8904_2015_436
   Koene S, 2014, NEUROLOGY, V83, P125, DOI 10.1212/WNL.0000000000000578
   Lee MS, 2015, ANN NY ACAD SCI, V1350, P61, DOI 10.1111/nyas.12822
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Liu WY, 2014, EXPERT OPIN THER TAR, V18, P1305, DOI 10.1517/14728222.2014.944898
   [刘银华 Liu Yinhua], 2016, 中国临床药理学与治疗学 CHINESE JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, V21, P6
   Lovadi E, 2017, MUSCLE NERVE, V55, P564, DOI 10.1002/mus.25364
   Lundåsen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068
   Mäkelä J, 2014, SPRINGERPLUS, V3, P0, DOI 10.1186/2193-1801-3-2
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Montero R, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0148709
   Morovat A, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6080080
   Mraz M, 2009, CLIN ENDOCRINOL, V71, P369, DOI 10.1111/j.1365-2265.2008.03502.x
   Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   Ost M, 2016, MOL METAB, V5, P79, DOI 10.1016/j.molmet.2015.11.002
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Rusli F, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep30484
   Salehi MH, 2013, MOL BIOL REP, V40, P6495, DOI 10.1007/s11033-013-2767-0
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Su SL, 2012, CLIN CHIM ACTA, V414, P225, DOI 10.1016/j.cca.2012.09.019
   Suomalainen Anu, 2013, EXPERT OPIN MED DIAGN, V7, P313, DOI 10.1517/17530059.2013.812070
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Suomalainen A, 2011, J INHERIT METAB DIS, V34, P277, DOI 10.1007/s10545-010-9222-3
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Vandanmagsar B, 2016, CELL REP, V15, P1686, DOI 10.1016/j.celrep.2016.04.057
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Yang CF, 2013, BMC GASTROENTEROL, V13, P0, DOI 10.1186/1471-230X-13-67
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Ye DW, 2014, HEPATOLOGY, V60, P977, DOI 10.1002/hep.27060
   Zhang FF, 2015, MOL ENDOCRINOL, V29, P1400, DOI 10.1210/me.2015-1155
   Zhu Sheng-long, 2013, YAOXUE XUEBAO, V48, P1778
NR 71
TC 22
Z9 22
U1 0
U2 9
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 0929-8673
EI 1875-533X
J9 CURR MED CHEM
JI Curr. Med. Chem.
PD JUN 15
PY 2018
VL 25
IS 18
BP 2070
EP 2081
DI 10.2174/0929867325666180111094336
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA GG9QD
UT WOS:000433035000001
PM 29332568
DA 2024-11-01
ER

PT J
AU Kouga, T
   Takagi, M
   Miyauchi, A
   Shimbo, H
   Iai, M
   Yamashita, S
   Murayama, K
   Klein, MB
   Miller, G
   Goto, T
   Osaka, H
AF Kouga, Takeshi
   Takagi, Mariko
   Miyauchi, Akihiko
   Shimbo, Hiroko
   Iai, Mizue
   Yamashita, Sumimasa
   Murayama, Kei
   Klein, Matthew B.
   Miller, Guy
   Goto, Tomohide
   Osaka, Hitoshi
TI Japanese Leigh syndrome case treated with EPI-743
SO BRAIN & DEVELOPMENT
LA English
DT Article
DE Leigh syndrome; EPI-743; Succinate; Mitochondria DNA
ID mitochondrial disease; nd3 gene; glutathione; succinate; mutations; diagnosis
AB Background: Leigh syndrome is a mitochondria] disease caused by respiratory chain deficiency, and there are no proven effective therapies. EPI-743 is a potent cellular oxidative stress protectant and results of clinical trials for mitochondria] diseases are accumulating. Case: At 5 months, a girl presented with the scarce eye movement and diminished muscle tone. She was diagnosed with Leigh encephalopathy from blood and cerebrospinal fluid lactate elevation and MRI findings. Sequence analysis for mitochondria] DNA revealed a T10158C mutation in the mitochondrial encoded ND3 gene in complex I. Results: At 8 months, succinate was prescribed expected to restore the electron transport chain system. After that her condition got worse and succinate was discontinued. Subsequent administration of EPI-743 improved her eye movement, fine motor movements of the extremities, and bowel movement. She is now 5 years old. Although brain atrophy has progressed, she has still respiratory free time. Conclusion: Our patient showed visible improvement with EPI-743 treatment and the only patient surviving after 4 years. There is a possibility that EPI-743 is modifying the natural course of the syndrome. (C) 2017 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
C1 [Kouga, Takeshi; Takagi, Mariko; Shimbo, Hiroko; Iai, Mizue; Yamashita, Sumimasa; Goto, Tomohide; Osaka, Hitoshi] Kanagawa Childrens Med Ctr, Div Neurol, Yokohama, Kanagawa, Japan.
   [Kouga, Takeshi; Miyauchi, Akihiko; Osaka, Hitoshi] Jichi Med Univ, Dept Pediat, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.
   [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Chiba, Japan.
   [Klein, Matthew B.; Miller, Guy] BioElectron Technol Corp, Mountain View, CA USA.
C3 Jichi Medical University; Chiba Children's Hospital
RP Osaka, H (corresponding author), Jichi Med Univ, Dept Pediat, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.
EM hosaka@jichi.ac.jp
FU Agency of Medical Research and Development; JSPS KAKENHI [15552768]
CR Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   Enns GM, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6050050
   Enns GM, 2012, MOL GENET METAB, V105, P91, DOI 10.1016/j.ymgme.2011.10.009
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Oguro H, 2004, INTERNAL MED, V43, P427, DOI 10.2169/internalmedicine.43.427
   Pastore A, 2013, MOL GENET METAB, V109, P208, DOI 10.1016/j.ymgme.2013.03.011
   Pfeffer G, 2012, COCHRANE DB SYST REV, V18, P4
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Shimbo H, 2014, MOL GENET METAB REP, V1, P133, DOI 10.1016/j.ymgmr.2014.02.006
   Shrader WD, 2011, BIOORG MED CHEM LETT, V21, P3693, DOI 10.1016/j.bmcl.2011.04.085
   Wonnapinij P, 2008, AM J HUM GENET, V83, P582, DOI 10.1016/j.ajhg.2008.10.007
NR 15
TC 18
Z9 19
U1 1
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0387-7604
EI 1872-7131
J9 BRAIN DEV-JPN
JI Brain Dev.
PD FEB 15
PY 2018
VL 40
IS 2
BP 145
EP 149
DI 10.1016/j.braindev.2017.08.005
PG 5
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA FV7AW
UT WOS:000424734600010
PM 28916229
DA 2024-11-01
ER

PT J
AU Kullar, PJ
   Gomez-Duran, A
   Gammage, PA
   Garone, C
   Minczuk, M
   Golder, Z
   Wilson, J
   Montoya, J
   Häkli, S
   Kärppä, M
   Horvath, R
   Majamaa, K
   Chinnery, PF
AF Kullar, Peter J.
   Gomez-Duran, Aurora
   Gammage, Payam A.
   Garone, Caterina
   Minczuk, Michal
   Golder, Zoe
   Wilson, Janet
   Montoya, Julio
   Hakli, Sanna
   Karppa, Mikko
   Horvath, Rita
   Majamaa, Kari
   Chinnery, Patrick F.
TI Heterozygous <i>SSBP1</i> start loss mutation co-segregates with hearing loss and the m.1555A&gt;G mtDNA variant in a large multigenerational family
SO BRAIN
LA English
DT Article
DE mitochondrial diseases; hearing; muscle disease; neurodegeneration; genetics
ID ribosomal-rna mutation; non-syndromic deafness; dna-binding-protein; mitochondrial-dna; biochemical-evidence; 7s dna; disease; maintenance; frequency
AB The m.1555A>G mtDNA variant causes maternally inherited deafness, but the reasons for the highly variable clinical penetrance are not known. Exome sequencing identified a heterozygous start loss mutation in SSBP1, encoding the single stranded binding protein 1 (SSBP1), segregating with hearing loss in a multi-generational family transmitting m.1555A>G, associated with mtDNA depletion and multiple deletions in skeletal muscle. The SSBP1 mutation reduced steady state SSBP1 levels leading to a perturbation of mtDNA metabolism, likely compounding the intra-mitochondrial translation defect due to m.1555A>G in a tissue-specific manner. This family demonstrates the importance of rare trans-acting genetic nuclear modifiers in the clinical expression of mtDNA disease.
C1 [Kullar, Peter J.; Gomez-Duran, Aurora; Gammage, Payam A.; Garone, Caterina; Minczuk, Michal; Golder, Zoe; Chinnery, Patrick F.] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge CB2 0XY, England.
   [Kullar, Peter J.; Gomez-Duran, Aurora; Golder, Zoe; Chinnery, Patrick F.] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 0QQ, England.
   [Wilson, Janet] Newcastle Univ, Inst Hlth & Soc, Baddiley Clark Bldg,Richardson Rd, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.
   [Montoya, Julio] Univ Zaragoza, CIBERER, Inst Invest Sanit Arago, Zaragoza, Spain.
   [Hakli, Sanna; Karppa, Mikko; Majamaa, Kari] Univ Oulu, Res Unit Clin Neurosci, Oulu, Finland.
   [Hakli, Sanna; Karppa, Mikko; Majamaa, Kari] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland.
   [Hakli, Sanna; Karppa, Mikko; Majamaa, Kari] Univ Oulu, Oulu, Finland.
   [Horvath, Rita] Newcastle Univ, Inst Genet Med, Newcastle, NSW, Australia.
C3 University of Cambridge; University of Cambridge; Newcastle University - UK; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Oulu; University of Oulu; University of Oulu; University of Newcastle
RP Chinnery, PF (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 0QQ, England.
EM pfc25@cam.ac.uk
FU Wellcome Trust [101700/A/13/Z, 101876/Z/13/Z]; Medical Research Council Mitochondrial Biology Unit [MC_UP_1501/2]; Wellcome Trust Centre for Mitochondrial Research [096919Z/11/Z]; Medical Research Council (UK) Centre for Translational Muscle Disease research [G0601943]; EU FP7 TIRCON; National Institute for Health Research (NIHR) Biomedical Research Centre based at Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge; European Commission under "Marie Sklodowska-Curie Actions", Individual Fellowship - Reintegration Panel [Mitobiopath-705560]; Instituto de Salud Carlos III [PI14/00005, PI14/00070]; Departamento de Ciencia, Tecnologia y Universidad del Gobierno de Aragon (Grupos Consolidados B33); FEDER Funding Program from the European Union; and Asociacion de Enfermos de Patologia Mitocondrial (AEPMI); Medical Research Council (UK) [MC_U105697135]; MRC [G0601943, MC_U105697135, MC_UU_00015/4, MR/N025431/2, G1000848, MR/N010035/1, MR/N025431/1] Funding Source: UKRI; Newton Fund [MR/N027302/2, MR/N027302/1] Funding Source: UKRI
CR Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x
   Bykhovskaya Y, 1998, AM J MED GENET, V77, P421, DOI 10.1002/(SICI)1096-8628(19980605)77:5<421::AID-AJMG13>3.0.CO;2-K
   Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109
   Fusté JM, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004832
   Grady JP, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0114462
   Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389
   Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963
   Häkli S, 2013, AUDIOL NEURO-OTOL, V18, P23, DOI 10.1159/000342905
   Keogh MJ, 2015, J NEUROL, V262, P1822, DOI 10.1007/s00415-015-7772-x
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Lehtonen MS, 2000, EUR J HUM GENET, V8, P315, DOI 10.1038/sj.ejhg.5200455
   Meng FL, 2017, J BIOL CHEM, V292, P2881, DOI 10.1074/jbc.M116.749374
   Mikhailov VS, 1996, J BIOL CHEM, V271, P30774, DOI 10.1074/jbc.271.48.30774
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Rahman S, 2012, BMJ OPEN, V2, P0, DOI 10.1136/bmjopen-2011-000411
   Ruhanen H, 2010, BBA-MOL CELL RES, V1803, P931, DOI 10.1016/j.bbamcr.2010.04.008
   Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575
   Stewart JD, 2011, BBA-MOL BASIS DIS, V1812, P321, DOI 10.1016/j.bbadis.2010.11.012
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Van Haute L, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms12039
NR 24
TC 17
Z9 20
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD JAN 15
PY 2018
VL 141
IS 
BP 55
EP 62
DI 10.1093/brain/awx295
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FS2PD
UT WOS:000419619700016
PM 29182774
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Mancuso, M
   Pareyson, D
   Burgunder, JM
   Klopstock, T
AF Finsterer, Josef
   Mancuso, Michelangelo
   Pareyson, Davide
   Burgunder, Jean-Marc
   Klopstock, Thomas
TI Mitochondrial disorders of the retinal ganglion cells and the optic nerve
SO MITOCHONDRION
LA English
DT Review
DE Optic nerve; Second cranial nerve; Optic neuropathy; mtDNA; Oxidative phosphorylation; Mitochondrial; Respiratory chain
ID placebo-controlled trial; optimized allotopic expression; of-the-literature; opa1 mutations; leigh-syndrome; chinese family; clinical-features; external ophthalmoplegia; missense mutation; gene-mutations
AB Objectives: To summarise and discuss recent findings and future perspectives concerning mitochondrial disorders (MIDs) affecting the retinal ganglion cells and the optic nerve (mitochondrial optic neuropathy. MON). Method: Literature review, Results: MON in MIDs is more frequent than usually anticipated. MON may occur in specific as well as nonspecific MIDs. In specific and non-specific Mips, MON may be a prominent or non-prominent phenotypic feature and due to mutations in genes located either in the mitochondrial DNA (mtDNA) or the nuclear DNA (nDNA). Clinically, MON manifests with painless, bilateral or unilateral, slowly or rapidly progressive visual impairment and visual field defects. In some cases, visual impairment may spontaneously recover. The most frequent MIDs with MON include LHON due to mutations in mtDNA-located genes and autosomal dominant optic atrophy (ADOA) or autosomal recessive optic atrophy (AROA) due to mutations in nuclear genes. Instrumental investigations for diagnosing MON include fundoscopy, measurement of visual acuity, visual fields, and color vision, visually-evoked potentials, optical coherence tomography, fluorescein angiography, electroretinography, and MRI of the orbita and cerebrum. In non-prominent MON, work-up of the muscle biopsy with transmission electron microscopy may indicate mitochondrial destruction. Treatment is mostly supportive but idebenone has been approved for LHON and experimental approaches are promising. Conclusions: MON needs to be appreciated, requires extensive diagnostic work-up, and supportive treatment should be applied although loss of vision, as the most severe outcome, can often not be prevented.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
   [Mancuso, Michelangelo] Univ Pisa, Neurol Clin, Dept Clin & Expt Med, Pisa, Italy.
   [Pareyson, Davide] IRCCS Fdn, C Besta Neurol Inst, Dept Clin Neurosci, Milan, Italy.
   [Burgunder, Jean-Marc] Univ Bern, Dept Neurol, Bern, Switzerland.
   [Burgunder, Jean-Marc] Sun Yat Sen Univ, Dept Neurol, Guangzhou, Guangdong, Peoples R China.
   [Burgunder, Jean-Marc] Sichuan Univ, Dept Neurol, Chendgu, Peoples R China.
   [Klopstock, Thomas] Ludwig Maximilians Univ Munchen, Dept Neurol, Friedrich Baur Inst, Munich, Germany.
   [Klopstock, Thomas] German Ctr Neurodegenerat Dis DZNE, Munich, Germany.
   [Klopstock, Thomas] Munich Cluster Syst Neurol SyNergy, Munich, Germany.
C3 Rudolfstiftung Hospital; University of Pisa; University of Bern; Sun Yat Sen University; Sichuan University; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de; davide.pareyson@istituto-besta.it; jmburgunder@bluewin.ch; Thomas.Klopstock@med.LMU.de
CR Abrams AJ, 2015, NAT GENET, V47, P926, DOI 10.1038/ng.3354
   Achilli A, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0042242
   Ahmad KE, 2015, J NEUROL, V262, P2323, DOI 10.1007/s00415-015-7849-6
   Ahola S, 2014, NEUROLOGY, V83, P743, DOI 10.1212/WNL.0000000000000716
   Almoguera B, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/s13023-014-0190-9
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Angebault C, 2015, AM J HUM GENET, V97, P754, DOI 10.1016/j.ajhg.2015.09.012
   Angebault Claire, 2011, BMC RES NOTES, V4, P557, DOI 10.1186/1756-0500-4-557
   Ayrignac X, 2012, EUR NEUROL, V68, P108, DOI 10.1159/000339310
   Barbet F, 2005, J MED GENET, V42, P0, DOI 10.1136/jmg.2004.025502
   Barbet F, 2003, EUR J HUM GENET, V11, P966, DOI 10.1038/sj.ejhg.5201070
   BARBONI P, 2013, BRAIN 2, V136, P0, DOI 10.1093/BRAIN/AWS280
   Barboni P, 2012, EUR J OPHTHALMOL, V22, P985, DOI 10.5301/ejo.5000154
   Barboni P, 2010, OPHTHALMOLOGY, V117, P1547, DOI 10.1016/j.ophtha.2009.12.042
   Benson Michael L, 2016, THE OXFORD HANDBOOK OF WHITE-COLLAR CRIME, V0, P1
   Bi R, 2012, MOL VIS, V18, P3087
   Bonnet C, 2008, BBA-MOL CELL RES, V1783, P1707, DOI 10.1016/j.bbamcr.2008.04.018
   Caporali L, 2013, BBA-MOL BASIS DIS, V1832, P445, DOI 10.1016/j.bbadis.2012.12.002
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carelli V, 2011, HUM MOL GENET, V20, P1893, DOI 10.1093/hmg/ddr071
   Carr AS, 2015, J PERIPHER NERV SYST, V20, P67, DOI 10.1111/jns.12117
   Castro-Gago M, 2003, REV NEUROLOGIA, V36, P1026, DOI 10.33588/rn.3611.2002519
   Charif M, 2015, AM J MED GENET A, V167, P2366, DOI 10.1002/ajmg.a.37188
   Chen YB, 2013, MOL VIS, V19, P292
   Cornille K, 2008, ANN NEUROL, V63, P667, DOI 10.1002/ana.21376
   Da YW, 2013, J NEURO-OPHTHALMOL, V33, P276, DOI 10.1097/WNO.0b013e31828f8d75
   Dahlmann-Noor A, 2010, CAN J OPHTHALMOL, V45, P333, DOI 10.3129/i10-077
   Désir J, 2012, MOL VIS, V18, P1849
   Di Meglio C, 2016, BRAIN DEV-JPN, V38, P498, DOI 10.1016/j.braindev.2015.11.006
   Eiberg H, 2006, J MED GENET, V43, P435, DOI 10.1136/jmg.2005.034892
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   Ferré M, 2009, HUM MUTAT, V30, PE692, DOI 10.1002/humu.21025
   Feuer WJ, 2016, OPHTHALMOLOGY, V123, P558, DOI 10.1016/j.ophtha.2015.10.025
   Filiano JJ, 2002, PEDIATR NEUROL, V26, P239, DOI 10.1016/S0887-8994(01)00377-0
   Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x
   Finsterer J, 2016, WORLD J CARDIOL, V8, P333, DOI 10.4330/wjc.v8.i5.333
   Finsterer J, 2016, J CHILD NEUROL, V31, P652, DOI 10.1177/0883073815599263
   Finsterer Josef, 2016, SULTAN QABOOS UNIV MED J, V16, Pe92, DOI 10.18295/squmj.2016.16.01.017
   Finsterer J, 2015, PEDIATR NEUROL, V52, P302, DOI 10.1016/j.pediatrneurol.2014.06.023
   Finsterer J, 2015, SINGAP MED J, V56, P122, DOI 10.11622/smedj.2015026
   Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002
   Frey S, 2016, BIOCHIM BIOPHYS ACTA, V1863, P284
   Gao Min, 2015, ZHONGHUA YI XUE YI CHUAN XUE ZA ZHI, V32, P485, DOI 10.3760/cma.j.issn.1003-9406.2015.04.007
   Glamuzina E, 2012, J INHERIT METAB DIS, V35, P459, DOI 10.1007/s10545-011-9413-6
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grau T, 2013, J MED GENET, V50, P848, DOI 10.1136/jmedgenet-2013-101774
   Grenier J, 2016, OPHTHALMOLOGY, V123, P1989, DOI 10.1016/j.ophtha.2016.05.036
   Gross-Jendroska M, 1992, EUR J OPHTHALMOL, V2, P15
   Guy J, 2014, INVEST OPHTH VIS SCI, V55, P841, DOI 10.1167/iovs.13-13365
   Guy J, 2009, INVEST OPHTH VIS SCI, V50, P4205, DOI 10.1167/iovs.08-3214
   Ha AD, 2012, MOVEMENT DISORD, V27, P1034, DOI 10.1002/mds.25033
   Han JY, 2014, J CLIN NEUROSCI, V21, P2009, DOI 10.1016/j.jocn.2014.03.020
   Han J, 2015, BRIT J OPHTHALMOL, V99, P528, DOI 10.1136/bjophthalmol-2014-305704
   Hanein S, 2009, AM J HUM GENET, V84, P493, DOI 10.1016/j.ajhg.2009.03.003
   Harlalka GV, 2016, HUM MUTAT, V37, P1157, DOI 10.1002/humu.23060
   Hartig MB, 2011, AM J HUM GENET, V89, P543, DOI 10.1016/j.ajhg.2011.09.007
   Heidary G, 2014, J NEURO-OPHTHALMOL, V34, P39, DOI 10.1097/WNO.0000000000000076
   Heimer G, 2016, AM J HUM GENET, V99, P1229, DOI 10.1016/j.ajhg.2016.09.021
   Heitz FD, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0045182
   Holder GE, 1998, DOC OPHTHALMOL, V95, P217, DOI 10.1023/A:1001844021014
   Holloman Conisha Mone, 2013, BMJ CASE REP, V2013, P0, DOI 10.1136/bcr-2012-007272
   Honda Hiroyuki, 2006, RINSHO SHINKEIGAKU, V46, P294
   Hsieh YT, 2011, OPHTHALMIC GENET, V32, P31, DOI 10.3109/13816810.2010.531880
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hwang JM, 1997, OPHTHALMIC GENET, V18, P101, DOI 10.3109/13816819709057122
   Imagawa E, 2016, J NEUROL NEUROSUR PS, V87, P212, DOI 10.1136/jnnp-2014-310084
   Inoue M, 2016, ACTA OPHTHALMOL, V0, P0, DOI DOI 10.1111/aos
   Ji YL, 2008, AM J HUM GENET, V83, P760, DOI 10.1016/j.ajhg.2008.11.002
   Jin X, 2015, GENET MOL RES, V14, P10961, DOI 10.4238/2015.September.21.8
   Kao SH, 2015, INVEST OPHTH VIS SCI, V56, P2269, DOI 10.1167/iovs.14-16288
   Katz BJ, 2006, AM J MED GENET A, V140A, P2207, DOI 10.1002/ajmg.a.31455
   Kerrison JB, 1999, ARCH OPHTHALMOL-CHIC, V117, P805
   Khan NA, 2017, INVEST OPHTH VIS SCI, V58, P3923, DOI 10.1167/iovs.16-20695
   Kim IS, 2010, J KOREAN MED SCI, V25, P180, DOI 10.3346/jkms.2010.25.1.180
   Kleffner I, 2015, J NEUROL SCI, V357, P115, DOI 10.1016/j.jns.2015.07.009
   Klopstock T, 2016, GENOME MED, V8, P0, DOI 10.1186/s13073-016-0380-2
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Kolarova H, 2016, OPHTHALMIC GENET, V0, P1
   La Morgia C, 2014, FRONT NEUROL, V5, P0, DOI 10.3389/fneur.2014.00141
   La Morgia C, 2014, BMC NEUROL, V14, P0, DOI 10.1186/1471-2377-14-116
   La Morgia C, 2010, BRAIN, V133, P2426, DOI 10.1093/brain/awq155
   Langwinska-Wosko E, 2016, J NEUROL SCI, V370, P237, DOI 10.1016/j.jns.2016.09.046
   Lee J, 2016, MOL MED REP, V14, P33, DOI 10.3892/mmr.2016.5209
   Leruez S, 2014, REV NEUROL-FRANCE, V170, P344, DOI 10.1016/j.neurol.2014.03.009
   Leshinsky-Silver E, 2011, J CHILD NEUROL, V26, P476, DOI 10.1177/0883073810384615
   Liao CY, 2017, NEUROLOGY, V88, P131, DOI 10.1212/WNL.0000000000003491
   Lieber DS, 2012, BMC MED GENET, V13, P0, DOI 10.1186/1471-2350-13-3
   Liskova P, 2013, ACTA OPHTHALMOL, V91, PE225, DOI 10.1111/aos.12038
   MAKELABENGS P, 1995, PEDIATR RES, V37, P634
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Mano Atsushi, 2003, RINSHO SHINKEIGAKU, V43, P564
   Marchetti V, 2010, J CLIN INVEST, V120, P3012, DOI 10.1172/JCI42951
   Maresca A, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00090
   Martín MA, 2017, CLIN GENET, V91, P46, DOI 10.1111/cge.12815
   Martínez-Romero I, 2014, CLIN EXP OPHTHALMOL, V42, P856, DOI 10.1111/ceo.12355
   Mashima Y, 2000, J NEURO-OPHTHALMOL, V20, P166, DOI 10.1097/00041327-200020030-00006
   Metodiev MD, 2014, J MED GENET, V51, P834, DOI 10.1136/jmedgenet-2014-102532
   Meyer E, 2010, MOL VIS, V16, P650
   Meyerson C, 2015, CLIN OPHTHALMOL, V9, P1165, DOI 10.2147/OPTH.S62021
   Milone M, 2011, ARCH NEUROL-CHICAGO, V68, P806, DOI 10.1001/archneurol.2011.124
   Mizutari K, 2010, J NEUROL SCI, V293, P23, DOI 10.1016/j.jns.2010.03.014
   MORRISSEY SP, 1995, J NEUROL NEUROSUR PS, V58, P70, DOI 10.1136/jnnp.58.1.70
   Newman NJ, 2005, AM J OPHTHALMOL, V140, P517, DOI 10.1016/j.ajo.2005.03.017
   Nguyen M, 2017, CLIN GENET, V91, P121, DOI 10.1111/cge.12774
   Park SW, 2015, GRAEF ARCH CLIN EXP, V253, P135, DOI 10.1007/s00417-014-2852-7
   Pavlidou E, 2016, EUR J PAEDIATR NEURO, V20, P483, DOI 10.1016/j.ejpn.2015.12.016
   Perganta G, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0056350
   Pfeffer G, 2013, NEUROLOGY, V81, P2073, DOI 10.1212/01.wnl.0000437308.22603.43
   Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R
   Puomila A, 2005, ACTA OPHTHALMOL SCAN, V83, P337, DOI 10.1111/j.1600-0420.2005.00448.x
   Qi XP, 2007, ARCH OPHTHALMOL-CHIC, V125, P268, DOI 10.1001/archopht.125.2.268
   Ramos CDF, 2009, INVEST OPHTH VIS SCI, V50, P1666, DOI 10.1167/iovs.08-2695
   Reuter MS, 2014, AM J MED GENET A, V164, P3162, DOI 10.1002/ajmg.a.36766
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Roubertie A, 2015, J NEUROL SCI, V349, P154, DOI 10.1016/j.jns.2015.01.008
   Rudolph G, 2013, J NEURO-OPHTHALMOL, V33, P30, DOI 10.1097/WNO.0b013e318272c643
   Sacai PY, 2010, DOC OPHTHALMOL, V121, P147, DOI 10.1007/s10633-010-9241-2
   Sadun Alfredo A, 2006, TRANS AM OPHTHALMOL SOC, V104, P51
   Sarzi E, 2016, HUM MOL GENET, V0, P0
   Sarzi E, 2012, BRAIN, V135, P3599, DOI 10.1093/brain/aws303
   Sergouniotis PI, 2015, NEUROGENETICS, V16, P69, DOI 10.1007/s10048-014-0416-y
   Smith TG, 2016, NEUROSCIENCE, V319, P92, DOI 10.1016/j.neuroscience.2016.01.042
   Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361
   Tarnopoisky M, 2013, AM J MED GENET A, V161, P2020, DOI 10.1002/ajmg.a.36000
   Taub PR, 2016, FOOD FUNCT, V7, P3686, DOI 10.1039/c6fo00611f
   Taub PR, 2012, CTS-CLIN TRANSL SCI, V5, P43, DOI 10.1111/j.1752-8062.2011.00357.x
   Tucci A, 2014, J NEUROL NEUROSUR PS, V85, P486, DOI 10.1136/jnnp-2013-306387
   Tuppen HAL, 2010, MOL GENET METAB, V100, P345, DOI 10.1016/j.ymgme.2010.04.010
   Valero T, 2014, CURR PHARM DESIGN, V20, P5507, DOI 10.2174/138161282035140911142118
   Van Bergen NJ, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0021347
   Vaphiades MS, 2003, J NEURO-OPHTHALMOL, V23, P104, DOI 10.1097/00041327-200303000-00057
   Ventura DF, 2007, INVEST OPHTH VIS SCI, V48, P2362, DOI 10.1167/iovs.06-0331
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Vodopivec I, 2016, NEUROLOGIST, V21, P61, DOI 10.1097/NRL.0000000000000084
   Votruba M, 1998, J MED GENET, V35, P793, DOI 10.1136/jmg.35.10.793
   Wasilewski M, 2012, CURR BIOL, V22, P1228, DOI 10.1016/j.cub.2012.04.054
   Watanabe M, 2006, J NEUROL SCI, V243, P31, DOI 10.1016/j.jns.2005.11.003
   Wray CD, 2013, MITOCHONDRION, V13, P656, DOI 10.1016/j.mito.2013.09.004
   Yang S, 2016, EBIOMEDICINE, V10, P258, DOI 10.1016/j.ebiom.2016.07.002
   Yoo DH, 2017, MITOCHONDRION, V35, P54, DOI 10.1016/j.mito.2017.05.005
   Yu DD, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0013426
   Yu H, 2012, P NATL ACAD SCI USA, V109, PE1238, DOI 10.1073/pnas.1119577109
   Yu-Wai-Man P, 2014, EYE, V28, P521, DOI 10.1038/eye.2014.37
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Zhang AM, 2017, MOL NEUROBIOL, V54, P1622, DOI 10.1007/s12035-016-9771-z
   Zhang AM, 2012, J TRANSL MED, V10, P0, DOI 10.1186/1479-5876-10-43
   Zhang AM, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0027750
   Zhang AM, 2009, BIOCHEM BIOPH RES CO, V386, P392, DOI 10.1016/j.bbrc.2009.06.051
   Zhang JJ, 2014, MITOCHONDRION, V18, P18, DOI 10.1016/j.mito.2014.08.008
   Zhang JJ, 2012, BIOCHEM BIOPH RES CO, V419, P670, DOI 10.1016/j.bbrc.2012.02.073
   Zhang Sai, 2015, ZHONGHUA YI XUE YI CHUAN XUE ZA ZHI, V32, P198, DOI 10.3760/cma.j.issn.1003-9406.2015.02.010
   Zhao HW, 2015, NEUROSCIENCE, V288, P187, DOI 10.1016/j.neuroscience.2014.12.039
   Zhu Y, 2016, CHINESE MED J-PEKING, V129, P259, DOI 10.4103/0366-6999.174491
   Zou Y, 2010, BIOCHEM BIOPH RES CO, V399, P179, DOI 10.1016/j.bbrc.2010.07.051
NR 160
TC 21
Z9 22
U1 2
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD SEP 15
PY 2018
VL 42
IS 
BP 1
EP 10
DI 10.1016/j.mito.2017.10.003
PG 10
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA GU5JJ
UT WOS:000445321500001
PM 29054473
DA 2024-11-01
ER

PT J
AU Meseguer, S
   Panadero, J
   Navarro-González, C
   Villarroya, M
   Boutoual, R
   Comi, GP
   Armengod, ME
AF Meseguer, Salvador
   Panadero, Joaquin
   Navarro-Gonzalez, Carmen
   Villarroya, Magda
   Boutoual, Rachid
   Pietro Comi, Giacomo
   Armengod, M. -Eugenia
TI The MELAS mutation m.3243A > G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE OXPHOS diseases; Heteroplasmy; Hypertrophic cardiomyopathy; miR-218-5p; miR-4775
ID mitochondrial-dna mutations; tgf-beta; clinical spectrum; binding-proteins; human-diseases; retinoic acid; smad pathways; small gtpases; stem-cells; heart
AB The pathomechanisms underlying oxidative phosphorylation (OXPHOS) diseases are not well-understood, but they involve maladaptive changes in mitochondria-nucleus communication. Many studies on the mitochondria nucleus cross-talk triggered by mitochondrial dysfunction have focused on the role played by regulatory proteins, while the participation of miRNAs remains poorly explored. MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) is mostly caused by mutation m.3243A > G in mitochondrial tRNA(Leu(UUR))) gene. Adverse cardiac and neurological events are the commonest causes of early death in m.3243A > G patients. Notably, the incidence of major clinical features associated with this mutation has been correlated to the level of m.3243A > G mutant mitochondrial DNA (heteroplasmy) in skeletal muscle. In this work, we used a transmitochondrial cybrid model of MELAS (100% m.3243A > G mutant mitochondrial DNA) to investigate the participation of miRNAs in the mitochondria-nucleus cross-talk associated with OXPHOS dysfunction. High-throughput analysis of small-RNA-Seq data indicated that expression of 246 miRNAs was significantly altered in MELAS cybrids. Validation of selected miRNAs, including miR-4775 and miR-218-5p, in patient muscle samples revealed miRNAs whose expression declined with high levels of mutant heteroplasmy. We show that miR-218-5p and miR-4775 are direct regulators of fetal cardiac genes such as NODAL, RHOA, ISL1 and RXRB, which are up-regulated in MELAS cybrids and in patient muscle samples with heteroplasmy above 60%. Our data clearly indicate that TGF-beta superfamily signaling and an epithelial-mesenchymal transition-like program are activated in MELAS cybrids, and suggest that down-regulation of miRNAs regulating fetal cardiac genes is a risk marker of heart failure in patients with OXPHOS diseases.
C1 [Meseguer, Salvador; Navarro-Gonzalez, Carmen; Villarroya, Magda; Boutoual, Rachid; Armengod, M. -Eugenia] CIPF, RNA Modificat & Mitochondrial Dis Lab, Carrer Eduardo Primo Yufera 3, Valencia 46012, Spain.
   [Panadero, Joaquin] Inst Invest Sanitaria La Fe, Unidad Genom, Ave Fernando Abril Martorell,106 Torre A 7a, Valencia 46026, Spain.
   [Pietro Comi, Giacomo] Univ Milan, Osped Maggiore Policlin, IRCCS Fdn Ca Granda, Dino Ferrari Ctr,Dept Pathophysiol & Transplantat, Via F Sforza 35, I-20122 Milan, Italy.
   [Armengod, M. -Eugenia] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Node 721, Madrid 28029, Spain.
C3 Prince Felipe Research Center; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; CIBER - Centro de Investigacion Biomedica en Red; CIBERER
RP Meseguer, S (corresponding author), CIPF, RNA Modificat & Mitochondrial Dis Lab, Carrer Eduardo Primo Yufera 3, Valencia 46012, Spain.
EM smeseguer@cipf.es; joaquin_panadero@iislafe.es; cnavarrog@cipf.es; mvillarroya@cipf.es; rboutoual@cipf.es; giacomo.comi@unimi.it; marmengod@cipf.es
FU Spanish Ministry of Economy and Competitiveness [BFU2014-58673-P]
CR Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23
   Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27
   Blanchette F, 2001, J BIOL CHEM, V276, P33986, DOI 10.1074/jbc.M100093200
   Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011
   Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372
   Cagin U, 2015, INT J BIOCHEM CELL B, V63, P10, DOI 10.1016/j.biocel.2015.01.026
   Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0
   Cannino G, 2007, MITOCHONDRION, V7, P359, DOI 10.1016/j.mito.2007.07.001
   Chandel NS, 2014, BMC BIOL, V12, P0, DOI 10.1186/1741-7007-12-34
   Chen C, 2015, PROTEIN CELL, V6, P862, DOI 10.1007/s13238-015-0175-z
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chomyn A, 1996, METHODS ENZYMOL, V264, P334, DOI 10.1016/S0076-6879(96)64031-2
   Clerk A, 2000, CIRC RES, V86, P1019, DOI 10.1161/01.RES.86.10.1019
   Cooley JR, 2014, DEV DYNAM, V243, P497, DOI 10.1002/dvdy.24085
   Derynck Rik, 2007, TGF BETA FAMILY, V0, P0
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   DiMauro S, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Dirkx E, 2013, BBA-MOL BASIS DIS, V1832, P2414, DOI 10.1016/j.bbadis.2013.07.023
   Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033
   Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256
   Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004
   Dong Y, 2017, MOL CELLS, V40, P195, DOI 10.14348/molcells.2017.2291
   Dorn T, 2015, STEM CELLS, V33, P1113, DOI 10.1002/stem.1923
   Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398
   Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fayssoil Abdallah, 2009, CONGEST HEART FAIL, V15, P284, DOI 10.1111/j.1751-7133.2009.00108.x
   Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018
   Garcia-Garcia F, 2016, BIOINFORMATICS, V32, P2809, DOI 10.1093/bioinformatics/btw334
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379
   Horbelt D, 2012, INT J BIOCHEM CELL B, V44, P469, DOI 10.1016/j.biocel.2011.12.013
   Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65
   Jiang M, 2017, CELL METAB, V26, P429, DOI 10.1016/j.cmet.2017.07.003
   Jin Yi, 2013, METHODS MOL BIOL, V936, P117
   Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104
   Kandel J, 2017, J R SOC INTERFACE, V14, P0, DOI 10.1098/rsif.2017.0071
   Kardassis D, 2009, FEBS J, V276, P2947, DOI 10.1111/j.1742-4658.2009.07031.x
   Kastner P, 1997, DEVELOPMENT, V124, P4749
   Kim DS, 2002, J KOREAN MED SCI, V17, P103, DOI 10.3346/jkms.2002.17.1.103
   Kovacic JC, 2012, CIRCULATION, V125, P1795, DOI 10.1161/CIRCULATIONAHA.111.040352
   Krainock M, 2016, J CLIN MED, V5, P0, DOI 10.3390/jcm5020027
   Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758
   Li XN, 2016, BIOCHEM BIOPH RES CO, V477, P768, DOI 10.1016/j.bbrc.2016.06.133
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Majamaa-Voltti K, 2008, J NEUROL NEUROSUR PS, V79, P0, DOI 10.1136/jnnp.2007.122648
   Majamaa-Voltti K, 2002, BMC CARDIOVASC DISOR, V2, P12, DOI 10.1093/BRAIN/AWH515
   Marques FZ, 2016, EUR J HEART FAIL, V18, P1000, DOI 10.1002/ejhf.517
   Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639
   Mercola M, 2011, GENE DEV, V25, P299, DOI 10.1101/gad.2018411
   Meseguer S, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-06553-w
   Mesegueri S, 2015, HUM MOL GENET, V24, P167, DOI 10.1093/hmg/ddu427
   Meyers DE, 2013, TEX HEART I J, V40, P385
   Minocherhomji S, 2012, EPIGENETICS-US, V7, P326, DOI 10.4161/epi.19547
   Miyamoto S, 2010, J CARDIOVASC TRANSL, V3, P330, DOI 10.1007/s12265-010-9192-8
   Ng YS, 2016, EUR HEART J, V37, P2552, DOI 10.1093/eurheartj/ehv306
   Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Oka T, 2007, SEMIN CELL DEV BIOL, V18, P117, DOI 10.1016/j.semcdb.2006.11.012
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   Paul P, 2018, J CELL PHYSIOL, V233, P2007, DOI 10.1002/jcp.25854
   Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473
   Phillips HM, 2005, CIRC RES, V96, P292, DOI 10.1161/01.RES.0000154912.08695.88
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501
   Ramos-Mondragón R, 2008, VASC HEALTH RISK MAN, V4, P1289
   Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003
   Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schier AF, 2009, CSH PERSPECT BIOL, V1, P0, DOI 10.1101/cshperspect.a003459
   Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X
   Singh R, 2006, J MOL DIAGN, V8, P225, DOI 10.2353/jmoldx.2006.050067
   Später D, 2014, DEVELOPMENT, V141, P4418, DOI 10.1242/dev.091538
   Stefanovic S, 2017, MECH DEVELOP, V143, P9, DOI 10.1016/j.mod.2016.12.002
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234
   Takefuji M, 2013, J EXP MED, V210, P665, DOI 10.1084/jem.20122126
   Tavares ALP, 2006, DEV DYNAM, V235, P1589, DOI 10.1002/dvdy.20771
   Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007
   Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006
   Thum T, 2007, ARTERIOSCL THROM VAS, V27, P748, DOI 10.1161/01.ATV.0000258787.18982.73
   Van Vliet P, 2012, CARDIOVASC RES, V96, P352, DOI 10.1093/cvr/cvs270
   Vendramin R, 2017, EMBO J, V36, P1123, DOI 10.15252/embj.201695546
   von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013
   Wang W, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep41639
   Wang Y, 2016, NUCLEIC ACIDS RES, V44, P6741, DOI 10.1093/nar/gkw301
   Wei L, 2002, DEVELOPMENT, V129, P1705
   Wrana JL, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011197
   Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5
   Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328
   Zhou Q, 2016, CELL PHYSIOL BIOCHEM, V39, P453, DOI 10.1159/000445638
NR 99
TC 12
Z9 12
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 0006-3002
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD SEP 15
PY 2018
VL 1864
IS 9
BP 3022
EP 3037
DI 10.1016/j.bbadis.2018.06.014
PG 16
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA GQ8ZR
UT WOS:000442056200025
PM 29928977
DA 2024-11-01
ER

PT J
AU Emami, NK
   Golian, A
   Mesgaran, MD
   Anthony, NB
   Rhoads, DD
AF Emami, N. Khodambashi
   Golian, A.
   Mesgaran, M. Danesh
   Anthony, N. B.
   Rhoads, D. D.
TI Mitochondrial biogenesis and PGC-1α gene expression in male broilers from ascites-susceptible and -resistant lines
SO JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION
LA English
DT Article
DE ascites; biogenesis; broilers; mitochondria; PGC-1 alpha
ID pulmonary-hypertension syndrome; slow-twitch; dysfunction; selection; muscle; pcr
AB Ascites is a cardiovascular metabolic disease characterized by accumulation of fluid around the heart and in the abdominal cavity that eventually leads to death. This syndrome is the end-point result of a series of metabolic incidents that are generally caused by impaired oxygen availability. Mitochondria are the major sites of oxygen consumption, therefore major contributors to oxidative stress. Genetic, metabolic and dietary factors can influence variations in mitochondrial biogenesis (mitochondrial size, number and mass) that might have an effect on oxygen consumption and reactive oxygen species production. This study evaluated the effect of genotype on PGC-1 alpha mRNA gene expression and mitochondrial biogenesis. These parameters were examined in male broiler chickens at 22 weeks of age from the SUS and RES lines divergently selected for ascites phenotype. From each line, five birds were sampled for right ventricle and breast muscle. Gene expression and mtDNA copy number were assessed by quantitative PCR. Results showed that birds from SUS had significantly higher PGC-1 alpha mRNA gene (p = .033) and mitochondrial DNA copy number (p = .038) in breast muscle. There was no difference in right ventricle PGC-1 alpha expression or mitochondrial DNA copy number between the two lines. These findings indicate that mitochondrial biogenesis and PGC-1 alpha mRNA gene expression differ between male broiler chickens from RES and SUS lines in a tissue-specific manner.
C1 [Emami, N. Khodambashi; Golian, A.; Mesgaran, M. Danesh] Ferdowsi Univ Mashhad, Dept Anim Sci, Mashhad, Iran.
   [Emami, N. Khodambashi; Anthony, N. B.; Rhoads, D. D.] Univ Arkansas, Interdisciplinary Grad Program Cell & Mol Biol, Fayetteville, AR 72701 USA.
   [Anthony, N. B.] Univ Arkansas, Dept Poultry Sci, Fayetteville, AR 72701 USA.
   [Rhoads, D. D.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA.
C3 Ferdowsi University Mashhad; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville
RP Golian, A (corresponding author), Ferdowsi Univ Mashhad, Fac Agr, Dept Anim Sci, Mashhad, Iran.
EM Golian_a@um.ac.ir
FU USDA-NIFA-AFRI [11640136]
CR Aksit M, 2008, ARCH GEFLUGELKD, V72, P221
   Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662
   Azizian M, 2013, J AGR SCI TECH-IRAN, V15, P517
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Cawthon D, 2001, POULTRY SCI, V80, P474, DOI 10.1093/ps/80.4.474
   Currie RJW, 1999, AVIAN PATHOL, V28, P313, DOI 10.1080/03079459994560
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, P884S, DOI 10.3945/ajcn.110.001917
   Hirabayashi M, 2005, ENDOCRINOLOGY, V146, P399, DOI 10.1210/en.2004-0723
   Iqbal M, 2001, POULTRY SCI, V80, P485, DOI 10.1093/ps/80.4.485
   Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Malan DD, 2003, BRIT POULTRY SCI, V44, P309, DOI 10.1080/000716603100024603
   Mecleiros DM, 2008, METHODS, V46, P288, DOI 10.1016/j.ymeth.2008.09.026
   Paton MG, 2000, BIOCHEM J, V346, P17, DOI 10.1042/0264-6021:3460017
   Pavlidis HO, 2007, POULTRY SCI, V86, P2517, DOI 10.3382/ps.2007-00134
   Pavlidis HO, 2003, THESIS, V0, P0
   Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177
   Sambrook J, 1989, MOLECULAR CLONING, V0, P0
   SAS, 2004, US GUID, V0, P0
   Ueda M, 2005, FEBS LETT, V579, P11, DOI 10.1016/j.febslet.2004.11.039
   Velleman SG, 2014, STURKIES AVIAN PHYSL, V0, P1
   Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098
   Walter I, 2007, AM J PHYSIOL-REG I, V293, PR2315, DOI 10.1152/ajpregu.00505.2007
   Wenz T, 2013, MITOCHONDRION, V13, P134, DOI 10.1016/j.mito.2013.01.006
   Wideman RF, 2013, POULTRY SCI, V92, P64, DOI 10.3382/ps.2012-02745
NR 26
TC 7
Z9 9
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0931-2439
EI 1439-0396
J9 J ANIM PHYSIOL AN N
JI J. Anim. Physiol. Anim. Nutr.
PD FEB 15
PY 2018
VL 102
IS 1
BP E482
EP E485
DI 10.1111/jpn.12706
PG 4
WC Agriculture, Dairy & Animal Science; Veterinary Sciences
SC Agriculture; Veterinary Sciences
GA GD3AD
UT WOS:000430374000055
PM 28439972
DA 2024-11-01
ER

PT J
AU Kowald, A
   Kirkwood, TBL
AF Kowald, Axel
   Kirkwood, Thomas B. L.
TI Resolving the Enigma of the Clonal Expansion of mtDNA Deletions
SO GENES
LA English
DT Article
DE aging; mitochondrial deletion mutants; model of clonal expansion
ID mitochondrial-dna mutations; aged muscle-fibers; causal role; fusion; accumulation; fission; replication; mutants; abnormality; transcription
AB Mitochondria are cell organelles that are special since they contain their own genetic material in the form of mitochondrial DNA (mtDNA). Damage and mutations of mtDNA are not only involved in several inherited human diseases but are also widely thought to play an important role during aging. In both cases, point mutations or large deletions accumulate inside cells, leading to functional impairment once a certain threshold has been surpassed. In most cases, it is a single type of mutant that clonally expands and out-competes the wild type mtDNA, with different mutant molecules being amplified in different cells. The challenge is to explain where the selection advantage for the accumulation comes from, why such a large range of different deletions seem to possess this advantage, and how this process can scale to species with different lifespans such as those of rats and man. From this perspective, we provide an overview of current ideas, present an update of our own proposal, and discuss the wider relevance of the phenomenon for aging.
C1 [Kowald, Axel; Kirkwood, Thomas B. L.] Newcastle Univ, Inst Cell & Mol Biosci, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Kowald, Axel; Kirkwood, Thomas B. L.] Newcastle Univ, Inst Ageing, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Kirkwood, Thomas B. L.] Univ Copenhagen, Dept Cellular & Mol Med, Ctr Healthy Aging, DK-2200 Copenhagen, Denmark.
C3 Newcastle University - UK; Newcastle University - UK; University of Copenhagen
RP Kowald, A (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.; Kowald, A (corresponding author), Newcastle Univ, Inst Ageing, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
EM axel.kowald@ncl.ac.uk; tom.kirkwood@ncl.ac.uk
CR ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Collins ML, 2003, J APPL PHYSIOL, V94, P2203, DOI 10.1152/japplphysiol.00691.2002
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Dai Y, 2013, HUM MOL GENET, V6, P327
   Damas J, 2014, NUCLEIC ACIDS RES, V42, PD1261, DOI 10.1093/nar/gkt982
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Greaves LC, 2011, MECH AGEING DEV, V132, P588, DOI 10.1016/j.mad.2011.10.004
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Herbst A, 2016, AGING CELL, V15, P1132, DOI 10.1111/acel.12520
   Holt IJ, 2014, PHILOS T R SOC B, V369, P0, DOI 10.1098/rstb.2013.0451
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HUEMER RP, 1971, EXP GERONTOL, V6, P327, DOI 10.1016/0531-5565(71)90001-5
   Kandul NP, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13100
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Khrapko K, 2011, NAT GENET, V43, P726, DOI 10.1038/ng.895
   Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768
   Kontis V, 2017, LANCET, V389, P1323, DOI 10.1016/S0140-6736(16)32381-9
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Kowald A, 2014, J THEOR BIOL, V340, P111, DOI 10.1016/j.jtbi.2013.09.009
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Kowald A, 2011, P NATL ACAD SCI USA, V108, P10237, DOI 10.1073/pnas.1101604108
   Lakshmanan LN, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0035271
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   Lehtinen SK, 2000, GENETICS, V154, P363
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959
   Nicholas A, 2009, EXP NEUROL, V218, P316, DOI 10.1016/j.expneurol.2009.04.029
   Popadin K, 2014, AGING CELL, V13, P579, DOI 10.1111/acel.12231
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Tam ZY, 2015, PLOS COMPUT BIOL, V11, P0, DOI 10.1371/journal.pcbi.1004183
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Yang JN, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0073318
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
NR 58
TC 27
Z9 30
U1 1
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2073-4425
EI 
J9 GENES-BASEL
JI Genes
PD MAR 15
PY 2018
VL 9
IS 3
BP 
EP 
DI 10.3390/genes9030126
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA GA7IE
UT WOS:000428508800009
PM 29495484
DA 2024-11-01
ER

PT J
AU Li, B
   Kaushik, S
   Kalinowski, P
   Kim, B
   Gershome, C
   Ching, J
   Poburko, D
AF Li, Brian
   Kaushik, Sonal
   Kalinowski, Pola
   Kim, BaRun
   Gershome, Cynthia
   Ching, Joyce
   Poburko, Damon
TI Droplet digital PCR shows the D-Loop to be an error prone locus for mitochondrial DNA copy number determination
SO SCIENTIFIC REPORTS
LA English
DT Article
ID alzheimers-disease; smooth-muscle; assay; depletion; mtdna; gene; quantitation; association; duplication; sensitivity
AB Absolute quantification of mitochondrial DNA copy number (mCN) provides important insights in many fields of research including cancer, cardiovascular and reproductive health. Droplet digital PCR (ddPCR) natively reports absolute copy number, and we have developed a single-dye, multiplex assay to measure rat mCN that is accurate, precise and affordable. We demonstrate simple methods to optimize this assay and to determine nuclear reference pseudogene copy number to extend the range of mCN that can be measured with this assay. We evaluated two commonly used mitochondrial DNA reference loci to determine mCN, the ND1 gene and the D-Loop. Harnessing the absolute measures of ddPCR, we found that the D-Loop amplifies with a copy number of similar to 1.0-1.5 relative to other sites on the mitochondrial genome. This anomalous copy number varied significantly between rats and tissues (aorta, brain, heart, liver, soleus muscle). We advocate for avoiding the D-Loop as a mitochondrial reference in future studies of mCN. Further, we report a novel approach to quantifying immunolabelled mitochondrial DNA that provides single-cell estimates of mCN that closely agree with the population analyses by ddPCR. The combination of these assays represents a cost-effective and powerful suite of tools to study mCN.
C1 [Li, Brian; Kaushik, Sonal; Kalinowski, Pola; Kim, BaRun; Gershome, Cynthia; Ching, Joyce; Poburko, Damon] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada.
   [Poburko, Damon] Simon Fraser Univ, Ctr Cell Biol Dev & Dis, Burnaby, BC, Canada.
C3 Simon Fraser University; Simon Fraser University
RP Poburko, D (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada.; Poburko, D (corresponding author), Simon Fraser Univ, Ctr Cell Biol Dev & Dis, Burnaby, BC, Canada.
EM dpoburko@sfu.ca
CR Abhyankar A, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0008148
   Aguet F, 2008, IEEE T IMAGE PROCESS, V17, P1144, DOI 10.1109/TIP.2008.924393
   Akiyama T, 2017, MOL PHYLOGENET EVOL, V106, P158, DOI 10.1016/j.ympev.2016.09.026
   Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013
   Belmonte FR, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep25186
   Chalmers S, 2012, ARTERIOSCL THROM VAS, V32, P3000, DOI 10.1161/ATVBAHA.112.255174
   Coskun PE, 2010, J ALZHEIMERS DIS, V20, PS293, DOI 10.3233/JAD-2010-100351
   DErchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Dai JZ, 2005, CELL CALCIUM, V37, P333, DOI 10.1016/j.ceca.2004.12.002
   Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g
   Hou YB, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0009545
   Janes MS, 2004, J HISTOCHEM CYTOCHEM, V52, P1011, DOI 10.1369/jhc.3a6209.2004
   Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804
   Kirsty F, 2018, AGING CELL, V0, P0
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Liu X, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-14491-w
   Maximov V, 2002, MED HYPOTHESES, V59, P670, DOI 10.1016/S0306-9877(02)00223-2
   McDermott GP, 2013, ANAL CHEM, V85, P11619, DOI 10.1021/ac403061n
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Miotke L, 2014, ANAL CHEM, V86, P2618, DOI 10.1021/ac403843j
   MORITZ C, 1986, SCIENCE, V233, P1425, DOI 10.1126/science.3018925
   Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Nicklas JA, 2004, ENVIRON MOL MUTAGEN, V44, P313, DOI 10.1002/em.20050
   Phillips NR, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep03887
   Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x
   Poburko D, 2004, TRENDS PHARMACOL SCI, V25, P8, DOI 10.1016/j.tips.2003.10.011
   Poburko D, 2009, CIRC RES, V104, P104, DOI 10.1161/CIRCRESAHA.108.180612
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   SNYDER M, 1987, P NATL ACAD SCI USA, V84, P7595, DOI 10.1073/pnas.84.21.7595
   Sun YB, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0037178
   Sze MA, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0110351
   Tanaka A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067642
   Tanaka T, 2017, IN VIVO, V31, P713, DOI 10.21873/invivo.11119
   Ungvari Z, 2010, J MOL MED, V88, P1021, DOI 10.1007/s00109-010-0667-5
   Var SR, 2016, AIDS, V30, P839, DOI 10.1097/QAD.0000000000001027
   Wachsmuth M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005939
   Wang SW, 2011, CIRC RES, V108, P862, DOI 10.1161/CIRCRESAHA.110.231811
   Weerakoon KG, 2016, J MICROBIOL METH, V125, P19, DOI 10.1016/j.mimet.2016.03.012
   Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213
   Xu YY, 2017, ENVIRON HEALTH-GLOB, V16, P0, DOI 10.1186/s12940-017-0234-4
   Yu M, 2013, TRANSL RES, V161, P165, DOI 10.1016/j.trsl.2012.10.011
   Yu M, 2010, CLIN CHIM ACTA, V411, P679, DOI 10.1016/j.cca.2010.01.035
   Zole E, 2017, MITOCHONDRIAL DNA A, V0, P1
NR 49
TC 14
Z9 17
U1 0
U2 12
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD JUL 30
PY 2018
VL 8
IS 
BP 
EP 
DI 10.1038/s41598-018-29621-1
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GO6IS
UT WOS:000440144400009
PM 30061621
DA 2024-11-01
ER

PT J
AU Hynynen, J
   Pokka, T
   Komulainen-Ebrahim, J
   Myllynen, P
   Kärppä, M
   Pylvänen, L
   Kälviäinen, R
   Sokka, A
   Jyrkilä, A
   Lähdetie, J
   Haataja, L
   Mäkitalo, A
   Ylikotila, P
   Eriksson, K
   Haapala, P
   Ansakorpi, H
   Hinttala, R
   Vieira, P
   Majamaa, K
   Rantala, H
   Uusimaa, J
AF Hynynen, Johanna
   Pokka, Tytti
   Komulainen-Ebrahim, Jonna
   Myllynen, Paivi
   Karppa, Mikko
   Pylvanen, Laura
   Kalviainen, Reetta
   Sokka, Arja
   Jyrkila, Aino
   Lahdetie, Jaana
   Haataja, Leena
   Makitalo, Anna
   Ylikotila, Pauli
   Eriksson, Kai
   Haapala, Piia
   Ansakorpi, Hanna
   Hinttala, Reetta
   Vieira, Paivi
   Majamaa, Kari
   Rantala, Heikki
   Uusimaa, Johanna
TI Variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma <i>POLG1</i> are not associated with increased risk for valproate-induced hepatotoxicity or pancreatic toxicity: A retrospective cohort study of patients with epilepsy
SO EPILEPSIA
LA English
DT Article
DE drug-induced liver injury; mtDNA; mutation; pancreatitis
ID w748s mutation; alpers-syndrome; liver-failure; spectrum; ataxia; encephalopathy; myopathy; gene
AB Objective Previous studies have suggested that heterozygous variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma (POLG1) increase the risk for liver injury for patients on valproate (VPA) therapy. We assessed the prevalence of these common variants and seven other pathogenic mutations in POLG1 and determined the occurrence of VPA-induced hepatotoxicity (VHT) or pancreatic toxicity in a cohort of patients with epilepsy. Methods Results Patients with epilepsy (N = 367) were retrospectively identified from medical record files and screened for mutations in POLG1. Patients who had received VPA monotherapy and carried either of the two variants, p.Q1236H or p.E1143G, without other pathogenic mutations in POLG1 (n = 33, variant group) and patients without these variants (n = 28, nonvariant group) were included in the study. Clinical data on epilepsy, characteristics of VPA treatment, risk factors for VHT, laboratory data on liver and pancreas functions, and adverse effects were collected. A total of 122 patients had either the POLG1 p.Q1236H (n = 99) or p.E1143G (n = 24) variant in the heterozygous or homozygous state. Transient liver dysfunction was identified in three (n = 33, 9.1%) variant group patients and in one (n = 28, 3.6%) nonvariant group patient (P = 0.62). Mild to moderate elevations in liver enzymes were encountered in both groups. Furthermore, two patients on VPA polytherapy developed acute pancreatitis, and two pediatric patients with heterozygous p.Q1236H variants and mutations in IQSEC2 and GLDC, respectively, had elevated levels of VPA metabolites in urine, elevated plasma glycine, and/or increased acylglycine excretion. Significance POLG1 p.Q1236H and p.E1143G variants could not be identified as statistically significant risk factors for VHT or pancreatic toxicity. We suggest that VPA treatment could be suitable for patients who harbor these common variants in the absence of other pathogenic mutations in POLG1.
C1 [Hynynen, Johanna; Pokka, Tytti; Komulainen-Ebrahim, Jonna; Hinttala, Reetta; Vieira, Paivi; Rantala, Heikki; Uusimaa, Johanna] Univ Oulu, Res Unit Pediat Pediat Neurol Pediat Surg Child P, Otorhinolaryngol & Ophthalmol, Oulu, Finland.
   [Hynynen, Johanna; Komulainen-Ebrahim, Jonna; Karppa, Mikko; Ansakorpi, Hanna; Hinttala, Reetta; Vieira, Paivi; Majamaa, Kari; Rantala, Heikki; Uusimaa, Johanna] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland.
   [Hynynen, Johanna; Komulainen-Ebrahim, Jonna; Hinttala, Reetta; Uusimaa, Johanna] Univ Oulu, Bioctr Oulu, Oulu, Finland.
   [Hynynen, Johanna; Pokka, Tytti; Komulainen-Ebrahim, Jonna; Vieira, Paivi; Rantala, Heikki; Uusimaa, Johanna] Oulu Univ Hosp, Div Pediat Neurol, Dept Children & Adolescents, Oulu, Finland.
   [Myllynen, Paivi] Oulu Univ Hosp, Nordlab Oulu, Oulu, Finland.
   [Karppa, Mikko; Kalviainen, Reetta; Ansakorpi, Hanna; Majamaa, Kari] Oulu Univ Hosp, Dept Neurol, Oulu, Finland.
   [Karppa, Mikko; Ansakorpi, Hanna; Majamaa, Kari] Univ Oulu, Res Unit Clin Neurosci, Neurol, Oulu, Finland.
   [Kalviainen, Reetta] Kuopio Univ Hosp, Dept Neurol, Kuopio, Finland.
   [Kalviainen, Reetta; Sokka, Arja; Jyrkila, Aino] Univ Eastern Finland, Inst Clin Med, Sch Med, Fac Hlth Sci, Kuopio, Finland.
   [Sokka, Arja; Jyrkila, Aino] Kuopio Univ Hosp, Dept Pediat Neurol, Kuopio, Finland.
   [Lahdetie, Jaana; Makitalo, Anna] Univ Turku, Dept Child Neurol, Turku, Finland.
   [Lahdetie, Jaana; Makitalo, Anna] Turku Univ Cent Hosp, Turku, Finland.
   [Haataja, Leena] Univ Helsinki, Childrens Hosp, Dept Pediat Neurol, Helsinki, Finland.
   [Haataja, Leena] Helsinki Univ Hosp, Helsinki, Finland.
   [Makitalo, Anna] Univ Turku, Dept Geriatr Med, Turku, Finland.
   [Ylikotila, Pauli] Univ Turku, Inst Clin Med, Dept Neurol, Turku, Finland.
   [Ylikotila, Pauli] Turku Univ Hosp, Div Clin Neurosci, Turku, Finland.
   [Eriksson, Kai] Tampere Univ Hosp, Tampere Ctr Child Hlth Res & Pediat Neurol, Tampere, Finland.
C3 University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Turku; University of Turku; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Turku; University of Turku; Tampere University; Tampere University Hospital
RP Uusimaa, J (corresponding author), Univ Oulu, PEDEGO Res Unit, Oulu, Finland.; Uusimaa, J (corresponding author), Univ Oulu, Med Res Ctr Oulu, Oulu, Finland.
EM johanna.uusimaa@oulu.fi
FU Special State Grants for Health Research in the Department of Pediatrics and Adolescence, Oulu University Hospital, Oulu, Finland; Arvo and Lea Ylppo Foundation; Orion Research Foundation; Foundation for Pediatric Research, Finland; Academy of Finland [138566]; Epilepsy Research Foundation, Finland; Academy of Finland (AKA) [138566] Funding Source: Academy of Finland (AKA)
CR ASCONAPE JJ, 1993, EPILEPSIA, V34, P177, DOI 10.1111/j.1528-1157.1993.tb02395.x
   Baruffini E, 2015, MITOCHONDRION, V20, P52, DOI 10.1016/j.mito.2014.11.003
   Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006
   Béreau M, 2016, J NEUROL SCI, V368, P70, DOI 10.1016/j.jns.2016.06.062
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Fromenty B, 1997, J HEPATOL, V26, P43, DOI 10.1016/S0168-8278(97)80496-5
   Glauser T, 2013, EPILEPSIA, V54, P551, DOI 10.1111/epi.12074
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hynynen J, 2014, LIVER TRANSPLANT, V20, P1402, DOI 10.1002/lt.23965
   Janssen W, 2016, ACTA NEUROL BELG, V116, P17, DOI 10.1007/s13760-015-0499-8
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kayihan N, 2000, PEDIATR TRANSPLANT, V4, P211, DOI 10.1034/j.1399-3046.2000.00115.x
   Koenig SA, 2006, EPILEPSIA, V47, P2027, DOI 10.1111/j.1528-1167.2006.00846.x
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Li SB, 2015, HEPATOLOGY, V61, P1730, DOI 10.1002/hep.27712
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Schmid MM, 2013, PHARMACOPSYCHIATRY, V46, P63, DOI 10.1055/s-0032-1323671
   Silva MFB, 2008, J INHERIT METAB DIS, V31, P205, DOI 10.1007/s10545-008-0841-x
   Sinclair DB, 2004, J CHILD NEUROL, V19, P498, DOI 10.1177/08830738040190070401
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Zabalza Ramon, 2014, BMC RES NOTES, V7, P883, DOI 10.1186/1756-0500-7-883
   Zerem A, 2016, EPILEPSIA, V57, P1858, DOI 10.1111/epi.13560
NR 38
TC 9
Z9 10
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0013-9580
EI 1528-1167
J9 EPILEPSIA
JI Epilepsia
PD NOV 15
PY 2018
VL 59
IS 11
BP 2125
EP 2136
DI 10.1111/epi.14568
PG 12
WC Clinical Neurology
SC Neurosciences & Neurology
GA HC4PA
UT WOS:000451784500014
PM 30255931
DA 2024-11-01
ER

PT J
AU Vandecasteele, SJ
   Seneca, S
   Smet, J
   Reynders, M
   De Ceulaer, J
   Vanlander, AV
   van Coster, R
AF Vandecasteele, S. J.
   Seneca, S.
   Smet, J.
   Reynders, M.
   De Ceulaer, J.
   Vanlander, A. V.
   van Coster, R.
TI Tigecycline-induced inhibition of mitochondrial DNA translation may cause lethal mitochondrial dysfunction in humans
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE 12SrRNApolymorphism; Mitochondrial toxicity; mtDNA Translation; Side effect; Tigecycline
ID ribosomal-rna; mutations; pathology
AB Background: A 65-year-old patient developed an unexplained and ultimately lethal metabolic acidosis under prolonged treatment with tigecycline. Tigecycline is known to have a selective inhibitory effect on eukaryotic mitochondrial translation. The underlying molecular mechanisms of the metabolic acidosis in this patient were explored. Methods: Oxidative phosphorylation system (OXPHOS) analysis, blue native polyacrylamide gel electrophoresis followed by in-gel activity staining in mitochondria, molecular analysis of mitochondrial DNA (mtDNA) for genomic rearrangements and sequencing of the rRNA genes was performed on the subject's skeletal muscle. Results: OXPHOS analysis revealed a combined deficiency of the complexes I, III, IV and V, with a preserved function of complex II (encoded by nuclear DNA), thus demonstrating a defective mtDNA translation. There were no known underlying mitochondrial genetic defects. The patient had a (m.1391T > A) variant within the 12SrRNA gene in heteroplasmy (50-60%). Conclusions: This patient developed an ultimately lethal mitochondrial toxicity while receiving prolonged treatment with tigecycline, which was caused by a defective translation of the mtDNA. Tigecycline is known to suppress eukaryotic mitochondrial DNA translation, but until now this effect has been considered to be clinically insignificant. The observations in this patient suggest a clinically significant mitochondrial toxicity of tigecycline in this patient, and warrant further investigation. (C) 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Vandecasteele, S. J.] AZ Sint Jan Brugge, Dept Nephrol & Infect Dis, Rudderhove 10, B-8000 Brugge, Belgium.
   [Vandecasteele, S. J.; Reynders, M.] AZ Sint Jan Brugge, Dept Microbiol, Brugge, Belgium.
   [De Ceulaer, J.] AZ Sint Jan Brugge, Dept Maxillofacial Surg, Brugge, Belgium.
   [Seneca, S.] Vrije Univ Brussel, UZ Brussel, Ctr Med Genet, Res Grp Reprod & Genet, Ixelles, Belgium.
   [Smet, J.; Vanlander, A. V.; van Coster, R.] Ghent Univ Hosp, Div Pediat Neurol & Metab, Dept Pediat, Ghent, Belgium.
C3 University Hospital Brussels; Vrije Universiteit Brussel; Ghent University; Ghent University Hospital
RP Vandecasteele, SJ (corresponding author), AZ Sint Jan Brugge, Dept Nephrol & Infect Dis, Rudderhove 10, B-8000 Brugge, Belgium.
EM stefaan.vandecasteele@azsintjan.be
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006
   Hargreaves IP, 2016, DRUG SAFETY, V39, P661, DOI 10.1007/s40264-016-0417-x
   Jhas B, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0058367
   Jitkova Y, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0095281
   Olson MW, 2006, ANTIMICROB AGENTS CH, V50, P2156, DOI 10.1128/AAC.01499-05
   Prasad P, 2012, CLIN INFECT DIS, V54, P1699, DOI 10.1093/cid/cis270
   Qian YP, 2009, ANTIMICROB AGENTS CH, V53, P4612, DOI 10.1128/AAC.00965-08
   Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Smith PM, 2014, HUM MOL GENET, V23, P949, DOI 10.1093/hmg/ddt490
   Stein GE, 2013, DIAGN MICR INFEC DIS, V75, P331, DOI 10.1016/j.diagmicrobio.2012.12.004
   Yamasoba T, 2002, NEUROMUSCULAR DISORD, V12, P506, DOI 10.1016/S0960-8966(01)00329-7
NR 15
TC 11
Z9 11
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD APR 15
PY 2018
VL 24
IS 4
BP 
EP 
DI 10.1016/j.cmi.2017.08.018
PG 3
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FZ8AG
UT WOS:000427826500021
PM 28870729
DA 2024-11-01
ER

PT J
AU Jackson, KC
   Tarpey, MD
   Valencia, AP
   Inigo, MR
   Pratt, SJ
   Patteson, DJ
   McClung, JM
   Lovering, RM
   Thomson, DM
   Spangenburg, EE
AF Jackson, Kathryn C.
   Tarpey, Michael D.
   Valencia, Ana P.
   Inigo, Melissa R.
   Pratt, Stephen J.
   Patteson, Daniel J.
   McClung, Joseph M.
   Lovering, Richard M.
   Thomson, David M.
   Spangenburg, Espen E.
TI Induced Cre-mediated knockdown of Brca1 in skeletal muscle reduces mitochondrial respiration and prevents glucose intolerance in adult mice on a high-fat diet
SO FASEB JOURNAL
LA English
DT Article
DE metabolism; disease; breast; cancer
ID cells
AB The breast cancer type 1 susceptibility protein (Brca1) is a regulator of DNA repair in mammary gland cells; however, recent cell culture evidence suggests that Brca1 influences other processes, including those in nonmammary cells. In this study, we sought to determine whether Brca1 is necessary for metabolic regulation of skeletal muscle using a . novel in vivo mouse model. We developed an inducible skeletal muscle-specific Brca1-knockout (BRCA1KO(smi)) model to test whether Brca1 expression is necessary for maintenance of metabolic function of skeletal muscle when exposed to a high-fat diet (HFD). Our data demonstrated that deletion of Brca1 prevented HFD-induced alterations in glucose and insulin tolerance. Irrespective of diet, BRCA1KO(smi) mice exhibited significantly lower ADP-stimulated complex I mitochondrial respiration rates compared to age-matched wild-type (WT) mice. The data show that Brca1 has the ability to localize to the mitochondria in skeletal muscle and that BRCA1KO(smi) mice exhibit higher whole-body CO2 production, respiratory exchange ratio, and energy expenditure, compared with the WT mice. Our results demonstrate that loss of Brca1 in skeletal muscle leads to dysregulated metabolic function, characterized by decreased mitochondrial respiration. Thus, any condition that results in loss of Brca1 function could induce metabolic imbalance in skeletal muscle.
EM spangenburge14@ecu.edu
FU U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases [R21AR059913, RO1AR066660, R01AR059179, R21AR067872]; NIH National Heart, Lung, and Blood Institute [RO1HL125695]; NIH National Institute on Aging [T32 AG000268]
CR Coene ED, 2005, MOL BIOL CELL, V16, P997, DOI 10.1091/mbc.E04-10-0895
   DiFranco Marino, 2009, J VIS EXP, V0, P0, DOI DOI 10.3791/1520
   Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, PC723, DOI 10.1152/ajpcell.00462.2010
   Garcia-Cazarin ML, 2011, J. VIS. EXP, V0, P2452
   Gilliam LAA, 2012, J PHARMACOL EXP THER, V342, P631, DOI 10.1124/jpet.112.192146
   Henderson BR, 2005, BIOESSAYS, V27, P884, DOI 10.1002/bies.20277
   Jackson KC, 2014, J LIPID RES, V55, P668, DOI 10.1194/jlr.M043851
   Lovren F, 2014, J THORAC CARDIOV SUR, V147, P1946, DOI 10.1016/j.jtcvs.2013.09.060
   Maniccia AW, 2009, J CELL PHYSIOL, V219, P634, DOI 10.1002/jcp.21708
   MARQUIS ST, 1995, NAT GENET, V11, P17, DOI 10.1038/ng0995-17
   McCarthy JJ, 2012, SKELET MUSCLE, V2, P0, DOI 10.1186/2044-5040-2-8
   Pao GM, 2014, P NATL ACAD SCI USA, V111, PE1240, DOI 10.1073/pnas.1400783111
   Privat M, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0102438
   Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181
   Singh KK, 2013, J THORAC CARDIOV SUR, V146, P702, DOI 10.1016/j.jtcvs.2012.12.046
   Spangenburg EE, 2011, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2011/598358
   StoneO MR, 2007, J CELL SCI, V120, P3999, DOI 10.1242/jcs.009241
   Suberbielle E, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9897
   Thompson ME, 2010, FEBS J, V277, P3072, DOI 10.1111/j.1742-4658.2010.07733.x
   Wall CE, 2015, P NATL ACAD SCI USA, V112, P8714, DOI 10.1073/pnas.1509930112
   White AT, 2015, MOL METAB, V4, P569, DOI 10.1016/j.molmet.2015.05.001
   Wohlers LM, 2011, J CELL BIOCHEM, V112, P3675, DOI 10.1002/jcb.23302
   Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743
NR 23
TC 14
Z9 18
U1 0
U2 7
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD JUN 15
PY 2018
VL 32
IS 6
BP 3070
EP 3084
DI 10.1096/fj.201700464R
PG 15
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology
GA GG2TP
UT WOS:000432546000015
PM 29401626
DA 2024-11-01
ER

PT J
AU Thompson, K
   Mai, N
   Oláhová, M
   Scialó, F
   Formosa, LE
   Stroud, DA
   Garrett, M
   Lax, NZ
   Robertson, FM
   Jou, C
   Nascimento, A
   Ortez, C
   Jimenez-Mallebrera, C
   Hardy, SA
   He, LP
   Brown, GK
   Marttinen, P
   McFarland, R
   Sanz, A
   Battersby, BJ
   Bonnen, PE
   Ryan, MT
   Chrzanowska-Lightowlers, ZMA
   Lightowlers, RN
   Taylor, RW
AF Thompson, Kyle
   Mai, Nicole
   Olahova, Monika
   Scialo, Filippo
   Formosa, Luke E.
   Stroud, David A.
   Garrett, Madeleine
   Lax, Nichola Z.
   Robertson, Fiona M.
   Jou, Cristina
   Nascimento, Andres
   Ortez, Carlos
   Jimenez-Mallebrera, Cecilia
   Hardy, Steven A.
   He, Langping
   Brown, Garry K.
   Marttinen, Paula
   McFarland, Robert
   Sanz, Alberto
   Battersby, Brendan J.
   Bonnen, Penelope E.
   Ryan, Michael T.
   Chrzanowska-Lightowlers, Zofia M. A.
   Lightowlers, Robert N.
   Taylor, Robert W.
TI <i>OXA1L</i> mutations cause mitochondrial encephalopathy and a combined oxidative phosphorylation defect
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE encephalopathy; insertase; mitochondria; OXA1L; OXPHOS
ID cytochrome-c-oxidase; computational platform; membrane insertase; f1fo-atp synthase; protein; export; gene; interacts; disease; tail
AB OXA1, the mitochondrial member of the YidC/Alb3/Oxa1 membrane protein insertase family, is required for the assembly of oxidative phosphorylation complexes IV and V in yeast. However, depletion of human OXA1 (OXA1L) was previously reported to impair assembly of complexes I and V only. We report a patient presenting with severe encephalopathy, hypotonia and developmental delay who died at 5 years showing complex IV deficiency in skeletal muscle. Whole exome sequencing identified biallelic OXA1L variants (c.500_507dup, p.(Ser170Glnfs*18) and c.620G>T, p.(Cys207Phe)) that segregated with disease. Patient muscle and fibroblasts showed decreased OXA1L and subunits of complexes IV and V. Crucially, expression of wild-type human OXA1L in patient fibroblasts rescued the complex IV and V defects. Targeted depletion of OXA1L in human cells or Drosophila melanogaster caused defects in the assembly of complexes I, IV and V, consistent with patient data. Immunoprecipitation of OXA1L revealed the enrichment of mtDNA-encoded subunits of complexes I, IV and V. Our data verify the pathogenicity of these OXA1L variants and demonstrate that OXA1L is required for the assembly of multiple respiratory chain complexes.
C1 [Thompson, Kyle; Mai, Nicole; Olahova, Monika; Lax, Nichola Z.; Robertson, Fiona M.; Hardy, Steven A.; He, Langping; McFarland, Robert; Chrzanowska-Lightowlers, Zofia M. A.; Lightowlers, Robert N.; Taylor, Robert W.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Scialo, Filippo; Sanz, Alberto] Newcastle Univ, Inst Ageing, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England.
   [Formosa, Luke E.; Garrett, Madeleine; Ryan, Michael T.] Monash Univ, Monash Biomed Discovery Inst, Dept Biochem & Mol Biol, Melbourne, Vic, Australia.
   [Stroud, David A.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic, Australia.
   [Stroud, David A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic, Australia.
   [Jou, Cristina] Hosp St Joan de Deu, CIBERER, Pathol Dept, Barcelona, Spain.
   [Nascimento, Andres; Ortez, Carlos; Jimenez-Mallebrera, Cecilia] Hosp St Joan de Deu, CIBERER ISCIII, Neuromuscular Unit, Neuropaediat Dept, Barcelona, Spain.
   [Brown, Garry K.] Oxford Univ Hosp NHS Fdn Trust, Churchill Hosp, Oxford Med Genet Labs, Oxford, England.
   [Marttinen, Paula; Battersby, Brendan J.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland.
   [Bonnen, Penelope E.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
C3 Newcastle University - UK; Newcastle University - UK; Monash University; University of Melbourne; University of Melbourne; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Helsinki; Baylor College of Medicine
RP Taylor, RW (corresponding author), Newcastle Univ, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC) Centre for Translational Research in Neuromuscular Disease, Mitochondrial Disease Patient Cohort (UK) [G0800674]; Lily Foundation; UK NIHR Biomedical Research Centre for Ageing and Age-related disease award; MRC/EPSRC Molecular Pathology Node; National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R01NS083726]; Biotechnology and Biological Sciences Research Council [BB/M023311/1]; Australian Mitochondria Disease Foundation (AMDF); National Health & Medical Research Council (NHMRC) of Australia [APP 1125390, 1107094, 1140906, 1140851]; Instituto de Salud Carlos III; European Regional Development Fund (FEDER) [CP09/00011]; Barbour Foundation; UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children; National Health and Medical Research Council of Australia [1107094, 1140851, 1140906] Funding Source: NHMRC; BBSRC [BB/M023311/1] Funding Source: UKRI; MRC [G0800674] Funding Source: UKRI
CR Adzhubei Ivan, 2013, CURR PROTOC HUM GENET, VChapter 7, P0, DOI 10.1002/0471142905.hg0720s76
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Altamura N, 1996, FEBS LETT, V382, P111, DOI 10.1016/0014-5793(96)00165-2
   Anghel SA, 2017, CELL REP, V21, P3708, DOI 10.1016/j.celrep.2017.12.006
   BONNEFOY N, 1994, P NATL ACAD SCI USA, V91, P11978, DOI 10.1073/pnas.91.25.11978
   BONNEFOY N, 1994, J MOL BIOL, V239, P201, DOI 10.1006/jmbi.1994.1363
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Bourens M, 2017, J BIOL CHEM, V292, P7774, DOI 10.1074/jbc.M117.778514
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Chomyn A, 1996, METHODS ENZYMOL, V264, P197, DOI 10.1016/S0076-6879(96)64020-8
   Coenen MJH, 2005, J INHERIT METAB DIS, V28, P1091, DOI 10.1007/s10545-005-4483-y
   Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405
   Davydov EV, 2010, PLOS COMPUT BIOL, V6, P0, DOI 10.1371/journal.pcbi.1001025
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Formosa LE, 2015, HUM MOL GENET, V24, P2952, DOI 10.1093/hmg/ddv058
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   Haque ME, 2010, J BIOL CHEM, V285, P34991, DOI 10.1074/jbc.M110.163808
   Hart T, 2015, CELL, V163, P0, DOI 10.1016/j.cell.2015.11.015
   He SC, 1997, MOL BIOL CELL, V8, P1449, DOI 10.1091/mbc.8.8.1449
   Hell K, 1998, P NATL ACAD SCI USA, V95, P2250, DOI 10.1073/pnas.95.5.2250
   Hell K, 1997, FEBS LETT, V418, P367, DOI 10.1016/S0014-5793(97)01412-9
   Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281
   Hennon SW, 2015, J BIOL CHEM, V290, P14866, DOI 10.1074/jbc.R115.638171
   Hildenbeutel M, 2012, J MOL BIOL, V423, P590, DOI 10.1016/j.jmb.2012.07.018
   Jia LX, 2007, MOL BIOL CELL, V18, P1897, DOI 10.1091/mbc.E06-10-0925
   Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Kohda M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005679
   Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Magwere T, 2006, J GERONTOL A-BIOL, V61, P136, DOI 10.1093/gerona/61.2.136
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802
   Oláhová M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   Pronicka E, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0930-9
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Rotig A, 1997, BBA-MOL BASIS DIS, V1361, P6, DOI 10.1016/S0925-4439(97)00031-8
   Saracco SA, 2002, MOL BIOL CELL, V13, P1122, DOI 10.1091/mbc.01-12-0580
   Scialò F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009
   Stiburek L, 2007, J MOL BIOL, V374, P506, DOI 10.1016/j.jmb.2007.09.044
   Stiles AR, 2015, MOL GENET METAB, V115, P161, DOI 10.1016/j.ymgme.2015.05.008
   Stiller SB, 2016, CELL METAB, V23, P901, DOI 10.1016/j.cmet.2016.04.005
   Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754
   Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136
   Tyanova S, 2016, NAT METHODS, V13, P731, DOI 10.1038/nmeth.3901
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
NR 51
TC 52
Z9 55
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD NOV 15
PY 2018
VL 10
IS 11
BP 
EP 
DI 10.15252/emmm.201809060
PG 13
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA GZ9PV
UT WOS:000449833900001
PM 30201738
DA 2024-11-01
ER

PT J
AU Schreglmann, SR
   Riederer, F
   Galovic, M
   Ganos, C
   Kägi, G
   Waldvogel, D
   Jaunmuktane, Z
   Schaller, A
   Hidding, U
   Krasemann, E
   Michels, L
   Baumann, CR
   Bhatia, K
   Jung, HH
AF Schreglmann, Sebastian R.
   Riederer, Franz
   Galovic, Marian
   Ganos, Christos
   Kagi, Georg
   Waldvogel, Daniel
   Jaunmuktane, Zane
   Schaller, Andre
   Hidding, Ute
   Krasemann, Ernst
   Michels, Lars
   Baumann, Christian R.
   Bhatia, Kailash
   Jung, Hans H.
TI Movement Disorders in Genetically Confirmed Mitochondrial Disease and the Putative Role of the Cerebellum
SO MOVEMENT DISORDERS
LA English
DT Article
DE Mitochondrial disorders; volumetric MRI; dystonia; cerebellum; basal ganglia
ID progressive external ophthalmoplegia; huntingtons-disease; basal ganglia; parkinsons-disease; leigh-syndrome; dna mutation; a8344g merrf; dystonia; children; adults
AB Background: Mitochondrial disease can present as a movement disorder. Data on this entity's epidemiology, genetics, and underlying pathophysiology, however, is scarce. Objective: The objective of this study was to describe the clinical, genetic, and volumetric imaging data from patients with mitochondrial disease who presented with movement disorders. Methods: In this retrospective analysis of all genetically confirmed mitochondrial disease cases from three centers (n=50), the prevalence and clinical presentation of video-documented movement disorders was assessed. Voxel-based morphometry from high-resolution MRI was employed to compare cerebral and cerebellar gray matter volume between mitochondrial disease patients with and without movement disorders and healthy controls. Results: Of the 50 (30%) patients with genetically confirmed mitochondrial disease, 15 presented with hypokinesia (parkinsonism 3/15), hyperkinesia (dystonia 5/15, myoclonus 3/15, chorea 2/15), and ataxia (3/15). In 3 patients, mitochondrial disease presented as adult-onset isolated dystonia. In comparison to healthy controls and mitochondrial disease patients without movement disorders, patients with hypo- and hyperkinetic movement disorders had significantly more cerebellar atrophy and an atrophy pattern predominantly involving cerebellar lobules VI and VII. Conclusion: This series provides clinical, genetic, volumetric imaging, and histologic data that indicate major involvement of the cerebellum in mitochondrial disease when it presents with hyper- and hypokinetic movement disorders. As a working hypothesis addressing the particular vulnerability of the cerebellum to energy deficiency, this adds substantially to the pathophysiological understanding of movement disorders in mitochondrial disease. Furthermore, it provides evidence that mitochondrial disease can present as adult-onset isolated dystonia. (c) 2017 International Parkinson and Movement Disorder Society
C1 [Schreglmann, Sebastian R.; Ganos, Christos; Bhatia, Kailash] UCL, Sobell Dept Motor Neurosci & Movement Disorders, Inst Neurol, Queen Sq, London, England.
   [Schreglmann, Sebastian R.; Riederer, Franz; Waldvogel, Daniel; Baumann, Christian R.; Jung, Hans H.] Univ Hosp Zurich, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland.
   [Schreglmann, Sebastian R.; Galovic, Marian; Kagi, Georg] Kantonsspital St Gallen, Dept Neurol, St Gallen, Switzerland.
   [Riederer, Franz] Neurol Ctr Rosenhuegel, Vienna, Austria.
   [Riederer, Franz] Karl Landsteiner Inst Epilepsy Res & Cognit Neuro, Vienna, Austria.
   [Galovic, Marian] Univ Coll London Hosp Biomed Res Ctr, UK Natl Inst Hlth Res, London, England.
   [Galovic, Marian] UCL, Dept Clin & Expt Epilepsy, Inst Neurol, London, England.
   [Galovic, Marian] Epilepsy Soc, Gerrards Cross, England.
   [Ganos, Christos; Hidding, Ute] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.
   [Jaunmuktane, Zane] UCL, Inst Neurol, Dept Mol Neurosci, London, England.
   [Jaunmuktane, Zane] Natl Hosp Neurol & Neurosurg, Div Neuropathol, London, England.
   [Schaller, Andre] Inselspital Bern, Dept Genet, Bern, Switzerland.
   [Krasemann, Ernst] Labor Fenner GmbH, Med Versorgungszentrum MVZ, Dept Human Genet, Hamburg, Germany.
   [Michels, Lars] Univ Hosp Zurich, Clin Neuroradiol, Zurich, Switzerland.
C3 University of London; University College London; University of Zurich; University Zurich Hospital; Kantonsspital St. Gallen; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Bern; University Hospital of Bern; University of Zurich; University Zurich Hospital
RP Jung, HH (corresponding author), Univ Hosp Zurich, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland.
EM hans.jung@usz.ch
CR Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Bargiela David, 2015, CEREBELLUM ATAXIAS, V2, P16, DOI 10.1186/s40673-015-0035-x
   Barragán-Campos HM, 2005, ARCH NEUROL-CHICAGO, V62, P737, DOI 10.1001/archneur.62.5.737
   Bauer E, 2015, BRAIN RES, V1622, P137, DOI 10.1016/j.brainres.2015.06.026
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bostan AC, 2010, P NATL ACAD SCI USA, V107, P8452, DOI 10.1073/pnas.1000496107
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   Caer M, 2005, MOVEMENT DISORD, V20, P490, DOI 10.1002/mds.20363
   Casali C, 2001, NEUROLOGY, V56, P802, DOI 10.1212/WNL.56.6.802
   Debray FG, 2007, AM J MED GENET A, V143A, P2046, DOI 10.1002/ajmg.a.31880
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034
   Feigin A, 2007, BRAIN, V130, P2858, DOI 10.1093/brain/awm217
   Filip P, 2017, MOVEMENT DISORD, V32, P757, DOI 10.1002/mds.26930
   Filip P, 2013, CLIN NEUROPHYSIOL, V124, P1269, DOI 10.1016/j.clinph.2013.01.003
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Ganos C, 2014, MOVEMENT DISORD, V29, P437, DOI 10.1002/mds.25867
   Hanna MG, 1997, CURR OPIN NEUROL, V10, P351, DOI 10.1097/00019052-199708000-00012
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Husárová I, 2014, J NEUROIMAGING, V24, P45, DOI 10.1111/j.1552-6569.2011.00663.x
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Jia X, 2015, AM J NEURORADIOL, V36, P2219, DOI 10.3174/ajnr.A4447
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   MACAYA A, 1993, NEUROPEDIATRICS, V24, P60, DOI 10.1055/s-2008-1071515
   Mancuso M, 2008, PARKINSONISM RELAT D, V14, P381, DOI 10.1016/j.parkreldis.2007.10.001
   Martikainen MH, 2016, JAMA NEUROL, V0, P0
   Mottolese C, 2013, BRAIN, V136, P330, DOI 10.1093/brain/aws186
   Mukai M, 2013, PARKINSONISM RELAT D, V19, P821, DOI 10.1016/j.parkreldis.2013.04.011
   Nakagaki Hideaki, 2005, RINSHO SHINKEIGAKU, V45, P502
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Planetta PJ, 2015, HUM BRAIN MAPP, V36, P1165, DOI 10.1002/hbm.22694
   Rees EM, 2014, MOVEMENT DISORD, V29, P1648, DOI 10.1002/mds.25984
   Reetz K, 2009, MOVEMENT DISORD, V24, P99, DOI 10.1002/mds.22333
   Sadnicka A, 2012, CLIN NEUROPHYSIOL, V123, P65, DOI 10.1016/j.clinph.2011.04.027
   Scaglia F, 2005, AM J NEURORADIOL, V26, P1675
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Shakkottai VG, 2016, CEREBELLUM, V73, P668
   Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039
   Sudarsky L, 1999, MOVEMENT DISORD, V14, P488, DOI 10.1002/1531-8257(199905)14:3<488::AID-MDS1017>3.0.CO;2-4
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tranchant C, 2016, REV NEUROL-FRANCE, V172, P524, DOI 10.1016/j.neurol.2016.07.003
   TRUONG DD, 1990, MOVEMENT DISORD, V5, P109, DOI 10.1002/mds.870050204
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   Wolf RC, 2015, J NEUROL, V262, P859, DOI 10.1007/s00415-015-7642-6
   Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360
   Zeviani Massimo, 2012, HANDB CLIN NEUROL, V103, P359, DOI 10.1016/B978-0-444-51892-7.00022-X
NR 47
TC 22
Z9 22
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-3185
EI 1531-8257
J9 MOVEMENT DISORD
JI Mov. Disord.
PD JAN 15
PY 2018
VL 33
IS 1
BP 146
EP 155
DI 10.1002/mds.27174
PG 10
WC Clinical Neurology
SC Neurosciences & Neurology
GA FS7FO
UT WOS:000419963500022
PM 28901595
DA 2024-11-01
ER

PT J
AU Kauppila, TES
   Bratic, A
   Jensen, MB
   Baggio, F
   Partridge, L
   Jasper, H
   Grönke, S
   Larsson, NG
AF Kauppila, Timo E. S.
   Bratic, Ana
   Jensen, Martin Borch
   Baggio, Francesca
   Partridge, Linda
   Jasper, Heinrich
   Groenke, Sebastian
   Larsson, Nils-Goeran
TI Mutations of mitochondrial DNA are not major contributors to aging of fruit flies
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
LA English
DT Article
DE mtDNA; aging; lifespan; dietary restriction; intestinal stem cells
ID mtdna mutator mice; drosophila-melanogaster; dietary restriction; point mutations; energy-expenditure; skeletal-muscle; copy number; stem-cells; life-span; disease
AB Mammals develop age-associated clonal expansion of somatic mtDNA mutations resulting in severe respiratory chain deficiency in a subset of cells in a variety of tissues. Both mathematical modeling based on descriptive data from humans and experimental data from mtDNA mutator mice suggest that the somatic mutations are formed early in life and then undergo mitotic segregation during adult life to reach very high levels in certain cells. To address whether mtDNA mutations have a universal effect on aging metazoans, we investigated their role in physiology and aging of fruit flies. To this end, we utilized genetically engineered flies expressing mutant versions of the catalytic subunit of mitochondrial DNA polymerase (DmPOL gamma A) as a means to introduce mtDNA mutations. We report here that lifespan and health in fruit flies are remarkably tolerant to mtDNA mutations. Our results show that the short lifespan and wide genetic bottleneck of fruit flies are limiting the extent of clonal expansion of mtDNA mutations both in individuals and between generations. However, an increase of mtDNA mutations to very high levels caused sensitivity to mechanical and starvation stress, intestinal stem cell dysfunction, and reduced lifespan under standard conditions. In addition, the effects of dietary restriction, widely considered beneficial for organismal health, were attenuated in flies with very high levels of mtDNA mutations.
C1 [Kauppila, Timo E. S.; Bratic, Ana; Baggio, Francesca; Larsson, Nils-Goeran] Max Planck Inst Biol Ageing, Dept Mitochondrial Biol, D-50931 Cologne, Germany.
   [Jensen, Martin Borch; Jasper, Heinrich] Buck Inst Res Aging, Novato, CA 94945 USA.
   [Partridge, Linda; Groenke, Sebastian] Max Planck Inst Biol Ageing, Dept Biol Mech Ageing, D-50931 Cologne, Germany.
   [Larsson, Nils-Goeran] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden.
C3 Max Planck Society; Buck Institute for Research on Aging; Max Planck Society; Karolinska Institutet
RP Bratic, A; Larsson, NG (corresponding author), Max Planck Inst Biol Ageing, Dept Mitochondrial Biol, D-50931 Cologne, Germany.; Larsson, NG (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden.
EM Ana.Groenke@age.mpg.de; nils-goran.larsson@ki.se
FU Max Planck Society; Swedish Research Council [2015-00418]; Knut and Alice Wallenberg Foundation; AXA Research Fund; Swedish Research Council [2015-00418] Funding Source: Swedish Research Council
CR Ahlqvist KJ, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7494
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Ameur A, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002028
   Bahadorani S, 2010, AGING CELL, V9, P100, DOI 10.1111/j.1474-9726.2009.00537.x
   Baines HL, 2014, MECH AGEING DEV, V139, P22, DOI 10.1016/j.mad.2014.06.003
   Ballard JWO, 2007, EVOLUTION, V61, P1735, DOI 10.1111/j.1558-5646.2007.00133.x
   Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071
   Biteau B, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001159
   Bratic A, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9808
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Buchon N, 2010, BMC BIOL, V8, P0, DOI 10.1186/1741-7007-8-152
   Burman JL, 2014, DIS MODEL MECH, V7, P1165, DOI 10.1242/dmm.015321
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Celotto AM, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0025823
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079
   Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016
   DellAgnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Fellous TG, 2009, HEPATOLOGY, V49, P1655, DOI 10.1002/hep.22791
   Fergestad Tim, 2006, GENETICS, V173, P1357, DOI 10.1534/genetics.106.057463
   Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130
   Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, PG914, DOI 10.1152/ajpgi.00402.2011
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   Greaves LC, 2011, MECH AGEING DEV, V132, P588, DOI 10.1016/j.mad.2011.10.004
   Hällberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001
   Herbst A, 2016, AGING CELL, V15, P1132, DOI 10.1111/acel.12520
   Hunt ND, 2006, AGEING RES REV, V5, P125, DOI 10.1016/j.arr.2006.03.006
   Hurd TR, 2016, DEV CELL, V39, P560, DOI 10.1016/j.devcel.2016.11.004
   Itsara LS, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1003974
   Jasper H, 2015, INVERTEBR REPROD DEV, V59, P51, DOI 10.1080/07924259.2014.963713
   Jiang M, 2017, CELL METAB, V26, P429, DOI 10.1016/j.cmet.2017.07.003
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lansing Albert I, 1947, JOURNALS OF GERONTOLOGY, V2, P228, DOI 10.1093/geronj/2.3.228
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Masoro EJ, 2002, BIOCHIM BIOPHYS ACTA, V1790, P1040
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   Mookerjee SA, 2010, MECH AGEING DEV, V131, P463, DOI 10.1016/j.mad.2010.03.010
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   Otten ABC, 2016, GENETICS, V204, P1423, DOI 10.1534/genetics.116.194035
   Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50
   Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313
   Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293
   Priest NK, 2002, EVOLUTION, V56, P927, DOI 10.1111/j.0014-3820.2002.tb01405.x
   Qi Y, 2016, CELL DEATH DIFFER, V23, P291, DOI 10.1038/cdd.2015.94
   Ramsey JJ, 2006, J NUTR, V136, P1958S, DOI 10.1093/jn/136.7.1958S
   Regan JC, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10956
   Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110
   Ross JM, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Selman C, 2005, MECH AGEING DEV, V126, P783, DOI 10.1016/j.mad.2005.02.004
   Sen A, 2017, CURR TOP DEV BIOL, V121, P1, DOI 10.1016/bs.ctdb.2016.07.001
   Siibak T, 2017, HUM MOL GENET, V26, P2515, DOI 10.1093/hmg/ddx146
   SOLIGNAC M, 1987, GENETICS, V117, P687
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Wang A, 2016, ONCOTARGET, V7, P80131, DOI 10.18632/oncotarget.12560
   Williams SL, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003990
   Wong R, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0006063
   Xu H, 2008, SCIENCE, V321, P575, DOI 10.1126/science.1160226
   Yui R, 2003, GENES GENET SYST, V78, P245
   Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034
   Zuryn S, 2010, MECH AGEING DEV, V131, P554, DOI 10.1016/j.mad.2010.07.004
NR 72
TC 29
Z9 34
U1 0
U2 18
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
EI 
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD OCT 9
PY 2018
VL 115
IS 41
BP E9620
EP E9629
DI 10.1073/pnas.1721683115
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GW3BF
UT WOS:000446764200014
PM 30249665
DA 2024-11-01
ER

PT J
AU Pickles, S
   Vigié, P
   Youle, RJ
AF Pickles, Sarah
   Vigie, Pierre
   Youle, Richard J.
TI Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance
SO CURRENT BIOLOGY
LA English
DT Review
ID unfolded protein response; transcription factor; dna deletions; autophagic degradation; paternal mitochondria; ubiquitin chain; skeletal-muscle; stress-response; parkin; pink1
AB The maintenance of a healthy and functional mitochondrial network is critical during development as well as throughout life in the response to physiological adaptations and stress conditions. Owing to their role in energy production, mitochondria are exposed to high levels of reactive oxygen species, making them particularly vulnerable to mitochondrial DNA mutations and protein misfolding. Given that mitochondria are formed from proteins encoded by both nuclear and mitochondrial genomes, an additional layer of complexity is inherent in the coordination of protein synthesis and the mitochondrial import of nuclear-encoded proteins. For these reasons, mitochondria have evolved multiple systems of quality control to ensure that the requisite number of functional mitochondria are present to meet the demands of the cell. These pathways work to eliminate damaged mitochondrial proteins or parts of the mitochondrial network by mitophagy and renew components by adding protein and lipids through biogenesis, collectively resulting in mitochondrial turnover. Mitochondrial quality control mechanisms are multi-tiered, operating at the protein, organelle and cell levels. Herein, we discuss mitophagy in different physiological contexts and then relate it to other quality control pathways, including the unfolded protein response, shedding of vesicles, proteolysis, and degradation by the ubiquitin-proteasome system. Understanding how these pathways contribute to the maintenance of mitochondrial homeostasis could provide insights into the development of targeted treatments when these systems fail in disease.
C1 [Pickles, Sarah; Youle, Richard J.] NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.
   [Vigie, Pierre] CNRS, IBGC, UMR5095, 1 Rue Camille St Saens, F-33000 Bordeaux, France.
   [Vigie, Pierre] Univ Bordeaux, IBGC, UMR5095, 1 Rue Camille St Saens, F-33000 Bordeaux, France.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Bordeaux
RP Youle, RJ (corresponding author), NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.
EM youle@helix.nih.gov
FU NIH National Institute of Neurological Disorders and Stroke Intramural Research Program; Canadian Institutes of Health Research; University of Bordeaux; International Doctoral Program of the Idex of Bordeaux; Agence Nationale de la Recherche [ANR-10-IDEX-03-02]
CR Abeliovich H, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3789
   Aerbajinai W, 2003, BLOOD, V102, P712, DOI 10.1182/blood-2002-11-3324
   Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878
   Aldridge JE, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0000874
   Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145
   Aouacheria A, 2005, MOL BIOL EVOL, V22, P2395, DOI 10.1093/molbev/msi234
   Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002
   Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580
   Breton S, 2015, GENOME, V58, P423, DOI 10.1139/gen-2015-0090
   Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082
   Burbulla LF, 2014, CELL DEATH DIS, V5, P0, DOI 10.1038/cddis.2014.103
   Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106
   Cai X, 2017, CSH PERSPECT BIOL, V9, P0, DOI 10.1101/cshperspect.a023580
   Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Costello MJ, 2013, EXP EYE RES, V116, P141, DOI 10.1016/j.exer.2013.08.017
   Dave KD, 2014, NEUROBIOL DIS, V70, P190, DOI 10.1016/j.nbd.2014.06.009
   Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526
   DeLuca SZ, 2012, DEV CELL, V22, P660, DOI 10.1016/j.devcel.2011.12.021
   Dhar SS, 2008, J BIOL CHEM, V283, P3120, DOI 10.1074/jbc.M707587200
   Dikic I, 2017, ANNU REV BIOCHEM, V86, P193, DOI 10.1146/annurev-biochem-061516-044908
   Diwan A, 2007, P NATL ACAD SCI USA, V104, P6794, DOI 10.1073/pnas.0610666104
   Dzierzak E, 2013, CSH PERSPECT MED, V3, P0, DOI 10.1101/cshperspect.a011601
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Eiyama A, 2013, FEBS LETT, V587, P1787, DOI 10.1016/j.febslet.2013.04.030
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002
   Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Hadjivasiliou Z, 2013, P ROY SOC B-BIOL SCI, V280, P0, DOI 10.1098/rspb.2013.1920
   Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933
   Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748
   Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016
   Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016
   Hernandez G, 2013, AUTOPHAGY, V9, P1852, DOI 10.4161/auto.26501
   Honda S, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms5004
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Hughes AL, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.13943
   Ito K, 2016, SCIENCE, V354, P1156, DOI 10.1126/science.aaf5530
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850
   Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122
   Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084
   Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3
   Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104
   Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200
   Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014
   Karbowski M, 2011, CURR OPIN CELL BIOL, V23, P476, DOI 10.1016/j.ceb.2011.05.007
   Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384
   Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013
   Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029
   Kim TY, 2012, MOL CELL PROTEOMICS, V11, P1586, DOI 10.1074/mcp.M112.021162
   Kissová I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200
   Kondapalli C, 2012, OPEN BIOL, V2, P0, DOI 10.1098/rsob.120080
   Kondo-Okamoto N, 2012, J BIOL CHEM, V287, P10631, DOI 10.1074/jbc.M111.299917
   Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kumar A, 2017, NAT STRUCT MOL BIOL, V24, P475, DOI 10.1038/nsmb.3400
   Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, PE463, DOI 10.1152/ajpendo.00666.2007
   Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Luo SM, 2013, P NATL ACAD SCI USA, V110, P13038, DOI 10.1073/pnas.1303231110
   Mao K, 2013, DEV CELL, V26, P9, DOI 10.1016/j.devcel.2013.05.024
   Martinus RD, 1996, EUR J BIOCHEM, V240, P98, DOI 10.1111/j.1432-1033.1996.0098h.x
   Matsumoto G, 2015, HUM MOL GENET, V24, P4429, DOI 10.1093/hmg/ddv179
   Matsushima M, 1998, GENE CHROMOSOME CANC, V21, P230, DOI 10.1002/(SICI)1098-2264(199803)21:3<230::AID-GCC7>3.0.CO;2-0
   McLelland GL, 2016, J CELL BIOL, V214, P275, DOI 10.1083/jcb.201603105
   McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902
   McWilliams TG, 2016, J CELL BIOL, V214, P333, DOI 10.1083/jcb.201603039
   Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x
   Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004
   Moore AS, 2016, P NATL ACAD SCI USA, V113, PE3349, DOI 10.1073/pnas.1523810113
   Münch C, 2016, NATURE, V534, P710, DOI 10.1038/nature18302
   Napolitano G, 2016, J CELL SCI, V129, P2475, DOI 10.1242/jcs.146365
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426
   Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Nezich CL, 2015, J CELL BIOL, V210, P435, DOI 10.1083/jcb.201501002
   Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256
   Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013
   Okatsu K, 2015, J CELL BIOL, V209, P111, DOI 10.1083/jcb.201410050
   Okatsu K, 2013, J BIOL CHEM, V288, P36372, DOI 10.1074/jbc.M113.509653
   Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x
   Ongwijitwat S, 2006, GENE, V374, P39, DOI 10.1016/j.gene.2006.01.009
   Onoue K, 2013, J CELL SCI, V126, P176, DOI 10.1242/jcs.111211
   Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007
   Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850
   Politi Y, 2014, DEV CELL, V29, P305, DOI 10.1016/j.devcel.2014.04.005
   Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697
   Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107
   Pyle A, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005040
   Quirós PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   Quirós PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984
   Rainbolt TK, 2013, CELL METAB, V18, P908, DOI 10.1016/j.cmet.2013.11.006
   REME CE, 1977, INVEST OPHTH VIS SCI, V16, P815
   Richter B, 2016, P NATL ACAD SCI USA, V113, P4039, DOI 10.1073/pnas.1523926113
   Riley BE, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms2982
   Rojansky R, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.17896
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006
   Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043
   Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Schwarten M, 2009, AUTOPHAGY, V5, P690, DOI 10.4161/auto.5.5.8494
   Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104
   Scott I, 2014, J BIOL CHEM, V289, P2864, DOI 10.1074/jbc.M113.521641
   Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718
   Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Shiba-Fukushima K, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004861
   Shiba-Fukushima K, 2012, SCI REP-UK, V2, P0, DOI 10.1038/srep01002
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8
   Song LY, 2017, NEUROBIOL DIS, V100, P30, DOI 10.1016/j.nbd.2016.12.024
   Song WH, 2016, P NATL ACAD SCI USA, V113, PE5261, DOI 10.1073/pnas.1605844113
   Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057
   Sowter HM, 2001, CANCER RES, V61, P6669
   Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108
   Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979
   Stotland A, 2016, J MOL CELL CARDIOL, V90, P53, DOI 10.1016/j.yjmcc.2015.11.032
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Sutovsky P, 2000, BIOL REPROD, V63, P582, DOI 10.1095/biolreprod63.2.582
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Nguyen TN, 2016, J CELL BIOL, V215, P857, DOI 10.1083/jcb.201607039
   Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138
   Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06
   Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tsunemi T, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003799
   Valenci I, 2015, MITOCHONDRION, V20, P64, DOI 10.1016/j.mito.2014.11.001
   Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110
   Wang XW, 2015, NATURE, V524, P481, DOI 10.1038/nature14859
   Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879
   Wauer T, 2015, EMBO J, V34, P307, DOI 10.15252/embj.201489847
   Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125
   Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042
   Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405
   Wong YC, 2014, P NATL ACAD SCI USA, V111, PE4439, DOI 10.1073/pnas.1405752111
   Wrobel L, 2015, NATURE, V524, P485, DOI 10.1038/nature14951
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748
   Yamano K, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.01612
   Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633
   Yamashita S, 2016, J CELL BIOL, V215, P649, DOI 10.1083/jcb.201605093
   Yang JY, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3428
   Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249
   Yun JN, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.01958
   Zhang J, 2012, AUTOPHAGY, V8, P1325, DOI 10.4161/auto.20764
   Zhang J, 2009, AUTOPHAGY, V5, P1064, DOI 10.4161/auto.5.7.9749
   Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445
   Zhou QH, 2016, SCIENCE, V353, P394, DOI 10.1126/science.aaf4777
   Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345
NR 170
TC 1276
Z9 1384
U1 14
U2 289
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0960-9822
EI 1879-0445
J9 CURR BIOL
JI Curr. Biol.
PD FEB 19
PY 2018
VL 28
IS 4
BP R170
EP R185
DI 10.1016/j.cub.2018.01.004
PG 16
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology
GA FW5SI
UT WOS:000425377900014
PM 29462587
DA 2024-11-01
ER

PT J
AU Rose, S
   Niyazov, DM
   Rossignol, DA
   Goldenthal, M
   Kahler, SG
   Frye, RE
AF Rose, Shannon
   Niyazov, Dmitriy M.
   Rossignol, Daniel A.
   Goldenthal, Michael
   Kahler, Stephen G.
   Frye, Richard E.
TI Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder
SO MOLECULAR DIAGNOSIS & THERAPY
LA English
DT Review
ID aspartate/glutamate carrier slc25a12; magnetic-resonance-spectroscopy; glutathione redox imbalance; spare respiratory capacity; comorbid anxiety disorder; peripheral-blood cells; amino-acid-transport; dna copy number; oxidative stress; propionic-acid
AB Autism spectrum disorder (ASD) affects similar to 2% of children in the United States. The etiology of ASD likely involves environmental factors triggering physiological abnormalities in genetically sensitive individuals. One of these major physiological abnormalities is mitochondrial dysfunction, which may affect a significant subset of children with ASD. Here we systematically review the literature on human studies of mitochondrial dysfunction related to ASD. Clinical aspects of mitochondrial dysfunction in ASD include unusual neurodevelopmental regression, especially if triggered by an inflammatory event, gastrointestinal symptoms, seizures, motor delays, fatigue and lethargy. Traditional biomarkers of mitochondrial disease are widely reported to be abnormal in ASD, but appear non-specific. Newer biomarkers include buccal cell enzymology, biomarkers of fatty acid metabolism, non-mitochondrial enzyme function, apoptosis markers and mitochondrial antibodies. Many genetic abnormalities are associated with mitochondrial dysfunction in ASD, including chromosomal abnormalities, mitochondrial DNA mutations and large-scale deletions, and mutations in both mitochondrial and non-mitochondrial nuclear genes. Mitochondrial dysfunction has been described in immune and buccal cells, fibroblasts, muscle and gastrointestinal tissue and thebrains of individuals with ASD. Several environmental factors, including toxicants, microbiome metabolites and an oxidized microenvironment are shown to modulate mitochondrial function in ASD tissues. Investigations of treatments for mitochondrial dysfunction in ASD are promising but preliminary. The etiology of mitochondrial dysfunction and how to define it in ASD is currently unclear. However, preliminary evidence suggests that the mitochondria may be a fruitful target for treatment and prevention of ASD. Further research is needed to better understand the role of mitochondrial dysfunction in the pathophysiology of ASD.
C1 [Rose, Shannon; Kahler, Stephen G.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA.
   [Rose, Shannon; Kahler, Stephen G.] Arkansas Childrens Res Inst, Little Rock, AR USA.
   [Niyazov, Dmitriy M.] Ochsner Hlth Syst, Sect Med Genet, New Orleans, LA USA.
   [Rossignol, Daniel A.] Rossignol Med Ctr, Aliso Viejo, CA USA.
   [Goldenthal, Michael] Drexel Univ, St Christophers Hosp Children, Coll Med, Dept Pediat,Neurol Sect, Philadelphia, PA 19104 USA.
   [Frye, Richard E.] Phoenix Childrens Hosp, Barrow Neurol Inst, Div Neurodev Disorders, Dept Neurol, 1919 E Thomas St, Phoenix, AZ 85016 USA.
   [Frye, Richard E.] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ 85004 USA.
C3 University of Arkansas System; University of Arkansas Medical Sciences; Ochsner Health System; Drexel University; Barrow Neurological Institute; Phoenix Children's Hospital; University of Arizona
RP Frye, RE (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Div Neurodev Disorders, Dept Neurol, 1919 E Thomas St, Phoenix, AZ 85016 USA.; Frye, RE (corresponding author), Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ 85004 USA.
EM rfrye@phoenixchildrens.com
FU Arkansas Biosciences Institute (Little Rock, AR, USA); Jonty Foundation (St. Paul, MN); Autism Research Institute (San Diego, CA); Gupta Family Foundation (Atherton, CA); Jane Bostford Johnson Foundation (New York, NY); Jager Family Foundation (Chicago, IL); Phoenix Children's Hospital Foundation (Phoenix, AZ)
CR Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346
   Abu Shmais GA, 2012, J NEURODEV DISORD, V4, P0, DOI 10.1186/1866-1955-4-4
   Adams JB, 2011, AUTISM INSIGHTS, V3, P3
   Adi A, 2015, MOL MED REP, V12, P2307, DOI 10.3892/mmr.2015.3663
   Al-Mosalem OA, 2009, CLIN BIOCHEM, V42, P949, DOI 10.1016/j.clinbiochem.2009.04.006
   Alvarez-Iglesias V, 2011, BMC MED GENET, V12, P0, DOI 10.1186/1471-2350-12-50
   Anitha A, 2013, BRAIN PATHOL, V23, P294, DOI 10.1111/bpa.12002
   Anitha A, 2012, MOL AUTISM, V3, P0, DOI 10.1186/2040-2392-3-12
   Aoki Y, 2012, TRANSL PSYCHIAT, V2, P0, DOI 10.1038/tp.2011.65
   Aoki Y, 2016, MOL NEUROBIOL, V53, P1579, DOI 10.1007/s12035-015-9116-3
   Avdjieva-Tzavella D, 2012, BALK J MED GENET, V15, P47, DOI 10.2478/bjmg-2013-0006
   Aydin HI, 2018, INDIAN PEDIATR, V55, P67, DOI 10.1007/s13312-018-1232-5
   Blasi F, 2006, EUR J HUM GENET, V14, P123, DOI 10.1038/sj.ejhg.5201444
   Blossom SJ, 2006, TOXICOL SCI, V92, P103, DOI 10.1093/toxsci/kfj212
   Blossom SJ, 2013, TOXICOL APPL PHARM, V269, P263, DOI 10.1016/j.taap.2013.03.025
   Boccuto L, 2013, MOL AUTISM, V4, P0, DOI 10.1186/2040-2392-4-16
   Brown Bradley D, 2015, INNOV CLIN NEUROSCI, V12, P29
   Bu XS, 2017, NEUROPSYCH DIS TREAT, V13, P1633, DOI 10.2147/NDT.S129081
   Budd MA, 2018, VIRUSES, V0, P0
   Burger BJ, 2017, FRONT PEDIATR, V5, P0, DOI 10.3389/fped.2017.00219
   Castro-Gago N, 2008, REV NEUROLOGIA, V47, P52, DOI 10.33588/rn.4701.2007542
   Celestino-Soper PBS, 2012, P NATL ACAD SCI USA, V109, P7974, DOI 10.1073/pnas.1120210109
   Chng C, 2015, AUTISM RES, V8, P593, DOI 10.1002/aur.1475
   Chalkia D, 2017, JAMA PSYCHIAT, V74, P1161, DOI 10.1001/jamapsychiatry.2017.2604
   Chauhan A, 2009, J NEUROCHEM, V109, P273
   Chauhan A, 2012, NEUROCHEM RES, V37, P1681, DOI 10.1007/s11064-012-0775-4
   Chauhan A, 2011, J NEUROCHEM, V117, P209, DOI 10.1111/j.1471-4159.2011.07189.x
   Chen C, 2015, PROTEIN CELL, V6, P862, DOI 10.1007/s13238-015-0175-z
   Chen S, 2015, BMC PSYCHIATRY, V15, P0, DOI 10.1186/s12888-015-0432-y
   Chien WH, 2010, PROG NEURO-PSYCHOPH, V34, P189, DOI 10.1016/j.pnpbp.2009.11.004
   Chiocchetti AG, 2014, MOL AUTISM, V5, P0, DOI 10.1186/2040-2392-5-10
   Chugani DC, 1999, PROG NEURO-PSYCHOPH, V23, P635, DOI 10.1016/S0278-5846(99)00022-6
   Clark-Taylor T, 2004, MED HYPOTHESES, V62, P970, DOI 10.1016/j.mehy.2004.01.011
   COLEMAN M, 1985, J AUTISM DEV DISORD, V15, P1, DOI 10.1007/BF01837894
   Comi AM, 1999, J CHILD NEUROL, V14, P388, DOI 10.1177/088307389901400608
   Connolly BS, 2010, BIOCHEM BIOPH RES CO, V402, P443, DOI 10.1016/j.bbrc.2010.10.060
   Correia C, 2006, J AUTISM DEV DISORD, V36, P1137, DOI 10.1007/s10803-006-0138-6
   Corrigan NM, 2012, J AUTISM DEV DISORD, V42, P105, DOI 10.1007/s10803-011-1216-y
   Craig AK, 2012, SEIZURE-EUR J EPILEP, V21, P17, DOI 10.1016/j.seizure.2011.08.010
   Dager SR, 2015, JAMA PSYCHIAT, V72, P190, DOI 10.1001/jamapsychiatry.2014.2419
   Dager SR, 2012, J AUTISM DEV DISORD, V42, P643, DOI 10.1007/s10803-011-1352-4
   De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/NATURE13772
   Delhey L, 2017, METAB BRAIN DIS, V32, P2021, DOI 10.1007/s11011-017-0087-0
   Delhey LM, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6020018
   Desler Claus, 2012, J AGING RES, V2012, P192503, DOI 10.1155/2012/192503
   Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005
   Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015
   Durdiaková J, 2014, MOL AUTISM, V5, P0, DOI 10.1186/2040-2392-5-25
   El-Ansary A, 2010, OPEN ACCESS J CLIN T, V2, P49
   El-Ansary A, 2017, METAB BRAIN DIS, V32, P1209, DOI 10.1007/s11011-017-0029-x
   El-Ansary AK, 2011, J NEUROINFLAMM, V8, P0, DOI 10.1186/1742-2094-8-142
   El-Ansary AK, 2011, LIPIDS HEALTH DIS, V10, P0, DOI 10.1186/1476-511X-10-62
   Enns GM, 2008, AAP NEWS, V29, P20
   Esparham Anna E, 2015, INTEGR MED (ENCINITAS), V14, P40
   Essa MM, 2012, BIOL TRACE ELEM RES, V147, P25, DOI 10.1007/s12011-011-9280-x
   Ezugha H, 2010, J CHILD NEUROL, V25, P1232, DOI 10.1177/0883073809361165
   Fahmy SF, 2013, RES AUTISM SPECT DIS, V7, P159, DOI 10.1016/j.rasd.2012.07.006
   Fayed N, 2005, ACAD RADIOL, V12, P566, DOI 10.1016/j.acra.2005.01.016
   Fernell E, 2007, NEUROSCI LETT, V418, P82, DOI 10.1016/j.neulet.2007.03.004
   Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008
   Filiano JJ, 2002, J CHILD NEUROL, V17, P435, DOI 10.1177/088307380201700607
   Filipek PA, 2004, J AUTISM DEV DISORD, V34, P615, DOI 10.1007/s10803-004-5283-1
   Filipek PA, 2003, ANN NEUROL, V53, P801, DOI 10.1002/ana.10596
   Finegold SM, 2002, CLIN INFECT DIS, V35, PS6, DOI 10.1086/341914
   Finsterer J, 2018, J CLIN MED, V7, P0, DOI 10.3390/jcm7020016
   Fluegge Keith, 2016, INNOV CLIN NEUROSCI, V13, P13
   Frackowiak J, 2013, ACTA NEUROPATHOL COM, V1, P0, DOI 10.1186/2051-5960-1-61
   Frye RE, 2018, MOL PSYCHIATR, V23, P247, DOI 10.1038/mp.2016.168
   Frye R, 2016, TRANSL PSYCHIAT, V6, P0, DOI 10.1038/tp.2016.189
   Frye RE, 2016, TRANSL PSYCHIAT, V6, P0, DOI 10.1038/tp.2016.89
   Frye RE, 2013, MOL PSYCHIATR, V18, P369, DOI 10.1038/mp.2011.175
   Frye RE, 2013, TRANSL PSYCHIAT, V3, P0, DOI 10.1038/tp.2013.51
   Frye RE, 2013, TRANSL PSYCHIAT, V3, P0, DOI 10.1038/tp.2012.143
   Frye RE, 2012, NAJ MED SCI, V5, P141
   Frye RE, 2017, FRONT IMMUNOL, V8, P0, DOI 10.3389/fimmu.2017.01670
   Frye RE, 2016, CLIN MED INSIGHTS-PE, V10, P43, DOI 10.4137/CMPed.S38337
   Frye RE, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep19544
   Frye Richard E, 2015, MICROBIAL ECOLOGY IN HEALTH AND DISEASE, V26, P27458, DOI 10.3402/mehd.v26.27458
   Frye RE, 2012, J CHILD NEUROL, V27, P942, DOI 10.1177/0883073811429858
   Frye RE, 2012, J PEDIATR NEUROL, V10, P35, DOI 10.3233/JPN-2012-0530
   Frye RE, 2011, J PEDIATR NEUROL, V9, P427, DOI 10.3233/JPN-2011-0507
   Frye RE, 2011, PEDIATR RES, V69, P41R, DOI 10.1203/PDR.0b013e318212f16b
   Frye RE, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-04821-3
   Frye RE, 2014, FRONT PEDIATR, V2, P0, DOI 10.3389/fped.2014.00066
   Geier DA, 2011, MED SCI MONITOR, V17, P0
   Gimelli S, 2014, MOL CYTOGENET, V7, P0, DOI 10.1186/s13039-014-0054-y
   Ginsberg MR, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044736
   Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706
   Goh S, 2014, JAMA PSYCHIAT, V71, P665, DOI 10.1001/jamapsychiatry.2014.179
   Goldenthal MJ, 2015, BIOMARK MED, V9, P957, DOI 10.2217/bmm.15.72
   Goldenthal MJ, 2012, MOL GENET METAB, V105, P457, DOI 10.1016/j.ymgme.2011.11.193
   Golomb BA, 2014, J CHILD NEUROL, V29, P187, DOI 10.1177/0883073813498466
   Golzio C, 2016, PEDIATRICS, V137, P0, DOI 10.1542/peds.2016-0049
   Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601
   Gu F, 2013, TRANSL PSYCHIAT, V3, P0, DOI 10.1038/tp.2013.68
   Guevara-Campos J, 2015, INT J MOL SCI, V16, P3870, DOI 10.3390/ijms16023870
   Guevara-Campos J, 2013, METAB BRAIN DIS, V28, P605, DOI 10.1007/s11011-013-9419-x
   Guevara-Campos J, 2010, INVEST CLIN, V51, P423
   Gupta S, 1996, J AUTISM DEV DISORD, V26, P439, DOI 10.1007/BF02172828
   Gvozdjáková A, 2014, OXID MED CELL LONGEV, V2014, P0, DOI 10.1155/2014/798957
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Haas RH, 2010, DEV DISABIL RES REV, V16, P144, DOI 10.1002/ddrr.112
   Hadjixenofontos A, 2013, ANN HUM GENET, V77, P9, DOI 10.1111/j.1469-1809.2012.00736.x
   Hall L, 2014, AUTISM, V18, P872, DOI 10.1177/1362361313503501
   Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76
   Hill BG, 2010, BBA-BIOENERGETICS, V1797, P285, DOI 10.1016/j.bbabio.2009.11.005
   Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934
   Holtzman D, 2008, ACTA PAEDIATR, V97, P859, DOI 10.1111/j.1651-2227.2008.00883.x
   Howsmon DP, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005385
   Ipser JC, 2012, METAB BRAIN DIS, V27, P275, DOI 10.1007/s11011-012-9293-y
   Iqbal M, 2015, FUTUR NEUROL, V10, P203, DOI 10.2217/FNL.15.11
   James SJ, 2013, TRANSL PSYCHIAT, V3, P0, DOI 10.1038/tp.2013.8
   James SJ, 2006, AM J MED GENET B, V141B, P947, DOI 10.1002/ajmg.b.30366
   James SJ, 2009, FASEB J, V23, P2374, DOI 10.1096/fj.08-128926
   James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611
   Karim M, 2016, J BANGLADESH SOC PHY, V10, P56, DOI 10.3329/JBSP.V10I2.27165
   Kaur K, 2014, FREE RADICAL BIO MED, V76, P25, DOI 10.1016/j.freeradbiomed.2014.07.030
   Kelley RI, 2009, EVALUATION TREATMENT, V0, P0
   Kent L, 2008, AM J MED GENET B, V147B, P987, DOI 10.1002/ajmg.b.30687
   Kent L, 2006, J PEDIATR-US, V149, P280, DOI 10.1016/j.jpeds.2005.08.060
   Khemakhem AM, 2017, METAB BRAIN DIS, V32, P1983, DOI 10.1007/s11011-017-0085-2
   Kong SW, 2013, NEUROGENETICS, V14, P143, DOI 10.1007/s10048-013-0363-z
   Kuwabara H, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0073814
   LASZLO A, 1994, CLIN CHIM ACTA, V229, P205, DOI 10.1016/0009-8981(94)90243-7
   Legido A, 2018, NEUROLOGY, V90, P0
   Legido A, 2013, SEMIN PEDIATR NEUROL, V20, P163, DOI 10.1016/j.spen.2013.10.008
   Lepagnol-Bestel AM, 2008, MOL PSYCHIATR, V13, P385, DOI 10.1038/sj.mp.4002120
   Lintas C, 2012, NEUROBIOL DIS, V45, P57, DOI 10.1016/j.nbd.2010.11.010
   Liu J, 2015, AM J MED GENET B, V168, P236, DOI 10.1002/ajmg.b.32304
   Lv MN, 2016, TRANSL NEUROSCI, V7, P6, DOI 10.1515/tnsci-2016-0002
   Macfabe Derrick, 2013, GLOB ADV HEALTH MED, V2, P52, DOI 10.7453/gahmj.2013.089
   MacFabe DF, 2007, BEHAV BRAIN RES, V176, P149, DOI 10.1016/j.bbr.2006.07.025
   MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005
   Maestrini E, 2010, MOL PSYCHIATR, V15, P954, DOI 10.1038/mp.2009.34
   Mahfouz A, 2015, J MOL NEUROSCI, V57, P580, DOI 10.1007/s12031-015-0641-3
   Martinez TN, 2012, ANTIOXID REDOX SIGN, V16, P920, DOI 10.1089/ars.2011.4033
   Marui T, 2011, ACTA PSYCHIAT SCAND, V123, P118, DOI 10.1111/j.1600-0447.2010.01600.x
   Melnyk S, 2012, J AUTISM DEV DISORD, V42, P367, DOI 10.1007/s10803-011-1260-7
   Ming X, 2016, BRAIN DEV-JPN, V38, P225, DOI 10.1016/j.braindev.2015.07.003
   MINSHEW NJ, 1993, BIOL PSYCHIAT, V33, P762, DOI 10.1016/0006-3223(93)90017-8
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   MORENO H, 1992, INVEST CLIN, V33, P13
   Morris G, 2015, BMC MED, V13, P0, DOI 10.1186/s12916-015-0310-y
   Morscher RJ, 2018, NATURE, V554, P128, DOI 10.1038/nature25460
   Mostafa GA, 2005, INT J CHILD NEUROPSY, V2, P179
   Mousavinejad E, 2017, J NEUROL NEUROREHABI, V2, P25, DOI 10.35841/neurology-neurorehabilitation.2.2.64-68
   Mousavinejad E, 2018, PSYCHIAT RES, V265, P62, DOI 10.1016/j.psychres.2018.03.061
   Mousavizadeh K, 2013, J RES MED SCI, V18, P926
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Murphy DGM, 2002, ARCH GEN PSYCHIAT, V59, P885, DOI 10.1001/archpsyc.59.10.885
   Mussap M, 2016, EXPERT REV MOL DIAGN, V16, P869, DOI 10.1080/14737159.2016.1202765
   Nankova BB, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0103740
   Napoli E, 2014, PEDIATRICS, V133, PE1405, DOI 10.1542/peds.2013-1545
   Napoli E, 2013, MOL AUTISM, V4, P0, DOI 10.1186/2040-2392-4-2
   Napoli E, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0042504
   Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   Novarino G, 2012, SCIENCE, V338, P394, DOI 10.1126/science.1224631
   Oikonomakis V, 2016, CLIN GENET, V89, P708, DOI 10.1111/cge.12740
   Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332
   Oliveira G, 2007, DEV MED CHILD NEUROL, V49, P726, DOI 10.1111/j.1469-8749.2007.00726.x
   Palmieri L, 2010, MOL PSYCHIATR, V15, P38, DOI 10.1038/mp.2008.63
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.164
   Park E, 2017, ADV EXP MED BIOL, V975, P3, DOI 10.1007/978-94-024-1079-2_1
   Parvaneh N, 2014, J CLIN IMMUNOL, V34, P753, DOI 10.1007/s10875-014-0076-6
   Pastural E, 2009, PROSTAG LEUKOTR ESS, V81, P253, DOI 10.1016/j.plefa.2009.06.003
   Patowary A, 2017, AUTISM RES, V10, P1338, DOI 10.1002/aur.1792
   Pecorelli A, 2016, CYTOKINE, V77, P180, DOI 10.1016/j.cyto.2015.10.002
   Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090
   Petek E, 2007, MOL GENET GENOMICS, V277, P71, DOI 10.1007/s00438-006-0173-1
   Peterson BS, 2015, JAMA PSYCHIAT, V72, P190, DOI 10.1001/jamapsychiatry.2014.2425
   Piryaei F, 2012, CELL J, V14, P98
   Poling JS, 2006, J CHILD NEUROL, V21, P170, DOI 10.1177/08830738060210021401
   Pons R, 2004, J PEDIATR-US, V144, P81, DOI 10.1016/j.jpeds.2003.10.023
   Priya L, 2011, REDOX REP, V16, P216, DOI 10.1179/1351000211Y.0000000012
   Rabionet R, 2006, AM J PSYCHIAT, V163, P0
   Ramaekers VT, 2007, NEUROPEDIATRICS, V38, P276, DOI 10.1055/s-2008-1065354
   Ramaekers VT, 2003, NEUROLOGY, V61, P506, DOI 10.1212/01.WNL.0000078939.64774.1B
   Ramaekers VT, 2004, DEV MED CHILD NEUROL, V46, P843, DOI 10.1017/S0012162204001471
   Ramoz N, 2004, AM J PSYCHIAT, V161, P662, DOI 10.1176/appi.ajp.161.4.662
   Ramoz N, 2008, AM J MED GENET B, V147B, P1152, DOI 10.1002/ajmg.b.30739
   Rogers George W, 2014, CURR PROTOC TOXICOL, V60, P0, DOI 10.1002/0471140856.tx2503s60
   Rose S, 2015, TRANSL PSYCHIAT, V5, P0, DOI 10.1038/tp.2015.29
   Rose S, 2014, TRANSL PSYCHIAT, V4, P0, DOI 10.1038/tp.2014.15
   Rose S, 2012, TRANSL PSYCHIAT, V2, P0, DOI 10.1038/tp.2012.61
   Rose S, 2018, TRANSL PSYCHIAT, V8, P0, DOI 10.1038/s41398-017-0089-z
   Rose S, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0186377
   Rose S, 2017, FASEB J, V31, P904, DOI 10.1096/fj.201601004R
   Rose S, 2015, J TOXICOL-US, V2015, P0, DOI 10.1155/2015/573701
   Rose S, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0085436
   Rose Shannon, 2012, AUTISM RES TREAT, V2012, P986519, DOI 10.1155/2012/986519
   Rosenfeld CS, 2015, DRUG METAB DISPOS, V43, P1557, DOI 10.1124/dmd.115.063826
   Rossi M, 2017, PEDIATR NEUROL, V70, P34, DOI 10.1016/j.pediatrneurol.2017.01.033
   Rossignol DA, 2014, TRANSL PSYCHIAT, V4, P0, DOI 10.1038/tp.2014.4
   Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165
   Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136
   Rossignol DA, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00150
   Rossignol DA, 2012, J AUTISM DEV DISORD, V42, P640, DOI 10.1007/s10803-011-1276-z
   Sandin S, 2014, JAMA-J AM MED ASSOC, V311, P1770, DOI 10.1001/jama.2014.4144
   Sansbury BE, 2011, CHEM-BIOL INTERACT, V191, P288, DOI 10.1016/j.cbi.2010.12.002
   Scaglia F, 2009, AM SOC HUM GEN 59 AN, V0, P0
   Schaefer GB, 2008, GENET MED, V10, P4, DOI 10.1097/GIM.0b013e31815efdd7
   Schaefer GB, 2013, GENET MED, V15, P669, DOI 10.1038/gim.2013.32
   Schaefer KA, 2016, INVEST OPHTH VIS SCI, V57, P2509, DOI 10.1167/iovs.15-18680
   Sdek P, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0058319
   Segurado R, 2005, AM J PSYCHIAT, V162, P2182, DOI 10.1176/appi.ajp.162.11.2182
   Serajee FJ, 2006, NEUROPEDIATRICS S1, V37, P0
   Shahjadi S, 2017, J DHAKA MED COLL, V26, P43, DOI 10.3329/JDMC.V26I1.34000
   Sharpe MA, 2013, J TOXICOL-US, V2013, P0, DOI 10.1155/2013/801517
   SHAW W, 1995, CLIN CHEM, V41, P1094
   Shaw William, 2017, INTEGR MED (ENCINITAS), V16, P50
   Shoffner J, 2016, NEUROLOGY, V86, P2258, DOI 10.1212/WNL.0000000000002766
   Shoffner J, 2010, J CHILD NEUROL, V25, P429, DOI 10.1177/0883073809342128
   Sie L, 2009, J NEUROSCI RES, V87, P1953, DOI 10.1002/jnr.22000
   Silverman JM, 2008, AM J MED GENET B, V147B, P408, DOI 10.1002/ajmg.b.30614
   Slattery J, 2016, CLIN MED INSIGHTS-PE, V10, P91, DOI 10.4137/CMPed.S38338
   Smith M, 2012, BBA-BIOENERGETICS, V1817, P1796, DOI 10.1016/j.bbabio.2012.04.004
   Smith M, 2009, ANN NY ACAD SCI, V1151, P102, DOI 10.1111/j.1749-6632.2008.03571.x
   Tammimies K, 2015, JAMA-J AM MED ASSOC, V314, P895, DOI 10.1001/jama.2015.10078
   Tang GM, 2013, NEUROBIOL DIS, V54, P349, DOI 10.1016/j.nbd.2013.01.006
   Tarlungeanu DC, 2016, CELL, V167, P1481, DOI 10.1016/j.cell.2016.11.013
   Taurines R, 2010, EUR CHILD ADOLES PSY, V19, P441, DOI 10.1007/s00787-009-0074-z
   Thomas RH, 2012, J NEUROINFLAMM, V9, P0, DOI 10.1186/1742-2094-9-153
   Thomas RH, 2010, J NEUROCHEM, V113, P515, DOI 10.1111/j.1471-4159.2010.06614.x
   Tsao CY, 2007, J CHILD NEUROL, V22, P1121, DOI 10.1177/0883073807306266
   Turunen JA, 2008, AUTISM RES, V1, P189, DOI 10.1002/aur.25
   Varga NA, 2018, BEHAV BRAIN FUNCT, V14, P0, DOI 10.1186/s12993-018-0135-x
   Villafuerte S, 2011, ACTA PSYCHIAT SCAND, V123, P95, DOI 10.1111/j.1600-0447.2010.01654.x
   Waly Mostafa I, 2012, AUTISM RES TREAT, V2012, P190930, DOI 10.1155/2012/190930
   Wang L, 2012, DIGEST DIS SCI, V57, P2096, DOI 10.1007/s10620-012-2167-7
   Wang YQ, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1006391
   Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002
   Weissman JR, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0003815
   Williams BL, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0024585
   Witters P, 2016, MOL GENET METAB, V119, P317, DOI 10.1016/j.ymgme.2016.10.009
   Wong S, 2016, PEDIATRICS, V137, P0, DOI 10.1542/peds.2015-1888
   Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007
   Yoo HJ, 2017, WORLD J BIOL PSYCHIA, V18, P151, DOI 10.1080/15622975.2016.1234069
   Yorns WR, 2012, J CHILD NEUROL, V27, P398, DOI 10.1177/0883073811420870
   Zaki MM, 2017, TURK J MED SCI, V47, P260, DOI 10.3906/sag-1506-105
   Zelnik N, 1996, PEDIATR NEUROL, V14, P251, DOI 10.1016/0887-8994(96)00046-X
   Zerbo O, 2015, BRAIN BEHAV IMMUN, V46, P232, DOI 10.1016/j.bbi.2015.02.001
   Zhang BD, 2010, J NEUROINFLAMM, V7, P0, DOI 10.1186/1742-2094-7-80
   Zhang LS, 2015, EUR ARCH PSY CLIN N, V265, P511, DOI 10.1007/s00406-014-0524-6
   Zhang YQ, 2018, AM J MED GENET B, V177, P93, DOI 10.1002/ajmg.b.32608
   Ziats MN, 2015, AM J MED GENET A, V167, P2162, DOI 10.1002/ajmg.a.37144
NR 246
TC 143
Z9 153
U1 2
U2 43
PU ADIS INT LTD
PI NORTHCOTE
PA 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND
SN 1177-1062
EI 1179-2000
J9 MOL DIAGN THER
JI Mol. Diagn. Ther.
PD OCT 15
PY 2018
VL 22
IS 5
BP 571
EP 593
DI 10.1007/s40291-018-0352-x
PG 23
WC Genetics & Heredity; Pharmacology & Pharmacy
SC Genetics & Heredity; Pharmacology & Pharmacy
GA GS8ZO
UT WOS:000444004500006
PM 30039193
DA 2024-11-01
ER

PT J
AU Tabebi, M
   Khabou, B
   Boukadi, H
   Ben Hamad, M
   Ben Rhouma, B
   Tounsi, S
   Maalej, A
   Kamoun, H
   Keskes-Ammar, L
   Abid, M
   Mnif, M
   Fakhfakh, F
AF Tabebi, Mouna
   Khabou, Bodour
   Boukadi, Hanen
   Ben Hamad, Mariam
   Ben Rhouma, Bochra
   Tounsi, Slim
   Maalej, Abdellatif
   Kamoun, Hassen
   Keskes-Ammar, Leila
   Abid, Mohamed
   Mnif, Mouna
   Fakhfakh, Faiza
TI Association study of apoptosis gene polymorphisms in mitochondrial diabetes: A potential role in the pathogenicity of MD
SO GENE
LA English
DT Article
DE Mitochondrial diabetes; Apoptosis; Polymorphisms; TUNEL; Cytochrome c; Protein expression
ID single-nucleotide polymorphisms; programmed cell-death; linkage disequilibrium; molecular-mechanisms; tunisian family; human genome; p53; mutation; midd; activation
AB Mitochondrial diabetes (MD) is a heterogeneous disorder characterized by a chronic hyperglycemia and is maternally transmitted. Syndromic MD is a subgroup of MD including diabetic microangiopathy and macroangiopathy, in addition to extrapancreatic disorder. MD is caused by genetic mutations and deletions affecting mitochondrial DNA. This mitochondrial damage initiates apoptosis. In this study, we hypothesized that functional polymorphisms in genes involved in apoptotic pathway could be associated with the development of apoptosis in MD disease and increased its risk. Detection of apoptosis was confirmed on muscle biopsies taken from MD patients using the TUNEL method and the Cytochrome c protein expression level. We genotyped then 11 published SNPs from intrinsic and extrinsic apoptotic pathway and assessed the signification of these polymorphisms in 43 MD patients and 100 healthy controls. We found 10 selected polymorphisms (p53 (rs1042522 and rs17878362), BCL2 (rs2279115), BAX (rs1805419), BAK1 (rs210132 and rs2227925), CASP3 (rs1405937), CASP7 (rs2227310), CASP8 (rs1045485) and CASPIO (rs13006529)) with a potential apoptosis effect in MD patients compared to control population. Specifically, SNPs involved in the intrinsic pathway (p53, BCL2, BAK1 and CASP3) presented the highest risk of apoptosis. Our result proved that apoptosis initiated by mtDNA mutations, can be emphasized by a functional apoptotic polymorphisms associated with high expression of cytochrome c protein and more myofibers with apoptosis in syndromic MD subgroup compared with non-syndromic MD subgroup.
C1 [Tabebi, Mouna; Khabou, Bodour; Ben Hamad, Mariam; Ben Rhouma, Bochra; Maalej, Abdellatif; Kamoun, Hassen; Keskes-Ammar, Leila] Univ Sfax, Fac Med Sfax, Human Mol Genet Lab, Sfax, Tunisia.
   [Boukadi, Hanen; Tounsi, Slim] Univ Sfax, Ctr Biotechnol Sfax, Lab Biopesticides, Sfax, Tunisia.
   [Abid, Mohamed; Mnif, Mouna] Univ Hosp Hedi Chaker, Dept Endocrinol, Sfax, Tunisia.
   [Fakhfakh, Faiza] Univ Sfax, Fac Sci Sfax, Dept Life Sci, Sfax, Tunisia.
C3 Universite de Sfax; Centre de Biotechnologie de Sfax; Universite de Sfax; Universite de Sfax; Hopital Hedi Chaker; Universite de Sfax; Faculty of Sciences Sfax
RP Tabebi, M (corresponding author), Fac Med, Lab Human Mol Genet, Ave Magida Boulila, Sfax 3029, Tunisia.
EM mounamouna62@yahoo.fr
FU Ministry of Higher Education and Scientific Research in Tunisia
CR Alimonti JB, 2001, J BIOL CHEM, V276, P6974, DOI 10.1074/jbc.M008444200
   Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777
   Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305
   Bendesky A, 2007, MUTAT RES-FUND MOL M, V619, P38, DOI 10.1016/j.mrfmmm.2007.01.001
   Biros E, 2002, PHYSIOL RES, V51, P59, DOI 10.33549/physiolres.930134
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Fan BJ, 2010, INVEST OPHTH VIS SCI, V51, P4110, DOI 10.1167/iovs.09-4974
   Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424
   Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320
   Hu ZB, 2008, J CANCER EPIDEMIOL, V2008, P0, DOI 10.1155/2008/147905
   Javid J, 2016, CELL DEATH DIS, V4, P0
   Ke XY, 2001, BIOINFORMATICS, V17, P838, DOI 10.1093/bioinformatics/17.9.838
   Ko CB, 2004, TOXICOLOGY, V199, P35, DOI 10.1016/j.tox.2004.01.039
   KORSMEYER SJ, 1995, TRENDS GENET, V11, P101, DOI 10.1016/S0168-9525(00)89010-1
   Lei W, 1998, CANCER RES, V58, P2102
   LEWIN HA, 1992, BIOTECHNIQUES, V13, P522
   Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098
   Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004
   Mezghani N, 2010, J DIABETES COMPLICAT, V24, P270, DOI 10.1016/j.jdiacomp.2009.11.002
   Miller JB, 2006, TRENDS MOL MED, V12, P279, DOI 10.1016/j.molmed.2006.04.003
   MIYASHITA T, 1995, CELL, V80, P293
   Mkaouar-Rebai E, 2009, PEDIATR NEUROL, V40, P437, DOI 10.1016/j.pediatrneurol.2009.01.004
   Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236
   Salem IH, 2012, MOL BIOL REP, V39, P7479, DOI 10.1007/s11033-012-1581-4
   Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579
   Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272
   Tabebi M, 2017, J DIABETES COMPLICAT, V31, P253, DOI 10.1016/j.jdiacomp.2016.06.028
   Tabebi M, 2015, BIOCHEM BIOPH RES CO, V459, P353, DOI 10.1016/j.bbrc.2015.01.151
   THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464
   WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x
   ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367
NR 35
TC 4
Z9 6
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD JAN 10
PY 2018
VL 639
IS 
BP 18
EP 26
DI 10.1016/j.gene.2017.09.063
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA FN9XL
UT WOS:000416396100003
PM 28987347
DA 2024-11-01
ER

PT J
AU Rubino, E
   Zhang, M
   Mongini, T
   Boschi, S
   Vercelli, L
   Vacca, A
   Govone, F
   Gai, A
   Giordana, MT
   Grinberg, M
   Rogaeva, E
   Rainero, I
AF Rubino, Elisa
   Zhang, Ming
   Mongini, Tiziana
   Boschi, Silvia
   Vercelli, Liliana
   Vacca, Alessandro
   Govone, Flora
   Gai, Annalisa
   Giordana, Maria Teresa
   Grinberg, Mark
   Rogaeva, Ekaterina
   Rainero, Innocenzo
TI Mutation analysis of <i>CHCHD2</i> and <i>CHCHD10</i> in Italian patients with mitochondrial myopathy
SO NEUROBIOLOGY OF AGING
LA English
DT Article
DE Mitochondrial myopathy; CHCHD10; CHCHD2; Mitochondrial disease
ID amyotrophic-lateral-sclerosis; frontotemporal dementia
AB Mutations in CHCHD2 and CHCHD10 were recently reported in a broad spectrum of neurodegenerative diseases, for example, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, or mitochondrial myopathy (MM). The aim of the study was to evaluate the prevalence of CHCHD2 and CHCHD10 mutations in Italian MM patients without mitochondrial DNA mutations. The coding regions of CHCHD2 and CHCHD10 were sequenced in 62 MM patients. None of the patients showed CHCHD2 mutations, whereas 1 sporadic MM patient carried a homozygous Pro96Thr substitution in CHCHD10. Muscle biopsy of this patient showed intracellular glycogen accumulation with cytochrome c oxidase negative and ragged red fibers. Our study suggests that the homozygous Pro96Thr mutation in CHCHD10 might be pathogenic but does not support a major role for CHCHD2 in MM pathogenesis. Crown Copyright (C) 2018 Published by Elsevier Inc. All rights reserved.
C1 [Rubino, Elisa; Mongini, Tiziana; Boschi, Silvia; Vercelli, Liliana; Vacca, Alessandro; Govone, Flora; Gai, Annalisa; Giordana, Maria Teresa; Rainero, Innocenzo] Univ Turin, Dept Neurosci Rita Levi Montalcini, Via Cherasco 15, I-10126 Turin, Italy.
   [Zhang, Ming; Grinberg, Mark; Rogaeva, Ekaterina] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.
   [Mongini, Tiziana; Giordana, Maria Teresa; Rainero, Innocenzo] AOU Citta Salute & Sci, Dept Neurosci & Mental Hlth, Neurol 1, Turin, Italy.
   [Boschi, Silvia] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth NEURO, Florence, Italy.
C3 University of Turin; University of Toronto; A.O.U. Citta della Salute e della Scienza di Torino; University of Florence
RP Rubino, E (corresponding author), Univ Turin, Dept Neurosci Rita Levi Montalcini, Via Cherasco 15, I-10126 Turin, Italy.
EM elisa.rubino@unito.it
FU ALS Canada-Brain Canada Hudson Grant; AIRAlzh Onlus-ANCC-COOP
CR Ajroud-Driss S, 2015, NEUROGENETICS, V16, P1, DOI 10.1007/s10048-014-0421-1
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Dols-Icardo O, 2015, BRAIN, V138, PE400, DOI 10.1093/brain/awv175
   Funayama M, 2015, LANCET NEUROL, V14, P274, DOI 10.1016/S1474-4422(14)70266-2
   Rubino E, 2017, NEUROBIOL AGING, V53, P0, DOI 10.1016/j.neurobiolaging.2016.12.027
   Straub IR, 2018, HUM MOL GENET, V27, P178, DOI 10.1093/hmg/ddx393
   Teyssou E, 2016, NEUROBIOL AGING, V42, P0, DOI 10.1016/j.neurobiolaging.2016.03.022
   Zhang M, 2015, BRAIN, V138, P0, DOI 10.1093/brain/awv082
NR 8
TC 8
Z9 9
U1 0
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0197-4580
EI 1558-1497
J9 NEUROBIOL AGING
JI Neurobiol. Aging
PD JUN 15
PY 2018
VL 66
IS 
BP 
EP 
DI 10.1016/j.neurobiolaging.2018.02.007
PG 2
WC Geriatrics & Gerontology; Neurosciences
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA GE1WA
UT WOS:000431006300030
PM 29519717
DA 2024-11-01
ER

PT J
AU Dölle, C
   Bindoff, LA
   Tzoulis, C
AF Dolle, Christian
   Bindoff, Laurence A.
   Tzoulis, Charalampos
TI 3,3′-Diaminobenzidine staining interferes with PCR-based DNA analysis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID real-time pcr; cytochrome-oxidase; mitochondrial; deletions; disease; cells; mtdna
AB 3,3'-Diaminobenzidine (DAB) is a widely used chromogen in histological staining methods and stained tissue is often used in downstream molecular analyses such as quantitative PCR (qPCR). Using microdissected muscle fibers from sequential muscle sections stained by DAB-dependent and -independent methods, we show that DAB exerts a strong inhibitory effect on qPCR-based mitochondrial DNA quantification. This effect introduces a significant bias in the estimation of mitochondrial DNA copy number and deletion levels between DAB-positive and -negative fibers. We reproduce our findings in microdissected neurons from human brain tissue, suggesting a general effect of DAB staining on PCR analyses independent of the underlying tissue or cell type. Using an exogenous DNA template added to tissue samples we provide evidence that DAB-staining predominantly interferes with the tissue-derived DNA template rather than inhibiting DNA polymerase activity. Our results suggest that DAB-based staining is incompatible with PCR-based quantification methods and some of the previously reported results employing this approach should be reconsidered.
C1 [Dolle, Christian; Bindoff, Laurence A.; Tzoulis, Charalampos] Haukeland Hosp, Dept Neurol, Bergen, Norway.
   [Dolle, Christian; Bindoff, Laurence A.; Tzoulis, Charalampos] Univ Bergen, Dept Clin Med, Bergen, Norway.
C3 University of Bergen; Haukeland University Hospital; University of Bergen
RP Tzoulis, C (corresponding author), Haukeland Hosp, Dept Neurol, Bergen, Norway.; Tzoulis, C (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.
EM charalampos.tzoulis@nevro.uib.no
FU Regional Health Authority of Western Norway [911903, 911988]; Research Council of Norway [240369/F20]
CR Alves G, 2009, J NEUROL NEUROSUR PS, V80, P851, DOI 10.1136/jnnp.2008.168211
   ANGERMULLER S, 1981, HISTOCHEMISTRY, V71, P33, DOI 10.1007/BF00592568
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Murase T, 2000, MODERN PATHOL, V13, P147, DOI 10.1038/modpathol.3880028
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Rådström P, 2004, MOL BIOTECHNOL, V26, P133, DOI 10.1385/MB:26:2:133
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Wong LJC, 2003, J MED GENET, V40, P0
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
NR 20
TC 10
Z9 10
U1 0
U2 3
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD JAN 19
PY 2018
VL 8
IS 
BP 
EP 
DI 10.1038/s41598-018-19745-9
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FT1JJ
UT WOS:000422891000102
PM 29352159
DA 2024-11-01
ER

PT J
AU Lee, JJ
   Sanchez-Martinez, A
   Zarate, AM
   Benincá, C
   Mayor, U
   Clague, MJ
   Whitworth, AJ
AF Lee, Juliette J.
   Sanchez-Martinez, Alvaro
   Zarate, Aitor Martinez
   Beninca, Cristiane
   Mayor, Ugo
   Clague, Michael J.
   Whitworth, Alexander J.
TI Basal mitophagy is widespread in <i>Drosophila</i> but minimally affected by loss of Pink1 or parkin
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID mitochondrial-dna deletions; substantia-nigra neurons; in-vivo; oxidative stress; disease; mutants; neurodegeneration; pathogenesis; dysfunction; mechanisms
AB The Parkinson's disease factors PINK1 and parkin are strongly implicated in stress-induced mitophagy in vitro, but little is known about their impact on basal mitophagy in vivo. We generated transgenic Drosophila melanogaster expressing fluorescent mitophagy reporters to evaluate the impact of Pink1/parkin mutations on basal mitophagy under physiological conditions. We find that mitophagy is readily detectable and abundant in many tissues, including Parkinson's diseaserelevant dopaminergic neurons. However, we did not detect mitolysosomes in flight muscle. Surprisingly, in Pink1 or parkin null flies, we did not observe any substantial impact on basal mitophagy. Because these flies exhibit locomotor defects and dopaminergic neuron loss, our findings raise questions about current assumptions of the pathogenic mechanism associated with the PINK1/parkin pathway. Our findings provide evidence that Pink1 and parkin are not essential for bulk basal mitophagy in Drosophila. They also emphasize that mechanisms underpinning basal mitophagy remain largely obscure.
C1 [Lee, Juliette J.; Sanchez-Martinez, Alvaro; Beninca, Cristiane; Whitworth, Alexander J.] Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Cambridge, England.
   [Zarate, Aitor Martinez; Mayor, Ugo] Univ Basque Country, Dept Biochem & Mol Biol, Leioa, Spain.
   [Zarate, Aitor Martinez; Clague, Michael J.] Univ Liverpool, Inst Translat Med, Dept Mol & Cellular Physiol, Liverpool, Merseyside, England.
C3 UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Basque Country; University of Liverpool
RP Whitworth, AJ (corresponding author), Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Cambridge, England.; Clague, MJ (corresponding author), Univ Liverpool, Inst Translat Med, Dept Mol & Cellular Physiol, Liverpool, Merseyside, England.
EM clague@liverpool.ac.uk; a.whitworth@mrc-mbu.cam.ac.uk
FU Medical Research Council [MC-A070-5PSB0, MC_UU_00015/6]; European Research Council [309742]; Medical Research Council; National Institutes of Health [P40OD018537]; MRC [MC_UU_00015/6, MC_UP_1501/1] Funding Source: UKRI; European Research Council (ERC) [309742] Funding Source: European Research Council (ERC)
CR Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168
   Ashrafi G, 2014, J CELL BIOL, V206, P655, DOI 10.1083/jcb.201401070
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Cummins N, 2018, CELL MOL LIFE SCI, V75, P1151, DOI 10.1007/s00018-017-2692-9
   Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007
   Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230
   Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170
   Greene JC, 2005, HUM MOL GENET, V14, P799, DOI 10.1093/hmg/ddi074
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Hewitt VL, 2017, CURR TOP DEV BIOL, V121, P173, DOI 10.1016/bs.ctdb.2016.07.005
   Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lee Y, 2017, CELL REP, V18, P918, DOI 10.1016/j.celrep.2016.12.090
   Lee Y, 2012, CSH PERSPECT MED, V2, P0, DOI 10.1101/cshperspect.a009324
   McLelland GL, 2016, J CELL BIOL, V214, P275, DOI 10.1083/jcb.201603105
   McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902
   McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008
   McWilliams TG, 2016, J CELL BIOL, V214, P333, DOI 10.1083/jcb.201603039
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007
   Rodger CE, 2018, FEBS J, V285, P1185, DOI 10.1111/febs.14336
   Rojansky R, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.17896
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104
   Sulzer D, 2013, MOVEMENT DISORD, V28, P41, DOI 10.1002/mds.25095
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Villa E, 2017, CELL REP, V20, P2846, DOI 10.1016/j.celrep.2017.08.087
   Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110
   Whitworth AJ, 2017, CURR OPIN GENET DEV, V44, P47, DOI 10.1016/j.gde.2017.01.016
   Yamano K, 2016, EMBO REP, V17, P300, DOI 10.15252/embr.201541486
   Yang JY, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3428
   Yun JN, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.01958
NR 37
TC 221
Z9 235
U1 0
U2 13
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD MAY 15
PY 2018
VL 217
IS 5
BP 1613
EP 1622
DI 10.1083/jcb.201801044
PG 10
WC Cell Biology
SC Cell Biology
GA GF0JL
UT WOS:000431616300009
PM 29500189
DA 2024-11-01
ER

PT J
AU Buzkova, J
   Nikkanen, J
   Ahola, S
   Hakonen, AH
   Sevastianova, K
   Hovinen, T
   Yki-Järvinen, H
   Pietiläinen, KH
   Lönnqvist, T
   Velagapudi, V
   Carroll, CJ
   Suomalainen, A
AF Buzkova, Jana
   Nikkanen, Joni
   Ahola, Sofia
   Hakonen, Anna H.
   Sevastianova, Ksenia
   Hovinen, Topi
   Yki-Jarvinen, Hannele
   Pietilainen, Kirsi H.
   Lonnqvist, Tuula
   Velagapudi, Vidya
   Carroll, Christopher J.
   Suomalainen, Anu
TI Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE biomarker; inclusion body myositis; metabolomics; mitochondrial diseases
ID onset spinocerebellar ataxia; recessive ataxia; dna deletions; melas; mutation; myopathy; hyperlactatemia; metaboanalyst; prevalence; deficiency
AB Mitochondrial disorders (MDs) are inherited multi-organ diseases with variable phenotypes. Inclusion body myositis (IBM), a sporadic inflammatory muscle disease, also shows mitochondrial dysfunction. We investigated whether primary and secondary MDs modify metabolism to reveal pathogenic pathways and biomarkers. We investigated metabolomes of 25 mitochondrial myopathy or ataxias patients, 16 unaffected carriers, six IBM and 15 non-mitochondrial neuromuscular disease (NMD) patients and 30 matched controls. MD and IBM metabolomes clustered separately from controls and NMDs. MDs and IBM showed transsulfuration pathway changes; creatine and niacinamide depletion marked NMDs, IBM and infantile-onset spinocerebellar ataxia (IOSCA). Low blood and muscle arginine was specific for patients with m.3243A>G mutation. A four-metabolite blood multi-biomarker (sorbitol, alanine, myoinositol, cystathionine) distinguished primary MDs from others (76% sensitivity, 95% specificity). Our omics approach identified pathways currently used to treat NMDs and mitochondrial stroke-like episodes and proposes nicotinamide riboside in MDs and IBM, and creatine in IOSCA and IBM as novel treatment targets. The disease-specific metabolic fingerprints are valuable "multi-biomarkers" for diagnosis and promising tools for follow-up of disease progression and treatment effect.
C1 [Buzkova, Jana; Nikkanen, Joni; Ahola, Sofia; Hakonen, Anna H.; Hovinen, Topi; Carroll, Christopher J.; Suomalainen, Anu] Univ Helsinki, Res Programs Unit, Mol Neurol, Biomedicum Helsinki, Helsinki, Finland.
   [Sevastianova, Ksenia; Yki-Jarvinen, Hannele] Univ Helsinki, Dept Med, Helsinki, Finland.
   [Sevastianova, Ksenia; Yki-Jarvinen, Hannele] Helsinki Univ Hosp, Helsinki, Finland.
   [Sevastianova, Ksenia; Yki-Jarvinen, Hannele] Minerva Fdn, Helsinki, Finland.
   [Pietilainen, Kirsi H.] Univ Helsinki, Res Programs Unit, Diabet & Uhes, Uhes Res Unit, Helsinki, Finland.
   [Pietilainen, Kirsi H.] Univ Helsinki, Cent Hosp, Abdominal Ctr, Endocrinol, Helsinki, Finland.
   [Pietilainen, Kirsi H.] Univ Helsinki, Helsinki, Finland.
   [Lonnqvist, Tuula] Univ Helsinki, Dept Child Neurol, Childrens Hosp, Helsinki, Finland.
   [Velagapudi, Vidya] Univ Helsinki, Metabol Unit, FIMM, HiLIFE, Helsinki, Finland.
   [Carroll, Christopher J.] St Georges Univ London, Genet Res Ctr, Mol & Clin Sci Inst, London, England.
   [Suomalainen, Anu] Helsinki Univ Hosp, Dept Neurosci, Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Ctr Neurosci, Helsinki Inst Life Sci, Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; City St Georges, University of London; University of Helsinki; Helsinki University Central Hospital; University of Helsinki
RP Suomalainen, A (corresponding author), Univ Helsinki, Res Programs Unit, Mol Neurol, Biomedicum Helsinki, Helsinki, Finland.; Suomalainen, A (corresponding author), Helsinki Univ Hosp, Dept Neurosci, Helsinki, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, Ctr Neurosci, Helsinki Inst Life Sci, Helsinki, Finland.
EM anu.wartiovaara@helsinki.fi
FU European Research Council; Academy of Finland (Centre of Excellence in Research on Mitochondria, Metabolism and Disease (FinMIT)) [272376]; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; University of Helsinki; Helsinki University Central Hospital; Doctoral Programme in Integrative Life Science; Academy of Finland postdoctoral fellowship; Gyllenberg Foundation; Novo Nordisk Foundation; Finnish Diabetes Research Foundation; Biocenter Finland
CR Abdullah M, 2017, METABOLITES, V7, P0, DOI 10.3390/metabo7030038
   Ahola S, 2016, EMBO MOL MED, V8, P1234, DOI 10.15252/emmm.201606592
   [Anonymous], 2011, GUID BIOAN METH VAL, V0, P0
   Askanas V, 2015, BBA-MOL BASIS DIS, V1852, P633, DOI 10.1016/j.bbadis.201409.005
   Bao XR, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10575
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   El-Hattab AW, 2012, MOL GENET METAB, V105, P607, DOI 10.1016/j.ymgme.2012.01.016
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hall AM, 2015, KIDNEY INT, V87, P610, DOI 10.1038/ki.2014.297
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kley RA, 2013, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004760.pub4
   Koenig MK, 2016, JAMA NEUROL, V73, P591, DOI 10.1001/jamaneurol.2015.5072
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Kolho KL, 2017, J CROHNS COLITIS, V11, P321, DOI 10.1093/ecco-jcc/jjw158
   Kühl I, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.30952
   Legault JT, 2015, CELL REP, V13, P981, DOI 10.1016/j.celrep.2015.09.054
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Lindgren U, 2017, NEUROMUSCULAR DISORD, V27, PS153, DOI 10.1016/j.nmd.2017.06.219
   Lönnqvist T, 1998, J NEUROL SCI, V161, P57, DOI 10.1016/S0022-510X(98)00249-4
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Mudd SH, 2012, MOL GENET METAB, V105, P228, DOI 10.1016/j.ymgme.2011.11.006
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Nandania J, 2018, METABOLITES, V8, P0, DOI 10.3390/metabo8030044
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Noguera A, 2004, PEDIATRICS, V114, PE598, DOI 10.1542/peds.2004-0955
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Ost M, 2015, FASEB J, V29, P1314, DOI 10.1096/fj.14-261503
   Park J, 2013, NEPHROL DIAL TRANSPL, V28, P2146, DOI 10.1093/ndt/gft213
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   SUOMALAINEN A, 1993, HUM MOL GENET, V2, P525, DOI 10.1093/hmg/2.5.525
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Suomalainen A, 2011, J INHERIT METAB DIS, V34, P277, DOI 10.1007/s10545-010-9222-3
   Tadiboyina VT, 2005, AM J MED GENET A, V135A, P289, DOI 10.1002/ajmg.a.30748
   Thabet H, 2000, AM J EMERG MED, V18, P508, DOI 10.1053/ajem.2000.3981
   Thauvin-Robinet C, 2004, J INHERIT METAB DIS, V27, P700, DOI 10.1023/B:BOLI.0000043017.90837.93
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Xia JG, 2015, NUCLEIC ACIDS RES, V43, PW251, DOI 10.1093/nar/gkv380
   Xia JG, 2009, NUCLEIC ACIDS RES, V37, PW652, DOI 10.1093/nar/gkp356
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
NR 50
TC 54
Z9 56
U1 1
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD DEC 15
PY 2018
VL 10
IS 12
BP 
EP 
DI 10.15252/emmm.201809091
PG 15
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA HD4TP
UT WOS:000452521400011
PM 30373890
DA 2024-11-01
ER

PT J
AU Kanungo, S
   Morton, J
   Neelakantan, M
   Ching, K
   Saeedian, J
   Goldstein, A
AF Kanungo, Shibani
   Morton, Jacob
   Neelakantan, Mekala
   Ching, Kevin
   Saeedian, Jasmine
   Goldstein, Amy
TI Mitochondrial disorders
SO ANNALS OF TRANSLATIONAL MEDICINE
LA English
DT Review
DE Mitochondria; energy metabolism; mtDNA; nDNA; heteroplasmy
ID pyruvate-dehydrogenase deficiency; complex ii; disease; mechanisms; medicine; features
AB Primary mitochondrial disorders are a group of clinically variable and heterogeneous inborn errors of metabolism (IEMs), resulting from defects in cellular energy, and can affect every organ system of the body. Clinical presentations vary and may include symptoms of fatigue, skeletal muscle weakness, exercise intolerance, short stature, failure to thrive, blindness, ptosis and ophthalmoplegia, nystagmus, hearing loss, hypoglycemia, diabetes mellitus, learning difficulties, intellectual disability, seizures, stroke-like episodes, spasticity, dystonia, hypotonia, pain, neuropsychiatric symptoms, gastrointestinal reflux, dysmotility, gastrointestinal pseudo-obstruction, cardiomyopathy, cardiac conduction defects, and other endocrine, renal, cardiac, and liver problems. Most phenotypic manifestations are multi-systemic, with presentations varying at different age of onset and may show great variability within members of the same family; making these truly complex IEMs. Most primary mitochondrial diseases are autosomal recessive (AR); but maternally-inherited [from mitochondrial (mt) DNA], autosomal dominant and X-linked inheritance are also known. Mitochondria are unique energy-generating cellular organelles, geared for survival and contain their own unique genetic coding material, a circular piece of mtDNA about 16,000 base pairs in size. Additional nuclear (n) DNA encoded genes maintain mitochondrial biogenesis by supervising mtDNA replication, repair and synthesis, which is modified during increased energy demands or physiological stress. Despite our growing knowledge of the hundreds of genetic etiologies for this group of disorders, diagnosis can also remain elusive due to unique aspects of mitochondrial genetics. Though cure and FDA-approved therapies currently elude these IEMs, and current suggested therapies which include nutritional supplements and vitamins are of questionable efficacy; multi-center, international clinical trials are in progress for primary mitochondrial disorders.
C1 [Kanungo, Shibani; Morton, Jacob; Neelakantan, Mekala; Ching, Kevin; Saeedian, Jasmine] Western Michigan Univ, Homer Stryker MD Sch Med, Dept Pediat & Adolescent Med, 1000 Oakland Dr, Kalamazoo, MI 49008 USA.
   [Goldstein, Amy] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Goldstein, Amy] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.
C3 Western Michigan University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania
RP Kanungo, S (corresponding author), Western Michigan Univ, Homer Stryker MD Sch Med, Dept Pediat & Adolescent Med, 1000 Oakland Dr, Kalamazoo, MI 49008 USA.
EM Shibani.Kanungo@med.wmich.edu
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Angelini C, 2009, ACTA MYOL, V28, P16
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   BROWN GK, 1994, J MED GENET, V31, P875, DOI 10.1136/jmg.31.11.875
   Cohen BH, 1993, GENEREVIEWS, V0, P0
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 1993, MITOCHONDRIAL DNA DE, V0, P0
   DiMauro S, 1993, MELAS GENEREVIEWS, V0, P0
   DiMauro S, 1993, MERRF GENEREVIEWS, V0, P0
   El-Hattab AW, 1993, MITOCHONDRIAL DNA MA, V0, P0
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Head RA, 2005, ANN NEUROL, V58, P234, DOI 10.1002/ana.20550
   Hirano M, 1993, MITOCHONDRIAL NEUROG, V0, P0
   Hoekstra AS, 2013, BBA-BIOENERGETICS, V1827, P543, DOI 10.1016/j.bbabio.2012.11.005
   Jain-Ghai S, 2013, AM J MED GENET A, V161A, P285, DOI 10.1002/ajmg.a.35714
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395
   Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486
   Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Mori M, 2015, MOLEC GENET METAB RE, V4, P39, DOI 10.1016/j.ymgmr.2015.06.001
   Muraresku CC, 2018, CURR GENET MED REP, V6, P62, DOI 10.1007/s40142-018-0138-9
   Naito E, 2002, BBA-MOL BASIS DIS, V1588, P79, DOI 10.1016/S0925-4439(02)00142-4
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.164
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Poole OV, 2015, DISCOV MED, V20, P325
   Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707
   Schultz KAP, 1993, GENEREVIEWS, V0, P0
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stenqvist L, 2005, PEDIATR RES, V58, P258, DOI 10.1203/01.PDR.0000169966.82325.1A
   Thorburn DR, 1993, GENEREVIEWS, V0, P0
   Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wang J, 1993, TK2-RELATED MITOCHONDRIAL DNA MAINTENANCE DEFECT, V0, P0
NR 40
TC 47
Z9 50
U1 0
U2 21
PU AME PUBLISHING COMPANY
PI SHATIN
PA FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA
SN 2305-5839
EI 2305-5847
J9 ANN TRANSL MED
JI ANN. TRANSL. MED.
PD DEC 15
PY 2018
VL 6
IS 24
BP 
EP 
DI 10.21037/atm.2018.12.13
PG 17
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA HF9II
UT WOS:000454555300010
PM 30740406
DA 2024-11-01
ER

PT J
AU Jang, YH
   Lim, KI
AF Jang, Yoon-ha
   Lim, Kwang-il
TI Recent Advances in Mitochondria-Targeted Gene Delivery
SO MOLECULES
LA English
DT Review
DE mitochondrial gene delivery; mitochondrial disease; mitochondrial genomes; heteroplasmy; mitochondrial matrix
ID hereditary optic neuropathy; nadh-quinone oxidoreductase; skeletal-muscle; plasmid dna; mutant mtdna; mito-porter; in-vitro; sequence; peptide; therapy
AB Mitochondria are the energy-producing organelles of cells. Mitochondrial dysfunctions link to various syndromes and diseases including myoclonic epilepsy and ragged-red fiber disease (MERRF), Leigh syndrome (LS), and Leber hereditary optic neuropathy (LHON). Primary mitochondrial diseases often result from mutations of mitochondrial genomes and nuclear genes that encode the mitochondrial components. However, complete intracellular correction of the mutated genetic parts relevant to mitochondrial structures and functions is technically challenging. Instead, there have been diverse attempts to provide corrected genetic materials with cells. In this review, we discuss recent novel physical, chemical and biological strategies, and methods to introduce genetic cargos into mitochondria of eukaryotic cells. Effective mitochondria-targeting gene delivery systems can reverse multiple mitochondrial disorders by enabling cells to produce functional mitochondrial components.
C1 [Jang, Yoon-ha; Lim, Kwang-il] Sookmyung Womens Univ, Dept Chem & Biol Engn, Seoul 04310, South Korea.
   [Lim, Kwang-il] Sookmyung Womens Univ, Inst Adv Mat & Syst, Seoul 04310, South Korea.
   [Lim, Kwang-il] Sookmyung Womens Univ, Res Inst ICT Convergence, Seoul 04310, South Korea.
C3 Sookmyung Women's University; Sookmyung Women's University; Sookmyung Women's University
RP Lim, KI (corresponding author), Sookmyung Womens Univ, Dept Chem & Biol Engn, Seoul 04310, South Korea.; Lim, KI (corresponding author), Sookmyung Womens Univ, Inst Adv Mat & Syst, Seoul 04310, South Korea.; Lim, KI (corresponding author), Sookmyung Womens Univ, Res Inst ICT Convergence, Seoul 04310, South Korea.
EM miin_yj@sookmyung.ac.kr; klim@sookmyung.ac.kr
FU Medical Research Center Program through the National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2011-0030074]
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bae Y, 2017, MITOCHONDRION, V37, P27, DOI 10.1016/j.mito.2017.06.005
   Bai YD, 2001, J BIOL CHEM, V276, P38808, DOI 10.1074/jbc.M106363200
   BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7
   Biswas S, 2012, J CONTROL RELEASE, V159, P393, DOI 10.1016/j.jconrel.2012.01.009
   Biswas S, 2012, BIOMATERIALS, V33, P4773, DOI 10.1016/j.biomaterials.2012.03.032
   Boddapati SV, 2008, NANO LETT, V8, P2559, DOI 10.1021/nl801908y
   Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024
   Bonnefoy Nathalie, 2007, METHODS MOL BIOL, V372, P153, DOI 10.1007/978-1-59745-365-3_11
   BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8
   Cardoso AM, 2015, MOL PHARMACEUT, V12, P716, DOI 10.1021/mp5005349
   Cardoso AMS, 2011, BBA-BIOMEMBRANES, V1808, P341, DOI 10.1016/j.bbamem.2010.09.026
   Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   Choi SK, 2013, ACS NANO, V7, P214, DOI 10.1021/nn3038995
   Chuah JA, 2016, BIOMACROMOLECULES, V17, P3547, DOI 10.1021/acs.biomac.6b01056
   Coutinho E, 2017, MOL PHARMACEUT, V14, P626, DOI 10.1021/acs.molpharmaceut.6b00823
   Cwerman-Thibault H, 2014, CR BIOL, V337, P193, DOI 10.1016/j.crvi.2013.11.011
   DErchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   DSouza GGM, 2003, J CONTROL RELEASE, V92, P189, DOI 10.1016/S0168-3659(03)00297-9
   Daya S, 2008, CLIN MICROBIOL REV, V21, P583, DOI 10.1128/CMR.00008-08
   Del Gaizo V, 2003, MOL THER, V7, P720, DOI 10.1016/S1525-0016(03)00130-8
   Esaki M, 1999, P NATL ACAD SCI USA, V96, P11770, DOI 10.1073/pnas.96.21.11770
   Flierl A, 2003, MOL THER, V7, P550, DOI 10.1016/S1525-0016(03)00037-6
   Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l
   Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   Holt IJ, 2012, COLD SPRING HARB PERSPECT BIOL, V4, P0
   Kogure K, 2008, ADV DRUG DELIVER REV, V60, P559, DOI 10.1016/j.addr.2007.10.007
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Lyrawati D, 2011, PHARM RES-DORDR, V28, P2848, DOI 10.1007/s11095-011-0544-0
   Ma XC, 2013, ADV HEALTHC MATER, V2, P1638, DOI 10.1002/adhm.201300037
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Marí M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI 10.1089/ars.2009.2695
   Menezes MP, 2012, DEV MED CHILD NEUROL, V54, P407, DOI 10.1111/j.1469-8749.2012.04271.x
   Midoux P, 2009, BRIT J PHARMACOL, V157, P166, DOI 10.1111/j.1476-5381.2009.00288.x
   NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210
   Pereira CV, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708084
   Pfanner N, 1997, CURR BIOL, V7, PR100, DOI 10.1016/S0960-9822(06)00048-0
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Salvado R, 2015, COLLOID SURFACE A, V480, P287, DOI 10.1016/j.colsurfa.2014.12.013
   Santos J, 2014, COLLOID SURFACE B, V121, P129, DOI 10.1016/j.colsurfb.2014.06.003
   Santos JL, 2010, MOL PHARMACEUT, V7, P763, DOI 10.1021/mp9002877
   Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tu MY, 2015, VIROL J, V12, P0, DOI 10.1186/s12985-015-0344-y
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tzen CY, 2003, MUSCLE NERVE, V28, P575, DOI 10.1002/mus.10473
   van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635
   van Dongen MA, 2014, J PHYS CHEM B, V118, P7195, DOI 10.1021/jp504059p
   WALBERG MW, 1981, NUCLEIC ACIDS RES, V9, P5411, DOI 10.1093/nar/9.20.5411
   Wang WX, 2011, ACTA PHYS-CHIM SIN, V27, P156, DOI 10.3866/PKU.WHXB20110120
   Wang XY, 2014, J MATER CHEM B, V2, P2546, DOI 10.1039/c3tb21348j
   Warrington KH, 2004, J VIROL, V78, P6595, DOI 10.1128/JVI.78.12.6595-6609.2004
   Weissig V, 2000, DRUG DELIV, V7, P1, DOI 10.1080/107175400266722
   Yamada Y, 2017, BIOMATERIALS, V136, P56, DOI 10.1016/j.biomaterials.2017.05.016
   Yamada Y, 2015, MITOCHONDRION, V24, P50, DOI 10.1016/j.mito.2015.07.003
   Yamada Y, 2013, MITOCHONDRION, V13, P526, DOI 10.1016/j.mito.2012.09.001
   Yamada Y, 2011, MOL THER, V19, P1449, DOI 10.1038/mt.2011.99
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
   Yasuzaki Y, 2015, MOL PHARMACEUT, V12, P4311, DOI 10.1021/acs.molpharmaceut.5b00511
   Yasuzaki Y, 2014, PHARMACEUTICALS, V7, P881, DOI 10.3390/ph7080881
   Yasuzaki Y, 2013, J CONTROL RELEASE, V172, P805, DOI 10.1016/j.jconrel.2013.09.029
   Yu H, 2013, MOL VIS, V19, P1482
   Yu H, 2012, MOL VIS, V18, P1668
   Yu H, 2012, P NATL ACAD SCI USA, V109, PE1238, DOI 10.1073/pnas.1119577109
   Zheng H, 2017, J BIOMED NANOTECHNOL, V13, P155, DOI 10.1166/jbn.2017.2337
   Zollo O, 2012, P NATL ACAD SCI USA, V109, P6508, DOI 10.1073/pnas.1118594109
NR 71
TC 30
Z9 34
U1 1
U2 23
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1420-3049
J9 MOLECULES
JI Molecules
PD SEP 15
PY 2018
VL 23
IS 9
BP 
EP 
DI 10.3390/molecules23092316
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA GW9YP
UT WOS:000447365100227
PM 30208599
DA 2024-11-01
ER

PT J
AU Thenappan, T
   Ormiston, ML
   Ryan, JJ
   Archer, SL
AF Thenappan, Thenappan
   Ormiston, Mark L.
   Ryan, John J.
   Archer, Stephen L.
TI Pulmonary arterial hypertension: pathogenesis and clinical management
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Review
ID right-ventricular function; calcium-channel blockers; continuous intravenous epoprostenol; muscle-cell proliferation; capillary wedge pressure; long-term response; activated t-cells; gated k+ channels; heart-failure; sex-differences
AB Pulmonary hypertension is defined as a resting mean pulmonary artery pressure of 25 mm Hg or above. This review deals with pulmonary arterial hypertension (PAH), a type of pulmonary hypertension that primarily affects the pulmonary vasculature. In PAH, the pulmonary vasculature is dynamically obstructed by vasoconstriction, structurally obstructed by adverse vascular remodeling, and pathologically non-compliant as a result of vascular fibrosis and stiffening. Many cell types are abnormal in PAH, including vascular cells (endothelial cells, smooth muscle cells, and fibroblasts) and inflammatory cells. Progress has been made in identifying the causes of PAH and approving new drug therapies. A cancerlike increase in cell proliferation and resistance to apoptosis reflects acquired abnormalities of mitochondrial metabolism and dynamics. Mutations in the type II bone morphogenetic protein receptor (BMPR2) gene dramatically increase the risk of developing heritable PAH. Epigenetic dysregulation of DNA methylation, histone acetylation, and microRNAs also contributes to disease pathogenesis. Aberrant bone morphogenetic protein signaling and epigenetic dysregulation in PAH promote cell proliferation in part through induction of a Warburg mitochondrial-metabolic state of uncoupled glycolysis. Complex changes in cytokines (interleukins and tumor necrosis factor), cellular immunity (T lymphocytes, natural killer cells, macrophages), and autoantibodies suggest that PAH is, in part, an autoimmune, inflammatory disease. Obstructive pulmonary vascular remodeling in PAH increases right ventricular afterload causing right ventricular hypertrophy. In some patients, maladaptive changes in the right ventricle, including ischemia and fibrosis, reduce right ventricular function and cause right ventricular failure. Patients with PAH have dyspnea, reduced exercise capacity, exertional syncope, and premature death from right ventricular failure. PAH targeted therapies (prostaglandins, phosphodiesterase-5 inhibitors, endothelin receptor antagonists, and soluble guanylate cyclase stimulators), used alone or in combination, improve functional capacity and hemodynamics and reduce hospital admissions. However, these vasodilators do not target key features of PAH pathogenesis and have not been shown to reduce mortality, which remains about 50% at five years. This review summarizes the epidemiology, pathogenesis, diagnosis, and treatment of PAH.
C1 [Thenappan, Thenappan] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.
   [Ormiston, Mark L.; Archer, Stephen L.] Queens Univ, Dept Med, Kingston, ON, Canada.
   [Ryan, John J.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA.
C3 University of Minnesota System; University of Minnesota Twin Cities; Queens University - Canada; Utah System of Higher Education; University of Utah
RP Archer, SL (corresponding author), Queens Univ, Dept Med, Kingston, ON, Canada.
EM stephen.archer@queensu.ca
FU Canada Foundation for Innovation [229252, 33012]; NIH [R01 HL113003, R01 HL071115]; Tier 1 Canada research chair in mitochondrial dynamics and translational medicine [950-229252]; William J Henderson Foundation; AHA scientist development grant [15SDG25560048]; CIHR [PJT-152916]; Tier 2 Canada research chair
CR Abdelmalak M, 2013, MOL GENET METAB, V109, P139, DOI 10.1016/j.ymgme.2013.03.019
   Abe K, 2016, CARDIOVASC RES, V111, P16, DOI 10.1093/cvr/cvw070
   Addetia K, 2014, CIRC-CARDIOVASC IMAG, V7, P115, DOI 10.1161/CIRCIMAGING.113.000932
   Aldred MA, 2006, HUM MUTAT, V27, P0, DOI 10.1002/humu.9398
   Aldred MA, 2010, AM J RESP CRIT CARE, V182, P1153, DOI 10.1164/rccm.201003-0491OC
   Anand V, 2016, JAMA CARDIOL, V1, P1021, DOI 10.1001/jamacardio.2016.3591
   Anavekar NS, 2007, ECHOCARDIOGR-J CARD, V24, P452, DOI 10.1111/j.1540-8175.2007.00424.x
   Archer SL, 1998, J CLIN INVEST, V101, P2319, DOI 10.1172/JCI333
   Archer SL, 2008, AM J PHYSIOL-HEART C, V294, PH570, DOI 10.1152/ajpheart.01324.2007
   Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233
   Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098
   Archer SL, 2009, NEW ENGL J MED, V361, P1864, DOI 10.1056/NEJMct0904473
   Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D
   Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888
   Badesch DB, 2007, CHEST, V131, P1917, DOI 10.1378/chest.06-2674
   Badesch DB, 2010, CHEST, V137, P376, DOI 10.1378/chest.09-1140
   Badesch DB, 2000, ANN INTERN MED, V132, P425, DOI 10.7326/0003-4819-132-6-200003210-00002
   Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504
   Benza RL, 2013, J HEART LUNG TRANSPL, V32, P889, DOI 10.1016/j.healun.2013.06.008
   Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122
   Benza RL, 2009, PREDICTING SURVIVAL, V0, P0, DOI DOI 10.1164/ajrccm-conference.2009.179.1_MeetingAbstracts.A2651
   Best DH, 2014, CHEST, V145, P231, DOI 10.1378/chest.13-2366
   Bhave NM, 2013, J AM SOC ECHOCARDIOG, V26, P860, DOI 10.1016/j.echo.2013.05.007
   Bian XM, 1998, AM J PHYSIOL-HEART C, V275, PH169, DOI 10.1152/ajpheart.1998.275.1.H169
   Bogaard HJ, 2011, AM J RESP CRIT CARE, V183, P1402, DOI 10.1164/rccm.201007-1106OC
   Bogaard HJ, 2010, AM J RESP CRIT CARE, V182, P652, DOI 10.1164/rccm.201003-0335OC
   Bonnet S, 2007, P NATL ACAD SCI USA, V104, P11418, DOI 10.1073/pnas.0610467104
   Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008
   Borlaug BA, 2010, CIRC-HEART FAIL, V3, P588, DOI 10.1161/CIRCHEARTFAILURE.109.930701
   BRISTOW MR, 1992, J CLIN INVEST, V89, P803, DOI 10.1172/JCI115659
   Brittain EL, 2016, CIRCULATION, V133, P1936, DOI 10.1161/CIRCULATIONAHA.115.019351
   Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491
   Califf RM, 1997, AM HEART J, V134, P44, DOI 10.1016/S0002-8703(97)70105-4
   Caruso P, 2017, CIRCULATION, V136, P2451, DOI 10.1161/CIRCULATIONAHA.117.028034
   Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591
   Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028
   Cavasin MA, 2015, PULM CIRC, V5, P63, DOI 10.1086/679700
   Cavasin MA, 2012, CIRC RES, V110, P739, DOI 10.1161/CIRCRESAHA.111.258426
   Chaouat A, 2005, AM J RESP CRIT CARE, V172, P189, DOI 10.1164/rccm.200401-006OC
   Chaouat A, 2004, THORAX, V59, P446, DOI 10.1136/thx.2003.11890
   Chaouat A, 2009, CHEST, V136, P678, DOI 10.1378/chest.08-2420
   Cho YK, 2010, CIRC J, V74, P760, DOI 10.1253/circj.CJ-09-0580
   Chua S, 2009, EUR J ECHOCARDIOGR, V10, P619, DOI 10.1093/ejechocard/jep013
   Chugh SS, 2003, CARDIOVASC RES, V57, P477, DOI 10.1016/S0008-6363(02)00703-4
   Cogan JD, 2005, GENET MED, V7, P169, DOI 10.1097/01.GIM.0000156525.09595.E9
   Cogan JD, 2006, AM J RESP CRIT CARE, V174, P590, DOI 10.1164/rccm.200602-165OC
   Colvin KL, 2013, AM J RESP CRIT CARE, V188, P1126, DOI 10.1164/rccm.201302-0403OC
   Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812
   Dasgupta A, 2015, CLIN PHARMACOL THER, V97, P88, DOI 10.1002/cpt.10
   Deano RC, 2013, JAMA INTERN MED, V173, P887, DOI 10.1001/jamainternmed.2013.319
   Decoene C, 2001, CAN J ANAESTH, V48, P584, DOI 10.1007/BF03016836
   Diebold I, 2015, CELL METAB, V21, P596, DOI 10.1016/j.cmet.2015.03.010
   Dorfmüller P, 2002, AM J RESP CRIT CARE, V165, P534, DOI 10.1164/rccm.2012112
   Drake KM, 2013, AM J RESP CELL MOL, V49, P403, DOI 10.1165/rcmb.2013-0100OC
   Drake KM, 2011, AM J RESP CRIT CARE, V184, P1400, DOI 10.1164/rccm.201106-1130OC
   Edwards AL, 2013, RESPIROLOGY, V18, P1271, DOI 10.1111/resp.12152
   El Kasmi KC, 2014, J IMMUNOL, V193, P597, DOI 10.4049/jimmunol.1303048
   Ernande L, 2013, J AM SOC ECHOCARDIOG, V26, P297, DOI 10.1016/j.echo.2012.11.011
   Esfandiari S, 2017, MED SCI SPORT EXER, V49, P1293, DOI 10.1249/MSS.0000000000001227
   Evans JDW, 2016, LANCET RESP MED, V4, P129, DOI 10.1016/S2213-2600(15)00544-5
   Eyries M, 2014, NAT GENET, V46, P65, DOI 10.1038/ng.2844
   Fang YH, 2012, J MOL MED, V90, P31, DOI 10.1007/s00109-011-0804-9
   Farha S, 2017, JCI INSIGHT, V2, P0, DOI 10.1172/jci.insight.95240
   Fijalkowska I, 2010, AM J PATHOL, V176, P1130, DOI 10.2353/ajpath.2010.090832
   Foderaro A, 2016, CURR HYPERTENS REP, V18, P0, DOI 10.1007/s11906-016-0689-7
   Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC
   Frank H, 1997, CHEST, V112, P714, DOI 10.1378/chest.112.3.714
   Freed BH, 2012, J CARDIOVASC MAGN R, V14, P0, DOI 10.1186/1532-429X-14-11
   Frid MG, 2006, AM J PATHOL, V168, P659, DOI 10.2353/ajpath.2006.050599
   FUSTER V, 1984, CIRCULATION, V70, P580, DOI 10.1161/01.CIR.70.4.580
   Galiè N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8
   Galie N, 2015, NEW ENGL J MED, V373, P834, DOI 10.1056/NEJMoa1413687
   Galiè N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010
   Galiè N, 2008, CIRCULATION, V117, P3010, DOI 10.1161/CIRCULATIONAHA.107.742510
   Galiè N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317
   Galiè N, 2009, CIRCULATION, V119, P2894, DOI 10.1161/CIRCULATIONAHA.108.839274
   Georgianos PI, 2015, AM J HYPERTENS, V28, P958, DOI 10.1093/ajh/hpv004
   Ghio S, 2011, AM J CARDIOL, V107, P628, DOI 10.1016/j.amjcard.2010.10.027
   Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657
   Gotthardt D, 2016, CANCER DISCOV, V6, P414, DOI 10.1158/2159-8290.CD-15-0732
   Graham BB, 2010, CHEST, V137, P20S, DOI 10.1378/chest.10-0048
   Guignabert C, 2009, FASEB J, V23, P4135, DOI 10.1096/fj.09-131664
   Gupta S, 2008, EUR J ECHOCARDIOGR, V9, P766, DOI 10.1093/ejechocard/jen147
   Gutierrez G, 2007, CRIT CARE, V11, P0, DOI 10.1186/cc5739
   Halpern SD, 2009, CHEST, V136, P37, DOI 10.1378/chest.08-2784
   Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452
   Hardziyenka M, 2006, J AM SOC ECHOCARDIOG, V19, P1272, DOI 10.1016/j.echo.2006.04.036
   Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865
   Hashimoto-Kataoka T, 2015, P NATL ACAD SCI USA, V112, PE2677, DOI 10.1073/pnas.1424774112
   Hatton N, 2014, CHEST, V145, P1184, DOI 10.1378/chest.13-3061
   HEATH D, 1991, J CLIN PATHOL, V44, P1003, DOI 10.1136/jcp.44.12.1003
   Hemnes AR, 2016, AM J RESP CRIT CARE, V194, P464, DOI 10.1164/rccm.201508-1678OC
   Hemnes AR, 2015, PULM CIRC, V5, P435, DOI 10.1086/682230
   Hemnes AR, 2015, CIRCULATION, V131, P401, DOI 10.1161/CIRCULATIONAHA.114.013317
   Hoeper MM, 2016, EUR RESPIR J, V48, P0, DOI 10.1183/13993003.congress-2016.OA263
   Hoeper MM, 2013, J AM COLL CARDIOL, V62, PD42, DOI 10.1016/j.jacc.2013.10.032
   Hoeper MM, 2013, INT J CARDIOL, V168, P871, DOI 10.1016/j.ijcard.2012.10.026
   Hong ZG, 2017, AM J RESP CRIT CARE, V195, P515, DOI 10.1164/rccm.201604-0814OC
   Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC
   HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628, DOI 10.1164/ajrccm.151.5.7735624
   Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818
   Hurst LA, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms14079
   Jacobs W, 2014, CHEST, V145, P1230, DOI 10.1378/chest.13-1291
   Jaïs X, 2012, EUR RESPIR J, V40, P881, DOI 10.1183/09031936.00141211
   Jiang R, 2015, HYPERTENS RES, V38, P539, DOI 10.1038/hr.2015.33
   Jing ZC, 2007, CHEST, V132, P373, DOI 10.1378/chest.06-2913
   Jing ZC, 2013, CIRCULATION, V127, P624, DOI 10.1161/CIRCULATIONAHA.112.124388
   Kane GC, 2011, CHEST, V139, P1285, DOI 10.1378/chest.10-1293
   Kang K, 2013, J BIOL CHEM, V288, P25414, DOI 10.1074/jbc.M113.460287
   Kawut SM, 2011, CIRCULATION, V123, P2542, DOI 10.1161/CIRCULATIONAHA.110.985515
   Kim J, 2015, CIRCULATION, V131, P190, DOI 10.1161/CIRCULATIONAHA.114.013339
   Kim J, 2013, NAT MED, V19, P74, DOI 10.1038/nm.3040
   Koehler R, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2004.023101
   Lahm T, 2017, EUR RESPIR J, V50, P0, DOI 10.1183/13993003.00983-2017
   Larkin EK, 2012, AM J RESP CRIT CARE, V186, P892, DOI 10.1164/rccm.201205-0886OC
   Lavoie JR, 2014, CIRCULATION, V129, P2125, DOI 10.1161/CIRCULATIONAHA.114.008777
   Leather HA, 2006, AM J PHYSIOL-HEART C, V290, PH2369, DOI 10.1152/ajpheart.01211.2004
   Lee SL, 2014, CIRC J, V78, P962, DOI 10.1253/circj.CJ-13-1234
   Li M, 2016, CIRCULATION, V134, P1105, DOI 10.1161/CIRCULATIONAHA.116.023171
   Li M, 2011, J IMMUNOL, V187, P2711, DOI 10.4049/jimmunol.1100479
   Lindqvist P, 2005, ECHOCARDIOGR-J CARD, V22, P305, DOI 10.1111/j.1540-8175.2005.04023.x
   Ling Y, 2012, AM J RESP CRIT CARE, V186, P790, DOI 10.1164/rccm.201203-0383OC
   Long L, 2015, NAT MED, V21, P777, DOI 10.1038/nm.3877
   Long L, 2013, CIRC RES, V112, P1159, DOI 10.1161/CIRCRESAHA.111.300483
   Ma L, 2013, NEW ENGL J MED, V369, P351, DOI 10.1056/NEJMoa1211097
   Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947
   Machuca TN, 2015, CIRCULATION, V132, P526, DOI 10.1161/CIRCULATIONAHA.114.012593
   Mair KM, 2014, BRIT J PHARMACOL, V171, P567, DOI 10.1111/bph.12281
   Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827
   Maresca A, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00090
   Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848
   Marsboom G, 2012, AM J RESP CRIT CARE, V185, P670, DOI 10.1164/rccm.201108-1562OC
   Mathai SC, 2015, CHEST, V147, P188, DOI 10.1378/chest.14-0263
   McLaughlin V, 2015, EUR RESPIR J, V46, P405, DOI 10.1183/13993003.02044-2014
   McLaughlin VV, 2015, J AM COLL CARDIOL, V65, PA1538, DOI 10.1016/S0735-1097(15)61538-8
   McLaughlin VV, 2010, J AM COLL CARDIOL, V55, P1915, DOI 10.1016/j.jacc.2010.01.027
   McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004
   McMurtry MS, 2007, AM J PHYSIOL-LUNG C, V292, PL872, DOI 10.1152/ajplung.00309.2006
   McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f
   Meluzín J, 2001, EUR HEART J, V22, P340, DOI 10.1053/euhj.2000.2296
   Michelakis ED, 2003, CIRCULATION, V108, P2066, DOI 10.1161/01.CIR.0000099502.17776.C2
   Michelakis ED, 2002, CIRCULATION, V105, P244, DOI 10.1161/hc0202.101974
   Michelakis ED, 2017, SCI TRANSL MED, V9, P0, DOI 10.1126/scitranslmed.aao4583
   Miyata M, 2000, INT ARCH ALLERGY IMM, V121, P246, DOI 10.1159/000024324
   Momparler RL, 2017, FRONT ONCOL, V7, P0, DOI 10.3389/fonc.2017.00019
   MONCADA S, 1985, J PHARMACOL-PARIS, V16, P71
   Montani D, 2017, LANCET RESP MED, V5, P125, DOI 10.1016/S2213-2600(16)30438-6
   Montani D, 2010, EUR HEART J, V31, P1898, DOI 10.1093/eurheartj/ehq170
   Morisaki H, 2004, HUM MUTAT, V23, P632, DOI 10.1002/humu.9251
   Mukerji B, 2000, SOUTHERN MED J, V93, P673
   Nagata Y, 2017, CIRC-CARDIOVASC IMAG, V10, P0, DOI 10.1161/CIRCIMAGING.116.005384
   Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266
   Nahar K, 2014, MOL PHARMACEUT, V11, P4374, DOI 10.1021/mp500456k
   NOOTENS M, 1995, J AM COLL CARDIOL, V26, P1581, DOI 10.1016/0735-1097(95)00399-1
   Oikawa M, 2005, J AM COLL CARDIOL, V45, P1849, DOI 10.1016/j.jacc.2005.02.065
   Oka M, 2007, CIRC RES, V100, P923, DOI 10.1161/01.RES.0000261658.12024.18
   Olsson KM, 2014, CIRCULATION, V129, P57, DOI 10.1161/CIRCULATIONAHA.113.004526
   Opotowsky AR, 2012, CIRC-CARDIOVASC IMAG, V5, P765, DOI 10.1161/CIRCIMAGING.112.976654
   Ormiston ML, 2012, CIRCULATION, V126, P1099, DOI 10.1161/CIRCULATIONAHA.112.110619
   Overbeek MJ, 2008, EUR RESPIR J, V31, P1160, DOI 10.1183/09031936.00135407
   Pandey A, 2015, CIRC-HEART FAIL, V8, P1032, DOI 10.1161/CIRCHEARTFAILURE.115.002130
   Parikh VN, 2012, CIRCULATION, V125, P1520, DOI 10.1161/CIRCULATIONAHA.111.060269
   Paul GA, 2005, BRIT J CLIN PHARMACO, V60, P107, DOI 10.1111/j.1365-2125.2005.02383.x
   Peacock AJ, 2007, EUR RESPIR J, V30, P104, DOI 10.1183/09031936.00092306
   Perros F, 2007, EUR RESPIR J, V29, P937, DOI 10.1183/09031936.00104706
   Perros F, 2007, EUR RESPIR J, V29, P462, DOI 10.1183/09031936.00094706
   Perros F, 2012, AM J RESP CRIT CARE, V185, P311, DOI 10.1164/rccm.201105-0927OC
   Piao L, 2012, CIRCULATION, V126, P2859, DOI 10.1161/CIRCULATIONAHA.112.109868
   Piao L, 2010, J MOL MED, V88, P47, DOI 10.1007/s00109-009-0524-6
   Pozeg ZI, 2003, CIRCULATION, V107, P2037, DOI 10.1161/01.CIR.0000062688.76508.B3
   Preston IR, 2015, CIRCULATION, V132, P2403, DOI 10.1161/CIRCULATIONAHA.115.018435
   Prins KW, 2017, PULM CIRC, V7, P145, DOI 10.1086/690017
   Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917
   Pullamsetti SS, 2012, AM J RESP CRIT CARE, V185, P409, DOI 10.1164/rccm.201106-1093OC
   Qian J, 2015, HYPERTENSION, V66, P1227, DOI 10.1161/HYPERTENSIONAHA.115.06370
   Rabinovitch M, 2014, CIRC RES, V115, P165, DOI 10.1161/CIRCRESAHA.113.301141
   Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1
   Raymond RJ, 2002, J AM COLL CARDIOL, V39, P1214, DOI 10.1016/S0735-1097(02)01744-8
   Redfield MM, 2013, JAMA-J AM MED ASSOC, V309, P1268, DOI 10.1001/jama.2013.2024
   Rexhaj E, 2011, AM J PHYSIOL-HEART C, V301, PH247, DOI 10.1152/ajpheart.01309.2010
   Reynolds AM, 2007, AM J PHYSIOL-LUNG C, V292, PL1182, DOI 10.1152/ajplung.00020.2006
   Rhodes CJ, 2013, AM J RESP CRIT CARE, V187, P294, DOI 10.1164/rccm.201205-0839OC
   Rich JD, 2011, CHEST, V139, P988, DOI 10.1378/chest.10-1269
   RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216
   Rich S, 1998, CHEST, V114, P787, DOI 10.1378/chest.114.3.787
   RICH S, 1992, NEW ENGL J MED, V327, P76, DOI 10.1056/NEJM199207093270203
   Rich S, 2010, CHEST, V138, P1234, DOI 10.1378/chest.09-2815
   Robbins IM, 2014, CIRC-HEART FAIL, V7, P116, DOI 10.1161/CIRCHEARTFAILURE.113.000468
   Romberg E, 1891, DEUTSCHES ARCHIV FUR KLINISCHE MEDIZIN, V48, P197
   Rothman AMK, 2016, J CLIN INVEST, V126, P2495, DOI 10.1172/JCI83361
   Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212
   Ryan JJ, 2015, CIRCULATION, V131, P1691, DOI 10.1161/CIRCULATIONAHA.114.006979
   Ryan JJ, 2013, AM J RESP CRIT CARE, V187, P865, DOI 10.1164/rccm.201209-1687OC
   Ryan JJ, 2012, AM HEART J, V163, P589, DOI 10.1016/j.ahj.2012.01.024
   Sachdev A, 2011, CHEST, V139, P1299, DOI 10.1378/chest.10-2015
   Sanchez O, 2007, AM J RESP CRIT CARE, V176, P1041, DOI 10.1164/rccm.200610-1559OC
   Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, PL861, DOI 10.1152/ajplung.00201.2010
   Schlosser K, 2013, AM J RESP CRIT CARE, V188, P1472, DOI 10.1164/rccm.201308-1403LE
   Scourzic L, 2015, GENOME MED, V7, P0, DOI 10.1186/s13073-015-0134-6
   Seeger W, 2013, J AM COLL CARDIOL, V62, PD109, DOI 10.1016/j.jacc.2013.10.036
   Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2
   Shapiro S, 2012, CHEST, V141, P363, DOI 10.1378/chest.10-3114
   Sharma S, 2004, AM J PHYSIOL-HEART C, V286, PH1185, DOI 10.1152/ajpheart.00916.2003
   Shehata ML, 2011, AM J ROENTGENOL, V196, P87, DOI 10.2214/AJR.09.4114
   Simonneau G, 2002, AM J RESP CRIT CARE, V165, P800, DOI 10.1164/ajrccm.165.6.2106079
   Simonneau G, 2013, J AM COLL CARDIOL, V62, PD34, DOI 10.1016/j.jacc.2013.10.029
   Sitbon O, 2005, CIRCULATION, V111, P3105, DOI 10.1161/CIRCULATIONAHA.104.488486
   Sitbon O, 2015, NEW ENGL J MED, V373, P2522, DOI 10.1056/NEJMoa1503184
   Sitbon O, 2014, EUR RESPIR J, V43, P1691, DOI 10.1183/09031936.00116313
   Sobolewski A, 2008, HUM MOL GENET, V17, P3180, DOI 10.1093/hmg/ddn214
   Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762
   Spiekerkoetter E, 2013, J CLIN INVEST, V123, P3600, DOI 10.1172/JCI65592
   Strange G, 2012, HEART, V98, P1805, DOI 10.1136/heartjnl-2012-301992
   Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046
   Syrris P, 2006, AM J HUM GENET, V79, P978, DOI 10.1086/509122
   Taichman DB, 2014, CHEST, V146, P449, DOI 10.1378/chest.14-0793
   Tamosiuniene R, 2011, CIRC RES, V109, P867, DOI 10.1161/CIRCRESAHA.110.236927
   Tapson VF, 2013, CHEST, V144, P952, DOI 10.1378/chest.12-2875
   Tei C, 1996, J AM SOC ECHOCARDIOGR, V9, P838, DOI 10.1016/S0894-7317(96)90476-9
   Thenappan T, 2007, EUR RESPIR J, V30, P1103, DOI 10.1183/09031936.00042107
   Thenappan T, 2010, EUR RESPIR J, V35, P1079, DOI 10.1183/09031936.00072709
   Thenappan T, 2011, CIRC-HEART FAIL, V4, P257, DOI 10.1161/CIRCHEARTFAILURE.110.958801
   Torbicki A, 2003, CIRCULATION, V108, P844, DOI 10.1161/01.CIR.0000084544.54513.E2
   Trembath RC, 2001, NEW ENGL J MED, V345, P325, DOI 10.1056/NEJM200108023450503
   Tuder RM, 2007, CLIN CHEST MED, V28, P23, DOI 10.1016/j.ccm.2006.11.010
   Tuder RM, 2013, J AM COLL CARDIOL, V62, PD4, DOI 10.1016/j.jacc.2013.10.025
   Tunariu N, 2007, J NUCL MED, V48, P680, DOI 10.2967/jnumed.106.039438
   Ulrich S, 2017, EUR HEART J, V38, P1159, DOI 10.1093/eurheartj/ehx099
   van Campen JSJA, 2016, EUR RESPIR J, V48, P787, DOI 10.1183/13993003.00090-2016
   van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068
   van Wolferen SA, 2007, EUR HEART J, V28, P1250, DOI 10.1093/eurheartj/ehl477
   Wang DR, 2014, CIRC RES, V114, P67, DOI 10.1161/CIRCRESAHA.114.301633
   Wang G, 2013, AM J PHYSIOL-HEART C, V305, PH1451, DOI 10.1152/ajpheart.00238.2013
   Waxman AB, 2017, CHEST, V0, P0
   Wei AH, 2016, J AM HEART ASSOC, V5, P0, DOI 10.1161/JAHA.116.003896
   White K, 2014, HYPERTENSION, V64, P185, DOI 10.1161/HYPERTENSIONAHA.113.03037
   Xu XF, 2010, J HYPERTENS, V28, P2227, DOI 10.1097/HJH.0b013e32833e08f1
   Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458
   Yuan JXJ, 1998, CIRCULATION, V98, P1400, DOI 10.1161/01.CIR.98.14.1400
   Zhang HR, 2017, ARTERIOSCL THROM VAS, V37, P2000, DOI 10.1161/ATVBAHA.117.309195
   Zhang R, 2011, CHEST, V140, P301, DOI 10.1378/chest.10-2327
   Zhao L, 2012, CIRCULATION, V126, P455, DOI 10.1161/CIRCULATIONAHA.112.103176
NR 242
TC 612
Z9 660
U1 16
U2 261
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0959-535X
EI 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAR 14
PY 2018
VL 360
IS 
BP 
EP 
DI 10.1136/bmj.j5492
PG 27
WC Medicine, General & Internal
SC General & Internal Medicine
GA FZ9FZ
UT WOS:000427916700001
PM 29540357
DA 2024-11-01
ER

PT J
AU Almannai, M
   El-Hattab, AW
   Scaglia, F
AF Almannai, Mohammed
   El-Hattab, Ayman W.
   Scaglia, Fernando
TI Mitochondrial DNA replication: clinical syndromes
SO MITOCHONDRIAL DISEASES
LA English
DT Review; Book Chapter
ID progressive external ophthalmoplegia; nucleotide translocator-1 gene; recessive twinkle mutations; impair mtdna replication; loss-of-function; polymerase-gamma; ribonucleotide reductase; depletion syndrome; gaba transaminase; rna-polymerase
AB Each nucleated cell contains several hundreds of mitochondria, which are unique organelles in being under dual genome control. The mitochondria contain their own DNA, the mtDNA, but most of mitochondrial proteins are encoded by nuclear genes, including all the proteins required for replication, transcription, and repair of mtDNA. MtDNA replication is a continuous process that requires coordinated action of several enzymes that are part of the mtDNA replisome. It also requires constant supply of deoxyribonucleotide triphosphates(dNTPs) and interaction with other mitochondria for mixing and unifying the mitochondrial compartment. MtDNA maintenance defects are a growing list of disorders caused by defects in nuclear genes involved in different aspects of mtDNA replication. As a result of defects in these genes, mtDNA depletion and/ or multiple mtDNA deletions develop in affected tissues resulting in variable manifestations that range from adult-onset mild disease to lethal presentation early in life.
C1 [Almannai, Mohammed] King Fahad Med City, Childrens Hosp, Sect Med Genet, POB 59046, Riyadh 11525, Saudi Arabia.
   [El-Hattab, Ayman W.] Tawam Hosp, Div Genet & Metab Disorders, POB 15258, Al Ain, U Arab Emirates.
   [Scaglia, Fernando] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Scaglia, Fernando] Texas Childrens Hosp, Houston, TX 77030 USA.
   [Scaglia, Fernando] Joint Baylor Coll Med, Hong Kong, Hong Kong, Peoples R China.
   [Scaglia, Fernando] Chinese Univ Hong Kong, Ctr Med Genet, Hong Kong, Hong Kong, Peoples R China.
C3 King Fahad Medical City; Baylor College of Medicine; Baylor College of Medicine; Chinese University of Hong Kong
RP Scaglia, F (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Scaglia, F (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.; Scaglia, F (corresponding author), Joint Baylor Coll Med, Hong Kong, Hong Kong, Peoples R China.; Scaglia, F (corresponding author), Chinese Univ Hong Kong, Ctr Med Genet, Hong Kong, Hong Kong, Peoples R China.
EM fscaglia@bcm.edu
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Caporali L, 2018, BRAIN, V141, P0, DOI 10.1093/brain/awx301
   Carelli V, 2015, BRAIN, V138, P0, DOI 10.1093/brain/awu234
   Chae JH, 2015, J MED GENET, V52, P208, DOI 10.1136/jmedgenet-2014-102819
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Cohen BH, 2010, GENEREVIEWS, V0, P1993
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Copeland WC, 2010, SUBCELL BIOCHEM, V50, P211, DOI 10.1007/978-90-481-3471-7_11
   Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006
   De Giorgio R, 2016, ANN NEUROL, V80, P448, DOI 10.1002/ana.24724
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   El-Hattab AW, 1993, GENEREVIEWS, V0, P0
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   El-Hattab AW, 2017, HUM MUTAT, V38, P1649, DOI 10.1002/humu.23341
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab AW, 2016, CELL CALCIUM, V60, P199, DOI 10.1016/j.ceca.2016.03.003
   Faqeih E, 1993, GENEREVIEWS, V0, P0
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Fusté JM, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004832
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Gilkerson R, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011080
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Haghighi A, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/s13023-014-0119-3
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   Hebbar M, 2017, EUR J MED GENET, V60, P533, DOI 10.1016/j.ejmg.2017.07.010
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Hirano M, 1993, GENEREVIEWS®, V0, P0
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   Holmes JB, 2015, P NATL ACAD SCI USA, V112, P9334, DOI 10.1073/pnas.1503653112
   Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454
   Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Körver-Keularts IMLW, 2015, JIMD REP, V22, P39, DOI 10.1007/8904_2015_409
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Louro P, 2016, J INHERIT METAB DIS, V39, P743, DOI 10.1007/s10545-016-9951-z
   Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Ngo HB, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4077
   Oldak M, 2017, J TRANSL MED, V15, P0, DOI 10.1186/s12967-017-1129-4
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Parikh S, 2016, MOL GENET METAB, V118, P178, DOI 10.1016/j.ymgme.2016.04.009
   Phowthongkum P, 2017, NEUROMUSCULAR DISORD, V27, P616, DOI 10.1016/j.nmd.2017.03.013
   Pierce SB, 2016, CSH MOL CASE STUD, V2, P0, DOI 10.1101/mcs.a001107
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   Pohjoismäki JLO, 2011, BIOESSAYS, V33, P290, DOI 10.1002/bies.201000137
   Rahman S, 2016, INBORN METABOLIC DIS, V0, P223
   Ranieri M, 2013, NEUROL RES INT, V2013, P0, DOI 10.1155/2013/293893
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rosa ID, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005779
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Shaheen R, 2014, GENOME RES, V24, P291, DOI 10.1101/gr.160572.113
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Sobek S, 2014, EXP GERONTOL, V56, P135, DOI 10.1016/j.exger.2014.01.009
   Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361
   Spinazzola A, 2011, SEMIN FETAL NEONAT M, V16, P190, DOI 10.1016/j.siny.2011.04.011
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Thelander L, 2007, NAT GENET, V39, P703, DOI 10.1038/ng0607-703
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Uhler JP, 2015, DNA REPAIR, V34, P28, DOI 10.1016/j.dnarep.2015.07.003
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Van Maldergem L, 2017, ANN CLIN TRANSL NEUR, V4, P4, DOI 10.1002/acn3.361
   Varma H, 2016, EUR J MED GENET, V59, P540, DOI 10.1016/j.ejmg.2016.08.012
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Yadak R, 2017, FRONT CELL NEUROSCI, V11, P0, DOI 10.3389/fncel.2017.00031
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 102
TC 22
Z9 22
U1 0
U2 18
PU PORTLAND PRESS LTD
PI LONDON
PA 5TH FL, 90 HIGH HOLBORN, LONDON, WC1V 6LJ, ENGLAND
SN 0071-1365
EI 1744-1358
J9 ESSAYS BIOCHEM
JI Essays Biochem.
PD JUN 15
PY 2018
VL 62
IS 3
BP 297
EP 308
DI 10.1042/EBC20170101
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BL4NC
UT WOS:000450601700006
PM 29950321
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Zarrouk-Mahjoub, S
   Shoffner, JM
AF Finsterer, Josef
   Zarrouk-Mahjoub, Sinda
   Shoffner, John M.
TI MERRF Classification: Implications for Diagnosis and Clinical Trials
SO PEDIATRIC NEUROLOGY
LA English
DT Review
DE myoclonic epilepsy; mitochondrial myopathy; MT-TK; MT-TL1; POLG; MT-tRNA; gene-disease relationship; variant curation
ID ragged-red fibers; mitochondrial-dna mutation; stroke-like episodes; merrf/melas overlap syndrome; transfer-rna mutations; mt-transfer-rna; myoclonic epilepsy; point mutation; trna(lys) gene; lactic-acidosis
AB BACKGROUND: Given the etiologic heterogeneity of disease classification using clinical phenomenology, we employed contemporary criteria to classify variants associated with myoclonic epilepsy with ragged-red fibers (MERRF) syndrome and to assess the strength of evidence of gene-disease associations. Standardized approaches are used to clarify the definition of MERRF, which is essential for patient diagnosis, patient classification, and clinical trial design. METHODS: Systematic literature and database search with application of standardized assessment of gene disease relationships using modified Smith criteria and of variants reported to be associated with MERRF using modified Yarham criteria. RESULTS: Review of available evidence supports a gene-disease association for two MT-tRNAs and for POW. Using modified Smith criteria, definitive evidence of a MERRF gene-disease association is identified for MT-TK. Strong gene-disease evidence is present for MT-TL1 and POLG. Functional assays that directly associate variants with oxidative phosphorylation impairment were critical to mtDNA variant classification. In silico analysis was of limited utility to the assessment of individual MT-tRNA variants. With the use of contemporary classification criteria, several mtDNA variants previously reported as pathogenic or possibly pathogenic are reclassified as neutral variants. CONCLUSIONS: MERRF is primarily an MT-TK disease, with pathogenic variants in this gene accounting for similar to 90% of MERRF patients. Although MERRF is phenotypically and genotypically heterogeneous, myoclonic epilepsy is the clinical feature that distinguishes MERRF from other categories of mitochondrial disorders. Given its low frequency in mitochondrial disorders, myoclonic epilepsy is not explained simply by an impairment of cellular energetics. Although MERRF phenocopies can occur in other genes, additional data are needed to establish a MERRF disease gene association. This approach to MERRF emphasizes standardized classification rather than clinical phenomenology, thus improving patient diagnosis and clinical trial design.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Postfach 20, A-1180 Vienna, Austria.
   [Zarrouk-Mahjoub, Sinda] Univ Tunis El Manar, Tunis, Tunisia.
   [Zarrouk-Mahjoub, Sinda] Pasteur Inst Tunis, Genom Platform, Tunis, Tunisia.
   [Shoffner, John M.] Mol Genet, Biochem Genet, Neurol, Atlanta, GA USA.
C3 Rudolfstiftung Hospital; Universite de Tunis-El-Manar; Pasteur Network; Universite de Tunis-El-Manar; Institut Pasteur Tunis
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Abbott JA, 2014, FRONT GENET, V5, P0, DOI 10.3389/fgene.2014.00158
   Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Ahadi AM, 2008, NEUROL NEUROCHIR POL, V42, P263
   Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   Amendola LM, 2016, AM J HUM GENET, V99, P247, DOI 10.1016/j.ajhg.2016.06.001
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Arenas J, 1999, NEUROLOGY, V52, P377, DOI 10.1212/WNL.52.2.377
   Arpa J, 1997, ACTA NEUROL SCAND, V96, P65
   ATTARDI G, 1995, BBA-MOL BASIS DIS, V1271, P241, DOI 10.1016/0925-4439(95)00034-2
   Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   Biesecker LG, 2014, NEW ENGL J MED, V371, P1170, DOI 10.1056/NEJMra1312543
   Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   Blok MJ, 2007, J MED GENET, V44, P0, DOI 10.1136/jmg.2006.045716
   Blumenthal DT, 1998, NEUROLOGY, V50, P524, DOI 10.1212/WNL.50.2.524
   Bornstein B, 2005, BIOCHEM J, V387, P773, DOI 10.1042/BJ20040949
   Bornstein B, 2002, HUM MUTAT, V19, P234, DOI 10.1002/humu.10050
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Brackmann F, 2012, EUR J PEDIATR, V171, P859, DOI 10.1007/s00431-011-1662-8
   BYRNE E, 1991, ACTA NEUROPATHOL, V81, P318, DOI 10.1007/BF00305874
   CALABRESI PA, 1994, MUSCLE NERVE, V17, P943, DOI 10.1002/mus.880170815
   Campos Y, 1996, MUSCLE NERVE, V19, P187, DOI 10.1002/(SICI)1097-4598(199602)19:2<187::AID-MUS10>3.0.CO;2-S
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Chan PA, 2007, HUM MUTAT, V28, P683, DOI 10.1002/humu.20492
   Chandra SR, 2015, J POSTGRAD MED, V61, P200, DOI 10.4103/0022-3859.150905
   CHANG TS, 1993, ARCH OPHTHALMOL-CHIC, V111, P1254, DOI 10.1001/archopht.1993.01090090106028
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Choi BO, 2010, EXP MOL MED, V42, P446, DOI 10.3858/emm.2010.42.6.046
   Chong P Siao Tick, 2003, J CLIN NEUROMUSCUL DIS, V5, P1, DOI 10.1097/00131402-200309000-00001
   COQUET M, 1993, NEUROMUSCULAR DISORD, V3, P593, DOI 10.1016/0960-8966(93)90122-Z
   Corona P, 2002, ANN NEUROL, V51, P118, DOI 10.1002/ana.10059
   CRIMMINS D, 1993, J NEUROL NEUROSUR PS, V56, P900, DOI 10.1136/jnnp.56.8.900
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   OCallaghan MD, 2012, NEUROGENETICS, V13, P245, DOI 10.1007/s10048-012-0322-0
   DiMauro S, 2003, GENEREVIEWS, V0, P1993
   Herrero-Martín MD, 2010, J NEUROL NEUROSUR PS, V81, P471, DOI 10.1136/jnnp.2009.173831
   Doss CGP, 2009, J BIOMED SCI, V16, P0, DOI 10.1186/1423-0127-16-42
   Eberhardt O, 2017, BRAIN SCI, V7, P0, DOI 10.3390/brainsci7080103
   El Meziane A, 1998, NAT GENET, V18, P350
   Emmanuele V, 2011, MUSCLE NERVE, V44, P448, DOI 10.1002/mus.22149
   Fabrizi GM, 1996, J NEUROL NEUROSUR PS, V61, P47, DOI 10.1136/jnnp.61.1.47
   FANG W, 1994, MUSCLE NERVE, V17, P52, DOI 10.1002/mus.880170107
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Fekete A, 2017, ORVOSI HETILAP, V158, P468, DOI 10.1556/650.2017.30634
   Fetoni V, 2004, NEUROMUSCULAR DISORD, V14, P723, DOI 10.1016/j.nmd.2004.07.002
   Finnila Saara, 2001, MUTATION RESEARCH, V458, P31, DOI 10.1016/S1383-5726(01)00012-7
   Finsterer J, 2017, IRAN J NEUROL, V16, P45
   Finsterer J, 2016, J NEUROL, V263, P586, DOI 10.1007/s00415-016-8028-0
   Flanagan SE, 2010, GENET TEST MOL BIOMA, V14, P533, DOI 10.1089/gtmb.2010.0036
   FOLGERO T, 1995, EUR NEUROL, V35, P168, DOI 10.1159/000117115
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   Fujioka H, 2014, ULTRASTRUCT PATHOL, V38, P13, DOI 10.3109/01913123.2013.831158
   Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200
   Garber KB, 2016, AM J HUM GENET, V99, P1140, DOI 10.1016/j.ajhg.2016.09.015
   Gebhart SSP, 1996, METABOLISM, V45, P526, DOI 10.1016/S0026-0495(96)90231-0
   Gnad F, 2013, BMC GENOMICS, V14, P0, DOI 10.1186/1471-2164-14-S3-S7
   González-Vioque E, 2014, MOL GENET GENOM MED, V2, P107, DOI 10.1002/mgg3.47
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   Hahn A, 2011, NEUROPEDIATRICS, V42, P148, DOI 10.1055/s-0031-1283167
   Hallmann K, 2014, NEUROLOGY, V83, P2183, DOI 10.1212/WNL.0000000000001055
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   HAYASHI JI, 1993, BIOCHEM BIOPH RES CO, V197, P1049, DOI 10.1006/bbrc.1993.2584
   Hogarth MW, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms14143
   Houshmand M, 2011, NOVEL TREATMENT EPIL, V0, P0
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Hutchin TP, 2001, J MED GENET, V38, P229, DOI 10.1136/jmg.38.4.229
   Hutchin TP, 2001, EUR J HUM GENET, V9, P385, DOI 10.1038/sj.ejhg.5200640
   Isashiki Y, 1998, ACTA OPHTHALMOL SCAN, V76, P6, DOI 10.1034/j.1600-0420.1998.760103.x
   Isotani H, 1999, DIABETOLOGIA, V42, P1266
   Jaksch M, 1998, J MED GENET, V35, P895, DOI 10.1136/jmg.35.11.895
   Kameoka K, 1998, BIOCHEM BIOPH RES CO, V245, P523, DOI 10.1006/bbrc.1998.8437
   Kameoka K, 1998, DIABETES CARE, V21, P2034, DOI 10.2337/diacare.21.11.2034
   Kazakos K, 2012, ANN HUM GENET, V76, P296, DOI 10.1111/j.1469-1809.2012.00711.x
   Kelland E, 2016, MOL GENET METAB REP, V6, P64, DOI 10.1016/j.ymgmr.2016.02.003
   Kerr ID, 2017, J COMMUN GENET, V8, P87, DOI 10.1007/s12687-016-0289-x
   Kirino Y, 2006, HUM MOL GENET, V15, P897, DOI 10.1093/hmg/ddl007
   Klopstock T, 1997, MOL CELL BIOCHEM, V174, P271, DOI 10.1023/A:1006877012241
   Kobayashi J, 2010, INTERNAL MED, V49, P479, DOI 10.2169/internalmedicine.49.2996
   KOGA Y, 1995, MUSCLE NERVE, V0, PS119
   Koge Junpei, 2016, RINSHO SHINKEIGAKU, V56, P667
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Lagarde J, 2012, MOVEMENT DISORD, V27, P1805, DOI 10.1002/mds.25206
   Larsson N G, 1995, MUSCLE NERVE SUPPL, V3, P0
   Leong IUS, 2015, BMC MED GENET, V16, P0, DOI 10.1186/s12881-015-0176-z
   Levy RJ, 2014, J CHILD NEUROL, V29, PNP105, DOI 10.1177/0883073813506783
   Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104
   Liu CY, 2004, ANN NY ACAD SCI, V1011, P133, DOI 10.1196/annals.1293.014
   Liu KM, 2014, METAB BRAIN DIS, V29, P139, DOI 10.1007/s11011-013-9464-5
   Lopez-Blanco R, 2017, BMJ CASE REP, V2017, P0
   Lorenzoni PJ, 2014, ARQ NEURO-PSIQUIAT, V72, P803, DOI 10.1590/0004-282X20140124
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Luigetti M, 2016, EUR J NEUROL, V23, P1020, DOI 10.1111/ene.12954
   MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Mancuso M, 2014, MOVEMENT DISORD, V29, P722, DOI 10.1002/mds.25839
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Martín-Jiménez R, 2012, MITOCHONDRION, V12, P288, DOI 10.1016/j.mito.2011.10.004
   MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872
   Masucci JP, 1997, MOL CELL BIOCHEM, V174, P215, DOI 10.1023/A:1006808524536
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Melone MAB, 2004, ARCH NEUROL-CHICAGO, V61, P269, DOI 10.1001/archneur.61.2.269
   Miosge LA, 2015, P NATL ACAD SCI USA, V112, PE5189, DOI 10.1073/pnas.1511585112
   Mkaouar-Rebai E, 2014, MITOCHONDR DNA, V25, P394, DOI 10.3109/19401736.2013.803086
   Möllers M, 2005, NUCLEIC ACIDS RES, V33, P5647, DOI 10.1093/nar/gki876
   Molnar MJ, 2009, J NEUROL, V256, P264, DOI 10.1007/s00415-009-0841-2
   Mongini T, 2002, CLIN NEUROPATHOL, V21, P72
   Muñoz-Málaga A, 2000, MUSCLE NERVE, V23, P538, DOI 10.1002/(SICI)1097-4598(200004)23:4<538::AID-MUS12>3.3.CO;2-K
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Nagashima T, 2001, NEUROMUSCULAR DISORD, V11, P470, DOI 10.1016/S0960-8966(01)00190-0
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   NAKAMURA M, 1995, BIOCHEM BIOPH RES CO, V214, P86, DOI 10.1006/bbrc.1995.2260
   Nakamura M, 2010, J MED GENET, V47, P659, DOI 10.1136/jmg.2009.072058
   Naumann M, 1997, MUSCLE NERVE, V20, P833, DOI 10.1002/(SICI)1097-4598(199707)20:7<833::AID-MUS7>3.0.CO;2-8
   Nesbitt V, 2012, DEV MED CHILD NEUROL, V54, P500, DOI 10.1111/j.1469-8749.2012.04224.x
   Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802
   Niroula A, 2016, NUCLEIC ACIDS RES, V44, P2020, DOI 10.1093/nar/gkw046
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Nurminen A, 2017, BBA CLIN, V7, P147, DOI 10.1016/j.bbacli.2017.04.001
   Nykamp K, 2017, GENET MED, V19, P1105, DOI 10.1038/gim.2017.37
   OKEEFFE ST, 1995, MUSCLE NERVE, V18, P478, DOI 10.1002/mus.880180420
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Ozawa M, 1998, J NEUROL SCI, V159, P170, DOI 10.1016/S0022-510X(98)00152-X
   OZAWA M, 1995, NEUROMUSCULAR DISORD, V5, P483, DOI 10.1016/0960-8966(95)00009-C
   Peng Y, 2003, MOVEMENT DISORD, V18, P716, DOI 10.1002/mds.10428
   Pepin MG, 2016, GENET MED, V18, P20, DOI 10.1038/gim.2015.31
   Pronicki M, 2007, FOLIA NEUROPATHOL, V45, P187
   Quattrocelli M, 2017, PLOS GENET, V13, P0, DOI 10.1371/journal.pgen.1007070
   Rachad L, 2017, MOL NEUROBIOL, V54, P939, DOI 10.1007/s12035-016-9712-x
   Remes AM, 2003, J NEUROL NEUROSUR PS, V74, P1158, DOI 10.1136/jnnp.74.8.1158
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Rommelaere G, 2012, INT J BIOCHEM CELL B, V44, P139, DOI 10.1016/j.biocel.2011.10.009
   Rossmanith W, 2003, ANN NEUROL, V54, P820, DOI 10.1002/ana.10753
   Sakuta R, 2002, PEDIATR NEUROL, V27, P397, DOI 10.1016/S0887-8994(02)00456-3
   SAKUTA R, 1993, J NEUROL SCI, V115, P158, DOI 10.1016/0022-510X(93)90219-O
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Sano M, 1996, J NEUROL, V243, P441, DOI 10.1007/BF00900496
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schaffer SW, 2014, AMINO ACIDS, V46, P47, DOI 10.1007/s00726-012-1414-8
   Schiemann AH, 2016, BRIT J ANAESTH, V117, P124, DOI 10.1093/bja/aew065
   Schinwelski M, 2015, METAB BRAIN DIS, V30, P1083, DOI 10.1007/s11011-014-9645-x
   Schuelke M, 1998, ANN NEUROL, V44, P700, DOI 10.1002/ana.410440420
   SEIBEL P, 1991, J NEUROL SCI, V105, P217, DOI 10.1016/0022-510X(91)90148-Z
   Sekino Y, 2012, WORLD J GASTROENTERO, V18, P4557, DOI 10.3748/wjg.v18.i33.4557
   Serra G, 1996, BRAIN DEV-JPN, V18, P185, DOI 10.1016/0387-7604(95)00147-6
   Shinde A, 2000, RINSHO SHINKEIGAKU, V40, P561
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SHOFFNER JM, 1991, REV NEUROL-FRANCE, V147, P431
   Shtilbans A, 2000, J CHILD NEUROL, V15, P759, DOI 10.1177/088307380001501109
   Shtilbans A, 1999, J CHILD NEUROL, V14, P610, DOI 10.1177/088307389901400910
   Silvestri G, 1998, NEUROMUSCULAR DISORD, V8, P291, DOI 10.1016/S0960-8966(98)00037-6
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Sissler M, 2004, RNA, V10, P841, DOI 10.1261/rna.5267604
   Slawek J, 2012, J CLIN PATHOL, V65, P1147, DOI 10.1136/jclinpath-2012-200778
   Smith ED, 2017, HUM MUTAT, V38, P600, DOI 10.1002/humu.23183
   Stenqvist L, 2005, PEDIATR RES, V58, P258, DOI 10.1203/01.PDR.0000169966.82325.1A
   Stratilova L, 1999, CAS LEK CESK, V138, P401
   Sunami Y, 2011, NEUROL SCI, V32, P861, DOI 10.1007/s10072-011-0719-9
   Suzuki Hidefumi, 2016, RINSHO SHINKEIGAKU, V56, P196, DOI 10.5692/clinicalneurol.cn-000783
   SUZUKI S, 1994, DIABETES CARE, V17, P1428, DOI 10.2337/diacare.17.12.1428
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Suzuki T, 2011, WIRES RNA, V2, P376, DOI 10.1002/wrna.65
   Swalwell H, 2008, EUR J HUM GENET, V16, P1265, DOI 10.1038/ejhg.2008.65
   Takeda A, 1998, JPN CIRC J, V62, P695, DOI 10.1253/jcj.62.695
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   TANNO Y, 1991, BIOCHEM BIOPH RES CO, V179, P880, DOI 10.1016/0006-291X(91)91900-W
   Tarnopolsky MA, 1998, MUSCLE NERVE, V21, P25, DOI 10.1002/(SICI)1097-4598(199801)21:1<25::AID-MUS4>3.0.CO;2-I
   Taylor RW, 2004, NEUROLOGY, V62, P1420, DOI 10.1212/01.WNL.0000120667.77372.46
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445
   Tiranti V, 1999, NEUROMUSCULAR DISORD, V9, P66, DOI 10.1016/S0960-8966(98)00103-5
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   TOKUNAGA M, 1993, ANN NEUROL, V33, P275, DOI 10.1002/ana.410330308
   Toompuu M, 1999, HUM MOL GENET, V8, P2275, DOI 10.1093/hmg/8.12.2275
   Toompuu M, 2004, BIOCHEM BIOPH RES CO, V322, P803, DOI 10.1016/j.bbrc.2004.07.181
   Toompuu M, 2002, J BIOL CHEM, V277, P22240, DOI 10.1074/jbc.M200338200
   Toyono M, 2001, NEUROMUSCULAR DISORD, V11, P300, DOI 10.1016/S0960-8966(00)00176-0
   TRAFF J, 1995, ACTA NEUROL SCAND, V92, P394
   Turner CJ, 2005, GENETICS, V170, P1879, DOI 10.1534/genetics.105.043653
   Uehara DT, 2010, GENET TEST MOL BIOMA, V14, P611, DOI 10.1089/gtmb.2010.0011
   Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443
   Valdmanis PN, 2009, HUM MUTAT, V30, PE481, DOI 10.1002/humu.20939
   Valentino ML, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.037507
   van de Glind G, 2007, EUR J PAEDIATR NEURO, V11, P243, DOI 10.1016/j.ejpn.2007.01.004
   Verhoeven K, 1999, EUR J HUM GENET, V7, P45, DOI 10.1038/sj.ejhg.5200247
   Verma A, 1996, NEUROLOGY, V46, P1334, DOI 10.1212/WNL.46.5.1334
   Vilela H, 2005, PEDIATR ANESTH, V15, P77, DOI 10.1111/j.1460-9592.2005.01384.x
   Virgilio R, 2009, J NEUROL SCI, V281, P85, DOI 10.1016/j.jns.2009.01.025
   Vollono C, 2017, CEPHALALGIA, V0, P0, DOI DOI 10.1177/0333102417723568.333102417723568
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Walters-Sen LC, 2015, MOL GENET GENOM MED, V3, P99, DOI 10.1002/mgg3.116
   Wiedemann FR, 2008, CLIN NEUROL NEUROSUR, V110, P859, DOI 10.1016/j.clineuro.2008.06.010
   Williams AJ, 1999, HUM MOL GENET, V8, P1691, DOI 10.1093/hmg/8.9.1691
   Wong LJC, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.040626
   Yanagawa T, 1998, INTERNAL MED, V37, P780, DOI 10.2169/internalmedicine.37.780
   Yao YG, 2009, AM J HUM GENET, V85, P929, DOI 10.1016/j.ajhg.2009.10.023
   Yarham JW, 2013, J NEUROL SCI, V325, P165, DOI 10.1016/j.jns.2012.12.003
   Yarham JW, 2012, MITOCHONDRION, V12, P533, DOI 10.1016/j.mito.2012.06.009
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yasukawa T, 2005, FEBS LETT, V579, P2948, DOI 10.1016/j.febslet.2005.04.038
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Ye KX, 2014, P NATL ACAD SCI USA, V111, PE4548, DOI 10.1073/pnas.1415171111
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yen HC, 2016, BBA-GEN SUBJECTS, V1860, P1864, DOI 10.1016/j.bbagen.2016.05.005
   YONEDA M, 1990, BIOCHEM INT, V21, P789
   YOON KL, 1993, PEDIATR RES, V33, P433, DOI 10.1203/00006450-199305000-00002
   ZEVIANI M, 1991, AM J HUM GENET, V48, P203
   Zeviani Massimo, 1993, EUROPEAN JOURNAL OF HUMAN GENETICS, V1, P80
   Zhou L, 1997, J NEUROSCI, V17, P7746
   Zhu CC, 2017, OPHTHALMIC GENET, V38, P67, DOI 10.3109/13816810.2015.1130153
   Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548
   Zsurka G, 2013, SEIZURE-EUR J EPILEP, V22, P483, DOI 10.1016/j.seizure.2013.03.003
NR 218
TC 57
Z9 60
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD MAR 15
PY 2018
VL 80
IS 
BP 8
EP 23
DI 10.1016/j.pediatrneurol.2017.12.005
PG 16
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA GD0AD
UT WOS:000430159200003
PM 29449072
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Zarrouk-Mahjoub, S
AF Finsterer, Josef
   Zarrouk-Mahjoub, Sinda
TI Phenotypic and Genotypic Heterogeneity of <i>RRM2B</i> Variants
SO NEUROPEDIATRICS
LA English
DT Review
DE mitochondrial; mtDNA; phenotype; genotype; myopathy; muscle biopsy; RRM2B
ID mitochondrial-dna depletion; peripheral neuropathy; gene defect; mutations
AB Objectives Genotype and phenotype of RRM2B mutation have become increasingly heterogeneous. This review aims at summarizing recent advances concerning the genotypic and phenotypic variability of RRM2B mutations. Method The review evaluated clinical and instrumental data of 82 patients carrying a mutation in the RRM2B gene reported in 18 publications with regard to onset, frequency, and type of clinical manifestations and genetic findings. Results The review showed marked variety of clinical manifestations and marked variety of age at onset. Organs predominantly affected in RRM2B mutation carriers are the skeletal muscle, the brain, and the kidneys. Additionally affected may be the eyes, ears, endocrine organs, heart, gastro-intestinal tract, bone marrow, or the peripheral nerves. So far 43 mutations in 81 patients have been reported. Diagnosing RRM2B-associated disease requires demonstration of an appropriate phenotype and a RRM2B mutation. Various clinical manifestations are accessible to various invasive or non-invasive therapeutic measures. The outcome of RRM2B-associated mitochondrial disorders is highly variable ranging from early death to survival into adulthood. Conclusions Phenotype and genotype in RRM2B mutation carriers are more widespread than anticipated. Particularly in patients with chronic progressive external ophthalmoplegia, ptosis, limb muscle weakness, muscle hypotonia, renal tubulopathy, ataxia, deafness, and lactic acidosis, a RRM2B mutation should be considered.
C1 [Finsterer, Josef] Vet Univ Vienna, Messerli Inst, Krankenanstalt Rudolfstiftung, Vienna, Austria.
   [Zarrouk-Mahjoub, Sinda] Univ Tunis El Manar, Tunis, Tunisia.
   [Zarrouk-Mahjoub, Sinda] Pasteur Inst Tunis, Genom Platform, Tunis, Tunisia.
C3 Rudolfstiftung Hospital; University of Veterinary Medicine Vienna; Universite de Tunis-El-Manar; Pasteur Network; Universite de Tunis-El-Manar; Institut Pasteur Tunis
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs@yahoo.de
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Gorman GS, 1993, GENEREVIEWS, V0, P0
   Hernández-Laín A, 2015, J NEUROL SCI, V358, P481, DOI 10.1016/j.jns.2015.08.1550
   Horga A, 2014, BRAIN, V137, P3200, DOI 10.1093/brain/awu279
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Kropach N, 2017, NEUROPEDIATRICS, V48, P456, DOI 10.1055/s-0037-1601867
   PAQUISFLUCKLINGER V, 1995, EUR J PEDIATR, V154, P557, DOI 10.1007/s004310050342
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stojanovic V, 2013, CROAT MED J, V54, P579, DOI 10.3325/cmj.2013.54.579
   Takata A, 2011, GENOME BIOL, V12, P0, DOI 10.1186/gb-2011-12-9-r92
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Valencia CA, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0156738
   Wilichowski EKG, 2014, NEUROMUSCULAR DISORD, V24, P866, DOI 10.1016/j.nmd.2014.06.244
NR 19
TC 11
Z9 13
U1 0
U2 4
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0174-304X
EI 1439-1899
J9 NEUROPEDIATRICS
JI Neuropediatrics
PD AUG 15
PY 2018
VL 49
IS 4
BP 231
EP 237
DI 10.1055/s-0037-1609039
PG 7
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA GM1UV
UT WOS:000437859300002
PM 29241262
DA 2024-11-01
ER

PT J
AU Cerbelli, B
   Pisano, A
   Colafrancesco, S
   Pignataro, MG
   Biffoni, M
   Berni, S
   De Luca, A
   Riccieri, V
   Priori, R
   Valesini, G
   d'Amati, G
   Giordano, C
AF Cerbelli, Bruna
   Pisano, Annalinda
   Colafrancesco, Serena
   Pignataro, Maria Gemma
   Biffoni, Marco
   Berni, Silvia
   De Luca, Antonia
   Riccieri, Valeria
   Priori, Roberta
   Valesini, Guido
   d'Amati, Giulia
   Giordano, Carla
TI Anti-aminoacyl-tRNA synthetase-related myositis and dermatomyositis: clues for differential diagnosis on muscle biopsy
SO VIRCHOWS ARCHIV
LA English
DT Article
DE Myositis; Anti-synthetase syndrome; Dermatomyositis; Muscle biopsy; mtDNA damage
ID mitochondrial neurogastrointestinal encephalomyopathy; idiopathic inflammatory myopathy; classification; autoantibody; immune; abnormality; pathology; depletion; features; criteria
AB Anti-synthetase syndrome is an autoimmune disease characterized by autoantibodies toward amino acyl-tRNA synthetases (ARS), anti-Jo 1 being the most commonly detected. Muscle damage develops in up to 90% of ARS-positive patients, characterized by a necrotizing myositis restricted to the perifascicular region. This topographic distribution of muscle damage may lead to a misdiagnosis of dermatomyositis (DM) at muscle biopsy. We compared morphological, immunohistochemical, and histoenzymatic features of muscle from ARS-positive patients (n = 11) with those of DM (n = 7) providing clues for their differential diagnosis. In addition, we evaluated markers of mitochondrial damage to provide a further distinction between these two entities. Necrosis occurred in the majority of ARS patients, mainly located in the perifascicular region. It was often limited to small foci of fibers, always associated with myocyte regeneration. This last often overwhelmed necrosis, representing occasionally the main finding. In DM, necrosis/regeneration was scarce while the peculiar feature was a diffuse atrophy of perifascicular fibers. These last showed decreased cytochrome c oxidase (COX) stain and mitochondrial DNA depletion, consistent with mitochondrial dysfunction. In contrast to DM, ARS displayed scattered COX-deficient fibers, not restricted to the perifascicular region. This feature occurred in up to 91% of patients, being prominent only in two.
C1 [Cerbelli, Bruna; Pisano, Annalinda; Pignataro, Maria Gemma; Berni, Silvia; De Luca, Antonia; d'Amati, Giulia; Giordano, Carla] Sapienza Univ Rome, Dept Radiol Oncol & Pathol Sci, Policlin Umberto 1, Viale Regina Elena 324, I-00161 Rome, Italy.
   [Colafrancesco, Serena; Riccieri, Valeria; Priori, Roberta; Valesini, Guido] Sapienza Univ Rome, Dept Internal Med & Med Specialties, Rheumatol Unit, I-00161 Rome, Italy.
   [Biffoni, Marco] Sapienza Univ Rome, Dept Surg Sci, I-00161 Rome, Italy.
C3 Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome; Sapienza University Rome
RP Giordano, C (corresponding author), Sapienza Univ Rome, Dept Radiol Oncol & Pathol Sci, Policlin Umberto 1, Viale Regina Elena 324, I-00161 Rome, Italy.
EM carla.giordano@uniroma1.it
CR Alhatou MI, 2004, J MOL HISTOL, V35, P615
   Allenbach Y, 2016, BRAIN, V139, P0, DOI 10.1093/brain/aww126
   BANKER BQ, 1966, MEDICINE, V45, P261, DOI 10.1097/00005792-196607000-00001
   Batten F E, 1912, PROC R SOC MED, V5, P103
   BROOKE MH, 1969, NEUROLOGY, V19, P378, DOI 10.1212/WNL.19.4.378
   Brouwer R, 2001, ANN RHEUM DIS, V60, P116, DOI 10.1136/ard.60.2.116
   CARPENTER S, 1976, NEUROLOGY, V26, P952, DOI 10.1212/WNL.26.10.952
   Cavagna L, 2015, MEDICINE, V94, P0, DOI 10.1097/MD.0000000000001144
   Cavazzana I, 2016, J IMMUNOL METHODS, V433, P1, DOI 10.1016/j.jim.2016.02.017
   Colafrancesco S, 2015, BEST PRACT RES CL RH, V29, P810, DOI 10.1016/j.berh.2016.02.005
   Dalakas MC, 2015, NEW ENGL J MED, V372, P1734, DOI 10.1056/NEJMra1402225
   EMSLIESMITH AM, 1990, ANN NEUROL, V27, P343, DOI 10.1002/ana.410270402
   Giordano C, 2006, GASTROENTEROLOGY, V130, P893, DOI 10.1053/j.gastro.2006.01.004
   Giordano C, 2011, METHODS MOL BIOL, V755, P223, DOI 10.1007/978-1-61779-163-5_18
   Greenberg SA, 2005, ANN NEUROL, V57, P664, DOI 10.1002/ana.20464
   Hoogendijk Jessica E, 2004, NEUROMUSCUL DISORD, V14, P337, DOI 10.1016/j.nmd.2004.02.006
   Iaccarino L, 2013, AUTOIMMUN REV, V12, P363, DOI 10.1016/j.autrev.2012.06.004
   Koenig M, 2007, ARTHRITIS RES THER, V9, P0, DOI 10.1186/ar2276
   Lahoria R, 2016, BRAIN, V139, P1891, DOI 10.1093/brain/aww122
   LOVE LA, 1991, MEDICINE, V70, P360, DOI 10.1097/00005792-199111000-00002
   Mahler M, 2014, AUTOIMMUN REV, V13, P367, DOI 10.1016/j.autrev.2014.01.022
   Mescam-Mancini L, 2015, BRAIN, V138, P2485, DOI 10.1093/brain/awv192
   Miró O, 1998, BRIT J RHEUMATOL, V37, P1047
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   Pestronk A, 2011, CURR OPIN RHEUMATOL, V23, P595, DOI 10.1097/BOR.0b013e32834bab42
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Senécal JL, 2017, ARTHRITIS RHEUMATOL, V69, P878, DOI 10.1002/art.40063
   Temiz P, 2009, J NEUROL SCI, V278, P25, DOI 10.1016/j.jns.2008.11.010
   Troyanov Y, 2005, MEDICINE, V84, P231, DOI 10.1097/01.md.0000173991.74008.b0
   Troyanov Y, 2014, MEDICINE, V93, P318, DOI 10.1097/MD.0000000000000222
   Uruha A, 2016, BRAIN, V139, P0, DOI 10.1093/brain/aww125
   Varadhachary AS, 2010, CURR OPIN RHEUMATOL, V22, P651, DOI 10.1097/BOR.0b013e32833f108a
   Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554
   WOO M, 1988, J NEUROL SCI, V88, P133, DOI 10.1016/0022-510X(88)90211-0
NR 35
TC 10
Z9 10
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0945-6317
EI 1432-2307
J9 VIRCHOWS ARCH
JI Virchows Arch.
PD MAR 15
PY 2018
VL 472
IS 3
BP 477
EP 487
DI 10.1007/s00428-017-2269-x
PG 11
WC Pathology
SC Pathology
GA GB8UF
UT WOS:000429350100018
PM 29147923
DA 2024-11-01
ER

PT J
AU Ignatenko, O
   Chilov, D
   Paetau, I
   de Miguel, E
   Jackson, CB
   Capin, G
   Paetau, A
   Terzioglu, M
   Euro, L
   Suomalainen, A
AF Ignatenko, Olesia
   Chilov, Dmitri
   Paetau, Ilse
   de Miguel, Elena
   Jackson, Christopher B.
   Capin, Gabrielle
   Paetau, Anders
   Terzioglu, Mugen
   Euro, Liliya
   Suomalainen, Anu
TI Loss of mtDNA activates astrocytes and leads to spongiotic encephalopathy
SO NATURE COMMUNICATIONS
LA English
DT Article
ID dna polymerase-gamma; mitochondrial myopathy; mutations; twinkle; disease; mice; neuropathology; degeneration; reproduce; deletions
AB Mitochondrial dysfunction manifests as different neurological diseases, but the mechanisms underlying the clinical variability remain poorly understood. To clarify whether different brain cells have differential sensitivity to mitochondrial dysfunction, we induced mitochondrial DNA (mtDNA) depletion in either neurons or astrocytes of mice, by inactivating Twinkle (TwKO), the replicative mtDNA helicase. Here we show that astrocytes, the most abundant cerebral cell type, are chronically activated upon mtDNA loss, leading to early-onset spongiotic degeneration of brain parenchyma, microgliosis and secondary neurodegeneration. Neuronal mtDNA loss does not, however, cause symptoms until 8 months of age. Findings in astrocyte-TwKO mimic neuropathology of Alpers syndrome, infantile-onset mitochondrial spongiotic encephalopathy caused by mtDNA maintenance defects. Our evidence indicates that (1) astrocytes are dependent on mtDNA integrity; (2) mitochondrial metabolism contributes to their activation; (3) chronic astrocyte activation has devastating consequences, underlying spongiotic encephalopathy; and that (4) astrocytes are a potential target for interventions.
C1 [Ignatenko, Olesia; Chilov, Dmitri; Paetau, Ilse; Jackson, Christopher B.; Capin, Gabrielle; Terzioglu, Mugen; Euro, Liliya; Suomalainen, Anu] Univ Helsinki, Biomedicum Helsinki, Mol Neurol, Res Programs Unit, Haartmaninkatu 8, FIN-00014 Helsinki, Finland.
   [de Miguel, Elena] Univ Helsinki, Fac Med, Dept Pharmacol, Haartmaninkatu 8, FIN-00014 Helsinki, Finland.
   [Paetau, Anders] Huslab, Dept Pathol, Haartmaninkatu 3, Helsinki 01051, Finland.
   [Paetau, Anders] Helsinki Univ Hosp, Haartmaninkatu 3, Helsinki 01051, Finland.
   [Paetau, Anders] Univ Helsinki, Medicum, Haartmaninkatu 3, Helsinki 01051, Finland.
   [Suomalainen, Anu] Univ Helsinki, Neurosci Ctr, Viikinkaari 4, FIN-00014 Helsinki, Finland.
   [Suomalainen, Anu] Helsinki Univ Hosp, Dept Neurosci, Haartmaninkatu 4, Helsinki 01051, Finland.
C3 University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital
RP Suomalainen, A (corresponding author), Univ Helsinki, Biomedicum Helsinki, Mol Neurol, Res Programs Unit, Haartmaninkatu 8, FIN-00014 Helsinki, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, Neurosci Ctr, Viikinkaari 4, FIN-00014 Helsinki, Finland.; Suomalainen, A (corresponding author), Helsinki Univ Hosp, Dept Neurosci, Haartmaninkatu 4, Helsinki 01051, Finland.
EM anu.wartiovaara@helsinki.fi
FU Academy of Finland; Sigrid Juselius Foundation; University of Helsinki; European Research Council Advanced Grants; Swiss National Foundation postdoc grant; Novartis Foundation for Medical-Biological Research; Helsinki Doctoral Program for Biomedicine
CR Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   [Anonymous], 2014, GENE REV, V0, P0
   Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Chilov D, 2011, DEV BIOL, V357, P259, DOI 10.1016/j.ydbio.2011.06.029
   COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3
   Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   HARDING BN, 1995, J NEUROL NEUROSUR PS, V58, P320, DOI 10.1136/jnnp.58.3.320
   Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008
   Jackson CB, 2014, J MED GENET, V51, P170, DOI 10.1136/jmedgenet-2013-101932
   JELLINGER K, 1970, ACTA NEUROPATHOL, V16, P125, DOI 10.1007/BF00687667
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Lake NJ, 2015, J NEUROPATH EXP NEUR, V74, P482, DOI 10.1097/NEN.0000000000000195
   Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Liddelow S, 2015, CELL, V162, P1170, DOI 10.1016/j.cell.2015.08.029
   Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006
   Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029
   Luong TN, 2011, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/2376
   Matsumura H, 1980, METH ENZYMOL, V69, P465, DOI 10.1016/S0076-6879(80)69045-4
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   PAUWELS PJ, 1985, J NEUROCHEM, V44, P143, DOI 10.1111/j.1471-4159.1985.tb07123.x
   PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x
   Pickrell AM, 2009, J BIOENERG BIOMEMBR, V41, P453, DOI 10.1007/s10863-009-9245-3
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Supplie LM, 2017, J NEUROSCI, V37, P4231, DOI 10.1523/JNEUROSCI.0756-16.2017
   Tao JF, 2011, J NEUROSCI, V31, P8306, DOI 10.1523/JNEUROSCI.0567-11.2011
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Vashchinkina E, 2014, FRONT PHARMACOL, V5, P0, DOI 10.3389/fphar.2014.00256
NR 45
TC 38
Z9 40
U1 1
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
EI 
J9 NAT COMMUN
JI Nat. Commun.
PD JAN 4
PY 2018
VL 9
IS 
BP 
EP 
DI 10.1038/s41467-017-01859-9
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FR9OY
UT WOS:000419404200020
PM 29302033
DA 2024-11-01
ER

PT J
AU Veitia, RA
AF Veitia, Reiner A.
TI How the most common mitochondrial DNA mutation (m.3243A>G) vanishes from leukocytes: a mathematical model
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID mtdna mutation; clinical-features; m.3243a-greater-than-g mutation; diabetes-mellitus; melas syndrome; gene mutation; heteroplasmy; disease; blood; diagnosis
AB Mitochondrial diseases may be caused by alterations of the mitochondrial genome. The pathogenic variant m.3243A>G is one of the most frequent causes of mitochondrial disease and the most common mitochondrial DNA mutation. Patients with a variant in mitochondrial DNA can have a mixture of mutated and wild-type genomes (heteroplasmy). In the case of the pathogenic variant m.3243A>G, the degree of heteroplasmy (H) correlates to some extent with the severity of the disease. Several longitudinal studies, where H is measured at two different time-points, have shown an annual decline in leukocyte H values. Thus far, only an exponential decay of H with time has been noted but a mechanistic model is lacking. Here, I describe a deterministic mathematical model that accounts for the decline of H in leukocytes based on selective mechanisms acting at the stem cell level. The 'inverted-sigmoid' model provides estimates of at-birth H levels closer to those observed in post-mitotic tissues, such as skeletal muscle, than the estimates provided by an exponential decay. The new model never leads to predictions of H > 100% and provides a stronger correlation between at-birth H values in leukocytes and the scores of the Newcastle Mitochondrial Disease Scale for Adults, which can be of practical utility. This model could be extended to other mitochondrial DNA disease-causing variants.
C1 [Veitia, Reiner A.] Univ Paris Diderot, Inst Jacques Monod, 15 Rue Helene Brion, F-75013 Paris, France.
C3 Universite Paris Cite
RP Veitia, RA (corresponding author), Univ Paris Diderot, Inst Jacques Monod, 15 Rue Helene Brion, F-75013 Paris, France.
EM reiner.veitia@ijm.fr
FU University Paris Diderot; Centre National de la Recherche Scientifique; Fondation pour la Recherche Medicale grant [DEQ20150331757]
CR Chaussenot A, 2014, REV NEUROL-FRANCE, V170, P323, DOI 10.1016/j.neurol.2014.03.007
   de Laat P, 2015, MITOCHONDRION, V25, P98, DOI 10.1016/j.mito.2015.10.005
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Demain LAM, 2017, CLIN GENET, V91, P199, DOI 10.1111/cge.12896
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Flierl A, 1997, J BIOL CHEM, V272, P27189, DOI 10.1074/jbc.272.43.27189
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Kärppä M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Langdahl JH, 2018, CLIN GENET, V93, P925, DOI 10.1111/cge.13201
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ng YS, 2016, NEUROMUSCULAR DISORD, V26, P702, DOI 10.1016/j.nmd.2016.08.009
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Saneto RP, 2013, NEUROTHERAPEUTICS, V10, P199, DOI 10.1007/s13311-012-0167-0
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Sunde K, 2016, MOL GENET METAB REP, V9, P94, DOI 10.1016/j.ymgmr.2016.11.002
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   tHart LM, 1996, HUM MUTAT, V7, P193
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 32
TC 6
Z9 7
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAY 1
PY 2018
VL 27
IS 9
BP 1565
EP 1571
DI 10.1093/hmg/ddy063
PG 7
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA GF3UU
UT WOS:000431882900006
PM 29474538
DA 2024-11-01
ER

PT J
AU Grady, JP
   Pickett, SJ
   Ng, YS
   Alston, CL
   Blakely, EL
   Hardy, SA
   Feeney, CL
   Bright, AA
   Schaefer, AM
   Gorman, GS
   McNally, RJQ
   Taylor, RW
   Turnbull, DM
   McFarland, R
AF Grady, John P.
   Pickett, Sarah J.
   Ng, Yi Shiau
   Alston, Charlotte L.
   Blakely, Emma L.
   Hardy, Steven A.
   Feeney, Catherine L.
   Bright, Alexandra A.
   Schaefer, Andrew M.
   Gorman, Grainne S.
   McNally, Richard J. Q.
   Taylor, Robert W.
   Turnbull, Doug M.
   McFarland, Robert
TI mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A&gt;G mitochondrial disease
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE m.3243A > G; MELAS; mitochondrial disease; mtDNA copy number; mtDNA heteroplasmy
ID 3243a-greater-than-g mutation; dna mutations; melas; phenotype; urine; blood; encephalomyopathy; progression; leukocytes; family
AB Mitochondrial disease associated with the pathogenic m.3243A>G variant is a common, clinically heterogeneous, neurogenetic disorder. Using multiple linear regression and linear mixed modelling, we evaluated which commonly assayed tissue (blood N=231, urine N=235, skeletal muscle N=77) represents the m.3243A>G mutation load and mitochondrial DNA (mtDNA) copy number most strongly associated with disease burden and progression. m.3243A>G levels are correlated in blood, muscle and urine (R-2=0.61-0.73). Blood heteroplasmy declines by similar to 2.3%/year; we have extended previously published methodology to adjust for age. In urine, males have higher mtDNA copy number and similar to 20% higher m.3243A>G mutation load; we present formulas to adjust for this. Blood is the most highly correlated mutation measure for disease burden and progression in m.3243A>G-harbouring individuals; increasing age and heteroplasmy contribute (R-2=0.27, P<0.001). In muscle, heteroplasmy, age and mtDNA copy number explain a higher proportion of variability in disease burden (R-2=0.40, P<0.001), although activity level and disease severity are likely to affect copy number. Whilst our data indicate that age-corrected blood m.3243A>G heteroplasmy is the most convenient and reliable measure for routine clinical assessment, additional factors such as mtDNA copy number may also influence disease severity.
C1 [Grady, John P.; Pickett, Sarah J.; Ng, Yi Shiau; Alston, Charlotte L.; Blakely, Emma L.; Hardy, Steven A.; Feeney, Catherine L.; Bright, Alexandra A.; Schaefer, Andrew M.; Gorman, Grainne S.; Taylor, Robert W.; Turnbull, Doug M.; McFarland, Robert] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.
   [Alston, Charlotte L.; Blakely, Emma L.; Hardy, Steven A.; Taylor, Robert W.] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne, Tyne & Wear, England.
   [McNally, Richard J. Q.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England.
   [Grady, John P.] Garvan Inst, Kinghorn Ctr Clin Genom, Sydney, NSW, Australia.
C3 Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Garvan Institute of Medical Research
RP Pickett, SJ; McFarland, R (corresponding author), Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.
EM sarah.pickett@ncl.ac.uk; robert.mcfarland@ncl.ac.uk
FU Wellcome Trust Fellowship [204709/Z/16/Z]; Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC) Centre for Translational Research in Neuromuscular Disease; Mitochondrial Disease Patient Cohort (UK) [G0800674]; Lily Foundation; UK NIHR Biomedical Research Centre for Ageing and Age-related Disease Award; UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children; National Institute for Health Research (NIHR) doctoral fellowship [NIHR-HCS-D12-03-04]; MRC [G0800674] Funding Source: UKRI; Wellcome Trust [204709/Z/16/Z] Funding Source: Wellcome Trust
CR [Anonymous], 2016, COMPUTER SOFTWARE, V0, P0
   Apabhai S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0022294
   Benda C, 2013, ADV BIOCHEM ENG BIOT, V129, P19, DOI 10.1007/10_2012_157
   Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Brown CE, 1998, APPLIED MULTIVARIATE STATISTICS IN GEOHYDROLOGY AND RELATED SCIENCES, V0, P0, DOI DOI 10.1007/978-3-642-80328-413
   Cao X, 2012, MOL MED REP, V6, P426, DOI 10.3892/mmr.2012.913
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   de Laat P, 2016, BBA CLIN, V6, P19, DOI 10.1016/j.bbacli.2016.04.007
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fayssoil A, 2017, EUR J NEUROL, V24, P255, DOI 10.1111/ene.13176
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0114462
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   HOLTZMAN WH, 1950, AM J PSYCHOL, V63, P615, DOI 10.2307/1418879
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kodaira M, 2015, FEBS OPEN BIO, V5, P219, DOI 10.1016/j.fob.2015.03.008
   Liu CS, 2006, ACTA NEUROL SCAND, V113, P334, DOI 10.1111/j.1600-0404.2006.00586.x
   Liu H, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067146
   Maeda K, 2016, JAMA NEUROL, V73, P990, DOI 10.1001/jamaneurol.2016.0886
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236
   Picard M, 2016, JAMA NEUROL, V73, P923, DOI 10.1001/jamaneurol.2016.1676
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   R Development Core Team, 2016, R: A LANGUAGE AND ENVIRONMENT FOR STATISTICAL COMPUTING, V0, P0
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   Weiduschat N, 2014, NEUROLOGY, V82, P798, DOI 10.1212/WNL.0000000000000169
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
NR 39
TC 176
Z9 186
U1 3
U2 12
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD JUN 15
PY 2018
VL 10
IS 6
BP 
EP 
DI 10.15252/emmm.201708262
PG 13
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA GI5LW
UT WOS:000434413000001
PM 29735722
DA 2024-11-01
ER

PT J
AU Galitsyna, EV
   Zhelankin, AV
   Sobenin, IA
   Orekhov, AN
AF Galitsyna, Elena V.
   Zhelankin, Andrey V.
   Sobenin, Igor A.
   Orekhov, Alexander N.
TI Mutations of Nuclear and Mitochondrial Genomes as Potential Targets for the Treatment of Metabolic Syndrome
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Review
DE Mitochondrial mutations; metabolic syndrome; coronary heart disease; type 2 diabetes mellitus; atherosclerosis; hypertension
ID skeletal-muscle; molecular-mechanisms; insulin-secretion; dna mutations; dysfunction; loci; atherosclerosis; susceptibility; complications; adiposity
AB In addition to external factors, such as exercise, food and the environment, genetic predisposition makes great contribution to the development of metabolic disorders and cardiovascular disease. This review is aimed to examine the genetic basis of complex metabolic disorders conventionally described as "metabolic syndrome" (MetS), with the special focus on currently known mutations in the nuclear and mitochondrial genomes, which are associated with both the individual components of MetS and combinations thereof, and also on the studies of the relationship of MetS phenotype as a binary trait. The defects in the mitochondrial genome should be considered as one of the possible genetic reasons leading to MetS. It is known that mitochondrial dysfunction is closely associated with metabolic disorders, as mitochondria are the center of energy metabolism. Consequently, the changes in mitochondrial genes and their functions affect regulation of metabolism. Until now, the role of mitochondrial DNA damage in the development of cardiovascular diseases, age-related and metabolic disorders is still poorly understood. The results of performed studies would help assessing the role of mitochondrial DNA mutations in susceptibility to metabolic syndrome and related metabolic diseases.
C1 [Galitsyna, Elena V.; Zhelankin, Andrey V.; Sobenin, Igor A.] Natl Med Res Ctr Cardiol, Lab Med Genet, 15a,3rd Cherepkovskaya Str, Moscow 121552, Russia.
   [Zhelankin, Andrey V.; Sobenin, Igor A.; Orekhov, Alexander N.] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, Moscow, Russia.
   [Orekhov, Alexander N.] Skolkovo Innovat Ctr, Inst Atherosclerosis Res, Skolkovo, Russia.
C3 National Medical Research Center of Cardiology; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS
RP Sobenin, IA (corresponding author), Natl Med Res Ctr Cardiol, Lab Med Genet, 15a,3rd Cherepkovskaya Str, Moscow 121552, Russia.
EM igor.sobenin@gmail.com
FU Russian Science Foundation [14-14-01038]; Russian Science Foundation [17-14-00092] Funding Source: Russian Science Foundation
CR Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Ashrafian H, 2007, CIRCULATION, V116, P434, DOI 10.1161/CIRCULATIONAHA.107.702795
   Avery CL, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002322
   Bhopal RS, 2009, INT J EPIDEMIOL, V38, P1072, DOI 10.1093/ije/dyp202
   Bugger H, 2008, CLIN SCI, V114, P195, DOI 10.1042/CS20070166
   Chistiakov DA, 2012, WORLD J CARDIOL, V4, P148, DOI 10.4330/wjc.v4.i5.148
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208
   Dastani Z, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1002607
   De Pauw A, 2009, AM J PATHOL, V175, P927, DOI 10.2353/ajpath.2009.081155
   Dumas JF, 2009, DIABETES METAB, V35, P159, DOI 10.1016/j.diabet.2009.02.002
   FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6
   Fukuda M, 1999, J DIABETES COMPLICAT, V13, P277, DOI 10.1016/S1056-8727(99)00060-4
   He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Hojlund K, 2008, ENDOCRIN METAB CLIN, V37, P713, DOI 10.1016/j.ecl.2008.06.006
   Hu F, 2011, CELL SIGNAL, V23, P1528, DOI 10.1016/j.cellsig.2011.05.008
   Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064
   Kato N, 2015, NAT GENET, V47, P1282, DOI 10.1038/ng.3405
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Kilpeläinen TO, 2011, NAT GENET, V43, P753, DOI 10.1038/ng.866
   Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478
   Kong XX, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011707
   Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011
   Kristiansson K, 2012, CIRC-CARDIOVASC GENE, V5, P242, DOI 10.1161/CIRCGENETICS.111.961482
   LAWS A, 1989, J CLIN ENDOCR METAB, V69, P343, DOI 10.1210/jcem-69-2-343
   Liese AD, 1997, DIABETOLOGIA, V40, P963, DOI 10.1007/s001250050775
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Maassen JA, 2006, BIOCHEM SOC T, V34, P819, DOI 10.1042/BST0340819
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   Mitchell C, 2009, AM J PATHOL, V175, P1929, DOI 10.2353/ajpath.2009.090332
   Mueller EE, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0016455
   Nomiyama T, 2004, ANN NY ACAD SCI, V1011, P193, DOI 10.1196/annals.1293.020
   Pagel-Langenickel I, 2010, ENDOCR REV, V31, P25, DOI 10.1210/er.2009-0003
   Palmieri VO, 2011, NUTRITION, V27, P773, DOI 10.1016/j.nut.2010.08.016
   Pérez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398
   Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004
   Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135
   Rossmeisl M, 2000, FASEB J, V14, P1793, DOI 10.1096/fj.99-0965com
   SCHUMACHER MC, 1992, DIABETES CARE, V15, P1285, DOI 10.2337/diacare.15.10.1285
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Sobenin I, 2016, ATHEROSCLEROSIS, V252, P0
   Sobenin IA, 2013, CURR PHARM DESIGN, V19, P5942
   Sobenin IA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0068070
   Sobenin IA, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0046573
   Sobenin IA, 2012, CLIN DEV IMMUNOL, V0, P0, DOI DOI 10.1155/2012/832464
   Stancáková A, 2014, REV ENDOCR METAB DIS, V15, P243, DOI 10.1007/s11154-014-9293-9
   Tang WH, 2003, DIABETES, V52, P2840, DOI 10.2337/diabetes.52.11.2840
   Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057
   Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217
   Ye W, 2013, MOL MED REP, V8, P1060, DOI 10.3892/mmr.2013.1616
   Zabaneh D, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011961
NR 52
TC 1
Z9 1
U1 0
U2 2
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PD JUN 15
PY 2018
VL 24
IS 15
BP 1711
EP 1716
DI 10.2174/1381612824666180115120725
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GO8CY
UT WOS:000440312700007
PM 29336249
DA 2024-11-01
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI 47th Annual Meeting of the American Aging Association, Philadelphia, PA, USA, June 27-July 1, 2018 Abstracts
SO GEROSCIENCE
LA English
DT Article
AB This American Aging Association 47th Annual Meeting " Improving Resilience to Delay Aging" meeting which focuses on GeroScience, contains approximately 34 abstracts written in English. Topics include Tis11 and Cth1 deficiency, Saccharomyces cerevisiae, metabolic reprogramming, Dietary Restriction, Mitochondrial Disease, single-cell transcriptional signatures, transgenerational inheritance, Physical Function in Older Mice, accelerated aging, brain protein aggregation, glucocerebrosidase deficiency, DNA repair pathway, genomic instability, esophageal keratinocytes, skeletal muscle atrophy, extracellular matrix homeostasis, TRIP12 promoter, InCHIANTI Study, visceral adipose tissue inflammation, rapamycin and acarbose, sulfur metabolism, aerobic fitness, sex dependent, translational aging, neuronal dysfunction, senescent astrocytes, genetic variation, Alzheimer's disease, cardiac aging and mitochondrial pharmacotherapeutics.
NR 0
TC 0
Z9 0
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD AUG 15
PY 2018
VL 40
IS 4
BP 405
EP 418
DI 
PG 14
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA GT5NV
UT WOS:000444557200007
DA 2024-11-01
ER

PT J
AU Celie, BM
   Mariman, A
   Boone, J
   Delesie, L
   Tobback, E
   Seneca, S
   De Paepe, B
   Vogelaers, D
   Van Coster, RN
   Bourgois, JG
AF Celie, Bert M.
   Mariman, An
   Boone, Jan
   Delesie, Liesbeth
   Tobback, Els
   Seneca, Sara
   De Paepe, Boel
   Vogelaers, Dirk
   Van Coster, Rudy N.
   Bourgois, Jan G.
TI Near-Infrared Spectroscopy Screening to Allow Detection of Pathogenic Mitochondrial DNA Variants in Individuals with Unexplained Abnormal Fatigue: A Preliminary Study
SO APPLIED SPECTROSCOPY
LA English
DT Article
DE Near-infrared spectroscopy; NIR; pathogenic mitochondrial DNA; unexplained abnormal fatigue; mitochondrial dysfunction
ID hereditary optic neuropathy; deafness-associated mutations; 1555a-greater-than-g mutation; ribosomal-rna; prevalence; nirs; population
AB Unexplained abnormal fatigue is characterized by chronic fatigue persisting for at least six months and not sufficiently explained by any recognized medical condition. In this pilot study, twelve individuals with abnormal fatigue remaining unexplained after thorough screening were investigated using a near-infrared (NIR) spectroscopy handgrip test. Four of them were found to have an abnormal oxygen extraction pattern similar to participants with documented mitochondrial myopathy. In three of the four individuals, diverse mitochondrial abnormalities were documented by spectrophotometric, immunocytological, fluorescent, and morphological analyses performed in skeletal muscle and in cultured skin fibroblasts. Three of the four participants with decreased muscular oxygen extraction were each shown to harbor a different homoplasmic pathogenic mitochondrial DNA point mutation (m.961T>C, m.1555A>G, m.14484T>C). In the fourth participant, the presence of multiple large mitochondrial DNA deletions was suspected in muscle tissue. In contrast, none of the eight abnormally fatigued participants with normal NIR spectroscopy results harbored either a pathogenic mitochondrial DNA point mutation or large deletions (P<0.001). This pilot study shows that NIR spectroscopy may serve as a noninvasive screening tool to delineate a subgroup (of participants) with mitochondrial dysfunction among the large group of individuals with unexplained abnormal fatigue.
C1 [Celie, Bert M.; Boone, Jan; Bourgois, Jan G.] Univ Ghent, Dept Movement & Sports Sci, Ghent, Belgium.
   [Mariman, An; Delesie, Liesbeth; Tobback, Els; Vogelaers, Dirk] Ghent Univ Hosp, Dept Gen Internal Med, Ghent, Belgium.
   [Mariman, An; Tobback, Els; Vogelaers, Dirk] Ghent Univ Hosp, Ctr Neurophysiol Monitoring, Ghent, Belgium.
   [Boone, Jan; Bourgois, Jan G.] Ghent Univ Hosp, Ctr Sports Med, Ghent, Belgium.
   [Seneca, Sara] VUB, Univ Hosp Brussels, Ctr Med Genet, Reprod Genet & Regenerat Med Res Grp,Neurogenet R, Brussels, Belgium.
   [De Paepe, Boel; Van Coster, Rudy N.] Ghent Univ Hosp, Dept Pediat, Div Pediat Neurol & Metab, Ghent, Belgium.
C3 Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; University Hospital Brussels; Vrije Universiteit Brussel; Ghent University; Ghent University Hospital
RP Bourgois, JG (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sport Sci, Watersportlaan 2, B-9000 Ghent, Belgium.
EM jan.bourgois@ugent.be
CR Billing-Ross P, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0771-6
   Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396
   Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x
   Celie B, 2012, EUR J APPL PHYSIOL, V112, P2369, DOI 10.1007/s00421-011-2183-x
   Celie BM, 2016, APPL SPECTROSC, V70, P363, DOI 10.1177/0003702815620562
   Celie BM, 2015, APPL SPECTROSC, V69, P342, DOI 10.1366/14-07604
   Chen GM, 2011, INT J PEDIATR OTORHI, V75, P532, DOI 10.1016/j.ijporl.2011.01.013
   De Paepe B, 2012, PEDIATR RES, V72, P232, DOI 10.1038/pr.2012.84
   Gorman GS, 2015, NEUROMUSCULAR DISORD, V25, P563, DOI 10.1016/j.nmd.2015.03.001
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Han B, 2013, INT J PEDIATR OTORHI, V77, P1440, DOI 10.1016/j.ijporl.2013.05.040
   HARDING AE, 1995, AM J HUM GENET, V57, P77
   Leber T, 1871, ARCH OPHTHALMOL-CHIC, V17, P249
   MACKEY D, 1992, AM J HUM GENET, V51, P1218
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Mariman A, 2013, J PSYCHOSOM RES, V75, P491, DOI 10.1016/j.jpsychores.2013.07.010
   Mascialino B, 2012, EUR J OPHTHALMOL, V22, P461, DOI 10.5301/ejo.5000055
   Miller RR, 2015, J TRANSL MED, V13, P0, DOI 10.1186/s12967-015-0527-8
   Gravina LP, 2007, INT J PEDIATR OTORHI, V71, P639, DOI 10.1016/j.ijporl.2006.12.015
   Raducu M, 2012, EUR J HUM GENET, V20, P945, DOI 10.1038/ejhg.2012.40
   Rahman S, 2012, BMJ OPEN, V2, P0, DOI 10.1136/bmjopen-2011-000411
   RIORDANEVA P, 1995, J MED GENET, V32, P81, DOI 10.1136/jmg.32.2.81
   Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378
   Rydzanicz M, 2009, GENET TEST MOL BIOMA, V13, P167, DOI 10.1089/gtmb.2008.0098
   Vancampenhout K, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0112950
   Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397
   Wang QJ, 2011, INT J PEDIATR OTORHI, V75, P535, DOI 10.1016/j.ijporl.2011.01.016
   Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2
NR 28
TC 1
Z9 1
U1 0
U2 17
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0003-7028
EI 1943-3530
J9 APPL SPECTROSC
JI Appl. Spectrosc.
PD MAY 15
PY 2018
VL 72
IS 5
BP 715
EP 724
DI 10.1177/0003702818756647
PG 10
WC Instruments & Instrumentation; Spectroscopy
SC Instruments & Instrumentation; Spectroscopy
GA GF5YS
UT WOS:000432044500004
PM 29336589
DA 2024-11-01
ER

PT J
AU Vecoli, C
   Borghini, A
   Pulignani, S
   Mercuri, A
   Turchi, S
   Carpeggiani, C
   Picano, E
   Andreassi, MG
AF Vecoli, Cecilia
   Borghini, Andrea
   Pulignani, Silvia
   Mercuri, Antonella
   Turchi, Stefano
   Carpeggiani, Clara
   Picano, Eugenio
   Andreassi, Maria Grazia
TI Prognostic value of mitochondrial DNA<SUP>4977</SUP> deletion and mitochondrial DNA copy number in patients with stable coronary artery disease
SO ATHEROSCLEROSIS
LA English
DT Article
DE Major adverse cardiac events; mtDNA(4977) common deletion; Mitochondrial DNA copy number; Coronary artery disease
ID 4977 bp deletion; blood-cells; damage; atherosclerosis; association; dysfunction; muscle; heart; mutations; risk
AB Background and aims: Mitochondrial DNA copy number (mtDNA-CN) depletion has been recently associated with an increased cardiovascular risk. However, the integrity of mtDNA is another key aspect of the energy metabolism and mitochondrial function. We investigated the prognostic role of peripheral blood common mitochondrial deletion (mtDNA(4977)) and mtDNA-CN on long-term major adverse cardiac events (MACEs) and all-cause mortality in a cohort of patients with coronary artery disease (CAD). Methods: Within the Italian GENOCOR (Genetic Mapping for Assessment of Cardiovascular Risk) cohort, we studied 515 patients (450 males, 65 +/- 8 years) with known or suspected stable CAD. mtDNA(4977) deletion and mtDNA-CN were assessed in peripheral blood using qRT-PCR. Results: During a mean follow-up of 4.5 +/- 1.1 years, 78 (15%) patients had MACEs (15 cardiac deaths, 17 nonfatal myocardial infarction and 46 coronary revascularizations) and 28 patients died for non-cardiac causes. Patients with high levels of mtDNA(4977) deletion (>75th) had increased risk of MACEs (log rank = 7.2, p = 0.007) and all-cause mortality (log rank = 5.7, p = 0.01) compared with patients with low mtDNA(4977) deletion (>75th). Multivariate Cox regression analysis showed that log mtDNA(4977) was a significant predictor of MACEs (HR = 2.17; 95% CI, 1.31-3.59; p = 0.003) and all-cause mortality (HR = 2.03; 95% CI: 1.13-3.65, p = 0.02). Log mtDNA-CN was not significantly associated with MACEs or all-cause mortality. However, patients with high mtDNA(4977) deletion (>75th) and low mtDNA-CN (<25th) had significantly increased risk for MACEs (HR: 3.73; 95% CI: 1.79-7.79; p = 0.0005). Conclusions: Mitochondria DNA damage was associated with an increased risk of MACEs and all-cause mortality in patients with stable CAD, confirming the critical role of mitochondrial dysfunction in atherosclerosis. (c) 2018 Elsevier B.V. All rights reserved.
C1 [Vecoli, Cecilia; Borghini, Andrea; Pulignani, Silvia; Mercuri, Antonella; Turchi, Stefano; Carpeggiani, Clara; Picano, Eugenio; Andreassi, Maria Grazia] CNR, Inst Clin Physiol, Via Moruzzi 1, I-56124 Pisa, Italy.
C3 Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)
RP Vecoli, C; Andreassi, MG (corresponding author), CNR, Inst Clin Physiol, Via Moruzzi 1, I-56124 Pisa, Italy.
EM vecoli@ifc.cnr.it; andreassi@ifc.cnr.it
FU National Research Council (CNR) grant, "Progetto di Interesse Strategico Invecchiamento (PNR-CNR Aging Program)"
CR Andreassi MG, 2003, MUTAT RES-REV MUTAT, V543, P67, DOI 10.1016/S1383-5742(02)00089-3
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3
   Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89
   Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960
   Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021
   Baykara O, 2016, CELL MOL BIOL, V62, P109, DOI 10.14715/cmb/2016.62.12.19
   Bogliolo M, 1999, MUTAGENESIS, V14, P77, DOI 10.1093/mutage/14.1.77
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Cifkova R, 2003, J HYPERTENS, V21, P1779
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812
   Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140
   Finsterer J, 2014, INT J CARDIOL, V177, P754, DOI 10.1016/j.ijcard.2014.11.014
   Gavin JR, 1999, DIABETES CARE, V22, P0
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   He YH, 2014, NEUROBIOL AGING, V35, P0, DOI 10.1016/j.neurobiolaging.2014.01.015
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Huang J, 2016, MEDICINE, V95, P0, DOI 10.1097/MD.0000000000003323
   Knez J, 2016, INT J CARDIOL, V214, P180, DOI 10.1016/j.ijcard.2016.03.090
   Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175
   Kuznetsova T, 2017, ADV EXP MED BIOL, V982, P347, DOI 10.1007/978-3-319-55330-6_19
   Lee SR, 2017, FRONT BIOSCI-LANDMRK, V22, P1177, DOI 10.2741/4541
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Mercer JR, 2012, FREE RADICAL BIO MED, V52, P841, DOI 10.1016/j.freeradbiomed.2011.11.026
   Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966
   Sabatino L, 2013, ENVIRON MOL MUTAGEN, V54, P299, DOI 10.1002/em.21783
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Yu EPK, 2017, ARTERIOSCL THROM VAS, V37, P2322, DOI 10.1161/ATVBAHA.117.310042
   Yu EPK, 2016, FREE RADICAL BIO MED, V100, P223, DOI 10.1016/j.freeradbiomed.2016.06.011
   Zhang M, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0185688
   Zhang YY, 2017, EUR HEART J, V38, P3443, DOI 10.1093/eurheartj/ehx354
NR 37
TC 30
Z9 35
U1 0
U2 10
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP 15
PY 2018
VL 276
IS 
BP 91
EP 97
DI 10.1016/j.atherosclerosis.2018.07.015
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA GR8UA
UT WOS:000443005800013
PM 30053637
DA 2024-11-01
ER

PT J
AU Nikkanen, J
   Landoni, JC
   Balboa, D
   Haugas, M
   Partanen, J
   Paetau, A
   Isohanni, P
   Brilhante, V
   Suomalainen, A
AF Nikkanen, Joni
   Landoni, Juan Cruz
   Balboa, Diego
   Haugas, Maarja
   Partanen, Juha
   Paetau, Anders
   Isohanni, Pirjo
   Brilhante, Virginia
   Suomalainen, Anu
TI A complex genomic locus drives mtDNA replicase POLG expression to its disease-related nervous system regions
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE enhancer; gene regulation; mtDNA maintenance; POLG; tissue specificity
ID mitochondrial-dna polymerase; progressive external ophthalmoplegia; gamma mutations; recessive ataxia; landscape; chromatin; brain; cells; mice
AB DNA polymerase gamma (POLG), the mtDNA replicase, is a common cause of mitochondrial neurodegeneration. Why POLG defects especially cause central nervous system (CNS) diseases is unknown. We discovered a complex genomic regulatory locus for POLG, containing three functional CNS-specific enhancers that drive expression specifically in oculomotor complex and sensory interneurons of the spinal cord, completely overlapping with the regions showing neuronal death in POLG patients. The regulatory locus also expresses two functional RNAs, LINC00925-RNA and MIR9-3, which are coexpressed with POLG. The MIR9-3 targets include NR2E1, a transcription factor maintaining neural stem cells in undifferentiated state, and MTHFD2, the regulatory enzyme of mitochondrial folate cycle, linking POLG expression to stem cell differentiation and folate metabolism. Our evidence suggests that distant genomic non-coding regions contribute to regulation of genes encoding mitochondrial proteins. Such genomic arrangement of POLG locus, driving expression to CNS regions affected in POLG patients, presents a potential mechanism for CNS-specific manifestations in POLG disease.
C1 [Nikkanen, Joni; Landoni, Juan Cruz; Balboa, Diego; Isohanni, Pirjo; Brilhante, Virginia; Suomalainen, Anu] Univ Helsinki, Mol Neurol, Res Programs Unit, Helsinki, Finland.
   [Balboa, Diego] Univ Helsinki, Biomed Stem Cell Ctr, Helsinki, Finland.
   [Haugas, Maarja; Partanen, Juha] Univ Helsinki, Dept Biosci, Helsinki, Finland.
   [Paetau, Anders] Univ Helsinki, HUSLAB, Helsinki, Finland.
   [Paetau, Anders] Univ Helsinki, Dept Pathol, Helsinki, Finland.
   [Paetau, Anders; Isohanni, Pirjo; Suomalainen, Anu] Helsinki Univ Hosp, Helsinki, Finland.
   [Isohanni, Pirjo] Univ Helsinki, Childrens Hosp, Dept Pediat Neurol, Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Dept Neurol, Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Neurosci Ctr, Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki
RP Suomalainen, A (corresponding author), Univ Helsinki, Mol Neurol, Res Programs Unit, Helsinki, Finland.; Suomalainen, A (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, Dept Neurol, Helsinki, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, Neurosci Ctr, Helsinki, Finland.
EM anu.wartiovaara@helsinki.fi
FU European Research Council; Academy of Finland; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; University of Finland; Helsinki Biomedical Graduate School
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Bao XR, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10575
   Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014
   Copp AJ, 1990, POSTIMPLANTATION MAM, V0, P0
   GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042
   Hikmat O, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18091845
   Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Madelaine R, 2017, CELL REP, V20, P1533, DOI 10.1016/j.celrep.2017.07.051
   Mameza MG, 2007, J NEUROCHEM, V103, P927, DOI 10.1111/j.1471-4159.2007.04854.x
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020
   Palin EJH, 2012, J NEUROL SCI, V315, P160, DOI 10.1016/j.jns.2011.11.028
   Plank JL, 2014, MOL CELL, V55, P5, DOI 10.1016/j.molcel.2014.06.015
   Rowland LP, 1997, NEUROMUSCULAR DISORD, V7, PS15, DOI 10.1016/S0960-8966(97)00076-X
   Selcuklu SD, 2012, J BIOL CHEM, V287, P29516, DOI 10.1074/jbc.M111.335943
   Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211
   Steinfeld R, 2009, AM J HUM GENET, V85, P354, DOI 10.1016/j.ajhg.2009.08.005
   Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232
   Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
NR 31
TC 6
Z9 7
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD JAN 15
PY 2018
VL 10
IS 1
BP 13
EP 21
DI 10.15252/emmm.201707993
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA FS3RD
UT WOS:000419699000005
PM 29109127
DA 2024-11-01
ER

PT J
AU Wu, YT
   Hsu, YH
   Huang, CY
   Ho, MC
   Cheng, YC
   Wen, CH
   Ko, HW
   Lu, HE
   Chen, YC
   Tsai, CL
   Hsu, YC
   Wei, YH
   Hsieh, PCH
AF Wu, Yu-Ting
   Hsu, Yu-Hung
   Huang, Ching-Ying
   Ho, Ming-Ching
   Cheng, Yu-Che
   Wen, Cheng-Hao
   Ko, Hui-Wen
   Lu, Huai-En
   Chen, Yen-Chun
   Tsai, Chia-Ling
   Hsu, Yi-Chao
   Wei, Yau-Huei
   Hsieh, Patrick C. H.
TI Generation of an induced pluripotent stem cell (iPSC) line from a 40-year-old patient with the A8344G mutation of mitochondrial DNA and MERRF (myoclonic epilepsy with ragged red fibers) syndrome
SO STEM CELL RESEARCH
LA English
DT Article
ID fibroblasts
AB Mitochondrial defects are associated with clinical manifestations from common diseases to rare genetic disorders. Myoclonus epilepsy associated with ragged-red fibers (MERRF) syndrome results from an A to G transition at nucleotide position 8344 in the tRNALys gene of mitochondrial DNA (mtDNA) and is characterized bymyoclonus, myopathy and severe neurological symptoms. In this study, Sendai reprogramming method was used to generate an iPS cell line carrying the A8344G mutation of mtDNA from a MERRF patient. This patient-specific iPSC line expressed pluripotent stem cell markers, possessed normal karyotype, and displayed the capability to differentiate into mature cells in three germ layers. (c) 2017 The Authors. Published by Elsevier B.V.
C1 [Wu, Yu-Ting; Wei, Yau-Huei] Changhua Christian Hosp, Ctr Mitochondrial Med & Free Rad Res, Changhua, Taiwan.
   [Hsu, Yu-Hung; Huang, Ching-Ying; Ho, Ming-Ching; Cheng, Yu-Che; Hsieh, Patrick C. H.] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.
   [Wen, Cheng-Hao; Ko, Hui-Wen; Lu, Huai-En] Food Ind Res & Dev Inst, Bioresource Collect & Res Ctr, Hsinchu, Taiwan.
   [Chen, Yen-Chun; Tsai, Chia-Ling; Hsu, Yi-Chao; Wei, Yau-Huei] Mackay Med Coll, Inst Biomed Sci, New Taipei, Taiwan.
C3 Changhua Christian Hospital; Academia Sinica - Taiwan; Mackay Medical College
RP Wei, YH (corresponding author), Changhua Christian Hosp, Ctr Mitochondrial Med & Free Rad Res, Changhua, Taiwan.; Hsieh, PCH (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.; Hsu, YC; Wei, YH (corresponding author), Mackay Med Coll, Inst Biomed Sci, New Taipei, Taiwan.
EM hsuyc@mmc.edu.tw; yhweibabi@gmail.com; phsieh@ibms.sinica.edu.tw
FU Ministry of Science and Technology (MOST), Taiwan [MOST 106-2319-B-001-003, MOST104-2314-B-715-003-MY3, MOST104-2627-M-715-002, MOST104-2320-B-715-006-MY2, MOST105-2627-M-715-001, MOST106-2627-M-371-001, MOST106-2320-B-371-002]; Taiwan Mouse Clinic [MOST 105-2325-B001-010]
CR James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Ma YS, 2005, ANN NY ACAD SCI, V1042, P55, DOI 10.1196/annals.1338.006
   Wu SB, 2010, MOL NEUROBIOL, V41, P256, DOI 10.1007/s12035-010-8123-7
NR 3
TC 10
Z9 11
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1873-5061
EI 1876-7753
J9 STEM CELL RES
JI Stem Cell Res.
PD MAR 15
PY 2018
VL 27
IS 
BP 10
EP 14
DI 10.1016/j.scr.2017.12.013
PG 5
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA FZ4AQ
UT WOS:000427533700003
PM 29288969
DA 2024-11-01
ER

PT J
AU Boczonadi, V
   King, MS
   Smith, AC
   Olahova, M
   Bansagi, B
   Roos, A
   Eyassu, F
   Borchers, C
   Ramesh, V
   Lochmüller, H
   Polvikoski, T
   Whittaker, RG
   Pyle, A
   Griffin, H
   Taylor, RW
   Chinnery, PF
   Robinson, AJ
   Kunji, ERS
   Horvath, R
AF Boczonadi, Veronika
   King, Martin S.
   Smith, Anthony C.
   Olahova, Monika
   Bansagi, Boglarka
   Roos, Andreas
   Eyassu, Filmon
   Borchers, Christoph
   Ramesh, Venkateswaran
   Lochmueller, Hanns
   Polvikoski, Tuomo
   Whittaker, Roger G.
   Pyle, Angela
   Griffin, Helen
   Taylor, Robert W.
   Chinnery, Patrick F.
   Robinson, Alan J.
   Kunji, Edmund R. S.
   Horvath, Rita
TI Mitochondrial oxodicarboxylate carrier deficiency is associated with mitochondrial DNA depletion and spinal muscular atrophy-like disease
SO GENETICS IN MEDICINE
LA English
DT Article
DE metabolite transport; metabolomics; mitochondrial respiratory chain deficiency; neural toxicity; spinal motor atrophy
ID kynurenine pathway; mutations; expression; protein; dhtkd1; identification; metabolism; astrocytes; zellweger; myopathy
AB Purpose: To understand the role of the mitochondrial oxodicarboxylate carrier (SLC25A21) in the development of spinal muscular atrophy-like disease. Methods: We identified a novel pathogenic variant in a patient by whole-exome sequencing. The pathogenicity of the mutation was studied by transport assays, computer modeling, followed by targeted metabolic testing and in vitro studies in human fibroblasts and neurons. Results: The patient carries a homozygous pathogenic variant c.695A > G; p.(Lys232Arg) in the SLC25A21 gene, encoding the mitochondrial oxodicarboxylate carrier, and developed spinal muscular atrophy and mitochondrial myopathy. Transport assays show that the mutation renders SLC25A21 dysfunctional and 2-oxoadipate cannot be imported into the mitochondrial matrix. Computer models of central metabolism predicted that impaired transport of oxodicarboxylate disrupts the pathways of lysine and tryptophan degradation, and causes accumulation of 2-oxoadipate, pipecolic acid, and quinolinic acid, which was confirmed in the patient's urine by targeted metabolomics. Exposure to 2-oxoadipate and quinolinic acid decreased the level of mitochondrial complexes in neuronal cells (SH-SY5Y) and induced apoptosis. Conclusion: Mitochondrial oxodicarboxylate carrier deficiency leads to mitochondrial dysfunction and the accumulation of oxoadipate and quinolinic acid, which in turn cause toxicity in spinal motor neurons leading to spinal muscular atrophy-like disease.
C1 [Boczonadi, Veronika; Bansagi, Boglarka; Roos, Andreas; Lochmueller, Hanns; Pyle, Angela; Griffin, Helen; Horvath, Rita] Newcastle Univ, Inst Genet Med, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [King, Martin S.; Smith, Anthony C.; Eyassu, Filmon; Chinnery, Patrick F.; Robinson, Alan J.; Kunji, Edmund R. S.] Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge, England.
   [Olahova, Monika; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Roos, Andreas] Leibniz Inst Analyt Sci ISAS, Dortmund, Germany.
   [Borchers, Christoph] UVic Genome BC Prote Ctr, Vancouver, BC, Canada.
   [Ramesh, Venkateswaran] Newcastle Upon Tyne Fdn Hosp NHS Trust, Royal Victoria Infirm, Dept Paediat Neurol, Newcastle Upon Tyne, Tyne & Wear, England.
   [Polvikoski, Tuomo] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne, Tyne & Wear, England.
   [Whittaker, Roger G.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.
   [Chinnery, Patrick F.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England.
C3 Newcastle University - UK; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Newcastle University - UK; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); University of Victoria; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Cambridge
RP Horvath, R (corresponding author), Newcastle Univ, Inst Genet Med, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.; Kunji, ERS (corresponding author), Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge, England.
EM ek@mrc-mbu.cam.ac.uk; rita.horvath@ncl.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z, 109915/Z/15/Z]; Medical Research Council (UK) [MR/N025431/1]; European Research Council [309548]; Newton Fund (UK/Turkey) [MR/N027302/1]; European Union Seventh Framework Programme (FP7/2007-2013) [305444, 305121]; Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen; Senatsverwaltung fur Wirtschaft, Technologie und Forschung des Landes Berlin; Bundesministerium fur Bildung und Forschung; Lily Foundation; UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children - Medical Research Council; Marie-Curie Initial Training Networks grant MEET (Mitochondrial European Educational Training Project) [317433]; Medical Research Council [MC_U105663139, MC_U105674181]; Wellcome Trust Pathfinder Scheme [201064/Z/16/Z]; MRC [MR/N025431/2, MR/N025431/1, MC_U105663139, G1000848, G0800674, MR/N010035/1, MC_U105674181, MC_UU_00015/1] Funding Source: UKRI; Newton Fund [MR/N027302/1, MR/N027302/2] Funding Source: UKRI
CR Abrams AJ, 2015, NAT GENET, V47, P926, DOI 10.1038/ng.3354
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   BANOS G, 1978, J PHYSIOL-LONDON, V280, P471, DOI 10.1113/jphysiol.1978.sp012395
   Bansagi B, 2017, NEUROLOGY, V88, P1226, DOI 10.1212/WNL.0000000000003772
   Barker JE, 1996, DEV NEUROSCI-BASEL, V18, P391, DOI 10.1159/000111432
   Bartsakoulia Marina, 2016, J NEUROMUSCUL DIS, V3, P363
   Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Boy N, 2013, J INHERIT METAB DIS, V36, P525, DOI 10.1007/s10545-012-9517-7
   Braidy N, 2009, NEUROTOX RES, V16, P77, DOI 10.1007/s12640-009-9051-z
   Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3
   Cappello AR, 2007, J MOL BIOL, V369, P400, DOI 10.1016/j.jmb.2007.03.048
   Chen YQ, 2011, J NEUROCHEM, V118, P816, DOI 10.1111/j.1471-4159.2010.07159.x
   DANCIS J, 1986, AM J HUM GENET, V38, P707
   Danhauser K, 2012, AM J HUM GENET, V91, P1082, DOI 10.1016/j.ajhg.2012.10.006
   Fiermonte G, 2001, J BIOL CHEM, V276, P8225, DOI 10.1074/jbc.M009607200
   GOVAERTS L, 1982, EUR J PEDIATR, V139, P125, DOI 10.1007/BF00441495
   Han J, 2013, ELECTROPHORESIS, V34, P2891, DOI 10.1002/elps.201200601
   Houten SM, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-57
   KELLEY RI, 1984, AM J MED GENET, V19, P791, DOI 10.1002/ajmg.1320190420
   King MS, 2016, BBA-BIOENERGETICS, V1857, P14, DOI 10.1016/j.bbabio.2015.09.013
   King MS, 2015, METHOD ENZYMOL, V556, P77, DOI 10.1016/bs.mie.2014.12.009
   Lugo-Huitrón R, 2013, OXID MED CELL LONGEV, V2013, P0, DOI 10.1155/2013/104024
   MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127
   Mayr JA, 2011, NEUROMUSCULAR DISORD, V21, P803, DOI 10.1016/j.nmd.2011.06.005
   Meyertholen K, 2012, MOL SYNDROMOL, V3, P25, DOI 10.1159/000339177
   Monné M, 2005, PROTEIN SCI, V14, P3048, DOI 10.1110/ps.051689905
   Oláhová M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5
   Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056
   Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92
   Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006
   Shamseldin HE, 2016, HUM GENET, V135, P21, DOI 10.1007/s00439-015-1608-8
   Smith AC, 2017, BMC SYST BIOL, V11, P0, DOI 10.1186/s12918-017-0500-7
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Tondo M, 2013, MOL GENET METAB, V110, P231, DOI 10.1016/j.ymgme.2013.06.021
   TRANCHANT C, 1993, NEUROLOGY, V43, P2044, DOI 10.1212/WNL.43.10.2044
   Vamos E, 2009, J NEUROL SCI, V283, P21, DOI 10.1016/j.jns.2009.02.326
   Wibom R, 2009, NEW ENGL J MED, V361, P489, DOI 10.1056/NEJMoa0900591
   Xu WY, 2012, AM J HUM GENET, V91, P1088, DOI 10.1016/j.ajhg.2012.09.018
   Xu WY, 2013, FEBS LETT, V587, P3587, DOI 10.1016/j.febslet.2013.08.047
NR 41
TC 34
Z9 35
U1 1
U2 11
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1098-3600
EI 1530-0366
J9 GENET MED
JI Genet. Med.
PD OCT 15
PY 2018
VL 20
IS 10
BP 1224
EP 1235
DI 10.1038/gim.2017.251
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA GY6AF
UT WOS:000448665700016
PM 29517768
DA 2024-11-01
ER

PT J
AU Bartsakoulia, M
   Pyle, A
   Troncoso-Chandía, D
   Vial-Brizzi, J
   Paz-Fiblas, MV
   Duff, J
   Griffin, H
   Boczonadi, V
   Lochmüller, H
   Kleinle, S
   Chinnery, PF
   Grünert, S
   Kirschner, J
   Eisner, V
   Horvath, R
AF Bartsakoulia, Marina
   Pyle, Angela
   Troncoso-Chandia, Diego
   Vial-Brizzi, Josefa
   Paz-Fiblas, Marysol V.
   Duff, Jennifer
   Griffin, Helen
   Boczonadi, Veronika
   Lochmueller, Hanns
   Kleinle, Stephanie
   Chinnery, Patrick F.
   Gruenert, Sarah
   Kirschner, Janbernd
   Eisner, Veronica
   Horvath, Rita
TI A novel mechanism causing imbalance of mitochondrial fusion and fission in human myopathies
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID dominant optic atrophy; skeletal-muscle; functional-analysis; drp1 recruitment; mammalian-cells; opa1 mutations; protein drp1; dynamics; mid51; disease
AB Mitochondrial dynamics play an important role in cellular homeostasis and a variety of human diseases are linked to its dysregulated function. Here, we describe a 15-year-old boy with a novel disease caused by altered mitochondrial dynamics. The patient was the second child of consanguineous Jewish parents. He developed progressive muscle weakness and exercise intolerance at 6 years of age. His muscle biopsy revealed mitochondrial myopathy with numerous ragged red and cytochrome c oxidase (COX) negative fibers and combined respiratory chain complex I and IV deficiency. MtDNA copy number was elevated and no deletions of the mtDNA were detected in muscle DNA. Whole exome sequencing identified a homozygous nonsense mutation (p.Q92*) in the MIEF2 gene encoding the mitochondrial dynamics protein of 49 kDa (MID49). Immunoblotting revealed increased levels of proteins promoting mitochondrial fusion (MFN2, OPA1) and decreased levels of the fission protein DRP1. Fibroblasts of the patient showed elongated mitochondria, and significantly higher frequency of fusion events, mtDNA abundance and aberrant mitochondrial cristae ultrastructure, compared with controls. Thus, our data suggest that mutations in MIEF2 result in imbalanced mitochondrial dynamics and a combined respiratory chain enzyme defect in skeletal muscle, leading to mitochondrial myopathy.
C1 [Bartsakoulia, Marina; Pyle, Angela; Duff, Jennifer; Griffin, Helen; Boczonadi, Veronika; Lochmueller, Hanns; Horvath, Rita] Newcastle Univ, Inst Genet Med, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Troncoso-Chandia, Diego; Vial-Brizzi, Josefa; Paz-Fiblas, Marysol V.; Eisner, Veronica] Pontificia Univ Catolica Chile, Sch Biol Sci, Dept Cellular & Mol Biol, Santiago 8330025, Chile.
   [Kleinle, Stephanie] Med Genet Ctr, Munich, Germany.
   [Chinnery, Patrick F.] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge CB2 0QQ, England.
   [Chinnery, Patrick F.] Univ Cambridge, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge CB2 0QQ, England.
   [Gruenert, Sarah] Univ Freiburg, Fac Med, Med Ctr, Dept Gen Pediat Adolescent Med & Neonatol, Freiburg, Germany.
   [Kirschner, Janbernd] Univ Freiburg, Fac Med, Med Ctr, Dept Neuropediat & Muscle Disorders, Freiburg, Germany.
C3 Newcastle University - UK; Pontificia Universidad Catolica de Chile; University of Cambridge; University of Cambridge; University of Freiburg; University of Freiburg
RP Eisner, V (corresponding author), Pontificia Univ Catolica Chile, Sch Biol Sci, Dept Cellular & Mol Biol, Santiago 8330025, Chile.; Horvath, R (corresponding author), Newcastle Univ, Inst Med Genet, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
EM veisner@bio.puc.cl; rita.horvath@ncl.ac.uk
FU Wellcome Trust [109915/Z/15/Z, 101876/Z/13/Z]; Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (UK) [MR/N025431/1]; European Research Council [309548]; Wellcome Trust Pathfinder Scheme [201064/Z/16/Z]; Newton Fund (UK/Turkey) [MR/N027302/1]; European Union Seventh Framework Programme [305444 RD-Connect, 305121 Neuromics]; Wellcome Trust; Medical Research Council Mitochondrial Biology Unit [MC_UP_1501/2]; UK NIHR; EU TIRCON; National Institute for Health Research (NIHR) Biomedical Research Centre based at Cambridge University Hospitals NHS Foundation Trust; University of Cambridge; Medical Research Council (UK) Centre for Translational Muscle Disease [G0601943]; FONDECYT [1150677]; MRC [G1000848, G0601943, MR/N025431/1, MR/N025431/2] Funding Source: UKRI; Newton Fund [MR/N027302/1, MR/N027302/2] Funding Source: UKRI
CR Calvo J, 2009, ARCH NEUROL-CHICAGO, V66, P1511, DOI 10.1001/archneurol.2009.284
   Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200
   Csordás G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029
   Duchen MR, 2010, ESSAYS BIOCHEM, V47, P115, DOI 10.1042/bse0470115
   Eisner V, 2017, P NATL ACAD SCI USA, V114, PE859, DOI 10.1073/pnas.1617288114
   Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066
   Eisner V, 2013, J CELL SCI, V126, P2965, DOI 10.1242/jcs.093609
   Fahrner JA, 2016, AM J MED GENET A, V170, P2002, DOI 10.1002/ajmg.a.37721
   Gerber S, 2017, BRAIN, V140, P2586, DOI 10.1093/brain/awx219
   Gilkerson RW, 2003, FEBS LETT, V546, P355, DOI 10.1016/S0014-5793(03)00633-1
   Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200
   Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078
   Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001
   Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Koch J, 2016, J MED GENET, V53, P270, DOI 10.1136/jmedgenet-2015-103500
   Liu T, 2013, EXP CELL RES, V319, P2893, DOI 10.1016/j.yexcr.2013.07.010
   Lodi R, 2011, ARCH NEUROL-CHICAGO, V68, P67, DOI 10.1001/archneurol.2010.228
   Losón OC, 2015, PROTEIN SCI, V24, P386, DOI 10.1002/pro.2629
   Losón OC, 2014, STRUCTURE, V22, P367, DOI 10.1016/j.str.2014.01.001
   Losón OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721
   Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Nasca A, 2016, HUM MUTAT, V37, P898, DOI 10.1002/humu.23033
   Osellame LD, 2016, J CELL SCI, V129, P2170, DOI 10.1242/jcs.185165
   Otera H, 2016, J CELL BIOL, V212, P531, DOI 10.1083/jcb.201508099
   Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152
   Palmer CS, 2013, J BIOL CHEM, V288, P27584, DOI 10.1074/jbc.M113.479873
   Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54
   Pyle A, 2015, BRAIN, V138, P276, DOI 10.1093/brain/awu348
   Richter V, 2014, J CELL BIOL, V204, P477, DOI 10.1083/jcb.201311014
   Shamseldin HE, 2012, J MED GENET, V49, P234, DOI 10.1136/jmedgenet-2012-100836
   Sitarz KS, 2012, BRAIN, V135, P0, DOI 10.1093/brain/aws049
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   Vanstone JR, 2016, EUR J HUM GENET, V24, P1084, DOI 10.1038/ejhg.2015.243
   Vital A, 2012, J NEUROPATH EXP NEUR, V71, P1036, DOI 10.1097/NEN.0b013e3182764d47
   Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 41
TC 50
Z9 55
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD APR 1
PY 2018
VL 27
IS 7
BP 1186
EP 1195
DI 10.1093/hmg/ddy033
PG 10
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA GB4CZ
UT WOS:000429009400006
PM 29361167
DA 2024-11-01
ER

PT J
AU Godschalk, R
   Remels, A
   Hoogendoorn, C
   van Benthem, J
   Luijten, M
   Duale, N
   Brunborg, G
   Olsen, AK
   Bouwman, FG
   Munnia, A
   Peluso, M
   Mariman, E
   van Schooten, FJ
AF Godschalk, Roger
   Remels, Alex
   Hoogendoorn, Camiel
   van Benthem, Jan
   Luijten, Mirjam
   Duale, Nur
   Brunborg, Gunnar
   Olsen, Ann-Karin
   Bouwman, Freek G.
   Munnia, Armelle
   Peluso, Marco
   Mariman, Edwin
   van Schooten, Frederik Jan
TI Paternal Exposure to Environmental Chemical Stress Affects Male Offspring's Hepatic Mitochondria
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE paternal exposure; offspring; mitochondria; oxidative stress; DNA damage
ID obstructive pulmonary-disease; adaptive response hypothesis; oxidative stress; gene-expression; dna-damage; germ-cells; mouse; inheritance; muscle; blood
AB Preconceptional paternal exposures may affect offspring's health, which cannot be explained by mutations in germ cells, but by persistent changes in the regulation of gene expression. Therefore, we investigated whether pre-conceptional paternal exposure to benzo[a] pyrene (B[a]P) could alter the offspring's phenotype. Male C57BL/6 mice were exposed to B[a] P by gavage for 6 weeks, 3 x per week, and were crossed with unexposed BALB-c females 6 weeks after the final exposure. The offspring was kept under normal feeding conditions and was sacrificed at 3 weeks of age. Analysis of the liver proteome by 2D-gel electrophoresis and mass spectrometry indicated that proteins involved in mitochondrial function were significantly downregulated in the offspring of exposed fathers. This down-regulation of mitochondrial proteins was paralleled by a reduction in mitochondrial DNA copy number and reduced activity of citrate synthase and b-hydroxyacyl-CoA dehydrogenase, but in male offspring only. Surprisingly, analysis of hepatic mRNA expression revealed a male-specific up-regulation of the genes, whose proteins were downregulated, including Aldh2 and Ogg1. This discrepancy could be related to several selected microRNA (miRNA)'s that regulate the translation of these proteins; miRNA-122, miRNA-129-2-5p, and miRNA-1941 were upregulated in a gender-specific manner. Since mitochondria are thought to be a source of intracellular reactive oxygen species, we additionally assessed oxidatively-induced DNA damage. Both 8-hydroxy-deoxyguanosine and malondialdehyde-dG adduct levels were significantly reduced in male offspring of exposed fathers. In conclusion, we show that paternal exposure to B[a]P can regulate mitochondrial metabolism in offspring, which may have profound implications for our understanding of health and disease risk inherited from fathers.
C1 [Godschalk, Roger; Remels, Alex; Hoogendoorn, Camiel; van Schooten, Frederik Jan] Maastricht Univ, Dept Pharmacol & Toxicol, NUTRIM, Sch Nutr & Translat Res Metab, Univ Singel 50,POB 616, NL-6200 MD Maastricht, Netherlands.
   [van Benthem, Jan; Luijten, Mirjam] Natl Inst Publ Hlth & Environm RIVM, Lab Hlth Protect, Bilthoven, Netherlands.
   [Duale, Nur; Brunborg, Gunnar; Olsen, Ann-Karin] Norwegian Inst Publ Hlth, Dept Mol Biol, Oslo, Norway.
   [Bouwman, Freek G.; Mariman, Edwin] Maastricht Univ, Sch Nutr & Translat Res Metab, Dept Human Biol, NUTRIM, Maastricht, Netherlands.
   [Munnia, Armelle; Peluso, Marco] ISPO Canc Prevent & Res Inst, Canc Risk Factor Branch, Canc Prevent Lab, Florence, Italy.
C3 Maastricht University; Netherlands National Institute for Public Health & the Environment; Norwegian Institute of Public Health (NIPH); Maastricht University; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica
RP Godschalk, R (corresponding author), Maastricht Univ, Dept Pharmacol & Toxicol, NUTRIM, Sch Nutr & Translat Res Metab, Univ Singel 50,POB 616, NL-6200 MD Maastricht, Netherlands.
EM r.godschalk@maastrichtuniversity.nl
CR Aarem Jeanette, 2016, BMC RES NOTES, V9, P430, DOI 10.1186/s13104-016-2224-y
   Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190
   Bateson P, 2014, J PHYSIOL-LONDON, V592, P2357, DOI 10.1113/jphysiol.2014.271460
   Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008
   Brevik A, 2012, TOXICOL SCI, V129, P157, DOI 10.1093/toxsci/kfs187
   Chaby LE, 2016, PHYSIOL BEHAV, V164, P164, DOI 10.1016/j.physbeh.2016.05.032
   Collins A, 2002, CARCINOGENESIS, V23, P2129, DOI 10.1093/carcin/23.12.2129
   de Roos B, 2008, J PROTEOME RES, V7, P2280, DOI 10.1021/pr700714x
   Delic D, 2010, STEROIDS, V75, P998, DOI 10.1016/j.steroids.2010.06.010
   Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485
   Filkowski JN, 2010, CARCINOGENESIS, V31, P1110, DOI 10.1093/carcin/bgp300
   Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695
   Godschalk RWL, 2015, TOXICOL RES-UK, V4, P718, DOI 10.1039/c4tx00114a
   Gosker HR, 2006, AM J PHYSIOL-ENDOC M, V290, PE976, DOI 10.1152/ajpendo.00336.2005
   Gosker HR, 2002, EUR RESPIR J, V19, P617, DOI 10.1183/09031936.02.00762001
   Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061
   Halappanavar S, 2011, TOXICOLOGY, V285, P133, DOI 10.1016/j.tox.2011.04.011
   Jin JC, 2014, MOL MED REP, V9, P1376, DOI 10.3892/mmr.2014.1930
   Laubenthal J, 2012, FASEB J, V26, P3946, DOI 10.1096/fj.11-201194
   Li JQ, 2004, J CELL SCI, V117, P4673, DOI 10.1242/jcs.01339
   Lindeman, 2012, INT J CELL BIOL, V2012, P1
   Linschooten JO, 2011, REPROD TOXICOL, V32, P106, DOI 10.1016/j.reprotox.2011.05.004
   Linschooten JO, 2009, MUTAT RES-FUND MOL M, V667, P70, DOI 10.1016/j.mrfmmm.2008.12.014
   Maclary E, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms5209
   McPherson NO, 2014, ANN NUTR METAB, V64, P231, DOI 10.1159/000365026
   Moyes CD, 1998, J EXP BIOL, V201, P299
   Nettle D, 2015, P ROY SOC B-BIOL SCI, V282, P23, DOI 10.1098/rspb.2015.1005
   Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491
   Northstone K, 2014, EUR J HUM GENET, V22, P1382, DOI 10.1038/ejhg.2014.31
   Peluso M, 2013, MUTAGENESIS, V28, P315, DOI 10.1093/mutage/get005
   Rando OJ, 2016, CSH PERSPECT MED, V6, P0, DOI 10.1101/cshperspect.a022988
   Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1
   Sipinen V, 2010, MUTAGENESIS, V25, P417, DOI 10.1093/mutage/geq024
   Straubinger K, 2014, J ALLERGY CLIN IMMUN, V134, P1271, DOI 10.1016/j.jaci.2014.05.034
   Thundathil J, 2005, MOL REPROD DEV, V71, P405, DOI 10.1002/mrd.20260
   van Helden YGJ, 2009, CARCINOGENESIS, V30, P2070, DOI 10.1093/carcin/bgp186
   Vanhees K, 2014, CELL MOL LIFE SCI, V71, P271, DOI 10.1007/s00018-013-1427-9
   Verhofstad N, 2011, TOXICOL SCI, V119, P218, DOI 10.1093/toxsci/kfq325
   Verhofstad N, 2010, ENVIRON MOL MUTAGEN, V51, P123, DOI 10.1002/em.20516
   Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009
   Wattez JS, 2015, AM J PHYSIOL-ENDOC M, V308, PE393, DOI 10.1152/ajpendo.00452.2014
   Wells JCK, 2012, INT J EPIDEMIOL, V41, P229, DOI 10.1093/ije/dyr239
   WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390
NR 45
TC 18
Z9 19
U1 0
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD MAR 15
PY 2018
VL 162
IS 1
BP 241
EP 250
DI 10.1093/toxsci/kfx246
PG 10
WC Toxicology
SC Toxicology
GA FY7DD
UT WOS:000427020900024
PM 29145655
DA 2024-11-01
ER

PT J
AU Simard, ML
   Mourier, A
   Greaves, LC
   Taylor, RW
   Stewart, JB
AF Simard, Marie-Lune
   Mourier, Arnaud
   Greaves, Laura C.
   Taylor, Robert W.
   Stewart, James B.
TI A novel histochemistry assay to assess and quantify focal cytochrome <i>c</i> oxidase deficiency
SO JOURNAL OF PATHOLOGY
LA English
DT Article
DE mitochondrial diseases; COX deficiency; cytochrome c oxidase; enzyme histochemistry; nitrotetrazolium blue chloride
ID mitochondrial-dna mutations; phenazine methosulfate; succinic dehydrogenase; dysfunction; knockout; defects; disease; muscle; heart; surf1
AB Defects in the respiratory chain, interfering with energy production in the cell, are major underlying causes of mitochondrial diseases. In spite of this, the surprising variety of clinical symptoms, disparity between ages of onset, as well as the involvement of mitochondrial impairment in ageing and age-related diseases continue to challenge our understanding of the pathogenic processes. This complexity can be in part attributed to the unique metabolic needs of organs or of various cell types. In this view, it remains essential to investigate mitochondrial dysfunction at the cellular level. For this purpose, we developed a novel enzyme histochemical method that enables precise quantification in fresh-frozen tissues using competing redox reactions which ultimately lead to the reduction of tetrazolium salts and formazan deposition in cytochrome c oxidase-deficient mitochondria. We demonstrate that the loss of oxidative activity is detected at very low levels-this achievement is unequalled by previous techniques and opens up new opportunities for the study of early disease processes or comparative investigations. Moreover, human biopsy samples of mitochondrial disease patients of diverse genotypic origins were used and the successful detection of COX-deficient cells suggests a broad application for this new method. Lastly, the assay can be adapted to a wide range of tissues in the mouse and extends to other animal models, which we show here with the fruit fly, Drosophila melanogaster. Overall, the new assay provides the means to quantify and map, on a cell-by-cell basis, the full extent of COX deficiency in tissues, thereby expending new possibilities for future investigation. (C) 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
C1 [Simard, Marie-Lune; Mourier, Arnaud; Stewart, James B.] Max Planck Inst Biol Ageing, Joseph Stelzmann Str 9b, D-50931 Cologne, Germany.
   [Mourier, Arnaud] Univ Bordeaux, CNRS, Inst Biochim & Genet Cellulaires, UMR5095, Bordeaux, France.
   [Greaves, Laura C.] Newcastle Univ, Newcastle Univ LLHW Ctr Ageing & Vital, Newcastle Upon Tyne, Tyne & Wear, England.
   [Greaves, Laura C.; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Taylor, Robert W.] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Bordeaux; Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust
RP Stewart, JB (corresponding author), Max Planck Inst Biol Ageing, Joseph Stelzmann Str 9b, D-50931 Cologne, Germany.
EM jstewart@age.mpg.de
FU Max Planck Society; Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Newcastle University Centre for Ageing and Vitality [Biotechnology and Biological Sciences Research Council], UK; Newcastle University Centre for Ageing and Vitality [Engineering and Physical Sciences Research Council], UK; Newcastle University Centre for Ageing and Vitality [Economic and Social Research Council], UK; Newcastle University Centre for Ageing and Vitality [Medical Research Council], UK [G0700718]; Medical Research Council (MRC) Centre for Translational Research in Neuromuscular Disease, Mitochondrial Disease Patient Cohort (UK) [G0800674]; Lily Foundation; UK NIHR Biomedical Research Centre for Ageing and an age-related disease; MRC/EPSRC Molecular Pathology Node; UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children; MRC [G0800674, G0700718] Funding Source: UKRI
CR Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Altman F P, 1976, PROG HISTOCHEM CYTOCHEM, V9, P1
   Baggio F, 2014, NUCLEIC ACIDS RES, V42, P13920, DOI 10.1093/nar/gku1132
   Baines HL, 2014, AGING CELL, V13, P201, DOI 10.1111/acel.12199
   Bertoni-Freddari C, 2004, ANN NY ACAD SCI, V1019, P33, DOI 10.1196/annals.1297.007
   Boveris A, 2008, IUBMB LIFE, V60, P308, DOI 10.1002/iub.46
   Bratic A, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9808
   BRODY IA, 1964, J HISTOCHEM CYTOCHEM, V12, P928, DOI 10.1177/12.12.928
   Chandel NS, 1996, J BIOL CHEM, V271, P18672, DOI 10.1074/jbc.271.31.18672
   DellAgnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477
   FARBER E, 1956, J HISTOCHEM CYTOCHEM, V4, P357, DOI 10.1177/4.4.357
   GONZALEZLIMA F, 1994, BRAIN RES, V660, P34, DOI 10.1016/0006-8993(94)90836-2
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grünewald A, 2014, J NEUROSCI METH, V232, P143, DOI 10.1016/j.jneumeth.2014.05.026
   HEVNER RF, 1989, J NEUROSCI, V9, P3884
   HUANG LK, 1995, PATTERN RECOGN, V28, P41, DOI 10.1016/0031-3203(94)E0043-K
   Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   KEARNEY EB, 1956, J BIOL CHEM, V219, P963
   LOW H, 1964, BIOCHEM BIOPH RES CO, V14, P347, DOI 10.1016/S0006-291X(64)80008-5
   MCMILLAN PJ, 1967, J HISTOCHEM CYTOCHEM, V15, P21, DOI 10.1177/15.1.21
   Melendez-Ferro M, 2013, J NEUROSCI METH, V214, P156, DOI 10.1016/j.jneumeth.2013.01.010
   Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100
   Mourier A, 2014, HUM MOL GENET, V23, P2580, DOI 10.1093/hmg/ddt652
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MULLERHOCKER J, 1983, VIRCHOWS ARCH A, V402, P61, DOI 10.1007/BF00695049
   MullerHocker J, 1996, MECH AGEING DEV, V86, P197, DOI 10.1016/0047-6374(95)01692-9
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   NACHLAS MM, 1960, J BIOL CHEM, V235, P499
   NACHLAS MM, 1957, J HISTOCHEM CYTOCHEM, V5, P420, DOI 10.1177/5.4.420
   Nakae Y, 2001, HISTOCHEM CELL BIOL, V115, P413
   Navarro A, 2002, AM J PHYSIOL-REG I, V282, PR985, DOI 10.1152/ajpregu.00537.2001
   Navarro A, 2006, AM J PHYSIOL-CELL PH, V292, P670, DOI 10.1152/AJPCELL.00213.2006
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Ross JM, 2011, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/3266
   Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392
   Sánchez-Martínez A, 2006, BBA-BIOENERGETICS, V1757, P1190, DOI 10.1016/j.bbabio.2006.05.008
   Saneto RP, 2013, NEUROTHERAPEUTICS, V10, P199, DOI 10.1007/s13311-012-0167-0
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI 10.1038/nmeth.2019
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Swerdlow RH, 2011, BBA-MOL BASIS DIS, V1812, P1630, DOI 10.1016/j.bbadis.2011.08.012
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Turnbull DM, 2016, NEUROBIOL DIS, V92, P55, DOI 10.1016/j.nbd.2015.02.003
   WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3
   WORSFOLD M, 1977, ANAL BIOCHEM, V79, P152, DOI 10.1016/0003-2697(77)90389-X
NR 48
TC 14
Z9 14
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
EI 1096-9896
J9 J PATHOL
JI J. Pathol.
PD JUL 15
PY 2018
VL 245
IS 3
BP 311
EP 323
DI 10.1002/path.5084
PG 13
WC Oncology; Pathology
SC Oncology; Pathology
GA GK0QF
UT WOS:000435815700007
PM 29660116
DA 2024-11-01
ER

PT J
AU Nido, GS
   Dölle, C
   Flones, I
   Tuppen, HA
   Alves, G
   Tysnes, OB
   Haugarvoll, K
   Tzoulis, C
AF Nido, Gonzalo S.
   Dolle, Christian
   Flones, Irene
   Tuppen, Helen A.
   Alves, Guido
   Tysnes, Ole-Bjorn
   Haugarvoll, Kristoffer
   Tzoulis, Charalampos
TI Ultradeep mapping of neuronal mitochondrial deletions in Parkinson's disease
SO NEUROBIOLOGY OF AGING
LA English
DT Article
DE Parkinson's disease; Mitochondrial DNA; Deletions; Neurodegeneration
ID dna-sequencing data; substantia-nigra; muscle-fibers; replication; mtdna; framework; cells
AB Mitochondrial DNA (mtDNA) deletions accumulate with age in postmitotic cells and are associated with aging and neurodegenerative disorders such as Parkinson's disease. Although the exact mechanisms by which deletions form remain elusive, the dominant theory is that they arise spontaneously at micro-homologous sites and undergo clonal expansion. We characterize mtDNA deletions at unprecedented resolution in individual substantia nigra neurons from individuals with Parkinson's disease, using ultradeep sequencing. We show that the number of deleted mtDNA species per neuron is substantially higher than previously reported. Moreover, each deleted mtDNA species shows significant differences in sequence composition compared with the remaining mtDNA population, which is highly consistent with independent segregation and clonal expansion. Deletion breakpoints occur consistently in regions of sequence homology, which may be direct or interrupted stretches of tandem repeats. While our results support a crucial role for misannealing in deletion generation, we find no overrepresentation of the 3'-repeat sequence, an observation that is difficult to reconcile with the current view of replication errors as the source of mtDNA deletions. (C) 2017 The Author(s). Published by Elsevier Inc.
C1 [Nido, Gonzalo S.; Dolle, Christian; Flones, Irene; Tysnes, Ole-Bjorn; Haugarvoll, Kristoffer; Tzoulis, Charalampos] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Nido, Gonzalo S.; Dolle, Christian; Flones, Irene; Tysnes, Ole-Bjorn; Haugarvoll, Kristoffer; Tzoulis, Charalampos] Univ Bergen, Dept Clin Med, Bergen, Norway.
   [Tuppen, Helen A.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Alves, Guido] Stavanger Univ Hosp, Norwegian Ctr Movement Disorders, Stavanger, Norway.
   [Alves, Guido] Stavanger Univ Hosp, Dept Neurol, Stavanger, Norway.
   [Alves, Guido] Univ Stavanger, Dept Math & Nat Sci, Stavanger, Norway.
C3 University of Bergen; Haukeland University Hospital; University of Bergen; Newcastle University - UK; Stavanger University Hospital; Stavanger University Hospital; Universitetet i Stavanger
RP Tzoulis, C (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
EM charalampos.tzoulis@nevro.uib.no
FU Regional Health Authority of Western Norway [911903, 911988]; Research Council of Norway [240369/F20]
CR Alves G, 2009, J NEUROL NEUROSUR PS, V80, P851, DOI 10.1136/jnnp.2008.168211
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   Blakely EL, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011296
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Damas J, 2014, NUCLEIC ACIDS RES, V42, PD1261, DOI 10.1093/nar/gkt982
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Markham Nicholas R, 2008, V453, V0, PP3, DOI 10.1007/978-1-60327-429-6_1
   Markham NR, 2005, NUCLEIC ACIDS RES, V33, PW577, DOI 10.1093/nar/gki591
   Martin M, 2011, EMBNET.JOURNAL, V17, P10, DOI 10.14806/ej.17.1.200
   Marzuki S, 1997, J NEUROL SCI, V145, P155, DOI 10.1016/S0022-510X(96)00241-9
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   ROBBERSODL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   VAZQUEZACEVEDO M, 1995, BBA-MOL BASIS DIS, V1271, P363, DOI 10.1016/0925-4439(95)00062-9
   Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
NR 30
TC 39
Z9 42
U1 4
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0197-4580
EI 1558-1497
J9 NEUROBIOL AGING
JI Neurobiol. Aging
PD MAR 15
PY 2018
VL 63
IS 
BP 120
EP 127
DI 10.1016/j.neurobiolaging.2017.10.024
PG 8
WC Geriatrics & Gerontology; Neurosciences
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA FX0PW
UT WOS:000425749100012
PM 29257976
DA 2024-11-01
ER

PT J
AU Skoczén, N
   Dautant, A
   Binko, K
   Godard, F
   Bouhier, M
   Su, X
   Lasserre, JP
   Giraud, MF
   Tribouillard-Tanvier, D
   Chen, HM
   di Rago, JP
   Kucharczyk, R
AF Skoczen, Natalia
   Dautant, Alain
   Binko, Krystyna
   Godard, Francois
   Bouhier, Marine
   Su, Xin
   Lasserre, Jean-Paul
   Giraud, Marie-France
   Tribouillard-Tanvier, Deborah
   Chen, Huimei
   di Rago, Jean-Paul
   Kucharczyk, Roza
TI Molecular basis of diseases caused by the mtDNA mutation m.8969G > A in I the subunit <i>a</i> of ATP synthase
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article
DE ATP synthase; Subunit a; mtDNA; MT-ATP6; Oxidative phosphorylation; Metabolic disease
ID human mitochondrial-dna; yeast model; complex-i; gene; mechanism; translocation; consequences; proteins; proteome; mutants
AB The ATP synthase which provides aerobic eukaryotes with ATP, organizes into a membrane-extrinsic catalytic domain, where ATP is generated, and a membrane-embedded F-o domain that shuttles protons across the membrane. We previously identified a mutation in the mitochondrial MT-ATP6 gene (m.8969G > A) in a 14-year-old Chinese female who developed an isolated nephropathy followed by brain and muscle problems. This mutation replaces a highly conserved serine residue into asparagine at amino acid position 148 of the membrane-embedded subunit a of ATP synthase. We showed that an equivalent of this mutation in yeast (aS(175)N) prevents Fo-mediated proton translocation. Herein we identified four first-site intragenic suppressors (aN(175)D, aN(175)K, aN(175)I, and aN(175)T), which, in light of a recently published atomic structure of yeast Fo indicates that the detrimental consequences of the original mutation result from the establishment of hydrogen bonds between aN(175) and a nearby glutamate residue (aE(172)) that was proposed to be critical for the exit of protons from the ATP synthase towards the mitochondrial matrix. Interestingly also, we found that the aS(175)N mutation can be suppressed by second-site suppressors (aP(12)S, aI(171)F, aI(171)N, aI(239)F, and aI(200)M), of which some are very distantly located (by 20-30 angstrom) from the original mutation. The possibility to compensate through long-range effects the aS(175)N mutation is an interesting observation that holds promise for the development of therapeutic molecules.
C1 [Skoczen, Natalia; Binko, Krystyna; Kucharczyk, Roza] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.
   [Skoczen, Natalia; Dautant, Alain; Binko, Krystyna; Godard, Francois; Bouhier, Marine; Lasserre, Jean-Paul; Giraud, Marie-France; Tribouillard-Tanvier, Deborah; di Rago, Jean-Paul] CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, F-33077 Bordeaux, France.
   [Dautant, Alain; Godard, Francois; Bouhier, Marine; Lasserre, Jean-Paul; Giraud, Marie-France; Tribouillard-Tanvier, Deborah; di Rago, Jean-Paul] Univ Bordeaux, IBGC, UMR 5095, F-33077 Bordeaux, France.
   [Su, Xin; Chen, Huimei] Nanjing Univ, Sch Med, Nanjing, Jiangsu, Peoples R China.
   [Su, Xin] China Pharmaceut Univ, State Key Lab Nat Med, Ctr Drug Discovery, Nanjing, Jiangsu, Peoples R China.
C3 Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Bordeaux; Nanjing University; China Pharmaceutical University
RP Kucharczyk, R (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.; di Rago, JP (corresponding author), CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, F-33077 Bordeaux, France.
EM jp.dirago@ibgc.cnrs.fr; roza@ibb.waw.pl
FU National Science Center of Poland [2016/23/B/NZ3/02098]; AFM (Association Francaise contre les Myopathies) [17122]; Agence Nationale de la Recherche [ANR-12-BSV8-024]; National Natural Science Foundation (NSF) [81370788, 8151101098]; Polonium grant [35301WC]; Ministry of Science and Higher Education of Poland; Ministere Francais de l'Enseignement Superieur et de la Recherche
CR ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0
   Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185
   Baile MG, 2013, FRONT BIOSCI-LANDMRK, V18, P241, DOI 10.2741/4098
   Bietenhader M, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1002876
   Bohovych I, 2016, FRONT CELL DEV BIOL, V4, P0, DOI 10.3389/fcell.2016.00109
   Bonnefoy N, 2001, METHOD CELL BIOL, V65, P381, DOI 10.1016/S0091-679X(01)65022-2
   Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108
   DIRAGO JP, 1990, J BIOL CHEM, V265, P3332
   EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X
   Guerin B, 1979, METHODS ENZYMOL, V55, P149
   Guo H, 2017, SCIENCE, V358, P936, DOI 10.1126/science.aao4815
   Hahn A, 2016, MOL CELL, V63, P445, DOI 10.1016/j.molcel.2016.05.037
   Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8
   Kabala AM, 2014, BIOCHIMIE, V100, P200, DOI 10.1016/j.biochi.2013.11.024
   Kucharczyk R, 2013, INT J BIOCHEM CELL B, V45, P130, DOI 10.1016/j.biocel.2012.07.001
   Kucharczyk R, 2010, BBA-BIOENERGETICS, V1797, P1105, DOI 10.1016/j.bbabio.2009.12.022
   Kucharczyk R, 2009, HUM MOL GENET, V18, P2889, DOI 10.1093/hmg/ddp226
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P817, DOI 10.1016/j.bbamcr.2009.02.011
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012
   Lasserre JP, 2015, DIS MODEL MECH, V8, P509, DOI 10.1242/dmm.020438
   Liu SD, 2015, BIOCHEM J, V468, P167, DOI 10.1042/BJ20150197
   MICHON T, 1988, EUR J BIOCHEM, V172, P621, DOI 10.1111/j.1432-1033.1988.tb13934.x
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Mitome N, 2010, BIOCHEM J, V430, P171, DOI 10.1042/BJ20100621
   Morales-Rios E, 2015, P NATL ACAD SCI USA, V112, P13231, DOI 10.1073/pnas.1517542112
   Morales-Rios E, 2015, OPEN BIOL, V5, P0, DOI 10.1098/rsob.150119
   Niedzwiecka K, 2016, MITOCHONDRION, V29, P7, DOI 10.1016/j.mito.2016.04.003
   Okamoto K, 1998, J CELL BIOL, V142, P613, DOI 10.1083/jcb.142.3.613
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pogoryelov D, 2010, NAT CHEM BIOL, V6, P891, DOI 10.1038/NCHEMBIO.457
   Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160
   Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200
   Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200
   Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f
   Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593
   RIGOULET M, 1979, FEBS LETT, V102, P18, DOI 10.1016/0014-5793(79)80919-9
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Sobti M, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.21598
   Srivastava AP, 2018, SCIENCE, V360, P0, DOI 10.1126/science.aas9699
   Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253
   Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929
   Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35
   van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9
   Venard R, 2003, BIOCHEMISTRY-US, V42, P7626, DOI 10.1021/bi034394t
   VIK SB, 1988, J BIOL CHEM, V263, P6599
   VIK SB, 1994, J BIOL CHEM, V269, P30364
   Wen SZ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep36313
   Zhou AN, 2015, ELIFE, V4, P0, DOI 10.7554/eLife.10180
NR 50
TC 17
Z9 17
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 1879-2650
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD AUG 15
PY 2018
VL 1859
IS 8
BP 602
EP 611
DI 10.1016/j.bbabio.2018.05.009
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA GK5NI
UT WOS:000436221400005
PM 29778688
DA 2024-11-01
ER

PT J
AU Becker, C
   Kukat, A
   Szczepanowska, K
   Hermans, S
   Senft, K
   Brandscheid, CP
   Maiti, P
   Trifunovic, A
AF Becker, Christina
   Kukat, Alexandra
   Szczepanowska, Karolina
   Hermans, Steffen
   Senft, Katharina
   Brandscheid, Christoph Paul
   Maiti, Priyanka
   Trifunovic, Aleksandra
TI CLPP deficiency protects against metabolic syndrome but hinders adaptive thermogenesis
SO EMBO REPORTS
LA English
DT Article
DE CLPP deficiency; fatty acid oxidation; metabolism; thermogenesis; VLCAD
ID fatty-acid oxidation; insulin-resistance; polymerase-gamma; skeletal-muscle; mice; obesity; mtdna; dysfunction; expression; mutations
AB Mitochondria are fundamental for cellular metabolism as they are both a source and a target of nutrient intermediates originating from converging metabolic pathways, and their role in the regulation of systemic metabolism is increasingly recognized. Thus, maintenance of mitochondrial homeostasis is indispensable for a functional energy metabolism of the whole organism. Here, we report that loss of the mitochondrial matrix protease CLPP results in a lean phenotype with improved glucose homeostasis. Whole-body CLPP-deficient mice are protected from diet-induced obesity and insulin resistance, which was not present in mouse models with either liver- or muscle-specific depletion of CLPP. However, CLPP ablation also leads to a decline in brown adipocytes function leaving mice unable to cope with a cold-induced stress due to non-functional adaptive thermogenesis. These results demonstrate a critical role for CLPP in different metabolic stress conditions such as high-fat diet feeding and cold exposure providing tools to understand pathologies with deregulated Clpp expression and novel insights into therapeutic approaches against metabolic dysfunctions linked to mitochondrial diseases.
C1 [Becker, Christina; Kukat, Alexandra; Szczepanowska, Karolina; Hermans, Steffen; Senft, Katharina; Brandscheid, Christoph Paul; Maiti, Priyanka; Trifunovic, Aleksandra] Univ Cologne, Med Fac, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.
   [Becker, Christina; Kukat, Alexandra; Szczepanowska, Karolina; Hermans, Steffen; Senft, Katharina; Brandscheid, Christoph Paul; Maiti, Priyanka; Trifunovic, Aleksandra] Univ Cologne, Med Fac, Inst Mitochondrial Dis & Aging, Cologne, Germany.
   [Trifunovic, Aleksandra] Univ Cologne, Ctr Mol Med CMMC, Cologne, Germany.
C3 University of Cologne; University of Cologne; University of Cologne
RP Trifunovic, A (corresponding author), Univ Cologne, Med Fac, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.; Trifunovic, A (corresponding author), Univ Cologne, Med Fac, Inst Mitochondrial Dis & Aging, Cologne, Germany.; Trifunovic, A (corresponding author), Univ Cologne, Ctr Mol Med CMMC, Cologne, Germany.
EM aleksandra.trifunovic@uk-koeln.de
FU European Research Council [ERC-StG-2012-310700]; German Research Council (Deutsche Forschungsgemeinschaft-DFG) [TR 1018/2-1]; CECAD graduate school
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054
   Cámara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002
   Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105
   De Taeye B, 2005, CURR OPIN PHARMACOL, V5, P149, DOI 10.1016/j.coph.2005.01.007
   Diaz F, 2008, GUT, V57, P232, DOI 10.1136/gut.2006.119180
   Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Fischer F, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms2397
   Gispert S, 2013, HUM MOL GENET, V22, P4871, DOI 10.1093/hmg/ddt338
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045
   Huynh FK, 2014, METHOD ENZYMOL, V542, P391, DOI 10.1016/B978-0-12-416618-9.00020-0
   Ikeda K, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3147
   Jenkinson EM, 2013, AM J HUM GENET, V92, P605, DOI 10.1016/j.ajhg.2013.02.013
   Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667
   Laron Z, 2001, J CLIN PATHOL-MOL PA, V54, P311
   Lee J, 2015, CELL REP, V10, P266, DOI 10.1016/j.celrep.2014.12.023
   Levéen P, 2011, HEPATOLOGY, V53, P437, DOI 10.1002/hep.24031
   LYONS GE, 1991, DEVELOPMENT, V113, P1017
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Montgomery MK, 2015, ENDOCR CONNECT, V4, P0, DOI 10.1530/EC-14-0092
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047
   Quirós PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23
   Quirós PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984
   Richter-Dennerlein R, 2014, CELL METAB, V20, P158, DOI 10.1016/j.cmet.2014.04.016
   Saleem A, 2015, MITOCHONDRION, V21, P19, DOI 10.1016/j.mito.2014.12.001
   Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623
   Seiferling D, 2016, EMBO REP, V17, P953, DOI 10.15252/embr.201642077
   Shimizu I, 2015, CURR OBES REP, V4, P224, DOI 10.1007/s13679-015-0157-8
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Szczepanowska K, 2016, EMBO J, V35, P2566, DOI 10.15252/embj.201694253
   Taylor R, 2004, NEW ENGL J MED, V350, P639, DOI 10.1056/NEJMp038239
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tschöp MH, 2012, NAT METHODS, V9, P57, DOI 10.1038/NMETH.1806
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Vernochet C, 2014, FASEB J, V28, P4408, DOI 10.1096/fj.14-253971
   Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016
   Wall CE, 2015, P NATL ACAD SCI USA, V112, P8714, DOI 10.1073/pnas.1509930112
   Wanagat J, 2016, CURR OPIN GENET DEV, V38, P118, DOI 10.1016/j.gde.2016.05.007
   Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029
   Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463
   YAMADA T, 1975, J LAB CLIN MED, V86, P38
   Zhang DY, 2010, CELL METAB, V11, P402, DOI 10.1016/j.cmet.2010.03.012
NR 49
TC 39
Z9 40
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-221X
EI 1469-3178
J9 EMBO REP
JI EMBO Rep.
PD MAY 15
PY 2018
VL 19
IS 5
BP 
EP 
DI 10.15252/embr.201745126
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA GF0PS
UT WOS:000431633800007
PM 29588285
DA 2024-11-01
ER

PT J
AU Gardeitchik, T
   Mohamed, M
   Ruzzenente, B
   Karall, D
   Guerrero-Castillo, S
   Dalloyaux, D
   van den Brand, M
   van Kraaij, S
   van Asbeck, E
   Assouline, Z
   Rio, M
   de Lonlay, P
   Scholl-Buergi, S
   Wolthuis, DFGJ
   Hoischen, A
   Rodenburg, RJ
   Sperl, W
   Urban, Z
   Brandt, U
   Mayr, JA
   Wong, S
   de Brouwer, APM
   Nijtmans, L
   Munnich, A
   Rötig, A
   Wevers, RA
   Metodiev, MD
   Morava, E
AF Gardeitchik, Thatjana
   Mohamed, Miski
   Ruzzenente, Benedetta
   Karall, Daniela
   Guerrero-Castillo, Sergio
   Dalloyaux, Daisy
   van den Brand, Mariel
   van Kraaij, Sanne
   van Asbeck, Ellyze
   Assouline, Zahra
   Rio, Marlene
   de Lonlay, Pascale
   Scholl-Buergi, Sabine
   Wolthuis, David F. G. J.
   Hoischen, Alexander
   Rodenburg, Richard J.
   Sperl, Wolfgang
   Urban, Zsolt
   Brandt, Ulrich
   Mayr, Johannes A.
   Wong, Sunnie
   de Brouwer, Arjan P. M.
   Nijtmans, Leo
   Munnich, Arnold
   Rotig, Agnes
   Wevers, Ron A.
   Metodiev, Metodi D.
   Morava, Eva
TI Bi-allelic Mutations in the Mitochondrial Ribosomal Protein MRPS2 Cause Sensorineural Hearing Loss, Hypoglycemia, and Multiple OXPHOS Complex Deficiencies
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID recessive cutis laxa; subunit; rna; cardiomyopathy; aldh18a1; disease
AB Biogenesis of the mitochondrial oxidative phosphorylation system, which produces the bulk of ATP for almost all eukaryotic cells, depends on the translation of 13 mtDNA-encoded polypeptides by mitochondria-specific ribosomes in the mitochondrial matrix. These mitoribosomes are dual-origin ribonucleoprotein complexes, which contain mtDNA-encoded rRNAs and tRNAs and similar to 80 nucleus-encoded proteins. An increasing number of gene mutations that impair mitoribosomal function and result in multiple OXPHOS deficiencies are being linked to human mitochondrial diseases. Using exome sequencing in two unrelated subjects presenting with sensorineural hearing impairment, mild developmental delay, hypoglycemia, and a combined OXPHOS deficiency, we identified mutations in the gene encoding the mitochondrial ribosomal protein S2, which has not previously been implicated in disease. Characterization of subjects' fibroblasts revealed a decrease in the steady-state amounts of mutant MRPS2, and this decrease was shown by complexome profiling to prevent the assembly of the small mitoribosomal subunit. In turn, mitochondrial translation was inhibited, resulting in a combined OXPHOS deficiency detectable in subjects' muscle and liver biopsies as well as in cultured skin fibroblasts. Reintroduction of wild-type MRPS2 restored mitochondrial translation and OXPHOS assembly. The combination of lactic acidemia, hypoglycemia, and sensorineural hearing loss, especially in the presence of a combined OXPHOS deficiency, should raise suspicion for a ribosomal-subunit-related mitochondrial defect, and clinical recognition could allow for a targeted diagnostic approach. The identification of MRPS2 as an additional gene related to mitochondrial disease further expands the genetic and phenotypic spectra of OXPHOS deficiencies caused by impaired mitochondrial translation.
C1 [Gardeitchik, Thatjana; Mohamed, Miski; Guerrero-Castillo, Sergio; Dalloyaux, Daisy; van den Brand, Mariel; van Kraaij, Sanne; van Asbeck, Ellyze; Wolthuis, David F. G. J.; Brandt, Ulrich; Nijtmans, Leo] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6500 HB Nijmegen, Netherlands.
   [Gardeitchik, Thatjana; Hoischen, Alexander; de Brouwer, Arjan P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.
   [Ruzzenente, Benedetta; Munnich, Arnold; Rotig, Agnes; Metodiev, Metodi D.] Univ Paris 05, INSERM, U1163, Sorbonne Paris Cite,Inst Imagine, F-75015 Paris, France.
   [Karall, Daniela; Scholl-Buergi, Sabine; Sperl, Wolfgang] Med Univ Innsbruck, Pediat Clin, Inherited Metab Disorders, A-6020 Innsbruck, Austria.
   [Guerrero-Castillo, Sergio; van den Brand, Mariel; Rodenburg, Richard J.; Brandt, Ulrich; Nijtmans, Leo] Radboud Ctr Mitochondrial Med, Dept Pediat, Med Ctr, NL-6500 HB Nijmegen, Netherlands.
   [Guerrero-Castillo, Sergio; van Kraaij, Sanne; Rodenburg, Richard J.; Brandt, Ulrich; Wevers, Ron A.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Translat Metab Lab, NL-6500 HB Nijmegen, Netherlands.
   [Assouline, Zahra; Rio, Marlene; Munnich, Arnold] Hop Necker Enfants Malad, Dept Pediat, F-75015 Paris, France.
   [Assouline, Zahra; Rio, Marlene; Munnich, Arnold] Hop Necker Enfants Malad, Dept Neurol, F-75015 Paris, France.
   [Assouline, Zahra; Rio, Marlene; Munnich, Arnold] Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France.
   [Urban, Zsolt] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA.
   [Mayr, Johannes A.] Paracelsus Med Univ, Dept Pediat, Salzburg, Austria.
   [Wong, Sunnie] Tulane Univ, Hayward Genet Ctr, New Orleans, LA 70112 USA.
   [de Brouwer, Arjan P. M.] Donders Inst Brain Cognit & Behav, Med Ctr, NL-6500 HB Nijmegen, Netherlands.
   [Morava, Eva] Mayo Clin, Dept Clin Genom, Rochester, MN 55905 USA.
   [de Lonlay, Pascale] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Reference Ctr Inherited Metab Dis,Inst Imagine, F-75015 Paris, France.
C3 Radboud University Nijmegen; Radboud University Nijmegen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Medical University of Innsbruck; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Paracelsus Private Medical University; Tulane University; Radboud University Nijmegen; Mayo Clinic; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP
RP Metodiev, MD (corresponding author), Univ Paris 05, INSERM, U1163, Sorbonne Paris Cite,Inst Imagine, F-75015 Paris, France.; Morava, E (corresponding author), Mayo Clin, Dept Clin Genom, Rochester, MN 55905 USA.
EM metodi.metodiev@inserm.fr; emoravakozicz@tulane.edu
FU Dutch Metakids foundation; Netherlands Organisation for Scientific Research (NWO) [017.008.052]; E-Rare project GENOMIT [01GM1207]; National Institutes of Health [HL090648]; Association Francais contre les Myopathies [19876]
CR Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193
   Aseev LV, 2008, RNA, V14, P1882, DOI 10.1261/rna.1099108
   Baertling F, 2015, NEUROGENETICS, V16, P237, DOI 10.1007/s10048-015-0440-6
   Berk DR, 2012, J AM ACAD DERMATOL, V66, P0, DOI 10.1016/j.jaad.2011.01.004
   Bicknell LS, 2008, EUR J HUM GENET, V16, P1176, DOI 10.1038/ejhg.2008.91
   Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359
   Dimopoulou A, 2013, MOL GENET METAB, V110, P352, DOI 10.1016/j.ymgme.2013.08.009
   Distelmaier F, 2015, NEUROGENETICS, V16, P319, DOI 10.1007/s10048-015-0444-2
   Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562
   Gardeitchik T, 2014, EUR J HUM GENET, V22, P888, DOI 10.1038/ejhg.2013.154
   Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004
   Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895
   Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890
   Haque ME, 2008, MITOCHONDRION, V8, P254, DOI 10.1016/j.mito.2008.04.004
   Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009
   Kaminishi T, 2007, STRUCTURE, V15, P289, DOI 10.1016/j.str.2006.12.008
   Kaushal PS, 2014, P NATL ACAD SCI USA, V111, P7284, DOI 10.1073/pnas.1401657111
   Kohda M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005679
   Lake NJ, 2017, AM J HUM GENET, V101, P239, DOI 10.1016/j.ajhg.2017.07.005
   LAUGHREA M, 1978, J MOL BIOL, V122, P109, DOI 10.1016/0022-2836(78)90111-0
   Menezes MJ, 2015, HUM MOL GENET, V24, P2297, DOI 10.1093/hmg/ddu747
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Mohamed M, 2011, J INHERIT METAB DIS, V34, P907, DOI 10.1007/s10545-011-9305-9
   Morava É, 2009, EUR J HUM GENET, V17, P1099, DOI 10.1038/ejhg.2009.22
   Pearce S, 2013, MOL CELL NEUROSCI, V55, P1, DOI 10.1016/j.mcn.2012.08.013
   Reversade B, 2009, NAT GENET, V41, P1016, DOI 10.1038/ng.413
   Rorbach J, 2016, P NATL ACAD SCI USA, V113, P12198, DOI 10.1073/pnas.1609338113
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   Serre V, 2013, BBA-MOL BASIS DIS, V1832, P1304, DOI 10.1016/j.bbadis.2013.04.014
   Smits P, 2011, EUR J HUM GENET, V19, P394, DOI 10.1038/ejhg.2010.214
   Wessels HJCT, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0068340
   Wolthuis DFGJ, 2014, EUR J PAEDIATR NEURO, V18, P511, DOI 10.1016/j.ejpn.2014.01.003
NR 32
TC 56
Z9 58
U1 0
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD APR 5
PY 2018
VL 102
IS 4
BP 685
EP 695
DI 10.1016/j.ajhg.2018.02.012
PG 11
WC Genetics & Heredity
SC Genetics & Heredity
GA GB8QQ
UT WOS:000429340800014
PM 29576219
DA 2024-11-01
ER

PT J
AU Flones, IH
   Fernandez-Vizarra, E
   Lykouri, M
   Brakedal, B
   Skeie, GO
   Miletic, H
   Lilleng, PK
   Alves, G
   Tysnes, OB
   Haugarvoll, K
   Dölle, C
   Zeviani, M
   Tzoulis, C
AF Flones, Irene H.
   Fernandez-Vizarra, Erika
   Lykouri, Maria
   Brakedal, Brage
   Skeie, Geir Olve
   Miletic, Hrvoje
   Lilleng, Peer K.
   Alves, Guido
   Tysnes, Ole-Bjorn
   Haugarvoll, Kristoffer
   Dolle, Christian
   Zeviani, Massimo
   Tzoulis, Charalampos
TI Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage
SO ACTA NEUROPATHOLOGICA
LA English
DT Article
DE Mitochondria; Parkinsonism; Substantia nigra; Respiratory chain; Complex I
ID blue native electrophoresis; respiratory-chain; substantia-nigra; diagnostic-criteria; skeletal-muscle; subunits; abnormality
AB Mitochondrial complex I deficiency occurs in the substantia nigra of individuals with Parkinson's disease. It is generally believed that this phenomenon is caused by accumulating mitochondrial DNA damage in neurons and that it contributes to the process of neurodegeneration. We hypothesized that if these theories are correct, complex I deficiency should extend beyond the substantia nigra to other affected brain regions in Parkinson's disease and correlate tightly with neuronal mitochondrial DNA damage. To test our hypothesis, we employed a combination of semiquantitative immunohistochemical analyses, Western blot and activity measurements, to assess complex I quantity and function in multiple brain regions from an extensively characterized population-based cohort of idiopathic Parkinson's disease (n = 18) and gender and age matched healthy controls (n = 11). Mitochondrial DNA was assessed in single neurons from the same areas by real-time PCR. Immunohistochemistry showed that neuronal complex I deficiency occurs throughout the Parkinson's disease brain, including areas spared by the neurodegenerative process such as the cerebellum. Activity measurements in brain homogenate confirmed a moderate decrease of complex I function, whereas Western blot was less sensitive, detecting only a mild reduction, which did not reach statistical significance at the group level. With the exception of the substantia nigra, neuronal complex I loss showed no correlation with the load of somatic mitochondrial DNA damage. Interestingly, alpha-synuclein aggregation was less common in complex I deficient neurons in the substantia nigra. We show that neuronal complex I deficiency is a widespread phenomenon in the Parkinson's disease brain which, contrary to mainstream theory, does not follow the anatomical distribution of neurodegeneration and is not associated with the neuronal load of mitochondrial DNA mutation. Our findings suggest that complex I deficiency in Parkinson's disease can occur independently of mitochondrial DNA damage and may not have a pathogenic role in the neurodegenerative process.
C1 [Flones, Irene H.; Lykouri, Maria; Brakedal, Brage; Skeie, Geir Olve; Tysnes, Ole-Bjorn; Haugarvoll, Kristoffer; Dolle, Christian; Tzoulis, Charalampos] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Flones, Irene H.; Lykouri, Maria; Brakedal, Brage; Skeie, Geir Olve; Tysnes, Ole-Bjorn; Haugarvoll, Kristoffer; Dolle, Christian; Tzoulis, Charalampos] Univ Bergen, Dept Clin Med, Pb 7804, N-5020 Bergen, Norway.
   [Fernandez-Vizarra, Erika; Zeviani, Massimo] Univ Cambridge, MRC Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 OXY, England.
   [Miletic, Hrvoje; Lilleng, Peer K.] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway.
   [Miletic, Hrvoje] Univ Bergen, Dept Biomed, Pb 7804, N-5020 Bergen, Norway.
   [Lilleng, Peer K.] Haukeland Hosp, Dept Clin Med, Gade Lab Pathol, N-5021 Bergen, Norway.
   [Lilleng, Peer K.] Univ Bergen, N-5021 Bergen, Norway.
   [Alves, Guido] Stavanger Univ Hosp, Norwegian Ctr Movement Disorders, Pb 8100, N-4068 Stavanger, Norway.
   [Alves, Guido] Stavanger Univ Hosp, Dept Neurol, Pb 8100, N-4068 Stavanger, Norway.
   [Alves, Guido] Univ Stavanger, Dept Math & Nat Sci, N-4062 Stavanger, Norway.
C3 University of Bergen; Haukeland University Hospital; University of Bergen; University of Cambridge; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Stavanger University Hospital; Stavanger University Hospital; Universitetet i Stavanger
RP Tzoulis, C (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.; Tzoulis, C (corresponding author), Univ Bergen, Dept Clin Med, Pb 7804, N-5020 Bergen, Norway.
EM charalampos.tzoulis@nevro.uib.no
FU Regional Health Authority of Western Norway [911903, 911988]; Research Council of Norway [240369/F20]; MRC [MC_UU_00015/5, MC_UU_00015/8, MC_UP_1002/1] Funding Source: UKRI
CR Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x
   Alves G, 2009, J NEUROL NEUROSUR PS, V80, P851, DOI 10.1136/jnnp.2008.168211
   BARROSO N, 1993, CLIN CHEM, V39, P667
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   Coxhead J, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.036
   Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437
   Davis CW, 2010, FREE RADICAL BIO MED, V48, P306, DOI 10.1016/j.freeradbiomed.2009.11.001
   de Rijk MC, 2000, NEUROLOGY, V54, P0
   Dickson DW, 2012, CSH PERSPECT MED, V2, P0, DOI 10.1101/cshperspect.a009258
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Gatt AP, 2016, MOVEMENT DISORD, V31, P352, DOI 10.1002/mds.26513
   Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   HATTORI N, 1991, ANN NEUROL, V30, P563, DOI 10.1002/ana.410300409
   JANETZKY B, 1994, NEUROSCI LETT, V169, P126, DOI 10.1016/0304-3940(94)90372-7
   Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kovács GG, 2007, J NEUROPATH EXP NEUR, V66, P628, DOI 10.1097/nen.0b013e318093ecc7
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   MANN VM, 1994, ANN NEUROL, V36, P876, DOI 10.1002/ana.410360612
   MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841
   Pryde KR, 2016, CELL REP, V17, P2522, DOI 10.1016/j.celrep.2016.11.027
   RAMSAY RR, 1986, BIOCHEM BIOPH RES CO, V134, P743, DOI 10.1016/S0006-291X(86)80483-1
   Reeve AK, 2012, ARCH NEUROL-CHICAGO, V69, P385, DOI 10.1001/archneurol.2011.2675
   Schagger H, 1996, METHODS ENZYMOL, V264, P555, DOI 10.1016/S0076-6879(96)64048-8
   SCHAGGER H, 1995, ELECTROPHORESIS, V16, P763, DOI 10.1002/elps.11501601125
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI 10.1038/nmeth.2019
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754
   Talasila KM, 2017, NEURO-ONCOLOGY, V19, P383, DOI 10.1093/neuonc/now175
   Tzoulis C, 2014, ANN NEUROL, V76, P66, DOI 10.1002/ana.24185
   van der Loos CM, 2008, J HISTOCHEM CYTOCHEM, V56, P313, DOI 10.1369/jhc.2007.950170
   WARD CD, 1990, ADV NEUROL, V53, P245
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696
   Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095
NR 46
TC 78
Z9 81
U1 1
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0001-6322
EI 1432-0533
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PD MAR 15
PY 2018
VL 135
IS 3
BP 409
EP 425
DI 10.1007/s00401-017-1794-7
PG 17
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA FX4OM
UT WOS:000426057700006
PM 29270838
DA 2024-11-01
ER

PT J
AU Sokol, AM
   Uszczynska-Ratajczak, B
   Collins, MM
   Bazala, M
   Topf, U
   Lundegaard, PR
   Sugunan, S
   Guenther, S
   Kuenne, C
   Graumann, J
   Chan, SSL
   Stainier, DYR
   Chacinska, A
AF Sokol, Anna M.
   Uszczynska-Ratajczak, Barbara
   Collins, Michelle M.
   Bazala, Michal
   Topf, Ulrike
   Lundegaard, Pia R.
   Sugunan, Sreedevi
   Guenther, Stefan
   Kuenne, Carsten
   Graumann, Johannes
   Chan, Sherine S. L.
   Stainier, Didier Y. R.
   Chacinska, Agnieszka
TI Loss of the Mia40a oxidoreductase leads to hepato-pancreatic insufficiency in zebrafish
SO PLOS GENETICS
LA English
DT Article
ID mitochondrial intermembrane space; dna-polymerase-gamma; disulfide relay; protein import; translocation; survival; cells; gene; machinery; dysfunction
AB Development and function of tissues and organs are powered by the activity of mitochondria. In humans, inherited genetic mutations that lead to progressive mitochondrial pathology often manifest during infancy and can lead to death, reflecting the indispensable nature of mitochondrial biogenesis and function. Here, we describe a zebrafish mutant for the gene mia40a (chchd4a), the life-essential homologue of the evolutionarily conserved Mia40 oxidoreductase which drives the biogenesis of cysteine-rich mitochondrial proteins. We report that mia40a mutant animals undergo progressive cellular respiration defects and develop enlarged mitochondria in skeletal muscles before their ultimate death at the larval stage. We generated a deep transcriptomic and proteomic resource that allowed us to identify abnormalities in the development and physiology of endodermal organs, in particular the liver and pancreas. We identify the acinar cells of the exocrine pancreas to be severely affected by mutations in the MIA pathway. Our data contribute to a better understanding of the molecular, cellular and organismal effects of mitochondrial deficiency, important for the accurate diagnosis and future treatment strategies of mitochondrial diseases.
C1 [Sokol, Anna M.; Bazala, Michal; Topf, Ulrike; Sugunan, Sreedevi; Chacinska, Agnieszka] Int Inst Mol & Cell Biol, Warsaw, Poland.
   [Sokol, Anna M.; Collins, Michelle M.; Stainier, Didier Y. R.] Max Planck Inst Heart & Lung Res, Dept Dev Genet, Bad Nauheim, Germany.
   [Sokol, Anna M.; Graumann, Johannes] Max Planck Inst Heart & Lung Res, Biomol Mass Spectrometry, Bad Nauheim, Germany.
   [Uszczynska-Ratajczak, Barbara; Topf, Ulrike; Sugunan, Sreedevi; Chacinska, Agnieszka] Univ Warsaw, Ctr New Technol, Warsaw, Poland.
   [Lundegaard, Pia R.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark.
   [Guenther, Stefan; Kuenne, Carsten] Max Planck Inst Heart & Lung Res, Bioinformat & Deep Sequencing Platform, Bad Nauheim, Germany.
   [Chan, Sherine S. L.] Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Coll Pharm, Charleston, SC 29425 USA.
C3 Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Max Planck Society; Max Planck Society; University of Warsaw; University of Copenhagen; Max Planck Society; Medical University of South Carolina
RP Sokol, AM; Chacinska, A (corresponding author), Int Inst Mol & Cell Biol, Warsaw, Poland.; Sokol, AM (corresponding author), Max Planck Inst Heart & Lung Res, Dept Dev Genet, Bad Nauheim, Germany.; Sokol, AM (corresponding author), Max Planck Inst Heart & Lung Res, Biomol Mass Spectrometry, Bad Nauheim, Germany.; Chacinska, A (corresponding author), Univ Warsaw, Ctr New Technol, Warsaw, Poland.
EM anna.sokol@mpi-bn.mpg.de; a.chacinska@cent.uw.edu.pl
FU FishMed within the EU Seventh Framework Programme [316125]; Ministerial funds for science within Ideas Plus programme in 2014-2017 [000263]; National Science Centre [2016/23/P/NZ3/03730, 2015/19/B/NZ1/03444, UMO-2015/18/A/NZ1/00025]; German Centre for Cardiovascular Research (DZHK); Max Planck Society; DFG; EU; Medical University of South Carolina funds
CR Apweiler R, 2004, NUCLEIC ACIDS RES, V32, PD115, DOI 10.1093/nar/gkh131
   Artuso L, 2012, BBA-BIOENERGETICS, V1817, P1002, DOI 10.1016/j.bbabio.2012.03.019
   Baden KN, 2007, J BIOL CHEM, V282, P34839, DOI 10.1074/jbc.M703528200
   Banci L, 2011, P NATL ACAD SCI USA, V108, P4811, DOI 10.1073/pnas.1014542108
   Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553
   Biemar F, 2001, DEV BIOL, V230, P189, DOI 10.1006/dbio.2000.0103
   Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21
   Böttinger L, 2012, MOL BIOL CELL, V23, P3957, DOI 10.1091/mbc.E12-05-0358
   Boglev Y, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003279
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Catalina-Rodriguez O, 2012, ONCOTARGET, V3, P1220
   Cermak T, 2011, NUCLEIC ACIDS RES, V39, P0, DOI 10.1093/nar/gkr218
   Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389
   Chacinska A, 2008, J BIOL CHEM, V283, P29723, DOI 10.1074/jbc.M805356200
   Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005
   Chatzi A, 2016, BBA-MOL CELL RES, V1863, P1298, DOI 10.1016/j.bbamcr.2016.03.023
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Crippa BL, 2015, AM J MED GENET A, V167, P621, DOI 10.1002/ajmg.a.36939
   Curado S, 2010, DIS MODEL MECH, V3, P486, DOI 10.1242/dmm.004390
   Dabir DV, 2013, DEV CELL, V25, P81, DOI 10.1016/j.devcel.2013.03.006
   Dahlem TJ, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1002861
   de Jong-Curtain TA, 2009, GASTROENTEROLOGY, V136, P902, DOI 10.1053/j.gastro.2008.11.012
   Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, PD1100, DOI 10.1093/nar/gkw936
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Doyle EL, 2012, NUCLEIC ACIDS RES, V40, PW117, DOI 10.1093/nar/gks608
   Erdogan AJ, 2017, CELL TISSUE RES, V367, P59, DOI 10.1007/s00441-016-2481-z
   Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108
   Flinn LJ, 2013, ANN NEUROL, V74, P837, DOI 10.1002/ana.23999
   Graham L, 2007, NAT PROTOC, V2, P2439, DOI 10.1038/nprot.2007.304
   Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200
   Gut P, 2013, NAT CHEM BIOL, V9, P97, DOI 10.1038/NCHEMBIO.1136
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Hangen E, 2015, MOL CELL, V58, P1001, DOI 10.1016/j.molcel.2015.04.020
   Herrmann JM, 2012, J BIOL CHEM, V287, P4426, DOI 10.1074/jbc.R111.270678
   Jackson HE, 2013, MECH DEVELOP, V130, P447, DOI 10.1016/j.mod.2013.06.001
   Jurczyk A, 2011, GEN COMP ENDOCR, V170, P334, DOI 10.1016/j.ygcen.2010.10.010
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kawamata H, 2017, J CELL BIOL, V216, P3917, DOI 10.1083/jcb.201709172
   Kawano S, 2009, P NATL ACAD SCI USA, V106, P14403, DOI 10.1073/pnas.0901793106
   Khuchua Z, 2006, CIRC RES, V99, P201, DOI 10.1161/01.RES.0000233378.95325.ce
   Kim MJ, 2008, BIOTECHNIQUES, V45, P331, DOI 10.2144/000112909
   Kim SH, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003563
   Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018
   Korzh S, 2001, MECH DEVELOP, V103, P137, DOI 10.1016/S0925-4773(01)00330-6
   Kühl I, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.30952
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Li Y, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0030835
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Liu RZ, 2005, MOL BIOL EVOL, V22, P469, DOI 10.1093/molbev/msi030
   Longen S, 2014, DEV CELL, V28, P30, DOI 10.1016/j.devcel.2013.11.007
   Love MI, 2014, GENOME BIOL, V15, P0, DOI 10.1186/s13059-014-0550-8
   Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107
   Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619
   Mendelsohn BA, 2008, DEV DYNAM, V237, P1780, DOI 10.1002/dvdy.21581
   Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3
   Modjtahedi N, 2016, TRENDS BIOCHEM SCI, V41, P245, DOI 10.1016/j.tibs.2015.12.004
   Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Onishi H, 1998, J MED GENET, V35, P255, DOI 10.1136/jmg.35.3.255
   Padilla PA, 2001, P NATL ACAD SCI USA, V98, P7331, DOI 10.1073/pnas.131213198
   Park MK, 2001, EMBO J, V20, P1863, DOI 10.1093/emboj/20.8.1863
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Peleh V, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.16177
   Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618
   Petrungaro C, 2015, CELL METAB, V22, P721, DOI 10.1016/j.cmet.2015.08.019
   Quirós PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   Rahn JJ, 2015, NUCLEIC ACIDS RES, V43, P10338, DOI 10.1093/nar/gkv1139
   Rahn JJ, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0059218
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, P0, DOI 10.1093/nar/gkv007
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003
   Schulz C, 2015, TRENDS CELL BIOL, V25, P265, DOI 10.1016/j.tcb.2014.12.001
   Sokol AM, 2014, FEBS LETT, V588, P2484, DOI 10.1016/j.febslet.2014.05.028
   Soman S, 2017, EUR J NEUROSCI, V45, P528, DOI 10.1111/ejn.13473
   Song YQ, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0008329
   Spinazzola A, 2009, ADV EXP MED BIOL, V652, P69, DOI 10.1007/978-90-481-2813-6_6
   Stackley KD, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0025652
   Stainier DYR, 2015, DEV CELL, V32, P7, DOI 10.1016/j.devcel.2014.12.012
   Stirling C, 2010, BMC HEALTH SERV RES, V10, P0, DOI 10.1186/1472-6963-10-122
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Tarifeño-Saldivia E, 2017, BMC BIOL, V15, P0, DOI 10.1186/s12915-017-0362-x
   Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514
   Tinel H, 1999, EMBO J, V18, P4999, DOI 10.1093/emboj/18.18.4999
   Topf U, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-017-02694-8
   Vettori A, 2011, NEUROMUSCULAR DISORD, V21, P58, DOI 10.1016/j.nmd.2010.09.002
   Vizcaíno JA, 2016, NUCLEIC ACIDS RES, V44, PD447, DOI 10.1093/nar/gkv1145
   Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352
   Wrobel L, 2015, NATURE, V524, P485, DOI 10.1038/nature14951
   Wrobel L, 2013, MOL BIOL CELL, V24, P543, DOI 10.1091/mbc.E12-09-0649
   Yee NS, 2005, DEV BIOL, V284, P84, DOI 10.1016/j.ydbio.2005.04.035
   Zhang ML, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0132567
NR 94
TC 10
Z9 10
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
EI 
J9 PLOS GENET
JI PLoS Genet.
PD NOV 15
PY 2018
VL 14
IS 11
BP 
EP 
DI 10.1371/journal.pgen.1007743
PG 29
WC Genetics & Heredity
SC Genetics & Heredity
GA HD3WD
UT WOS:000452454300017
PM 30457989
DA 2024-11-01
ER

PT J
AU El-Hattab, AW
   Wang, JL
   Dai, HZ
   Almannai, M
   Staufner, C
   Alfadhel, M
   Gambello, MJ
   Prasun, P
   Raza, S
   Lyons, HJ
   Afqi, M
   Saleh, MAM
   Faqeih, EA
   Alzaidan, HI
   Alshenqiti, A
   Flore, LA
   Hertecant, J
   Sacharow, S
   Barbouth, DS
   Murayama, K
   Shah, AA
   Lin, HC
   Wong, LJC
AF El-Hattab, Ayman W.
   Wang, Julia
   Dai, Hongzheng
   Almannai, Mohammed
   Staufner, Christian
   Alfadhel, Majid
   Gambello, Michael J.
   Prasun, Pankaj
   Raza, Saleem
   Lyons, Hernando J.
   Afqi, Manal
   Saleh, Mohammed A. M.
   Faqeih, Eissa A.
   Alzaidan, Hamad I.
   Alshenqiti, Abduljabbar
   Flore, Leigh Anne
   Hertecant, Jozef
   Sacharow, Stephanie
   Barbouth, Deborah S.
   Murayama, Kei
   Shah, Amit A.
   Lin, Henry C.
   Wong, Lee-Jun C.
TI <i>MPV17</i>-related mitochondrial DNA maintenance defect: New cases and review of clinical, biochemical, and molecular aspects
SO HUMAN MUTATION
LA English
DT Review
DE mitochondrial DNA (mtDNA); MPV17; mtDNA depletion; mtDNA maintenance; multiple mtDNA deletions
ID depletion syndrome; navajo neurohepatopathy; hepatocerebral form; mpv17 mutation; liver-failure; protein; disease; gene
AB Mitochondrial DNA (mtDNA) maintenance defects are a group of diseases caused by deficiency of proteins involved in mtDNA synthesis, mitochondrial nucleotide supply, or mitochondrial dynamics. One of the mtDNA maintenance proteins is MPV17, which is a mitochondrial inner membrane protein involved in importing deoxynucleotides into the mitochondria. In 2006, pathogenic variants in MPV17 were first reported to cause infantile-onset hepatocerebral mtDNA depletion syndrome and Navajo neurohepatopathy. To date, 75 individuals with MPV17-related mtDNA maintenance defect have been reported with 39 different MPV17 pathogenic variants. In this report, we present an additional 25 affected individuals with nine novel MPV17 pathogenic variants. We summarize the clinical features of all 100 affected individuals and review the total 48 MPV17 pathogenic variants. The vast majority of affected individuals presented with an early-onset encephalohepatopathic disease characterized by hepatic and neurological manifestations, failure to thrive, lactic acidemia, and mtDNA depletion detected mainly in liver tissue. Rarely, MPV17 deficiency can cause a late-onset neuromyopathic disease characterized by myopathy and peripheral neuropathy with no or minimal liver involvement. Approximately half of the MPV17 pathogenic variants are missense. A genotype with biallelic missense variants, in particular homozygous p.R50Q, p.P98L, and p.R41Q, can carry a relatively better prognosis.
C1 [El-Hattab, Ayman W.; Hertecant, Jozef] Tawam Hosp, Pediat Dept, Div Clin Genet & Metab Disorders, Al Ain, U Arab Emirates.
   [Wang, Julia] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA.
   [Wang, Julia] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.
   [Dai, Hongzheng; Wong, Lee-Jun C.] Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza,MS225, Houston, TX 77030 USA.
   [Staufner, Christian] Univ Hosp Heidelberg, Dept Gen Pediat, Div Neuropediat & Metab Med, Heidelberg, Germany.
   [Alfadhel, Majid] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, King Abdulaziz Med City, Minist Natl Guard Hlth Affairs NGHA,Div Genet,Dep, Riyadh, Saudi Arabia.
   [Gambello, Michael J.] Emory Univ, Sch Med, Dept Human Genet, Div Med Genet, Atlanta, GA USA.
   [Prasun, Pankaj] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.
   [Raza, Saleem; Lyons, Hernando J.] St John Hosp & Med Ctr, Dept Pediat, Detroit, MI USA.
   [Raza, Saleem; Lyons, Hernando J.] Wayne State Univ, Sch Med, Detroit, MI USA.
   [Afqi, Manal; Saleh, Mohammed A. M.; Faqeih, Eissa A.] Childrens Specialist Hosp, King Fahad Med City, Sect Med Genet, Riyadh, Saudi Arabia.
   [Alzaidan, Hamad I.; Alshenqiti, Abduljabbar] King Faisal Specialist Hosp & Res Ctr, Dept Med Genet, Riyadh, Saudi Arabia.
   [Flore, Leigh Anne] Childrens Hosp Michigan, Div Genet Genom & Metab Disorders, Detroit, MI 48201 USA.
   [Flore, Leigh Anne] Wayne State Univ, Detroit, MI USA.
   [Sacharow, Stephanie] Boston Childrens Hosp, Div Genet & Genom, Boston, MA USA.
   [Barbouth, Deborah S.] Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn,Div Clin & Translat Genet, Miami, FL 33136 USA.
   [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Chiba, Japan.
   [Shah, Amit A.; Lin, Henry C.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Ruprecht Karls University Heidelberg; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Abdullah International Medical Research Center (KAIMRC); Ministry of National Guard - Health Affairs; National Guard Health Affairs - Saudi Arabia; Emory University; Icahn School of Medicine at Mount Sinai; St. John Hospital & Medical Center; Wayne State University; King Fahad Medical City; King Faisal Specialist Hospital & Research Center; Children's Hospital of Michigan; Wayne State University; Harvard University; Boston Children's Hospital; University of Miami; Chiba Children's Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia
RP Wong, LJC (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza,MS225, Houston, TX 77030 USA.
EM ljwong@bcm.edu
FU Japan Agency for Medical Research and Development (AMED) [JP17ek0109273]
CR Al Sarkhy A, 2014, ANN SAUDI MED, V34, P175, DOI 10.5144/0256-4947.2014.175
   Al-Hussaini A, 2014, J PEDIAT, V164, P553
   Al-Jasmi F, 2011, MOL GENET METAB, V104, P529, DOI 10.1016/j.ymgme.2011.09.023
   AlSaman A, 2012, SAUDI J GASTROENTERO, V18, P285, DOI 10.4103/1319-3767.98439
   Bijarnia-Mahay S, 2014, INDIAN PEDIATR, V51, P666, DOI 10.1007/s13312-014-0475-z
   Bitting CP, 2016, ACTA GASTRO-ENT BELG, V79, P463
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Choi YR, 2015, BMC NEUROL, V15, P0, DOI 10.1186/s12883-015-0430-1
   El-Hattab AW, 2012, GENEREVIEWS, V0, P0
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Iida R, 2003, J BIOL CHEM, V278, P6301, DOI 10.1074/jbc.M210886200
   Kaji S, 2009, MOL GENET METAB, V97, P292, DOI 10.1016/j.ymgme.2009.04.014
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kim J, 2016, MOL GENET METAB REP, V8, P74, DOI 10.1016/j.ymgmr.2016.06.006
   Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351
   Löllgen S, 2015, BIOL CHEM, V396, P13, DOI 10.1515/hsz-2014-0198
   McKiernan P, 2016, J PEDIATR GASTR NUTR, V63, P592, DOI 10.1097/MPG.0000000000001345
   Mendelsohn BA, 2014, JIMD REP, V13, P37, DOI 10.1007/8904_2013_267
   Merkle A N, 2012, AJNR AM J NEURORADIOL, V33, PE34, DOI 10.3174/ajnr.A2455
   Navarro-Sastre A, 2008, MOL GENET METAB, V94, P234, DOI 10.1016/j.ymgme.2008.01.012
   Nogueira C, 2012, MOL GENET METAB, V107, P764, DOI 10.1016/j.ymgme.2012.10.010
   Parikh S, 2016, MOL GENET METAB, V118, P178, DOI 10.1016/j.ymgme.2016.04.009
   Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019
   Piekutowska-Abramczuk D, 2014, CLIN GENET, V85, P573, DOI 10.1111/cge.12228
   Rosa ID, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005779
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2011, SEMIN FETAL NEONAT M, V16, P190, DOI 10.1016/j.siny.2011.04.011
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   Vilarinho S, 2014, J HEPATOL, V61, P1056, DOI 10.1016/j.jhep.2014.06.038
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
NR 35
TC 40
Z9 45
U1 1
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD APR 15
PY 2018
VL 39
IS 4
BP 461
EP 470
DI 10.1002/humu.23387
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA FY3NV
UT WOS:000426727800001
PM 29282788
DA 2024-11-01
ER

PT J
AU de Beaurepaire, I
   Grévent, D
   Rio, M
   Desguerre, I
   de Lonlay, P
   Levy, R
   Dangouloff-Ros, V
   Bonnefont, JP
   Barcia, G
   Funalot, B
   Besmond, C
   Metodiev, MD
   Ruzzenente, B
   Assouline, Z
   Munnich, A
   Rötig, A
   Boddaert, N
AF de Beaurepaire, Isaure
   Grevent, David
   Rio, Marlene
   Desguerre, Isabelle
   de Lonlay, Pascale
   Levy, Raphael
   Dangouloff-Ros, Volodia
   Bonnefont, Jean-Paul
   Barcia, Giulia
   Funalot, Benoit
   Besmond, Claude
   Metodiev, Metodi D.
   Ruzzenente, Benedetta
   Assouline, Zahra
   Munnich, Arnold
   Rotig, Agnes
   Boddaert, Nathalie
TI High predictive value of brain MRI imaging in primary mitochondrial respiratory chain deficiency
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID neuroradiologic findings; magnetic-resonance; leigh-syndrome; disorders; disease; encephalopathy; spectroscopy; diagnosis; thiamine; children
AB Background Because the mitochondrial respiratory chain (RC) is ubiquitous, its deficiency can theoretically give rise to any symptom in any organ or tissue at any age with any mode of inheritance, owing to the twofold genetic origin of respiratory enzyme machinery, that is, nuclear and mitochondrial. Not all respiratory enzyme deficiencies are primary and secondary or artefactual deficiency is frequently observed, leading to a number of misleading conclusions and inappropriate investigations in clinical practice. This study is aimed at investigating the potential role of brain MRI in distinguishing primary RC deficiency from phenocopies and other aetiologies. Methods Starting from a large series of 189 patients (median age: 3.5 years (8 days-56 years), 58% males) showing signs of RC enzyme deficiency, for whom both brain MRIs and disease-causing mutations were available, we retrospectively studied the positive predictive value (PPV) and the positive likelihood ratio (LR+) of brain MRI imaging and its ability to discriminate between two groups: primary deficiency of the mitochondrial RC machinery and phenocopies. Results Detection of (1) brainstem hyperintensity with basal ganglia involvement (P <= 0.001) and (2) lactate peak with either brainstem or basal ganglia hyperintensity was highly suggestive of primary RC deficiency (P <= 0.01). Fourteen items had a PPV>95% and LR+ was greater than 9 for seven signs. Biallelic SLC19A3 mutations represented the main differential diagnosis. Non-significant differences between the two groups were found for cortical/subcortical atrophy, leucoencephalopathy and involvement of caudate nuclei, spinothalamic tract and corpus callosum. Conclusion Based on these results and owing to invasiveness of skeletal muscle biopsies and cost of high-throughput DNA sequencing, we suggest giving consideration to brain MRI imaging as a diagnostic marker and an informative investigation to be performed in patients showing signs of RC enzyme deficiency.
C1 [de Beaurepaire, Isaure; Grevent, David; Levy, Raphael; Dangouloff-Ros, Volodia; Boddaert, Nathalie] INSERM UMR 1163, Dept Pediat Radiol, Paris, France.
   [de Beaurepaire, Isaure; Grevent, David; Rio, Marlene; Desguerre, Isabelle; de Lonlay, Pascale; Levy, Raphael; Dangouloff-Ros, Volodia; Bonnefont, Jean-Paul; Barcia, Giulia; Funalot, Benoit; Besmond, Claude; Metodiev, Metodi D.; Ruzzenente, Benedetta; Assouline, Zahra; Munnich, Arnold; Rotig, Agnes; Boddaert, Nathalie] Paris Descartes Univ, Sorbonne Paris Cite, Hop Necker Enfants Malad, INSERM U1000, Paris, France.
   [Grevent, David; Dangouloff-Ros, Volodia; Besmond, Claude; Metodiev, Metodi D.; Ruzzenente, Benedetta; Assouline, Zahra; Munnich, Arnold; Rotig, Agnes; Boddaert, Nathalie] INSERM UMR 1163, IMAGINE Inst, Paris, France.
   [Rio, Marlene; Bonnefont, Jean-Paul; Barcia, Giulia; Funalot, Benoit; Munnich, Arnold] INSERM UMR 1163, Dept Genet, Paris, France.
   [Desguerre, Isabelle; de Lonlay, Pascale] INSERM UMR 1163, Dept Neurol & Metab, Paris, France.
   [Funalot, Benoit] GHU Henri Mondor, Dept Genet, Creteil, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP
RP de Beaurepaire, I (corresponding author), Hop Necker Enfants Malad, Dept Radiopediat, Batiment Laennec, F-75015 Paris, France.
EM isaure.debeaurepaire@orange.fr
CR Alfadhel M, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-83
   Argov Z, 1998, EUR NEUROL, V39, P65, DOI 10.1159/000007912
   Baertling F, 2016, CHILD NERV SYST, V32, P2077, DOI 10.1007/s00381-016-3190-3
   Bianchi MC, 2007, BIOSCIENCE REP, V27, P69, DOI 10.1007/s10540-007-9046-z
   Bricout M, 2014, J MED GENET, V51, P429, DOI 10.1136/jmedgenet-2013-102256
   da Rocha AJ, 2008, J NEUROIMAGING, V18, P1, DOI 10.1111/j.1552-6569.2007.00205.x
   Ortigoza-Escobar JD, 2016, BRAIN, V139, P31, DOI 10.1093/brain/awv342
   Delonlay P, 2013, HAND CLINIC, V113, P1651, DOI 10.1016/B978-0-444-59565-2.00033-2
   Diogo L, 2010, PEDIATR NEUROL, V42, P196, DOI 10.1016/j.pediatrneurol.2009.09.010
   Ferreira CR, 2017, AM J MED GENET A, V173, P1502, DOI 10.1002/ajmg.a.38189
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Finsterer J, 2005, METAB BRAIN DIS, V20, P219, DOI 10.1007/s11011-005-7209-9
   Friedman SD, 2010, DEV DISABIL RES REV, V16, P129, DOI 10.1002/ddrr.103
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Kevelam SH, 2013, BRAIN, V136, P1534, DOI 10.1093/brain/awt054
   Kim J, 2008, EUR RADIOL, V18, P1741, DOI 10.1007/s00330-008-0921-1
   Lake NJ, 2017, AM J HUM GENET, V101, P239, DOI 10.1016/j.ajhg.2017.07.005
   Lebre AS, 2010, PATHOL BIOL, V58, P353, DOI 10.1016/j.patbio.2009.09.012
   Lee SK, 2010, YONSEI MED J, V51, P672, DOI 10.3349/ymj.2010.51.5.672
   Longo N, 2003, NEUROL CLIN, V21, P817, DOI 10.1016/S0733-8619(03)00015-X
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pyle A, 2015, NEUROL-GENET, V1, P0, DOI 10.1212/NXG.0000000000000006
   Rötig A, 2014, REV NEUROL-FRANCE, V170, P309, DOI 10.1016/j.neurol.2013.11.006
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   Tabarki B, 1993, GENEREVIEWS, V0, P0
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   Wong SSN, 2017, MITOCHONDRION, V32, P36, DOI 10.1016/j.mito.2016.11.008
NR 27
TC 15
Z9 15
U1 0
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD JUN 15
PY 2018
VL 55
IS 6
BP 378
EP 383
DI 10.1136/jmedgenet-2017-105094
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA GU2OP
UT WOS:000445109900003
PM 29358270
DA 2024-11-01
ER

PT J
AU Kraya, T
   Deschauer, M
   Joshi, PR
   Zierz, S
   Gaul, C
AF Kraya, Torsten
   Deschauer, Marcus
   Joshi, Pushpa Raj
   Zierz, Stephan
   Gaul, Charly
TI Prevalence of Headache in Patients With Mitochondrial Disease: A Cross-Sectional Study
SO HEADACHE
LA English
DT Article
DE mitochondrial disease; headache; migraine; MELAS; CPEO; MERRF
ID lactic-acidosis; episodes melas; dna mutations; migraine; encephalopathy; dysfunction; myopathy; features
AB BackgroundMitochondrial diseases are a heterogeneous group of diseases with different phenotypes and genotypes. Headache and, particularly migraine, seems to occur often in patients with MELAS and in patients with CPEO phenotypes. The International Classification of Headache Disorders (ICHD-3 beta) has classified headache as a secondary entity only in MELAS patients. Other headache phenotypes in mitochondrial diseases are not considered in ICHD-3beta. In this study, we analyzed headache phenomenology in a large group of patients with mitochondrial disorders. MethodsA cross-sectional questionnaire-based study on 85 patients with mitochondrial disease with different genotypes and phenotypes was conducted between 2010 and 2011. A structured headache questionnaire according to ICHD-2 was used followed by a telephone interview by a headache expert. Prevalence and characteristics of headache could be analyzed in 42 patients. Headache diagnosis was correlated with genotypes and phenotypes. In addition, the mtDNA haplotype H was analyzed. ResultsHeadache was reported in 29/42 (70%; 95% CI, from 55.1 to 83.0%) of the patients. Tension-type headache (TTH) showed the highest prevalence in 16/42 (38%; 95% CI, from 23.4 to 52.8%) patients, followed by migraine and probable migraine in 12/42 (29%; 95% CI, from 14.9 to 42.2%) patients. Nine of the 42 (21%; 95% CI, from 9 to 33.8%) patients reported two different headache types. Patients with the mtDNA mutation m.3243A>G (n=8) and MELAS (n=7) showed the highest prevalence of headaches (88% and 85%, respectively). In patients with the CPEO phenotype (n=32), headache occurred in 14/18 (78%; 95% CI, from 58.6 to 97%) of patients with single deletions, and in 7/13 (54%; 95% CI, from 26.7 to 80.9%) patients with multiple mtDNA deletions. There were no association between the mtDNA haplotype Hand the headache-diagnosis. ConclusionsThe prevalence of headache was higher in patients with mitochondrial diseases than reported in the general population. In all phenotype and genotype groups, TTH was more frequent than migraine. The data also show that the current ICHD-3 beta exclusively focused on MELAS syndrome as vasculopathy does not consider the broader spectrum of headache phenotypes in mitochondrial disorders.
C1 [Kraya, Torsten; Joshi, Pushpa Raj; Zierz, Stephan] Univ Hosp Halle Saale, Dept Neurol, Ernst Grube Str 40, D-06097 Halle, Saale, Germany.
   [Deschauer, Marcus] Tech Univ Munich, Dept Neurol, Munich, Germany.
   [Gaul, Charly] Headache & Migraine Clin, Konigstein, Germany.
C3 Martin Luther University Halle Wittenberg; Technical University of Munich
RP Kraya, T (corresponding author), Univ Hosp Halle Saale, Dept Neurol, Ernst Grube Str 40, D-06097 Halle, Saale, Germany.
EM torsten.kraya@medizin.uni-halle.de
FU Genzyme; Ultragenyx
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658
   Boehnke C, 2004, EUR J NEUROL, V11, P475, DOI 10.1111/j.1468-1331.2004.00813.x
   de Vries B, 2009, HUM GENET, V126, P115, DOI 10.1007/s00439-009-0684-z
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Di Lorenzo C, 2009, NEUROLOGY, V72, P1588, DOI 10.1212/WNL.0b013e3181a41269
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Guo S, 2016, EUR J NEUROL, V23, P175, DOI 10.1111/ene.12832
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Klopstock T, 1996, NEUROLOGY, V46, P1735, DOI 10.1212/WNL.46.6.1735
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   LAFORET P, 1995, NEUROMUSCULAR DISORD, V5, P399, DOI 10.1016/0960-8966(94)00080-S
   MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751
   Okada H, 1998, HEADACHE, V38, P39, DOI 10.1046/j.1526-4610.1998.3801039.x
   Pfaffenrath V, 2009, CEPHALALGIA, V29, P48, DOI 10.1111/j.1468-2982.2008.01699.x
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844
   Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x
   Sparaco M, 2006, CEPHALALGIA, V26, P361, DOI 10.1111/j.1468-2982.2005.01059.x
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stuart S, 2012, MOL GENET GENOMICS, V287, P837, DOI 10.1007/s00438-012-0723-7
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yorns WR, 2013, SEMIN PEDIATR NEUROL, V20, P188, DOI 10.1016/j.spen.2013.09.002
NR 27
TC 32
Z9 34
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0017-8748
EI 1526-4610
J9 HEADACHE
JI Headache
PD JAN 15
PY 2018
VL 58
IS 1
BP 45
EP 52
DI 10.1111/head.13219
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA FR4WP
UT WOS:000419067600004
PM 29139113
DA 2024-11-01
ER

PT J
AU Jakus, IA
   Jakus, D
   Marinovic, J
   Cavar, M
   Banic, I
   Vilovic, K
AF Jakus, Ivana Alujevic
   Jakus, Dora
   Marinovic, Jasna
   Cavar, Marija
   Banic, Ivana
   Vilovic, Katarina
TI Expression of Mitochondrial Respiratory Chain Complexes in the Vaginal Wall in Postmenopausal Women with Pelvic Organ Prolapse
SO GYNECOLOGIC AND OBSTETRIC INVESTIGATION
LA English
DT Article
DE Mitochondria; Pelvic organ prolapse; Postmenopause; Vagina
ID dna deletion mutations; muscle-fiber atrophy; uterosacral ligaments; abnormality
AB Background/Aims: Pelvic organ prolapse (POP) is a common disease affecting adult women. It is a result of the vaginal wall disorder as well as damage of the supportive structures contributing to the integrity of the pelvic floor. Mitochondrial disorders may have an important role in the vaginal wall degeneration leading to POP. The goal of this research is to examine if POP is associated with an altered expression of mitochondrial respiratory chain complexes. Methods: Samples of vaginal tissue were collected from 16 postmenopausal women: 10 had POP and 6 had other forms of benign gynecological disease. Using western blot, samples were analyzed to assess the expression of mitochondrial proteins including citrate synthase (CS), individual complexes of the mitochondrial respiratory chain and alpha smooth muscle actin (SMA). Results: A significantly reduced expression of SMA and complex II in vaginal tissue of women with POP was found, compared to the control group (p < 0.05), with a tendency for a reduced expression of CS (p = 0.06) and other complexes in the POP group. Conclusions: Our results indicate that there is a decreased quantity of the smooth muscle and a decreased expression of mitochondria! markers in the vaginal wall of women with prolapse suggesting their possible role in the pathogenesis of POP. (C) 2017 S. Karger AG, Basel
C1 [Jakus, Ivana Alujevic] Split Univ Hosp, Clin Dept Gynecol & Obstet, Spinciceva 1, HR-21000 Split, Croatia.
   [Jakus, Dora; Marinovic, Jasna; Cavar, Marija; Banic, Ivana] Univ Split, Sch Med, Dept Physiol, Split, Croatia.
   [Vilovic, Katarina] Split Univ Hosp, Clin Dept Pathol, Split, Croatia.
C3 University of Split; University of Split; University of Split
RP Jakus, IA (corresponding author), Split Univ Hosp, Clin Dept Gynecol & Obstet, Spinciceva 1, HR-21000 Split, Croatia.
EM alujevicivana@hotmail.com
FU Ministry of Science, Education and Sports of the Republic of Croatia [021-2160528-0507]
CR Ackrell BAC, 2002, MOL ASPECTS MED, V23, P369, DOI 10.1016/S0098-2997(02)00012-2
   Badiou W, 2008, INT UROGYNECOL J, V19, P723, DOI 10.1007/s00192-007-0516-4
   BITTLES AH, 1992, MUTAT RES, V275, P217, DOI 10.1016/0921-8734(92)90025-K
   Boreham MK, 2002, AM J OBSTET GYNECOL, V187, P1501, DOI 10.1067/mob.2002.130005
   Boreham MK, 2002, AM J OBSTET GYNECOL, V187, P56, DOI 10.1067/mob.2002.124843
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Cortopassi GA, 1999, BBA-BIOENERGETICS, V1410, P183, DOI 10.1016/S0005-2728(98)00166-2
   DELANCEY JOL, 1992, AM J OBSTET GYNECOL, V166, P1717, DOI 10.1016/0002-9378(92)91562-O
   Healy JC, 2008, GRAYS ANATOMY- THE ANATOMICAL BASIS OF CLINICAL PRACTICE, V40th, P1279
   Kerkhof MH, 2009, INT UROGYNECOL J, V20, P461, DOI 10.1007/s00192-008-0737-1
   Knuuti E, 2011, ARCH GYNECOL OBSTET, V283, P1081, DOI 10.1007/s00404-010-1518-x
   Kokcu A, 2002, ARCHIVES OF GYNECOLOGY AND OBSTETRICS, V266, P75, DOI 10.1007/s004040100194
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lopez ME, 2000, MUTAT RES-FUND MOL M, V452, P123, DOI 10.1016/S0027-5107(00)00059-2
   Maher C, 2008, NEUROUROL URODYNAM, V27, P3, DOI 10.1002/nau.20542
   Meijerink AM, 2013, GYNECOL OBSTET INVES, V75, P21, DOI 10.1159/000341709
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Novara G, 2005, CURR OPIN UROL, V15, P256, DOI 10.1097/01.mou.0000172399.47019.e9
   Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6
   Persu C, 2011, J MED LIFE, V4, P75
   RICHTER C, 1988, FEBS LETT, V241, P1, DOI 10.1016/0014-5793(88)81018-4
   Sun MJ, 2009, INT UROGYNECOL J, V20, P867, DOI 10.1007/s00192-009-0871-4
   Takacs P, 2010, ARCH GYNECOL OBSTET, V282, P389, DOI 10.1007/s00404-009-1262-2
   Towers, 2004, J PELVIC MED SURG, V10, P109, DOI 10.1097/01.spv.0000130408.99003.7c
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Weber AM, 2005, OBSTET GYNECOL, V106, P615, DOI 10.1097/01.AOG.0000175832.13266.bb
   Yiou R, 2012, J UROLOGY, V188, P1772
NR 30
TC 4
Z9 5
U1 0
U2 3
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0378-7346
EI 1423-002X
J9 GYNECOL OBSTET INVES
JI Gynecol.Obstet.Invest.
PD JUN 15
PY 2018
VL 83
IS 5
BP 487
EP 492
DI 10.1159/000480236
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GT7YO
UT WOS:000444748800011
PM 28850957
DA 2024-11-01
ER

PT J
AU Hsieh, AYY
   Budd, M
   Deng, D
   Gadawska, I
   Côté, HCF
AF Hsieh, Anthony Y. Y.
   Budd, Matthew
   Deng, David
   Gadawska, Izabella
   Cote, Helene C. F.
TI A Monochrome Multiplex Real-Time Quantitative PCR Assay for the Measurement of Mitochondrial DNA Content
SO JOURNAL OF MOLECULAR DIAGNOSTICS
LA English
DT Article
ID hiv-infected patients; copy number; transcription factor; oxidative stress; gastric-cancer; blood-cells; biogenesis; depletion; decrease; nuclear
AB Mitochondrial DNA copies per cell (mtDNA content) can fluctuate with cellular aging, oxidative stress, and mitochondrial dysfunction, and has been investigated in cancer, diabetes, HIV, and metabolic disease. mtDNA content testing in both clinical and basic settings is expected to increase as research uncovers its biological relevance. Herein, we present a novel mtDNA content assay developed on monochrome multiplex real-time quantitative PCR (MMqPCR) principles. This assay offers a greater than twofold improvement on time effectiveness and cost-effectiveness over conventional (monoplex) qPCR, as well as improved reproducibility given the reduced effects of human pipetting errors. The new MMqPCR method was compared with the gold standard monoplex qPCR assay on DNA from a variety of sources, including human whole blood, skeletal muscle, and commercial cell lines. The MMqPCR assay is reproducible (n = 98, r = 0.99, P < 0.0001) and highly correlated to the monoplex qPCR assay (n = 160, r > 0.98, P < 0.0001). Intra-assay and interassay variabilities, as established independently by multiple operators, range between 4.3% and 7.9% and between 2.9% and 9.2%, respectively. This robust assay can quantify >82 pg of template DNA per reaction, with a minimum mtDNA/nuclear DNA ratio of 20, and is especially suitable for studies that require high throughput.
C1 [Hsieh, Anthony Y. Y.; Budd, Matthew; Deng, David; Gadawska, Izabella; Cote, Helene C. F.] Univ British Columbia, Dept Pathol & Lab Med, G227,2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.
   [Hsieh, Anthony Y. Y.; Cote, Helene C. F.] Univ British Columbia, Ctr Blood Res, Vancouver, BC, Canada.
   [Cote, Helene C. F.] Womens Hlth Res Inst, Vancouver, BC, Canada.
C3 University of British Columbia; University of British Columbia
RP Côté, HCF (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, G227,2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.
EM helene.cote@ubc.ca
FU Canadian Institutes of Health Research (CIHR) Emerging Team grant on Cellular Aging and HIV Comorbidities in Women and Children [TCO-125269]; University of British Columbia (UBC); UBC Centre for Blood Research; CIHR
CR Ajaykumar A, 2017, 26 ANN CAN C HIV AID, V0, P0
   Amaudo E, 1991, LANCET, V337, P508
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Casula M, 2005, J INFECT DIS, V191, P1468, DOI 10.1086/429412
   Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, P0, DOI 10.1093/nar/gkn1027
   Coté HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035
   Côté HCF, 2006, AIDS, V20, P1343, DOI 10.1097/01.aids.0000232250.89404.00
   Coté HC, 2007, CRIT CARE, V11, P0, DOI 10.1186/cc6096
   Cui HH, 2013, BMC CANCER, V13, P0, DOI 10.1186/1471-2407-13-110
   Dalakas MC, 2001, LAB INVEST, V81, P1537, DOI 10.1038/labinvest.3780367
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Fernandes J, 2014, CANCER EPIDEM BIOMAR, V23, P2430, DOI 10.1158/1055-9965.EPI-14-0471
   FISHER RP, 1985, J BIOL CHEM, V260, P1330
   FUKUHARA H, 1969, EUR J BIOCHEM, V11, P135, DOI 10.1111/j.1432-1033.1969.tb00750.x
   Goto M, 2003, J MED VIROL, V70, P497, DOI 10.1002/jmv.10423
   He X, 2014, ONCOTARGET, V7, P22834
   Hsieh AYY, 2016, J MOL DIAGN, V18, P425, DOI 10.1016/j.jmoldx.2016.01.004
   Kim MY, 2011, ARCH GERONTOL GERIAT, V53, PE218, DOI 10.1016/j.archger.2010.11.019
   Kogelnik AM, 1996, NUCLEIC ACIDS RES, V24, P177, DOI 10.1093/nar/24.1.177
   Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6
   Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425
   Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010
   Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Malik AN, 2015, DIABETES RES CLIN PR, V110, P257, DOI 10.1016/j.diabres.2015.10.006
   Meierhofer D, 2004, CARCINOGENESIS, V25, P1005, DOI 10.1093/carcin/bgh104
   Memon Ashfaque A, 2017, BIOMOL DETECT QUANTIF, V13, P32, DOI 10.1016/j.bdq.2017.08.001
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Miró O, 2003, AIDS RES HUM RETROV, V19, P1027, DOI 10.1089/088922203322588387
   Miró O, 2004, CLIN INFECT DIS, V39, P710, DOI 10.1086/423176
   Moraes CT, 1999, MOL BIOL CELL, V10, P3345, DOI 10.1091/mbc.10.10.3345
   MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474
   Pisano A, 2016, CARDIOVASC PATHOL, V25, P103, DOI 10.1016/j.carpath.2015.09.009
   Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, P0, DOI 10.1093/nar/gkp045
   Schick BA, 2007, CLIN PHARMACOL THER, V81, P650, DOI 10.1038/sj.clpt.6100124
   Serth J, 2000, AM J PATHOL, V156, P1189, DOI 10.1016/S0002-9440(10)64989-9
   Shikuma CM, 2001, AIDS, V15, P1801, DOI 10.1097/00002030-200109280-00009
   Song J, 2001, DIABETES CARE, V24, P865, DOI 10.2337/diacare.24.5.865
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Stringer HAJ, 2013, J NEUROL SCI, V325, P142, DOI 10.1016/j.jns.2012.12.023
   TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
   Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377
   Wen SL, 2013, ONCOL LETT, V6, P1098, DOI 10.3892/ol.2013.1492
   Yen MY, 2002, BRIT J OPHTHALMOL, V86, P1027, DOI 10.1136/bjo.86.9.1027
   Yu M, 2011, LIFE SCI, V89, P65, DOI 10.1016/j.lfs.2011.05.010
   Zanet DL, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0057787
NR 48
TC 16
Z9 16
U1 1
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1525-1578
EI 1943-7811
J9 J MOL DIAGN
JI J. Mol. Diagn.
PD SEP 15
PY 2018
VL 20
IS 5
BP 612
EP 620
DI 10.1016/j.jmoldx.2018.05.001
PG 9
WC Pathology
SC Pathology
GA GS8AR
UT WOS:000443929200006
PM 29936256
DA 2024-11-01
ER

PT J
AU Santacatterina, F
   Torresano, L
   Núñez-Salgado, A
   Esparza-Molto, PB
   Olive, M
   Gallardo, E
   García-Arumi, E
   Blazquez, A
   González-Quintana, A
   Martín, MA
   Cuezva, JM
AF Santacatterina, Fulvio
   Torresano, Laura
   Nunez-Salgado, Alfonso
   Esparza-Molto, Pau B.
   Olive, Montse
   Gallardo, Eduard
   Garcia-Arumi, Elena
   Blazquez, Alberto
   Gonzalez-Quintana, Adrian
   Martin, Miguel A.
   Cuezva, Jose M.
TI Different mitochondrial genetic defects exhibit the same protein signature of metabolism in skeletal muscle of PEO and MELAS patients: A role for oxidative stress
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Oxidative stress; Mitochondrial diseases; Metabolic enzymes; Protein arrays; Mn-superoxide dismutase; Catalase
ID stroke-like episodes; dna mutations; superoxide-dismutase; biomarker discovery; lactic-acidosis; down-regulation; microarrays; deletions; array; phosphorylation
AB A major challenge in mitochondrial diseases (MDs) is the identification of biomarkers that could inform of the mechanisms involved in the phenotypic expression of genetic defects. Herein, we have investigated the protein signature of metabolism and of the antioxidant response in muscle biopsies of clinically and genetically diagnosed patients with Progressive External Ophthalmoplegia due to single large-scale (PEO-sD) or multiple (PEO-mD) deletions of mtDNA and Mitochondrial Encephalopathy Lactic Acidosis and Stroke-like episode (MELAS) syndrome, and healthy donors. A high-throughput immunoassay technique that quantitates the expression of relevant proteins of glycolysis, glycogenolysis, pentose phosphate pathway, oxidative phosphorylation, pyruvate and fatty acid oxidation, tricarboxylic acid cycle and the antioxidant response in two large independent and retrospectively collected cohorts of PEO-sD, PEO-mD and MELAS patients revealed that despite the heterogeneity of the genetic alterations, the three MDs showed the same metabolic signatures in both cohorts of patients, which were highly divergent from those of healthy individuals. Linear Discriminant Analysis and Support Vector Machine classifier provided a minimum of four biomarkers to discriminate healthy from pathological samples. Regardless of the induction of a large number of enzymes involved in ameliorating oxidative stress, the down-regulation of mitochondrial superoxide dismutase (SOD2) and catalase expression favored the accumulation of oxidative damage in patients' proteins. Down-regulation of SOD2 and catalase expression in MD patients is not due to relevant changes in the availability of their mRNAs, suggesting that oxidative stress regulates the expression of the two enzymes post-transcriptionally. We suggest that SOD2 and catalase could provide specific targets to improve the detoxification of reactive oxygen species that affects muscle proteins in these patients.
C1 [Santacatterina, Fulvio; Torresano, Laura; Nunez-Salgado, Alfonso; Esparza-Molto, Pau B.; Cuezva, Jose M.] CSIC UAM, Ctr Biol Mol Severo Ochoa, Dept Biol Mol, Madrid, Spain.
   [Santacatterina, Fulvio; Torresano, Laura; Esparza-Molto, Pau B.; Gallardo, Eduard; Garcia-Arumi, Elena; Blazquez, Alberto; Gonzalez-Quintana, Adrian; Martin, Miguel A.; Cuezva, Jose M.] ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Bizkaia, Spain.
   [Santacatterina, Fulvio; Torresano, Laura; Esparza-Molto, Pau B.; Blazquez, Alberto; Gonzalez-Quintana, Adrian; Martin, Miguel A.; Cuezva, Jose M.] Inst Invest Hosp, 12 Octubre I 12, Madrid, Spain.
   [Olive, Montse] IDIBELL Hosp Univ Bellvitge, Serv Anat Patol, Unidad Patol Neuromuscular, Barcelona, Spain.
   [Gallardo, Eduard] Hosp Santa Creu & Sant Pau, Inst Recerca, Barcelona, Spain.
   [Garcia-Arumi, Elena] Univ Autonoma Barcelona, Hosp Univ Vali dHebron Inst Recerca VHIR, Area Genet Clin & Mol, Lab Patol Mitocondrial & Neuromuscular, Barcelona, Spain.
   [Blazquez, Alberto; Gonzalez-Quintana, Adrian; Martin, Miguel A.] Hosp Univ, Lab Enfermedades Mitocondriales & Neuromusculares, Octubre 12, Madrid, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; CIBERNED; University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; University of Sevilla
RP Cuezva, JM (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.
EM jmcuezva@cbm.csic.es
FU Fundacion La Caixa (Obra Social La Caixa); ACCI-CIBERER-2015; MINECO [SAF2016-75916-R]; CIBERER-ISCIII; Fundacion Ramon Areces; ISCIII-FIS, Spain [PI15-0435, PI15/01428, PMP15-00025]
CR Aitken RJ, 2012, J BIOL CHEM, V287, P33048, DOI 10.1074/jbc.M112.366690
   Aldea M, 2011, CANCER LETT, V311, P210, DOI 10.1016/j.canlet.2011.07.022
   Baldelli E, 2017, METHODS MOL BIOL, V1606, P149, DOI 10.1007/978-1-4939-6990-6_11
   Berardo A, 2010, NEUROMUSCULAR DISORD, V20, P204, DOI 10.1016/j.nmd.2010.01.006
   Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Campos Y, 1996, NEUROLOGY, V47, P1012, DOI 10.1212/WNL.47.4.1012
   Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013
   Choksi KB, 2008, FREE RADICAL BIO MED, V45, P826, DOI 10.1016/j.freeradbiomed.2008.06.006
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   Da Pozzo P, 2015, NEUROL SCI, V36, P1713, DOI 10.1007/s10072-015-2247-5
   DiMauro S, 1993, GENEREVIEWS, V0, P0
   El-Hattab AW, 2016, MOL GENET METAB, V117, P407, DOI 10.1016/j.ymgme.2016.01.010
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Enns GM, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6050050
   Fryer RH, 2016, PEDIATR NEUROL, V56, P59, DOI 10.1016/j.pediatrneurol.2015.12.010
   Gallego-Villar L, 2016, FREE RADICAL BIO MED, V96, P1, DOI 10.1016/j.freeradbiomed.2016.04.007
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Guo J, 2011, J PROTEOMICS, V74, P2370, DOI 10.1016/j.jprot.2011.07.009
   Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Huang Y, 2017, GENOM PROTEOM BIOINF, V15, P73, DOI 10.1016/j.gpb.2017.03.001
   Jones E, 2001, SCIPY: OPEN SOURCE SCIENTIFIC TOOLS FOR PYTHON ONLINE; ACCESSED 2016-11-29 SEE P. 50, V0, P0
   Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282
   Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603
   Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013
   Li MY, 2006, J BIOL CHEM, V281, P40429, DOI 10.1074/jbc.M606596200
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Lu CY, 2002, CLIN CHIM ACTA, V318, P97, DOI 10.1016/S0009-8981(01)00809-9
   Luo XP, 1997, J CLIN INVEST, V99, P2877, DOI 10.1172/JCI119481
   Mancuso M, 2009, CURR MOL MED, V9, P1095, DOI 10.2174/156652409789839099
   May C, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0089596
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, P0, DOI 10.1007/s11910-016-0652-7
   Mesegueri S, 2015, HUM MOL GENET, V24, P167, DOI 10.1093/hmg/ddu427
   Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Mrácek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014
   Mueller C, 2010, MOL ONCOL, V4, P461, DOI 10.1016/j.molonc.2010.09.003
   Nenoi M, 2001, CANCER RES, V61, P5885
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021
   Pagano G, 2014, OXID MED CELL LONGEV, V2014, P0, DOI 10.1155/2014/541230
   Papa S, 1996, BBA-BIOENERGETICS, V1276, P87, DOI 10.1016/0005-2728(96)00077-1
   Pedregosa F, 2011, J MACH LEARN RES, V12, P2825
   PICCOLO G, 1991, J NEUROL SCI, V105, P57, DOI 10.1016/0022-510X(91)90118-Q
   Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798
   Qin HL, 2011, DIABETES, V60, P857, DOI 10.2337/db09-1706
   Ramachandran P, 2011, COMPUT SCI ENG, V13, P40, DOI 10.1109/MCSE.2011.35
   Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003
   Rikimaru M, 2012, INTERNAL MED, V51, P3351, DOI 10.2169/internalmedicine.51.7529
   Santacatterina F, 2017, J TRANSL MED, V15, P0, DOI 10.1186/s12967-017-1136-5
   Santacatterina F, 2015, J TRANSL MED, V13, P0, DOI 10.1186/s12967-015-0424-1
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001
   Sheehan KM, 2005, MOL CELL PROTEOMICS, V4, P346, DOI 10.1074/mcp.T500003-MCP200
   Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037
   Soldevilla B, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0178376
   Sommerville Ewen W, 2014, J NEUROMUSCUL DIS, V1, P119
   Sundaram C, 2011, J CLIN NEUROSCI, V18, P535, DOI 10.1016/j.jocn.2010.06.014
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tessa A, 2000, FUNCT NEUROL, V15, P211
   Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Ummanni R, 2014, BBA-PROTEINS PROTEOM, V1844, P950, DOI 10.1016/j.bbapap.2013.11.017
   Vamecq J, 2012, CURR DRUG METAB, V13, P1388, DOI 10.2174/138920012803762792
   VanMeter A, 2007, EXPERT REV MOL DIAGN, V7, P625, DOI 10.1586/14737159.7.5.625
   Venkatesan B, 2007, J CELL PHYSIOL, V211, P457, DOI 10.1002/jcp.20953
   Villarroya J, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0029691
   Wang K, 2010, NUCLEIC ACIDS RES, V38, P0, DOI 10.1093/nar/gkq603
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   Witten IH, 2011, MOR KAUF D, V0, P1
   YEN TC, 1994, FREE RADICAL BIO MED, V16, P207, DOI 10.1016/0891-5849(94)90145-7
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhao Y, 2014, FREE RADICAL BIO MED, V72, P55, DOI 10.1016/j.freeradbiomed.2014.03.001
NR 80
TC 10
Z9 10
U1 0
U2 20
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD OCT 15
PY 2018
VL 126
IS 
BP 235
EP 248
DI 10.1016/j.freeradbiomed.2018.08.020
PG 14
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA GV0NQ
UT WOS:000445759000022
PM 30138712
DA 2024-11-01
ER

PT J
AU Trifunov, S
   Pyle, A
   Valentino, ML
   Liguori, R
   Yu-Wai-Man, P
   Burté, F
   Duff, J
   Kleinle, S
   Diebold, I
   Rugolo, M
   Horvath, R
   Carelli, V
AF Trifunov, Selena
   Pyle, Angela
   Valentino, Maria Lucia
   Liguori, Rocco
   Yu-Wai-Man, Patrick
   Burte, Florence
   Duff, Jennifer
   Kleinle, Stephanie
   Diebold, Isabel
   Rugolo, Michela
   Horvath, Rita
   Carelli, Valerio
TI Clonal expansion of mtDNA deletions: different disease models assessed by digital droplet PCR in single muscle cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID mitochondrial-dna-deletion; skeletal-muscle; optic atrophy; maintenance; mechanisms; mitophagy; dynamics; genm; length; son
AB Deletions in mitochondrial DNA (mtDNA) are an important cause of human disease and their accumulation has been implicated in the ageing process. As mtDNA is a high copy number genome, the coexistence of deleted and wild-type mtDNA molecules within a single cell defines heteroplasmy. When deleted mtDNA molecules, driven by intracellular clonal expansion, reach a sufficiently high level, a biochemical defect emerges, contributing to the appearance and progression of clinical pathology. Consequently, it is relevant to determine the heteroplasmy levels within individual cells to understand the mechanism of clonal expansion. Heteroplasmy is reflected in a mosaic distribution of cytochrome c oxidase (COX)-deficient muscle fibers. We applied droplet digital PCR (ddPCR) to single muscle fibers collected by laser-capture microdissection (LCM) from muscle biopsies of patients with different paradigms of mitochondrial disease, characterized by the accumulation of single or multiple mtDNA deletions. By combining these two sensitive approaches, ddPCR and LCM, we document different models of clonal expansion in patients with single and multiple mtDNA deletions, implicating different mechanisms and time points for the development of COX deficiency in these molecularly distinct mitochondrial cytopathies.
C1 [Trifunov, Selena; Valentino, Maria Lucia; Liguori, Rocco; Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Unit Neurol, Bologna, Italy.
   [Trifunov, Selena; Pyle, Angela; Burte, Florence; Duff, Jennifer; Horvath, Rita] Newcastle Univ, Inst Genet Med, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Valentino, Maria Lucia; Liguori, Rocco; Carelli, Valerio] Bellaria Hosp, IRCCS, Inst Neurol Sci Bologna ISNB, Bologna, Italy.
   [Yu-Wai-Man, Patrick] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England.
   [Yu-Wai-Man, Patrick] UCL Inst Ophthalmol, London, England.
   [Yu-Wai-Man, Patrick] Univ Cambridge, Dept Clin Neurosci, Cambridge Ctr Brain Repair, Cambridge, England.
   [Yu-Wai-Man, Patrick] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England.
   [Kleinle, Stephanie; Diebold, Isabel] Med Genet Ctr Munich, D-80335 Munich, Germany.
   [Rugolo, Michela] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy.
C3 University of Bologna; Newcastle University - UK; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); AUSL di Bologna; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of Cambridge; University of Cambridge; University of Bologna
RP Carelli, V (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Unit Neurol, Bologna, Italy.; Carelli, V (corresponding author), Bellaria Hosp, IRCCS, Inst Neurol Sci Bologna ISNB, Bologna, Italy.
EM valerio.carelli@unibo.it
FU Mitochondrial European Educational Training (MEET), ITN MARIE CURIE PEOPLE [317433]; Wellcome Centre for Mitochondrial Research [109915/Z/15/Z, 203105/Z/16/Z]; Medical Research Council (UK) [MR/N025431/1]; European Research Council [309548]; Wellcome Trust [201064/Z/16/Z]; Newton Fund (UK/Turkey) [MR/N027302/1]; European Union [SC1-PM-03-2017]; Wellcome Trust [201064/Z/16/Z] Funding Source: Wellcome Trust; MRC [G1000848, MR/N010035/1, MR/N025431/1, G1002570, MR/N025431/2, G0701386] Funding Source: UKRI; Newton Fund [MR/N027302/1, MR/N027302/2] Funding Source: UKRI
CR Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, PE672, DOI 10.1152/ajpendo.00043.2007
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Belmonte FR, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep25186
   BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X
   Blakely EL, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011296
   Brenner CA, 1998, MOL HUM REPROD, V4, P887, DOI 10.1093/molehr/4.9.887
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carelli V, 2015, INT J BIOCHEM CELL B, V63, P21, DOI 10.1016/j.biocel.2015.01.023
   Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Elson JL, 2002, NEUROMUSCULAR DISORD, V12, P858, DOI 10.1016/S0960-8966(02)00047-0
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Herbst A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0059006
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Iommarini L, 2012, NEUROLOGY, V79, P1517, DOI 10.1212/WNL.0b013e31826d5f72
   Kandul NP, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13100
   Liao CY, 2017, NEUROLOGY, V88, P131, DOI 10.1212/WNL.0000000000003491
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Manoj P, 2016, MITOCHONDRIAL DNA A, V27, P742, DOI 10.3109/19401736.2014.913168
   Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   POULTON J, 1991, AM J HUM GENET, V48, P649
   Reichmann H, 1996, EUR NEUROL, V36, P98, DOI 10.1159/000117217
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   Sitarz KS, 2012, NEUROLOGY, V79, P1515, DOI 10.1212/WNL.0b013e31826d5f60
   Tam ZY, 2015, PLOS COMPUT BIOL, V11, P0, DOI 10.1371/journal.pcbi.1004183
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 40
TC 16
Z9 18
U1 0
U2 5
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD AUG 3
PY 2018
VL 8
IS 
BP 
EP 
DI 10.1038/s41598-018-30143-z
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GP2NG
UT WOS:000440670200045
PM 30076399
DA 2024-11-01
ER

PT J
AU Singh, B
   Schoeb, TR
   Bajpai, P
   Slominski, A
   Singh, KK
AF Singh, Bhupendra
   Schoeb, Trenton R.
   Bajpai, Prachi
   Slominski, Andrzej
   Singh, Keshav K.
TI Reversing wrinkled skin and hair loss in mice by restoring mitochondrial function
SO CELL DEATH & DISEASE
LA English
DT Article
ID dna copy number; renal-cell carcinoma; mtdna depletion; skeletal-muscle; gene-expression; kinase gene; mutations; disease; association; protein
AB Mitochondrial DNA (mtDNA) depletion is involved in mtDNA depletion syndromes, mitochondrial diseases, aging and aging-associated chronic diseases, and other human pathologies. To evaluate the consequences of depletion of mtDNA in the whole animal, we created an inducible mtDNA-depleter mouse expressing, in the polymerase domain of POLG1, a dominant-negative mutation to induce depletion of mtDNA in various tissues. These mice showed reduced mtDNA content, reduced mitochondrial gene expression, and instability of supercomplexes involved in oxidative phosphorylation (OXPHOS) resulting in reduced OXPHOS enzymatic activities. We demonstrate that ubiquitous depletion of mtDNA in mice leads to predominant and profound effects on the skin resulting in wrinkles and visual hair loss with an increased number of dysfunctional hair follicles and inflammatory responses. Development of skin wrinkle was associated with the significant epidermal hyperplasia, hyperkeratosis, increased expression of matrix metalloproteinases, and decreased expression of matrix metalloproteinase inhibitor TIMP1. We also discovered markedly increased skin inflammation that appears to be a contributing factor in skin pathology. Histopathologic analyses revealed dysfunctional hair follicles. mtDNA-depleter mice also show changes in expression of agingassociated markers including IGF1R, KLOTHO, VEGF, and MRPS5. mtDNA-repleter mice showed that, by turning off the mutant POLG1 transgene expression, mitochondrial function, as well as the skin and hair pathology, is reversed to wildtype level. To our knowledge that restoration of mitochondrial functions can reverse the skin and hair pathology is unprecedented.
C1 [Singh, Bhupendra; Schoeb, Trenton R.; Bajpai, Prachi; Singh, Keshav K.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA.
   [Slominski, Andrzej] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA.
   [Singh, Keshav K.] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35294 USA.
   [Singh, Keshav K.] Univ Alabama Birmingham, Ctr Aging, Ctr Free Radical Biol, Birmingham, AL 35294 USA.
   [Singh, Keshav K.] Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Birmingham, AL 35294 USA.
C3 University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham
RP Singh, KK (corresponding author), Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA.; Singh, KK (corresponding author), Birmingham Vet Affairs Med Ctr, Birmingham, AL 35294 USA.; Singh, KK (corresponding author), Univ Alabama Birmingham, Ctr Aging, Ctr Free Radical Biol, Birmingham, AL 35294 USA.; Singh, KK (corresponding author), Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Birmingham, AL 35294 USA.
EM kksingh@uab.edu
FU Veterans Administration [1I01BX001716]; NIH [R01 CA204430, 1R01AR071189-01A1, R01AR073004]
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Bielenberg DR, 1998, J INVEST DERMATOL, V111, P864, DOI 10.1046/j.1523-1747.1998.00378.x
   Birch-Machin MA, 1998, J INVEST DERMATOL, V110, P149, DOI 10.1046/j.1523-1747.1998.00099.x
   Bonomi M, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0042423
   Bosset S, 2003, BRIT J DERMATOL, V149, P826, DOI 10.1046/j.1365-2133.2003.05456.x
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Carson FL, 2009, HISTOTECHNOLOGY: A SELF-INSTRUCTIONAL TEXT, V3rd, P0
   Cho YS, 2009, MOL CELLS, V28, P537, DOI 10.1007/s10059-009-0148-2
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0
   Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Hamanaka RB, 2013, SCI SIGNAL, V6, P0, DOI 10.1126/scisignal.2003638
   Hebert SL, 2015, J GERONTOL A-BIOL, V70, P1409, DOI 10.1093/gerona/glv086
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Iriyama S, 2010, EXP DERMATOL, V19, P965, DOI 10.1111/j.1600-0625.2009.01027.x
   Jazayeri M, 2003, J BIOL CHEM, V278, P9823, DOI 10.1074/jbc.M211730200
   Johnston AJ, 2002, J BIOL CHEM, V277, P42197, DOI 10.1074/jbc.M205613200
   Keisala T, 2009, J STEROID BIOCHEM, V115, P91, DOI 10.1016/j.jsbmb.2009.03.007
   Kloepper JE, 2015, J INVEST DERMATOL, V135, P679, DOI 10.1038/jid.2014.475
   Koochekpour S, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0074688
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Lahmann C, 2001, LANCET, V357, P935, DOI 10.1016/S0140-6736(00)04220-3
   Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011
   Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7
   Lee JW, 2010, CLIN CHIM ACTA, V411, P592, DOI 10.1016/j.cca.2010.01.024
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu LP, 2017, ATHEROSCLEROSIS, V261, P105, DOI 10.1016/j.atherosclerosis.2017.02.013
   López-Armada MJ, 2013, MITOCHONDRION, V13, P106, DOI 10.1016/j.mito.2013.01.003
   Mambo E, 2005, INT J CANCER, V116, P920, DOI 10.1002/ijc.21110
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   McCullough JL, 2006, ANN NY ACAD SCI, V1067, P323, DOI 10.1196/annals.1354.044
   Melkonian SC, 2015, CARCINOGENESIS, V36, P249, DOI 10.1093/carcin/bgu248
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Miettinen TP, 2016, DEV CELL, V39, P370, DOI 10.1016/j.devcel.2016.09.004
   Monickaraj F, 2012, MOL CELL BIOCHEM, V365, P343, DOI 10.1007/s11010-012-1276-0
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   NAG AC, 1983, J MOL CELL CARDIOL, V15, P301, DOI 10.1016/0022-2828(83)91342-1
   Niccoli T, 2012, CURR BIOL, V22, PR741, DOI 10.1016/j.cub.2012.07.024
   Nile DL, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0115433
   Owens KM, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0023846
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Pinto M, 2014, BBA-MOL BASIS DIS, V1842, P1198, DOI 10.1016/j.bbadis.2013.11.012
   Rodríguez-Santiago B, 2001, EUR J HUM GENET, V9, P279, DOI 10.1038/sj.ejhg.5200629
   Ross JM, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6
   Schroeder P, 2008, J INVEST DERMATOL, V128, P2297, DOI 10.1038/jid.2008.57
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Singh B, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0139846
   Singh KK, 2009, J HUM GENET, V54, P516, DOI 10.1038/jhg.2009.71
   SLOMINSKI A, 1993, J INVEST DERMATOL, V101, PS90, DOI 10.1111/1523-1747.ep12362991
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449
   STOCCO DM, 1978, J GERONTOL, V33, P802, DOI 10.1093/geronj/33.6.802
   TAUCHI H, 1968, J GERONTOL, V23, P454, DOI 10.1093/geronj/23.4.454
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Varani J, 2000, J INVEST DERMATOL, V114, P480, DOI 10.1046/j.1523-1747.2000.00902.x
   Velarde Michael C, 2014, LONGEV HEALTHSPAN, V3, P2, DOI 10.1186/2046-2395-3-2
   Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377
   Weiland D, 2018, J INVEST DERMATOL, V138, P132, DOI 10.1016/j.jid.2017.08.019
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213
   Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhang RY, 2017, BMC GENOMICS, V18, P0, DOI 10.1186/s12864-017-4287-0
NR 78
TC 75
Z9 79
U1 8
U2 46
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
EI 
J9 CELL DEATH DIS
JI Cell Death Dis.
PD JUL 20
PY 2018
VL 9
IS 
BP 
EP 
DI 10.1038/s41419-018-0765-9
PG 14
WC Cell Biology
SC Cell Biology
GA GN7MA
UT WOS:000439324200001
PM 30026579
DA 2024-11-01
ER

PT J
AU Nicholls, TJ
   Nadalutti, CA
   Motori, E
   Sommerville, EW
   Gorman, GS
   Basu, S
   Hoberg, E
   Turnbull, DM
   Chinnery, PF
   Larsson, NG
   Larsson, E
   Falkenberg, M
   Taylor, RW
   Griffith, JD
   Gustafsson, CM
AF Nicholls, Thomas J.
   Nadalutti, Cristina A.
   Motori, Elisa
   Sommerville, Ewen W.
   Gorman, Grainne S.
   Basu, Swaraj
   Hoberg, Emily
   Turnbull, Doug M.
   Chinnery, Patrick F.
   Larsson, Nils-Goran
   Larsson, Erik
   Falkenberg, Maria
   Taylor, Robert W.
   Griffith, Jack D.
   Gustafsson, Claes M.
TI Topoisomerase 3α Is Required for Decatenation and Segregation of Human mtDNA
SO MOLECULAR CELL
LA English
DT Article
ID mitochondrial-dna instability; iii-alpha; optic atrophy; external ophthalmoplegia; single-copy; replication; maintenance; mutations; mechanism; genome
AB How mtDNA replication is terminated and the newly formed genomes are separated remain unknown. We here demonstrate that the mitochondrial isoform of topoisomerase 3 alpha (Top3 alpha) fulfills this function, acting independently of its nuclear role as a component of the Holliday junction-resolving BLMTop-3 alpha-RMI1-RMI2 (BTR) complex. Our data indicate that mtDNA replication termination occurs via a hemicatenane formed at the origin of H-strand replication and that Top3 alpha is essential for resolving this structure. Decatenation is a prerequisite for separation of the segregating unit of mtDNA, the nucleoid, within the mitochondrial network. The importance of this process is highlighted in a patient with mitochondrial disease caused by biallelic pathogenic variants in TOP3A, characterized by muscle-restricted mtDNA deletions and chronic progressive external ophthalmoplegia (CPEO) plus syndrome. Our work establishes Top3 alpha as an essential component of the mtDNA replication machinery and as the first component of the mtDNA separation machinery.
C1 [Nicholls, Thomas J.; Basu, Swaraj; Hoberg, Emily; Larsson, Erik; Falkenberg, Maria; Gustafsson, Claes M.] Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, S-40530 Gothenburg, Sweden.
   [Nadalutti, Cristina A.; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27514 USA.
   [Motori, Elisa; Larsson, Nils-Goran] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany.
   [Sommerville, Ewen W.; Gorman, Grainne S.; Turnbull, Doug M.; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Chinnery, Patrick F.] Univ Cambridge, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge CB2 0QQ, England.
   [Larsson, Nils-Goran] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.
C3 University of Gothenburg; University of North Carolina; University of North Carolina Chapel Hill; Max Planck Society; Newcastle University - UK; University of Cambridge; Karolinska Institutet
RP Gustafsson, CM (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, S-40530 Gothenburg, Sweden.
EM claes.gustafsson@medkem.gu.se
FU Swedish Research Council; Swedish Cancer Foundation; European Research Council [683191]; IngaBritt and Arne Lundberg Foundation; Knut and Alice Wallenbergs Foundation; NIH [GM31819, ESO13773]; Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC) Centre for Translational Research in Neuromuscular Disease; Mitochondrial Disease Patient Cohort (UK) [G0800674]; UK NIHR Biomedical Research Centre for Ageing and Age-related disease award; MRC/EPSRC Molecular Pathology Node; UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children; Medical Research Council PhD studentship; Wellcome Trust [101876/Z/13/Z]; Medical Research Council Mitochondrial Biology Unit [MC_UP_1501/2]; Medical Research Council (UK) Centre for Translational Muscle Disease research [G0601943]; EU FP7 TIRCON; National Institute for Health Research (NIHR) Biomedical Research Centre based at Cambridge University Hospitals NHS Foundation Trust; University of Cambridge; European Research Council (ERC) [683191] Funding Source: European Research Council (ERC); MRC [MR/K000608/1, G0800674, G0601943, MR/L016354/1] Funding Source: UKRI
CR Akman G, 2016, P NATL ACAD SCI USA, V113, PE4276, DOI 10.1073/pnas.1600537113
   ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Cejka P, 2012, MOL CELL, V47, P886, DOI 10.1016/j.molcel.2012.06.032
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Douarre C, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0041094
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Goulaouic H, 1999, NUCLEIC ACIDS RES, V27, P2443, DOI 10.1093/nar/27.12.2443
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Hanai R, 1996, P NATL ACAD SCI USA, V93, P3653, DOI 10.1073/pnas.93.8.3653
   Harmon FG, 1999, MOL CELL, V3, P611, DOI 10.1016/S1097-2765(00)80354-8
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   HUDSON B, 1967, NATURE, V216, P647, DOI 10.1038/216647a0
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Ishihara T, 2015, MOL CELL BIOL, V35, P211, DOI 10.1128/MCB.01054-14
   Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Langmead B, 2012, NAT METHODS, V9, P357, DOI 10.1038/NMETH.1923
   Lewis SC, 2016, SCIENCE, V353, P0, DOI 10.1126/science.aaf5549
   Low RL, 2003, EUR J BIOCHEM, V270, P4173, DOI 10.1046/j.1432-1033.2003.03814.x
   Pallotti F, 2007, METHOD CELL BIOL, V80, P3, DOI 10.1016/S0091-679X(06)80001-4
   PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021
   Plank JL, 2005, J BIOL CHEM, V280, P3564, DOI 10.1074/jbc.M411337200
   Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Reyes A, 2009, METHODS MOL BIOL, V554, P15, DOI 10.1007/978-1-59745-521-3_2
   Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Sarbajna S, 2014, TRENDS BIOCHEM SCI, V39, P409, DOI 10.1016/j.tibs.2014.07.003
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Shi YH, 2012, P NATL ACAD SCI USA, V109, P16510, DOI 10.1073/pnas.1119738109
   Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534
   Suski C, 2008, MOL CELL, V30, P779, DOI 10.1016/j.molcel.2008.04.020
   THRESHER R, 1992, METHOD ENZYMOL, V211, P481
   Tsai HZ, 2016, J BIOMED SCI, V23, P0, DOI 10.1186/s12929-016-0255-2
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499
   Wu JH, 2010, P NATL ACAD SCI USA, V107, P6228, DOI 10.1073/pnas.1001855107
   Yang J, 2010, J BIOL CHEM, V285, P21426, DOI 10.1074/jbc.M110.123216
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998
   Zhang HL, 2014, NUCLEIC ACIDS RES, V42, P7259, DOI 10.1093/nar/gku384
   Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5
NR 48
TC 87
Z9 93
U1 0
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1097-2765
EI 1097-4164
J9 MOL CELL
JI Mol. Cell
PD JAN 4
PY 2018
VL 69
IS 1
BP 9
EP +
DI 10.1016/j.molcel.2017.11.033
PG 21
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA FR7NA
UT WOS:000419255100004
PM 29290614
DA 2024-11-01
ER

PT J
AU Ahmed, ST
   Craven, L
   Russell, OM
   Turnbull, DM
   Vincent, AE
AF Ahmed, Syeda T.
   Craven, Lyndsey
   Russell, Oliver M.
   Turnbull, Doug M.
   Vincent, Amy E.
TI Diagnosis and Treatment of Mitochondrial Myopathies
SO NEUROTHERAPEUTICS
LA English
DT Review
DE Mitochondrial myopathy; diagnosis; treatment; mtDNA; muscle
ID large-scale deletions; nicotinamide riboside; selective degradation; oxidative-metabolism; pronuclear transfer; controlled-trial; coenzyme q(10); dna-deletion; mutant mtdna; biomarker
AB Mitochondrial myopathies are progressive muscle conditions caused primarily by the impairment of oxidative phosphorylation (OXPHOS) in the mitochondria. This causes a deficit in energy production in the form of adenosine triphosphate (ATP), particularly in skeletal muscle. The diagnosis of mitochondrial myopathy is reliant on the combination of numerous techniques including traditional histochemical, immunohistochemical, and biochemical testing combined with the fast-emerging molecular genetic techniques, namely next-generation sequencing (NGS). This has allowed for the diagnosis to become more effective in terms of determining causative or novel genes. However, there are currently no effective or disease-modifying treatments available for the vast majority of patients with mitochondrial myopathies. Existing therapeutic options focus on the symptomatic management of disease manifestations. An increasing number of clinical trials have investigated the therapeutic effects of various vitamins, cofactors, and small molecules, though these trials have failed to show definitive outcome measures for clinical practice thus far. In addition, new molecular strategies, specifically mtZFNs and mtTALENs, that cause beneficial heteroplasmic shifts in cell lines harboring varying pathogenic mtDNA mutations offer hope for the future. Moreover, recent developments in the reproductive options for patients with mitochondrial myopathies mean that for some families, the possibility of preventing transmission of the mutation to the next generation is now possible.
C1 [Ahmed, Syeda T.; Craven, Lyndsey; Russell, Oliver M.; Turnbull, Doug M.; Vincent, Amy E.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Turnbull, Doug M.; Vincent, Amy E.] Newcastle Univ, MRC, Ctr Ageing & Vital, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK
RP Vincent, AE (corresponding author), Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.; Vincent, AE (corresponding author), Newcastle Univ, MRC, Ctr Ageing & Vital, Newcastle Upon Tyne, Tyne & Wear, England.
EM amy.vincent@ncl.ac.uk
FU MRC [MR/L016354/1] Funding Source: UKRI; Medical Research Council [MR/L016354/1] Funding Source: Medline; Wellcome Trust [203105/Z/16/Z] Funding Source: Medline
CR Ahmed ST, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-14623-2
   Ahola S, 2016, EMBO MOL MED, V8, P1234, DOI 10.15252/emmm.201606592
   Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Alam NM, 2015, DIS MODEL MECH, V8, P701, DOI 10.1242/dmm.020248
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Bacman SR, 2014, METHOD ENZYMOL, V547, P373, DOI 10.1016/B978-0-12-801415-8.00018-7
   Bates MGD, 2013, INT J CARDIOL, V168, P3599, DOI 10.1016/j.ijcard.2013.05.062
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Cantó C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Craven L, 2016, STEM CELLS, V34, P265, DOI 10.1002/stem.2221
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Frazier AE, 2017, J BIOL CHEM, V0, P0
   Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006
   Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Giorgio V, 2012, BBA-BIOENERGETICS, V1817, P363, DOI 10.1016/j.bbabio.2011.10.012
   Glover EI, 2010, MUSCLE NERVE, V42, P739, DOI 10.1002/mus.21758
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, NEUROMUSCULAR DISORD, V25, P563, DOI 10.1016/j.nmd.2015.03.001
   Gorman GS, 2015, NEW ENGL J MED, V372, P885, DOI 10.1056/NEJMc1500960
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Grady JP, 2018, MTDNA HETEROPLASMY L, V10, P0
   Greenfield A, 2017, NAT BIOTECHNOL, V35, P1059, DOI 10.1038/nbt.3997
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   Hirano M, 2012, STUDY IDEBENONE TREA, V0, P0
   Horvath R, 2012, J NEUROL NEUROSUR PS, V83, P174, DOI 10.1136/jnnp-2011-301258
   Hyslop LA, 2016, NATURE, V534, P383, DOI 10.1038/nature183030
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592
   Karaa A, 2018, NEUROLOGY, V90, PE1212, DOI 10.1212/WNL.0000000000005255
   Kaufmann P, 2009, STUDY OF IDEBENONE I, V0, P0
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koene S, 2017, ORPHANET J RARE DIS, V12, P0, DOI 10.1186/s13023-017-0715-0
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Morovat A, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6080080
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Nesbitt V, 2014, EUR J HUM GENET, V22, P1255, DOI 10.1038/ejhg.2014.35
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Reisman SA, 2014, RADIAT RES, V181, P512, DOI 10.1667/RR13578.1
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rygiel KA, 2016, J PHYSIOL-LONDON, V594, P4499, DOI 10.1113/JP271212
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Shen W, 2008, DIABETOLOGIA, V51, P165, DOI 10.1007/s00125-007-0852-4
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Siegel MP, 2013, AGING CELL, V12, P763, DOI 10.1111/acel.12102
   Smeets HJM, 2015, ANN NY ACAD SCI, V1350, P29, DOI 10.1111/nyas.12866
   Smith AC, 2016, NUCLEIC ACIDS RES, V44, PD1258, DOI 10.1093/nar/gkv1001
   Sommerville Ewen W, 2014, J NEUROMUSCUL DIS, V1, P119
   Stacpoole PW, 2012, MITOCHONDRION, V12, P623, DOI 10.1016/j.mito.2012.09.005
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Szeto HH, 2014, CLIN PHARMACOL THER, V96, P672, DOI 10.1038/clpt.2014.174
   Taivassalo T, 2002, ANN NEUROL, V51, P38, DOI 10.1002/ana.10027
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   van de Weijer T, 2015, DIABETES, V64, P1193, DOI 10.2337/db14-0667
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Volpi L, 2011, MUSCULOSKELET SURG, V95, P59, DOI 10.1007/s12306-011-0096-9
   Yamada M, 2016, CELL STEM CELL, V18, P749, DOI 10.1016/j.stem.2016.04.001
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   Zeviani M, 2008, BRAIN, V131, P2809, DOI 10.1093/brain/awn264
NR 78
TC 66
Z9 85
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1933-7213
EI 1878-7479
J9 NEUROTHERAPEUTICS
JI Neurotherapeutics
PD OCT 15
PY 2018
VL 15
IS 4
BP 943
EP 953
DI 10.1007/s13311-018-00674-4
PG 11
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA HD1QN
UT WOS:000452286500010
PM 30406383
DA 2024-11-01
ER

PT J
AU AlJabri, MF
   Kamal, NM
   Halabi, A
   Korbi, H
   Alsayyali, MMA
   Alzahrani, YA
AF AlJabri, Mohamed F.
   Kamal, Naglaa M.
   Halabi, Abdulrahman
   Korbi, Haifa
   Alsayyali, Mashhour M. A.
   Alzahrani, Yahea A.
TI Lethal neonatal mitochondrial phenotype caused by a novel polymerase subunit gamma mutation A case report
SO MEDICINE
LA English
DT Article
DE mitochondrial; neonatal; novel; polymerase subunit gamma mutation; Saudi
ID chain complex i; progressive external ophthalmoplegia; dna; deficiency; disease; polg; prevalence; depletion; childhood; myopathy
AB Rationale: Polymerase subunit gamma (POLG) is a gene that codes for the catalytic subunit of the mitochondrial DNA polymerase, which is involved in the replication of mitochondrial DNA. Mutations in these genes are associated with a range of clinical syndromes characterized by secondary mtDNA defect including mtDNA mutation and mtDNA depletion which may culminate in complete failure of energy production (respiratory changes complex 1 defect) as in this case. Patient concerns: We herein report a full term Saudi female neonate born to consanguineous parents, who was noticed immediately after birth to have severe hypotonia, poor respiratory effort, and dysmorphic features. She had 3 siblings who died with same clinical scenario in neonatal period. Diagnoses: Molecular genetic testing revealed a novel compound heterozygous mutation of POLG gene c.680G>A (p.Arg227Gin) and c.3098C>T (p.Ala1033Val). Interventions: The patient remained in neonatal intensive care unit with multidisciplinary team management and was ventilator dependent until she passed away. Outcomes: The detected mutation had led to complete failure of energy production (respiratory changes complex 1 defect) until she died at the age of 5 months. Lessons: Mitochondrial respiratory chain defect should be considered in patients with severe neonatal hypotonia, encephalopathy, and respiratory failure especially in highly consanguineous population.
C1 [AlJabri, Mohamed F.] Cairo Univ, Fac Med, Pediat Neurol, Cairo, Egypt.
   [Kamal, Naglaa M.] Cairo Univ, Fac Med, Pediat Hepatol, Cairo, Egypt.
   [Kamal, Naglaa M.] Alhada Armed Forces Hosp, Pediat Hepatol, At Taif, Saudi Arabia.
   [Halabi, Abdulrahman] Alhada Armed Forces Hosp, Pediat Neonatol, At Taif, Saudi Arabia.
   [Korbi, Haifa; Alsayyali, Mashhour M. A.] Alhada Armed Forces Hosp, Pediat, At Taif, Saudi Arabia.
   [Alzahrani, Yahea A.] Taif Univ, Coll Med, Neuroradiol, At Taif, Saudi Arabia.
C3 Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Al Hada Armed Forces Hospital; Al Hada Armed Forces Hospital; Al Hada Armed Forces Hospital; Taif University
RP Kamal, NM (corresponding author), Cairo Univ, Fac Med, Pediat & Pediat Hepatol, Cairo, Egypt.
EM Nagla.kamal@kasralainy.edu.eg
CR Arpa J, 2003, MUSCLE NERVE, V28, P690, DOI 10.1002/mus.10507
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Emmanuele V, 2011, J NEUROL SCI, V303, P39, DOI 10.1016/j.jns.2011.01.018
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Finsterer J, 2012, SEIZURE-EUR J EPILEP, V21, P316, DOI 10.1016/j.seizure.2012.03.003
   Giordano C, 2009, NEUROLOGY, V72, P1103, DOI 10.1212/01.wnl.0000345002.47396.e1
   Horváth R, 2005, NEUROMUSCULAR DISORD, V15, P851, DOI 10.1016/j.nmd.2005.09.005
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Uusimaa J, 2013, EPILEPSIA, V54, P1002, DOI 10.1111/epi.12115
   van den Heuvel L, 2001, BIOESSAYS, V23, P518, DOI 10.1002/bies.1071
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Worle H, 1998, CLIN NEUROPATHOL, V17, P63
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 29
TC 3
Z9 3
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD OCT 15
PY 2018
VL 97
IS 40
BP 
EP 
DI 10.1097/MD.0000000000012591
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA HD0WR
UT WOS:000452230500040
PM 30290626
DA 2024-11-01
ER

PT J
AU Hedermann, G
   Dahlqvist, JR
   Lokken, N
   Vissing, CR
   Knak, KL
   Andersen, LK
   Thomsen, C
   Vissing, J
AF Hedermann, Gitte
   Dahlqvist, Julia R.
   Lokken, Nicoline
   Vissing, Christoffer R.
   Knak, Kirsten Lykke
   Andersen, Linda Kahr
   Thomsen, Carsten
   Vissing, John
TI Progressive fat replacement of muscle contributes to the disease mechanism of patients with single, large-scale deletions of mitochondrial DNA
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Single large-scale deletion; Chronic progressive external ophthalmoplegia; CPEO; Mitochondrial myopathy; Mitochondrial DNA deletion; Muscle fat fraction; MRI; 3243A > G
ID external ophthalmoplegia; muscular-dystrophy; myopathy; phenotypes
AB Muscle dysfunction in mitochondrial myopathy is predominantly caused by insufficient generation of energy. We hypothesise that structural changes in muscles could also contribute to their pathophysiology. The aims of this study were to determine fat fractions and strength in selected muscles in patients with chronic progressive external ophthalmoplegia (CPEO), and compare progression of muscle fat fraction with age in individuals with CPEO vs. healthy controls and patients with the m.3243A>G mutation of mitochondrial DNA (mtDNA). Seventeen patients with CPEO and single large-scale deletions of mtDNA, 52 healthy controls, and 12 patients carrying the m.3243A>G mtDNA mutation were included. Muscle fat fractions were measured from cross-sections of paraspinal and leg muscles. Peak muscle strength was assessed from a static dynamometer. There was a direct correlation between age and fat fraction in all muscle groups in CPEO patients and healthy controls (p < 0.05). Analysis of covariance showed a higher progression rate of fat replacement in CPEO patients vs. healthy controls in studied muscle groups (p < 0.05). Patients with the m.3243A>G mutation had slower progression rates of fat replacement. Muscle strength decreased with increasing muscular fat fraction in CPEO patients, no correlation was seen in other groups. This indicates that structural muscle changes contribute to the phenotype of older patients affected by CPEO and large-scale deletions. It should therefore be considered, along with known energy deficiencies, as the cause of exercise intolerance. (C) 2018 Elsevier B.V. All rights reserved.
C1 [Hedermann, Gitte; Dahlqvist, Julia R.; Lokken, Nicoline; Vissing, Christoffer R.; Knak, Kirsten Lykke; Andersen, Linda Kahr; Vissing, John] Univ Copenhagen, Rigshosp, Dept Neurol, Copenhagen Neuromuscular Ctr, Copenhagen, Denmark.
   [Thomsen, Carsten] Univ Copenhagen, Rigshosp, Dept Diagnost Radiol, Copenhagen, Denmark.
C3 University of Copenhagen; Rigshospitalet; Rigshospitalet; University of Copenhagen
RP Hedermann, G (corresponding author), Univ Copenhagen, Rigshosp, Copenhagen Neuromuscular Ctr, Sect 3342,Dept Neurol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
EM hedermann@gmail.com
FU Genzyme/Sanofi; Ultragenyx Pharmaceuticals
CR Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Dahlqvist JR, 2017, MED SCI SPORT EXER, V49, P595, DOI 10.1249/MSS.0000000000001119
   Dahlqvist JR, 2014, NEUROLOGY, V83, P1178, DOI 10.1212/WNL.0000000000000828
   Danneskiold-Samsoe B, 2009, ACTA PHYSIOL, V197, P1, DOI 10.1111/j.1748-1716.2009.02022.x
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Harbo T, 2012, EUR J APPL PHYSIOL, V112, P267, DOI 10.1007/s00421-011-1975-3
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Kiyomoto BH, 2006, J NEUROL NEUROSUR PS, V77, P541, DOI 10.1136/jnnp.2005.079954
   Krag TO, 2013, MITOCHONDRION, V13, P63, DOI 10.1016/j.mito.2013.01.009
   Lokken N, 2016, ANN NEUROL, V80, P466, DOI 10.1002/ana.24743
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, P0, DOI 10.1007/s11910-016-0652-7
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Olsen DB, 2003, J NEUROL, V250, P1328, DOI 10.1007/s00415-003-0206-1
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Schoser BGH, 2006, STRABISMUS, V14, P107, DOI 10.1080/09273970600701218
   Smits BW, 2011, NEUROMUSCULAR DISORD, V21, P272, DOI 10.1016/j.nmd.2010.12.008
NR 17
TC 8
Z9 8
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD MAY 15
PY 2018
VL 28
IS 5
BP 408
EP 413
DI 10.1016/j.nmd.2018.02.008
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GJ1VP
UT WOS:000435056300004
PM 29567350
DA 2024-11-01
ER

PT J
AU Scarpelli, M
   Carreño-Gago, L
   Russignan, A
   de Luna, N
   Carnicer-Cáceres, C
   Ariatti, A
   Verriello, L
   Devigili, G
   Tonin, P
   Garcia-Arumi, E
   Pinós, T
AF Scarpelli, Mauro
   Carreno-Gago, Lidia
   Russignan, Anna
   de Luna, Noemi
   Carnicer-Caceres, Clara
   Ariatti, Alessandra
   Verriello, Lorenzo
   Devigili, Grazia
   Tonin, Paola
   Garcia-Arumi, Elena
   Pinos, Tomas
TI Identification and characterization of the novel m.8305C&gt;T <i>MTTK</i> and m.4440G&gt;A <i>MTTM</i> gene mutations causing mitochondrial myopathies
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Myopathy; Mitochondrial diseases; PEO; mtDNA
ID exercise intolerance; merrf mutation; muscle
AB We report on two novel mtDNA mutations in patients affected with mitochondrial myopathy. The first patient, a 44-year-old woman, had bilateral eyelid ptosis and the m.8305C>T mutation in the MTTK gene. The second patient, a 56-year-old man, had four-limb muscle weakness and the MTTM gene m.4440G>A mutation. Muscle biopsies in both patients showed ragged red fibers and numerous COX-negative fibers as well as a combined defect of complex I, III and IV activities. The two mutations were heteroplasmic and detected only in muscle tissue, with a higher mutation load in COX-negative fibers. Additionally, both mutations occurred in highly conserved mt-tRNA sites, and were not found by an in silico search in 30,589 human mtDNA sequences. Our report further expands the mutational and phenotypic spectrum of diseases associated with mutations in mitochondrial tRNA genes and reinforces the notion that mutations in mitochondrial tRNAs represent hot spots for mitochondrial myopathies in adults. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Scarpelli, Mauro; Russignan, Anna; Tonin, Paola] Univ Verona, Dept Neurol Biomed & Movement Sci, Neurol Sect, Verona, Italy.
   [Carreno-Gago, Lidia; Garcia-Arumi, Elena; Pinos, Tomas] Vall Hebron Inst Recerca, Mitochondrial Disorders Unit, Barcelona, Spain.
   [Carreno-Gago, Lidia; de Luna, Noemi; Garcia-Arumi, Elena; Pinos, Tomas] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain.
   [de Luna, Noemi] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Inst Recerca, Lab Malalties Neuromusculars, Barcelona, Spain.
   [Carnicer-Caceres, Clara] Hosp Univ Vall dHebron, Serv Bioquim, Unidad Metabolopatias, Barcelona, Spain.
   [Ariatti, Alessandra] Univ Hosp Modena, Dept Neurosci, Modena, Italy.
   [Ariatti, Alessandra] Univ Hosp Modena, Dept Oncohaematol, Modena, Italy.
   [Ariatti, Alessandra] Univ Hosp Reggio Emilia, Dept Neurosci, Reggio Emilia, Italy.
   [Ariatti, Alessandra] Univ Hosp Reggio Emilia, Dept Oncohaematol, Reggio Emilia, Italy.
   [Verriello, Lorenzo; Devigili, Grazia] Azienda Osped Univ, Dept Neurosci, Div Neurol, Udine, Italy.
   [Garcia-Arumi, Elena] Hosp Univ Vall dHebron, Area Genet Clin & Mol, Barcelona, Spain.
   [Scarpelli, Mauro] Azienda Osped Univ Integrata, Dept Neurosci, Div Neurol, Verona, Italy.
C3 University of Verona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital Universitari Vall d'Hebron; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; University of Udine; University Hospital of Udine; Hospital Universitari Vall d'Hebron; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona
RP Garcia-Arumi, E; Pinós, T (corresponding author), Vall Hebron Inst Recerca, Mitochondrial Disorders Unit, Barcelona, Spain.; Garcia-Arumi, E (corresponding author), Hosp Univ Vall dHebron Inst Recerca VHIR, Dept Patol Mitocondrial & Neuromuscular, Barcelona, Spain.
EM elena.garcia@vhir.org; tomas.pinos@vhir.org
FU Spanish Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias (FIS); FIS [PI12-02149-FEDER, PI15/01428-FEDER]
CR Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Born AP, 2015, EUR J PAEDIATR NEURO, V19, P69, DOI 10.1016/j.ejpn.2014.10.006
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Dubowitz V, 2007, MUSCLE BIOPSY: A PRACTICAL APPROACH, V0, P0
   Jeppesen TD, 2014, NEUROMUSCULAR DISORD, V24, P162, DOI 10.1016/j.nmd.2013.08.004
   King TE, 1967, METHODS ENZYMOLOGY, V10, P322, DOI 10.1016/0076-6879(67)10061-X
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Marotta M, 2007, NEUROMUSCULAR DISORD, V17, P707, DOI 10.1016/j.nmd.2007.05.007
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   MORAES CT, 1989, BIOCHEM BIOPH RES CO, V160, P765, DOI 10.1016/0006-291X(89)92499-6
   Olsen DB, 2003, J NEUROL, V250, P1328, DOI 10.1007/s00415-003-0206-1
   Peverelli L, 2014, MUSCLE NERVE, V50, P292, DOI 10.1002/mus.24262
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
NR 16
TC 4
Z9 4
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD FEB 15
PY 2018
VL 28
IS 2
BP 137
EP 143
DI 10.1016/j.nmd.2017.10.006
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GA7AP
UT WOS:000428487300005
PM 29174468
DA 2024-11-01
ER

PT J
AU Peralta, S
   Goffart, S
   Williams, SL
   Diaz, F
   Garcia, S
   Nissanka, N
   Area-Gomez, E
   Pohjoismäki, J
   Moraes, CT
AF Peralta, Susana
   Goffart, Steffi
   Williams, Sion L.
   Diaz, Francisca
   Garcia, Sofia
   Nissanka, Nadee
   Area-Gomez, Estela
   Pohjoismaki, Jaakko
   Moraes, Carlos T.
TI ATAD3 controls mitochondrial cristae structure in mouse muscle, influencing mtDNA replication and cholesterol levels
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE ATAD3; Mitochondria; Cristae; MICOS complex; Muscle; Cholesterol
ID domain-containing 3a; membrane-protein; skeletal-muscle; atp synthase; molecular characterization; helicase twinkle; control region; contact site; cell-lines; dna
AB Mutations in the mitochondrial inner membrane ATPase ATAD3A result in neurological syndromes in humans. In mice, the ubiquitous disruption of Atad3 (also known as Atad3a) was embryonic lethal, but a skeletal muscle-specific conditional knockout (KO) was viable. At birth, ATAD3 muscle KO mice had normal weight, but from 2 months onwards they showed progressive motor-impaired coordination and weakness. Loss of ATAD3 caused early and severe mitochondrial structural abnormalities, mitochondrial proliferation and muscle atrophy. There was dramatic reduction in mitochondrial cristae junctions and overall cristae morphology. The lack of mitochondrial cristae was accompanied by a reduction in high molecular weight mitochondrial contact site and cristae organizing system (MICOS) complexes, and to a lesser extent in OPA1. Moreover, muscles lacking ATAD3 showed altered cholesterol metabolism, accumulation of mitochondrial DNA (mtDNA) replication intermediates, progressive mtDNA depletion and deletions. Unexpectedly, decreases in the levels of some OXPHOS components occurred after cristae destabilization, indicating that ATAD3 is not crucial for mitochondrial translation, as previously suggested. Our results show a critical early role of ATAD3 in regulating mitochondrial inner membrane structure, leading to secondary defects in mtDNA replication and complex V and cholesterol levels in postmitotic tissue. This article has an associated First Person interview with the first author of the paper.
C1 [Peralta, Susana; Williams, Sion L.; Diaz, Francisca; Garcia, Sofia; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Goffart, Steffi; Pohjoismaki, Jaakko] Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu 80101, Finland.
   [Nissanka, Nadee; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Neurosci Grad Program, Miami, FL 33136 USA.
   [Area-Gomez, Estela] Columbia Univ, Dept Neurol, Res ARTICLE ATAD3 controls mitochondrial cristae, New York, NY 10032 USA.
   [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.
C3 University of Miami; University of Eastern Finland; University of Miami; Columbia University; University of Miami
RP Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.; Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Neurosci Grad Program, Miami, FL 33136 USA.; Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.
EM cmoraes@med.miami.edu
FU National Institute of Neurological Disorders and Stroke [1R01NS079965]; National Institute on Aging [1R01AG036871]; National Eye Institute [5R01EY010804]; National Institutes of Health [P30-EY014801]; American Heart Association [16PRE30480009]; American Heart Association (AHA) [16PRE30480009] Funding Source: American Heart Association (AHA)
CR [Anonymous], 2009, CURRENT PROTOCOLS HU, V0, P0, DOI DOI 10.1002/0471142905.HG1904S63
   Barrientos Antoni, 2009, CURR PROTOC HUM GENET, VChapter 19, P0, DOI 10.1002/0471142905.hg1903s63
   Baudier J, 2018, BIOL REV, V93, P827, DOI 10.1111/brv.12373
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F
   BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8
   Cámara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002
   Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005
   Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Civiletto G, 2015, CELL METAB, V21, P845, DOI 10.1016/j.cmet.2015.04.016
   Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Cooper HM, 2017, HUM MOL GENET, V26, P1432, DOI 10.1093/hmg/ddx042
   Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109
   Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108
   Desai R, 2017, BRAIN, V140, P1595, DOI 10.1093/brain/awx094
   Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Fang HY, 2010, J CELL SCI, V123, P1171, DOI 10.1242/jcs.062034
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020
   Friedman KL, 1995, METHOD ENZYMOL, V262, P613
   Gerhold JM, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15292
   Gilkerson RW, 2003, FEBS LETT, V546, P355, DOI 10.1016/S0014-5793(03)00633-1
   Gilquin B, 2010, MOL CELL BIOL, V30, P1984, DOI 10.1128/MCB.00007-10
   Glytsou C, 2016, CELL REP, V17, P3024, DOI 10.1016/j.celrep.2016.11.049
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Goller T, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0054799
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Harel T, 2016, AM J HUM GENET, V99, P831, DOI 10.1016/j.ajhg.2016.08.007
   HARMALA AS, 1994, BBA-LIPID LIPID MET, V1211, P317, DOI 10.1016/0005-2760(94)90156-2
   Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379
   He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266
   He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158
   Hoffmann M, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0007644
   Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004
   Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053
   Hubstenberger A, 2008, EXP CELL RES, V314, P2870, DOI 10.1016/j.yexcr.2008.06.017
   Hubstenberger A, 2010, J BIOENERG BIOMEMBR, V42, P143, DOI 10.1007/s10863-010-9269-8
   Iaea DB, 2015, ESSAYS BIOCHEM, V57, P43, DOI 10.1042/bse0570043
   Iommarini L, 2015, MITOCHONDRION, V22, P96, DOI 10.1016/j.mito.2015.01.008
   Issop L, 2015, ENDOCRINOLOGY, V156, P334, DOI 10.1210/en.2014-1503
   John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.E04-08-0697
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Lewis SC, 2016, SCIENCE, V353, P0, DOI 10.1126/science.aaf5549
   Li H, 2016, CELL DEATH DIFFER, V23, P380, DOI 10.1038/cdd.2015.102
   Li SJ, 2014, GENE, V535, P60, DOI 10.1016/j.gene.2013.10.062
   Li SJ, 2012, J BIOENERG BIOMEMBR, V44, P189, DOI 10.1007/s10863-012-9424-5
   LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Mourier A, 2014, HUM MOL GENET, V23, P2580, DOI 10.1093/hmg/ddt652
   Neuhaus JFG, 2014, BRAIN, V137, P354, DOI 10.1093/brain/awt291
   Odgren PR, 1996, J CELL SCI, V109, P2253
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   Peralta S, 2016, HUM MOL GENET, V25, P3178, DOI 10.1093/hmg/ddw167
   Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006
   Pohjoismäki JLO, 2011, MITOCHONDRION, V11, P630, DOI 10.1016/j.mito.2011.04.002
   Rebelo AP, 2009, NUCLEIC ACIDS RES, V37, P6701, DOI 10.1093/nar/gkp727
   ROWLAND LP, 1991, REV NEUROL-FRANCE, V147, P467
   Schaffrik M, 2006, CELL MOL LIFE SCI, V63, P2162, DOI 10.1007/s00018-006-6200-x
   SCHMALBRUCH H, 1977, ANAT RECORD, V189, P169, DOI 10.1002/ar.1091890204
   SLOTTE JP, 1990, BIOCHIM BIOPHYS ACTA, V1030, P251, DOI 10.1016/0005-2736(90)90301-4
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Szczepanowska K, 2016, EMBO J, V35, P2566, DOI 10.15252/embj.201694253
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138
   von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352
   Williams SL, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003990
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   You WC, 2013, NEURO-ONCOLOGY, V15, P1342, DOI 10.1093/neuonc/not077
NR 83
TC 65
Z9 71
U1 1
U2 18
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD JUL 15
PY 2018
VL 131
IS 13
BP 
EP 
DI 10.1242/jcs.217075
PG 15
WC Cell Biology
SC Cell Biology
GA GS2WE
UT WOS:000443422700013
PM 29898916
DA 2024-11-01
ER

PT J
AU Miyaue, N
   Yamanishi, Y
   Tada, S
   Ando, R
   Nagai, M
   Nomoto, M
AF Miyaue, Noriyuki
   Yamanishi, Yuki
   Tada, Satoshi
   Ando, Rina
   Nagai, Masahiro
   Nomoto, Masahiro
TI Falling After Starting Running in a Case of Myoclonus Epilepsy Associated with Ragged-red Fibers with a 8344A&gt;G mtDNA Mutation
SO INTERNAL MEDICINE
LA English
DT Article
DE MERRF; mitochondrial myopathy; paroxysmal exercise-induced dyskinesia; paroxysmal kinesigenic dyskinesia
ID mitochondrial-dna mutations; disease; heterogeneity; prevalence
AB Myoclonus epilepsy associated with ragged-red fibers (MERRF) is traditionally characterized by myoclonus, generalized epilepsy and ragged-red fibers. We herein report a 42-year-old man who complained of falling after starting running, symptoms resembling those of paroxysmal kinesigenic dyskinesia. He showed only slight muscle weakness of the right quadriceps femoris. Muscle pathology and a genetic analysis identified him as having MERRF with a 8344A>G mtDNA mutation. We diagnosed his symptoms as having been caused by slight quadriceps femoris muscle weakness and exercise intolerance. This case suggests that mitochondrial myopathy should be considered in cases with strong muscle symptoms for muscle weakness.
C1 [Miyaue, Noriyuki; Yamanishi, Yuki; Tada, Satoshi; Ando, Rina; Nagai, Masahiro; Nomoto, Masahiro] Ehime Univ, Grad Sch Med, Dept Neurol & Clin Pharmacol, Matsuyama, Ehime, Japan.
C3 Ehime University
RP Miyaue, N (corresponding author), Ehime Univ, Grad Sch Med, Dept Neurol & Clin Pharmacol, Matsuyama, Ehime, Japan.
EM miyaue.noriyuki.ec@ehime-u.ac.jp
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   Arnold CM, 2012, PHYSIOTHER CAN, V64, P302, DOI 10.3138/ptc.2011-12BH
   Bhatia KP, 2011, MOVEMENT DISORD, V26, P1157, DOI 10.1002/mds.23765
   Bruno MK, 2004, NEUROLOGY, V63, P2280, DOI 10.1212/01.WNL.0000147298.05983.50
   Burgstaller JP, 2015, MOL HUM REPROD, V21, P11, DOI 10.1093/molehr/gau090
   Erro R, 2014, MOVEMENT DISORD, V29, P1108, DOI 10.1002/mds.25933
   Finsterer J, 2002, CAN J NEUROL SCI, V29, P49, DOI 10.1017/S0317167100001712
   Friedman J, 2017, NEUROLOGY, V89, P2297, DOI 10.1212/WNL.0000000000004689
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Gámez J, 1998, NEUROLOGY, V51, P258, DOI 10.1212/WNL.51.1.258
   Gardiner AR, 2015, BRAIN, V138, P3567, DOI 10.1093/brain/awv310
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Han JY, 2014, J CLIN NEUROSCI, V21, P2009, DOI 10.1016/j.jocn.2014.03.020
   Lorenzoni PJ, 2014, ARQ NEURO-PSIQUIAT, V72, P803, DOI 10.1590/0004-282X20140124
   Mancuso M, 2012, NEUROMUSCULAR DISORD, V22, PS226, DOI 10.1016/j.nmd.2012.10.012
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Méneret A, 2016, REV NEUROL-FRANCE, V172, P433, DOI 10.1016/j.neurol.2016.07.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Sharma NK, 2002, J NEUROL NEUROSUR PS, V73, P95, DOI 10.1136/jnnp.73.1.95
   SHOFFNER JM, 1992, AM J HUM GENET, V51, P1179
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   van Rootselaar Anne-Fleur, 2009, PRACT NEUROL, V9, P102, DOI 10.1136/jnnp.2009.172213
NR 22
TC 5
Z9 5
U1 0
U2 1
PU JAPAN SOC INTERNAL MEDICINE
PI TOKYO
PA 34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN
SN 0918-2918
EI 1349-7235
J9 INTERNAL MED
JI Intern. Med.
PD JUN 15
PY 2018
VL 57
IS 23
BP 3439
EP 3443
DI 10.2169/internalmedicine.1210-18
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA HD2QE
UT WOS:000452354400018
PM 29984755
DA 2024-11-01
ER

PT J
AU Lee, SJ
   Na, JH
   Han, J
   Lee, YM
AF Lee, Sang-Jun
   Na, Ji-Hoon
   Han, Jinu
   Lee, Young-Mock
TI Ophthalmoplegia in Mitochondrial Disease
SO YONSEI MEDICAL JOURNAL
LA English
DT Article
DE Mitochondrial diseases; Kearns-Sayre syndrome; ophthalmoplegia; chronic progressive external ophthalmoplegia
ID kearns-sayre-syndrome; pediatric-patients; clinical spectrum; disorders; childhood; children; manifestations; adults
AB Purpose: To evaluate the classification, diagnosis, and natural course of ophthalmoplegia associated with mitochondrial disease. Materials and Methods: Among 372 patients with mitochondria' disease who visited our hospital between Janu-ary 2006 and January 2016, 21 patients with ophthalmoplegia were retrospectively identified. Inclusion criteria included onset before 20 years of age, pigmentary retinopathy, and cardiac involvement. The 16 patients who were finally included in the study were divided into three groups according to disease type: Kearns-Sayre syndrome (KSS), KSS-like, and chronic progressive external oplithalmoplegia (CPEO). Results: The prevalences of clinical findings were as Ibllows: ptosis and retinopathy, both over 80%; myopathy, including extraocular muscles, 75%; lactic acidosis, 71%; and elevated levels of serum creatine kinase, 47%. Half of the patients had normal mag-netic resonance imaging findings. A biochemical enzyme assay revealed mitochondria' respiratory chain complex I defect as the most common (50%). The prevalence of abnormal muscle findings in light or electron microscopic examinations was 50% each, while that of large-scale mitochondria' DNA (mtDNA) deletions in a gene study was 25%. We compared the KSS and KSS-like groups with the CPEO patient group, which showed pigmentary retinopathy (p<0.001), cardiac conduction disease (p=0.013), and large-scale mtDNA deletions (p=0.038). KSS and KSS-like groups also had gastrointestinal tract disorders such as abnormal gastrointestinal motility (p=0.013) unlike the CPEO group. Conclusion: Patients with KSS had gastrointestinal symptoms, which may indicate another aspect of systemic involvement. The presence of large-scale mtDNA deletions was an objective diagnostic factor for KSS and a gene study may be helpful for evaluating patients with KSS.
C1 [Lee, Sang-Jun; Na, Ji-Hoon; Lee, Young-Mock] Yonsei Univ, Dept Pediat, Gangnam Severance Hosp, Severance Childrens Hosp,Coll Med, Seoul, South Korea.
   [Han, Jinu] Yonsei Univ, Dept Ophthalmol, Inst Vis Res, Gangnam Severance Hosp,Coll Med, Seoul, South Korea.
   [Lee, Young-Mock] Yonsei Univ, Epilepsy Res Inst, Coll Med, Seoul, South Korea.
C3 Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System
RP Lee, YM (corresponding author), Yonsei Univ, Dept Pediat, Coll Med, 211 Eonju Ro, Seoul 06273, South Korea.
EM ymleemd@yuhs.ac
FU Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health& Welfare, Republic of Korea [HI16C0673]
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Chawla S, 2008, PEDIATR CARDIOL, V29, P659, DOI 10.1007/s00246-007-9040-z
   Choi HS, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-17256-7
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Eom S, 2017, PEDIATR NEUROL, V71, P43, DOI 10.1016/j.pediatrneurol.2017.01.019
   Eom S, 2017, PEDIATR NEUROL, V66, P82, DOI 10.1016/j.pediatrneurol.2016.10.006
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Finsterer J, 2006, NETH J MED, V64, P61
   García-Cazorla A, 2005, PEDIATRICS, V116, P1170, DOI 10.1542/peds.2004-2407
   Grönlund MA, 2010, BRIT J OPHTHALMOL, V94, P121, DOI 10.1136/bjo.2008.154187
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Han J, 2015, BRIT J OPHTHALMOL, V99, P528, DOI 10.1136/bjophthalmol-2014-305704
   Heidenreich JO, 2006, AM J ROENTGENOL, V187, P820, DOI 10.2214/AJR.05.0180
   Joyce NC, 2012, PHYS MED REH CLIN N, V23, P609, DOI 10.1016/j.pmr.2012.06.006
   Kisler JE, 2010, DEV MED CHILD NEUROL, V52, P422, DOI 10.1111/j.1469-8749.2009.03605.x
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Mkaouar-Rebai E, 2010, MITOCHONDRION, V10, P449, DOI 10.1016/j.mito.2010.04.003
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   Park SB, 2004, YONSEI MED J, V45, P727, DOI 10.3349/ymj.2004.45.4.727
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Sharma AK, 2016, BMJ CASE REP, V2016, P0
   Skladal D, 2003, CLIN PEDIATR, V42, P703, DOI 10.1177/000992280304200806
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Young TJ, 2005, PACE, V28, P454, DOI 10.1111/j.1540-8159.2005.40049.x
NR 26
TC 13
Z9 14
U1 0
U2 3
PU YONSEI UNIV COLL MEDICINE
PI SEOUL
PA 50-1 YONSEI-RO, SEODAEMUN-GU, SEOUL 120-752, SOUTH KOREA
SN 0513-5796
EI 1976-2437
J9 YONSEI MED J
JI Yonsei Med. J.
PD DEC 15
PY 2018
VL 59
IS 10
BP 1190
EP 1196
DI 10.3349/ymj.2018.59.10.1190
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA HA6FD
UT WOS:000450374400007
PM 30450853
DA 2024-11-01
ER

PT J
AU Li, L
   Wu, CS
   Hou, GM
   Dong, MZ
   Wang, ZB
   Hou, Y
   Schatten, H
   Zhang, GR
   Sun, QY
AF Li, Li
   Wu, Chang-Sheng
   Hou, Guan-Mei
   Dong, Ming-Zhe
   Wang, Zhen-Bo
   Hou, Yi
   Schatten, Heide
   Zhang, Gui-Rong
   Sun, Qing-Yuan
TI Type 2 diabetes increases oocyte mtDNA mutations which are eliminated in the offspring by bottleneck effect
SO REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY
LA English
DT Article
DE Diabetes; Oocyte; mtDNA mutation; Bottleneck
ID mitochondrial-dna mutations; dysfunction; prevalence; fertility; disease; muscle; growth
AB BackgroundDiabetes induces many complications including reduced fertility and low oocyte quality, but whether it causes increased mtDNA mutations is unknown.MethodsWe generated a T2D mouse model by using high-fat-diet (HFD) and Streptozotocin (STZ) injection. We examined mtDNA mutations in oocytes of diabetic mice by high-throughput sequencing techniques.ResultsT2D mice showed glucose intolerance, insulin resistance, low fecundity compared to the control group. T2D oocytes showed increased mtDNA mutation sites and mutation numbers compared to the control counterparts. mtDNA mutation examination in F1 mice showed that the mitochondrial bottleneck could eliminate mtDNA mutations.ConclusionsT2D mice have increased mtDNA mutation sites and mtDNA mutation numbers in oocytes compared to the counterparts, while these adverse effects can be eliminated by the bottleneck effect in their offspring. This is the first study using a small number of oocytes to examine mtDNA mutations in diabetic mothers and offspring.
C1 [Li, Li; Hou, Guan-Mei; Dong, Ming-Zhe; Wang, Zhen-Bo; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.
   [Li, Li; Dong, Ming-Zhe; Wang, Zhen-Bo; Sun, Qing-Yuan] Univ Chinese Acad Sci, Beijing 100101, Peoples R China.
   [Wu, Chang-Sheng; Zhang, Gui-Rong] Peking Medriv Acad Genet & Reprod, Beijing 102629, Peoples R China.
   [Hou, Guan-Mei] Qingdao Agr Univ, Coll Life Sci, Qingdao 266109, Peoples R China.
   [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.
C3 Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Qingdao Agricultural University; University of Missouri System; University of Missouri Columbia
RP Sun, QY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Sun, QY (corresponding author), Univ Chinese Acad Sci, Beijing 100101, Peoples R China.; Zhang, GR (corresponding author), Peking Medriv Acad Genet & Reprod, Beijing 102629, Peoples R China.
EM guirong_zhang@126.com; sunqy1@yahoo.com
FU National Key R&D Program of China [2016YFA0100400]; National Natural Science Foundation of China [31272260, 31371451]
CR Abuaisha B, 1998, DIABETES RES CLIN PR, V39, P93, DOI 10.1016/S0168-8227(97)00111-3
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chinnery PF, 2000, ANN NEUROL, V48, P1097, DOI 10. 1002/1531-8249(200008)48:2&LT;188::AID-ANA8&GT;3. 0. CO;2-P
   Diot A, 2016, BIOCHEM SOC T, V44, P1091, DOI 10.1042/BST20160095
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Gokina NI, 2013, AM J PHYSIOL-HEART C, V304, PH935, DOI 10.1152/ajpheart.00513.2012
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   HOLT IJ, 1989, NUCLEIC ACIDS RES, V17, P4465, DOI 10.1093/nar/17.12.4465
   Jiang J, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0154665
   Langmead B, 2009, GENOME BIOL, V10, P0, DOI 10.1186/gb-2009-10-3-r25
   Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Isidro ML, 2012, POSTGRAD MED J, V88, P152, DOI 10.1136/postgradmedj-2011-130069
   Luo J, 1998, METABOLISM, V47, P663, DOI 10.1016/S0026-0495(98)90027-0
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   McLaren W, 2016, GENOME BIOL, V17, P0, DOI 10.1186/s13059-016-0974-4
   Morimoto S, 2012, J DEV ORIG HLTH DIS, V3, P483, DOI 10.1017/S2040174412000463
   Navarro-Casado L, 2010, J ANDROL, V31, P584, DOI 10.2164/jandrol.108.007260
   Otten ABC, 2015, HUM REPROD UPDATE, V21, P671, DOI 10.1093/humupd/dmv024
   Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b
   Pamir N, 2003, AM J PHYSIOL-ENDOC M, V284, PE931, DOI 10.1152/ajpendo.00270.2002
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Sutton-McDowall ML, 2010, REPRODUCTION, V139, P685, DOI 10.1530/REP-09-0345
   Tam ZY, 2015, PLOS COMPUT BIOL, V11, P0, DOI 10.1371/journal.pcbi.1004183
   Tian Y, 2016, TRENDS CELL BIOL, V26, P563, DOI 10.1016/j.tcb.2016.06.006
   Vrachnis N, 2012, EXP DIABETES RES, V0, P0, DOI DOI 10.1155/2012/538474
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang QA, 2010, MITOCHONDRION, V10, P403, DOI 10.1016/j.mito.2010.03.002
   Wei YC, 2014, P NATL ACAD SCI USA, V111, P1873, DOI 10.1073/pnas.1321195111
   Wyman A, 2008, ENDOCRINOLOGY, V149, P466, DOI 10.1210/en.2007-1273
   Zhang CH, 2013, REPROD BIOL ENDOCRIN, V11, P0, DOI 10.1186/1477-7827-11-31
NR 38
TC 16
Z9 16
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1477-7827
EI 
J9 REPROD BIOL ENDOCRIN
JI Reprod. Biol. Endocrinol.
PD NOV 3
PY 2018
VL 16
IS 
BP 
EP 
DI 10.1186/s12958-018-0423-1
PG 8
WC Endocrinology & Metabolism; Reproductive Biology
SC Endocrinology & Metabolism; Reproductive Biology
GA HC3ZB
UT WOS:000451741000001
PM 30390692
DA 2024-11-01
ER

PT J
AU Zhou, Y
   Yi, JH
   Liu, L
   Wang, XP
   Dong, L
   Du, AL
AF Zhou, Ying
   Yi, Jianhua
   Liu, Li
   Wang, Xiaoping
   Dong, Liang
   Du, Ailian
TI Acute mitochondrial myopathy with respiratory insufficiency and motor axonal polyneuropathy
SO INTERNATIONAL JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE Pure mitochondrial myopathy; lactic acidosis; respiratory failure; acute motor axonal neuropathy; pyrosequencing
ID merrf mutation; gene; diagnosis; dna; failure
AB Background: Mitochondrial myopathies (MMs) are mainly presented with chronic muscle weakness and accompanied with other syndromes. MM with acute respiratory insufficiency is rare. Aims: To reveal the clinical, pathological and molecular characteristics of a life-threatening MM. Methods: Muscle biopsy and enzyme staining were performed in skeletal muscles. Mitochondrial DNA (mtDNA) sequencing was analyzed and heteroplasmy were quantified by pyrosequencing. Results: All three patients had tachycardia, acute lactic acidosis, dyspnea and sudden severe muscle weakness. Two patients had calf edema and abdominal pain, and one had a heart attack. Electromyography in two patients showed dramatically decreased axonal amplitudes of motor nerves. Muscle biopsies showed ragged red fibers and dramatic mitochondrial abnormality. A mtDNA m.3243A>G mutation was identified in Patient 1 (mutation load: 29% in blood and 73% in muscle) and Patient 3 (79% in blood and 89% in muscle). A mtDNA m.8344A>G mutation was found in Patient 2 (mutation load 80.4% in blood). Conclusion: MM characterized by lactic acidosis, respiratory failure and acute motor axonal neuropathy is life threatening.
C1 [Zhou, Ying; Dong, Liang] Zhejiang Univ, Affiliated Hosp 2, Dept Cardiol, Sch Med, Hangzhou, Zhejiang, Peoples R China.
   [Yi, Jianhua] Zhejiang Univ, Affiliated Hosp 2, Dept Emergency Med, Sch Med, Hangzhou, Zhejiang, Peoples R China.
   [Liu, Li] Zhejiang Univ, Inst Genet, Coll Life Sci, Mitochondrial Dis Res Ctr, Hangzhou, Zhejiang, Peoples R China.
   [Wang, Xiaoping; Du, Ailian] Shanghai Jiao Tong Univ, Tongren Hosp, Dept Neurol, Sch Med, Shanghai, Peoples R China.
C3 Zhejiang University; Zhejiang University; Zhejiang University; Shanghai Jiao Tong University
RP Du, AL (corresponding author), Shanghai Jiao Tong Univ, Tongren Hosp, Dept Neurol, Sch Med, Shanghai, Peoples R China.
EM lotusdu@126.com
FU National Natural Science Foundation of China [81200967]; Shanghai Municipal Health and Family Planning Commission [201540050]
CR Amornvit Jakkrit, 2014, JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, V97, P467
   Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Bruno C, 2003, J CHILD NEUROL, V18, P300, DOI 10.1177/08830738030180040401
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Houshmand M, 1996, HUM GENET, V97, P269, DOI 10.1007/BF02185750
   Kärppä M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   Milone M, 2013, MOL GENET METAB, V110, P35, DOI 10.1016/j.ymgme.2013.07.007
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Rivera H, 2010, MITOCHONDRION, V10, P362, DOI 10.1016/j.mito.2010.03.003
   Steele HE, 2016, NEUROLOGY, V87, P1031, DOI 10.1212/WNL.0000000000003064
   Swalwell H, 2006, NEUROLOGY, V66, P447, DOI 10.1212/01.wnl.0000196490.36349.83
   SWEENEY MG, 1993, Q J MED, V86, P709
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Yan JB, 2014, J MOL DIAGN, V16, P431, DOI 10.1016/j.jmoldx.2014.03.005
NR 15
TC 9
Z9 10
U1 0
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0020-7454
EI 1563-5279
J9 INT J NEUROSCI
JI Int. J. Neurosci.
PD JUN 15
PY 2018
VL 128
IS 3
BP 231
EP 236
DI 10.1080/00207454.2017.1387113
PG 6
WC Neurosciences
SC Neurosciences & Neurology
GA GA2GQ
UT WOS:000428135600004
PM 28969510
DA 2024-11-01
ER

PT J
AU Ishikawa, T
   Somiya, K
   Munechika, R
   Harashima, H
   Yamada, Y
AF Ishikawa, Takuya
   Somiya, Kana
   Munechika, Reina
   Harashima, Hideyoshi
   Yamada, Yuma
TI Mitochondrial transgene expression <i>via</i> an artificial mitochondrial DNA vector in cells from a patient with a mitochondrial disease
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Mitochondria; Transgene expression; Independent clinical study; Mitochondrial disease's patient; Mitochondrial delivery; MITO-Porter
ID skeletal-muscle; gene delivery; mito-porter; peptide; validation; injection; promoter; mutation; system
AB To achieve mitochondrial gene therapy, developing a mitochondrial transgene expression system that produces therapeutic proteins in mitochondria of disease cells is essential. We previously reported on the design of pCMV-mtLuc (CGG) containing a CMV promotor and a NanoLuc (Nluc) luciferase gene that records adjustments to the mitochondrial codon system, and showed that the mitochondrial transfection of pCMV-mtLuc (CGG) resulted in the efficient production of the Nluc luciferase protein in human HeLa cells. This mitochondrial transfection was achieved using a MITO-Porter, a liposome-based carrier for delivering a cargo to mitochondria via membrane fusion. We report herein that mitochondrial transfection using the MITO-Porter results in mitochondrial transgene expression in G625A fibroblasts obtained from a patient with a mitochondrial disease. We investigated the effect of promoters and the basic structure of pCMV-mtLuc (CGG) on gene expression efficiency, and were able to construct a high performance mitochondrial DNA vector, pCMV-mtLuc (CGG) [hND4] that contains a human mitochondrial endogenous gene. We also constructed an RP/KALA-MITO-Porter composed of the KALA peptide (cell-penetrating peptide) with a mitochondrial RNA aptamer to enhance cellular uptake and mitochondrial targeting. Finally, the mitochondrial transfection of pCMV-mtLuc (CGG) [hND4] in G625A fibroblasts using the RP/KALA-MITO-Porter resulted in strong mitochondrial transgene expression.
C1 [Ishikawa, Takuya; Somiya, Kana; Munechika, Reina; Harashima, Hideyoshi; Yamada, Yuma] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan.
C3 Hokkaido University
RP Yamada, Y (corresponding author), Kita 12,Nishi 6,Kita Ku, Sapporo, Hokkaido 0600812, Japan.
EM u-ma@pharm.hokudai.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology [26282131, 25560219]; Japanese Government (MEXT); Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from Japan Agency for Medical Research and development (AMED); Grants-in-Aid for Scientific Research [25560219, 17H02094] Funding Source: KAKEN
CR Bonamassa B, 2011, PHARM RES-DORDR, V28, P694, DOI 10.1007/s11095-010-0338-9
   BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8
   DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598
   Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Kajimoto K, 2014, J CONTROL RELEASE, V190, P593, DOI 10.1016/j.jconrel.2014.03.058
   Kobayashi N, 2005, ADV DRUG DELIVER REV, V57, P713, DOI 10.1016/j.addr.2004.12.006
   Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947
   Ma XC, 2013, ADV HEALTHC MATER, V2, P1638, DOI 10.1002/adhm.201300037
   Martin LJ, 2006, J NEUROPATH EXP NEUR, V65, P1103, DOI 10.1097/01.jnen.0000248541.05552.c4
   Nayak D, 2009, J BIOL CHEM, V284, P13641, DOI 10.1074/jbc.M900718200
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Shaheen SM, 2011, BIOMATERIALS, V32, P6342, DOI 10.1016/j.biomaterials.2011.05.014
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314
   Sudo A, 2011, J LARYNGOL OTOL, V125, P1282, DOI 10.1017/S0022215111002453
   Wyman TB, 1997, BIOCHEMISTRY-US, V36, P3008, DOI 10.1021/bi9618474
   Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002
   Yamada Y, 2017, HANDB EXP PHARMACOL, V240, P457, DOI 10.1007/164_2016_4
   Yamada Y, 2017, BIOMATERIALS, V136, P56, DOI 10.1016/j.biomaterials.2017.05.016
   Yamada Y, 2016, J PHARM SCI-US, V105, P1705, DOI 10.1016/j.xphs.2016.03.002
   Yamada Y, 2011, MOL THER, V19, P1449, DOI 10.1038/mt.2011.99
   Yasuzaki Y, 2015, MOL PHARMACEUT, V12, P4311, DOI 10.1021/acs.molpharmaceut.5b00511
   Yasuzaki Y, 2013, J CONTROL RELEASE, V172, P805, DOI 10.1016/j.jconrel.2013.09.029
   Zarrin AA, 1999, BBA-GENE STRUCT EXPR, V1446, P135, DOI 10.1016/S0167-4781(99)00067-6
NR 25
TC 34
Z9 36
U1 0
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD MAR 28
PY 2018
VL 274
IS 
BP 109
EP 117
DI 10.1016/j.jconrel.2018.02.005
PG 9
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA FZ7VP
UT WOS:000427812700010
PM 29408532
DA 2024-11-01
ER

PT J
AU Wang, X
   Posey, JE
   Rosenfeld, JA
   Bacino, CA
   Scaglia, F
   Immken, L
   Harris, JM
   Hickey, SE
   Mosher, TM
   Slavotinek, A
   Zhang, J
   Beuten, J
   Leduc, MS
   He, WM
   Vetrini, F
   Walkiewicz, MA
   Bi, WM
   Xiao, R
   Liu, PF
   Shao, YR
   Gezdirici, A
   Gulec, EY
   Jiang, YY
   Darilek, SA
   Hansen, AW
   Khayat, MM
   Pehlivan, D
   Piard, J
   Muzny, DM
   Hanchard, N
   Belmont, JW
   Van Maldergem, L
   Gibbs, RA
   Eldomery, MK
   Akdemir, ZC
   Adesina, AM
   Chen, S
   Lee, YC
   Lee, B
   Lupski, JR
   Eng, CM
   Xia, F
   Yang, YP
   Graham, BH
   Moretti, P
AF Wang, Xia
   Posey, Jennifer E.
   Rosenfeld, Jill A.
   Bacino, Carlos A.
   Scaglia, Fernando
   Immken, LaDonna
   Harris, Jill M.
   Hickey, Scott E.
   Mosher, Theresa M.
   Slavotinek, Anne
   Zhang, Jing
   Beuten, Joke
   Leduc, Magalie S.
   He, Weimin
   Vetrini, Francesco
   Walkiewicz, Magdalena A.
   Bi, Weimin
   Xiao, Rui
   Liu, Pengfei
   Shao, Yunru
   Gezdirici, Alper
   Gulec, Elif Y.
   Jiang, Yunyun
   Darilek, Sandra A.
   Hansen, Adam W.
   Khayat, Michael M.
   Pehlivan, Davut
   Piard, Juliette
   Muzny, Donna M.
   Hanchard, Neil
   Belmont, John W.
   Van Maldergem, Lionel
   Gibbs, Richard A.
   Eldomery, Mohammad K.
   Akdemir, Zeynep C.
   Adesina, Adekunle M.
   Chen, Shan
   Lee, Yi-Chien
   Lee, Brendan
   Lupski, James R.
   Eng, Christine M.
   Xia, Fan
   Yang, Yaping
   Graham, Brett H.
   Moretti, Paolo
TI Phenotypic expansion in <i>DDX3X</i> - a common cause of intellectual disability in females
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
ID de-novo mutations; malformations; dominant
AB De novo variants in DDX3X account for 1-3% of unexplained intellectual disability (ID) cases and are amongst the most common causes of ID especially in females. Forty-seven patients (44 females, 3 males) have been described. We identified 31 additional individuals carrying 29 unique DDX3X variants, including 30 postnatal individuals with complex clinical presentations of developmental delay or ID, and one fetus with abnormal ultrasound findings. Rare or novel phenotypes observed include respiratory problems, congenital heart disease, skeletal muscle mitochondrial DNA depletion, and late-onset neurologic decline. Our findings expand the spectrum of DNA variants and phenotypes associated with DDX3X disorders.
C1 [Wang, Xia; Posey, Jennifer E.; Rosenfeld, Jill A.; Bacino, Carlos A.; Scaglia, Fernando; Leduc, Magalie S.; Walkiewicz, Magdalena A.; Bi, Weimin; Xiao, Rui; Liu, Pengfei; Shao, Yunru; Jiang, Yunyun; Darilek, Sandra A.; Hansen, Adam W.; Khayat, Michael M.; Pehlivan, Davut; Muzny, Donna M.; Hanchard, Neil; Belmont, John W.; Gibbs, Richard A.; Eldomery, Mohammad K.; Akdemir, Zeynep C.; Chen, Shan; Lee, Yi-Chien; Lee, Brendan; Lupski, James R.; Eng, Christine M.; Xia, Fan; Yang, Yaping; Graham, Brett H.; Moretti, Paolo] Baylor Coll Med, Mol & Human Genet, Houston, TX 77030 USA.
   [Wang, Xia; Zhang, Jing; Beuten, Joke; Leduc, Magalie S.; He, Weimin; Vetrini, Francesco; Walkiewicz, Magdalena A.; Bi, Weimin; Xiao, Rui; Liu, Pengfei; Eng, Christine M.; Xia, Fan; Yang, Yaping] Baylor Genet, Houston, TX USA.
   [Bacino, Carlos A.; Scaglia, Fernando; Shao, Yunru; Adesina, Adekunle M.; Lupski, James R.; Graham, Brett H.] Texas Childrens Hosp, Houston, TX 77030 USA.
   [Moretti, Paolo] Baylor Coll Med, Neurol, Houston, TX 77030 USA.
   [Moretti, Paolo] Michael E DeBakey VA Med Ctr, Houston, TX USA.
   [Immken, LaDonna; Harris, Jill M.] Specially Children, Austin, TX USA.
   [Hickey, Scott E.] Ohio State Univ, Pediat Clin, Columbus, OH 43210 USA.
   [Hickey, Scott E.; Mosher, Theresa M.] Nationwide Childrens Hosp, Div Mol & Human Genet, Columbus, OH USA.
   [Slavotinek, Anne] Univ Calif San Francisco, Div Genet, Dept Pediat, San Francisco, CA 94143 USA.
   [Gezdirici, Alper; Gulec, Elif Y.] Kanuni Sultan Suleyman Training & Res Hosp, Dept Genet, Istanbul, Turkey.
   [Pehlivan, Davut] Baylor Coll Med, Dept Pediat, Neurol Sect, Houston, TX 77030 USA.
   [Muzny, Donna M.; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.
   [Piard, Juliette; Van Maldergem, Lionel] Univ Franche Comte, Ctr Genet Humaine, Besancon, France.
   [Adesina, Adekunle M.] Baylor Coll Med, Pathol, Houston, TX 77030 USA.
   [Graham, Brett H.] Indiana Univ Sch Med, Med & Mol Genet, Indianapolis, IN 46202 USA.
   [Moretti, Paolo] Univ Utah, Neurol, Salt Lake City, UT USA.
   [Moretti, Paolo] George E Wahlen VA Med Ctr, Salt Lake City, UT USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of California System; University of California San Francisco; Istanbul Kanuni Sultan Suleyman Training & Research Hospital; Baylor College of Medicine; Baylor College of Medicine; Universite de Franche-Comte; Baylor College of Medicine; Indiana University System; Indiana University Bloomington; Utah System of Higher Education; University of Utah
RP Wang, X (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 2450 Holcombe Blvd, Houston, TX 77021 USA.; Moretti, P (corresponding author), Univ Utah, Dept Neurol, 729 Arapeen Dr, Salt Lake City, UT 84108 USA.; Graham, BH (corresponding author), Indiana Univ, Dept Med & Mol Genet, IUPUI Nuys Med Sci Bldg,635 Barnhill Dr,MS 1015, Indianapolis, IN 46202 USA.
EM xiaw@bcm.edu; bregraha@iu.edu; paolo.moretti@hsc.utah.edu
FU NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director [U01HG007709]; National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI) [UM1 HG006542]; National Human Genome Research Institute [K08 HG008986]
CR Abdelhaleem M, 2005, CLIN BIOCHEM, V38, P499, DOI 10.1016/j.clinbiochem.2005.01.010
   Bassani S, 2013, NEUROSCIENTIST, V19, P541, DOI 10.1177/1073858413493972
   Blok LS, 2015, AM J HUM GENET, V97, P343, DOI 10.1016/j.ajhg.2015.07.004
   de Lange IM, 2016, J MED GENET, V53, P850, DOI 10.1136/jmedgenet-2016-103909
   Dikow N, 2017, AM J MED GENET A, V173, P1369, DOI 10.1002/ajmg.a.38164
   Dobyns WB, 2004, AM J MED GENET A, V129A, P136, DOI 10.1002/ajmg.20004.a.30123
   Eldomery MK, 2017, GENOME MED, V9, P0, DOI 10.1186/s13073-017-0412-6
   Garbelli A, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0019810
   Karaca E, 2015, NEURON, V88, P499, DOI 10.1016/j.neuron.2015.09.048
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Lessel D, 2017, AM J HUM GENET, V101, P716, DOI 10.1016/j.ajhg.2017.09.014
   Lubs HA, 2012, AM J HUM GENET, V90, P579, DOI 10.1016/j.ajhg.2012.02.018
   Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018
   Posey JE, 2017, NEW ENGL J MED, V376, P21, DOI 10.1056/NEJMoa1516767
   Posey JE, 2016, GENET MED, V18, P678, DOI 10.1038/gim.2015.142
   Ramocki MB, 2009, ANN NEUROL, V66, P771, DOI 10.1002/ana.21715
   Reijnders MRF, 2016, AM J HUM GENET, V98, P373, DOI 10.1016/j.ajhg.2015.12.015
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Wang X, 2017, NAT GENET, V49, P613, DOI 10.1038/ng.3815
   Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601
   Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555
   Zweier C, 2013, J MED GENET, V50, P838, DOI 10.1136/jmedgenet-2013-101918
NR 22
TC 52
Z9 62
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
EI 
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD OCT 15
PY 2018
VL 5
IS 10
BP 1277
EP 1285
DI 10.1002/acn3.622
PG 9
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GW8WW
UT WOS:000447263000014
PM 30349862
DA 2024-11-01
ER

PT J
AU Saneto, RP
AF Saneto, Russell P.
TI An update on Alpers-Huttenlocher syndrome: pathophysiology of disease and rational treatment designs
SO EXPERT OPINION ON ORPHAN DRUGS
LA English
DT Review
DE Mitochondrial disease; polymerase gamma 1 (POLG1); Alpers-Huttenlocher syndrome; nuclear-encoded; epilepsy; mitochondrial DNA replication
ID mitochondrial-dna polymerase; progressive neuronal degeneration; diffuse cerebral degeneration; transfer-rna synthetase; polg mutations; w748s mutation; caenorhabditis-elegans; status epilepticus; mtdna depletion; gray-matter
AB Introduction: Alpers-Huttenlocher syndrome (AHS) is a unique nuclear DNA-encoded mitochondrial disease. Clinically, after normal development the syndrome is manifested by psychomotor decline, medically refractory seizures, and hepatopathy. The disease is caused by biallelic recessive mutations in the mitochondrial DNA polymerase catalytic subunit, polymerase gamma 1 (POLG1), which is relentlessly progressive with death occurring several years after diagnosis. Areas covered: The consistency of neuropathology, biochemical, genetic, and clinical findings are discussed. However, the lack of phenotype and genotype correlations, presence of ecovariants, and multiple environmental influences create variable onset of symptoms and degrees of clinical expression. Coupled with the low prevalence of AHS, standard clinical trials are not possible and treatment modalities must be extrapolated from other mitochondrial and clinical diseases or animal models. Expert opinion: Currently, treatment is mostly supportive. Animal models of AHS are sorely needed. However, there are hints to possible disease-altering treatments based on animal and in vitro and other disease treatment studies. In a worm model of POLG1 dysfunction, the cardiac medication clofilium tosylate can correct the deficit. Exosomes made from stem cells can deliver genes and protein products to muscle cells and presumably neurons. These studies begin the journey toward possible treatments.
C1 [Saneto, Russell P.] Univ Washington, Dept Neurol, Div Pediat Neurol, Seattle, WA 98195 USA.
   [Saneto, Russell P.] Seattle Childrens Hosp, Seattle, WA USA.
   [Saneto, Russell P.] Seattle Childrens Hosp, Neurosci Inst, Ctr Integrat Brain Res, Seattle, WA USA.
C3 University of Washington; University of Washington Seattle; Seattle Children's Hospital; Seattle Children's Hospital
RP Saneto, RP (corresponding author), Univ Washington, Seattle Childrens Hosp, Dept Neurol, Div Pediat Neurol, 4800 Sand Point Way NE, Seattle, WA 98105 USA.
EM russ.saneto@seattlechildrens.org
CR Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807
   Aminzadeh MA, 2018, STEM CELL REP, V10, P942, DOI 10.1016/j.stemcr.2018.01.023
   Anagnostou ME, 2016, EPILEPSIA, V57, P1531, DOI 10.1111/epi.13508
   [Anonymous], 2017, J INBORN ERRORS META, V0, P0
   Avula B, 2012, J PHARMACEUT BIOMED, V70, P53, DOI 10.1016/j.jpba.2012.05.021
   BICKNESE AR, 1992, ANN NEUROL, V32, P767, DOI 10.1002/ana.410320610
   BLACKWOOD W, 1963, ARCH DIS CHILD, V38, P193, DOI 10.1136/adc.38.199.193
   Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Clark-Matott J, 2015, NEUROBIOL AGING, V36, P2972, DOI 10.1016/j.neurobiolaging.2015.07.020
   Cohen BH, 1993, GENEREVIEWS((R)), V0, P0
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Diener HC, 2004, EUR NEUROL, V51, P89, DOI 10.1159/000076535
   El-Hattab Ayman W, 2017, J. INBORN ERRORS METAB. SCREEN., V5, Pe160051, DOI 10.1177/2326409817697399
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   FORD FR, 1951, J PEDIATR-US, V39, P33, DOI 10.1016/S0022-3476(51)80278-6
   Ganetzky RD, 2018, MOL GENET METAB, V123, P301, DOI 10.1016/j.ymgme.2018.01.010
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HARDING BN, 1995, J NEUROL NEUROSUR PS, V58, P320, DOI 10.1136/jnnp.58.3.320
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   HUTTENLOCHER PR, 1976, ARCH NEUROL-CHICAGO, V33, P186, DOI 10.1001/archneur.1976.00500030042009
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Krasich R, 2017, FRONT BIOSCI-LANDMRK, V22, P692, DOI 10.2741/4510
   Lagrue E, 2007, PEDIATR RES, V62, P14, DOI 10.1203/PDR.0b013e31806790d7
   Lax NZ, 2016, NEUROPATH APPL NEURO, V42, P180, DOI 10.1111/nan.12238
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   Lee CF, 2016, CIRCULATION, V134, P883, DOI 10.1161/CIRCULATIONAHA.116.022495
   Lee Y, 2012, HUM MOL GENET, V21, PR125, DOI 10.1093/hmg/dds317
   Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   MORSE WI, 1949, B JOHNS HOPKINS HOSP, V84, P116
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Naviaux RK, 2006, ALPERS SYNDROME, V0, P0
   Naviaux RK, 2016, MITOCHONDRIAL CASE STUDIES: UNDERLYING MECHANISMS AND DIAGNOSIS, V0, P135
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nikkanen J, 2018, EMBO MOL MED, V10, P13, DOI 10.15252/emmm.201707993
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Pitayu L, 2016, HUM MOL GENET, V25, P715, DOI 10.1093/hmg/ddv509
   Polyak E, 2018, MOL GENET METAB, V123, P449, DOI 10.1016/j.ymgme.2018.02.013
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   SANDBANK U, 1972, J NEUROL NEUROSUR PS, V35, P749, DOI 10.1136/jnnp.35.6.749
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Saneto RP, 2017, ADV GENET, V98, P63, DOI 10.1016/bs.adgen.2017.06.002
   Saneto RP, 2016, J MULTIDISCIP HEALTH, V9, P323, DOI 10.2147/JMDH.S84900
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Siegmund SE, 2017, HUM MOL GENET, V26, P4588, DOI 10.1093/hmg/ddx341
   Singh B, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0140409
   Sofou K, 2015, MOL GENET GENOM MED, V3, P59, DOI 10.1002/mgg3.115
   Sofou K, 2012, EUR J PAEDIATR NEURO, V16, P379, DOI 10.1016/j.ejpn.2011.12.006
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2014, ANN NEUROL, V76, P66, DOI 10.1002/ana.24185
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Uusimaa J, 2013, EPILEPSIA, V54, P1002, DOI 10.1111/epi.12115
   West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Young MJ, 2017, FRONT MOL BIOSCI, V4, P0, DOI 10.3389/fmolb.2017.00074
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
NR 83
TC 0
Z9 0
U1 0
U2 13
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2167-8707
EI 
J9 EXPERT OPIN ORPHAN D
JI Exp. Opin. Orphan Drugs
PD DEC 2
PY 2018
VL 6
IS 12
BP 741
EP 751
DI 10.1080/21678707.2018.1540979
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA HD8FF
UT WOS:000452789500005
DA 2024-11-01
ER

PT J
AU Kato, TM
   Kubota-Sakashita, M
   Fujimori-Tonou, N
   Saitow, F
   Fuke, S
   Masuda, A
   Itohara, S
   Suzuki, H
   Kato, T
AF Kato, Tomoaki M.
   Kubota-Sakashita, Mie
   Fujimori-Tonou, Noriko
   Saitow, Fumihito
   Fuke, Satoshi
   Masuda, Akira
   Itohara, Shigeyoshi
   Suzuki, Hidenori
   Kato, Tadafumi
TI <i>Ant1</i> mutant mice bridge the mitochondrial and serotonergic dysfunctions in bipolar disorder
SO MOLECULAR PSYCHIATRY
LA English
DT Article
ID oxidative damage; rat-brain; deficiency; oxidase; dna; apoptosis; neurons; disease; choice; cells
AB Although mitochondrial and serotonergic dysfunctions have been implicated in the etiology of bipolar disorder (BD), the relationship between these unrelated pathways has not been elucidated. A family of BD and chronic progressive external ophthalmoplegia (CPEO) caused by a mutation of the mitochondrial adenine nucleotide translocator 1 (ANT1, SLC25A4) implicated that ANT1 mutations confer a risk of BD. Here, we sequenced ANT1 in 324 probands of NIMH bipolar disorder pedigrees and identified two BD patients carrying heterozygous loss- of-function mutations. Behavioral analysis of brain specific Ant1 heterozygous conditional knockout (cKO) mice using lntelliCage showed a selective diminution in delay discounting. Delay discounting is the choice of smaller but immediate reward than larger but delayed reward and an index of impulsivity. Diminution of delay discounting suggests an increase in serotonergic activity. This finding was replicated by a 5-choice serial reaction time test. An anatomical screen showed accumulation of COX (cytochrome c oxidase) negative cells in dorsal raphe. Dorsal raphe neurons in the heterozygous cKO showed hyperexcitability, along with enhanced serotonin turnover in the nucleus accumbens and upregulation of Maob in dorsal raphe. These findings altogether suggest that mitochondrial dysfunction as the genetic risk of BD may cause vulnerability to BD by altering serotonergic neurotransmission.
C1 [Kato, Tomoaki M.; Kubota-Sakashita, Mie; Fujimori-Tonou, Noriko; Fuke, Satoshi; Kato, Tadafumi] RIKEN, Ctr Brain Sci, Lab Mol Dynam Mental Disorders, Wako, Saitama, Japan.
   [Saitow, Fumihito; Suzuki, Hidenori] Nippon Med Sch, Dept Pharmacol, Tokyo, Japan.
   [Masuda, Akira; Itohara, Shigeyoshi] RIKEN, Ctr Brain Sci, Lab Behav Genet, Wako, Saitama, Japan.
   [Kato, Tomoaki M.] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Fundamental Cell Technol, Kyoto, Japan.
C3 RIKEN; Nippon Medical School; RIKEN; Kyoto University
RP Kato, TM (corresponding author), RIKEN, Ctr Brain Sci, Lab Mol Dynam Mental Disorders, Wako, Saitama, Japan.
EM kato@brain.riken.jp
FU JSPS KAKENHI [JP27860956, JP17H01573]; Advanced Genome Research and Bioinformatics Study to Facilitate Medical Innovation (GRIFIN) from the Japan Agency for Medical Research and Development (AMED) [16815678]
CR Agarwal A, 2017, NEURON, V93, P587, DOI 10.1016/j.neuron.2016.12.034
   Alves E, 2007, J NEUROSCI, V27, P10203, DOI 10.1523/JNEUROSCI.2645-07.2007
   Andreazza AC, 2010, ARCH GEN PSYCHIAT, V67, P360, DOI 10.1001/archgenpsychiatry.2010.22
   Asinof SK, 2014, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/51574
   Bernardi P, 2015, J MOL CELL CARDIOL, V78, P100, DOI 10.1016/j.yjmcc.2014.09.023
   Bortolato M, 2008, ADV DRUG DELIVER REV, V60, P1527, DOI 10.1016/j.addr.2008.06.002
   Cannon DM, 2007, BIOL PSYCHIAT, V62, P870, DOI 10.1016/j.biopsych.2007.03.016
   Cataldo AM, 2010, AM J PATHOL, V177, P575, DOI 10.2353/ajpath.2010.081068
   El-Khoury R, 2009, GENETICS, V183, P861, DOI 10.1534/genetics.109.107813
   Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303
   Giusti SA, 2014, J PSYCHIATR RES, V55, P87, DOI 10.1016/j.jpsychires.2014.04.002
   Gocho Y, 2013, J PHYSIOL SCI, V63, P147, DOI 10.1007/s12576-012-0250-7
   Goodwin FK, 2007, BIPOLAR DISORDERS RE, V0, P0
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Heisler LK, 2007, J NEUROSCI, V27, P6956, DOI 10.1523/JNEUROSCI.2584-06.2007
   Hiroi N, 2018, PSYCHIAT CLIN NEUROS, V72, P301, DOI 10.1111/pcn.12641
   Hüttemann M, 2012, ADV EXP MED BIOL, V748, P237, DOI 10.1007/978-1-4614-3573-0_10
   Inczedy-Farkas G, 2012, BEHAV BRAIN FUNCT, V8, P0, DOI 10.1186/1744-9081-8-9
   Kanba S, 2013, PSYCHIAT CLIN NEUROS, V67, P285, DOI 10.1111/pcn.12060
   Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137
   Kasahara T, 2016, MOL PSYCHIATR, V21, P39, DOI 10.1038/mp.2015.156
   Kasahara T, 2017, PSYCHIAT CLIN NEUROS, V71, P518, DOI 10.1111/pcn.12496
   Kato T, 1997, BIOL PSYCHIAT, V42, P871, DOI 10.1016/S0006-3223(97)00012-7
   KATO T, 1992, J AFFECT DISORDERS, V26, P223, DOI 10.1016/0165-0327(92)90099-R
   Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x
   Kobayashi Y, 2013, FRONT BEHAV NEUROSCI, V7, P0, DOI 10.3389/fnbeh.2013.00017
   Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300
   Kubota M, 2006, J NEUROSCI, V26, P12314, DOI 10.1523/JNEUROSCI.3933-06.2006
   Lee J, 2009, BBA-BIOENERGETICS, V1787, P364, DOI 10.1016/j.bbabio.2009.01.014
   López-Figueroa AL, 2004, BIOL PSYCHIAT, V55, P225, DOI 10.1016/j.biopsych.2003.09.017
   Mancuso M, 2013, NEUROL SCI, V34, P71, DOI 10.1007/s10072-011-0901-0
   Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229
   Masuda A, 2016, NEUROBIOL LEARN MEM, V135, P73, DOI 10.1016/j.nlm.2016.07.001
   Matsuo N, 2010, FRONT BEHAV NEUROSCI, V4, P0, DOI 10.3389/fnbeh.2010.00029
   Miyazaki KW, 2014, CURR BIOL, V24, P2033, DOI 10.1016/j.cub.2014.07.041
   Nguyen KT, 2011, NEUROBIOL DIS, V42, P381, DOI 10.1016/j.nbd.2011.01.031
   PEET M, 1994, BRIT J PSYCHIAT, V164, P549, DOI 10.1192/bjp.164.4.549
   Picard M, 2015, P NATL ACAD SCI USA, V112, PE6614, DOI 10.1073/pnas.1515733112
   Qamhawi Z, 2015, BRAIN, V138, P2964, DOI 10.1093/brain/awv215
   RACHLIN H, 1972, J EXP ANAL BEHAV, V17, P15, DOI 10.1901/jeab.1972.17-15
   Robinson ESJ, 2009, BEHAV BRAIN RES, V196, P310, DOI 10.1016/j.bbr.2008.09.021
   Shao L, 2008, ANN MED, V40, P281, DOI 10.1080/07853890801923753
   Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Sigitova E, 2017, PSYCHIAT CLIN NEUROS, V71, P77, DOI 10.1111/pcn.12476
   SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Sugawara H, 2011, TRANSL PSYCHIAT, V1, P0, DOI 10.1038/tp.2011.26
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Winstanley CA, 2005, NEUROPSYCHOPHARMACOL, V30, P669, DOI 10.1038/sj.npp.1300610
   Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073
   Zhang J, 1999, AM J PATHOL, V154, P1423, DOI 10.1016/S0002-9440(10)65396-5
NR 52
TC 29
Z9 32
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1359-4184
EI 1476-5578
J9 MOL PSYCHIATR
JI Mol. Psychiatr.
PD OCT 15
PY 2018
VL 23
IS 10
BP 2039
EP 2049
DI 10.1038/s41380-018-0074-9
PG 11
WC Biochemistry & Molecular Biology; Neurosciences; Psychiatry
SC Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry
GA HB2TM
UT WOS:000450896400009
PM 29892051
DA 2024-11-01
ER

PT J
AU Nissanka, N
   Bacman, SR
   Plastini, MJ
   Moraes, CT
AF Nissanka, Nadee
   Bacman, Sandra R.
   Plastini, Melanie J.
   Moraes, Carlos T.
TI The mitochondrial DNA polymerase gamma degrades linear DNA fragments precluding the formation of deletions
SO NATURE COMMUNICATIONS
LA English
DT Article
ID targeted restriction-endonuclease; progressive external ophthalmoplegia; double-strand breaks; mtdna deletions; mutations; replication; defects; mice; heteroplasmy; maintenance
AB Double-strand breaks in the mitochondrial DNA (mtDNA) result in the formation of linear fragments that are rapidly degraded. However, the identity of the nuclease(s) performing this function is not known. We found that the exonuclease function of the mtDNA polymerase gamma (POLG) is required for this rapid degradation of mtDNA fragments. POLG is recruited to linearized DNA fragments in an origin of replication-independent manner. Moreover, in the absence of POLG exonuclease activity, the prolonged existence of mtDNA linear fragments leads to increased levels of mtDNA deletions, which have been previously identified in the mutator mouse, patients with POLG mutations and normal aging.
C1 [Nissanka, Nadee; Plastini, Melanie J.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Neurosci Grad Program, Miami Beach, FL 33136 USA.
   [Bacman, Sandra R.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami Beach, FL 33136 USA.
C3 University of Miami; University of Miami
RP Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Neurosci Grad Program, Miami Beach, FL 33136 USA.; Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami Beach, FL 33136 USA.
EM cmoraes@med.miami.edu
FU National Institutes of Health [1R01AG036871, 5R01EY010804, 1R01NS079965]; American Heart Association [16PRE30480009]; Lois Pope LIFE Fellowship program; NEI center grant from the National Institutes of Health (NIH) [P30-EY014801]; American Heart Association (AHA) [16PRE30480009] Funding Source: American Heart Association (AHA)
CR Alexeyev M, 2013, COLD SPRING HARB PERSPECT BIOL, V5, P0, DOI 10.1101/CSHPERSPECT.A012641
   Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HUARD J, 1995, GENE THER, V2, P107
   Kasiviswanathan R, 2012, BBA-GENE REGUL MECH, V1819, P970, DOI 10.1016/j.bbagrm.2011.12.005
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Macao B, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8303
   Matic S, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03552-x
   Medeiros TC, 2018, J CELL BIOL, V217, P1601, DOI 10.1083/jcb.201801168
   Moretton A, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0176795
   Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Pinto M, 2015, FREE RADICAL BIO MED, V85, P250, DOI 10.1016/j.freeradbiomed.2015.05.005
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155
   Yu ZS, 2017, CURR BIOL, V27, P1033, DOI 10.1016/j.cub.2017.02.014
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
NR 43
TC 82
Z9 92
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
EI 
J9 NAT COMMUN
JI Nat. Commun.
PD JUN 27
PY 2018
VL 9
IS 
BP 
EP 
DI 10.1038/s41467-018-04895-1
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GK9DU
UT WOS:000436540700009
PM 29950568
DA 2024-11-01
ER

PT J
AU Semeraro, M
   Boenzi, S
   Carrozzo, R
   Diodato, D
   Martinelli, D
   Olivieri, G
   Antonetti, G
   Sacchetti, E
   Catesini, G
   Rizzo, C
   Dionisi-Vici, C
AF Semeraro, Michela
   Boenzi, Sara
   Carrozzo, Rosalba
   Diodato, Dania
   Martinelli, Diego
   Olivieri, Giorgia
   Antonetti, Giacomo
   Sacchetti, Elisa
   Catesini, Giulio
   Rizzo, Cristiano
   Dionisi-Vici, Carlo
TI The urinary organic acids profile in single large-scale mitochondrial DNA deletion disorders
SO CLINICA CHIMICA ACTA
LA English
DT Article
DE Single large-scale mitochondrial DNA deletion disorders; Pearson marrow-pancreas syndrome; Kearns-Sayre syndrome; Urinary organic acids; Gas chromatography-mass spectrometry
ID pearson syndrome; external ophthalmoplegia; mtdna deletions; aciduria; duplications; defects; disease; plus
AB Single large-scale mitochondrial DNA deletions disorders are classified into three main phenotypes with frequent clinical overlap: Pearson marrow-pancreas syndrome (PMS), Kearns-Sayre syndrome (KSS) and chronic progressive external ophtalmoplegia (PEO). So far, only few anecdotal studies have reported on the urinary organic acids profile in this disease class. In this single-center retrospective study, we performed quantitative evaluation of urinary organic acids in a series of 15 pediatric patients, 7 with PMS and 8 with KSS. PMS patients showed an organic acids profile almost constantly altered, whereas KSS patients frequently presented with normal profiles. Lactate, 3-hydroxybutyrate, 3-hydroxyisobutyrate, fumarate, pyruvate, 2-hydroxybutyrate, 2-ethyl-3-hydroxypropionate, and 3-methylglutaconate represented the most frequent metabolites observed in PMS urine. We also found novel metabolites, 3-methylglutarate, tiglylglycine and 2-methyl-2,3-dihydroxybutyrate, so far never reported in this disease. Interestingly, patients with a disease onset as PMS evolving overtime into KSS phenotype, presented persistent and more pronounced alterations of organic acid signature than in patients with a pure KSS phenotype. Our study shows that the quantitative analysis of urinary organic acid profile represents a helpful tool for the diagnosis of PMS and for the differential diagnosis with other inherited diseases causing abnormal organic acidurias.
C1 [Semeraro, Michela; Boenzi, Sara; Martinelli, Diego; Olivieri, Giorgia; Antonetti, Giacomo; Sacchetti, Elisa; Catesini, Giulio; Rizzo, Cristiano; Dionisi-Vici, Carlo] Bambino Gesu Pediat Hosp, IRCCS Inst Treatment & Res, Div Metab, Viale S Paolo 15, I-00146 Rome, Italy.
   [Semeraro, Michela; Boenzi, Sara; Martinelli, Diego; Olivieri, Giorgia; Antonetti, Giacomo; Sacchetti, Elisa; Catesini, Giulio; Rizzo, Cristiano; Dionisi-Vici, Carlo] Bambino Gesu Pediat Hosp, IRCCS Inst Treatment & Res, Res Unit Metab Biochem, Viale S Paolo 15, I-00146 Rome, Italy.
   [Carrozzo, Rosalba; Diodato, Dania] Bambino Gesu Pediat Hosp, IRCCS Inst Treatment & Res, Lab Mol Med, Unit Neuromuscular & Neurodegenerat Disorders, Viale S Paolo 15, I-00146 Rome, Italy.
C3 IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu
RP Semeraro, M (corresponding author), Bambino Gesu Pediat Hosp, IRCCS Inst Treatment & Res, Div Metab, Viale S Paolo 15, I-00146 Rome, Italy.; Semeraro, M (corresponding author), Bambino Gesu Pediat Hosp, IRCCS Inst Treatment & Res, Res Unit Metab Biochem, Viale S Paolo 15, I-00146 Rome, Italy.
EM michela.semeraro@opbg.net
CR Barshop BA, 2000, MOL GENET METAB, V69, P64, DOI 10.1006/mgme.1999.2946
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Crippa BL, 2015, AM J MED GENET A, V167, P621, DOI 10.1002/ajmg.a.36939
   DRACHMAN DA, 1968, ARCH NEUROL-CHICAGO, V18, P654, DOI 10.1001/archneur.1968.00470360076008
   GIBSON KM, 1992, J PEDIATR-US, V121, P940, DOI 10.1016/S0022-3476(05)80348-8
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   JAKOBS C, 1991, EUR J PEDIATR, V150, P684, DOI 10.1007/BF02072635
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lamont PJ, 1998, ARCH DIS CHILD, V79, P22, DOI 10.1136/adc.79.1.22
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Muraki K, 1997, J INHERIT METAB DIS, V20, P697, DOI 10.1023/A:1005378527077
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Peters H, 2015, MOL GENET METAB, V115, P168, DOI 10.1016/j.ymgme.2015.06.008
   PETTERSEN JE, 1973, CLIN CHIM ACTA, V48, P213, DOI 10.1016/0009-8981(73)90367-7
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   POULTON J, 1989, LANCET, V1, P236
   POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23
   RIBES A, 1993, J INHERIT METAB DIS, V16, P537, DOI 10.1007/BF00711675
   ROWLAND LP, 1983, NEUROLOGY, V33, P1179, DOI 10.1212/WNL.33.9.1179
   Sato T, 2015, EUR J PEDIATR, V174, P1593, DOI 10.1007/s00431-015-2576-7
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SUPERTIFURGA A, 1993, EUR J PEDIATR, V152, P44, DOI 10.1007/BF02072515
   TANAKA K, 1980, CLIN CHEM, V26, P1847
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P913, DOI 10.1007/s10545-012-9579-6
NR 24
TC 9
Z9 10
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0009-8981
EI 1873-3492
J9 CLIN CHIM ACTA
JI Clin. Chim. Acta
PD JUN 15
PY 2018
VL 481
IS 
BP 156
EP 160
DI 10.1016/j.cca.2018.03.002
PG 5
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA GF4MK
UT WOS:000431936800025
PM 29534959
DA 2024-11-01
ER

PT J
AU Moon, J
   Kim, HR
   Shin, MG
AF Moon, James
   Kim, Hye Ran
   Shin, Myung Geun
TI Rejuvenating Aged Hematopoietic Stem Cells Through Improvement of Mitochondrial Function
SO ANNALS OF LABORATORY MEDICINE
LA English
DT Review
DE Hematopoietic stem cells; Aging; Mitochondrial dysfunction; Restoration; NAD(+) precursors
ID nicotinamide riboside; dna mutations; metabolic checkpoint; oxidative stress; bone-marrow; life-span; nad(+); mice; quiescence; distinct
AB Mitochondria are the powerhouses of the cell as well as the primary site of hematopoiesis, which also occurs in the cytoplasm. Hematopoietic stem cells (HSCs) are characterized by a very high turnover rate, and are thus considered to be relatively free from the age-related insults generated by mitochondria. However, HSCs are also subject to these age-related insults, including the incidence of myeloid proliferative diseases, marrow failure, hematopoietic neoplasms, and deterioration of the adaptive human immune system. Recently, NAD(+) dietary supplements, known as niacin or vitamin B-3, including tryptophan, nicotinic acid, nicotinamide, and the newly identified NAD(+) precursor nicotinamide riboside, have been shown to play a role in restoring adult stem cell function through the amelioration of mitochondrial dysfunction. This insight motivated a study that focused on reversing aging-related cellular dysfunction in adult mouse muscle stem cells by supplementing their diet with nicotinamide riboside. The remedial effect of nicotinamide riboside enhanced mitochondrial function in these muscle stem cells in a SIRT1-dependent manner, affecting cellular respiration, membrane potential, and production of ATP. Accordingly, numerous studies have demonstrated that sirtuins, under nuclear/mitochondrial control, have age-specific effects in determining HSC phenotypes. Based on the evidence accumulated thus far, we propose a clinical intervention for the restoration of aged HSC function by improving mitochondrial function through NAD(+) precursor supplementation.
C1 [Moon, James; Shin, Myung Geun] Chonnam Natl Univ, Med Sch, Dept Lab Med, Jeollanam Do, South Korea.
   [Moon, James; Shin, Myung Geun] Chonnam Natl Univ, Hwasun Hosp, Jeollanam Do, South Korea.
   [Moon, James] Univ Calif, Dept Biomed Engn, Oakland, CA USA.
   [Kim, Hye Ran] Dongshin Univ, Coll Korean Med, 185 Gunjae Ro, Naju 58245, Jeollanam Do, South Korea.
   [Shin, Myung Geun] Chonnam Natl Univ, Med Sch, Brain Korea Plus Project 21, Gwangju, South Korea.
   [Shin, Myung Geun] Chonnam Natl Univ, Med Sch, Environm Hlth Ctr Childhood Leukemia & Canc, Jeollanam Do, South Korea.
C3 Chonnam National University; Chonnam National University; University of California System; University of California Berkeley; Dongshin University; Chonnam National University; Chonnam National University
RP Kim, HR (corresponding author), Dongshin Univ, Coll Korean Med, 185 Gunjae Ro, Naju 58245, Jeollanam Do, South Korea.; Shin, MG (corresponding author), Chonnam Natl Univ, Hwasun Hosp, Dept Lab Med, 322 Seoyang Ro, Hwasun Gun 58128, Jeollanam Do, South Korea.
EM 98lani@gmail.com; mgshin@jnu.ac.kr
FU National Research Foundation of Korea (NRF) grant - Korean Ministry of Science, ICT and Future Planning [2016-R1C1B106130]; Leading Foreign Research Institute Recruitment Program through the NRF - Ministry of Education, Science and Technology (MEST) [20110030034]; Environmental Health Center - Ministry of Environment, Korea
CR Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006
   Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024
   Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7
   Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005
   Cantó C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Cantó C, 2009, TRENDS ENDOCRIN MET, V20, P325, DOI 10.1016/j.tem.2009.03.008
   Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297
   Ergen AV, 2010, EXP GERONTOL, V45, P286, DOI 10.1016/j.exger.2009.12.010
   Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999
   Gattermann N, 2000, LEUKEMIA RES, V24, P141, DOI 10.1016/S0145-2126(99)00160-5
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989
   Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759
   Kim HR, 2015, ANN LAB MED, V35, P1, DOI 10.3343/alm.2015.35.1.1
   Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lin Jimin, 2015, QUANTITATIVE BIOLOGY 定量生物学, V3, P193
   Massudi H, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0042357
   Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361
   Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Preyat N, 2013, J LEUKOCYTE BIOL, V93, P669, DOI 10.1189/jlb.1112557
   Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x
   Rimmele P, 2014, STEM CELL R IN PRESS, V3, P1, DOI 10.1016/J.STEMCR.2014.04.015
   Ryu D, 2016, SCI TRANSL MED, V8, P0, DOI 10.1126/scitranslmed.aaf5504
   Shin MG, 2004, BLOOD, V103, P553, DOI 10.1182/blood-2003-05-1724
   Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011
   Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Unwin RD, 2006, BLOOD, V107, P4687, DOI 10.1182/blood-2005-12-4995
   van de Ven RAH, 2017, TRENDS MOL MED, V23, P320, DOI 10.1016/j.molmed.2017.02.005
   Wang H, 2016, CELL STEM CELL, V18, P495, DOI 10.1016/j.stem.2016.03.005
   Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693
   Zheng JK, 2014, BLOOD, V123, P992, DOI 10.1182/blood-2013-04-498469
NR 37
TC 11
Z9 14
U1 3
U2 17
PU KOREAN SOC LABORATORY MEDICINE
PI SEOUL
PA A505-ASTERIUM SEOUL, 372 HANGANG-DAERO, YONGSAN-GU, SEOUL, 04323, SOUTH KOREA
SN 2234-3806
EI 2234-3814
J9 ANN LAB MED
JI Ann. Lab. Med.
PD SEP 15
PY 2018
VL 38
IS 5
BP 395
EP 401
DI 10.3343/alm.2018.38.5.395
PG 7
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA GL9OX
UT WOS:000437666200002
PM 29797808
DA 2024-11-01
ER

PT J
AU Rocha, MC
   Rosa, HS
   Grady, JP
   Blakely, EL
   He, LP
   Romain, N
   Haller, RG
   Newman, J
   McFarland, R
   Ng, YS
   Gorman, GS
   Schaefer, AM
   Tuppen, HA
   Taylor, RW
   Turnbull, DM
AF Rocha, Mariana C.
   Rosa, Hannah S.
   Grady, John P.
   Blakely, Emma L.
   He, Langping
   Romain, Nadine
   Haller, Ronald G.
   Newman, Jane
   McFarland, Robert
   Ng, Yi Shiau
   Gorman, Grainne S.
   Schaefer, Andrew M.
   Tuppen, Helen A.
   Taylor, Robert W.
   Turnbull, Doug M.
TI Pathological Mechanisms Underlying Single Large-Scale Mitochondrial DNA Deletions
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID progressive external ophthalmoplegia; real-time pcr; deficient muscle-fibers; ragged-red fibers; wild-type; protein-synthesis; lactic-acidosis; episodes melas; disease; mtdna
AB Objective: Single, large-scale deletions in mitochondrial DNA (mtDNA) are a common cause of mitochondrial disease. This study aimed to investigate the relationship between the genetic defect and molecular phenotype to improve understanding of pathogenic mechanisms associated with single, large-scale mtDNA deletions in skeletal muscle. Methods: We investigated 23 muscle biopsies taken from adult patients (6 males/17 females with a mean age of 43 years) with characterized single, large-scale mtDNA deletions. Mitochondrial respiratory chain deficiency in skeletal muscle biopsies was quantified by immunoreactivity levels for complex I and complex IV proteins. Single muscle fibers with varying degrees of deficiency were selected from 6 patient biopsies for determination of mtDNA deletion level and copy number by quantitative polymerase chain reaction. Results: We have defined 3 "classes" of single, large-scale deletion with distinct patterns of mitochondrial deficiency, determined by the size and location of the deletion. Single fiber analyses showed that fibers with greater respiratory chain deficiency harbored higher levels of mtDNA deletion with an increase in total mtDNA copy number. For the first time, we have demonstrated that threshold levels for complex I and complex IV deficiency differ based on deletion class. Interpretation: Combining genetic and immunofluorescent assays, we conclude that thresholds for complex I and complex IV deficiency are modulated by the deletion of complex-specific protein-encoding genes. Furthermore, removal of mt-tRNA genes impacts specific complexes only at high deletion levels, when complex-specific protein-encoding genes remain. These novel findings provide valuable insight into the pathogenic mechanisms associated with these mutations.
C1 [Rocha, Mariana C.] Kings Coll London, Cardiovasc Div, British Heart Fdn, Ctr Excellence, London, England.
   [Grady, John P.] Garvan Inst, Sydney, NSW, Australia.
   [Rocha, Mariana C.; Rosa, Hannah S.; Grady, John P.; Blakely, Emma L.; He, Langping; Newman, Jane; McFarland, Robert; Ng, Yi Shiau; Gorman, Grainne S.; Schaefer, Andrew M.; Tuppen, Helen A.; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Blakely, Emma L.; He, Langping; Taylor, Robert W.] Natl Hlth Serv Fdn Trust, Newcastle Upon Tyne Hosp, Natl Hlth Serv, Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne, Tyne & Wear, England.
   [Romain, Nadine; Haller, Ronald G.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.
   [Romain, Nadine; Haller, Ronald G.] Texas Hlth Presbyterian Hosp, Inst Exercise & Environm Med, Dallas, TX USA.
C3 University of London; University College London; King's College London; Garvan Institute of Medical Research; Newcastle University - UK; NHS Blood & Transplant (NHSBT); Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; University of Texas System; University of Texas Southwestern Medical Center Dallas
RP Turnbull, DM (corresponding author), Newcastle Univ, Med Sch, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@ncl.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC) Centre for Translational Research in Neuromuscular Disease; Newcastle University Centre for Ageing and Vitality (Biotechnology and Biological Sciences Research Council); Newcastle University Centre for Ageing and Vitality (MRC); Mitochondrial Disease Patient Cohort (U.K.) [G0800674]; Lily Foundation; U.K. National Institute for Health Research Biomedical Research Centre for Ageing and Age-Related Disease award; MRC/Engineering and Physical Sciences Research Council Molecular Pathology Node; U.K. NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR050597]; MRC [MR/L016354/1, MR/K000608/1] Funding Source: UKRI
CR ARPE J, 1994, ACTA NEUROL SCAND, V90, P281
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   COLLINS S, 1991, BIOCHIM BIOPHYS ACTA, V1097, P309, DOI 10.1016/0925-4439(91)90086-O
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Enns GM, 2005, CLIN GENET, V68, P337, DOI 10.1111/j.1399-0004.2005.00499.x
   FASSATI A, 1994, J NEUROL SCI, V123, P140, DOI 10.1016/0022-510X(94)90216-X
   Gehrig SM, 2016, ORPHANET J RARE DIS, V11, P0, DOI 10.1186/s13023-016-0488-x
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   GERBITZ KD, 1990, J NEUROL, V237, P5, DOI 10.1007/BF00319660
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   HAMMANS SR, 1992, J NEUROL SCI, V107, P87, DOI 10.1016/0022-510X(92)90213-5
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kiyomoto BH, 1997, J NEUROL SCI, V152, P160, DOI 10.1016/S0022-510X(97)00158-5
   KOO B, 1993, ANN NEUROL, V34, P25, DOI 10.1002/ana.410340107
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   LAFORET P, 1995, NEUROMUSCULAR DISORD, V5, P399, DOI 10.1016/0960-8966(94)00080-S
   LERTRIT P, 1992, AM J HUM GENET, V51, P457
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   NAKASE H, 1990, AM J HUM GENET, V46, P418
   OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   R Development Core Team, 2016, R: A LANGUAGE AND ENVIRONMENT FOR STATISTICAL COMPUTING, V0, P0
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Rowan SL, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0029082
   Rygiel KA, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep09906
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schröder R, 2000, J NEUROPATH EXP NEUR, V59, P353, DOI 10.1093/jnen/59.5.353
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   YAMAMOTO M, 1991, NEUROLOGY, V41, P1822, DOI 10.1212/WNL.41.11.1822
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 47
TC 32
Z9 32
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD JAN 15
PY 2018
VL 83
IS 1
BP 115
EP 130
DI 10.1002/ana.25127
PG 16
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FT5FE
UT WOS:000423178600012
PM 29283441
DA 2024-11-01
ER

PT J
AU Cardaioli, E
   Mignarri, A
   Cantisani, TA
   Malandrini, A
   Nesti, C
   Rubegni, A
   Funel, N
   Federico, A
   Santorelli, FM
   Dotti, MT
AF Cardaioli, Elena
   Mignarri, Andrea
   Cantisani, Teresa Anna
   Malandrini, Alessandro
   Nesti, Claudia
   Rubegni, Anna
   Funel, Niccola
   Federico, Antonio
   Santorelli, Filippo Maria
   Dotti, Maria Teresa
TI Myoclonus epilepsy, retinitis pigmentosa, leukoencephalopathy and cerebral calcifications associated with a novel m.5513G>A mutation in the <i>MT</i>-<i>TW</i> gene
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Mitochondrial disease; mtDNA; tRNA(Trp); MT-TW gene; New mutation
ID mitochondrial transfer-rna; trna(trp) gene; dna mutations; mtdna mutation; point mutation; onset; encephalomyopathy; encephalopathy; pathogenicity; deficiency
AB We sequenced the mitochondrial genome from a 40-year-old woman with myoclonus epilepsy, retinitis pigmentosa, leukoencephalopathy and cerebral calcifications. Histological and biochemical features of mitochondrial respiratory chain dysfunction were present. Direct sequencing showed a novel hetero-plasmic mutation at nucleotide 5513 in the MT-TW gene that encodes tRNA(TrP). Restriction Fragment Length Polymorphism analysis confirmed that about 80% of muscle mtDNA harboured the mutation while it was present in minor percentages in mtDNA from other tissues. The mutation is predicted to disrupt a highly conserved base pair within the aminoacyl acceptor stem of the tRNA. This is the 17 mutation in MT-TW gene and expands the known causes of late-onset mitochondrial diseases. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Cardaioli, Elena; Mignarri, Andrea; Malandrini, Alessandro; Federico, Antonio; Dotti, Maria Teresa] Univ Siena, Dept Med Surg & Neurosci, Viale Bracci 2, I-53100 Siena, Italy.
   [Cantisani, Teresa Anna] Azienda Osped Perugia, Perugia Hosp, Neurophysiopathol Unit, I-06156 Perugia, Italy.
   [Nesti, Claudia; Rubegni, Anna; Santorelli, Filippo Maria] IRCCS Stella Maris, Mol Med, Via Giacinti 2, I-56128 Pisa, Italy.
   [Funel, Niccola] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Via Paradisa 2, I-56124 Pisa, Italy.
C3 University of Siena; University of Perugia; Azienda Ospedaliera di Perugia; IRCCS Fondazione Stella Maris; University of Pisa
RP Cardaioli, E (corresponding author), Univ Siena, Dept Med Surg & Neurosci, Viale Bracci 2, I-53100 Siena, Italy.
EM cardaioli@unisi.it
CR Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Baric I, 2013, EUR J HUM GENET, V21, P871, DOI 10.1038/ejhg.2012.272
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Da Pozzo P, 2004, BIOCHEM BIOPH RES CO, V324, P360, DOI 10.1016/j.bbrc.2004.09.058
   OCallaghan MD, 2012, NEUROGENETICS, V13, P245, DOI 10.1007/s10048-012-0322-0
   Jacobs HT, 2005, EUR J HUM GENET, V13, P26, DOI 10.1038/sj.ejhg.5201250
   Malfatti E, 2010, J NEUROL SCI, V297, P105, DOI 10.1016/j.jns.2010.06.009
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Mkaouar-Rebai E, 2009, MOL GENET METAB, V97, P179, DOI 10.1016/j.ymgme.2009.03.003
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Niroula A, 2016, NUCLEIC ACIDS RES, V44, P2020, DOI 10.1093/nar/gkw046
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Sanaker PS, 2010, ACTA NEUROL SCAND, V121, P109, DOI 10.1111/j.1600-0404.2009.01243.x
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   Silvestri G, 1998, NEUROMUSCULAR DISORD, V8, P291, DOI 10.1016/S0960-8966(98)00037-6
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Smits P, 2010, EUR J HUM GENET, V18, P324, DOI 10.1038/ejhg.2009.169
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
NR 23
TC 4
Z9 4
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUN 2
PY 2018
VL 500
IS 2
BP 158
EP 162
DI 10.1016/j.bbrc.2018.04.009
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA GF3HR
UT WOS:000431836700009
PM 29625105
DA 2024-11-01
ER

PT J
AU Bacalhau, M
   Simoes, M
   Rocha, MC
   Hardy, SA
   Vincent, AE
   Duraes, J
   Macário, MC
   Santos, MJ
   Rebelo, O
   Lopes, C
   Pratas, J
   Mendes, C
   Zuzarte, M
   Rego, AC
   Girao, H
   Wong, LJC
   Taylor, RW
   Grazina, M
AF Bacalhau, Mafalda
   Simoes, Marta
   Rocha, Mariana C.
   Hardy, Steven A.
   Vincent, Amy E.
   Duraes, Joao
   Macario, Maria C.
   Santos, Maria Joao
   Rebelo, Olinda
   Lopes, Carla
   Pratas, Joao
   Mendes, Candida
   Zuzarte, Monica
   Cristina Rego, A.
   Girao, Henrique
   Wong, Lee-Jun C.
   Taylor, Robert W.
   Grazina, Manuela
TI Disclosing the functional changes of two genetic alterations in a patient with Chronic Progressive External Ophthalmoplegia: Report of the novel mtDNA m.7486G&gt;A variant
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE CPEO; mtDNA common deletion; mt-tRNA variant (m. 7486G > A); Bioenergetic dysfunction; Translation defect
ID mitochondrial-dna deletions; real-time pcr; transfer-rna; point mutation; trna(ile) gene; trna(ala) gene; myopathy; cells; deficiency; defects
AB Chronic Progressive External Ophthalmoplegia (CPEO) is characterized by ptosis and ophthalmoplegia and is usually caused by mitochondrial DNA (mtDNA) deletions or mt-tRNA mutations. The aim of the present work was to clarify the genetic defect in a patient presenting with CPEO and elucidate the underlying pathogenic mechanism. This 62-year-old female first developed ptosis of the right eye at the age of 12 and subsequently the left eye at 45 years, and was found to have external ophthalmoplegia at the age of 55 years. Histopathological abnormalities were detected in the patient's muscle, including ragged-red fibres, a mosaic pattern of COX-deficient muscle fibres and combined deficiency of respiratory chain complexes I and IV. Genetic investigation revealed the "common deletion" in the patient's muscle and fibroblasts. Moreover, a novel, heteroplasmic mt-tRNA(Ser)( UCN) variant (m.7486G>A) in the anticodon loop was detected in muscle homogenate (50%), fibroblasts (11%) and blood (4%). Single-fibre analysis showed segregation with COX-deficient fibres for both genetic alterations. Assembly defects of mtDNA-encoded complexes were demonstrated in fibroblasts. Functional analyses showed significant bioenergetic dysfunction, reduction in respiration rate and ATP production and mitochondria] depolarization. Multilamellar bodies were detected by electron microscopy, suggesting disturbance in autophagy. In conclusion, we report a CPEO patient with two possible genetic origins, both segregating with biochemical and histochemical defect. The "common mtDNA deletion" is the most likely cause, yet the potential pathogenic effect of a novel mt-tRNA(Ser)(UCN) variant cannot be fully excluded. (C) 2017 The Authors. Published by Elsevier B.V.
C1 [Bacalhau, Mafalda; Santos, Maria Joao; Cristina Rego, A.; Girao, Henrique; Grazina, Manuela] Univ Coimbra, FMUC Fac Med, Coimbra, Portugal.
   [Bacalhau, Mafalda; Simoes, Marta; Santos, Maria Joao; Pratas, Joao; Mendes, Candida; Grazina, Manuela] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Lab Biochem Genet, Coimbra, Portugal.
   [Rocha, Mariana C.; Hardy, Steven A.; Vincent, Amy E.; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Sch Med, Wellcome Ctr Mitochondria Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Duraes, Joao; Macario, Maria C.; Rebelo, Olinda] Coimbra Univ Hosp, CHUC Neurol Dept, Coimbra, Portugal.
   [Lopes, Carla] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.
   [Zuzarte, Monica; Girao, Henrique] Univ Coimbra, IBILI Inst Biomed Imaging & Life Sci, Coimbra, Portugal.
   [Wong, Lee-Jun C.] Baylor Coll Med, Mitochondria Diagnost Lab, Houston, TX 77030 USA.
C3 Universidade de Coimbra; Universidade de Coimbra; Newcastle University - UK; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Universidade de Coimbra; Baylor College of Medicine
RP Grazina, M (corresponding author), Univ Coimbra, FMUC Fac Med, Coimbra, Portugal.
EM mgrazina.fmuc@gmail.com
FU Feder funds through Operational Competitiveness Program - COMPETE2020 [POCI-01-0145-FEDER-007440, CENTRO-01-0145-FEDER-000012-N2323]; National Funds by FCT - Portuguese Science and Technology Foundation [UID/NEU/04539/2013]; Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC) Centre for Translational Research in Neuromuscular Disease, Mitochondrial Disease Patient Cohort (UK) [G0800674]; Lily Foundation; UK NIHR Biomedical Research Centre;  [Pest-C/SAU/LA0001/2013e2014];  [FCT-SFRH/BD/86622/2012]; MRC [G0700718, MR/L016354/1, G0800674] Funding Source: UKRI
CR Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014
   Alston CL, 2010, J NEUROL SCI, V298, P140, DOI 10.1016/j.jns.2010.08.014
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Berardo A, 2010, NEUROMUSCULAR DISORD, V20, P204, DOI 10.1016/j.nmd.2010.01.006
   Bidooki S, 2004, NEUROMUSCULAR DISORD, V14, P417, DOI 10.1016/j.nmd.2004.03.004
   Blakely EL, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011296
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023
   Cardaioli E, 2008, J NEUROL SCI, V272, P106, DOI 10.1016/j.jns.2008.05.005
   Cardaioli E, 2007, NEUROMUSCULAR DISORD, V17, P681, DOI 10.1016/j.nmd.2007.05.001
   Chinnery PF, 1997, NEUROLOGY, V49, P1166, DOI 10.1212/WNL.49.4.1166
   DSilva S, 2011, RNA, V17, P1100, DOI 10.1261/rna.2652611
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   Grazina MM, 2012, METHODS MOL BIOL, V837, P73, DOI 10.1007/978-1-61779-504-6_6
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Herrera Alan, 2015, FRONT BIOSCI (SCHOL ED), V7, P109
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Jackson CB, 2014, BRIT J OPHTHALMOL, V98, P1453, DOI 10.1136/bjophthalmol-2014-305300
   Caballero PEJ, 2007, NEUROLOGIST, V13, P33, DOI 10.1097/01.nrl.0000252953.49721.f5
   Kirchner S, 2015, NAT REV GENET, V16, P98, DOI 10.1038/nrg3861
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   LEZZA AMS, 1994, BIOCHEM BIOPH RES CO, V205, P772, DOI 10.1006/bbrc.1994.2732
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Meulemans A, 2007, ARCH NEUROL-CHICAGO, V64, P1339, DOI 10.1001/archneur.64.9.1339
   Moore D, 1997, CURRENT PROTOCOLS IN, V0, P0
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   Noma A, 2011, RNA, V17, P1111, DOI 10.1261/rna.2653411
   Ohno K, 1996, ANN NEUROL, V39, P761, DOI 10.1002/ana.410390612
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Pinós T, 2011, MITOCHONDRION, V11, P228, DOI 10.1016/j.mito.2010.08.008
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Rygiel KA, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep09906
   Sambrook J, 1987, MOLECULAR CLONING - A LABORATORY MANUAL, V2nd, P9.14, DOI 10.1101/PDB.PROT3225
   Schaller A, 2011, MITOCHONDRION, V11, P488, DOI 10.1016/j.mito.2011.01.005
   SEIBEL P, 1994, BIOCHEM BIOPH RES CO, V204, P482, DOI 10.1006/bbrc.1994.2485
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Sievers F, 2011, MOL SYST BIOL, V7, P0, DOI 10.1038/msb.2011.75
   Signorini C, 2014, OXID MED CELL LONGEV, V2014, P0, DOI 10.1155/2014/195935
   Silvestri G, 1996, BIOCHEM BIOPH RES CO, V220, P623, DOI 10.1006/bbrc.1996.0453
   Smits P, 2010, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2010/737385
   Souilem S, 2011, J NEUROL SCI, V300, P187, DOI 10.1016/j.jns.2010.08.065
   Souilem S, 2010, DIAGN MOL PATHOL, V19, P28, DOI 10.1097/PDM.0b013e3181b00f02
   Spagnolo M, 2001, NEUROMUSCULAR DISORD, V11, P481, DOI 10.1016/S0960-8966(01)00195-X
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
   Thomas AC, 2014, AM J HUM GENET, V95, P611, DOI 10.1016/j.ajhg.2014.10.007
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Vincent AE, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep30610
   White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
   Yarham JW, 2012, MITOCHONDRION, V12, P533, DOI 10.1016/j.mito.2012.06.009
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 64
TC 7
Z9 9
U1 0
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD APR 15
PY 2018
VL 28
IS 4
BP 350
EP 360
DI 10.1016/j.nmd.2017.11.006
PG 11
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GG5US
UT WOS:000432761800008
PM 29398297
DA 2024-11-01
ER

PT J
AU Rusecka, J
   Kaliszewska, M
   Bartnik, E
   Tonska, K
AF Rusecka, Joanna
   Kaliszewska, Magdalena
   Bartnik, Ewa
   Tonska, Katarzyna
TI Nuclear genes involved in mitochondrial diseases caused by instability of mitochondrial DNA
SO JOURNAL OF APPLIED GENETICS
LA English
DT Review
DE Mitochondrial diseases; Nuclear genes; Mitochondrial DNA instability; Mitochondrial DNA deletions; Depletion
ID progressive external ophthalmoplegia; multiple mtdna deletions; transcription-factor; binding-protein; polymerase-gamma; copy number; autosomal-dominant; depletion myopathy; thymidine kinase; mpv17 encodes
AB Mitochondrial diseases are defined by a respiratory chain dysfunction and in most of the cases manifest as multisystem disorders with predominant expression in muscles and nerves and may be caused by mutations in mitochondrial (mtDNA) or nuclear (nDNA) genomes. Most of the proteins involved in respiratory chain function are nuclear encoded, although 13 subunits of respiratory chain complexes (together with 2 rRNAs and 22 tRNAs necessary for their translation) encoded by mtDNA are essential for cell function. nDNA encodes not only respiratory chain subunits but also all the proteins responsible for mtDNA maintenance, especially those involved in replication, as well as other proteins necessary for the transcription and copy number control of this multicopy genome. Mutations in these genes can cause secondary instability of the mitochondrial genome in the form of depletion (decreased number of mtDNA molecules in the cell), vast multiple deletions or accumulation of point mutations which in turn leads to mitochondrial diseases inherited in a Mendelian fashion. The list of genes involved in mitochondrial DNA maintenance is long, and still incomplete.
C1 [Rusecka, Joanna; Kaliszewska, Magdalena; Bartnik, Ewa; Tonska, Katarzyna] Univ Warsaw, Inst Genet & Biotechnol, Fac Biol, Pawinskiego 5a, PL-02106 Warsaw, Poland.
   [Bartnik, Ewa] Polish Acad Sci, Inst Biochem & Biophys, Pawinskiego 5a, PL-02106 Warsaw, Poland.
C3 University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences
RP Tonska, K (corresponding author), Univ Warsaw, Inst Genet & Biotechnol, Fac Biol, Pawinskiego 5a, PL-02106 Warsaw, Poland.
EM kaska@igib.uw.edu.pl
FU National Science Center [2014/15/B/NZ5/00434]
CR Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Antonenkov VD, 2015, J BIOL CHEM, V290, P13840, DOI 10.1074/jbc.M114.608083
   Arpa J, 2003, MUSCLE NERVE, V28, P690, DOI 10.1002/mus.10507
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Bronckaers A, 2009, MED RES REV, V29, P903, DOI 10.1002/med.20159
   Cámara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002
   Capps GJ, 2003, J THEOR BIOL, V221, P565, DOI 10.1006/jtbi.2003.3207
   Capt C, 2016, MITOCHONDRIAL DNA A, V27, P3098, DOI 10.3109/19401736.2014.1003924
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Ciesielski GL, 2016, METHODS MOL BIOL, V1351, P211, DOI 10.1007/978-1-4939-3040-1_16
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614
   Dinwiddie GY, 2013, SOC SCI MED, V80, P67, DOI 10.1016/j.socscimed.2012.11.024
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Fahrner JA, 2016, AM J MED GENET A, V170, P2002, DOI 10.1002/ajmg.a.37721
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Filadi R, 2015, P NATL ACAD SCI USA, V112, PE2174, DOI 10.1073/pnas.1504880112
   Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385
   García-Gómez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Holt IJ, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a012971
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Javaid S, 2017, BIOORG CHEM, V70, P44, DOI 10.1016/j.bioorg.2016.11.007
   Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200
   Jüllig M, 2000, EUR J BIOCHEM, V267, P5466, DOI 10.1046/j.1432-1327.2000.01607.x
   Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kawamata H, 2011, HUM MOL GENET, V20, P2964, DOI 10.1093/hmg/ddr200
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kühl I, 2016, SCI ADV, V2, P0, DOI 10.1126/sciadv.1600963
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Linkowska K, 2015, ANN HUM GENET, V79, P320, DOI 10.1111/ahg.12111
   Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918
   Liu YX, 2015, MOL BIOL CELL, V26, P1985, DOI 10.1091/mbc.E15-01-0030
   Lodeiro MF, 2012, P NATL ACAD SCI USA, V109, P6513, DOI 10.1073/pnas.1118710109
   Losón OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721
   MacVicar T, 2016, J CELL SCI, V129, P2297, DOI 10.1242/jcs.159186
   Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Martin-Garcia J, 2013, INTRO MITOCHONDRIA H, V0, P63
   McKinney EA, 2013, GENET MOL BIOL, V36, P308, DOI 10.1590/s1415-47572013000300002
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Minczuk M, 2011, NUCLEIC ACIDS RES, V39, P4284, DOI 10.1093/nar/gkq1224
   Moustafa IM, 2015, BBA-GENE REGUL MECH, V1849, P987, DOI 10.1016/j.bbagrm.2015.05.010
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Oliveira MT, 2015, GENOME BIOL EVOL, V7, P943, DOI 10.1093/gbe/evv042
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Paramasivam A, 2016, MITOCHONDRION, V26, P81, DOI 10.1016/j.mito.2015.12.006
   Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056
   Pfeffer G, 2015, NEUROLOGY, V84, P1174, DOI 10.1212/WNL.0000000000001369
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001
   Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109
   Posse V, 2015, NUCLEIC ACIDS RES, V43, P2615, DOI 10.1093/nar/gkv105
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Ruhanen H, 2010, BBA-MOL CELL RES, V1803, P931, DOI 10.1016/j.bbamcr.2010.04.008
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sánchez-Ferrero E, 2013, CLIN GENET, V83, P257, DOI 10.1111/j.1399-0004.2012.01896.x
   SCHATZ G, 1963, BIOCHEM BIOPH RES CO, V12, P448, DOI 10.1016/0006-291X(63)90313-9
   Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002
   Shokolenko IN, 2015, BBA-MOL BASIS DIS, V1852, P1805, DOI 10.1016/j.bbadis.2015.05.016
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Szymanski MR, 2015, EMBO J, V34, P1959, DOI 10.15252/embj.201591520
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Uhler JP, 2016, NUCLEIC ACIDS RES, V44, P5861, DOI 10.1093/nar/gkw468
   VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x
   Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y
   Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200
   Wong LJC, 2013, MITOCHONDRION, V13, P379, DOI 10.1016/j.mito.2013.02.001
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Yoon G, 2016, J PEDIATR-US, V171, P313, DOI 10.1016/j.jpeds.2015.12.060
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
NR 92
TC 59
Z9 66
U1 0
U2 14
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1234-1983
EI 2190-3883
J9 J APPL GENET
JI J. Appl. Genetics
PD FEB 15
PY 2018
VL 59
IS 1
BP 43
EP 57
DI 10.1007/s13353-017-0424-3
PG 15
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA FV1BN
UT WOS:000424296100005
PM 29344903
DA 2024-11-01
ER

PT J
AU Pacheu-Grau, D
   Callegari, S
   Emperador, S
   Thompson, K
   Aich, A
   Topol, SE
   Spencer, EG
   McFarland, R
   Ruiz-Pesini, E
   Torkamani, A
   Taylor, RW
   Montoya, J
   Rehling, P
AF Pacheu-Grau, David
   Callegari, Sylvie
   Emperador, Sonia
   Thompson, Kyle
   Aich, Abhishek
   Topol, Sarah E.
   Spencer, Emily G.
   McFarland, Robert
   Ruiz-Pesini, Eduardo
   Torkamani, Ali
   Taylor, Robert W.
   Montoya, Julio
   Rehling, Peter
TI Mutations of the mitochondrial carrier translocase channel subunit TIM22 cause early-onset mitochondrial myopathy
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID deafness dystonia syndrome; acylglycerol kinase; inner membrane; import pathway; protein translocase; sengers syndrome; complex; machinery; biogenesis; transport
AB Protein import into mitochondria is facilitated by translocases within the outer and the inner mitochondrial membranes that are dedicated to a highly specific subset of client proteins. The mitochondrial carrier translocase (TIM22 complex) inserts multispanning proteins, such as mitochondrial metabolite carriers and translocase subunits (TIM23, TIM17A/B and TIM22), into the inner mitochondrial membrane. Both types of substrates are essential for mitochondrial metabolic function and biogenesis. Here, we report on a subject, diagnosed at 1.5 years, with a neuromuscular presentation, comprising hypotonia, gastroesophageal reflux disease and persistently elevated serum and Cerebrospinal fluid lactate (CSF). Patient fibroblasts displayed reduced oxidative capacity and altered mitochondrial morphology. Using trans-mitochondrial cybrid cell lines, we excluded a candidate variant in mitochondrial DNA as causative of these effects. Whole-exome sequencing identified compound heterozygous variants in the TIM22 gene (NM_013337), resulting in premature truncation in one allele (p.Tyr25Ter) and a point mutation in a conserved residue (p.Val33Leu), within the intermembrane space region, of the TIM22 protein in the second allele. Although mRNA transcripts of TIM22 were elevated, biochemical analyses revealed lower levels of TIM22 protein and an even greater deficiency of TIM22 complex formation. In agreement with a defect in carrier translocase function, carrier protein amounts in the inner membrane were found to be reduced. This is the first report of pathogenic variants in the TIM22 pore-forming subunit of the carrier translocase affecting the biogenesis of inner mitochondrial membrane proteins critical for metabolite exchange.
C1 [Pacheu-Grau, David; Callegari, Sylvie; Aich, Abhishek; Rehling, Peter] Univ Med Ctr Gottingen, Dept Cellular Biochem, D-37073 Gottingen, Germany.
   [Emperador, Sonia; Ruiz-Pesini, Eduardo; Montoya, Julio] Univ Zaragoza, CIBER Enfermedades Raras CIBERER, IIS Aragon, Dept Bioquim & Biol Mol & Celular, E-50013 Zaragoza, Spain.
   [Rehling, Peter] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany.
   [Thompson, Kyle; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Topol, Sarah E.; Spencer, Emily G.; Torkamani, Ali] Scripps Res Inst, Scripps Translat Sci Inst, La Jolla, CA 92037 USA.
   [Torkamani, Ali] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.
C3 University of Gottingen; UNIVERSITY GOTTINGEN HOSPITAL; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Max Planck Society; Newcastle University - UK; Scripps Research Institute; Scripps Research Institute
RP Rehling, P (corresponding author), Univ Med Ctr Gottingen, Dept Cellular Biochem, D-37073 Gottingen, Germany.; Rehling, P (corresponding author), Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany.
EM Peter.Rehling@medizin.uni-goettingen.de
FU Deutsche Forschungsgemeinschaft [SFB1190]; European Research Council [ERC335080]; Max Planck Society; Copernicus Award of the Foundation for Polish Science and Deutsche Forschungsgemeinschaft; Instituto de Salud Carlos III-FIS [PI17/00021, PI/00166]; Departamento de Ciencia, Tecnologia y Universidad del Gobierno de Aragon; Asociacion de Enfermos con Patologia Mitocondrial; Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council Centre for Translational Research in Neuromuscular Disease, Mitochondrial Disease Patient Cohort (UK) [G0800674]; Lily Foundation; UK NIHR Biomedical Research Centre for ageing and age-related disease award; Newcastle upon Tyne Foundation Hospitals NHS Trust; MRC/EPSRC Molecular Pathology Node; Scripps Translational Science Institute; NIH-NCATS Clinical and Translational Science Award [5 UL1 TR001114]; Shaffer Family Foundation; Anne and Henry Zarrow Foundation; Lavin Family Foundation [NIH-U01 HG006476, U54GM114833]; MRC [G0800674] Funding Source: UKRI
CR Baker MJ, 2009, MOL BIOL CELL, V20, P769, DOI 10.1091/mbc.E08-09-0903
   Bauer MF, 1999, FEBS LETT, V464, P41, DOI 10.1016/S0014-5793(99)01665-8
   Beverly KN, 2008, J MOL BIOL, V382, P1144, DOI 10.1016/j.jmb.2008.07.069
   Bloss CS, 2015, GENET MED, V17, P995, DOI 10.1038/gim.2015.21
   Callegari S, 2016, FEBS LETT, V590, P4147, DOI 10.1002/1873-3468.12450
   Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005
   CHOMYN A, 1994, AM J HUM GENET, V54, P966
   Chomyn A, 1996, METHODS ENZYMOL, V264, P197, DOI 10.1016/S0076-6879(96)64020-8
   Curran SP, 2002, J CELL BIOL, V158, P1017, DOI 10.1083/jcb.200205124
   OCallaghan MD, 2012, NEUROGENETICS, V13, P245, DOI 10.1007/s10048-012-0322-0
   Dudek J, 2013, BBA-MOL CELL RES, V1833, P274, DOI 10.1016/j.bbamcr.2012.05.028
   Ehmke N, 2017, AM J HUM GENET, V101, P833, DOI 10.1016/j.ajhg.2017.09.016
   Emperador S, 2015, FRONT GENET, V5, P0, DOI 10.3389/fgene.2014.00469
   Endo T, 2011, BBA-BIOMEMBRANES, V1808, P955, DOI 10.1016/j.bbamem.2010.07.018
   Gebert N, 2008, EMBO REP, V9, P548, DOI 10.1038/embor.2008.49
   Gómez-Durán A, 2012, BBA-MOL BASIS DIS, V1822, P1216, DOI 10.1016/j.bbadis.2012.04.014
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Hasson SA, 2010, P NATL ACAD SCI USA, V107, P9578, DOI 10.1073/pnas.0914387107
   Jia ZD, 2013, HUM MOL GENET, V22, P4064, DOI 10.1093/hmg/ddt256
   Kang YL, 2018, SEMIN CELL DEV BIOL, V76, P142, DOI 10.1016/j.semcdb.2017.07.028
   Kang YL, 2017, MOL CELL, V67, P457, DOI 10.1016/j.molcel.2017.06.014
   Kang YL, 2016, ELIFE, V5, P0, DOI 10.7554/elife.17463
   Koehler CM, 1999, P NATL ACAD SCI USA, V96, P2141, DOI 10.1073/pnas.96.5.2141
   Kovermann P, 2002, MOL CELL, V9, P363, DOI 10.1016/S1097-2765(02)00446-X
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Morgenstern M, 2017, CELL REP, V19, P2836, DOI 10.1016/j.celrep.2017.06.014
   Mühlenbein N, 2004, J BIOL CHEM, V279, P13540, DOI 10.1074/jbc.M312485200
   Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409
   Pacheu-Grau D, 2015, CELL METAB, V21, P823, DOI 10.1016/j.cmet.2015.04.012
   Pacheu-Grau D, 2011, HUM MOL GENET, V20, P4224, DOI 10.1093/hmg/ddr350
   Paschen SA, 2000, EMBO J, V19, P6392, DOI 10.1093/emboj/19.23.6392
   PFANNER N, 1987, J BIOL CHEM, V262, P7528
   PFANNER N, 1985, EMBO J, V4, P2819, DOI 10.1002/j.1460-2075.1985.tb04009.x
   Pham PH, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0116815
   Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426
   Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945
   Roesch K, 2002, HUM MOL GENET, V11, P477, DOI 10.1093/hmg/11.5.477
   Rorbach J, 2012, NUCLEIC ACIDS RES, V40, P4097, DOI 10.1093/nar/gkr1282
   Salmon P, 2000, MOL THER, V2, P404, DOI 10.1006/mthe.2000.0141
   Sirrenberg C, 1996, NATURE, V384, P582, DOI 10.1038/384582a0
   Stroud DA, 2015, HUM MOL GENET, V24, P5404, DOI 10.1093/hmg/ddv265
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Vögtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045
   Vukotic M, 2017, MOL CELL, V67, P471, DOI 10.1016/j.molcel.2017.06.013
   Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   Wrobel L, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep27484
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
NR 49
TC 27
Z9 27
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD DEC 1
PY 2018
VL 27
IS 23
BP 4135
EP 4144
DI 10.1093/hmg/ddy305
PG 10
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA HD4ZC
UT WOS:000452536200011
PM 30452684
DA 2024-11-01
ER

PT J
AU Garone, C
   Taylor, RW
   Nascimento, A
   Poulton, J
   Fratter, C
   Domínguez-González, C
   Evans, JC
   Loos, M
   Isohanni, P
   Suomalainen, A
   Ram, D
   Hughes, MI
   McFarland, R
   Barca, E
   Gomez, CL
   Jayawant, S
   Thomas, ND
   Manzur, AY
   Kleinsteuber, K
   Martin, MA
   Kerr, T
   Gorman, GS
   Sommerville, EW
   Chinnery, PF
   Hofer, M
   Karch, C
   Ralph, J
   Cámara, Y
   Madruga-Garrido, M
   Domínguez-Carral, J
   Ortez, C
   Emperador, S
   Montoya, J
   Chakrapani, A
   Kriger, JF
   Schoenaker, R
   Levin, B
   Thompson, JLP
   Long, YL
   Rahman, S
   Donati, MA
   DiMauro, S
   Hirano, M
AF Garone, Caterina
   Taylor, Robert W.
   Nascimento, Andres
   Poulton, Joanna
   Fratter, Carl
   Dominguez-Gonzalez, Cristina
   Evans, Julie C.
   Loos, Mariana
   Isohanni, Pirjo
   Suomalainen, Anu
   Ram, Dipak
   Hughes, M. Imelda
   McFarland, Robert
   Barca, Emanuele
   Gomez, Carlos Lopez
   Jayawant, Sandeep
   Thomas, Neil D.
   Manzur, Adnan Y.
   Kleinsteuber, Karin
   Martin, Miguel A.
   Kerr, Timothy
   Gorman, Grainne S.
   Sommerville, Ewen W.
   Chinnery, Patrick F.
   Hofer, Monika
   Karch, Christoph
   Ralph, Jeffrey
   Camara, Yolanda
   Madruga-Garrido, Marcos
   Dominguez-Carral, Jana
   Ortez, Carlos
   Emperador, Sonia
   Montoya, Julio
   Chakrapani, Anupam
   Kriger, Joshua F.
   Schoenaker, Robert
   Levin, Bruce
   Thompson, John L. P.
   Long, Yuelin
   Rahman, Shamima
   Donati, Maria Alice
   DiMauro, Salvatore
   Hirano, Michio
TI Retrospective natural history of thymidine kinase 2 deficiency
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID mitochondrial-dna depletion; spinal muscular-atrophy; tk2 gene; mtdna depletion; myopathic form; mutations; patient; deletions; spectrum; defect
AB Background Thymine kinase 2 (TK2) is a mitochondrial matrix protein encoded in nuclear DNA and phosphorylates the pyrimidine nucleosides: thymidine and deoxycytidine. Autosomal recessive TK2 mutations cause a spectrum of disease from infantile onset to adult onset manifesting primarily as myopathy. Objective To perform a retrospective natural history study of a large cohort of patients with TK2 deficiency. Methods The study was conducted by 42 investigators across 31 academic medical centres. Results We identified 92 patients with genetically confirmed diagnoses of TK2 deficiency: 67 from literature review and 25 unreported cases. Based on clinical and molecular genetics findings, we recognised three phenotypes with divergent survival: (1) infantile-onset myopathy (42.4%) with severe mitochondrial DNA (mtDNA) depletion, frequent neurological involvement and rapid progression to early mortality (median post-onset survival (POS) 1.00, CI 0.58 to 2.33 years); (2) childhood-onset myopathy (40.2%) with mtDNA depletion, moderate-to-severe progression of generalised weakness and median POS at least 13 years; and (3) late-onset myopathy (17.4%) with mild limb weakness at onset and slow progression to respiratory insufficiency with median POS of 23 years. Ophthalmoparesis and facial weakness are frequent in adults. Muscle biopsies show multiple mtDNA deletions often with mtDNA depletion. Conclusions In TK2 deficiency, age at onset, rate of weakness progression and POS are important variables that define three clinical subtypes. Nervous system involvement often complicates the clinical course of the infantile-onset form while extraocular muscle and facial involvement are characteristic of the late-onset form. Our observations provide essential information for planning future clinical trials in this disorder.
C1 [Garone, Caterina; Barca, Emanuele; Gomez, Carlos Lopez; Schoenaker, Robert; DiMauro, Salvatore; Hirano, Michio] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA.
   [Garone, Caterina; Chinnery, Patrick F.] MRC Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge, England.
   [Taylor, Robert W.; McFarland, Robert; Gorman, Grainne S.; Sommerville, Ewen W.] Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Nascimento, Andres; Dominguez-Gonzalez, Cristina; Ortez, Carlos] Hosp Univ 12 Octubre, Neuromuscular Unit, Madrid, Spain.
   [Poulton, Joanna] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.
   [Fratter, Carl; Evans, Julie C.] Oxford Univ Hosp NHS Fdn Trust, Oxford Med Genet Labs, Oxford, England.
   [Dominguez-Gonzalez, Cristina; Martin, Miguel A.] Inst Salud Carlos III, Ctr Biomed Network Res Rare Dis CIBERER, Madrid, Spain.
   [Dominguez-Gonzalez, Cristina; Martin, Miguel A.] Hosp Univ 12 Octubre, Inst Invest, Madrid, Spain.
   [Loos, Mariana] Hosp Pediat Prof Dr JP Garrahan, Neurol Dept, Buenos Aires, DF, Argentina.
   [Isohanni, Pirjo; Suomalainen, Anu] Univ Helsinki, Res Programs Unit, Mol Neurol, Biomed Helsinki, Helsinki, Finland.
   [Isohanni, Pirjo] Univ Helsinki, Helsinki Univ Hosp, Childrens Hosp, Dept Child Neurol, Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Neurosci Ctr, Helsinki, Finland.
   [Suomalainen, Anu] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland.
   [Ram, Dipak; Hughes, M. Imelda] Royal Manchester Childrens Hosp, Dept Paediat Neurol, Manchester, Lancs, England.
   [Barca, Emanuele] Univ Messina, Dept Clin & Expt Med, UOC Neurol & Neuromuscular Dis, Messina, Italy.
   [Jayawant, Sandeep] Oxford Univ Hosp NHS Fdn Trust, Paediat Neurol, Oxford, England.
   [Thomas, Neil D.] Univ Hosp Southampton NHS Fdn Trust, Paediat Neurol, Southampton, Hants, England.
   [Manzur, Adnan Y.] Great Ormond St Hosp Children NHS Fdn Trust, Dubowitz Neuromuscular Ctr, London, England.
   [Kleinsteuber, Karin] Univ Chile, Fac Med, Pediat Neurol, Clin Los Condes, Santiago, Chile.
   [Kerr, Timothy] St Georges Univ Hosp NHS Fdn Trust, Paediat Neurol, London, England.
   [Chinnery, Patrick F.] Newcastle Univ, Inst Genet Med, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Hofer, Monika] Oxford Univ Hosp NHS Fdn Trust, Dept Neuropathol, Oxford, England.
   [Karch, Christoph; Ralph, Jeffrey] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA.
   [Camara, Yolanda] Vall dHebron Inst Rec, Res Grp Neuromuscular & Mitochondrial Disorders, Barcelona, Spain.
   [Camara, Yolanda] Inst Salud Carlos III, Ctr Biomed Network Res Rare Dis CIBERER, Barcelona, Spain.
   [Madruga-Garrido, Marcos] Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Secc Neuropediat, Seville, Spain.
   [Dominguez-Carral, Jana] Univ Barcelona, ISCIII, CIBERER, Hosp Sant Joan de Deu,Dept Neurol,Neuromuscular U, Barcelona, Spain.
   [Emperador, Sonia; Montoya, Julio] Univ Zaragoza, CIBERER Inst Invest Sanitarias Aragon, Dept Biochem & Mol Biol, Zaragoza, Spain.
   [Chakrapani, Anupam; Rahman, Shamima] Great Ormond St Hosp NHS Fdn Trust, Metab Unit, London, England.
   [Kriger, Joshua F.; Levin, Bruce; Thompson, John L. P.; Long, Yuelin] Columbia Univ, Med Ctr, Dept Biostat, Mailman Sch Publ Hlth, New York, NY 10032 USA.
   [Rahman, Shamima] UCL Great Ormond St Inst Child Hlth, Mitochondrial Res Grp, Genet & Genom Med, London, England.
   [Donati, Maria Alice] Meyer Hosp, Metab & Neuromuscular Unit, Florence, Italy.
C3 Columbia University; Newcastle University - UK; Hospital Universitario 12 de Octubre; University of Oxford; Oxford University Hospitals NHS Foundation Trust; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de Octubre; Hospital de Pediatria Doctor Juan Garrahan; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Royal Manchester Children's Hospital; University of Messina; Oxford University Hospitals NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Clinica Las Condes; Universidad de Chile; Newcastle University - UK; Oxford University Hospitals NHS Foundation Trust; University of California System; University of California San Francisco; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Instituto de Salud Carlos III; University of Zaragoza; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Columbia University; University of London; University College London; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER
RP Hirano, M (corresponding author), Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA.
EM mh29@columbia.edu
FU NIH [P01 HD080642]; NINDS, NICHD, ODS [U54 NS078059]; National Center for Advancing Translational Science (NCATS); Muscular Dystrophy Association (MIH); Associarione Maalattie Metaboliche Congenite eredit arie (AMMeC); Arturo Estopinan TK2 Research Fund; Marriott Mitochondrial Disease Clinic Research Fund (MMDCRF); Wellcome Trust Strategic Award [096919/Z/11/Z]; MRC Centre for Nleuromuscular Diseases [G0601943]; Lily Foundation; UK NHS Highly Specialised 'Rare Mitochondrial Disorders of Adults and Children' Service; Medical Research Council Project Grant [MR/101044811]; Wellcome Trust Project Grant [0948685/Z/10/Z]; Great Ormond Street Hospital Children's Charity Research Leadership award [V1260]; Wellcome Trust Senior Fellow in Clinical Science [101876/Z/13/Z]; K NIHR Senior Investigator; Medical Research Council Mitochondrial Biology Unit [MC_UP_150112]; Wellcome Trust Centre for Mitochondrial Research [096919Z/11/Z]; Medical Research Council (UK) Centre for Translational Muscle Disease research [G0601943]; EU FP7 TIRCON; National Institute for Health Research (NIHR) Biomedical Research Centre based at Cambridge University Hospitals NHS Foundation Trust; University of Cambridge; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; Academy of Finland; European Research Council; University of Helsinki; Spanish Instituto Salud Carlos III (ISCIII) [FIS-P112/01683]; ISCIII [FIS-P114/00005]; Departamento de Ciencia, Tecnologia y Universidad del Gobierno de Aragon (Grupos Consolidados B33); European Union; European Union, and CIBERER; ISCIII; 'Biobanc de l'Hospital Infantil Sant Joan de Deu per a la Investigacia' integrated in the Spanish Biobank Network of ISCIII; Spanish Ministry of Economy and Competitiveness [BFU2014-52618-R]; AFM-Telethon [19965]; MRC [G0200335, G0800674] Funding Source: UKRI
CR Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Cámara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   Carrozzo R, 2003, HUM MUTAT, V21, P0, DOI 10.1002/humu.9135
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Collins J, 2009, NEUROMUSCULAR DISORD, V19, P784, DOI 10.1016/j.nmd.2009.08.002
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Knierim E, 2015, MITOCHONDRION, V20, P1, DOI 10.1016/j.mito.2014.10.007
   Leshinsky-Silver E, 2008, EUR J PAEDIATR NEURO, V12, P309, DOI 10.1016/j.ejpn.2007.09.005
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Martí R, 2010, PEDIATR RES, V68, P151, DOI 10.1203/00006450-201011001-00294
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Piepers S, 2008, J NEUROL, V255, P1400, DOI 10.1007/s00415-008-0929-0
   Roos S, 2014, NEUROMUSCULAR DISORD, V24, P713, DOI 10.1016/j.nmd.2014.05.009
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Stewart JD, 2011, BBA-MOL BASIS DIS, V1812, P321, DOI 10.1016/j.bbadis.2010.11.012
   Tawil R, 2015, NEUROLOGY, V85, P357, DOI 10.1212/WNL.0000000000001783
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tizzano EF, 2017, NEUROMUSCULAR DISORD, V27, P883, DOI 10.1016/j.nmd.2017.05.011
   Tulinius M, 2005, NEUROMUSCULAR DISORD, V15, P412, DOI 10.1016/j.nmd.2005.03.010
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Vilà MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
NR 32
TC 64
Z9 68
U1 0
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD AUG 15
PY 2018
VL 55
IS 8
BP 515
EP 521
DI 10.1136/jmedgenet-2017-105012
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA GR2ZW
UT WOS:000442457100002
PM 29602790
DA 2024-11-01
ER

